Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,neutrophil chemotaxis (GO:0030593),0.8109301137381094,2.001984737971426,0.0,0.0,0.0,12/53,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,B cell receptor signaling pathway (GO:0050853),0.8544740806684672,1.9939608262235051,0.0,0.0,0.0,13/32,6.13%,NCKAP1L;PTPRC;BTK;BLNK;SYK;RFTN1;PIK3CD;PLCG2;TEC;LAT2;VAV3;NFAM1;PRKCB
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7931267742057379,-1.9864177880180836,0.0,0.3023510054787258,0.255,3/12,2.24%,FOXP1;SMARCA4;NCOR1
prerank,regulation of immune response (GO:0050776),0.77584272011991,1.9834760169246404,0.0,0.0,0.0,33/135,6.56%,SLAMF7;CD300LB;CD22;CD226;LILRB1;TREM2;ITGAL;TREML2;FGR;LYN;SLAMF6;KLRK1;IRF4;NCR1;TREML4;CD3E;SYK;ITGB2;FCGR2B;ADCY7;PDCD1;TREML1;ITGA4;CD300A;CD200R1;CRTAM;FCGR1A;LAIR1;CD300LF;TRAF3;SAMHD1;TYROBP;RAET1E
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5970836196132893,-1.982833481247742,0.0,0.15999040085827623,0.269,10/25,13.87%,CDH5;BMPR1A;FOXD1;BMP4;SULF1;ZNF423;ACVRL1;SMAD4;CCN1;UBE2O
prerank,regulation of T cell proliferation (GO:0042129),0.808345289820126,1.9799293703853056,0.0,0.0,0.0,19/61,11.69%,NCKAP1L;PTPRC;CD86;LILRB1;GPNMB;LGALS3;CD3E;PDCD1LG2;NCK2;TNFSF8;CCDC88B;ANXA1;AIF1;CD80;CEBPB;PNP;CD274;TNFRSF21;TNFRSF1B
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.8948771026692621,1.9716254167768261,0.0,0.0,0.0,9/22,2.44%,CD22;LGALS3;FCGR2B;DGKZ;CD300A;LAPTM5;PTPRJ;THY1;DUSP3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8847517038709971,1.962821672553462,0.0,0.0,0.0,7/23,2.20%,ARRB2;CD226;LILRB1;SLAMF6;KLRK1;NCR1;CRTAM
prerank,positive regulation of interleukin-12 production (GO:0032735),0.85114730943245,1.9582200192094823,0.0,0.0,0.0,9/31,5.85%,IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;MDK;MAPK14;HMGB1
prerank,neutrophil migration (GO:1990266),0.7932839088792466,1.9572805147077827,0.0,0.00012802378657142134,0.001,12/58,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of immunoglobulin production (GO:0002637),0.8668372096418338,1.9558248871427995,0.0,0.00011379892139681896,0.001,5/23,1.94%,PTPRC;CD86;CD22;FCGR2B;VAMP3
prerank,positive regulation of T cell proliferation (GO:0042102),0.8108388345355035,1.9537346907395226,0.0,0.00020483805851427412,0.002,17/55,9.75%,NCKAP1L;PTPRC;CD86;CD3E;SYK;CCR2;PDCD1LG2;NCK2;PYCARD;CCDC88B;IL18;HMGB1;ANXA1;AIF1;CD80;PNP;CD274
prerank,negative regulation of T cell activation (GO:0050868),0.8379247302213425,1.9495584256999867,0.0,0.0001862164168311583,0.002,15/35,10.63%,NCKAP1L;CD86;LILRB1;GPNMB;LGALS3;FCGR2B;PDCD1LG2;LAPTM5;HAVCR2;DUSP3;RIPOR2;CD80;CEBPB;CD274;TNFRSF21
prerank,regulation of interleukin-2 production (GO:0032663),0.8130446876375861,1.9474369678150008,0.0,0.00017069838209522845,0.002,18/43,8.56%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;LAPTM5;HAVCR2;PLCG2;PRKD2;TRAF2;TNFAIP3;ANXA1;CD80;MALT1;PNP;TRIM27
prerank,granulocyte chemotaxis (GO:0071621),0.7870523488986106,1.9413529856741554,0.0,0.0001575677373186724,0.002,12/55,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,positive regulation of T cell activation (GO:0050870),0.7977228268699348,1.9393596262498516,0.0,0.00014631289893876723,0.002,19/62,8.29%,NCKAP1L;PTPRC;CD86;DOCK8;CD3E;CCR2;PDCD1LG2;SIRPA;CYRIB;THY1;MDK;NCK2;PYCARD;CCDC88B;ANXA1;AIF1;CD80;PRKCQ;PNP
prerank,positive regulation of leukocyte migration (GO:0002687),0.8365062486812962,1.9368293277379518,0.0,0.00013655870567618275,0.002,8/27,6.51%,NCKAP1L;LGALS3;ADAM8;THY1;MDK;TNF;IL6R;AIF1
prerank,dendritic cell differentiation (GO:0097028),0.8729049881527841,1.9322065003739544,0.0,0.00025604757314284267,0.004,6/22,1.15%,BATF3;LILRB1;TREM2;LYN;IRF8;FLT3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.8074364122149965,1.9302825475834642,0.0,0.00024098595119326368,0.004,13/48,5.10%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;CYRIB;CRTAM;TLR8;TLR7;IL12RB2;PYCARD;IL18;CD14
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.7708245324768142,1.9212143792920557,0.0,0.0006258940676825042,0.01,17/63,9.75%,NCKAP1L;PTPRC;CD86;CD3E;PDCD1LG2;CD74;NCK2;CCDC88B;VAV3;IL18;ANXA1;AIF1;CD80;MEF2C;PNP;GPR183;CD274
prerank,T cell activation (GO:0042110),0.7769752687116349,1.9207616738840545,0.0,0.000592952274646583,0.01,18/69,6.22%,PTPRC;TREML2;PIK3CG;IRF4;CD3E;LCP1;CD7;CD74;LAT;PIK3CD;CRTAM;LFNG;MDK;NCK2;NLRC3;CTPS1;CD44;CHD7
prerank,positive regulation of interleukin-2 production (GO:0032743),0.8511120706718691,1.919801834608995,0.0,0.0005633046609142538,0.01,14/25,8.29%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;PLCG2;PRKD2;TRAF2;ANXA1;CD80;MALT1;PNP
prerank,B cell activation (GO:0042113),0.7726158818268957,1.9197293780778504,0.0,0.0005364806294421466,0.01,22/68,9.96%,PTPRC;CD86;CD22;BTK;BLNK;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LAT2;CTPS1;NFAM1;HDAC5;ADGRG3;PRKCB;KLF6;MALT1;MEF2C;GPR183;HDAC4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.8250355451886813,1.9179267966711537,0.0,0.000558649250493475,0.011,13/31,10.63%,CD86;LILRB1;GPNMB;LYN;FCGR2B;PDCD1LG2;CD300A;TYROBP;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,regulation of interferon-gamma production (GO:0032649),0.7769246774162026,1.917363574443762,0.0,0.0005343601526459326,0.011,21/71,5.85%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;PDCD1LG2;SIRPA;VSIR;LAPTM5;CYRIB;HAVCR2;CRTAM;TLR8;TLR7;IL12RB2;NR1H4;PYCARD;DDIT3;IL18;CD14;HMGB1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.8323745653712855,1.9162216457520576,0.0,0.0005547697418094924,0.011,11/33,4.09%,CD226;LGALS3;CARD11;DGKZ;CD300A;LAPTM5;KCNN4;PTPRJ;THY1;DUSP3;PRKD2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.9702230519852585,1.9147433138804784,0.0,0.0006145141755428225,0.013,5/10,1.05%,ARRB2;PTPRC;LILRB1;CX3CR1;FCGR2B
prerank,regulation of phagocytosis (GO:0050764),0.7976591459146903,1.9120372254654727,0.0,0.0007090548179340258,0.015,14/53,4.78%,PTPRC;DOCK2;TREM2;FGR;HCK;SLC11A1;SYK;FCGR2B;SIRPA;TLR2;CAMK1D;TNF;FCER1G;PYCARD
prerank,positive regulation of phagocytosis (GO:0050766),0.7993597517739208,1.9027135597135756,0.0,0.0010621232663703105,0.021,14/47,5.11%,NCKAP1L;PTPRC;DOCK2;TREM2;SLC11A1;FCGR2B;STAP1;SIRPA;PTPRJ;CAMK1D;TNF;FCER1G;PYCARD;CD300LF
prerank,regulation of B cell proliferation (GO:0030888),0.794168950787174,1.9007175367200944,0.0,0.0010607685173060627,0.022,14/44,11.78%,NCKAP1L;PTPRC;CD22;LYN;FCGR2B;CD74;CD300A;VAV3;TYROBP;MEF2C;RC3H1;GPR183;TNFRSF21;SASH3
prerank,T cell activation involved in immune response (GO:0002286),0.9366009906653955,1.8989861566476742,0.0,0.0010595071992117629,0.023,7/12,3.89%,LILRB1;ITGAL;SLC11A1;LCP1;CD74;MDK;FCER1G
prerank,regulation of interleukin-6 production (GO:0032675),0.7521369254752254,1.8968016344645122,0.0,0.0011607489982475535,0.027,26/96,6.55%,NCKAP1L;SLAMF1;TREM2;SCIMP;SYK;CD74;IL1A;SIRPA;POU2F2;LPL;CD200R1;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;NLRC3;TNF;IL6R;PYCARD;TNFAIP3;RAB7B;HMGB1;AIF1;TYROBP
prerank,regulation of B cell activation (GO:0050864),0.853254920374877,1.8958018255481637,0.0,0.0011233054821750518,0.027,8/25,7.56%,THEMIS2;CD22;FCGR2B;LAPTM5;SLAMF8;TNFAIP3;SAMSN1;SH3KBP1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.8918881492533992,1.8909002443179956,0.0,0.0013762557056427795,0.033,6/17,2.44%,LGALS3;DGKZ;LAPTM5;PTPRJ;THY1;DUSP3
prerank,regulation of interleukin-17 production (GO:0032660),0.8393317562022496,1.8874373550717363,0.0,0.0014897313346492664,0.038,10/31,5.08%,NCKAP1L;SLAMF6;LY9;TGFB1;RFTN1;VSIR;OSM;NR1H4;DDIT3;IL18
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8989206277099319,1.8826168408000084,0.0,0.001686901658352846,0.045,3/16,1.91%,PTPRC;LILRB1;CYRIB
prerank,ethanol metabolic process (GO:0006067),-0.7293781578334696,-1.8789595811662572,0.0036101083032490976,0.3766899796148946,0.691,7/12,21.57%,ALDH2;ALDH1A1;ACSS2;SULT1A1;ADH5;ACSS1;ADH1A
prerank,regulation of myeloid cell differentiation (GO:0045637),0.7454092348391002,1.8780402464872865,0.0,0.001931330265991728,0.053,22/62,12.44%,RUNX1;NFE2;PTK2B;PF4;LYN;LGALS3;ITGA2B;GP1BA;GATA1;SPI1;PRKCB;TNRC6A;LEO1;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3;CDK6
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.7552989091881196,1.8776261207250577,0.0,0.0019345816637459225,0.054,32/71,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,toll-like receptor signaling pathway (GO:0002224),0.7459463956533057,1.8767767771551567,0.0,0.0019099764915520155,0.055,30/84,9.31%,CTSS;BTK;SCIMP;RFTN1;ITGB2;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PIK3AP1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;NR1H4;UBE2D3;CD14;TRAF3;HMGB1;TICAM1;CNPY3;MAP3K1;LY96;ITGAM
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7525903877337133,1.876114242333297,0.0,0.0018597139523006468,0.055,32/73,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.7527726742560177,1.873870887100659,0.0,0.0019958580060365173,0.06,31/70,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.8281127391941897,1.869997514100927,0.0,0.0022020091290284468,0.067,9/30,3.16%,PTPRC;PLD4;MEOX1;SHH;TGFB1;PLEK;FLT3;CSF1R;SP7
prerank,regulation of T cell activation (GO:0050863),0.7907131218037589,1.8698073887669262,0.0,0.002173281840334372,0.068,17/42,12.01%,GPNMB;LGALS3;CCR2;LAT;SIRPA;LAPTM5;CYRIB;CRTAM;THY1;DUSP3;TNFSF8;PYCARD;CCDC88B;PRKCQ;CCL2;TNFRSF1B;METTL3
prerank,T cell proliferation (GO:0042098),0.9024606378173783,1.8681303466004195,0.0,0.0022434644503944315,0.073,6/13,4.13%,LILRB1;DOCK8;PIK3CG;SLC11A1;CRTAM;CTPS1
prerank,regulation of interleukin-12 production (GO:0032655),0.7761743191764316,1.8677611603973294,0.0,0.0022389276163188106,0.074,11/47,3.06%,SLAMF1;LILRB1;IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;TLR8;MDK;MAPK14
prerank,mononuclear cell differentiation (GO:1903131),0.8320790267960394,1.8592804428518928,0.0,0.0027001380440517956,0.093,8/24,2.01%,BATF3;LILRB1;TREM2;LYN;IRF8;IKZF1;FLT3;CSF1R
prerank,lymphocyte proliferation (GO:0046651),0.8342273440259814,1.8555412650467953,0.0,0.0028449730349204747,0.101,6/22,8.10%,PTPRC;PIK3CG;FLT3;ELF4;CTPS1;MEF2C
prerank,regulation of B cell differentiation (GO:0045577),0.8550994869159112,1.8539352618800833,0.0012804097311139564,0.0030057758586333706,0.107,4/17,1.96%,NCKAP1L;BTK;SYK;SLAMF8
prerank,positive regulation of interleukin-6 production (GO:0032755),0.7456595801454688,1.8519198398467924,0.0,0.0031815272918174495,0.117,19/68,6.55%,SCIMP;SYK;CD74;IL1A;POU2F2;LPL;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;TNF;IL6R;PYCARD;RAB7B;HMGB1;AIF1;TYROBP
prerank,regulation of mast cell degranulation (GO:0043304),0.9153714297742188,1.8505534878116994,0.0,0.0032219319620474373,0.12,6/14,1.54%,CD84;FGR;LYN;SYK;UNC13D;CD300A
prerank,regulation of interleukin-4 production (GO:0032673),0.8380030780434897,1.84353983659671,0.0,0.0039504482713467156,0.146,8/21,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;DDIT3;CEBPB;PRKCQ
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.7385231313079692,1.8384357653967547,0.0,0.0045269210931654594,0.163,18/73,6.55%,PTPRC;CD86;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;ADAM8;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9391800105824073,1.8368142363331599,0.0,0.004759472536066958,0.175,3/10,0.52%,LILRB1;FGR;LYN
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.8052657502589061,1.836298540779361,0.0,0.004687640185230504,0.175,9/29,6.56%,CD226;SLAMF6;KLRK1;STAP1;CYRIB;CRTAM;SPI1;TYROBP;RAET1E
prerank,negative regulation of lymphocyte activation (GO:0051250),0.8269874617531732,1.8352655020047346,0.0,0.004676491524571165,0.177,7/21,5.42%,GPNMB;LGALS3;FCGR2B;LAPTM5;DUSP3;TNFAIP3;SAMSN1
prerank,natural killer cell mediated immunity (GO:0002228),0.8806789796810357,1.8329707763438177,0.0,0.004950253080761626,0.187,5/15,1.19%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST
prerank,positive regulation of lymphocyte activation (GO:0051251),0.8088415867067985,1.8327256536241043,0.0,0.004860248479293232,0.187,13/28,12.25%,NCKAP1L;CCR2;SIRPA;CYRIB;THY1;PYCARD;CCDC88B;TYROBP;TICAM1;SH3KBP1;PRKCQ;CCL2;NOD2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.7864688268682577,1.8310114472211874,0.0,0.00504779501338747,0.197,5/33,0.95%,NCKAP1L;FERMT3;LYN;PIK3CG;SYK
prerank,regulation of cytokine production (GO:0001817),0.713740713268195,1.8279134663994436,0.0,0.0053545387225661135,0.209,27/126,6.34%,CLEC9A;PTPRC;PLD4;TREM2;GPNMB;FGR;LYN;PIK3CG;IRF8;SLC11A1;FCGR2B;CCR2;IL1A;SIRPA;SRGN;PIK3CD;CRTAM;MAPK14;TNF;RGCC;CCDC88B;TRAF3;NFAM1;PPP1R11;BTN3A3;PLD3;ANXA1
prerank,homotypic cell-cell adhesion (GO:0034109),0.7760954658069488,1.8273958499541794,0.0,0.005315194449379011,0.212,18/39,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,negative regulation of T cell proliferation (GO:0042130),0.8079437840113448,1.8267541406739023,0.0,0.005329261352871369,0.215,10/28,10.63%,CD86;LILRB1;GPNMB;PDCD1LG2;CRTAM;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,defense response to fungus (GO:0050832),0.8678879258289895,1.8264325365747534,0.0,0.005325789521371128,0.217,3/17,2.02%,CLEC4D;CX3CR1;PLCG2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.8953160441886037,1.8262413078467554,0.0,0.00525527150122687,0.217,4/14,3.73%,SLC6A3;SLC6A4;DAGLB;ALDH9A1
prerank,platelet aggregation (GO:0070527),0.7923371430427159,1.8226811767892144,0.0,0.005781719393548061,0.241,18/33,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,organophosphate catabolic process (GO:0046434),0.90842398683363,1.82184984970345,0.0,0.00585251595755069,0.246,3/11,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,negative regulation of organelle assembly (GO:1902116),-0.4842205939204987,-1.820471181553718,0.0,0.5467440558255968,0.894,23/35,27.04%,MTM1;FEZ1;TRIM37;SMAD4;CCP110;TMEM39A;EVI5L;CEP97;CDK5RAP2;PINK1;RBM14;CHMP4B;CHMP4A;NUPR1;CDK10;TBC1D7;PHF23;KAT2B;SMCR8;FEZ2;KAT2A;TESK1;STYXL1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.824559332579595,1.8203072599850403,0.0,0.006017117968856804,0.253,7/22,3.81%,BTK;LILRB1;SCIMP;CCR2;LAPTM5;FFAR2;TNF
prerank,myeloid dendritic cell activation (GO:0001773),0.9092530053601587,1.819945243396064,0.0,0.006003330791841419,0.254,6/12,6.68%,DOCK2;BATF3;SLAMF1;PYCARD;HMGB1;TGFBR2
prerank,embryonic organ morphogenesis (GO:0048562),-0.49050400139527683,-1.819814221043821,0.0,0.4402160120585296,0.894,23/42,26.10%,RYR2;NIPBL;EFEMP1;HOXC4;ACVR1;HOXB9;DSCAML1;HOXA3;MFAP5;PDGFRA;FBN1;SIX1;HES1;TBX1;HOXC9;SOX17;FUZ;RBP4;FOXE1;HOXD4;FGFR2;HOXD3;MFAP2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.8694495836831775,1.8174773064116312,0.0013245033112582781,0.006455502450146821,0.278,6/16,1.76%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST;CORO1A
prerank,natural killer cell activation (GO:0030101),0.8197604467634478,1.8142594184000034,0.0,0.006894176447010273,0.299,7/23,2.82%,SLAMF7;PTPRC;KLRK1;NCR1;PIK3CD;IL21R;ELF4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.74422612810124,1.8093378812871583,0.0010845986984815619,0.007636242328436544,0.328,12/45,5.81%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;TRIM25;PRKCD;FCGR1A;TRIM5;CD44;IFNGR2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.7480985232898827,1.8083501639628135,0.0,0.0077333788757925235,0.339,16/49,11.72%,RUNX1;NFE2;PF4;ITGA2B;GP1BA;GATA1;RAB7B;TNRC6A;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.778594639999344,1.8075137097491758,0.0,0.007798477513436294,0.343,7/33,3.90%,RUNX1;PF4;HCLS1;CD74;ACIN1;TNF;OCSTAMP
prerank,regulation of interleukin-10 production (GO:0032653),0.7509401392485091,1.80715747158562,0.0,0.007731915448144432,0.344,13/44,12.25%,LILRB1;IRF4;SYK;FCGR2B;PDCD1LG2;VSIR;PLCG2;PYCARD;HMGB1;TYROBP;CD274;TNFRSF21;NOD2
prerank,neuron fate commitment (GO:0048663),0.881303252442772,1.8045754375659027,0.00130718954248366,0.008136622879872556,0.361,4/14,5.19%,ASCL1;SHH;TGFBR1;MYT1L
prerank,superoxide anion generation (GO:0042554),0.8738082858090309,1.802353224450966,0.0,0.00868457248084491,0.38,4/13,2.52%,CYBB;NCF4;ALOX12;NCF2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5509797301999013,-1.8018576106204673,0.0056179775280898875,0.43721894669809913,0.932,11/24,13.22%,ZFPM2;PARVA;BMPR1A;ROBO2;BMP4;ACVR1;ROBO1;SEMA3C;SMAD4;TBX1;SMAD6
prerank,inflammatory response (GO:0006954),0.6964634732332857,1.7980555114227121,0.0,0.00977132900750524,0.42,54/195,14.08%,ITGAL;BLNK;PF4;CIITA;PIK3CG;CYBB;SLC11A1;TGFB1;ITGB2;CXCL5;FCGR2B;CCR2;TMIGD3;NRROS;LAT;IL1A;PIK3CD;IL10RB;TLR1;CSF1R;ADAM8;CXCL2;TLR2;ADGRE5;CCL8;TNF;CXCR4;IL18;CD14;NFAM1;HDAC5;CD44;HMGB1;ANXA1;AIF1;CEBPB;CCL14;HDAC4;NFX1;F11R;CMKLR1;CCL13;THBS1;CCL2;TACR1;TPST1;HDAC9;LTB4R2;IKBKG;ITCH;NFKB1;ADCY8;C3AR1;SIGLEC1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.8478544884078371,1.7980366974241262,0.0,0.009641044620738504,0.42,7/17,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;CEBPB;PRKCQ
prerank,positive regulation of cytokine production (GO:0001819),0.6944647283525461,1.7963327328862133,0.0,0.009972379164510716,0.432,71/292,8.85%,CLEC9A;PTPRC;CD86;RUNX1;CD226;LILRB1;IRF5;SCIMP;FGR;SLAMF6;PIK3CG;LY9;CARD11;IRF4;HPSE;SLC11A1;TGFB1;SYK;RFTN1;CCR2;CD74;IL1A;POU2F2;LPL;PIK3CD;LAPTM5;TLR1;CYRIB;HAVCR2;CSF1R;PLCG2;CRTAM;TLR2;DHX9;TLR8;TLR7;MDK;MAPK14;OSM;IL12RB2;FFAR2;NR1H4;TNF;FCER1G;RGCC;PRKD2;TRAF2;IL6R;PYCARD;LRRFIP1;DDIT3;CCDC88B;IL18;CD14;RAB7B;NFAM1;HMGB1;XRCC5;CTNNB1;ANXA1;AIF1;TYROBP;CD80;TICAM1;CEBPB;MALT1;PRKCQ;PNP;TRIM27;LURAP1;SULF2
prerank,negative regulation of B cell activation (GO:0050869),0.8220825442574436,1.7950447145320843,0.0,0.010255204098344505,0.447,10/21,10.63%,LYN;FCGR2B;CD300A;LAPTM5;TNFAIP3;SAMSN1;TYROBP;RC3H1;INHBA;TNFRSF21
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.7632617878254018,1.7947965867784095,0.0,0.010215641636160597,0.45,6/34,3.52%,PTPRC;CD86;SCIMP;LAPTM5;VAMP3;FFAR2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.7368369147860668,1.7920440193276965,0.0,0.010864195761706438,0.47,21/56,8.92%,CTSS;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;FFAR2;CD14;TRAF3;HMGB1;CNPY3;LY96
prerank,vasculature development (GO:0001944),-0.631748762390299,-1.791155211824809,0.008438818565400843,0.4164409725606607,0.955,11/16,25.06%,ERRFI1;CDH5;ACVRL1;PDGFRA;FBXW7;STRA6;NOTCH4;FLT4;BMPR2;SOX18;ACVR2B
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.5009552691139351,-1.7872278521644105,0.007142857142857143,0.3805832262840813,0.958,18/30,28.67%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP
prerank,innate immune response (GO:0045087),0.6966463959477344,1.787221610917636,0.0,0.011893409772485044,0.512,56/217,13.13%,CD300LB;SLA;CLEC4D;PTK2B;BTK;TREM2;IRF5;FGR;LYN;CIITA;PIK3CG;HCK;CYBB;SLC11A1;CX3CR1;SYK;CLEC5A;NRROS;TREML1;CD74;PIK3CD;CORO1A;NLRC5;PLCG2;TRIM25;TLR2;NCF2;S100B;TLR8;MASP1;TRIM5;SNCA;FCER1G;GCH1;OTULIN;DMBT1;HMGB1;TYROBP;KYNU;CAPZA1;MALT1;TRIM27;ADAR;SETD2;TRIM8;TRIM56;YES1;MID2;TRIM35;NOD2;DEFA6;FYN;ALPK1;IKBKG;RNF135;B2M
prerank,cholesterol biosynthetic process (GO:0006695),-0.503294788434183,-1.7864938358293987,0.007462686567164179,0.3408427272646472,0.958,20/31,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,positive regulation of immune system process (GO:0002684),0.8537214204157945,1.7863960712382774,0.0,0.01196153107126564,0.519,4/16,6.34%,NCKAP1L;PIK3CD;PIK3CB;ANXA1
prerank,B cell differentiation (GO:0030183),0.7489961047741358,1.785683448520706,0.0,0.012040481000473188,0.525,12/46,6.73%,PTPRC;BLNK;FLT3;ITGA4;TPD52;PLCG2;PTPRJ;FNIP1;NFAM1;HDAC5;ADGRG3;KLF6
prerank,negative regulation of interleukin-6 production (GO:0032715),0.7896114848420629,1.7841686358530267,0.0,0.012389000647489833,0.539,7/27,5.09%,NCKAP1L;SLAMF1;SIRPA;CD200R1;NLRC3;TNF;TNFAIP3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7947679126317246,1.7837237136991893,0.0,0.012363439960325833,0.542,5/25,5.57%,CD22;TREM2;PLEK;PLCG2;P2RX4
prerank,negative regulation of immune response (GO:0050777),0.6902167192514382,1.7820187388045576,0.0,0.013037339959555567,0.561,41/154,13.49%,TSHB;LILRB1;TREM2;FGR;LYN;LGALS3;CALCR;HCK;SYK;FCGR2B;CCR2;ADCY7;PDCD1;CD300A;PRKAR2B;HAVCR2;PLCG2;CYSLTR2;MAPK14;FCGR1A;NLRC3;ADCY6;RHBDF2;TRAFD1;SPI1;TNFAIP3;MYH9;SAMSN1;RAMP1;PLK2;TRIM27;RC3H1;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ITCH;ADCY3;ADCY8
prerank,negative regulation of cytokine production (GO:0001818),0.6893097630429877,1.7814361627376685,0.0,0.013088199203906237,0.568,51/163,13.54%,NCKAP1L;CD84;PTPRC;SLAMF1;LILRB1;TREM2;GPNMB;SLC11A1;FCGR2B;ADCY7;PDCD1LG2;SIRPA;VSIR;SRGN;CD200R1;NLRC5;LAPTM5;HAVCR2;TRIM25;TLR8;NLRC3;NR1H4;TNF;RGCC;PYCARD;DDIT3;TNFAIP3;HMGB1;PPP1R11;ANXA1;TYROBP;ABCD1;TAX1BP1;TMSB4X;ATP2B1;TRIM27;CD274;ANXA4;INHBA;TNFRSF21;CMKLR1;THBS1;RPS6KA4;HDAC9;RNF216;NLRX1;RNF135;ITCH;NPTN;GAS6;GPATCH3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.7024274369183061,1.7794362884353259,0.0,0.013644098265404813,0.58,34/101,13.46%,CD86;LILRB1;PF4;LYN;HCK;TGFB1;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;CXCL2;MAPK14;TNF;PYCARD;CD68;IL18;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,positive regulation of chemokine production (GO:0032722),0.7410573536715827,1.7777076992575676,0.0,0.014070977996804401,0.591,13/44,6.51%,SYK;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;HMGB1;AIF1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.8249404120642975,1.7756799030049752,0.0,0.014522788193540111,0.603,6/20,6.62%,MRAP;PLEK;GRK3;SNCA;MGRN1;YWHAB
prerank,positive regulation of immune response (GO:0050778),0.7261445645218104,1.7749534464309757,0.0,0.014554882046653147,0.606,10/64,4.78%,PTPRC;CD226;LILRB1;ITGB2;FCGR2B;CD74;ADAM8;DHX9;TLR8;PYCARD
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8492595027080292,1.7746062410208832,0.002677376171352075,0.014507486671697769,0.609,6/14,7.53%,LILRB1;CD74;LAPTM5;PLCG2;GPRC5B;TICAM1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.8336335302177237,1.7745450841118853,0.0012919896640826874,0.014360929102359438,0.609,4/18,2.20%,NCKAP1L;CCR2;SLAMF8;CRTAM
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.854182900280066,1.7709731380471825,0.0013513513513513514,0.015781340744674993,0.655,7/13,3.89%,SYK;ITGB2;LPL;ABCA1;CD9;SREBF2;FCER1G
prerank,negative regulation of interleukin-17 production (GO:0032700),0.9111734045985467,1.7689283669004428,0.0,0.016278088267038592,0.673,3/10,4.84%,NCKAP1L;VSIR;DDIT3
prerank,cellular lipid catabolic process (GO:0044242),0.7746418988727892,1.7686586247028149,0.0,0.016246892325316377,0.676,7/27,7.03%,PLBD1;LPIN2;ABHD12;ANGPTL3;CEL;NUDT19;ACADL
prerank,regulation of lymphocyte activation (GO:0051249),0.8900261232228156,1.7678982102676168,0.0013679890560875513,0.01641905062778479,0.684,3/12,2.20%,THEMIS2;LAT;CRTAM
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.9113007001844279,1.767545366330849,0.0,0.01635536869271189,0.686,4/10,1.54%,NCKAP1L;TREM2;STAP1;CD300A
prerank,negative regulation of interleukin-10 production (GO:0032693),0.842747506298633,1.767408433348517,0.0,0.016261633624908706,0.686,7/16,10.63%,LILRB1;FCGR2B;PDCD1LG2;VSIR;TYROBP;CD274;TNFRSF21
prerank,integrin-mediated signaling pathway (GO:0007229),0.7101420962320056,1.7667293163522346,0.0,0.01639739003763255,0.693,17/73,3.11%,PTK2B;FERMT3;FGR;FYB1;ITGA2B;HCK;PLEK;SYK;ITGB2;LAT;ITGB3;ITGB5;THY1;ITGA2;TEC;ANGPTL3;CCM2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8762843776833898,1.7631623011197757,0.0,0.01781066918781614,0.732,4/12,1.54%,PTPRC;RUNX1;LYN;CD300A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.695006910963947,1.7595565729300122,0.0,0.019053995641005995,0.763,29/121,7.60%,PTPRC;PTK2B;TREM2;LYN;TGFB1;CASS4;HCLS1;FLT3;GATA1;CD74;ITGB3;CSF1R;PLCG2;GPRC5B;PTPRJ;ANGPT4;PTPN1;TEC;OSM;FCGR1A;SEMA4D;TNF;IL6R;IL18;CD44;TP53;CD80;NEDD9;EPO
prerank,regulation of interferon-alpha production (GO:0032647),0.7797979807393706,1.7593132146812827,0.001184834123222749,0.01895756149387008,0.766,6/23,3.58%,IRF5;HAVCR2;DHX9;TLR8;TLR7;NLRC3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.6937180641805332,1.7589746622184417,0.0,0.01891271782981308,0.769,32/95,13.46%,CD86;LILRB1;PF4;CX3CR1;CXCL5;FCGR2B;STAP1;PDCD1LG2;IL1A;SIRPA;CYRIB;CXCL2;TLR2;MAPK14;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,phagosome maturation (GO:0090382),0.7656527705385814,1.7573595353486138,0.0,0.019548247411097796,0.779,16/35,10.51%,ATP6V0D2;CORO1A;SLAMF8;ATP6V0E1;RAB39A;RAB34;TCIRG1;RAB32;ATP6V1C1;ATP6V1E1;RAB14;ATP6V0A2;RAB7A;ATP6V0D1;RAB31;ATP6V0A1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8915663645044063,1.756211147152153,0.002824858757062147,0.01982052070957167,0.783,4/11,5.09%,TREM2;LYN;TLR1;TNFAIP3
prerank,regulation of microglial cell activation (GO:1903978),0.8612183812534286,1.7555446946544813,0.0,0.019894413324570308,0.786,4/15,3.45%,PTPRC;TREM2;STAP1;CST7
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.6840714803165844,1.7549022082965298,0.0,0.02003392787244747,0.792,55/163,15.61%,NCKAP1L;THEMIS2;PTPRC;LCP2;GRAP2;BTK;BLNK;INPP5D;FYB1;CARD11;CD3E;SYK;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;LAT2;PRKD2;VAV3;NFAM1;BTN3A3;PRKCB;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;MEF2C;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;BMX;PSMD8;PLEKHA1;PAG1;ICOSLG;PSMD7;PSMB9
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8229305258003673,1.754122503339303,0.0012953367875647669,0.0202087917913851,0.805,5/16,6.56%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,B cell homeostasis (GO:0001782),0.8946794244870652,1.7538145238984826,0.0014619883040935672,0.020154937408858625,0.81,6/10,8.10%,NCKAP1L;LYN;TNFAIP3;DOCK11;DOCK10;MEF2C
prerank,immunoglobulin mediated immune response (GO:0016064),0.8939980255180395,1.7530217368634697,0.0014064697609001407,0.02044656256806118,0.819,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7318050786255624,1.7525737843746705,0.0,0.02045612503270927,0.823,11/42,11.55%,PTK2B;PF4;CXCL5;CCR2;CXCL2;CCL8;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,myeloid cell differentiation (GO:0030099),0.7185636780562521,1.7514559271587893,0.0,0.02084044354259066,0.832,15/47,12.56%,RUNX1;LYN;IKZF1;HCLS1;GATA1;ACIN1;CEBPA;SPI1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;PRDX3;RPS14
prerank,positive regulation of interleukin-17 production (GO:0032740),0.8079835063771482,1.750649079776478,0.0,0.0210366873367978,0.834,8/22,8.09%,SLAMF6;LY9;TGFB1;RFTN1;OSM;NR1H4;IL18;PRKCQ
prerank,regulation of macrophage cytokine production (GO:0010935),0.8628646965205446,1.7503296607348242,0.0,0.0210498057499537,0.837,6/13,2.16%,LILRB1;TGFB1;CD74;LAPTM5;PLCG2;GPRC5B
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8206301580868028,1.7502350812211467,0.0,0.02091129397354416,0.837,5/17,6.56%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.7070314758192171,1.749092735257587,0.0,0.021243119344195847,0.842,16/69,6.55%,PTPRC;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,B cell proliferation (GO:0042100),0.8292718153803206,1.749043103644459,0.0013192612137203166,0.021096569274333364,0.842,4/17,8.10%,PTPRC;CTPS1;CD180;MEF2C
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6956454296261967,1.748128234634065,0.0,0.021317045411485477,0.846,15/72,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;TNF;IL18
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6033439568729563,-1.7447060109205896,0.008733624454148471,0.4586391491270584,0.993,5/16,20.47%,CLDN5;CLDN11;CLDN14;CLDN12;CLDN1
prerank,T cell differentiation (GO:0030217),0.7366514582061794,1.7443313528085618,0.0010893246187363835,0.02275595910553533,0.866,8/40,6.34%,PTPRC;SHH;PIK3CD;LFNG;FCER1G;SPI1;CHD7;ANXA1
prerank,positive regulation of neutrophil migration (GO:1902624),0.8171989173771482,1.7443055049230516,0.0025906735751295338,0.022583395951198723,0.866,6/18,5.96%,NCKAP1L;CD74;ADAM8;CAMK1D;MDK;RIPOR2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.8131450919478908,1.7441874820254613,0.0013157894736842105,0.022489864523653983,0.866,7/18,6.55%,DOCK2;SLAMF1;SYK;PLCG2;FCER1G;PYCARD;TYROBP
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.7369593461793508,1.7439317679765436,0.0,0.022431446407792648,0.867,11/37,7.53%,PLD4;TREM2;ADCY7;SIRPA;MAPK14;NLRC3;TNF;PYCARD;PLD3;ABCD1;TICAM1
prerank,positive regulation of B cell activation (GO:0050871),0.7150091762637023,1.7416495678625543,0.0,0.02328992071806605,0.877,12/50,12.25%,NCKAP1L;PTPRC;BTK;SYK;CD74;MAD2L2;VAV3;SH3KBP1;MEF2C;GPR183;SASH3;NOD2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8583498716525519,1.7411036709691192,0.00425531914893617,0.023391184746468726,0.881,2/11,0.35%,PTPRC;LILRB1
prerank,sterol biosynthetic process (GO:0016126),-0.48368924728350193,-1.7409782170452812,0.015151515151515152,0.4307279762650812,0.994,20/33,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,positive regulation of immune effector process (GO:0002699),0.7765061880138069,1.7388541198138214,0.0,0.02443308361958262,0.893,4/27,2.35%,PTPRC;LILRB1;CCR2;PTPRJ
prerank,positive regulation of B cell proliferation (GO:0030890),0.7573592752075601,1.7378491216375525,0.0,0.024816293358892023,0.899,7/29,11.78%,NCKAP1L;PTPRC;CD74;VAV3;MEF2C;GPR183;SASH3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.6851603045464437,1.737605936250305,0.0,0.024693469888610528,0.9,24/112,6.55%,PTPRC;SLAMF1;LILRB1;PF4;CX3CR1;SYK;CCR2;IL1A;SIRPA;VSIR;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;NLRC3;NR1H4;PYCARD;TNFAIP3;CD14;HMGB1;TYROBP
prerank,cholesterol efflux (GO:0033344),0.7812726079552597,1.7370362147735328,0.0025031289111389237,0.024876622028159313,0.903,6/20,5.56%,ABCA1;NPC2;ABCG1;APOE;NPC1;SOAT2
prerank,cellular response to chemokine (GO:1990869),0.7154427856309271,1.7347364817475515,0.002185792349726776,0.02619227732707715,0.924,13/46,11.55%,PTK2B;DOCK8;PF4;CXCL5;CCR2;CXCL2;CCL8;RIPOR2;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7867110075464017,1.732949253829857,0.0036231884057971015,0.02703862372388419,0.934,6/24,3.56%,ITGAL;FERMT3;SYK;ITGB2;ITGA4;SEMA4D
prerank,regulation of mast cell activation (GO:0033003),0.8922581326116114,1.7317415450459857,0.0,0.02746549998323073,0.935,4/10,5.11%,CD84;CD226;LYN;CD300LF
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.8538071309612705,1.7308392065520766,0.0026490066225165563,0.027893667437833922,0.938,3/14,6.74%,CD84;IL18;CD80
prerank,positive regulation of immunoglobulin production (GO:0002639),0.7439106831927454,1.7295832030095293,0.0,0.028377001715229333,0.94,4/31,2.40%,PTPRC;CD86;VAMP3;MAD2L2
prerank,neutrophil activation (GO:0042119),0.8759385109032006,1.7285688932691814,0.0,0.028753760303384307,0.942,5/12,6.55%,PREX1;SYK;PRKCD;FCER1G;TYROBP
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8694937749245388,1.7281207388660562,0.0,0.02879871370815499,0.942,6/11,9.31%,ITGB2;STAP1;SPI1;TYROBP;TICAM1;ITGAM
prerank,cortical actin cytoskeleton organization (GO:0030866),0.7820227783109122,1.7276547527253918,0.0025252525252525255,0.02887312927734291,0.942,6/20,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.8628933526771173,1.7269567668719492,0.004149377593360996,0.029118402843543712,0.945,6/12,9.45%,PTK2B;FCGR2B;LFNG;DOCK11;DOCK10;GPR183
prerank,plasma membrane invagination (GO:0099024),0.7583134347576348,1.726374247552102,0.0035335689045936395,0.02924879668857806,0.948,11/29,6.51%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;SNX9;SNX33;MYH9;AIF1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8749392782005949,1.7254284412974765,0.0,0.02973835986200038,0.957,3/12,5.08%,SLC11A1;CCR2;IL18
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.8044516067709593,1.7248697698310707,0.0,0.02985514702845546,0.958,6/18,8.71%,RUNX1;TGFB1;RGCC;COLGALT1;RB1;SMAD3
prerank,peptidyl-tyrosine modification (GO:0018212),0.7115216150269325,1.7247697872690597,0.0,0.029730573528330643,0.958,9/56,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6725378999030214,1.7221788569950207,0.0,0.03128829217728596,0.964,27/116,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;FCGR2B;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY3;ADCY8
prerank,catecholamine biosynthetic process (GO:0042423),0.8519284009642987,1.7213425384669485,0.0014367816091954023,0.031599493502271946,0.966,3/11,4.50%,SNCA;GCH1;DDC
prerank,arachidonic acid metabolic process (GO:0019369),0.7421607436391497,1.7209771830977496,0.0011248593925759281,0.03159342555279186,0.967,6/35,3.21%,TBXAS1;CYP1A1;ALOX12;DAGLB;PTGES3;HPGDS
prerank,lymphocyte differentiation (GO:0030098),0.6963322387958246,1.7200938946963285,0.0,0.0320112441788514,0.969,15/68,6.73%,PTPRC;BLNK;IKZF1;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LFNG;NFAM1;HDAC5;ADGRG3;CHD7;KLF6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7714158893262026,1.7200619652126783,0.001182033096926714,0.0318060190857438,0.969,11/27,8.09%,ITGB2;CCR2;SIRPA;CYRIB;THY1;MDK;TNF;PYCARD;CCDC88B;CD44;PRKCQ
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.7941759814077602,1.7195208672203757,0.002506265664160401,0.031951950215866026,0.969,4/19,3.02%,NCKAP1L;BTK;SYK;MDK
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7993604569461658,1.7173746936474232,0.00510204081632653,0.03308549857286299,0.971,5/19,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,regulation of mononuclear cell migration (GO:0071675),0.7729578446299684,1.7130416690396701,0.002430133657351154,0.03577792263646969,0.972,10/23,11.24%,LYN;LGALS3;CSF1R;MDK;TNF;AIF1;STK10;AKIRIN1;CMKLR1;THBS1
prerank,defense response to protozoan (GO:0042832),0.866821798588577,1.7125805773503493,0.004322766570605188,0.03588762785170083,0.975,4/12,1.19%,PF4;IRF4;SLC11A1;LYST
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7866931872590716,1.7125572753921028,0.003703703703703704,0.035656744159256265,0.975,7/20,7.53%,LYN;HCK;TGFB1;TNF;IL18;CD14;TICAM1
prerank,regulation of tissue remodeling (GO:0034103),0.8044655524781787,1.7111638407111733,0.0024968789013732834,0.03639918395046411,0.979,5/18,5.08%,RUNX1;GPNMB;TGFB1;MDK;IL18
prerank,regulation of platelet activation (GO:0010543),0.7806463437480002,1.7105138693798032,0.0,0.036609782418776646,0.98,8/21,10.99%,LYN;PLEK;SYK;TEC;FCER1G;APOE;PRKCQ;TXK
prerank,superoxide metabolic process (GO:0006801),0.7482695581291644,1.7104956015980348,0.0011876484560570072,0.03637870714522985,0.98,8/29,4.06%,CYBB;PREX1;NRROS;NCF4;SH3PXD2B;ALOX12;NCF2;ATP7A
prerank,response to thyroid hormone (GO:0097066),0.84687876087801,1.7096690141115554,0.004054054054054054,0.03672548158781728,0.983,6/13,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,monocyte chemotaxis (GO:0002548),0.7308046765776012,1.7093705586309849,0.002306805074971165,0.0366476295713679,0.984,9/32,11.55%,LGALS3;TNFRSF11A;CCL8;IL6R;ANXA1;CCL14;CCL13;PTPRO;CCL2
prerank,defense response to bacterium (GO:0042742),0.6756428332294238,1.709291460955541,0.0,0.036485963734724056,0.984,19/105,7.68%,TREM2;FGR;SLC11A1;SYK;LYST;AQP1;MPEG1;SLAMF8;PRKCD;TLR2;FCER1G;IL6R;PYCARD;DMBT1;STAB2;PPP1R11;STAB1;EPX;CEBPB
prerank,positive regulation of calcium ion import (GO:0090280),0.8419032389336998,1.7086498978776539,0.0027624309392265192,0.03673472397469594,0.984,2/12,0.54%,LGALS3;CALCR
prerank,regulation of osteoclast differentiation (GO:0045670),0.7346811822707462,1.7083347991256868,0.0011547344110854503,0.036684048529521736,0.984,8/33,7.68%,LILRB3;UBASH3B;MTOR;TNF;OCSTAMP;GPR137B;TMEM178A;CEBPB
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8486792033846184,1.7079894431174965,0.006811989100817439,0.0366596112847265,0.984,5/13,8.29%,NCKAP1L;RUNX1;SHH;TGFBR2;PNP
prerank,muscle organ development (GO:0007517),-0.420131214646875,-1.707413656642918,0.0,0.532787133803984,0.998,21/54,18.19%,SGCD;UTRN;TCF12;FHL1;CHD2;MRAS;DMD;VAMP5;COL6A3;MKX;SRI;TEAD4;EVC;SGCE;ITGA11;TBX1;MAPK12;EMD;MEF2B;TAGLN;HBEGF
prerank,positive regulation of interleukin-8 production (GO:0032757),0.7163106671809919,1.7067096333922762,0.001092896174863388,0.037386126394049354,0.986,13/49,5.85%,SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.8510017832681389,1.704832262945847,0.004092769440654843,0.03859047867812128,0.987,6/12,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,activation of phospholipase C activity (GO:0007202),0.7460346073761385,1.704581921797882,0.001152073732718894,0.03849824492383306,0.987,7/29,7.66%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12
prerank,cellular response to interferon-gamma (GO:0071346),0.6763979161796349,1.7043521470608385,0.0,0.038450851410743475,0.987,24/88,11.55%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;SIRPA;TRIM25;PRKCD;TLR2;FCGR1A;CCL8;TRIM5;CASP1;CD44;IFNGR2;AIF1;IRF2;CCL14;EPRS1;TRIM8;CCL13;GBP3;CCL2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.680569992086204,1.7032027781473225,0.0010570824524312897,0.03909303310675451,0.988,23/67,11.24%,NCKAP1L;VAV1;PTK2B;CYBB;MAPKAPK3;NCF4;ITGB3;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;NCK2;PRKD2;VAV3;SHC2;VEGFB;WASF2;PDCD6;ABI1;BCAR1;CYFIP1;NRP1
prerank,T cell differentiation in thymus (GO:0033077),0.8392253802898417,1.7013601888687198,0.0013245033112582781,0.040227233178104435,0.99,2/14,0.68%,PTPRC;SHH
prerank,neutrophil activation involved in immune response (GO:0002283),0.6590850416132126,1.7009879296544614,0.0,0.04019486932642374,0.991,126/428,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;SYK;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7645618445798867,1.7006402592644465,0.0036991368680641184,0.0401994689834263,0.991,8/21,6.13%,RUNX1;CD22;LYN;FCGR2B;STAP1;CD300A;NFAM1;PRKCB
prerank,negative regulation of interferon-gamma production (GO:0032689),0.776808862386389,1.7000798441596117,0.004889975550122249,0.04042218491982866,0.991,10/23,10.55%,LILRB1;PDCD1LG2;VSIR;LAPTM5;HAVCR2;NR1H4;DDIT3;HMGB1;CD274;INHBA
prerank,B cell mediated immunity (GO:0019724),0.8798920607922067,1.6989116957675043,0.002857142857142857,0.040955562405295166,0.991,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.8548577865748981,1.6979260463421622,0.004178272980501393,0.041404839137695236,0.991,5/11,8.10%,LYN;PIK3CD;PIK3CB;ANXA1;MEF2C
prerank,receptor metabolic process (GO:0043112),0.6967609532133057,1.6973446119826812,0.0,0.04155711658055579,0.992,29/53,18.52%,ARRB2;LILRB1;TGFB1;SYK;ITGB2;LGMN;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;DNM2;RAMP1;RAB31;UVRAG;ARFGEF2;CLTC;BECN1;SNX25;GRK4;LRP1;AP2M1;CD36;SMURF1;PIK3R4;ADM;PICALM;ITGB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8614819650197632,1.696820207864267,0.001455604075691412,0.0417668353415666,0.993,3/11,5.57%,TREM2;PLCG2;P2RX4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.8031300877009149,1.6961245006516885,0.00784313725490196,0.042074208110920455,0.993,5/17,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,neutrophil degranulation (GO:0043312),0.6568347011866174,1.6948613442025047,0.0,0.042857974357143704,0.994,125/425,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.8501653049636991,1.6944625938502127,0.002789400278940028,0.04296361892076381,0.994,4/12,5.08%,TREM2;STAP1;TNF;IL18
prerank,regulation of chemokine production (GO:0032642),0.7204133206800736,1.6932179551244197,0.0,0.04364670834387485,0.995,12/36,6.51%,TREM2;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;AIF1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7876316627890219,1.6917957607741652,0.0025284450063211127,0.044408430775650785,0.995,7/19,9.31%,SCIMP;ITGB2;PIK3AP1;NR1H4;CD14;LY96;ITGAM
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8210390541415487,1.69141549309783,0.0013550135501355014,0.04439493005620819,0.995,5/14,6.68%,SYK;RASAL3;CCR2;IL18;TGFBR2
prerank,erythrocyte differentiation (GO:0030218),0.7046665761123835,1.6913709169043625,0.002197802197802198,0.04417105134017529,0.995,13/44,12.56%,NCKAP1L;LYN;IKZF1;HCLS1;GATA1;ACIN1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;SH2B3;RPS14
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.8266737619296711,1.691007984016517,0.0026560424966799467,0.0441986208578728,0.995,5/13,9.31%,FGR;SYK;ITGB2;GAB2;ITGAM
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6606407611395122,1.6908240839745683,0.0,0.04412459386841823,0.995,26/117,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY3;ADCY8
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7882143780068841,1.690329677546609,0.0013315579227696406,0.04429203265251272,0.995,5/17,9.61%,NCKAP1L;CD3E;SYK;P2RY12;PODXL
prerank,neutrophil mediated immunity (GO:0002446),0.6535062603252809,1.6866214856532584,0.0,0.04704039218761225,0.997,125/432,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,positive regulation of macrophage migration (GO:1905523),0.7811856275217586,1.6854780987217688,0.005037783375314861,0.047860135563672974,0.997,8/19,11.24%,TREM2;CSF1R;MDK;P2RX4;P2RY12;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.7320382841602708,1.6845683419013813,0.004667444574095682,0.048318654931794505,0.997,5/29,1.24%,PTK2B;FGR;TGFB1;FLT3;DGKZ
prerank,hyaluronan catabolic process (GO:0030214),0.7887409738412208,1.6841726997777309,0.010376134889753566,0.04831220626081316,0.998,7/18,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6781361983253484,1.6833825157092437,0.0,0.048785234414769285,1.0,24/86,8.95%,PTPRC;PTK2B;TREM2;TGFB1;ITGB2;HCLS1;GATA1;CD74;ITGB3;PLCG2;PRKCD;PTPRJ;ANGPT4;TEC;OSM;SEMA4D;PDCL3;IL6R;SAMSN1;CD44;TP53;CD80;RAP2B;NTF3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.8483541036511114,1.6829378963159145,0.0028735632183908046,0.048922698208118176,1.0,3/11,5.06%,ARRB2;GRK3;SAG
prerank,presynapse organization (GO:0099172),-0.6732846413602257,-1.681525777485763,0.01639344262295082,0.6094484945599434,0.999,4/10,17.63%,NLGN1;WNT5A;LRRTM3;FZD1
prerank,pinocytosis (GO:0006907),0.8596652434713243,1.6799136835161157,0.001451378809869376,0.05136583841006627,1.0,6/10,4.90%,DOCK2;MAPKAPK3;SNX5;RAB34;PYCARD;SNX33
prerank,microglial cell activation (GO:0001774),0.774314552024908,1.6781575171625243,0.0048484848484848485,0.05270558317112044,1.0,10/21,11.64%,TREM2;CX3CR1;ITGB2;TNF;SNCA;AIF1;TYROBP;C1QA;ITGAM;GRN
prerank,intracellular pH reduction (GO:0051452),0.7303285923779418,1.6779854566559926,0.002232142857142857,0.052564433036449414,1.0,11/33,7.43%,ATP6V0D2;SLC11A1;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1
prerank,positive regulation of bone resorption (GO:0045780),0.8475075392654181,1.6778286624157397,0.002857142857142857,0.05242474559747447,1.0,6/11,11.02%,SYK;ADAM8;TNFRSF11A;SPP1;PLEKHM1;ATP6AP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7652906440075783,1.6774664276802174,0.0024390243902439024,0.05254518547403532,1.0,8/21,6.13%,PTPRC;CD226;CARD11;STAP1;KCNN4;PRKD2;NFAM1;PRKCB
prerank,vitamin D metabolic process (GO:0042359),0.8264056182426299,1.6760092072528177,0.002577319587628866,0.05372534616775668,1.0,2/13,1.26%,CYP1A1;LGMN
prerank,regulation of macrophage chemotaxis (GO:0010758),0.7618340307507716,1.6748211034392606,0.007453416149068323,0.05457471130416019,1.0,8/21,11.24%,PTK2B;STAP1;SLAMF8;CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,negative regulation of B cell proliferation (GO:0030889),0.8498168758129351,1.6743843259469526,0.002962962962962963,0.05470839821689611,1.0,6/11,10.63%,LYN;FCGR2B;CD300A;TYROBP;RC3H1;TNFRSF21
prerank,dendritic cell chemotaxis (GO:0002407),0.824338891695018,1.6734137405553182,0.001375515818431912,0.055363175259552436,1.0,5/14,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,vesicle transport along actin filament (GO:0030050),0.7754084426532533,1.672864436493363,0.005044136191677175,0.055707717220062895,1.0,7/19,8.48%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,positive regulation of T cell differentiation (GO:0045582),0.7119087432794425,1.672316195582712,0.0011299435028248588,0.056002725197802555,1.0,7/36,8.91%,NCKAP1L;SHH;VSIR;ADAM8;MDK;PNP;DUSP10
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.83588619495345,1.6711103360258133,0.00860832137733142,0.056850204448849674,1.0,2/11,0.65%,PF4;CIITA
prerank,dendritic cell migration (GO:0036336),0.8013321952587984,1.6699389027773661,0.00267379679144385,0.05782618953849744,1.0,5/16,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,prostaglandin metabolic process (GO:0006693),0.7449556344521098,1.6677786192844606,0.004629629629629629,0.05966034586037665,1.0,6/26,4.51%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS;HPGD
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.7031112646550102,1.6674805725821673,0.0011049723756906078,0.059669125623582064,1.0,8/41,5.09%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3
prerank,T cell homeostasis (GO:0043029),0.8491707362775766,1.6653800852842864,0.0070921985815602835,0.061446421504074575,1.0,1/10,0.04%,NCKAP1L
prerank,regulation of superoxide anion generation (GO:0032928),0.8155839570257448,1.663837544685645,0.006535947712418301,0.06288826704240422,1.0,6/14,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,macrophage migration (GO:1905517),0.8276002924844986,1.6632454965831494,0.007112375533428165,0.06320293138795502,1.0,6/13,11.55%,LGALS3;CCR2;EDNRB;P2RX4;P2RY12;CCL2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5979330668478164,-1.662897969739137,0.02109704641350211,0.6614951402664501,0.999,10/15,33.00%,RAI2;STOX2;RICTOR;UBR3;USP22;TGFB2;CELF4;SCEL;NR5A2;BRCA1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7389109169370595,1.6616710316534924,0.0023094688221709007,0.06469140415289745,1.0,8/29,8.34%,LGALS3;CCR2;LGMN;CREB3;TNF;HMGB1;AIF1;PLA2G7
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.7757179706560647,1.6616059701080765,0.00510204081632653,0.06444068108762452,1.0,5/18,4.50%,PTK2B;LYN;CAMK1D;MDK;IL6R
prerank,receptor internalization (GO:0031623),0.692399347380151,1.6607524333349553,0.0011123470522803114,0.0650116980951256,1.0,15/44,9.24%,ARRB2;LILRB1;SYK;ITGB2;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;SAG;DNM2;RAMP1;RAB31;SCYL2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7685800864448727,1.6605008716295677,0.007614213197969543,0.06504821853435516,1.0,1/17,0.08%,PLBD1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.8305312054882742,1.6601476265242732,0.005277044854881266,0.06507473226856776,1.0,6/13,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,T cell receptor signaling pathway (GO:0050852),0.6498519826723708,1.6574224304268481,0.0,0.06775042827385265,1.0,44/138,15.61%,THEMIS2;PTPRC;LCP2;GRAP2;INPP5D;FYB1;CARD11;CD3E;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;PRKD2;BTN3A3;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;PAG1;ICOSLG;PSMD7;PSMB9
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.8136808495253867,1.6573077972510162,0.002631578947368421,0.06758698743781728,1.0,4/14,3.45%,PTPRC;TREM2;CD200R1;CST7
prerank,myeloid leukocyte differentiation (GO:0002573),0.6691587090068788,1.6557139903529279,0.0010638297872340426,0.06900184366463398,1.0,15/65,6.68%,RUNX1;BATF3;TREM2;PIK3CD;CBFA2T3;CSF1R;TNFRSF11A;MAPK14;CEBPA;SPI1;MYH9;EFNA2;TYROBP;GAB2;TGFBR2
prerank,phagosome acidification (GO:0090383),0.7458915658174073,1.654565730920278,0.005841121495327103,0.07007168585009128,1.0,11/26,10.51%,ATP6V0D2;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1;ATP6V0A1
prerank,triglyceride catabolic process (GO:0019433),0.7546000654301726,1.6538291300812624,0.008905852417302799,0.0705133777466188,1.0,4/19,8.57%,LPL;FABP4;FABP5;LIPC
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5986249217769767,-1.6523117350194176,0.023972602739726026,0.6720478325859491,1.0,10/13,23.07%,MTM1;FEZ1;TMEM39A;PINK1;CHMP4B;CHMP4A;NUPR1;PHF23;SMCR8;FEZ2
prerank,hyaluronan metabolic process (GO:0030212),0.746556421090531,1.6521580056614285,0.011166253101736972,0.07199869831952412,1.0,7/23,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,mesoderm development (GO:0007498),0.7812789905775837,1.6518634113684818,0.005121638924455826,0.07194118388413423,1.0,4/18,2.20%,BTK;HCK;IKZF1;HES7
prerank,regulation of T cell differentiation (GO:0045580),0.7174439017878367,1.651160253782617,0.0034562211981566822,0.07238232122227123,1.0,4/33,3.02%,RUNX1;CCR2;CRTAM;MDK
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.8088730187334735,1.6490436197393727,0.0013175230566534915,0.07459905492996088,1.0,4/14,4.09%,CD226;CARD11;KCNN4;PRKD2
prerank,negative regulation of leukocyte activation (GO:0002695),0.8042163053103297,1.6488439848447365,0.0,0.07452599092881948,1.0,5/15,5.11%,CD84;FCGR2B;CD300A;HAVCR2;CD300LF
prerank,regulation of chemotaxis (GO:0050920),0.7204531937331325,1.6481512923472814,0.0011614401858304297,0.07497715931043779,1.0,12/30,13.68%,TREM2;TGFB1;CYRIB;DUSP3;CXCR4;P2RX4;AIF1;P2RY12;GPR183;THBS1;STX3;ZSWIM6
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7887610151115895,1.6476134104508575,0.01455026455026455,0.07529627561636311,1.0,3/14,7.31%,PTK2B;CCR2;WNK1
prerank,negative regulation of phagocytosis (GO:0050765),0.7884849279279738,1.6474231123318361,0.007692307692307693,0.07519832725901798,1.0,6/17,5.85%,FCGR2B;SIRPA;CD300A;TLR2;CD300LF;HMGB1
prerank,phagolysosome assembly (GO:0001845),0.8411682145966393,1.646137404827159,0.0027359781121751026,0.07635202676655954,1.0,7/12,5.43%,CORO1A;RAB39A;RAB34;CLN3;RAB14;RAB7A;RAB7B
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6980236891479965,1.6447971434092525,0.001098901098901099,0.0777166422446778,1.0,7/42,5.05%,TREM2;SLC11A1;AQP1;MPEG1;IL6R;PYCARD;DMBT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.824781544559044,1.6439851782157344,0.01078167115902965,0.07836852563245672,1.0,3/12,8.09%,SLC11A1;CCR2;PRKCQ
prerank,regulation of cholesterol storage (GO:0010885),0.7825422492255489,1.6420064184950278,0.013297872340425532,0.0803117252563498,1.0,6/15,4.11%,TREM2;LPL;ABCA1;MSR1;SREBF2;ABCG1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8386451042236331,1.641931513834679,0.012875536480686695,0.08006496287144889,1.0,4/11,9.75%,RUNX1;VSIR;HMGB1;CD274
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7775238042801746,1.6387339551728972,0.016304347826086956,0.08357570136350796,1.0,6/16,7.24%,TREM2;ADCY7;SIRPA;NLRC3;PYCARD;ABCD1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6739124387299705,1.638107454836939,0.0021436227224008574,0.08397918937752236,1.0,9/49,7.60%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO
prerank,negative regulation of type I interferon production (GO:0032480),0.6918998930210231,1.6363889434121122,0.002280501710376283,0.08586494924930968,1.0,15/40,13.54%,LILRB1;SIRPA;NLRC5;HAVCR2;TRIM25;NLRC3;PYCARD;TNFAIP3;YY1;TAX1BP1;RNF216;NLRX1;RNF135;ITCH;GPATCH3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.688220655071244,1.6358115323802707,0.0022099447513812156,0.08629459747152626,1.0,10/43,9.75%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3;TRIM27;CD274
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7485563969566,1.6350897176721675,0.008706467661691543,0.08681211250097505,1.0,4/19,2.91%,IRF5;DHX9;TLR8;TLR7
prerank,negative regulation of inflammatory response (GO:0050728),0.6304027229204288,1.6330146873850357,0.0,0.08913059418996107,1.0,42/182,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;SIRPA;CD200R1;METRNL;PRKAR2B;SLAMF8;PLCG2;CYSLTR2;PRKCD;MDK;MAPK14;FCGR1A;NLRC3;NR1H4;APOE;OTULIN;ADCY6;RHBDF2;TNFAIP3;MYH9;RAMP1;PLK2;RB1;CYSLTR1;YES1;PRKACB;GRN;TNFRSF1B;IAPP;FYN;CREB1;GPS2;FNDC4;ADCY3;ADCY8
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.8649163184937485,1.6317195550849004,0.001440922190201729,0.09040532034005518,1.0,4/10,5.85%,NCKAP1L;RUNX1;IRF4;HMGB1
prerank,prostaglandin biosynthetic process (GO:0001516),0.7717311072596122,1.6303935897397854,0.006188118811881188,0.09189310717465989,1.0,5/18,3.21%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS
prerank,regulation of interleukin-8 production (GO:0032677),0.6635707437081039,1.629701206218229,0.0010504201680672268,0.09238282145294398,1.0,16/69,7.46%,PTPRC;SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1;ANXA1;TMSB4X
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.639494998861276,1.6291574056784608,0.0,0.09282151272383285,1.0,27/150,7.98%,CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;IL18;P2RX4;GAB2;CD80;P2RY12;FLT3LG
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7520416303848912,1.6288408741051756,0.019083969465648856,0.09285708669163671,1.0,4/18,7.06%,GNA15;RGS10;GNAQ;AGRN
prerank,lymphocyte migration (GO:0072676),0.6970983917294022,1.6283620488553698,0.006864988558352402,0.09313783375462048,1.0,7/32,11.55%,MYO1G;CRTAM;ADAM8;CCL8;CCL14;CCL13;CCL2
prerank,negative regulation of immune effector process (GO:0002698),0.8046249966706038,1.62776583224769,0.011065006915629323,0.09350899518925279,1.0,5/13,1.96%,LILRB1;LGALS3;CD300A;HAVCR2;SLAMF8
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.8354896527030993,1.6276077071000845,0.004267425320056899,0.09297557672277493,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.8354896527030993,1.6276077071000845,0.004267425320056899,0.09297557672277493,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6852646426425744,1.625765777976258,0.0021953896816684962,0.09514144945463808,1.0,9/40,10.99%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12;NTF3;TXK
prerank,negative regulation of transport (GO:0051051),0.6707156171765118,1.625734826474376,0.004287245444801715,0.09479358007479395,1.0,10/51,5.43%,LILRB1;LGALS3;FCGR2B;SIRPA;ITGB3;TLR2;SNCA;MCTP1;SNX33;RAB7A
prerank,response to peptide (GO:1901652),0.6938766109710994,1.624966320802904,0.012865497076023392,0.09541488919181028,1.0,14/33,13.80%,IRF5;MMP12;CALCR;STAT5A;ANXA1;STAT4;CACNA1A;ERBIN;STAT5B;EIF2B2;NOD2;FYN;KAT7;CACNA1B
prerank,negative regulation of complement activation (GO:0045916),-0.6698050947537133,-1.624065339817578,0.0196078431372549,0.7885477298500371,1.0,4/10,8.07%,CD55;SERPING1;CR1L;CD46
prerank,actin filament-based transport (GO:0099515),0.7411452590532616,1.6240451427069265,0.009987515605493134,0.09635203856821027,1.0,7/21,8.48%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,regulation of protein processing (GO:0070613),0.7378769393458148,1.6236702768048836,0.007643312101910828,0.09649511260490426,1.0,4/21,4.53%,RUNX1;BAG2;ADAM8;CLN3
prerank,lipid modification (GO:0030258),0.675080070419857,1.6235359964561096,0.012471655328798186,0.09627796794112148,1.0,9/37,8.67%,CYP1A1;DGKZ;ALOX12;DGKK;DGKE;DGKG;DGKD;PLA2G7;PLPPR1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7570442636671062,1.6235349763566966,0.017434620174346202,0.09589591251278369,1.0,5/18,8.56%,PTPRC;LAPTM5;HAVCR2;TNFAIP3;TRIM27
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.630571692685262,1.623504708980773,0.0,0.095541166383308,1.0,18/100,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;NLRC3;TNF;PIP5K1C;PIP4K2A;IL18
prerank,response to lipopolysaccharide (GO:0032496),0.6313869464744933,1.6232816720454837,0.0,0.09549969641441079,1.0,38/138,13.46%,CD86;LILRB1;PF4;SLC11A1;CX3CR1;CXCL5;STAP1;PDCD1LG2;MAPKAPK3;IL1A;SIRPA;CXCL2;TNFRSF11A;MAPK14;SNCA;GCH1;IFNAR1;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;ERBIN;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;PRDX3;NOD2;DEFA6;TAB2;SHPK;NFKB1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7956338429520098,1.6228907795834058,0.015193370165745856,0.09571158694892457,1.0,5/14,11.24%,SLAMF1;LILRB1;TLR8;CMKLR1;THBS1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.6659332995861125,1.6215998633656594,0.0010471204188481676,0.09706603468111952,1.0,9/67,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7122290083803386,1.6189850346444743,0.008206330597889801,0.10036666349575865,1.0,4/27,1.15%,PTK2B;FGR;TGFB1;FLT3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.8175180197936833,1.6189653286146186,0.006954102920723227,0.10001734271835538,1.0,3/12,3.90%,LYN;CSF1R;OCSTAMP
prerank,regulation of acute inflammatory response (GO:0002673),0.7635077802691986,1.6184635015238946,0.011508951406649617,0.10029156061851394,1.0,3/18,3.52%,ADAM8;OSM;FFAR2
prerank,response to interferon-gamma (GO:0034341),0.6549462399835247,1.6182047599236153,0.001049317943336831,0.1002800472230361,1.0,17/67,11.55%,CIITA;IRF8;SLC11A1;CD74;SIRPA;TLR2;CCL8;SNCA;GCH1;CASP1;AIF1;KYNU;CCL14;EPRS1;CCL13;GBP3;CCL2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.7796282104280097,1.616114556584997,0.022818791946308724,0.10281536343165702,1.0,6/14,7.90%,CD86;IL18;ANXA1;CD80;NFKBID;MALT1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7882677533042415,1.6147156925640842,0.006459948320413436,0.10437359088418167,1.0,3/16,4.38%,CD22;LGALS3;TNFSF8
prerank,cellular defense response (GO:0006968),0.6676314237466965,1.613069148647883,0.013201320132013201,0.10637949133905754,1.0,6/40,2.52%,PTK2B;NCR1;CX3CR1;CLEC5A;TCIRG1;NCF2
prerank,macrophage activation involved in immune response (GO:0002281),0.8038801717686268,1.6130061253871375,0.0070126227208976155,0.10607352643744855,1.0,7/13,11.64%,TREM2;CX3CR1;SYK;PLCG2;TYROBP;DYSF;GRN
prerank,protein autoprocessing (GO:0016540),0.7657657777962223,1.6124247010238035,0.012836970474967908,0.1065621688557654,1.0,4/17,5.12%,PCSK9;FAM111A;CTSL;CASP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.6256857600949034,1.6109919906644623,0.0,0.10827924589357928,1.0,21/151,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;TGFB1;CD74;P2RY6;CSF1R;DSTYK;TNFRSF11A;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,regulation of platelet aggregation (GO:0090330),0.7660260342188078,1.6107662701923218,0.01694915254237288,0.10824962567926623,1.0,8/17,10.93%,LYN;SYK;ALOX12;PRKCD;CD9;PRKCQ;F11R;SH2B3
prerank,regulation of interferon-beta production (GO:0032648),0.6740674786213082,1.6101865072021722,0.003289473684210526,0.10879346734672307,1.0,15/46,13.88%,LILRB1;IRF5;SIRPA;TLR2;DHX9;TLR8;TLR7;NLRC3;PYCARD;TRAF3;YY1;TRIM56;RNF216;RNF135;IRF1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7187450920754883,1.609644157016652,0.01098901098901099,0.10918096962742241,1.0,5/24,7.72%,PTK2B;IL10RA;IL10RB;TNF;OCIAD1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.7297941785916456,1.6067449620253778,0.013189448441247002,0.1131616474369968,1.0,10/25,13.47%,CD226;SCIMP;LAPTM5;PLCG2;FFAR2;TRAF2;MALT1;NOD2;B2M;LACC1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7309135870312301,1.604506660688024,0.011111111111111112,0.11627016365667242,1.0,7/22,11.85%,NCKAP1L;LGALS3;MGAT5;TNF;PPP1R11;BOD1L1;PPP4R4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.6324450861378651,1.6040234739280923,0.0,0.11655436145681694,1.0,28/138,11.29%,LCP2;SLA;PTK2B;GP6;BLNK;FGR;LYN;HCK;CD3E;SYK;CASS4;STAP1;FLT3;CD7;CSF1R;PIK3CB;GUCY2F;CLNK;SHC2;MTSS1;NEDD9;NTF3;ABI1;BCAR1;NPR2;YES1;RAPGEF1;PTPRU
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6904531219894856,1.602986375641758,0.014590347923681257,0.11791694170626649,1.0,7/30,12.25%,IRF4;SYK;PLCG2;PYCARD;HMGB1;CD274;NOD2
prerank,negative regulation of immune system process (GO:0002683),0.7623466548543637,1.6021562451594316,0.021333333333333333,0.11882476354215805,1.0,3/16,1.25%,LYN;FCGR2B;PDCD1
prerank,response to amyloid-beta (GO:1904645),0.6648923656980809,1.6005615707426042,0.005537098560354375,0.1207650706433428,1.0,6/44,1.53%,TREM2;MMP12;CALCR;FCGR2B;LGMN;ITGA4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.37723280079015853,-1.600219912318894,0.0,0.8738156652936867,1.0,21/73,13.87%,FSTL1;CDH5;CRIM1;BMPR1A;BMPER;FOXD1;NBL1;BMP4;SULF1;ZNF423;ACVRL1;SMAD9;XIAP;PCSK6;SMAD4;SMAD5;SMAD1;TWSG1;CCN1;SMAD6;UBE2O
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7208784567585462,1.5990597647474192,0.015853658536585366,0.12269131754814214,1.0,3/22,3.02%,RUNX1;VSIR;MDK
prerank,platelet degranulation (GO:0002576),0.6291286863306372,1.5986838648299295,0.0,0.12289174279492654,1.0,33/118,13.41%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;CD9;PSAP;TUBA4A;TTN;CYB5R1;TIMP1;LHFPL2;ACTN4;VEGFB;TMSB4X;SYTL4;VCL;ACTN1;BRPF3;THBS1;CD63;TLN1;F5;TEX264;NHLRC2;GAS6
prerank,vacuolar acidification (GO:0007035),0.740534168827419,1.5973768369023542,0.014634146341463415,0.12460490674585938,1.0,10/21,11.64%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;CLN3;ATP6V0A2;ATP6V0D1;ATP6AP2;ATP6V0A1;GRN
prerank,prostanoid biosynthetic process (GO:0046457),0.7772521504107495,1.5951946809384585,0.011450381679389313,0.1276566932765929,1.0,4/15,2.88%,TBXAS1;CD74;DAGLB;PTGES3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7234499851594816,1.5951149032833885,0.02103960396039604,0.1273178268340418,1.0,6/23,8.45%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2;MPP1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7269199797919981,1.595094042458393,0.013414634146341463,0.12688296250887743,1.0,8/24,8.34%,LYN;CCR2;LGMN;SLAMF8;CREB3;HMGB1;AIF1;PLA2G7
prerank,iron ion transport (GO:0006826),0.6652288280976294,1.5950890598069085,0.0054525627044711015,0.12644028668645285,1.0,18/47,15.44%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;IREB2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC;FTH1;ATP6V0B;STEAP3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.6579730452424168,1.5947602380635049,0.007526881720430108,0.1264893106560494,1.0,16/55,9.07%,HPSE;TGFB1;HEXB;GUSB;PRELP;ARSB;GNS;IDS;HEXA;CD44;STAB2;FUCA1;FMOD;AGRN;SLC9A1;BCAN
prerank,receptor-mediated endocytosis (GO:0006898),0.628067765576837,1.594647209391854,0.0,0.12622424095172727,1.0,48/132,18.52%,CLEC9A;ARRB2;LILRB1;SYK;ITGB2;FCGR2B;GRB2;CTSL;CD9;MSR1;FCGR1A;MASP1;GRK3;SNX9;SNCA;FCER1G;PIP5K1C;APOE;LDLRAP1;CLN3;STAB2;STAB1;DNM2;MICALL1;AP2S1;RAMP1;GPR107;DNAJC13;RAB31;ITGAM;CLTC;ARHGAP27;GRK4;SORL1;FNBP1L;CUBN;GAK;EPS15;LRP1;AP2M1;CD36;CXCL16;HSP90AA1;VLDLR;ADM;PICALM;LRP1B;ITGB1
prerank,regulation of neutrophil migration (GO:1902622),0.8146367016963632,1.5940232238311534,0.018922852983988356,0.12685585027287505,1.0,3/10,8.45%,NCKAP1L;SLAMF8;MPP1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7611928591527902,1.5937323449909155,0.01675257731958763,0.12684560962647035,1.0,5/15,8.24%,TREM2;LPL;PLIN2;OSBPL11;PLIN3
prerank,cellular response to cytokine stimulus (GO:0071345),0.6133462356723571,1.5930552921143355,0.0,0.1277026119152143,1.0,121/416,16.88%,CD86;SLA;GRAP2;VAV1;DOCK8;IRF5;INPP5D;PTPN7;PF4;PTAFR;IL10RA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;HCLS1;FLT3;CCR2;CSF3R;AIM2;STAT5A;NFE2L2;IL1A;SIRPA;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;PTPRJ;TLR2;GRB2;PIK3CB;TEC;DHX9;OSM;PTPN18;IL12RB2;CCL8;TNF;OCSTAMP;LDLRAP1;MYLK3;TANK;IL6R;CEBPA;IFNAR1;CXCR4;FOXO3;PYCARD;IL18;CASP1;TIMP1;IFNGR2;RIPOR2;ANXA1;BCL2L1;AIF1;GAB2;TP53;CD80;PIM1;WNK1;STAT4;ERBIN;FLT3LG;SMAD3;RC3H1;CCL14;ITGAM;EPRS1;STAT5B;TPR;NPR2;TNFRSF21;IL18BP;SH2B3;CCL13;RAPGEF1;SOX9;GBP3;CCL2;TNFRSF1B;CDC34;FYN;STX3;LRP8;PRLR;SHPK;UBE2G2;GAS6;NFKB1;TRADD;IRF1;PID1;IL2RG;PTPRT;SOX2;RO60;MAOA;IL3RA;SELPLG;GSK3A;IL13RA1;CD36;IRGM;HIF1A;SBNO2;CD47;HSP90AA1;ASAH1;PTPN12;CCL25;IL20RB
prerank,positive regulation of chemotaxis (GO:0050921),0.667116322579667,1.5926465212221599,0.007760532150776054,0.1279775557596039,1.0,16/43,13.51%,TREM2;TGFB1;CCR2;LGMN;SMOC2;MDK;PRKD2;IL6R;P2RX4;AIF1;TMSB4X;P2RY12;NRP1;THBS1;STX3;MEGF8
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.770351811544491,1.5918502265605525,0.015665796344647518,0.12880699091279946,1.0,3/15,1.16%,SHH;SYK;CCR2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7590793682600792,1.5904426309137907,0.018893387314439947,0.1306584278067946,1.0,4/15,7.81%,LILRB1;TGFB1;TNF;HFE
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6684630552757695,1.5904336102948924,0.003243243243243243,0.1302199884359043,1.0,13/47,11.24%,TGFB1;SYK;ITGB2;PLCG2;PRKCD;GRB2;MAPK14;XDH;TYROBP;TGFBR2;TP53;ITGAM;THBS1
prerank,fibrinolysis (GO:0042730),0.7912351626450783,1.5899370235982695,0.01742627345844504,0.13060530730886152,1.0,1/13,0.82%,GP1BA
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7427224768994805,1.5897607109079221,0.01856763925729443,0.13043570227747678,1.0,4/18,7.29%,LILRB3;LILRB1;GPR137B;TMEM178A
prerank,"phagocytosis, engulfment (GO:0006911)",0.6806855975974585,1.5884835707201028,0.01233183856502242,0.13213099866305958,1.0,11/36,11.24%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;MYH9;AIF1;ITGAM;THBS1
prerank,lipid oxidation (GO:0034440),0.7887974022652081,1.587189573908314,0.01808066759388039,0.13383563250282635,1.0,5/12,16.65%,ALOX12;PLA2G7;PPARGC1A;ADIPOR1;ADIPOR2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5525628704646638,-1.586879666868698,0.023529411764705882,0.9046044336253681,1.0,12/15,30.69%,SIK1;GPLD1;FBXW7;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1;FITM2
prerank,phospholipid homeostasis (GO:0055091),0.7901128179643584,1.5866520840072171,0.018544935805991442,0.13433155313681866,1.0,3/11,4.11%,ABCA1;ANGPTL3;ABCG1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.6179944316593897,1.5860737595050751,0.0,0.13502414446340746,1.0,27/140,9.01%,ARHGAP45;ARHGAP30;FGD2;VAV1;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;ARHGAP22;CYRIB;ARHGAP24;NUP62;VAV2;ARHGEF18;ARAP1;VAV3;FAM13B;TAGAP;MYO9B;GNA13;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7045169729721856,1.585411143398213,0.01570048309178744,0.13557804919917932,1.0,5/23,7.72%,IL10RA;IL10RB;MGAT5;TNF;OCIAD1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7672290222276288,1.5849010235381782,0.028985507246376812,0.136107696572988,1.0,4/14,3.81%,ADAM8;OSM;FFAR2;TNF
prerank,negative regulation of macrophage activation (GO:0043031),0.764607227113495,1.5848444160549635,0.005235602094240838,0.1357530093126933,1.0,3/16,3.45%,PTPRC;FCGR2B;CST7
prerank,negative regulation of interferon-beta production (GO:0032688),0.8192453593592757,1.584800357237378,0.014925373134328358,0.1353802630250403,1.0,5/10,7.16%,LILRB1;SIRPA;NLRC3;PYCARD;YY1
prerank,lipid translocation (GO:0034204),0.722741886692612,1.5841253816757548,0.02122347066167291,0.13609522000294408,1.0,8/21,12.70%,ATP8B4;ABCA1;RFT1;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.768133036032029,1.5840087459861771,0.010512483574244415,0.135842110487981,1.0,6/17,8.34%,CCR2;LGMN;CREB3;HMGB1;AIF1;PLA2G7
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.753090864298726,1.5832384146937828,0.021850899742930592,0.13685068975081935,1.0,3/17,2.52%,PTPRC;CD300A;MTOR
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6939182241745316,1.58295736359774,0.011695906432748537,0.1368754771000054,1.0,4/29,6.35%,PLBD1;DBI;LPCAT1;LPCAT2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.7362232757477235,1.5826991128445047,0.01643489254108723,0.1369402667655721,1.0,11/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;CSK;TMEM59
prerank,positive regulation of type 2 immune response (GO:0002830),0.7714132878760305,1.5821950384574401,0.01856763925729443,0.13736159969489778,1.0,5/14,12.25%,CD86;CD74;IL18;DENND1B;NOD2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7329342583772951,1.5820433869243888,0.02072538860103627,0.1371550415824635,1.0,4/18,7.31%,GPNMB;LAPTM5;DUSP3;WNK1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6860439295815157,1.5819124232241177,0.013714285714285714,0.13691667509882907,1.0,10/34,8.92%,TREM2;LYN;CD300A;TNFAIP3;CD14;CD300LF;RAB7B;TICAM1;GRAMD4;LY96
prerank,pyroptosis (GO:0070269),0.7732882931556642,1.5798529342090477,0.01576872536136662,0.1401323589013377,1.0,4/15,5.12%,TREM2;AIM2;DHX9;CASP1
prerank,negative regulation of bone mineralization (GO:0030502),0.7838444925488404,1.5789984916827677,0.015047879616963064,0.14116701312335814,1.0,2/13,1.55%,PTK2B;SRGN
prerank,macrophage activation (GO:0042116),0.6835106092019727,1.5783886674391376,0.010123734533183352,0.14171248375098103,1.0,13/34,11.79%,TREM2;SLC11A1;SYK;ITGB2;TLR1;PLCG2;TNF;SNCA;AIF1;C1QA;ITGAM;DYSF;CD93
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.7344376244458565,1.5780349879974187,0.01893939393939394,0.14182908639365335,1.0,10/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59
prerank,negative regulation of cell development (GO:0010721),0.6908604159639676,1.5769160827321207,0.024330900243309004,0.14327247962164796,1.0,9/25,16.66%,HOOK3;LILRB1;TNF;PCM1;SORL1;B2M;RFLNA;GSK3A;APPL2
prerank,T cell migration (GO:0072678),0.7723470029175257,1.576723786862317,0.015748031496062992,0.1431948084924944,1.0,3/13,1.59%,MYO1G;PIK3CG;PIK3CD
prerank,negative regulation of cholesterol transport (GO:0032375),0.7977865967495503,1.5767019418672883,0.03299856527977044,0.14276434812399919,1.0,2/10,3.88%,SHH;SREBF2
prerank,transferrin transport (GO:0033572),0.6851827667162924,1.5755575659187504,0.010262257696693273,0.14443344744198913,1.0,13/33,11.11%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC
prerank,keratan sulfate catabolic process (GO:0042340),0.8143568152429219,1.5747697426895264,0.018335684062059238,0.14539315213065845,1.0,5/11,6.81%,HEXB;PRELP;GNS;HEXA;FMOD
prerank,leukocyte tethering or rolling (GO:0050901),0.7447087865841538,1.5741944464203361,0.02040816326530612,0.14582671814605536,1.0,4/17,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,regulation of leukocyte migration (GO:0002685),0.7439988333772407,1.573033708660794,0.019973368841544607,0.14745139618363454,1.0,2/16,6.34%,NCKAP1L;ANXA1
prerank,positive chemotaxis (GO:0050918),0.7417802788983571,1.5725412765992564,0.017699115044247787,0.14789499262168457,1.0,4/17,2.35%,GPNMB;LGALS3;CORO1A;PTPRJ
prerank,cellular response to zinc ion (GO:0071294),0.7612409260148802,1.5719992909369245,0.02677376171352075,0.1484376166885737,1.0,13/15,22.28%,P2RX4;GLRA2;HVCN1;ATP13A2;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,response to molecule of bacterial origin (GO:0002237),0.6277254860780789,1.5711305833002807,0.01053740779768177,0.14959202920321846,1.0,14/69,8.92%,IRF5;SLC11A1;FCGR2B;MAPKAPK3;CYRIB;CXCL2;TNFRSF11A;SNCA;GCH1;IFNAR1;TNFAIP3;CD14;ERBIN;LY96
prerank,negative regulation of ossification (GO:0030279),0.704322876138047,1.5709532382785574,0.01820388349514563,0.1494401113620727,1.0,6/23,12.22%,PTK2B;SRGN;MDK;MEF2C;SOX9;CHSY1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7880384124754333,1.5703621361820397,0.01646090534979424,0.1501399941814702,1.0,5/13,7.46%,GATA1;MAD2L2;DDIT3;TAF1;TMSB4X
prerank,regulation of macrophage differentiation (GO:0045649),0.7555498703424298,1.5676530762437482,0.029649595687331536,0.15477526001082387,1.0,5/15,12.90%,PF4;C1QC;HSF1;INHBA;CASP8
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.6238094422156534,1.5676194341274832,0.0031185031185031187,0.15436771486138406,1.0,22/76,12.90%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;NLRC3;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;SETD6;TAX1BP1;TMSB4X;ERBIN;ANXA4;CMKLR1;USP7;DAP;ITCH
prerank,erythrocyte development (GO:0048821),0.8083436033570863,1.5666442605225401,0.01729106628242075,0.15571751737878564,1.0,2/10,1.17%,NCKAP1L;GATA1
prerank,stem cell differentiation (GO:0048863),0.6728693858008293,1.5661235702805962,0.009988901220865706,0.1561656718141119,1.0,10/39,12.31%,PTPRC;MEOX1;SHH;SP7;EEF1AKMT4-ECE2;TP53;SETD6;MEF2C;SETD2;MTF2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6868249596724986,1.5655634031523007,0.015151515151515152,0.15669490754952536,1.0,7/27,5.08%,PF4;LPL;ABCA1;ITGB3;MSR1;ABCG1;IL18
prerank,positive regulation of lipid transport (GO:0032370),0.7811729811977314,1.5634768158117949,0.02638888888888889,0.16000575292797023,1.0,6/12,15.26%,DBI;APOE;SPP1;ABCB4;LRP1;ABCA3
prerank,regulation of erythrocyte differentiation (GO:0045646),0.672551405621885,1.563219864295665,0.024110218140068886,0.16002664830375687,1.0,10/35,12.44%,NCKAP1L;LYN;GATA1;MAPK14;FOXO3;SPI1;TAL1;STAT5B;INHBA;CDK6
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7985145485023123,1.5628620621013445,0.025899280575539568,0.1601950492149545,1.0,4/11,12.90%,PF4;TGFB1;HSF1;CASP8
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6669123223684947,1.5607840377618998,0.010440835266821345,0.16370792559732866,1.0,11/35,11.24%,PTK2B;HCK;HCLS1;STAP1;IQGAP2;CSF1R;MDK;NTF3;ARHGDIB;F11R;NRP1
prerank,Fc receptor signaling pathway (GO:0038093),0.6151185898528349,1.5591920239861892,0.0,0.166212326704284,1.0,22/110,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,negative regulation of lipid storage (GO:0010888),0.7181525458783636,1.5591706896004196,0.022988505747126436,0.16576336994143964,1.0,5/19,4.11%,TREM2;ABCA1;ITGB3;TNF;ABCG1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7864531690152343,1.5590064760843179,0.02785923753665689,0.1655936393808198,1.0,3/11,9.57%,TREM2;KCNIP2;NOS1AP
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5626074281824484,-1.5586477533266607,0.029166666666666667,1.0,1.0,6/15,12.21%,FOXC1;EDA;GLI2;WNT6;HDAC2;TBX1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.6141560620359166,1.5570339938221962,0.0,0.1689156445544114,1.0,22/109,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,positive regulation of dendrite development (GO:1900006),-0.6419540921147231,-1.5569652698617984,0.048859934853420196,1.0,1.0,6/10,11.30%,COBL;PTN;ALK;DAB2IP;BMP5;PACSIN1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.7132226207194237,1.5568907903348717,0.02781289506953224,0.16867719240280885,1.0,8/21,12.98%,CX3CR1;MDK;FZD9;FZD3;CTNNB1;DISC1;NAP1L1;SMARCD3
prerank,secretory granule organization (GO:0033363),0.8033588038484107,1.556848744441693,0.028735632183908046,0.1682533787987468,1.0,3/10,1.71%,LYST;SRGN;ABCA1
prerank,positive regulation of locomotion (GO:0040017),0.697672316877379,1.5567510926665464,0.02063106796116505,0.16795219052873453,1.0,7/27,12.76%,TREM2;TGFB1;CSF1R;AIF1;P2RY12;THBS1;STX3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6462691027008751,1.5562762891118798,0.008849557522123894,0.16834454124738898,1.0,6/44,4.78%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD
prerank,response to acidic pH (GO:0010447),0.7656369627785671,1.5556601563370167,0.036585365853658534,0.16912576726309747,1.0,5/13,12.59%,CTSS;LGMN;SLC9A1;IMPACT;RAB11FIP5
prerank,regulation of adaptive immune response (GO:0002819),0.7460930917865009,1.555528796950853,0.0247074122236671,0.1689020793534124,1.0,7/18,13.88%,FCGR2B;ADCY7;PYCARD;SAMSN1;TRIM27;SASH3;IRF1
prerank,response to ATP (GO:0033198),0.7313947496529829,1.5542898264928688,0.030418250950570342,0.17068353875765496,1.0,6/18,7.66%,KCNJ11;P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,negative regulation of endocytosis (GO:0045806),0.697818660730763,1.5541393737065738,0.028151774785801713,0.17048920257497305,1.0,5/24,4.90%,LILRB1;LGALS3;CD300A;MCTP1;SNX33
prerank,regulation of innate immune response (GO:0045088),0.6318424900252051,1.5540135379905806,0.006396588486140725,0.17032845361299326,1.0,18/57,13.88%,TREM2;FGR;FCGR2B;ADAM8;PTPN1;DHX9;TLR8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;RNASEL;USP18;RNF135;CASP8;LRP8;ERAP1;IRF1
prerank,transepithelial transport (GO:0070633),-0.5558084916449202,-1.553844286480891,0.04365079365079365,0.975473416121076,1.0,4/15,8.42%,SLC12A2;ABCG2;CXADR;GPLD1
prerank,positive regulation of endocytosis (GO:0045807),0.6544741521777557,1.5536552808988906,0.005500550055005501,0.17050119603315295,1.0,18/45,18.32%,NCKAP1L;TREM2;STAP1;CBL;SNCA;APOE;LDLRAP1;CLN3;HFE;RAB31;NEDD4L;B2M;TOR1A;LRP1;APPL2;VPS28;CDC42;FLOT1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6817578359795019,1.5528995467454785,0.01990632318501171,0.1715122563296309,1.0,3/27,5.93%,GNA15;LPAR6;GPR17
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.716321956594657,1.5528580660491649,0.022781774580335732,0.1710924515030369,1.0,2/22,1.26%,CYP1A1;LGMN
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5115189219529949,-1.5514430525599208,0.038461538461538464,0.9470806674397884,1.0,7/19,11.70%,DLG2;CLIC4;PRKCI;SYNJ2BP;PARD3;DLG1;MTCL1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7172073033987252,1.5511412292323215,0.03669724770642202,0.17385849060478628,1.0,5/19,7.23%,RUNX1;CIITA;TGFB1;RGCC;CREB3L1
prerank,inositol lipid-mediated signaling (GO:0048017),0.6419514269692207,1.5510653022431515,0.005422993492407809,0.17351296564545773,1.0,9/50,6.59%,PTAFR;PIK3CG;PLCB2;PLCL2;PIK3CD;CSF1R;PIK3CB;ADAP2;GAB2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6987896795294684,1.551039202812496,0.027127003699136867,0.17257606429827596,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6987896795294684,1.551039202812496,0.027127003699136867,0.17257606429827596,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,eosinophil migration (GO:0072677),0.763558826736347,1.550763263605213,0.018893387314439947,0.17208123078613474,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.763558826736347,1.550763263605213,0.018893387314439947,0.17208123078613474,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.6544353643626521,1.5494062708913345,0.015521064301552107,0.17422997383235833,1.0,10/36,11.48%,PTPRC;IL10RA;IL10RB;TNF;OCIAD1;DOT1L;SH2B3;NF2;NLK;ADIPOR1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6827360105468773,1.5489433913488857,0.03143189755529686,0.17463302748363582,1.0,6/25,8.46%,TGFB1;GATA1;MAD2L2;NSD1;DOT1L;RB1
prerank,regulation of protein kinase activity (GO:0045859),0.6100273610543088,1.5489356732082358,0.002034587995930824,0.17415514320339645,1.0,27/106,14.54%,PTPRC;LCP2;PTK2B;FGR;UBASH3B;LAT;MMD;THY1;GNAQ;SNX9;TNF;SNCA;TTN;XRCC5;MAP2K3;RAP2B;RB1;TRIM27;UVRAG;QARS1;DUSP19;DTNBP1;TAB2;CAMKK2;GAS6;RTRAF;RAP1A
prerank,positive regulation of response to external stimulus (GO:0032103),0.6085333663222329,1.5485824352677553,0.0,0.17439400206759015,1.0,31/128,13.66%,TREM2;SCIMP;TGFB1;CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;LY86;MDK;OSM;TNF;SNCA;CEBPA;IL18;AIF1;USF1;P2RY12;CD180;PLA2G7;LY96;PUM2;ABCC1;THBS1;GRN;STX3;NINJ1;TRADD
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.788005900044147,1.5479397267249682,0.01466275659824047,0.175085472369687,1.0,3/11,8.09%,LYN;SYK;PRKCQ
prerank,regulation of hemopoiesis (GO:1903706),0.7945318996919275,1.5463133229228967,0.025110782865583457,0.17770833278094025,1.0,3/10,6.13%,RUNX1;LGALS3;PRKCB
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6889578841628691,1.545668685787066,0.030376670716889428,0.178443292158888,1.0,2/25,0.45%,ARRB2;NPAS4
prerank,zymogen activation (GO:0031638),0.6510146453394076,1.5454943897315712,0.01452513966480447,0.17834698267757237,1.0,7/39,8.96%,KLK3;LGMN;VSIR;CTSL;ASPH;TBC1D10A;BAK1
prerank,acylglycerol homeostasis (GO:0055090),0.7041265638684993,1.5448711644884723,0.043478260869565216,0.17904810514708658,1.0,7/20,12.23%,LPL;MLXIPL;ANGPTL3;APOE;IL18;LIPC;ANGPTL4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6193279584247029,1.5436440898880468,0.008290155440414507,0.1810158400425253,1.0,22/72,15.15%,PTPRC;RUNX1;SYK;CD74;IRAK2;PTPN1;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;IFNGR2;CFLAR;TAX1BP1;RNASEL;USP18;IKBKG;CASP8;GAS6;TRADD;SPPL2A;PIAS1
prerank,inorganic ion transmembrane transport (GO:0098660),0.7710222465435311,1.5431576990419658,0.03526093088857546,0.1815830783834915,1.0,2/12,4.10%,KCNJ11;PKD2
prerank,cellular response to copper ion (GO:0071280),0.7470665704873579,1.5427056549393137,0.0174496644295302,0.18204147512717606,1.0,12/16,22.28%,AQP1;SNCA;HSF1;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,regulation of protein kinase B signaling (GO:0051896),0.6028659591607234,1.5417116766414736,0.0,0.18352990437858197,1.0,34/193,9.56%,ARRB2;CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;DDIT3;IL18;XDH;P2RX4;OTUD3;GAB2;CD80;P2RY12;FLT3LG;FLCN;PDCD6;STRN
prerank,phospholipid catabolic process (GO:0009395),0.6948316579696128,1.541601333089229,0.02539298669891173,0.18327470073283908,1.0,3/24,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8074706942961181,1.5415170176018036,0.03070175438596491,0.1829270117430101,1.0,4/10,9.61%,FERMT3;CD3E;WNK1;PODXL
prerank,macrophage chemotaxis (GO:0048246),0.7994183677349036,1.5414306388411592,0.03619909502262444,0.18259771124709262,1.0,2/10,2.42%,LGALS3;EDNRB
prerank,excitatory postsynaptic potential (GO:0060079),0.7125421702125712,1.5406430099161617,0.030927835051546393,0.1837419351420869,1.0,2/19,0.45%,ARRB2;NPAS4
prerank,regulation of defense response (GO:0031347),0.6190712296788681,1.540510887199814,0.007284079084287201,0.1835108018336703,1.0,27/76,14.52%,TREM2;FGR;HCK;FCGR2B;CCR2;PIK3AP1;DAGLB;APOE;CASP1;TRAF3;SAMHD1;ANXA1;SETD6;AKNA;TMSB4X;ZMPSTE24;GRN;USP18;NOD2;RNF135;CASP8;LRP8;SHPK;LACC1;ERAP1;IRF1;AREL1
prerank,negative regulation of signaling (GO:0023057),0.6857495896677962,1.5398547053508218,0.02040816326530612,0.1842013069124894,1.0,4/25,3.12%,UBASH3B;PCSK9;PTPN1;OSM
prerank,phosphatidylinositol metabolic process (GO:0046488),0.6004327412346538,1.5397935115562469,0.0020242914979757085,0.18383398578550328,1.0,15/109,4.84%,PLBD1;INPP5D;PIK3CG;PLCB2;PIK3R5;PLEK;PIK3CD;CSF1R;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14
prerank,negative regulation of biomineral tissue development (GO:0070168),0.7076061462933464,1.5393021093352128,0.024600246002460024,0.1844113030504966,1.0,3/21,1.55%,PTK2B;TGFB1;SRGN
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7176546302853647,1.5391066510162743,0.042801556420233464,0.18431631968904777,1.0,5/17,7.23%,RUNX1;TGFB1;VSIR;RGCC;CREB3L1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.7188648112762598,1.5385341655256437,0.03372243839169909,0.18504605402141738,1.0,7/19,11.24%,CSF1R;CAMK1D;MDK;MPP1;AKIRIN1;CMKLR1;THBS1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7765037323127484,1.5379480885512493,0.0456490727532097,0.18573421432020606,1.0,3/10,7.53%,TREM2;CD68;TICAM1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.6129397368771121,1.5373510212433508,0.005175983436853002,0.18644295570045294,1.0,18/76,12.21%,NCKAP1L;PTK2B;HCK;PLEK;HCLS1;STAP1;P2RX7;NUP62;NCK2;SNX9;MYLK3;PYCARD;PLK4;NTF3;PFN2;PFN1;NRP1;DYNC1H1
prerank,regulated exocytosis (GO:0045055),0.5983351385980751,1.5372172785232023,0.0,0.18623104115708747,1.0,44/173,13.41%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;SYT17;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;SDF4;CD9;PSAP;SNCA;PIP5K1C;TUBA4A;TTN;CYB5R1;TIMP1;MYH9;LHFPL2;ACTN4;SYT2;VEGFB;TMSB4X;RAB31;SYTL4;SYT10;VCL;SYNGR1;ACTN1;SYNGR2;BRPF3;THBS1;CD63;TLN1;F5;RAB11FIP5;TEX264;NHLRC2;GAS6
prerank,hemopoiesis (GO:0030097),0.6069247599903044,1.5370595086477208,0.006166495375128468,0.1860549968562551,1.0,17/87,11.96%,PTPRC;RUNX1;PLD4;TGFB1;PLEK;FLT3;CSF1R;CEBPA;TGFBR2;TP53;TAL1;FLT3LG;FLCN;INHBA;SH2B3;ETV6;PRDX3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7201522279856296,1.537052152963439,0.028858218318695106,0.18558648160859667,1.0,4/18,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6161635609056354,1.536147902251199,0.005219206680584551,0.186878815228172,1.0,11/66,6.91%,PIK3CG;PIK3R5;TGFB1;FLT3;TAOK3;FZD10;ADAM8;TNFRSF11A;TNF;TRAF2;MAP3K5
prerank,positive regulation of lipid storage (GO:0010884),0.7124946261924057,1.5358227717454296,0.02457002457002457,0.18707127561516043,1.0,8/21,13.46%,LPL;MSR1;SREBF2;PLIN2;OSBPL11;PLIN3;VSTM2A;NFKB1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7378989351763233,1.535179598155126,0.03830911492734478,0.1878926051723246,1.0,1/16,0.06%,MRAP
prerank,negative regulation of bone remodeling (GO:0046851),0.7908011746776719,1.53491865360477,0.029957203994293864,0.1879072426984165,1.0,4/11,5.09%,UBASH3B;P2RX7;GPR137B;TNFAIP3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7551278578851621,1.5347579839527625,0.04700854700854701,0.1877401362521701,1.0,4/13,2.91%,IRAK2;PIK3AP1;UNC93B1;TLR7
prerank,somite development (GO:0061053),0.7892857629474215,1.5344636710613895,0.03253182461103253,0.1878312473996788,1.0,2/11,0.68%,MEOX1;SHH
prerank,heart process (GO:0003015),-0.5612981033620926,-1.5337782616885034,0.05263157894736842,1.0,1.0,4/14,9.66%,SGCD;SGCZ;SOD1;ACE
prerank,positive regulation of protein kinase activity (GO:0045860),0.5943949452042141,1.5335214148612255,0.0,0.18927350936220488,1.0,44/148,16.74%,PTPRC;LCP2;PTK2B;SLC11A1;CASS4;LAT;ITGB3;TAOK3;CSF1R;GPRC5B;MMD;PRKCD;PTPN1;FCGR1A;SNX9;TNF;SNCA;IL6R;XRCC5;MAP2K3;TGFBR2;NEDD9;TNIK;KIF14;STRADB;DUSP19;MAP2K2;PARP16;PPP2CA;TAB2;LRP8;GAS6;STK3;RAP1A;PIH1D1;SRC;STRADA;SYAP1;ALS2;INCENP;IRGM;EPHA4;HSP90AA1;STK4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6877503592150911,1.532990986033026,0.036101083032490974,0.18977044265391935,1.0,11/24,19.95%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59;INPP5K
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6748542062660808,1.5329758874733603,0.030660377358490566,0.18930841486686245,1.0,4/26,1.40%,HPSE;TGFB1;CCR2;IL1A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6295861296085961,1.5328187979263788,0.019629225736095966,0.1891684669314817,1.0,13/48,13.41%,PTPRC;TREM2;STAP1;NLRC5;RFFL;SAMHD1;YTHDF3;SH2B3;TTLL12;USP18;METTL3;GPS2;GAS6
prerank,intracellular sterol transport (GO:0032366),0.7652739423535939,1.5323190015789416,0.029045643153526972,0.18961781290061858,1.0,7/13,14.79%,ABCA1;NPC2;ABCG1;NPC1;OSBP;STARD4;ARV1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6212182845509194,1.532315233843997,0.013727560718057022,0.18914415271800378,1.0,12/57,12.34%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO;SH2B3;NF2;PPP2CA
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6902561567435292,1.5321755196409461,0.019883040935672516,0.18894891994513793,1.0,6/25,3.69%,ITGAX;ITGB2;ITGA4;CD200R1;ITGB3;PKP2
prerank,response to copper ion (GO:0046688),0.709569075731871,1.5296233822006406,0.023106546854942234,0.19354365852910896,1.0,13/20,22.28%,IL1A;AQP1;SNCA;HSF1;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,regulation of MAP kinase activity (GO:0043405),0.6099156739577953,1.528158956964917,0.0010224948875255625,0.19604901700609276,1.0,13/92,4.14%,LYN;PIK3CG;PIK3R5;TGFB1;FLT3;CD300A;ADAM8;PRKCD;PTPRJ;PTPN1;PIK3CB;TNF;APOE
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.45517797201196913,-1.527751771193468,0.046632124352331605,1.0,1.0,5/26,2.24%,FOXP1;SMARCA4;KANK2;CLOCK;NCOR1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.7644447549263471,1.5275244914083843,0.04067321178120617,0.1968519347079489,1.0,4/11,7.53%,SCIMP;RFTN1;UNC93B1;TICAM1
prerank,lysosome localization (GO:0032418),0.6466870754593979,1.5261282080025012,0.025,0.19928035757503398,1.0,13/37,12.67%,PIK3CG;PLEKHM2;PIK3CD;RAB34;KLC2;PLEKHM1;MYH9;TFEB;FLCN;SYTL4;HDAC6;BORCS5;PIP4P1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.6897342262870113,1.5257902701931185,0.03143893591293833,0.19947507203202855,1.0,7/25,10.55%,NCKAP1L;GATA1;MAPK14;FOXO3;TAL1;STAT5B;INHBA
prerank,intracellular cholesterol transport (GO:0032367),0.7440392243928033,1.5252153170626699,0.03042328042328042,0.20016947894242898,1.0,7/15,14.52%,ABCA1;NPC2;ABCG1;LDLRAP1;NPC1;OSBP;STARD4
prerank,melanocyte differentiation (GO:0030318),0.7841157351221997,1.525108781309984,0.036011080332409975,0.19986667939612449,1.0,3/11,8.10%,LRMDA;MITF;MEF2C
prerank,regulation of neuroinflammatory response (GO:0150077),0.712939892032588,1.5249828009696684,0.03759398496240601,0.19963618337397954,1.0,4/19,5.08%,TREM2;CD200R1;TNF;IL18
prerank,lymphocyte chemotaxis (GO:0048247),0.6559821432409514,1.5246357481658612,0.024054982817869417,0.19991135003793947,1.0,12/34,18.57%,PIK3CG;PIK3CD;ADAM8;CCL8;CCL14;GPR183;CCL13;CCL2;GAS6;CXCL16;CCL25;CKLF
prerank,negative regulation of ion transport (GO:0043271),0.6908119998990527,1.5242145422377873,0.031630170316301706,0.20026065767351908,1.0,4/24,7.31%,PTK2B;LILRB1;SNCA;WNK1
prerank,regulation of T cell migration (GO:2000404),0.7083850164244893,1.5238461242517694,0.03530895334174023,0.2005078422037702,1.0,5/18,6.51%,DOCK8;CD200R1;PYCARD;RIPOR2;AIF1
prerank,positive regulation of leukocyte activation (GO:0002696),0.7169583024996622,1.523794154160643,0.03286978508217446,0.2001302889542884,1.0,3/18,4.57%,CLEC4D;CD226;CEBPA
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.6548878566743201,1.5231937397669504,0.02422145328719723,0.20105355048196774,1.0,4/33,2.72%,PIK3CG;PIK3R5;PIK3CD;PIK3CB
prerank,tryptophan metabolic process (GO:0006568),0.7764219126238977,1.5228026389500062,0.04519774011299435,0.2014340586611051,1.0,4/11,7.82%,ATP7A;HAAO;KYNU;KMO
prerank,negative regulation of cilium assembly (GO:1902018),-0.5869042693409557,-1.5225046796525927,0.03985507246376811,1.0,1.0,6/12,18.91%,MAP4;CCP110;EVI5L;CEP97;CDK10;TBC1D7
prerank,renal water homeostasis (GO:0003091),0.692486943498293,1.5224059931645173,0.03836930455635491,0.20180774791562245,1.0,10/23,14.21%,ADCY7;PRKAR2B;AQP1;ADCY6;TFAP2B;RAB11A;PRKACB;ADCY3;ADCY8;WFS1
prerank,stem cell development (GO:0048864),0.7457871129404183,1.5214372492328025,0.03861003861003861,0.20320629770916046,1.0,2/16,0.68%,PTPRC;SHH
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.6132806881125361,1.521153192420887,0.0041797283176593526,0.20332403808177735,1.0,8/69,2.72%,PTAFR;PIK3CG;PLCB2;PIK3R5;PLCL2;PIK3CD;CSF1R;PIK3CB
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6493236538289664,1.5195285242810792,0.030577576443941108,0.2064175327004083,1.0,6/32,12.30%,PF4;CXCL5;CXCL2;CXCL14;CCL13;DEFA6
prerank,lysosome organization (GO:0007040),0.6422699003234887,1.5194793996739637,0.02491506228765572,0.20600750656468617,1.0,15/36,17.35%,HOOK3;ABCA1;CORO1A;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;TMEM165;LAMTOR1
prerank,osteoclast differentiation (GO:0030316),0.6787327394950725,1.5188572855276838,0.031525851197982346,0.20701906805816714,1.0,9/22,9.45%,TREM2;CSF1R;TNFRSF11A;MAPK14;OCSTAMP;EFNA2;TYROBP;GAB2;GPR183
prerank,acylglycerol catabolic process (GO:0046464),0.652329804553108,1.5187112717451097,0.03348729792147806,0.2068349845631872,1.0,8/30,17.09%,LPL;FABP4;ABHD12;FABP5;LIPC;LIPE;ABHD16A;PNPLA3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7944719136646294,1.5173739097364451,0.03474320241691843,0.20904726062360088,1.0,2/10,0.52%,LILRB1;LYN
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6714213972429111,1.51718488186301,0.027446300715990454,0.20892994258792838,1.0,4/29,4.28%,TGFB1;MYL3;PKP2;TTN
prerank,vesicle organization (GO:0016050),0.6257660375608355,1.516852859836517,0.016286644951140065,0.2091999900928501,1.0,23/46,19.71%,HOOK3;SRGN;CORO1A;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;EXOC8;PI4K2B;SAR1A;FNBP1L;HOOK2;USP8;EPS15;ALS2;LAMTOR1;SNX10;VPS33B;LAPTM4B;SORT1
prerank,phospholipid metabolic process (GO:0006644),0.6000435453295264,1.5146486798799068,0.009345794392523364,0.21344174237011662,1.0,9/71,4.92%,PLBD1;PLCB2;LPL;ABHD12;LPCAT1;ANGPTL3;CLN8;PIP4K2A;SMPD3
prerank,cellular component disassembly (GO:0022411),0.6186258044279083,1.512489295396513,0.015906680805938492,0.2174721600429678,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,regulation of B cell apoptotic process (GO:0002902),0.7411222576189515,1.51247793201275,0.05397727272727273,0.21697857835027345,1.0,3/12,3.86%,BTK;LYN;FNIP1
prerank,calcium-mediated signaling (GO:0019722),0.6012056826711071,1.5121918402327499,0.003076923076923077,0.21718376879390502,1.0,17/93,7.66%,PTPRC;BTK;CX3CR1;CCR2;LAT;PLCG2;PTPRJ;EDNRB;P2RX7;SLC8A1;LAT2;CXCR4;MCTP1;P2RX4;NUDT4;SLC9A1;P2RY12
prerank,base conversion or substitution editing (GO:0016553),0.7635923967756139,1.5120297694926867,0.045845272206303724,0.2170465991379301,1.0,4/11,13.05%,APOBEC1;ADAR;METTL3;ADARB1
prerank,extracellular matrix disassembly (GO:0022617),0.618372772220681,1.511963927089646,0.017970401691331923,0.21667980903985926,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6894190840485799,1.5117394523828185,0.04305043050430504,0.21670478669385693,1.0,5/22,9.17%,TREM2;LYN;TNFAIP3;RAB7B;WDFY1
prerank,regulation of macrophage migration (GO:1905521),0.7747190406369678,1.5099614280691256,0.048316251830161056,0.2202176246325603,1.0,4/10,7.66%,PTK2B;CX3CR1;CD200R1;P2RY12
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7148644043373136,1.5098932784580845,0.04849279161205767,0.21982934619205138,1.0,4/16,6.92%,TREM2;TNF;APOE;MYOCD
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5946485975555672,1.5091699244064787,0.006224066390041493,0.22081637760302103,1.0,23/84,11.64%,PTK2B;PIK3CG;TGFB1;RIN2;LGMN;STAT5A;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;TMSB4X;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,positive regulation of cellular component movement (GO:0051272),0.6700669300232873,1.5085484158572668,0.03532277710109622,0.22166607401582875,1.0,4/24,6.77%,LYN;CSF1R;TGFBR1;ACTN4
prerank,regulation of response to external stimulus (GO:0032101),0.592656864368135,1.5079678650030104,0.003048780487804878,0.2225142110694378,1.0,41/121,16.66%,TREM2;FGR;HCK;GP1BA;FCGR2B;CCR2;CYRIB;PIK3AP1;DAGLB;TRIM5;GUCY2F;CXCR4;SAG;CASP1;TRAF3;P2RX4;SAMHD1;ANXA1;CNGB1;SETD6;AKNA;TMSB4X;P2RY12;ZMPSTE24;GRN;USP18;NOD2;GRK4;RNF135;CASP8;LRP8;SHPK;LACC1;STK24;ERAP1;IRF1;AREL1;METAP2;CD36;SBNO2;APPL2
prerank,regulation of calcium ion import (GO:0090279),0.6870122929219518,1.5075118195774082,0.04025157232704402,0.22297849809721454,1.0,6/21,12.33%,LGALS3;PKD2;CTNNB1;TRIM27;CCL2;FYN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.73392829773746,1.506103443588368,0.036290322580645164,0.22557850055395512,1.0,7/15,16.03%,PF4;LPL;MSR1;IL18;PRKCH;NFKB1;CD36
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6665105506864275,1.505225348875036,0.0425273390036452,0.22701788590523486,1.0,10/27,16.03%,BTK;IRAK2;TLR1;TLR2;CD14;MAP3K1;LY96;TAB2;TAB3;CD36
prerank,cellular response to lipid (GO:0071396),0.5863789576508515,1.5048688269037125,0.0,0.22732805862300384,1.0,48/191,13.92%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;MAP4K1;AQP1;FZD10;CXCL2;MAPK14;FFAR2;NR1H4;ADCY6;PYCARD;CD68;SPP1;TNFAIP3;CD14;CASP1;HMGB1;ABCB4;CD80;TICAM1;CD180;MEF2C;LY96;CD274;SOX9;CCL2;TNFRSF1B;NRIP1;TWF2;NOD2;DEFA6;CREB1;SHPK;NFKB1;ADCY3;ADCY8;MGST1;PID1
prerank,phagosome-lysosome fusion (GO:0090385),0.7992454549048148,1.5045749696623247,0.03151862464183381,0.22745208664088995,1.0,5/10,5.43%,RAB39A;RAB34;CLN3;RAB7A;RAB7B
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.7337115490181317,1.504240867698694,0.0380952380952381,0.22770386502336756,1.0,3/13,8.18%,PTPRC;MGAT5;DOT1L
prerank,positive regulation of MAPK cascade (GO:0043410),0.5816670477250939,1.504176611205785,0.0,0.22733765707789882,1.0,30/245,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;PIK3CG;PIK3R5;TGFB1;FLT3;CD74;P2RY6;LAPTM5;TAOK3;CSF1R;PLCG2;ADAM8;PTPRJ;DSTYK;OSM;CCL8;TRIM5;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5762817439435372,-1.5039196658443035,0.08620689655172414,1.0,1.0,6/12,26.19%,CAV1;SRI;CALM3;GJD3;PDE4D;CALM2
prerank,regulation of viral entry into host cell (GO:0046596),0.6522948471442784,1.503886096336119,0.03263403263403263,0.22742830562502633,1.0,8/30,11.21%,CIITA;CD74;TRIM25;TRIM5;P4HB;TRIM27;LGALS1;MID2
prerank,cellular component maintenance (GO:0043954),0.7413029909039338,1.503714060322373,0.05955678670360111,0.22725438632046294,1.0,1/12,0.36%,TREM2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.718717705583044,1.5036389105119892,0.03959131545338442,0.22691248044084628,1.0,3/17,1.83%,SCIMP;LYN;TAOK3
prerank,retinol metabolic process (GO:0042572),0.7419635493723419,1.5035126478367842,0.040106951871657755,0.2266666908084248,1.0,2/14,3.05%,CYP1A1;DHRS3
prerank,triglyceride homeostasis (GO:0070328),0.6595198710074046,1.5021765868427712,0.04373522458628842,0.22912402697992157,1.0,8/26,12.23%,LPL;MLXIPL;ANGPTL3;NR1H4;APOE;IL18;LIPC;ANGPTL4
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6493875756061438,1.5007239824040226,0.022753128555176336,0.23195384096871977,1.0,9/33,11.27%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6
prerank,negative regulation of nervous system development (GO:0051961),0.7049694824913285,1.5006727987429713,0.04392764857881137,0.23157927754022598,1.0,6/17,13.13%,HOOK3;TLR2;TNF;PCM1;SORL1;B2M
prerank,positive regulation of T cell migration (GO:2000406),0.694295030227189,1.5004996511312352,0.05112219451371571,0.23146014770399206,1.0,5/20,7.31%,DOCK8;CCR2;PYCARD;AIF1;WNK1
prerank,regulation of activated T cell proliferation (GO:0046006),0.6631324368020358,1.4987910669135813,0.03468208092485549,0.23484751840084198,1.0,7/30,9.75%,PDCD1LG2;CRTAM;PYCARD;IL18;HMGB1;RC3H1;CD274
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.7012681382501649,1.4986258902828433,0.04743083003952569,0.2347262072299347,1.0,5/17,8.92%,SCIMP;LY86;TRIM5;CD180;LY96
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5015576038434596,-1.498419163717448,0.04,1.0,1.0,7/17,10.62%,FSTL1;SULF1;XIAP;SLIT2;PCSK6;TMEM204;TWSG1
prerank,regulation of nervous system process (GO:0031644),-0.499370560564782,-1.498003719312163,0.05855855855855856,1.0,1.0,7/18,12.62%,APP;DLGAP1;HTR2C;DLGAP2;SLC8A3;CHRNA7;NOS3
prerank,Golgi localization (GO:0051645),0.7604561095189156,1.4971161790677823,0.06025824964131994,0.23761214787655802,1.0,4/11,9.42%,HOOK3;RIPOR1;ARHGAP21;UVRAG
prerank,sulfur compound catabolic process (GO:0044273),0.626997354972086,1.49669533047406,0.030167597765363128,0.2379837567437742,1.0,9/38,9.55%,HEXB;PRELP;ARSB;GNS;IDS;HEXA;FMOD;BCAN;TXN2
prerank,anterior/posterior axis specification (GO:0009948),0.7403086557854136,1.4964844714189227,0.03795811518324607,0.23793093558351733,1.0,3/15,4.84%,SHH;SKI;DDIT3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6433473061487367,1.4962471656689496,0.02705749718151071,0.23797535192304256,1.0,10/38,8.02%,PTPRC;CASS4;CSF1R;GPRC5B;THY1;PTPN1;FCGR1A;NCK2;NEDD9;RAP2B
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5750849282419578,1.4956559045489288,0.0,0.23891770912862703,1.0,118/532,14.01%,CD86;SLA;GRAP2;VAV1;PTK2B;IRF5;INPP5D;PF4;PTAFR;IL10RA;CIITA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;CXCL5;LCP1;FLT3;CCR2;CSF3R;AIM2;STAT5A;IL1A;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;TRIM25;PRKCD;PTPRJ;IL21R;GRB2;PIK3CB;TEC;TNFRSF11A;OSM;FCGR1A;IL12RB2;CCL8;TRIM5;TNF;FCER1G;AIP;UBE2V1;TNFSF8;TRAF2;IL6R;CEBPA;IFNAR1;FOXO3;PYCARD;SPI1;IL18;CD300LF;CASP1;TRAF3;TIMP1;RAP1B;CD44;MAP3K14;IFNGR2;SAMHD1;ANXA1;BCL2L1;GAB2;TP53;CD80;ACTN4;PSMB10;PIM1;STAT4;TMSB4X;P4HB;EPO;CAPZA1;ST18;FLT3LG;IL18RAP;ADAR;IRF2;CCL14;ITGAM;STAT5B;TRAF5;TRIM8;RNASEL;IL18BP;SH2B3;PSMA2;CCL13;RAPGEF1;LIMS1;RPS6KA4;ADIPOR1;CCL2;TNFRSF1B;NOD2;FYN;PSME3;TAB2;STX3;IKBKG;LRP8;B2M;PRLR;NFKB1;TRADD;PSMB5;IRF1;IL2RG
prerank,lipid phosphorylation (GO:0046834),0.7679119162196488,1.495651703895897,0.05726872246696035,0.2384027509094201,1.0,6/10,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;DGKI
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7303648945421131,1.4947452764129125,0.04617414248021108,0.23998324925410838,1.0,2/14,2.40%,CD226;MAD2L2
prerank,endothelial cell differentiation (GO:0045446),-0.5740072491987452,-1.4939579613407221,0.0421455938697318,1.0,1.0,8/12,25.31%,FSTL1;ACVRL1;JAG1;SCUBE1;BMPR2;SOX18;ACVR2B;EDF1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7346179442420899,1.4939474761952685,0.06051873198847262,0.2412907352810993,1.0,4/12,7.03%,WDTC1;ERLIN1;ERLIN2;ACADL
prerank,cellular protein catabolic process (GO:0044257),0.619256586453317,1.493867348428489,0.01703940362087327,0.24095024957086472,1.0,22/59,16.53%,CTSS;CTSB;PCSK9;LGMN;CTSC;MYLIP;TCIRG1;CTSK;CTSL;RAB7A;LONP1;AP2S1;MALT1;CHEK2;CTSZ;CLTC;CASP8;UBE2G2;CAPN2;AP2M1;IDE;YME1L1
prerank,mesenchyme development (GO:0060485),0.7270351274011768,1.492597778032623,0.05357142857142857,0.24351682756329554,1.0,3/15,4.10%,MEOX1;TGFBR1;PKD2
prerank,reverse cholesterol transport (GO:0043691),0.7265006691614773,1.4918826890404808,0.040446304044630406,0.2447037214424752,1.0,4/13,8.57%,ABCA1;ABCG1;APOE;LIPC
prerank,second-messenger-mediated signaling (GO:0019932),0.5958066791947159,1.491537134331797,0.0062047569803516025,0.2450541539634889,1.0,19/82,14.53%,BTK;CX3CR1;CCR2;LAT;PLCG2;EDNRB;LAT2;APOE;CXCR4;MCTP1;P2RX4;NUDT4;P2RY12;DGKD;RCAN1;PPP2CA;CAMKK2;DDAH1;LRRK2
prerank,amyloid-beta metabolic process (GO:0050435),-0.5177502188576024,-1.4893234398452628,0.06060606060606061,1.0,1.0,9/16,23.91%,MGAT3;BACE1;DYRK1A;MME;ACE;BACE2;PSEN2;APEH;PSENEN
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7434662094418122,1.4882540728409344,0.06497175141242938,0.25204593115739643,1.0,3/12,3.87%,CBL;PTPRJ;SNCA
prerank,acylglycerol metabolic process (GO:0006639),0.6231878307248965,1.4882172531008846,0.04575892857142857,0.25159102098615826,1.0,10/37,8.24%,DGKZ;LPL;ABHD12;APOE;SEL1L;PGS1;DGKK;DGKE;DGKG;DGKD
prerank,positive regulation of phospholipid transport (GO:2001140),0.756811098247081,1.4879646777057578,0.05706134094151213,0.2516050100888288,1.0,3/10,6.00%,DBI;APOE;ABCB4
prerank,positive regulation of protein maturation (GO:1903319),0.7501098700532615,1.487921177367358,0.052941176470588235,0.25118157033650573,1.0,4/11,14.60%,BAG2;ADAM8;CCBE1;SOX4
prerank,endosome organization (GO:0007032),0.6249607298404034,1.4868564042987318,0.020879120879120878,0.25315703180320875,1.0,19/41,19.29%,HOOK3;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;TMCC1;EXOC8;PI4K2B;HOOK2;USP8;ALS2;CORO1C;LAMTOR1;SNX10;VPS33B;LAPTM4B
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7689983738299334,1.4863902324793106,0.04755043227665706,0.25372126057659616,1.0,3/10,8.09%,NCKAP1L;TGFBR2;PRKCQ
prerank,glycoprotein catabolic process (GO:0006516),0.7004570492723714,1.4862367527922637,0.05786163522012579,0.253507843270219,1.0,4/17,6.91%,MMP12;EDEM1;CTSL;OGA
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5746721387695738,1.4850622445673551,0.0,0.2557751821075844,1.0,26/214,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;LYN;CALCR;TGFB1;SYK;CD74;SIRPA;P2RY6;CSF1R;DUSP3;PTPN1;DUSP29;DSTYK;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6149635530927305,1.4850371777807156,0.01933404940923738,0.2552691015404211,1.0,14/51,13.41%,CCR2;LGMN;CSF1R;MDK;CREB3;IL6R;HMGB1;AIF1;VEGFB;PLA2G7;AKIRIN1;CMKLR1;THBS1;GAS6
prerank,positive regulation of neuron death (GO:1901216),0.6143858899689902,1.484805780983351,0.021953896816684963,0.2553141487384166,1.0,16/46,12.48%,ITGB2;FCGR2B;PCSK9;TNF;SNCA;FOXO3;DDIT3;CTNNB1;TYROBP;MAP3K5;C1QA;TFAP2B;ITGAM;GRN;FYN;DDIT4
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7440058178521739,1.4841415574170753,0.0773405698778833,0.25632040184657207,1.0,2/12,0.77%,PTK2B;UBASH3B
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5847948972829393,-1.4838962587502682,0.0726643598615917,1.0,1.0,3/11,2.48%,ZFPM2;BMPR1A;BMP4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.690165809195273,1.483649763573478,0.05019815059445178,0.2569550835286654,1.0,5/18,8.96%,FCGR2B;ERN1;DDIT3;ATXN3;BAK1
prerank,receptor catabolic process (GO:0032801),0.6629568904966552,1.483021803105022,0.039806996381182146,0.2579277709009948,1.0,14/24,17.85%,TGFB1;PCSK9;LGMN;MYLIP;AP2S1;UVRAG;CLTC;BECN1;SNX25;AP2M1;SMURF1;ZNRF3;PIK3R4;VLDLR
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.635789679482291,1.4828942102376987,0.03444316877152698,0.2576914415956253,1.0,5/34,3.03%,PTK2B;FGR;TGFB1;FLT3;WDR91
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7076684879970929,1.4822030391810546,0.06429548563611491,0.25887536898208063,1.0,2/15,3.58%,TREM2;NLRC3
prerank,myeloid cell development (GO:0061515),0.6942149881308457,1.4821607452602308,0.057034220532319393,0.2584559201906465,1.0,4/18,2.43%,NCKAP1L;GATA1;NRROS;TLR2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5672517709246538,-1.482006714246057,0.07913669064748201,1.0,1.0,8/13,25.26%,CPSF6;FIP1L1;CPSF7;CSTF2;TUT1;CSTF2T;NCBP2;CPSF1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6266048084531818,1.4819423647445409,0.032474804031354984,0.2584573068792267,1.0,14/40,19.20%,ARRB2;PCSK9;CBL;LDLRAP1;HFE;DGKD;NTF3;SCYL2;CD63;B2M;AHI1;GREM1;ANGPT1;TBC1D5
prerank,response to hydrogen peroxide (GO:0042542),0.6134702811015585,1.4810259893458768,0.02282608695652174,0.2601912763682044,1.0,14/45,14.89%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;APTX;HDAC6;PRDX3;FYN;STK24;PLEKHA1
prerank,defense response to symbiont (GO:0140546),0.582542285991464,1.4805347581103938,0.0071794871794871795,0.26081293254985877,1.0,21/92,13.88%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;AGBL5;IRF1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7546201613998311,1.4798472703052679,0.07262569832402235,0.26183573570915886,1.0,2/10,5.08%,IRF4;IL18
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6888387313048927,1.4796289626340302,0.05432098765432099,0.261876763855635,1.0,3/19,2.82%,RUNX1;IRAK2;DHX9
prerank,water transport (GO:0006833),0.7293772400873394,1.479153705973884,0.07776261937244201,0.26264555936647394,1.0,2/12,8.14%,AQP1;AQP11
prerank,regulation of Golgi organization (GO:1903358),0.7025151435267523,1.4789440188150575,0.03534031413612566,0.26262350834091946,1.0,9/17,17.70%,MYO5A;ARMH3;RBSN;USP6NL;MAP2K2;STX5;RAB33B;CAMSAP2;AKAP9
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.756096412085975,1.478835698789678,0.05611510791366906,0.262308621207101,1.0,6/11,12.18%,ATF3;DDIT3;TP53;CREB3L1;CEBPB;ATF6B
prerank,angiogenesis involved in wound healing (GO:0060055),0.7540340082545725,1.4784930625802106,0.05873925501432665,0.2626028116273293,1.0,2/11,1.74%,HPSE;ITGB3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6590611576219519,1.4776515836734405,0.055229142185663924,0.26414035545463616,1.0,10/28,16.65%,CX3CR1;SIRPA;NR1H4;MITF;NOS1AP;ADIPOR1;TNFRSF1B;CTNS;CD47;ADIPOR2
prerank,cyclooxygenase pathway (GO:0019371),0.7698363841297557,1.4755299269447375,0.05698005698005698,0.26892639954165937,1.0,3/10,3.21%,TBXAS1;PTGES3;HPGDS
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.71579047209679,1.474576148650593,0.0644718792866941,0.27070185506369554,1.0,4/14,11.02%,TNF;OCSTAMP;TYROBP;ATP6AP1
prerank,regulation of cellular component size (GO:0032535),0.6393795786599684,1.4735098716558503,0.049943246311010214,0.2728455454973788,1.0,6/30,4.99%,VAV1;PEX11A;RIN3;MTOR;VAV2;VAV3
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.63433857784484,1.4731158817748098,0.032879818594104306,0.27331308998549914,1.0,9/38,11.64%,SCIMP;ADAM8;DHX9;TLR8;LY86;CD180;LY96;PUM2;GRN
prerank,sterol homeostasis (GO:0055092),0.5945545623333659,1.4728914238728343,0.016967126193001062,0.273278068653161,1.0,16/65,12.14%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;ABCD1;LIPC;LRP5;TTC39B;HDAC9
prerank,positive regulation of transport (GO:0051050),0.5930964786497123,1.4726281025712125,0.006179196704428424,0.27338831728670293,1.0,35/85,22.71%,DOCK2;TREM2;SLC11A1;FCGR2B;SIRPA;CAMK1D;TNF;SNCA;FCER1G;APOE;PYCARD;ANXA1;ACTB;BAK1;NEDD4L;DYNC1H1;MERTK;GAS6;IL2RG;LRP1;GSK3A;CD47;LMAN2;RXRA;FLOT1;PLAA;SMPD1;INPP5K;PLA2G5;GSK3B;CYBA;CDH3;CHP1;BID;SGK1
prerank,cholesterol transport (GO:0030301),0.6076476388050152,1.4720609422579631,0.025246981339187707,0.27423470985335247,1.0,10/45,8.57%,ABCA1;MSR1;NPC2;ABCG1;APOE;LDLRAP1;CEL;NPC1;SOAT2;LIPC
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.6409899636086441,1.4718129957243802,0.049008168028004666,0.2743136766268877,1.0,8/33,10.55%,NCKAP1L;GATA1;MAPK14;FOXO3;RAB7B;TAL1;STAT5B;INHBA
prerank,cellular response to ATP (GO:0071318),0.7220041666569971,1.4717754287085116,0.06283422459893048,0.2738297422265416,1.0,5/14,7.66%,P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.7686098128596887,1.4700815470653856,0.057692307692307696,0.2773972105468254,1.0,4/10,9.75%,PDCD1LG2;CRTAM;RC3H1;CD274
prerank,phosphatidylcholine metabolic process (GO:0046470),0.5876456457104398,1.4692141853086302,0.01962809917355372,0.27882195287505096,1.0,14/70,9.94%,PLBD1;DBI;LPIN2;LPCAT1;PCYT1A;CHKB;LPCAT2;CSNK2A2;CSNK2A1;PLA2G7;LIPC;SLC44A2;ABHD4;STARD10
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.628792162524446,1.468759560277217,0.02753303964757709,0.27939911181346994,1.0,10/40,8.27%,PTK2B;RPL23;LAPTM5;PDCL3;XPO1;TAF1;GNA12;HFE;CSNK2A2;CSNK2A1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.44317705612011304,-1.4685647837485787,0.058394160583941604,1.0,1.0,12/26,20.43%,STMN2;SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;RAC1;TRPV4
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.7507243436679176,1.4683389419092838,0.07735583684950774,0.2798431320361177,1.0,5/10,12.98%,CX3CR1;FZD3;CTNNB1;DISC1;SMARCD3
prerank,regulation of neurogenesis (GO:0050767),0.6077200322070037,1.4678736349219985,0.017112299465240642,0.28037719314067855,1.0,12/55,13.13%,HOOK3;ASCL1;CX3CR1;HES7;TNF;BHLHE41;CTNNB1;NAP1L1;PCM1;NUMB;SORL1;B2M
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5935553465020167,1.4675971602876552,0.011652542372881356,0.28044488544023866,1.0,13/62,13.12%,VAV1;LPAR6;LYN;PIK3CG;GRB2;PIK3CB;GPR17;EPO;ERBIN;F11R;RAPGEF1;ADGRG1;ARHGEF3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.6858038612807669,1.467396440060152,0.05562422744128554,0.2803598998498345,1.0,9/21,19.36%,HK3;RPE;GPI;SHPK;HK2;PGLS;GCK;PGD;RBKS
prerank,regulation of cell killing (GO:0031341),-0.5053616632248638,-1.4672870968490022,0.08547008547008547,1.0,1.0,5/16,8.72%,MAPK8;CD55;WNT5A;CR1L;CFH
prerank,response to axon injury (GO:0048678),0.6772966188102247,1.4668564852620216,0.0646830530401035,0.2811493617589929,1.0,5/18,7.66%,TREM2;RTN4RL1;P2RX4;TYROBP;P2RY12
prerank,acetyl-CoA metabolic process (GO:0006084),-0.531493333241616,-1.4660992021776416,0.07450980392156863,1.0,1.0,9/15,24.90%,DIP2A;ACACB;HMGCS2;ACLY;MLYCD;ACSS1;PMVK;MVK;PPCS
prerank,positive regulation of receptor internalization (GO:0002092),0.6581668271245975,1.4660168866323149,0.06765067650676507,0.2827797494155504,1.0,9/22,19.20%,ARRB2;PCSK9;NTF3;SCYL2;CD63;AHI1;GREM1;ANGPT1;TBC1D5
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6797175839694779,1.4658090583337822,0.04040404040404041,0.28271086243603705,1.0,8/20,13.14%,SMOC2;DSTYK;PRKD2;FGFBP3;CREB3L1;SULF2;THBS1;NPTN
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.6191261138346428,1.4657436972835614,0.04352678571428571,0.2823055541870347,1.0,8/39,8.48%,MYO1F;MYO1G;MYO1E;MYO5A;CLN3;ACTN4;MYO7A;MYO19
prerank,positive regulation of glucose import (GO:0046326),-0.47431369738541496,-1.4652366346879597,0.06334841628959276,0.985309723069641,1.0,6/21,15.11%,SORBS1;PRKCI;IRS1;ARPP19;AKT1;OCLN
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6552698661905463,1.4648070831849986,0.06521739130434782,0.28422789740111787,1.0,11/24,17.01%,NFE2L2;ATF3;DDIT3;TP53;CREB3L1;CEBPB;HSF1;ATF6B;RBPJ;HIF1A;GCN1
prerank,positive regulation of nuclear division (GO:0051785),0.6499012159917903,1.4644601289560795,0.07270560190703218,0.2844979728974674,1.0,5/25,11.88%,IL1A;NUP62;RGCC;LRP5;PHIP
prerank,defense response to virus (GO:0051607),0.5741531195012269,1.4644133055825044,0.007135575942915392,0.28406148257389957,1.0,24/100,14.25%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;RNF135;AGBL5;IRF1;ATAD3A;ZDHHC1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6446760341207842,1.4635315467348609,0.05149700598802395,0.2857991009190419,1.0,5/26,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7090509149035854,1.4624424965304543,0.06836461126005362,0.288084964224505,1.0,5/14,11.24%,CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,lytic vacuole organization (GO:0080171),0.6282722219768792,1.4612425596091463,0.05471478463329453,0.2906269473398924,1.0,13/32,17.35%,HOOK3;ABCA1;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;LAMTOR1
prerank,response to organic cyclic compound (GO:0014070),0.5978512800163128,1.460849460279018,0.02553191489361702,0.2910271518924307,1.0,13/52,14.53%,CYP1A1;TGFB1;TNF;SPP1;IL18;ABCB4;CTNNB1;ANXA1;KYNU;STAT5B;CCL2;TIPARP;LRRK2
prerank,response to glucagon (GO:0033762),0.680179237444639,1.4599070737729694,0.05295566502463054,0.29283902907908865,1.0,8/19,13.49%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;CREB1;ADCY3;ADCY8
prerank,regulation of microtubule polymerization (GO:0031113),-0.3967752391616561,-1.4596336240515064,0.04878048780487805,0.9883406715219402,1.0,15/40,15.12%,CDH5;STMN2;SLAIN2;EML2;CLIP1;PAK1;DYRK1A;ABL1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;TUBB4A
prerank,regulation of actin filament polymerization (GO:0030833),0.585094690646383,1.4576492796811176,0.0125,0.2980235269325811,1.0,10/69,5.03%,NCKAP1L;PTK2B;HCK;HCLS1;CYRIB;PRKCD;NCK2;SNX9;PYCARD;ARFGEF1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5644928502330911,-1.4574711632192088,0.06390977443609022,0.9742550160427348,1.0,7/13,15.60%,NFIB;BMP4;REST;PPARA;NFATC4;RELA;PPARG
prerank,macromolecule catabolic process (GO:0009057),0.6454616496116384,1.457366008721318,0.05489260143198091,0.29818371083587064,1.0,13/26,17.55%,TGFB1;LGMN;MTOR;CLN8;UVRAG;TRIM24;BECN1;SNX25;CAPN3;SMURF1;IDE;PIK3R4;USE1
prerank,negative regulation of protein metabolic process (GO:0051248),0.6039502576743627,1.4573510103366907,0.03282275711159737,0.29764667018986485,1.0,6/48,4.14%,CD84;TREM2;ITGB3;MAD2L2;EDNRB;APOE
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6256609878109298,1.4571360182079096,0.055872291904218926,0.29759424628034364,1.0,8/34,11.88%,IL1A;NUP62;ESPL1;RGCC;CDC23;RB1;LRP5;PHIP
prerank,mammary gland development (GO:0030879),-0.46732206147236033,-1.455916758929915,0.061224489795918366,0.9573431403197212,1.0,8/21,16.40%,CAV1;ARHGAP35;WNT4;GLI2;TBX3;GPAT4;TGFB3;NOTCH4
prerank,negative regulation of receptor binding (GO:1900121),0.7531618967325674,1.4556977406730116,0.06715328467153285,0.30071288530697726,1.0,4/10,13.41%,PCSK9;HFE;B2M;ATP2A3
prerank,protein homotrimerization (GO:0070207),-0.5297452246437448,-1.4553409043059893,0.05860805860805861,0.9134814421375312,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,protein trimerization (GO:0070206),-0.5297452246437448,-1.4553409043059893,0.05860805860805861,0.9134814421375312,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,androgen metabolic process (GO:0008209),0.6871620484597006,1.4552747526732317,0.06766917293233082,0.3012335931388555,1.0,3/18,11.50%,SHH;SPP1;HSD17B11
prerank,type I interferon signaling pathway (GO:0060337),0.6055342794086808,1.454728542332783,0.042382588774341354,0.3015771316832196,1.0,9/41,10.76%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,cellular response to type I interferon (GO:0071357),0.6055342794086808,1.454728542332783,0.042382588774341354,0.3015771316832196,1.0,9/41,10.76%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6862791940995762,1.4546960036154633,0.06555269922879177,0.30107683092023774,1.0,5/18,13.98%,LYN;FCER1G;BCAR1;CMKLR1;C3AR1
prerank,negative regulation of cell communication (GO:0010648),0.6594068728789557,1.454260563004344,0.06411837237977805,0.30161430551309976,1.0,3/21,3.12%,UBASH3B;PTPN1;OSM
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6337387493631192,1.4542225591685236,0.056,0.30111777632125386,1.0,10/30,12.34%,PTPRC;CD300A;PRKCD;THY1;SEMA4D;SAMSN1;NTF3;SH2B3;NF2;PPP2CA
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6692483688956641,1.4539444456278978,0.05528255528255528,0.3012613071003163,1.0,4/21,5.47%,RUNX1;CTSK;CTSL;MAFG
prerank,metanephric mesenchyme development (GO:0072075),0.7535154850069901,1.4536797162952833,0.07048458149779736,0.30136944565475804,1.0,3/10,4.10%,SHH;BASP1;PKD2
prerank,positive regulation of kinase activity (GO:0033674),0.5742463905818457,1.4535316215074239,0.008171603677221655,0.30117378392044014,1.0,14/107,6.25%,PTPRC;LCP2;PTK2B;TREM2;FLT3;CD74;LAT;CSF1R;MMD;DSTYK;SNX9;TNF;XRCC5;MAP2K3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7222230953563493,1.4534998409781938,0.0763888888888889,0.3006876110548423,1.0,5/13,9.07%,HEXB;ARSB;IDS;HEXA;BCAN
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.664993989014105,1.4531059430181952,0.057177615571776155,0.3010907691490314,1.0,7/21,16.50%,BAG2;RPL23;MAD2L2;UBE2S;FZR1;RPL11;PTEN
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5786283382029528,1.4529003155295577,0.0196078431372549,0.3005192965770232,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5786283382029528,1.4529003155295577,0.0196078431372549,0.3005192965770232,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,small GTPase mediated signal transduction (GO:0007264),0.572328033280751,1.4521700390938455,0.010224948875255624,0.30183557953110823,1.0,19/103,9.01%,ARHGAP30;GRAP2;ABR;RIN2;LAT;RREB1;GRB2;MAPK14;ARHGEF18;RASGRP2;RGS19;PLD2;RGL2;SHC2;TP53;PLK2;RASGRP3;RB1;ARHGAP1
prerank,cellular response to glucagon stimulus (GO:0071377),0.6868835013243766,1.450327405847533,0.06447534766118837,0.3058430937107716,1.0,7/17,13.49%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;ADCY3;ADCY8
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6629470659025789,1.449746173384394,0.07037037037037037,0.30678790562621094,1.0,10/20,14.79%,NR1H4;SREBF2;APOE;LDLRAP1;FMO5;ACADL;SEC14L2;TTC39B;SREBF1;ARV1
prerank,pre-miRNA processing (GO:0031054),0.6991007891486518,1.44953011191707,0.08165997322623829,0.3067735481165541,1.0,11/14,25.04%,ADAR;AGO4;AGO3;PRKRA;TUT7;TARBP2;AGO2;DICER1;LIN28B;DROSHA;AGO1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6374654843323659,1.4488110291426481,0.06651108518086347,0.3080095541088106,1.0,4/28,2.00%,TREM2;BAG2;LAPTM5;CTSC
prerank,cholesterol homeostasis (GO:0042632),0.5857349580650567,1.4487038146701432,0.028692879914984058,0.30769900691616886,1.0,15/64,12.14%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;LIPC;LRP5;TTC39B;HDAC9
prerank,steroid metabolic process (GO:0008202),0.5905205621021198,1.448165032663738,0.018691588785046728,0.3084838443510531,1.0,7/72,5.97%,CYP1A1;SHH;LGMN;TSPO;LIPA;NPC1;DHRS11
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5983811736634251,1.4470279217981294,0.03771551724137931,0.31074727129609636,1.0,15/57,9.02%,SYK;LGMN;AIM2;CTSD;TNF;PYCARD;CASP1;HMGB1;ASPH;MAP3K5;TBC1D10A;MALT1;GRAMD4;BAK1;PDCD6
prerank,megakaryocyte differentiation (GO:0030219),0.739398392551218,1.4468482231669924,0.07670454545454546,0.31059560861459967,1.0,3/11,10.93%,GATA1;TAL1;SH2B3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5886112118027028,1.4461552185916635,0.03598691384950927,0.3120127949019908,1.0,20/54,18.47%,TGFB1;STAT5A;ANGPT4;MAPK14;TNF;RGCC;PRKD2;APOE;P2RX4;HMGB1;MAP2K3;TMSB4X;MEF2C;THBS1;ATP5F1A;PRCP;NF1;HIF1A;PDPK1;ANGPT1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6072803388265599,1.445509608755087,0.048298572996706916,0.3131785989858927,1.0,12/41,16.34%,CASS4;STAP1;CSF1R;GPRC5B;PTPN1;FCGR1A;NEDD9;FYN;LRP8;GAS6;SRC;EPHA4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.678063233670723,1.4453041868751544,0.0850253807106599,0.31315087146968823,1.0,3/16,3.81%,ITGB2;MDK;TNF
prerank,carboxylic acid catabolic process (GO:0046395),0.7170365035943875,1.4451497205142032,0.07282913165266107,0.31299592368865303,1.0,4/12,7.33%,NPL;RENBP;NAGK;PON3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.589376798693568,1.4450846749463537,0.034519956850053934,0.312574280074998,1.0,17/54,14.82%,SYK;LAPTM5;RFFL;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;CASP1;CFLAR;TAX1BP1;IKBKG;CASP8;GPS2;GAS6;TRADD;SPPL2A
prerank,regulation of store-operated calcium entry (GO:2001256),0.7384177995015293,1.4446727793102971,0.10089020771513353,0.3131653039036035,1.0,1/10,0.09%,CD84
prerank,regulation of GTPase activity (GO:0043087),0.5614755487406832,1.444578271580691,0.002,0.31283799378384103,1.0,52/177,17.17%,FGD2;VAV1;DOCK8;RGS10;KLRK1;ARHGAP9;ARHGAP15;FZD10;THY1;PLXNC1;VAV2;RASA4;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;GPR137B;PLXNB2;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;FGD6;USP6NL;DOCK11;DOCK10;AGRN;WNK1;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;ADAP1;MMUT;LRRK2;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;EPHA4;CPEB2;SNX13;CCL25;SNX18
prerank,cortical cytoskeleton organization (GO:0030865),0.6068365252401993,1.4443921998066882,0.0550561797752809,0.3127999833293928,1.0,6/41,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5520238450427533,-1.4438642366041015,0.09385113268608414,0.9501830536608603,1.0,4/11,15.07%,GHR;IRS1;EIF2AK3;AKT1
prerank,cell projection organization (GO:0030030),0.6322554305809941,1.4437133435379657,0.041666666666666664,0.3139774088578125,1.0,6/30,11.19%,NCKAP1L;PLEK;NEFH;P2RY12;PARVB;CYFIP1
prerank,embryonic appendage morphogenesis (GO:0035113),0.7330353503323535,1.443480409441156,0.08276797829036635,0.3139893331846064,1.0,2/12,4.36%,SHH;SKI
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.570688208004012,-1.443391057663587,0.09454545454545454,0.9306277439635038,1.0,4/12,4.78%,NFIB;GLI2;PAFAH1B1;EPHB2
prerank,ganglion development (GO:0061548),0.7442650405781447,1.443022921269248,0.0784313725490196,0.31464826609217,1.0,5/11,11.24%,ASCL1;TUBB3;FZD3;CTNNB1;NRP1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7500255613992446,1.442001352772469,0.0707070707070707,0.3167294639367605,1.0,2/10,3.12%,HK3;PFKL
prerank,regulation of glucose import (GO:0046324),-0.41603952765951885,-1.441456472797434,0.060240963855421686,0.9198346187086017,1.0,8/30,15.11%,SORBS1;GRB10;PRKCI;IRS1;SELENOS;ARPP19;AKT1;OCLN
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5720950253968926,1.4412032609370942,0.024640657084188913,0.31819897686830684,1.0,22/79,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6829705955543677,1.440777368160325,0.08609271523178808,0.31872728354351215,1.0,4/16,7.23%,RUNX1;TGFB1;RGCC;CREB3L1
prerank,regulation of leukocyte activation (GO:0002694),0.704013711680793,1.4396010156198924,0.08083441981747067,0.32124884870379755,1.0,3/14,4.54%,LYN;CD74;GPR137B
prerank,regulation of cellular respiration (GO:0043457),0.6782580355484106,1.439403424152934,0.06962025316455696,0.32118717506017713,1.0,4/17,7.84%,IL10RB;CBFA2T3;IFNAR1;TRAP1
prerank,response to sterol (GO:0036314),0.7289313006320929,1.439334730362964,0.09195402298850575,0.32079468874572065,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.687717581630179,1.4384421490455748,0.08653846153846154,0.3224848439752219,1.0,5/15,11.09%,TREM2;MAPK14;RIPOR2;TYROBP;CD53
prerank,ventricular septum morphogenesis (GO:0060412),-0.4266535577732734,-1.438262252510426,0.0641025641025641,0.9149276587557399,1.0,9/27,7.15%,ZFPM2;BMPR1A;ROBO2;BMP4;ACVR1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.611791746565123,1.4368104919572604,0.051762114537444934,0.32622465461319566,1.0,12/38,16.50%,ARRB2;PTPRJ;PIK3CB;DDIT3;XDH;OTUD3;FLCN;PDCD6;SH2B3;PLEKHA1;PHLPP1;PTEN
prerank,actin crosslink formation (GO:0051764),0.7284799011417211,1.4366585957437266,0.07607192254495158,0.3260326970247489,1.0,4/12,6.51%,LCP1;GAS2L1;GAS2L3;AIF1
prerank,estrogen metabolic process (GO:0008210),0.6883393674110957,1.4366333707263388,0.09054593874833555,0.3255290784165409,1.0,1/15,0.47%,CYP1A1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6200375747733586,1.4350017461644586,0.07482993197278912,0.32920195092516163,1.0,2/33,0.14%,RUNX1;KLK3
prerank,regulation of cell size (GO:0008361),0.6499138841667208,1.4347698217512126,0.06779661016949153,0.32919936955183604,1.0,5/23,4.99%,VAV1;PLEK;MTOR;VAV2;VAV3
prerank,regulation of neuron death (GO:1901214),0.5678613503936759,1.4338367406642134,0.02158273381294964,0.3311964069027135,1.0,21/82,13.27%,GPNMB;ITGB2;FCGR2B;PCSK9;CD200R1;SNCA;TRAF2;TYROBP;MAP3K5;C1QA;MEF2C;KIF14;CTSZ;PPARGC1A;ITGAM;TNFRSF1B;FYN;DDIT4;SORL1;IKBKG;RRAS2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6533795424224353,1.4331844196618975,0.07840772014475271,0.3324994115490637,1.0,6/23,12.71%,PTK2B;UBASH3B;NOS1AP;DIAPH1;FYN;CACNB1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5631925569500912,1.4320599371274023,0.01020408163265306,0.33502722456190526,1.0,31/98,19.41%,ARRB2;TGFB1;PCSK9;IL10RB;VAMP3;GRB2;MAPK14;SNCA;APOE;IFNAR1;XDH;TGFBR2;TP53;NTF3;SCYL2;RAB1B;INHBA;THBS1;CD63;PID1;STARD4;FASN;AHI1;ACACA;PPARD;GREM1;ANGPT1;GHITM;TBC1D5;SCRIB;RAB29
prerank,cell chemotaxis (GO:0060326),0.5881426459822442,1.4317327922620176,0.022532188841201718,0.33530912083741865,1.0,11/60,11.24%,ARRB2;CX3CR1;BIN2;CCR2;PRKCD;CXCR4;DOCK4;PRKCQ;BCAR1;ABCC1;NRP1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4697236796196209,-1.4300658512719822,0.06914893617021277,0.9344175262488039,1.0,7/21,10.09%,CACNA1C;ANK2;RYR2;DMD;SRI;ATP1A2;CALM3
prerank,protein-DNA complex disassembly (GO:0032986),0.6746655303976253,1.4297006726618386,0.07942708333333333,0.340206957604224,1.0,5/16,13.09%,NFE2;RPL23;ARID1A;SMARCD3;SMARCB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.6295474427307358,1.4296341389815077,0.06159420289855073,0.339818102579821,1.0,14/28,16.66%,TREM2;FGR;FCGR2B;TRIM5;TRAF3;SAMHD1;ZMPSTE24;RNF135;CASP8;LRP8;ERAP1;IRF1;CD36;APPL2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7312919102914387,1.4292307263047548,0.0951683748169839,0.3403243136223194,1.0,5/10,13.17%,LYN;STAT5A;PTPN1;STAT5B;PRLR
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5749417879314822,1.4286005049332777,0.04250797024442083,0.3414407770137149,1.0,12/66,7.90%,CX3CR1;AIM2;SIRPA;LPL;P2RX7;TLR8;TNF;PYCARD;TNFAIP3;CASP1;TYROBP;MALT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6448755269738425,1.428310728787607,0.07627118644067797,0.3416413823936682,1.0,3/23,4.96%,HOOK3;TUBB;CCDC88B
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.698040829195495,1.4278812790266215,0.09907529722589167,0.3422484779927862,1.0,2/13,1.20%,ANAPC15;PCID2
prerank,regulation of cell development (GO:0060284),0.6102438949918082,1.4268944065333122,0.05747126436781609,0.34438354212049754,1.0,8/36,12.14%,ASCL1;CX3CR1;SLAMF8;HES7;BHLHE41;CTNNB1;GRN;HDAC9
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6917220530773046,1.4259126855630875,0.07320261437908497,0.3464757793725914,1.0,3/15,2.40%,BAG2;RPL23;MAD2L2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6538651541626195,1.4253902712953792,0.09261576971214018,0.34725180714108084,1.0,2/19,2.35%,PTPRC;PTPRJ
prerank,regulation of interleukin-13 production (GO:0032656),0.6897621346208812,1.424518638650827,0.10233160621761658,0.34896635451371427,1.0,3/13,10.63%,IRF4;IL18;TNFRSF21
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.649341533945515,1.4244396723226576,0.09125,0.34855963261641504,1.0,2/19,5.09%,CX3CR1;TNFAIP3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.638727252783688,1.4244352820909436,0.07334963325183375,0.34796601223542073,1.0,12/25,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,positive regulation of macrophage activation (GO:0043032),0.6810742550547503,1.42350380759364,0.08408796895213454,0.3499024039843958,1.0,3/17,4.57%,TREM2;STAP1;CEBPA
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7170234441659274,1.4233960617330115,0.09431345353675451,0.3496329611265517,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,lipid homeostasis (GO:0055088),0.5778524075117577,1.4217609457820433,0.0255863539445629,0.3534576991058828,1.0,12/57,9.00%,TREM2;ABCA1;MLXIPL;ANGPTL3;CLN8;ABCG1;APOE;CEBPA;ABCB4;USF1;ABCD1;ABHD4
prerank,glycogen catabolic process (GO:0005980),-0.5013512474566428,-1.4217057494507075,0.09663865546218488,0.957372956123506,1.0,7/15,21.94%,PHKA2;PYGB;PHKG2;PHKB;PYGM;AGL;PHKA1
prerank,cellular response to drug (GO:0035690),0.6342731423504158,1.421375205617137,0.07891637220259129,0.3539049357385271,1.0,5/25,8.10%,AIM2;SLAMF8;RAP2A;TP53;MEF2C
prerank,regulation of vesicle-mediated transport (GO:0060627),0.5730090357932058,1.4206144273777324,0.020387359836901122,0.3554236929106365,1.0,15/91,11.64%,PTPRC;CD22;FGR;HCK;SYK;RAB8B;PTPN1;AP2S1;STON2;DNAJC13;RAB11A;MAP2K2;USP7;NRP1;STON1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6915978994509744,1.420481567181131,0.09153005464480875,0.3552372677019741,1.0,4/13,9.57%,ITGB2;MDK;TNF;FUT9
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6191841687258203,1.4200868578287258,0.07068366164542295,0.3557418041173663,1.0,6/30,11.04%,VAV1;LYN;GRB2;EPO;ERBIN;RAPGEF1
prerank,regulation of stem cell proliferation (GO:0072091),0.6747648026894265,1.4199164615778765,0.08226221079691516,0.3556110209910308,1.0,1/17,0.11%,PTPRC
prerank,phospholipid translocation (GO:0045332),0.6276247283801888,1.4192740836728286,0.05764705882352941,0.3567856132565039,1.0,8/28,12.70%,ATP8B4;ABCA1;P2RX7;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,cell projection assembly (GO:0030031),0.6445379057235696,1.4191435450529204,0.06569343065693431,0.35654278549906865,1.0,2/22,1.31%,NCKAP1L;NEFH
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6885788471518752,1.4188893049493203,0.09779614325068871,0.35667901900569415,1.0,3/14,2.55%,LYN;STAT5A;PTPN1
prerank,positive regulation of proteolysis (GO:0045862),0.5774977085536455,1.418492411187418,0.0417558886509636,0.3571992962298788,1.0,18/55,14.80%,BAG2;CTSC;ADAM8;SNX9;TNF;AURKAIP1;APOE;TANK;SNX33;ASPH;TBC1D10A;ATP5IF1;BAK1;TNFRSF1B;CCBE1;CASP8;STUB1;CAPN3
prerank,negative regulation of leukocyte migration (GO:0002686),0.7160805536168796,1.4183924880198262,0.0915805022156573,0.3568640458245446,1.0,3/10,1.96%,CD300A;CD200R1;SLAMF8
prerank,sympathetic nervous system development (GO:0048485),0.6842273549281497,1.4179757439446767,0.09894459102902374,0.3574011695452914,1.0,7/15,16.02%,ASCL1;FZD3;CTNNB1;TFAP2B;NRP1;SOX4;NF1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.6398298806653342,1.4175480505684988,0.0752157829839704,0.35734992669637355,1.0,12/24,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,canonical glycolysis (GO:0061621),0.6398298806653342,1.4175480505684988,0.0752157829839704,0.35734992669637355,1.0,12/24,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,TOR signaling (GO:0031929),0.61297077623318,1.417410122593714,0.0821256038647343,0.3570713782284635,1.0,7/26,9.29%,CARD11;MTOR;FNIP1;EIF4EBP2;FLCN;LARP1;SMG1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6774893423984995,1.4171120156391583,0.09833795013850416,0.3572973184826275,1.0,5/15,7.46%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X
prerank,high-density lipoprotein particle assembly (GO:0034380),0.7307892133869499,1.416960297239474,0.09662576687116564,0.35710839996540505,1.0,3/10,11.47%,ABCA1;APOE;PRKACB
prerank,fluid transport (GO:0042044),0.7113770672584556,1.4169119933445793,0.10814606741573034,0.35664279510158026,1.0,2/12,8.14%,AQP1;AQP11
prerank,positive regulation of interferon-beta production (GO:0032728),0.6191039721004887,1.416549725190487,0.05074971164936563,0.3570857289209407,1.0,5/33,2.91%,IRF5;TLR2;DHX9;TLR8;TLR7
prerank,regulation of endocytosis (GO:0030100),0.587309780359672,1.4161412466189998,0.034736842105263156,0.35764589362248883,1.0,12/61,11.64%,CD22;LILRB1;LGALS3;PTPN1;SNCA;APOE;MCTP1;SNX33;AP2S1;STON2;NEDD4L;STON1
prerank,cellular response to fluid shear stress (GO:0071498),0.7119082623453831,1.4160102586057353,0.09322033898305085,0.3574000901944922,1.0,5/12,8.10%,NFE2L2;SREBF2;PKD2;MTSS1;MEF2C
prerank,protein processing (GO:0016485),0.5586002511047711,1.4158563832421371,0.019348268839103868,0.3572531228124117,1.0,19/102,9.46%,CTSS;KLK3;PCSK9;LGMN;FAM111A;VSIR;SRGN;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CASP1;DDI2;SPCS2;ATP23;SEC11C;ZMPSTE24;SPPL3;SPCS1
prerank,regulation of chromatin binding (GO:0035561),-0.5732392428139834,-1.4147136267191067,0.09634551495016612,0.9714935945596499,1.0,5/10,16.92%,WAPL;BTAF1;DTX3L;KDM4D;HMBOX1
prerank,regulation of T cell mediated immunity (GO:0002709),0.7489463395948947,1.414645504155143,0.0979020979020979,0.3600678488376243,1.0,3/10,11.69%,CCR2;HMGB1;TNFRSF1B
prerank,sensory perception of pain (GO:0019233),0.6494657071038107,1.4145700295278503,0.08848484848484849,0.3596861974194233,1.0,7/21,13.51%,CCR2;P2RX7;PRDM12;P2RX4;CCL2;SCN9A;RETREG1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5870047118619665,1.4145679815910122,0.06111111111111111,0.3590989432045886,1.0,13/45,16.03%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.647066404497264,1.414564784390449,0.06610576923076923,0.35852033041532777,1.0,3/23,4.51%,CYP1A1;ALOX12;HPGD
prerank,positive regulation of cellular component organization (GO:0051130),0.5586071274194978,1.4142137607812235,0.013278855975485188,0.3589141618240658,1.0,18/107,10.05%,RUNX1;TREM2;LGALS3;PLEKHM2;TGFB1;SYK;FNIP2;TGFBR1;TNF;FNIP1;SNCA;ASAP1;APOE;ABCB4;TAL1;RB1;BAK1;NEDD4L
prerank,positive regulation of cellular catabolic process (GO:0031331),0.5525913404882569,1.413653577342642,0.007049345417925478,0.35986900675484057,1.0,48/132,17.02%,LAPTM5;ADAM8;DAGLB;PRKCD;P2RX7;PTPN1;MLXIPL;PIK3CB;SNX9;TRIM5;TNF;SNCA;APOE;CNOT8;FOXO3;SNX33;PFKFB4;HMGB1;TFEB;GTPBP1;ABCD1;PIM2;SVIP;TICAM1;PLK2;GRSF1;VPS11;FLCN;MOV10;TRIM27;RC3H1;AMER1;TRIM8;ZC3H18;MID2;TNFRSF1B;ITCH;LRRK2;RNF152;MTDH;GSK3A;PFKFB3;IRGM;HIF1A;FAF1;HSP90AA1;GAPDHS;FURIN
prerank,cell proliferation in forebrain (GO:0021846),0.7351620483475168,1.4136289982363919,0.10186513629842181,0.3593404221765129,1.0,5/10,12.62%,HOOK3;AKNA;KIF14;PCM1;NUMB
prerank,cellular response to amyloid-beta (GO:1904646),0.6030197150690211,1.413435896018125,0.06719817767653759,0.3592806168344665,1.0,11/35,16.34%,TREM2;FCGR2B;LGMN;ITGA4;CACNA1A;ABCC1;FYN;CACNB1;LRP1;CD36;EPHA4
prerank,regulation of cholesterol efflux (GO:0010874),0.6090651208812955,1.4131487590206928,0.09004739336492891,0.3595307610942125,1.0,12/30,18.30%,TREM2;SHH;SREBF2;APOE;EEPD1;TTC39B;GPS2;LRP1;ABCA3;LAMTOR1;NAXE;RXRA
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.46069623157589296,-1.413041757078713,0.09375,0.9408317060278532,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.46069623157589296,-1.413041757078713,0.09375,0.9408317060278532,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.661233266694134,1.4126622638081905,0.09718670076726342,0.3602273451269815,1.0,8/18,16.02%,CD300A;NLRC3;SKI;MORC3;TP53;B4GALT7;FTH1;NF1
prerank,positive regulation of cation channel activity (GO:2001259),0.5994594034196252,1.4125817112867143,0.05855855855855856,0.3598593020036546,1.0,7/40,7.46%,CTSS;CCR2;P2RY6;PKD2;KCNIP2;STAC;TMSB4X
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5914118674765814,1.4125684519257014,0.04896626768226333,0.35931677977876475,1.0,6/46,2.61%,PTPRC;LYN;SIRPA;DUSP3;PTPN1;DUSP29
prerank,diacylglycerol metabolic process (GO:0046339),0.6318306347180485,1.4119933294054032,0.0880893300248139,0.3602800314155827,1.0,8/23,12.79%,DGKZ;PGS1;DGKK;DGKE;DGKG;DGKD;DGKI;LIPE
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6609545986450562,1.411981714189196,0.10894941634241245,0.3597303210674267,1.0,3/17,7.57%,TREM2;NFE2L2;P4HB
prerank,dendrite morphogenesis (GO:0048813),-0.385594086617584,-1.4117944270026541,0.06796116504854369,0.9282951924913626,1.0,11/35,11.11%,PTN;DCDC2;BTBD3;TAOK2;FARP1;EPHB2;DIP2A;CHRNA7;MAP6;SHANK3;SHANK1
prerank,regulation of protein kinase A signaling (GO:0010738),0.6536425318550593,1.411492320181905,0.10279187817258884,0.3605496174394607,1.0,5/20,14.53%,CALCR;PRKAR2B;AKAP5;IAPP;LRRK2
prerank,pancreas development (GO:0031016),-0.5313931464362127,-1.4114040840162252,0.10616438356164383,0.9123080518532221,1.0,5/12,20.28%,TCF7L2;NPHP3;MET;CCDC39;ZIC3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5516556108490784,1.4112058286471842,0.009027081243731194,0.3607323352658612,1.0,21/152,7.66%,GNA15;CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;PSAP;GNAZ;ADCY6;AKAP5;S1PR4;ADGRG3;GNA13;GNA12;RAMP1;WASF2;P2RY12
prerank,regulation of hydrolase activity (GO:0051336),0.5665589426241426,1.4108834689094751,0.03333333333333333,0.361077219068685,1.0,11/71,5.92%,FGD2;VAV1;ARHGAP9;ARHGAP15;PLXNC1;VAV2;GPR137B;PLXNB2;VAV3;RAB3GAP2;FGD6
prerank,substrate-dependent cell migration (GO:0006929),0.6804849966091133,1.4108341817723085,0.10807113543091655,0.3606151041515438,1.0,5/14,12.29%,PTPRC;ITGA2;P2RY12;NRP1;SDCBP
prerank,positive regulation of JUN kinase activity (GO:0043507),0.626048399772151,1.410677469171883,0.09888751545117429,0.3604264929438444,1.0,7/23,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP19
prerank,activation of GTPase activity (GO:0090630),0.560652644016932,1.4102355312058648,0.031664964249233915,0.3610745246465593,1.0,19/89,12.62%,ARHGAP45;ARHGAP25;TBC1D9;ABR;SIPA1L2;ARHGAP22;TBC1D10C;ARHGAP24;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;SIPA1;NTF3;RAP1GAP2;TBC1D2;TBC1D17;TBC1D2B;TBC1D8
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.5486506464514534,1.4101127256851413,0.001001001001001001,0.3608269771571817,1.0,43/190,12.90%,ARRB2;CD22;TREM2;LYN;ARHGAP25;PLEK;CYRIB;PTPRJ;DUSP3;P2RX7;PIK3CB;RFFL;MAPK14;TSPAN6;NLRC3;NR1H4;FNIP1;HERPUD1;TANK;PYCARD;DDIT3;SPI1;MGRN1;TNFAIP3;WWC2;XDH;ADGRG3;MAP2K3;BCL2L1;OTUD3;TMSB4X;DGKG;DGKD;FLCN;PDCD6;PDE11A;SH2B3;THBS1;ADIPOR1;CDC34;DDIT4;NLRX1;CASP8
prerank,regulation of hormone secretion (GO:0046883),0.6779289925642329,1.409938601070269,0.08672086720867209,0.3607237351466658,1.0,4/15,6.34%,VAMP3;OSM;FFAR2;ANXA1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6573077267104258,1.409199849563577,0.09796437659033079,0.3620944179355107,1.0,6/18,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6419323452138237,1.4084627003746153,0.09500609013398295,0.36352740300438396,1.0,3/23,3.69%,TGFB1;MYL3;PKP2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5661998230667784,1.408424270935779,0.04994686503719448,0.3630681546653361,1.0,18/59,14.64%,CARD11;IRAK2;TLR2;TLR8;TLR7;NLRC3;TNF;TANK;TRAF2;CD14;MAP3K14;TICAM1;LY96;IRAK1BP1;TAB2;IKBKG;TRADD;TAB3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5962161001039016,1.4081421536034369,0.06152125279642058,0.3633023363130066,1.0,6/40,5.90%,FGR;MPEG1;TLR2;DMBT1;STAB2;PPP1R11
prerank,positive regulation of stem cell proliferation (GO:2000648),0.662346193768668,1.4081106718442844,0.10586734693877552,0.3628206246390154,1.0,1/17,0.11%,PTPRC
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6310140542628868,1.4080823698992837,0.09617755856966707,0.3623339707918029,1.0,4/22,4.11%,GSAP;LYN;TNF;ABCG1
prerank,protein-containing complex subunit organization (GO:0043933),0.5530766365587235,1.407352857928039,0.02028397565922921,0.3638036822080407,1.0,27/109,13.71%,NCKAP1L;PTK2B;CD3E;CD74;VAMP3;SKAP2;SNX9;WIPF1;MITF;TRAF2;TEAD1;TP53;SEH1L;CAPZA1;HFE;PPARGC1A;EPRS1;TUBGCP4;TPR;SOX9;NUP205;DET1;MDN1;RANBP9;IKBKG;DARS1;TSPAN4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7075853647494053,1.4070322295165403,0.09707446808510638,0.36413024588893184,1.0,3/11,8.09%,NFKBID;MALT1;PRKCQ
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7124222775500233,1.4069115803321015,0.10422535211267606,0.3638721404904428,1.0,2/11,5.65%,CD74;CD44
prerank,wound healing (GO:0042060),0.5669876466476885,1.4067951569566246,0.05042016806722689,0.36362929202522976,1.0,18/62,17.18%,MMP12;HPSE;SLC11A1;ITGB3;TGFBR1;MYH9;MACF1;CFLAR;SMAD3;SYTL4;DYSF;NRG1;PRCP;DST;AHNAK2;NF1;ARL8B;DCBLD2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7119586903801937,1.4061886760869506,0.1056338028169014,0.36408524633313305,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7119586903801937,1.4061886760869506,0.1056338028169014,0.36408524633313305,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6256234032452861,1.4056307411714202,0.08472553699284009,0.36504954156596114,1.0,3/24,1.40%,HPSE;TGFB1;IL1A
prerank,"wound healing, spreading of cells (GO:0044319)",0.6372117376232301,1.4055142937774876,0.06467065868263473,0.3647936097213786,1.0,5/24,6.17%,MMP12;LCP1;ARHGAP24;CD44;MRTFA
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6210260185862191,1.4039305803344395,0.09057527539779682,0.36856515054135225,1.0,9/24,11.64%,PCSK9;TNF;FOXO3;DDIT3;CTNNB1;TYROBP;TFAP2B;ITGAM;GRN
prerank,cellular response to nutrient levels (GO:0031669),0.5646077336269749,1.4033384796994077,0.04772004241781548,0.36956570807056294,1.0,12/62,8.33%,PCSK9;LPL;GAS2L1;MTOR;ATG7;FNIP1;SREBF2;MAP1LC3B;CD68;TFEB;RIPOR1;FLCN
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6341676006276586,1.4031174179596224,0.08695652173913043,0.3695754943175446,1.0,1/23,0.08%,PLBD1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.689476365297292,1.4029763059494345,0.1078167115902965,0.36941719427426845,1.0,2/13,2.21%,SHH;ADAM8
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6101694183619698,1.4027996321912142,0.09382422802850356,0.3693068730700397,1.0,14/28,17.04%,IRAK2;MAP2K6;UBE2V1;OTULIN;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;LACC1;TAB3;IRGM;UBE2N
prerank,regulation of plasminogen activation (GO:0010755),0.6871543153806933,1.4020102199667093,0.1136986301369863,0.37071263077473743,1.0,4/12,15.23%,RUNX1;CTSZ;THBS1;PLGRKT
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6292907017978014,1.4019859775503671,0.08220858895705521,0.3701950804498879,1.0,4/23,4.54%,PTPRC;CBL;THY1;ZFYVE28
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4599234965457731,-1.4019343306163619,0.07246376811594203,0.938903072846968,1.0,15/19,46.05%,NPHP3;CCDC39;SPEF2;OFD1;NEK10;CABYR;CFAP53;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;ODAD4;CCDC40;DNAAF4
prerank,positive regulation of phosphatase activity (GO:0010922),0.6462632498144876,1.4017573194546735,0.09950248756218906,0.37025266915141647,1.0,4/21,8.10%,PLEK;CD300A;MTOR;MEF2C
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6927982841925252,1.4012665251389416,0.1103448275862069,0.3710967094180488,1.0,3/12,10.47%,CD74;CD44;RPL26
prerank,regulation of nervous system development (GO:0051960),0.6003617410750519,1.4007385585264043,0.06621773288439955,0.37202298618048735,1.0,6/37,8.15%,ASCL1;CX3CR1;HES7;BHLHE41;CTNNB1;KIF14
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6950341372525819,1.399925607866846,0.11126564673157163,0.37246908189612726,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6950341372525819,1.399925607866846,0.11126564673157163,0.37246908189612726,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6950341372525819,1.399925607866846,0.11126564673157163,0.37246908189612726,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.602751166124465,1.3994373377122138,0.06775700934579439,0.37324554342052946,1.0,4/34,8.10%,ARRB2;NPAS4;GABRA5;MEF2C
prerank,regulation of receptor internalization (GO:0002090),0.5993128896574629,1.3992604850830135,0.08352402745995423,0.3731575754855089,1.0,13/35,19.20%,ARRB2;PCSK9;RIN3;NTF3;SCYL2;CD63;SDCBP;ANKRD13A;AHI1;FLOT1;GREM1;ANGPT1;TBC1D5
prerank,T cell mediated immunity (GO:0002456),0.6959492409693815,1.399089585618038,0.10267229254571027,0.3730387445262004,1.0,3/13,6.12%,MYO1G;CRTAM;BTN3A3
prerank,dopaminergic neuron differentiation (GO:0071542),0.6546416545423773,1.3989551593648137,0.08796895213454076,0.37287675777588536,1.0,2/19,6.29%,SHH;CTNNB1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.6161792765128521,1.3979047765852701,0.10204081632653061,0.3752043546661537,1.0,4/26,4.78%,LYN;AIM2;VSIR;PYCARD
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.6364809427693727,1.3973568155276592,0.11012658227848102,0.3761551899642684,1.0,2/20,0.51%,PTK2B;PF4
prerank,activation of protein kinase activity (GO:0032147),0.5473486231678144,1.3969513653745063,0.019367991845056064,0.37673339210449663,1.0,25/106,13.59%,CD86;PTK2B;SLC11A1;ADCY7;PRKAR2B;ITGB3;TAOK3;PRKCD;MTOR;TRAF2;ADCY6;IL18;TGFBR2;TNIK;MALT1;KIF14;STRADB;NTF3;PRKACB;NRG1;PRLR;GAS6;ADCY3;ADCY8;STK3
prerank,polyol metabolic process (GO:0019751),0.579963903109728,1.3968352147690914,0.06820682068206821,0.3764895709421067,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6659201703112387,1.396580623646347,0.12080536912751678,0.37662592817474294,1.0,6/15,11.24%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X;THBS1
prerank,inositol phosphate metabolic process (GO:0043647),0.5795025012401556,1.3958062812075211,0.06263736263736264,0.37815415805402464,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of phospholipase C activity (GO:1900274),-0.5070420713365306,-1.3957448605271883,0.12790697674418605,0.9506377904685821,1.0,4/15,6.80%,NTRK3;PLCG1;ABL1;PDGFRA
prerank,response to fatty acid (GO:0070542),0.6647736788214383,1.3953669324638434,0.10182767624020887,0.37876740728321495,1.0,7/17,16.03%,LPL;FFAR2;NR1H4;FOXO3;SOX9;PID1;CD36
prerank,positive regulation of GTPase activity (GO:0043547),0.5427994567806153,1.395171244183449,0.008016032064128256,0.3787246871524447,1.0,55/188,17.23%,ARHGAP45;DOCK8;ARHGAP25;RGS10;TBC1D9;ABR;SIPA1L2;ARHGAP22;FZD10;TBC1D10C;THY1;ARHGAP24;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;RASGRP2;TBC1D16;TBC1D22A;USP6NL;DOCK11;DOCK10;AGRN;TBC1D10A;FLCN;SIPA1;NTF3;CCL14;RAP1GAP2;F11R;TBC1D2;TBC1D17;CCL13;RAPGEF1;LIMS1;CCL2;TBC1D2B;ARHGAP27;TBC1D8;MMUT;RAP1A;TBC1D14;BCAR3;SIPA1L3;TBC1D22B;NF1;GNB5;ALS2;RGS1;ARHGEF26;SNX13;CCL25;SNX18;CORO1C
prerank,positive regulation of lymphocyte migration (GO:2000403),0.701254098871533,1.3951582639213385,0.10511756569847856,0.3781883984079821,1.0,3/12,6.51%,DOCK8;PYCARD;AIF1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.5380721522436736,1.394499848188883,0.002002002002002002,0.3793928462103805,1.0,46/198,16.82%,PLBD1;PTPRC;HK3;PLD4;INPP5D;PIK3CG;PLCB2;TGFB1;LPL;PIK3CD;PLCG2;DUSP3;MTOR;PIK3CB;ANGPTL3;PFKL;CLN8;ALDOB;INPP4B;PIP4K2A;PFKFB4;NADK;NUDT4;CERK;PLPPR1;DUSP10;PPA2;AGK;FRA10AC1;GPI;SYNJ1;PIP4P1;SHPK;THNSL2;PXYLP1;PLCH1;HK2;LRRK2;GDE1;XYLB;PFKFB3;PTEN;PLAAT3;GK;GCK;PPP3CB
prerank,regulation of calcium ion transport (GO:0051924),0.5630051191795482,1.3944628761139388,0.05555555555555555,0.3789290072602191,1.0,9/54,10.60%,CD84;LILRB1;PKD2;P2RX4;CTNNB1;ATP2B1;EPB41;CACNB2;SLC8B1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5807559264432427,1.3943422062355542,0.06535947712418301,0.3787077163638977,1.0,13/45,14.05%,CD74;CD300A;AQP1;DHX9;NLRC3;SKI;MORC3;CTNNB1;TP53;CDK6;B4GALT7;GAS6;FTH1
prerank,negative regulation of GTPase activity (GO:0034260),0.6443077898146736,1.3942131852146626,0.09168704156479218,0.37851451773998546,1.0,8/22,16.45%,KLRK1;FZD10;RASA4;ARFGEF1;WNK1;F11R;LRRK2;CPEB2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6812406760003638,1.394189709057718,0.08743169398907104,0.37801904947123827,1.0,5/15,4.90%,ADAM8;SNX9;TNF;APOE;SNX33
prerank,response to purine-containing compound (GO:0014074),0.6603690154662418,1.3938144412183984,0.10449735449735449,0.37850365462230334,1.0,5/17,10.39%,KCNJ11;P2RY6;P2RX7;P2RX4;VGF
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6227948772854992,1.3937262273768276,0.08323424494649227,0.3781659543532451,1.0,7/26,11.17%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;SLC8B1;CHERP
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5779664005502598,1.3936544207875685,0.08342602892102335,0.37780198185825764,1.0,12/38,18.51%,LGALS3;RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;THBS1;CASP8;TRADD;FEM1B;ARHGEF2;TNFSF10
prerank,cellular response to osmotic stress (GO:0071470),0.6392639521691545,1.3925976953648875,0.10572139303482588,0.38013042070075087,1.0,7/21,17.28%,AQP1;LRRC8D;PKD2;EPO;CAPN3;RCSD1;ARHGEF2
prerank,negative regulation of innate immune response (GO:0045824),0.6016178310232413,1.3918407100185306,0.07825086306098965,0.3816936672061411,1.0,11/34,12.01%,NLRC5;SLAMF8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;YTHDF3;TTLL12;GRN;USP18;METTL3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7227327086240757,1.3916060598780067,0.10201149425287356,0.3817424203744552,1.0,3/10,6.70%,MEOX1;SP7;TP53
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6530611289584654,1.3914480345049265,0.11180904522613065,0.3816072783633129,1.0,2/18,1.16%,PTK2B;CCR2
prerank,positive regulation of protein transport (GO:0051222),0.5530790861791623,1.3914265749935524,0.051255230125523014,0.3810935377182416,1.0,23/67,19.99%,TREM2;TGFB1;IL1A;ADAM8;TNF;ABCG1;TTN;CLN3;RIPOR1;ATP2C1;KIF20B;SYTL4;TPR;EXOC1;PCM1;ARF6;MYH10;CD33;VPS28;GOLPH3;RAB29;DNM1L;ATP13A2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6793804155295086,1.3909600650232277,0.12570621468926554,0.3819388813924879,1.0,4/13,11.24%,SHH;CTNNB1;TGFBR2;NRP1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4835243400843874,-1.390899057186776,0.08764940239043825,0.9558234436650013,1.0,6/16,10.09%,CACNA1C;ANK2;RYR2;DMD;ATP1A2;CALM3
prerank,positive regulation of defense response (GO:0031349),0.5503265733372003,1.390885067059395,0.027579162410623085,0.3815986074559182,1.0,20/89,13.66%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18;MEF2C;PLA2G7;ABCC1;GRN;NINJ1;TRADD
prerank,regulation of inflammatory response (GO:0050727),0.5391655704505603,1.3896601010421696,0.007007007007007007,0.3844531850426349,1.0,44/190,13.66%,HCK;CCR2;SIRPA;LPL;CD200R1;METRNL;PIK3AP1;VAMP3;GPRC5B;DAGLB;PRKCD;TLR2;DHX9;TLR7;MDK;OSM;FFAR2;NLRC3;NR1H4;TNF;SNCA;APOE;OTULIN;CEBPA;IL18;TNFAIP3;CASP1;ANXA1;SETD6;AKNA;TMSB4X;PLA2G7;RB1;ABCC1;GRN;TNFRSF1B;USP18;NOD2;NINJ1;SHPK;GPS2;FNDC4;LACC1;TRADD
prerank,granulocyte differentiation (GO:0030851),0.6593161793678183,1.3894370987050142,0.09786700125470514,0.38448552133622355,1.0,5/18,6.88%,GATA1;CBFA2T3;CEBPA;SPI1;TAL1
prerank,lipoxygenase pathway (GO:0019372),0.6752308251395616,1.3887799722784906,0.11170212765957446,0.3857793388610594,1.0,3/14,7.33%,ALOX12;HPGD;PON3
prerank,regulation of transmembrane transport (GO:0034762),0.6053132346133193,1.3882128357315267,0.09267734553775744,0.3868562031880971,1.0,7/31,13.74%,KCNJ11;SNCA;PRKCB;ACTB;PIM1;NEDD4L;CTTNBP2NL
prerank,neuronal action potential (GO:0019228),-0.4394411281060539,-1.3875574829390895,0.0972972972972973,0.9549997658472665,1.0,12/22,28.36%,SCN1A;CACNA1G;KCNA1;KCNA2;SCN8A;ANK3;SCN3A;KCNMB2;GPER1;CACNA1H;MYH14;CACNA1I
prerank,indolalkylamine catabolic process (GO:0046218),0.7238786224720645,1.3873997318130489,0.14222873900293256,0.3885685673797555,1.0,3/10,7.82%,HAAO;KYNU;KMO
prerank,regulation of T cell cytokine production (GO:0002724),0.6665368638021059,1.3873109045341305,0.12661498708010335,0.38827812100305503,1.0,6/15,13.13%,CCR2;TRAF2;HFE;MALT1;TNFRSF1B;B2M
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6551832812060926,1.386994489846342,0.10394736842105264,0.3885481103264311,1.0,3/17,1.15%,HCK;HCLS1;STAP1
prerank,negative regulation of neurogenesis (GO:0050768),0.6006178813143536,1.386831440727293,0.07233065442020666,0.38844380741771634,1.0,14/34,17.75%,HOOK3;THY1;TNF;PCM1;SORL1;B2M;ARHGDIA;EFNB3;YWHAH;NF1;RTN4;PTEN;APPL2;RHOA
prerank,sterol transport (GO:0015918),0.6332671818187651,1.386752894472904,0.11041405269761606,0.3881103991773093,1.0,7/19,16.03%,MSR1;NPC2;LDLRAP1;NPC1;OSBP;ARV1;CD36
prerank,response to laminar fluid shear stress (GO:0034616),0.7104066180164144,1.386752170618306,0.1210762331838565,0.38755331112739266,1.0,3/10,3.88%,NFE2L2;ABCA1;SREBF2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6230844897644804,1.3863634447019901,0.13032581453634084,0.38809580773709135,1.0,3/21,1.91%,ARHGAP25;RASAL3;CYRIB
prerank,regulation of metal ion transport (GO:0010959),-0.48281338478634933,-1.3863585280224053,0.11522633744855967,0.9437198996641483,1.0,6/16,14.13%,ANK2;SRI;CAMK2G;DLG1;CACNA2D1;IL16
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5506734544877236,1.3854128749839447,0.027921406411582212,0.39009124078642815,1.0,25/88,16.38%,LGALS3;TGFB1;PLEK;SYK;FNIP2;TNF;FNIP1;RGCC;SMPD3;RAB7A;TAL1;SMAD3;BAK1;TPR;PFN2;PFN1;SDCBP;NRG1;SLX4;SYNPO;BMF;SLF2;PIH1D1;PDCD6IP;FAF1
prerank,embryonic digestive tract development (GO:0048566),-0.472181984412983,-1.3850960105895247,0.1085972850678733,0.9336800879953776,1.0,9/18,14.15%,PCSK5;NIPBL;GLI2;SALL1;GLI3;PDGFRA;PKDCC;RARB;STRA6
prerank,negative regulation of secretion by cell (GO:1903531),0.5836384317391752,1.3848758271988786,0.08987485779294653,0.39113474104234247,1.0,7/38,6.34%,LILRB1;VAMP3;OSM;SNCA;APOE;RHBDF2;ANXA1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.7202031394020041,1.3848549583887804,0.11832611832611832,0.39064998229653375,1.0,4/10,11.18%,SHH;TGFBR2;LRP5;SOX9
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6022305812345867,1.3845006904659676,0.11084043848964677,0.3910514073099116,1.0,5/25,7.81%,CALCR;CBL;TNF;ZFYVE28;HFE
prerank,regulation of neuroblast proliferation (GO:1902692),0.6687387567994267,1.384462085755257,0.11067708333333333,0.3905915983436526,1.0,8/15,16.02%,CX3CR1;FZD3;CTNNB1;DISC1;TAFA1;SMARCD3;LRRK2;NF1
prerank,regulation of proteolysis (GO:0030162),0.5782755678252189,1.384370128479723,0.0627062706270627,0.39027795288724654,1.0,16/48,14.80%,GSAP;SHH;CLN8;AURKAIP1;CLN3;TRAF3;ASPH;TBC1D10A;BAK1;HDAC6;SPOP;PARL;CASP8;ITCH;STUB1;CAPN3
prerank,cell differentiation in spinal cord (GO:0021515),0.7091141661258871,1.3838421046500828,0.13901345291479822,0.39117640592364294,1.0,3/10,14.60%,DRAXIN;SOX6;SOX4
prerank,digestive tract morphogenesis (GO:0048546),-0.503819830292437,-1.3835547077556987,0.09541984732824428,0.9245035266105686,1.0,5/14,14.15%,NIPBL;PDGFRA;GLI1;SOX17;STRA6
prerank,serine family amino acid metabolic process (GO:0009069),0.655618299095307,1.3834650337683163,0.13430851063829788,0.39169880536891233,1.0,1/16,0.19%,SEPSECS
prerank,negative regulation of MAP kinase activity (GO:0043407),0.589152153899752,1.3833935707514102,0.07969432314410481,0.3913485012667448,1.0,11/44,12.78%,LYN;CD300A;PRKCD;PTPRJ;PTPN1;PIK3CB;APOE;DUSP10;DUSP19;SH2B3;SORL1
prerank,positive regulation of wound healing (GO:0090303),0.5882170713527335,1.382755793834552,0.09244644870349493,0.3924220021565363,1.0,8/36,11.24%,HPSE;SMOC2;RREB1;MTOR;ARFGEF1;ANXA1;ACTG1;THBS1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7125856528292254,1.3824753147462183,0.10719530102790015,0.39263678661497436,1.0,2/10,6.71%,SAG;CNGB1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.5372392898809252,1.3819846048126228,0.001,0.3934965216559584,1.0,66/291,14.54%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;P2RY6;AQP1;FZD10;HCN4;CXCL2;PRKCD;TLR2;P2RX7;MTOR;MAPK14;P2RY2;FFAR2;NR1H4;PKD2;ADCY6;PYCARD;CD68;TNFAIP3;CD14;CASP1;RAP1B;P2RX4;HMGB1;TAF1;ABCB4;ACTB;CD80;TICAM1;P2RY12;CD180;MEF2C;LY96;CD274;IMPACT;CPEB3;RAPGEF1;SOX9;GLRA2;CCL2;TNFRSF1B;NRIP1;PRDX3;TWF2;NOD2;DEFA6;CREB1;CAMKK2;SHPK;NFKB1;PID1;LAMTOR3;GNG2;CAPN2;RAP1A
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6831774422729181,1.3814060013913778,0.11416781292984869,0.3944537809686615,1.0,2/12,0.90%,PF4;TGFB1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6775733543655142,1.3810628225864416,0.12078651685393259,0.3948658624870996,1.0,4/13,6.47%,PLEK;APOE;ERLIN1;ERLIN2
prerank,regulation of cell projection organization (GO:0031344),0.691164298047907,1.3808560636850504,0.12165775401069519,0.39488241775319793,1.0,4/13,8.46%,TREM2;SEMA4D;MACF1;MOV10
prerank,plasma membrane tubulation (GO:0097320),0.6751703969339438,1.380846821339046,0.11005434782608696,0.3943478831569097,1.0,6/13,13.31%,BIN2;SNX9;SNX33;MICALL1;BIN3;FNBP1L
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6202875954662879,1.3804646691607962,0.09735576923076923,0.39492979350526686,1.0,6/24,11.17%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;CHERP
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.658482585686599,1.3803520218816714,0.10165184243964422,0.3946887031826197,1.0,6/16,18.04%,KLK3;DDAH1;KLK2;GSK3A;PRCP;ADM
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.462091999036323,-1.3796602850449509,0.08823529411764706,0.9267690052288136,1.0,6/17,15.60%,CAV1;PANK2;NCOR1;PPARA;PRKAB2;PPARG
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6485341918395129,1.3793131848725682,0.12724935732647816,0.396923295966208,1.0,5/18,7.95%,CBL;IL6R;CEBPA;SPI1;ST18
prerank,lipoprotein localization (GO:0044872),0.6977628934326956,1.3792201465134206,0.1225071225071225,0.3966356213005843,1.0,5/11,16.03%,PRKCB;VMP1;ZDHHC3;LRP1;CD36
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6305925327527526,1.3781411463976787,0.11843711843711843,0.39911764619422163,1.0,5/22,10.55%,PLEK;STAP1;CDA;TP53;INHBA
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6018368535129878,1.377555981165292,0.10869565217391304,0.4001265438536789,1.0,6/26,12.44%,LILRB3;C1QC;GPR137B;TMEM178A;INHBA;CDK6
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6958967123984301,1.3768522711677083,0.12383488681757657,0.4016325807140861,1.0,3/12,5.65%,THY1;TNF;CD44
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6860966752400104,1.3764853875748997,0.12756598240469208,0.4020203659140211,1.0,2/10,6.55%,LILRB1;TYROBP
prerank,response to cytokine (GO:0034097),0.5402319637453569,1.3737358980963015,0.012072434607645875,0.40906074817404087,1.0,28/141,10.79%,PTPN7;CIITA;SLC11A1;HCLS1;FLT3;MAPKAPK3;CD74;IRAK2;CSF1R;TNFRSF11A;PTPN18;SNCA;GCH1;LDLRAP1;IL6R;CXCR4;CASP1;TIMP1;ANXA1;BCL2L1;KYNU;ADAR;SMAD3;CD274;HDAC4;SETD2;TRIM56;IL18BP
prerank,response to organophosphorus (GO:0046683),0.652140571298245,1.3735386930458595,0.1309987029831388,0.40908578512380234,1.0,4/16,10.39%,KCNJ11;P2RX7;P2RX4;VGF
prerank,response to retinoic acid (GO:0032526),0.5575011729016385,1.3735140687060434,0.07195767195767196,0.4085880036247901,1.0,6/59,3.60%,PTK2B;LYN;ASCL1;AQP1;FZD10;RXRB
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5946395973089775,1.3728233017962972,0.09707602339181287,0.40996975607364844,1.0,9/33,11.24%,TGFB1;ANGPT4;TNF;RGCC;APOE;HDAC5;HMGB1;MEF2C;THBS1
prerank,response to iron ion (GO:0010039),0.6813069928785812,1.3727645058872988,0.11608391608391608,0.4095712898063487,1.0,5/12,16.30%,SNCA;HFE;ACO1;B2M;HIF1A
prerank,focal adhesion assembly (GO:0048041),-0.4322417972955694,-1.3727467580341777,0.10179640718562874,0.9449859796528125,1.0,7/21,5.31%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5631809718317639,1.3726729390851404,0.0735930735930736,0.4092644604330534,1.0,14/51,16.03%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;HMGB1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.7000877426972645,1.3725362747174985,0.11206896551724138,0.40907714229192726,1.0,3/11,2.08%,STAP1;SLAMF8;RIN3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5410487612352172,1.3710270482451556,0.028455284552845527,0.4126753299238744,1.0,14/110,7.48%,CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;ADCY6;S1PR4;ADGRG3;GNA13;RAMP1
prerank,retrograde axonal transport (GO:0008090),-0.4637683588136866,-1.3707890221399588,0.11203319502074689,0.9385733860000981,1.0,6/16,10.38%,DLG2;KIF5B;PAFAH1B1;SOD1;NEFL;KIF5A
prerank,response to zinc ion (GO:0010043),0.6167568757780915,1.3698490439127815,0.10319410319410319,0.4154380679179801,1.0,15/25,22.28%,HAAO;P2RX4;GLRA2;HVCN1;ATP13A2;SLC30A4;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5258936284533056,1.3693096895506152,0.0,0.4163516430426295,1.0,75/390,12.63%,NCKAP1L;LCP2;SLA;VAV1;PTK2B;BLNK;FGR;LYN;ATP6V0D2;HCK;CYBB;UBASH3B;CD3E;SYK;CASS4;STAP1;FLT3;CD7;MAPKAPK3;NCF4;ITGB3;CBL;CSF1R;ATP6V0E1;PTPRJ;TCIRG1;GRB2;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;ATP6V1C1;NCK2;PRKD2;ATP6V1E1;CLNK;RAB14;ATP6V0A2;VAV3;ARPC2;SHC2;EFNA2;MTSS1;ACTB;NEDD9;AP2S1;VEGFB;ATP6V0D1;ARPC3;WASF2;ITSN1;AP3S1;SULF2;NTF3;ABI1;ACTG1;BCAR1;ACTR2;FLRT1;ATP6V0A1;ACTR3;POLR2L;YES1;ATP6AP1;RAPGEF1;CYFIP1;NRP1;ARPC4;ZNF106;PHIP;SDCBP;FYN;DDIT4;NRG1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6916345699959326,1.3689603761407865,0.13864306784660768,0.41675131910452834,1.0,3/11,8.57%,ABCG1;PLA2G7;LIPC
prerank,PERK-mediated unfolded protein response (GO:0036499),0.702909706951851,1.368845943841489,0.1562043795620438,0.4164918929755506,1.0,4/10,11.55%,NFE2L2;HERPUD1;DDIT3;CCL2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5381218363999714,1.368533285208488,0.04205128205128205,0.4167333625876208,1.0,22/92,11.64%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;PLCG2;RREB1;ANGPT4;MTOR;PIK3CB;PRKD2;PDCD6;BCAR1;RAB11A;PFN1;SOX9;NRP1;THBS1;HDAC6;GPI;GRN
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5913535238559025,1.3684468712793028,0.10520361990950226,0.4164340939590397,1.0,5/32,5.57%,CALCR;THY1;P2RX7;SNCA;P2RX4
prerank,protein insertion into membrane (GO:0051205),-0.3876810681848277,-1.3677670758185643,0.0859375,0.9375973380133008,1.0,12/32,19.11%,APP;EGFR;OXA1L;ALDH3A2;TRAM1;SEC61G;COX18;EMD;SERP1;SEC61B;GET4;VAPA
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5310802183183595,1.3667299629752134,0.014056224899598393,0.42059708746065994,1.0,44/149,17.33%,BTK;CARD11;CX3CR1;AIM2;IRAK2;ADAM8;TRIM25;TLR2;TNFRSF11A;DHX9;TRIM5;TNF;PRKD2;UBE2V1;TRAF2;PYCARD;IL18;RAB7B;PRKCB;CFLAR;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;PRKCH;TRAF5;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;NFKB1;TRADD;TAB3;CAPN3;MTDH;CD36;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5638247536441169,1.366596416662721,0.08223684210526316,0.4204077894265951,1.0,13/48,13.07%,TGFB1;STAT5A;ANGPT4;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;ANXA1;TMSB4X;THBS1;HDAC9;ATP5F1A
prerank,regulation of establishment of cell polarity (GO:2000114),0.6501281457819107,1.3660505299455503,0.116751269035533,0.421378362031289,1.0,6/16,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,activation of protein kinase A activity (GO:0034199),0.6518473784573673,1.3657755953165325,0.12706480304955528,0.421626859192411,1.0,6/16,13.49%,ADCY7;PRKAR2B;ADCY6;PRKACB;ADCY3;ADCY8
prerank,mesonephric tubule development (GO:0072164),-0.48052341904000434,-1.365611880172069,0.11016949152542373,0.932478488197918,1.0,6/15,10.33%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6038041791770008,1.3655074009211854,0.12291169451073986,0.42183438143791996,1.0,7/25,12.29%,NCKAP1L;PTGES3;SNCA;ITGA6;NRP1;THBS1;SDCBP
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6781494625059041,1.3653976109516355,0.1301859799713877,0.4215667165227916,1.0,6/12,20.11%,HOOK3;BICD2;PCM1;NINL;CCDC120;KIF3A
prerank,activation of adenylate cyclase activity (GO:0007190),0.5902451121296731,1.3650950630416485,0.09244644870349493,0.42179731905673395,1.0,8/35,15.71%,CALCR;ADCY7;TMIGD3;ADCY6;CAP1;ADCY3;ADCY8;LGR4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6159442932526658,1.3647097936369514,0.10144927536231885,0.42226535338156074,1.0,2/24,1.30%,LILRB1;AIM2
prerank,early endosome to late endosome transport (GO:0045022),0.6323049303868471,1.3645647799517482,0.11083437110834371,0.4220921782946328,1.0,7/20,14.29%,HOOK3;WDR91;RAB7A;BECN1;WDR81;STX8;HOOK2
prerank,regulation of establishment of protein localization (GO:0070201),0.6779257500480981,1.3645115579591098,0.11497326203208556,0.42170138094887416,1.0,3/14,7.13%,TREM2;CTSD;GAPVD1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6976306837027944,1.3644549757399576,0.12426900584795321,0.42128406649522865,1.0,4/10,16.79%,PTPRJ;SNCA;LRP1;PTPN12
prerank,endocytic recycling (GO:0032456),0.5626598361341658,1.3641459313707398,0.07411385606874328,0.421653912372182,1.0,15/50,15.18%,DENND1C;MICALL2;CCDC93;RAB14;RAB7A;MICALL1;VPS35L;DENND1A;SNX27;DENND1B;ACAP2;ARF6;VPS29;EPS15;VPS39
prerank,aminoglycan catabolic process (GO:0006026),0.6012408453107185,1.3638766884167792,0.10428736964078796,0.42187429215067684,1.0,6/28,7.06%,HPSE;GUSB;GNS;IDS;FUCA1;AGRN
prerank,response to organonitrogen compound (GO:0010243),0.5783743836180713,1.3637396875996752,0.09706546275395034,0.42166573341598235,1.0,9/38,15.36%,IRF5;MTOR;NR1H4;SEL1L;KYNU;DERL1;GLRA2;KAT7;CCDC47
prerank,ruffle organization (GO:0031529),0.6460466841134521,1.3635217942861229,0.1256544502617801,0.421674362343531,1.0,9/16,20.37%,PLEK;CSF1R;AIF1;CYFIP1;ARF6;PLEKHA1;ARFIP2;INPP5K;AIF1L
prerank,eye morphogenesis (GO:0048592),-0.4466915019799972,-1.3633431133411424,0.12272727272727273,0.9279239829054199,1.0,7/19,9.04%,COL5A2;NIPBL;EFEMP1;SHROOM2;MFAP5;FBN1;TENM3
prerank,positive regulation of myelination (GO:0031643),0.6909804666245549,1.3632573378793515,0.13655172413793104,0.42188561547622067,1.0,4/11,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6715453833272569,1.3632093766263083,0.12727272727272726,0.42146045873933613,1.0,5/13,12.90%,LGMN;ASPH;TBC1D10A;BAK1;CASP8
prerank,negative regulation of cyclase activity (GO:0031280),0.6778810853166485,1.3628954203650974,0.1262002743484225,0.4217861430479122,1.0,6/14,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,retina homeostasis (GO:0001895),0.6140360137034893,1.362618390312935,0.10097323600973236,0.4220004947568672,1.0,11/23,22.05%,WHRN;POTEF;ACTB;CNGB1;ACTG1;PRDX1;B2M;ATP1B2;CCDC66;HSPB1;CDH3
prerank,cellular response to interleukin-12 (GO:0071349),0.5676329355908054,1.362539210035581,0.08934337997847147,0.42166677040062056,1.0,9/48,7.75%,LCP1;SIRPA;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6522762746055452,1.3623014804129223,0.1270053475935829,0.4217120531493505,1.0,7/15,11.37%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41101912755878867,-1.3620919346728186,0.11976047904191617,0.91946065333386,1.0,7/26,15.11%,SORBS1;PRKCI;IRS1;C2CD5;ARPP19;AKT1;OCLN
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5991450000830754,1.3620572010664445,0.1056338028169014,0.42184958307897885,1.0,9/29,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5738305259245179,1.3619201618621777,0.07742639040348964,0.4216720306142551,1.0,5/42,2.38%,PTK2B;CD3E;RIN2;PTPRJ;THY1
prerank,regulation of lipase activity (GO:0060191),0.6629442075606277,1.3615144710441667,0.14500683994528044,0.4222319313559973,1.0,6/13,17.75%,LPL;ANGPTL3;SNCA;LIPC;FURIN;RHOA
prerank,urogenital system development (GO:0001655),0.6824370223293577,1.3614144026749215,0.15049226441631505,0.4219569298233572,1.0,3/11,11.18%,SHH;ANXA1;SOX9
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.6327034227511413,1.3611257360778257,0.1181702668360864,0.42222042135075494,1.0,9/18,18.54%,PCSK9;CTSC;APOE;VPS11;ATP5IF1;AMER1;FAF1;HSP90AA1;DACT1
prerank,positive regulation of biosynthetic process (GO:0009891),0.5607027813662744,1.3608715390667079,0.09481808158765159,0.4224076524836351,1.0,8/40,7.23%,RUNX1;TGFB1;PLCG2;MTOR;MLXIPL;RGCC;APOE;CREB3L1
prerank,positive regulation of cell adhesion (GO:0045785),0.5442063245463585,1.360460883441588,0.055036344755970926,0.4229407289361536,1.0,14/74,13.82%,NCKAP1L;SYK;ADAM8;PTPRJ;MDK;TNF;PRKD2;P4HB;P2RY12;FLCN;LIMS1;ADGRG1;STX3;ZFHX3
prerank,actin nucleation (GO:0045010),0.6189293348620025,1.3603553089150497,0.1225,0.4226702790190563,1.0,7/21,11.37%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6284111692404096,1.3603479188079386,0.13333333333333333,0.42213709892150003,1.0,4/17,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6303555380610141,1.360322103261824,0.13857677902621723,0.4216603515397897,1.0,5/19,9.97%,RUNX1;TNF;SNAI1;PRKCH;F11R
prerank,regulation of type I interferon production (GO:0032479),0.5415303958295092,1.360019185223858,0.054865424430641824,0.42196103828656406,1.0,22/84,14.78%,IRF5;IRF8;NLRC5;TRIM25;DHX9;LRRFIP1;TNFAIP3;CD14;TRAF3;XRCC5;CTNNB1;TAX1BP1;TRIM56;POLR2L;RNF216;NLRX1;RNF135;ITCH;NFKB1;GPATCH3;IRF1;DTX4
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5951955729159835,1.3596598881243753,0.10175438596491228,0.4224657769827108,1.0,9/30,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7079230166410402,1.359345677251599,0.1301859799713877,0.42276329011430364,1.0,5/11,13.41%,LILRB1;HCLS1;NOD2;MERTK;GAS6
prerank,apoptotic cell clearance (GO:0043277),0.5992641226964887,1.3593131391467435,0.09733487833140209,0.4223095777300056,1.0,13/30,22.31%,TREM2;ITGB3;HMGB1;ANXA1;TYROBP;THBS1;GAS6;LRP1;TXNDC5;XKR4;MEGF10;RHOG;TGM2
prerank,vasoconstriction (GO:0042310),0.6892333328801665,1.3590284404006803,0.15143246930422918,0.4225331725112053,1.0,2/11,3.19%,EDNRB;SLC8A1
prerank,positive regulation of lipid localization (GO:1905954),0.6977938533403087,1.3583989133410477,0.13578500707213578,0.42373642511525306,1.0,4/11,15.03%,LPL;VSTM2A;NFKB1;LRP1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.5416074808163959,1.3583363257685404,0.057172557172557176,0.4233417417894292,1.0,24/78,15.42%,MRAP;TREM2;LGALS3;TGFB1;PLS1;TNF;LDLRAP1;CLN3;AKAP5;STAC;BCL2L1;ACTB;ZDHHC7;PRKCH;CLTC;NUMB;STX3;STAC3;PPFIA1;STX8;PID1;ARF6;LRP1;AP2M1
prerank,positive regulation of isotype switching (GO:0045830),0.6476268681011479,1.3573635036247538,0.13797634691195795,0.42557032824854374,1.0,2/15,2.40%,TGFB1;MAD2L2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5347986086770703,1.3568239127418007,0.04878048780487805,0.426563316813705,1.0,11/86,6.54%,NCKAP1L;PTK2B;HCK;PLEK;NCK2;SNX9;APOE;COLGALT1;MYLK3;PYCARD;MAPRE1
prerank,lipid catabolic process (GO:0016042),0.6353671497696136,1.355336090909781,0.13513513513513514,0.4301824471166817,1.0,6/18,16.78%,LPL;CEL;ACADL;LIPC;LIPE;PLAAT3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.5244868000314615,1.3549847976076552,0.0,0.43060320937611446,1.0,97/509,12.90%,PTPRC;CD86;VAV1;TREM2;FGR;LYN;CALCR;PIK3CG;PIK3R5;CARD11;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;CD74;PIK3CD;RPL23;CBL;LAPTM5;PIK3AP1;PLCG2;TGFBR1;GPRC5B;ADAM8;TRIM25;PTPRJ;TLR2;GRB2;PIK3CB;S100B;TLR7;NUP62;OSM;TSPAN6;SEMA4D;TRIM5;NEK6;TNF;FNIP1;PRKD2;UBE2V1;TRAF2;DDIT3;IL18;CD14;CASP1;P2RX4;MAP3K14;HMGB1;PRKCB;CFLAR;BCL2L1;GAB2;TP53;CD80;ACTN4;SEH1L;PIM2;TICAM1;EPO;PLK2;P2RY12;MALT1;FLT3LG;ATP2C1;FLCN;TRIM27;ZDHHC13;SLC44A2;LURAP1;NTF3;PUM2;STRN;NOS1AP;TRAF5;LITAF;TRIM8;DUSP19;RPS20;LGALS1;GPR37;LIMS1;SOX9;MID2;THBS1;BECN1;IAPP;NOD2;FYN;ALPK1;TAB2;NRG1;IKBKG;CASP8
prerank,endocardial cushion development (GO:0003197),-0.4282209998118865,-1.3549134396985794,0.11059907834101383,0.9369973569117694,1.0,4/21,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,negative regulation of developmental growth (GO:0048640),0.6005195957972758,1.3545028352340278,0.09134045077105575,0.431404809661398,1.0,5/30,8.91%,SLC6A4;FGF13;DIP2B;WWC2;DUSP10
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6480263926274142,1.3542390233298394,0.13994565217391305,0.4316328563419726,1.0,6/15,12.01%,NLRC5;SAMHD1;YTHDF3;TTLL12;USP18;METTL3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5299974039969766,-1.354000423988753,0.15699658703071673,0.9275606176481198,1.0,3/10,7.23%,ERRFI1;CAV1;MVP
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5469381987058166,-1.3538706598126014,0.13523131672597866,0.9147564708792278,1.0,5/11,18.57%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK
prerank,positive regulation of protein polymerization (GO:0032273),0.5463807985918598,1.353423012602456,0.06444906444906445,0.43339726053577404,1.0,7/65,6.54%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD;MAPRE1
prerank,positive regulation of TOR signaling (GO:0032008),0.5706468586023128,1.3532452496551455,0.09242761692650334,0.43332859387511613,1.0,18/40,21.78%,NCKAP1L;TREM2;FNIP1;GPR137B;SEH1L;FLCN;PIP4P1;GAS6;LAMTOR3;PIH1D1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB
prerank,glycine transport (GO:0015816),0.7106764448681754,1.3532445327373959,0.14727540500736377,0.43277233123856274,1.0,3/10,9.26%,SLC7A8;SLC36A1;SLC25A38
prerank,regulation of myelination (GO:0031641),0.5927989961525579,1.3530262015562697,0.1314878892733564,0.4328858447355888,1.0,7/25,11.69%,ITGAX;CST7;KIF14;TMEM98;RNF10;TNFRSF21;TNFRSF1B
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6904055369231661,1.3528797978176985,0.12716763005780346,0.4327197429197956,1.0,4/10,8.51%,NPL;RENBP;NAGK;ST3GAL1
prerank,negative regulation of MAPK cascade (GO:0043409),0.5431612449480333,1.3527052741180166,0.04679552390640895,0.4326103832858594,1.0,12/87,4.14%,PTPRC;LYN;SIRPA;CD300A;PRKCD;PTPRJ;DUSP3;P2RX7;PTPN1;DUSP29;PIK3CB;APOE
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6430988938569492,1.3519039835137097,0.13766233766233765,0.4342213671436208,1.0,5/16,9.89%,PLEKHN1;ZC3H12D;MOV10;RC3H1;CPEB3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5371177960960878,1.3516858883241623,0.06217616580310881,0.43430501956151774,1.0,12/74,6.37%,PF4;LGALS3;GATA1;IL1A;TGFBR1;RFFL;TNF;ITGA6;TRAF2;TNFAIP3;CFLAR;BCL2L1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5229960241146736,1.3516050028500508,0.009027081243731194,0.4340048767553997,1.0,32/172,9.94%,INPP5D;PIK3CG;PIK3R5;DGKZ;PIK3CD;LPIN2;PLCG2;DDHD1;LPCAT1;PIK3CB;PIP5K1C;INPP4B;CLN3;PIP4K2A;PI4K2A;RAB14;PCYT1A;CHKB;PLD2;PGS1;CDS2;DGKE;LPCAT2;MTMR3;DGKG;DGKD;CSNK2A2;CSNK2A1;SLC44A2;ABHD4;AGK;STARD10
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6536253617926627,1.351421505536679,0.15885416666666666,0.43391659032715546,1.0,4/15,9.08%,HAAO;KYNU;KMO;QDPR
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6814060270173399,1.351419833689371,0.14147018030513175,0.43336913922239123,1.0,6/13,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,regulation of mitochondrion organization (GO:0010821),0.5677543638344846,1.3512578788084808,0.08970099667774087,0.43323379349156366,1.0,22/47,20.78%,TREM2;CYRIB;SREBF2;CSNK2A2;FLCN;MYO19;PPARGC1A;HDAC6;IAPP;PARL;PID1;LRRK2;SREBF1;VDAC1;GSK3A;GOLPH3;DNM1L;FIS1;INF2;ATP13A2;GSK3B;PRKN
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.479003317034849,-1.3512167543592226,0.12030075187969924,0.9130723325802353,1.0,7/14,19.56%,IRS1;DDB1;GPLD1;ARPP19;AKT1;NNMT;IRS2
prerank,negative regulation of secretion (GO:0051048),0.6873511759430108,1.3511844459195779,0.13976945244956773,0.43288590464727594,1.0,2/10,1.94%,CD74;VAMP3
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5654036490588218,1.3509718261828696,0.11731843575418995,0.4329044935753853,1.0,15/37,22.31%,PCSK9;ITGB3;RIN3;EDNRB;APOE;TRAP1;SDCBP;NFKB1;ANKRD13A;OPTN;PRKN;SIRT5;ABCA2;MT3;AATF
prerank,regulation of Rac protein signal transduction (GO:0035020),0.641838319224423,1.3509207103466594,0.13237221494102228,0.4325216461336422,1.0,3/16,2.72%,PIK3CG;ARHGAP24;PIK3CB
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4998484897126329,-1.3505418493127297,0.1297071129707113,0.9030676892584716,1.0,3/13,0.51%,CACNA1C;ANK2;KCNN2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5730263523005269,1.3499849329158637,0.12731481481481483,0.434670498309886,1.0,10/33,13.80%,CX3CR1;ABR;CEL;BTBD9;CACNA1A;FABP5;EIF4EBP2;NTF3;LRP8;CACNA1B
prerank,regulation of defense response to virus by host (GO:0050691),0.5927375122742816,1.3498567624828979,0.10574712643678161,0.43447237103495157,1.0,4/30,5.09%,LILRB1;AIM2;DHX9;TNFAIP3
prerank,keratan sulfate metabolic process (GO:0042339),0.5961499889438678,1.3492045492083151,0.11161731207289294,0.4357504023862784,1.0,7/31,8.51%,HEXB;PRELP;GNS;HEXA;B4GALT1;FMOD;ST3GAL1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6494684913352033,1.3489834728200474,0.15637860082304528,0.4358296857448897,1.0,2/15,8.46%,RUNX1;RB1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5317272063033611,1.3486783286733048,0.0296220633299285,0.4361480907463415,1.0,33/110,16.71%,LGALS3;HCK;TGFB1;SYK;FNIP2;ABCA1;TNF;FNIP1;APOE;TRAF2;TAL1;TFIP11;SVIP;RB1;BAK1;HSF1;ATF7IP;IMPACT;GFAP;HDAC6;IAPP;NRG1;SORL1;SAR1A;HCFC1;BMF;SLF2;PIH1D1;SRC;CD36;IRGM;FAF1;HSP90AA1
prerank,negative regulation of cell activation (GO:0050866),0.6622476301229352,1.348667638965917,0.14208389715832206,0.43562141440247054,1.0,2/14,4.14%,TREM2;APOE
prerank,negative regulation of autophagy (GO:0010507),0.5536327513204274,1.3486550185398731,0.08842794759825327,0.43510504217480966,1.0,15/54,15.12%,TREM2;IL10RA;CTSA;MTOR;ATG7;SNCA;SMG1;EIF4G3;DAP;TAB2;FOXK1;BMF;LRRK2;TAB3;TBC1D14
prerank,integrated stress response signaling (GO:0140467),0.6582845546027755,1.3484467787234558,0.1455026455026455,0.4351244898425901,1.0,5/14,11.55%,NFE2L2;HERPUD1;DDIT3;IMPACT;CCL2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6726738136639572,1.3476409279301165,0.1388888888888889,0.4368133190680925,1.0,1/11,0.13%,RUNX1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6917239744625316,1.3472649148798252,0.14449213161659513,0.43679417296714307,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6917239744625316,1.3472649148798252,0.14449213161659513,0.43679417296714307,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,Golgi to lysosome transport (GO:0090160),0.667163172123774,1.3460398567336889,0.1574585635359116,0.4396237983107099,1.0,6/11,19.71%,LAPTM5;RBSN;CLN3;GAK;CCDC91;SORT1
prerank,endoderm development (GO:0007492),-0.5139377197388247,-1.3459209753350867,0.13565891472868216,0.9103096315745537,1.0,11/13,48.64%,KIF16B;DUSP1;SOX17;LAMC1;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6180527045065989,1.3448031164411325,0.1258023106546855,0.4425164475540333,1.0,4/20,7.06%,RGS10;GNAQ;LY6G6D;AGRN
prerank,mRNA polyadenylation (GO:0006378),-0.3924652510748493,-1.3447358427454918,0.075,0.8907931030141281,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,RNA polyadenylation (GO:0043631),-0.3924652510748493,-1.3447358427454918,0.075,0.8907931030141281,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,regulation of neuron apoptotic process (GO:0043523),0.5323704598677425,1.3445315603934191,0.03597122302158273,0.44272120332538833,1.0,25/96,16.02%,PTK2B;TREM2;PCSK9;LGMN;ADAM8;MDK;TNF;APOE;CLN3;FOXO3;DDIT3;FZD9;CTNNB1;MEF2C;KIF14;TFAP2B;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;NF1
prerank,receptor clustering (GO:0043113),0.5961599520297025,1.3441748212045415,0.13615023474178403,0.44320500668089097,1.0,4/27,2.38%,ITGAL;ITGB2;ITGA4;THY1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5912592442429442,1.3437976120944162,0.13357400722021662,0.44367999622168924,1.0,12/26,17.04%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;ALPK1;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,positive regulation of secretion by cell (GO:1903532),0.5338543780800789,1.343566431777249,0.07255520504731862,0.44383945460946855,1.0,17/70,14.20%,TREM2;TGFB1;UNC13D;IL1A;ADAM8;SNCA;RGCC;ABCG1;TTN;P2RX4;SYTL4;ATP6AP1;DTNBP1;EXOC1;ARF6;NMB;MYH10
prerank,positive regulation of integrin activation (GO:0033625),0.6988951263527206,1.343322559998834,0.13636363636363635,0.4439985187861533,1.0,3/11,7.66%,PLEK;RAP1B;P2RY12
prerank,blood vessel endothelial cell migration (GO:0043534),-0.42000954082320735,-1.3430958379998634,0.0891089108910891,0.8859442737407532,1.0,8/22,8.42%,CDH5;PIK3R3;EPHB4;EFNB2;ID1;ROBO1;SLIT2;GPLD1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5145300167321327,-1.343042799867496,0.13654618473895583,0.8745422803476065,1.0,8/13,28.97%,BMP4;NR3C2;AR;CALCOCO1;GPER1;PLPP1;PGR;BMP7
prerank,triglyceride metabolic process (GO:0006641),0.5464155591908303,1.3429075843245912,0.09090909090909091,0.44467560752036994,1.0,14/48,20.90%,LPL;LPIN2;FABP4;APOE;SEL1L;FABP5;LIPC;AGMO;PLAAT3;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,glycolytic process (GO:0006096),0.5970610226510377,1.3424982483880858,0.13237063778580024,0.4453270318982028,1.0,11/28,16.87%,HK3;PFKL;ALDOB;ENO3;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5377122154566911,1.3409151855273096,0.07415036045314109,0.44934583241236875,1.0,7/76,7.66%,GNA15;LPAR6;CX3CR1;P2RY6;GPR17;CCKBR;P2RY12
prerank,positive regulation of cell migration (GO:0030335),0.5175941566225756,1.3401359647677835,0.006,0.4510796079949083,1.0,46/253,11.64%,NCKAP1L;PTPRC;PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;CCR2;F10;VSIR;PIK3CD;CSF1R;PLCG2;TGFBR1;MGAT5;RREB1;MTOR;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;KIF20B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;RAB11A;SEMA4A;PFN1;SOX9;NRP1;THBS1;HDAC6;GRN
prerank,cellular response to interferon-beta (GO:0035458),0.6518165246464799,1.3400962350359997,0.14884979702300405,0.45063743763624,1.0,7/14,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,catecholamine metabolic process (GO:0006584),0.6530271584230536,1.3399246664056605,0.15127175368139223,0.4505331413133095,1.0,3/14,4.50%,RNF180;ATP7A;DDC
prerank,negative regulation of protein kinase activity (GO:0006469),0.5348078586479948,1.3392916806837514,0.06418219461697723,0.4517005525381986,1.0,22/88,14.08%,PTPRC;UBASH3B;THY1;DUSP3;PTPN1;GNAQ;SLC8A1;SNCA;PYCARD;RB1;TRIM27;ADAR;DUSP10;QARS1;LRP5;DUSP19;DTNBP1;PTPRO;SORL1;ADARB1;RTRAF;PTPRT
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5237182106886923,1.3380389876276786,0.022066198595787363,0.4546088620183104,1.0,23/140,13.98%,GNA15;LPAR6;CALCR;CX3CR1;CCR2;CD52;P2RX7;SLC8A1;CXCR4;P2RX4;S1PR4;HMGB1;GPR17;CCKBR;CACNA1A;SPPL3;CYSLTR1;CMKLR1;TACR1;IAPP;NPTN;ADCY8;C3AR1
prerank,ceramide catabolic process (GO:0046514),0.6596175973892897,1.3378506656321227,0.151797603195739,0.45465785352111443,1.0,4/14,9.80%,HEXB;GM2A;HEXA;ACER3
prerank,histone H2A ubiquitination (GO:0033522),-0.4635109211342797,-1.337793511996144,0.10526315789473684,0.8856225108795467,1.0,7/17,12.26%,DDB2;RYBP;DDB1;UBR2;UBE2B;TRIM37;DTX3L
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6266550703781899,1.3375952367604693,0.14086294416243655,0.45480676839437023,1.0,4/19,7.24%,DAGLB;PRKCD;ANGPTL3;ABCD1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.664997449747287,1.3375778807043022,0.15352697095435686,0.4543145766214851,1.0,3/12,4.11%,ABCA1;ITGB3;ABCG1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.517421267577555,1.337103422653821,0.01,0.4551072523207093,1.0,66/234,17.33%,BTK;SHH;CARD11;CX3CR1;HCLS1;AIM2;IRAK2;PLCG2;ADAM8;TRIM25;TLR2;CAMK1D;TNFRSF11A;DHX9;TRIM5;TNF;RGCC;PRKD2;UBE2V1;TRAF2;PYCARD;DDIT3;IL18;RAB7B;NFAM1;HDAC5;TAF1;PRKCB;CFLAR;CTNNB1;MYOCD;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;SMAD3;HSF1;PPARGC1A;PRKCH;TRAF5;HDAC4;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;LRP8;SMARCB1;NFKB1;ADCY8;STK3;TRADD;TAB3;CAPN3;BUD31;MTDH;FANK1;CD36;PTEN;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6009577106594134,1.336852090950229,0.1437125748502994,0.45528622633495663,1.0,8/24,16.47%,PTK2B;CTSC;APOE;ATP5IF1;PSME3;RHBDF1;EPHA4;TMF1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5120794217046214,-1.3367893526367873,0.12121212121212122,0.8786419217298339,1.0,6/12,10.73%,CACNA1C;CAV1;RYR2;JUP;DLG1;CTNNA3
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.531763135801494,1.3363275607138023,0.04757085020242915,0.45617659633865987,1.0,25/105,15.61%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FFAR2;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5738912385315528,1.335643711880831,0.12166859791425261,0.45749610868643464,1.0,9/32,12.50%,LPIN2;LPCAT1;PCYT1A;CHKB;CSNK2A2;CSNK2A1;SLC44A2;STARD10;ABHD3
prerank,gas transport (GO:0015669),0.6746162568513986,1.335293603745532,0.15159944367176634,0.4579309978433958,1.0,2/10,13.10%,AQP1;IPCEF1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.630522145212993,1.3350470083596266,0.1646586345381526,0.4580908072994221,1.0,5/16,11.18%,WDTC1;ERLIN1;ERLIN2;ACADL;SOX9
prerank,response to interleukin-1 (GO:0070555),0.5333640053851757,1.3348458456623833,0.08125,0.4580879945701535,1.0,22/73,16.84%,SIRPA;IRAK2;TNFRSF11A;CCL8;SNCA;MYLK3;TANK;PYCARD;ANXA1;RC3H1;CCL14;HDAC4;CCL13;SOX9;GBP3;CCL2;NFKB1;SRC;TLE5;HIF1A;CD47;CCL25
prerank,thymus development (GO:0048538),0.67084854429556,1.3346642829865514,0.14931506849315068,0.4580567389045676,1.0,2/13,2.10%,SHH;TGFBR1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6263966849116864,1.333968326300812,0.13583441138421734,0.4594352101812679,1.0,4/18,4.53%,ABCG1;APOE;LDLRAP1;CLN3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5730927199566266,1.333549694804073,0.10479375696767002,0.46009219267142604,1.0,9/36,13.36%,TREM2;SIRPA;TAOK3;DUSP3;DUSP10;QARS1;DUSP19;ITCH;GPS2
prerank,bone development (GO:0060348),0.5654508780824576,1.3329545851264524,0.11672278338945005,0.4612652352793936,1.0,6/39,9.91%,PTPRC;SH3PXD2B;SKI;TP53;SULF2;LRP5
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5890186549234268,1.3327634008699494,0.15724815724815724,0.46124262106197944,1.0,11/24,17.04%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,regulation of bone mineralization (GO:0030500),0.5426104454385856,1.3326114633237698,0.10790598290598291,0.4611192404873552,1.0,9/55,8.52%,PTK2B;TGFB1;SRGN;P2RX7;BMP2K;SLC8A1;FZD9;MEF2C;ATP2B1
prerank,filopodium assembly (GO:0046847),0.6453191609188734,1.3324939240453206,0.15951742627345844,0.46090528039174655,1.0,2/16,5.92%,FGD2;FGD6
prerank,regulation of transposition (GO:0010528),0.6505384872247794,1.3324235442375025,0.15598885793871867,0.4605213388225136,1.0,1/13,0.89%,SMYD5
prerank,sodium ion import across plasma membrane (GO:0098719),0.6471399638654024,1.332363171938129,0.13240857503152584,0.4601726187979343,1.0,5/17,7.37%,HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,regulation of fibroblast migration (GO:0010762),0.6209664498907714,1.3317095533777346,0.14052697616060225,0.4614717572845263,1.0,8/20,18.52%,TGFB1;RFFL;CLN3;GNA12;THBS1;APPL2;CORO1C;ITGB1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5955118672145209,1.3311214202980042,0.12530120481927712,0.4625465798762153,1.0,13/26,24.42%,PLCG2;TNF;SLC9A1;SPPL3;CHERP;RCAN1;LMCD1;GSK3B;PTBP1;CHP1;IGF1;ATP2B4;CAMTA1
prerank,positive regulation of inflammatory response (GO:0050729),0.530157150035499,1.330448978590151,0.06790123456790123,0.4638349090669529,1.0,13/86,5.08%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18
prerank,protein kinase A signaling (GO:0010737),0.6671581025467513,1.3301867220323642,0.15841584158415842,0.46406062156408817,1.0,3/12,11.47%,LCP1;TTN;PRKACB
prerank,"phototransduction, visible light (GO:0007603)",0.6446693615085033,1.330118833323585,0.1422872340425532,0.46370367724214673,1.0,4/14,12.70%,GNAQ;SAG;CNGB1;ABCA4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5828526498686853,1.3299010799587794,0.1160609613130129,0.4638329155988038,1.0,8/30,12.83%,HEXB;ARSB;IDS;HEXA;CHSY3;BCAN;CHSY1;CHST15
prerank,carbohydrate transport (GO:0008643),0.6712293228064918,1.329547698726272,0.17629629629629628,0.4642339928034119,1.0,2/11,8.14%,AQP1;AQP11
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5559401058896242,1.3295053169603859,0.10816777041942605,0.4638174370443828,1.0,11/40,12.94%,TGFB1;TGFBR1;MTOR;MDK;RGCC;CTNNB1;TGFBR2;SNAI1;SMAD3;SDCBP;BAMBI
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.6069092914407566,1.3294706735419677,0.13840399002493767,0.46336308131157344,1.0,7/22,16.66%,MDK;FZD9;SLC16A2;NAP1L1;TAFA1;LRRK2;APPL2
prerank,carbohydrate catabolic process (GO:0016052),0.566901017798571,1.329130626023067,0.1324200913242009,0.4638250335842602,1.0,13/38,16.87%,HK3;PFKL;ALDOB;ENO3;MAN2B1;MAN2B2;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,ganglioside metabolic process (GO:0001573),0.6105828290160482,1.3288972072459921,0.15925925925925927,0.46396303932487853,1.0,5/20,7.47%,HEXB;GM2A;ST8SIA4;HEXA;ST6GALNAC4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.559353018072524,1.3280388725595311,0.1275626423690205,0.46583870287154516,1.0,7/33,8.71%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3
prerank,actin filament organization (GO:0007015),0.5170474410677943,1.3274841217226636,0.026078234704112337,0.466962011520111,1.0,26/151,11.37%,MYO1F;ARHGAP25;MYO1G;CASS4;LCP1;MYO1E;CORO1A;GAS2L1;MYO5A;MAD2L2;ELMO1;PLS1;TTN;GAS2L3;FHOD1;FLII;AIF1;NEDD9;MYO7A;MYO19;ABI1;TPM4;BCAR1;ACTN1;BIN3;ARPC4
prerank,regulation of cell adhesion (GO:0030155),0.5226423595552954,1.3274585037893643,0.038306451612903226,0.4664777106545565,1.0,34/129,16.80%,PTK2B;LYN;PIK3CG;ADAM8;PTPRJ;PLXNC1;MDK;SEMA4D;TNF;PRKD2;TGFBI;CXCR4;PLXNB2;CYTIP;IL18;RIPOR2;ATXN3;P4HB;KIF14;FLCN;SIPA1;PODXL;ARHGDIB;CYTH1;PPP2CA;ADGRG1;STX3;ARHGDIA;ZFHX3;SRC;RASA1;EPHA4;LPXN;EPHA8
prerank,response to lipid (GO:0033993),0.5174869433685929,1.3272689650617304,0.06795131845841786,0.4664807675797541,1.0,20/105,12.55%,ASCL1;SLC11A1;TGFB1;MAPKAPK3;TNFRSF11A;RXRB;SNCA;GCH1;ABCG1;IFNAR1;FOXO3;SPP1;CTNNB1;ANXA1;ERBIN;LY96;STAT5B;SOX9;PRDX3;TAB2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.531486371050294,1.3268960165604122,0.059123343527013254,0.4670740490587101,1.0,18/93,12.29%,PTK2B;SLAMF1;SCIMP;FCGR2B;TAOK3;TRAF2;PYCARD;SPI1;TRAF3;XDH;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;RELL1;NOD2;SDCBP
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6768904300096106,1.3268872575032586,0.1696551724137931,0.4665577007568908,1.0,2/12,6.74%,IL18;CD80
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5914019650977241,1.3267264503306864,0.15776699029126215,0.4664539168191881,1.0,4/23,15.67%,CX3CR1;TNFAIP3;GAS6;CD33
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.46653212778734326,-1.3262797076347377,0.14746543778801843,0.9105120270904347,1.0,5/17,13.93%,BMP4;AR;TFPI;ATP1A2;UBE2L3
prerank,microtubule anchoring at centrosome (GO:0034454),0.6796269226127222,1.32605464824736,0.17287630402384502,0.4678477298798359,1.0,1/10,0.15%,HOOK3
prerank,ureteric bud development (GO:0001657),-0.46156647048272853,-1.3256688631102358,0.1382488479262673,0.9017200030742348,1.0,7/17,14.63%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1;GPC3
prerank,response to cholesterol (GO:0070723),0.6273452392620781,1.3256513777589196,0.1613316261203585,0.46843544561287076,1.0,3/17,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,neurotransmitter uptake (GO:0001504),-0.5205813489825761,-1.3255393751440492,0.16842105263157894,0.8910447261486202,1.0,10/12,42.75%,SNAP25;ATP1A2;GLUL;SLC29A1;SLC22A2;SLC1A6;SLC38A1;SLC22A3;SLC29A2;SLC29A4
prerank,regulation of defense response to virus (GO:0050688),0.6463285670323141,1.32476018773955,0.16973684210526316,0.47040092116639726,1.0,6/14,12.90%,DHX9;TNFAIP3;TRAF3;ZMPSTE24;RNF216;ITCH
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6448514573624785,1.3246953021511632,0.1781767955801105,0.470035303676417,1.0,3/13,5.85%,ITGA4;MDK;HMGB1
prerank,cellular response to retinoic acid (GO:0071300),0.55425575809592,1.3245047716506828,0.13024282560706402,0.47001272908393155,1.0,4/42,1.89%,PTK2B;LYN;AQP1;FZD10
prerank,cAMP-mediated signaling (GO:0019933),-0.41090487310724405,-1.3242910383608801,0.13612565445026178,0.8854242664175757,1.0,9/24,16.49%,PDE7A;RAPGEF3;ADGRG6;ADCY2;RIMS2;RAPGEF2;CAP2;DGKQ;PDE2A
prerank,response to glucocorticoid (GO:0051384),0.581291236602399,1.3240839027814042,0.12956419316843346,0.47067022170800804,1.0,3/26,6.34%,CALCR;TNF;ANXA1
prerank,regulation of mitotic nuclear division (GO:0007088),0.542370951757224,1.3238229580389094,0.10043196544276457,0.4708194448200246,1.0,9/55,11.88%,ANAPC15;IL1A;NUP62;NME6;AURKAIP1;RGCC;KIF20B;LRP5;PHIP
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6736126958442452,1.323753589923498,0.16809116809116809,0.47044672131410276,1.0,4/10,8.99%,NFKBID;RC3H2;MALT1;RC3H1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6469515923077108,1.3236230957542332,0.1829436038514443,0.4702540652255507,1.0,4/13,13.92%,TREM2;TMSB4X;PPARGC1A;PID1
prerank,tryptophan catabolic process (GO:0006569),0.6841192586462895,1.323335777518026,0.1951219512195122,0.47050993835316657,1.0,3/11,7.82%,HAAO;KYNU;KMO
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6583798857337873,1.3232477097434159,0.16332378223495703,0.4702170116522093,1.0,2/12,3.81%,TGFB1;TNF
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5150622670940194,1.322997287328706,0.02814070351758794,0.47032805116738224,1.0,28/136,11.72%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;MAD2L2;NLRC3;PKD2;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;ADGRG3;TAF1;SETD6;PIM1;TAX1BP1;TMSB4X;ERBIN;RB1;ANXA4;HDAC4;CMKLR1;USP7;DAP
prerank,phospholipid transport (GO:0015914),0.5419480836244935,1.3229882931352408,0.1073326248671626,0.4698115622807262,1.0,13/52,15.26%,ATP8B4;ABCA1;ATP8A1;NPC2;ABCG1;APOE;ATP8A2;PRELID3B;ABCB4;ABCC1;ABCA4;OSBPL8;ABCA3
prerank,negative regulation of neuron death (GO:1901215),0.5217953858001175,1.322878457083858,0.06448311156601842,0.4695924290867068,1.0,25/93,15.93%,PTK2B;GPNMB;LGMN;CD200R1;ADAM8;MDK;SNCA;APOE;TRAF2;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;TNFRSF1B;SORL1;IKBKG;RETREG1;WFS1;LRRK2;CPEB4;RASA1
prerank,B cell activation involved in immune response (GO:0002312),0.6446337252402279,1.322839731706536,0.18030513176144244,0.46914869050777036,1.0,3/13,9.45%,FCGR2B;CD180;GPR183
prerank,regulation of phospholipase activity (GO:0010517),0.6811877326306658,1.3223877575393523,0.1827637444279346,0.46994206374993475,1.0,5/10,20.31%,ANGPTL3;SNCA;LRP1;PDPK1;PLA2G5
prerank,regulation of receptor recycling (GO:0001919),0.6252078736240148,1.3223285160418536,0.15733333333333333,0.4695612642387375,1.0,4/16,5.41%,PCSK9;VAMP3;SNCA;TBC1D16
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.43647986668814925,-1.3222800476124164,0.12735849056603774,0.8829554214580879,1.0,7/20,10.09%,CACNA1C;ANK2;RYR2;ATP1B1;DMD;ATP1A2;CALM3
prerank,negative regulation of lyase activity (GO:0051350),0.6408604057935613,1.3216158594094676,0.166446499339498,0.4709724966027624,1.0,5/16,14.14%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,regulation of JUN kinase activity (GO:0043506),0.5636821478906574,1.321605278326338,0.14844649021864212,0.4704728974886097,1.0,8/33,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP10;DUSP19
prerank,non-motile cilium assembly (GO:1905515),-0.3836102266996626,-1.321506483850979,0.10687022900763359,0.8754872860294023,1.0,15/30,25.28%,TTC8;IFT57;CEP250;BBS4;PIBF1;TBC1D32;CEP89;FUZ;TMEM216;BBS1;VANGL2;RPGRIP1L;GORAB;ARL13B;IFT122
prerank,cytosolic transport (GO:0016482),0.521099024538275,1.321267795374354,0.05656565656565657,0.47092597768314837,1.0,37/108,19.71%,HOOK3;LAPTM5;TBC1D10C;VAMP3;SNX5;WDR91;TMEM87B;HEATR5A;RBSN;CLN3;RAB14;RAB7A;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;BECN1;YKT6;WDR81;STX5;STX8;VPS29;HOOK2;VTI1A;SNX2;GAK;EPS15;HEATR5B;CCDC91;MON2;TBC1D23;DENND5A;TBC1D5;RAB29;SORT1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6080513827040156,1.3205850122989213,0.14356435643564355,0.47232730035412845,1.0,8/20,13.98%,P2RX7;PSTPIP1;PYCARD;IL18;CASP1;P2RX4;ENTPD1;C3AR1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6368719689746665,1.3201057638500067,0.17563739376770537,0.47314317849195503,1.0,4/13,12.76%,TNF;SNX33;TYROBP;STX3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5816208555699096,1.3200376656227375,0.1406799531066823,0.47281388667230945,1.0,6/26,11.48%,WDTC1;MLXIPL;ERLIN1;ERLIN2;ACADL;ADIPOR1
prerank,regulation of steroid metabolic process (GO:0019218),0.593190435201377,1.3197858004885283,0.16361416361416362,0.4729624449817084,1.0,10/23,17.35%,NR1H4;ABCG1;APOE;FMO5;ACADL;TTC39B;STUB1;ARV1;ASAH1;LAMTOR1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.616946335930753,1.3193569836662022,0.1564102564102564,0.4735720752356346,1.0,7/17,14.65%,SREBF2;ABCG1;APOE;ERLIN1;ERLIN2;SEC14L2;SREBF1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.518754091073836,1.318821272959523,0.045824847250509164,0.47451318181134194,1.0,25/101,17.87%,PIK3CG;PIK3R5;TGFB1;FLT3;CSF1R;ADAM8;CCND3;TNF;SNCA;RGCC;PKD2;CCND2;MAP2K2;PARP16;NOD2;PPP2CA;LRRK2;PIH1D1;SRC;SYAP1;INCENP;IRGM;CEMIP;RHOA;CCNYL1
prerank,regulation of lipid storage (GO:0010883),0.6047500045988001,1.3187272123129687,0.1536555142503098,0.4742338188753966,1.0,5/22,13.46%,LPL;ITGB3;TNF;VSTM2A;NFKB1
prerank,cellular response to hormone stimulus (GO:0032870),0.5350755502874844,1.3184903430191217,0.075,0.47437196505612356,1.0,13/69,11.20%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL;OCSTAMP;RAMP1;LMO2;MEF2C;STAT5B;TRIM24;SRA1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6258078973264647,1.3184294933503606,0.17218543046357615,0.47401452171557135,1.0,7/15,16.79%,LGMN;PTPN18;RHBDF2;MVB12B;RBPJ;RHBDF1;PTPN12
prerank,heterochromatin organization (GO:0070828),-0.4784967841447019,-1.3175632860186641,0.15555555555555556,0.8805979516110624,1.0,5/14,10.18%,SMCHD1;EZH1;MECOM;SETDB2;SETD7
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.675175699790671,1.317438254339276,0.1819484240687679,0.4762925123252324,1.0,2/10,7.31%,CCR2;WNK1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6731633796081906,1.3171806608490426,0.15722379603399433,0.476497300636538,1.0,4/12,11.30%,BASP1;MYO1E;PODXL;PTPRO
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5821387690474994,1.3171759566095969,0.14338235294117646,0.4759860806321279,1.0,6/23,12.63%,TGFB1;MAPK14;MYLK3;MYOCD;MEF2C;NRG1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5866209542421424,1.3171711377022535,0.13899138991389914,0.47546677598021864,1.0,7/25,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,chromatin disassembly (GO:0031498),0.637481613149713,1.3171624233812997,0.15477792732166892,0.4744236070541991,1.0,4/14,13.09%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.637481613149713,1.3171624233812997,0.15477792732166892,0.4744236070541991,1.0,4/14,13.09%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,protein localization to organelle (GO:0033365),-0.26149679895150124,-1.3170907564707586,0.0,0.8722956681556717,1.0,41/133,16.77%,APP;ANK2;RAB6A;UBAC2;LMBRD1;BMP4;SSB;ZNF423;CEP250;ATP6V1D;ARL3;YBX1;TOLLIP;PAF1;CALR;GCC2;BBS4;ARL6;EHD1;ALDH3A2;TRAM1;SCG3;ARL1;SIX1;TOPORS;SEC61G;BBS2;XPA;WDR35;GBP2;COL1A1;CTDNEP1;EMD;DNAJA1;SERP1;IFT20;SEC61B;AUP1;MTCH2;LAMP2;LMNA
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5038924655037974,-1.3170316692871777,0.16382252559726962,0.8624921866350503,1.0,4/12,13.17%,REST;HES1;HNRNPU;JAG1
prerank,neurogenesis (GO:0022008),0.5549807942005918,1.3168758762583914,0.1251372118551043,0.4746868835434184,1.0,7/43,6.34%,ASCL1;PCSK9;DAGLB;PRDM12;CXCR4;THOC2;ANXA1
prerank,negative regulation of response to stimulus (GO:0048585),0.531746655432792,1.316698689755792,0.09816612729234088,0.47465760011424096,1.0,14/60,15.37%,LYN;UBASH3B;FCGR2B;PDCD1;THY1;PTPN1;MCTP1;AQP11;CASK;SH2B3;CDK6;DDAH1;WFS1;TLE5
prerank,import into cell (GO:0098657),0.5560629914443839,1.316589305272486,0.12709030100334448,0.4744354855165729,1.0,6/41,7.47%,TREM2;IL10RA;LRRC8D;SLC7A8;SLC36A1;SLC16A2
prerank,positive regulation of translational initiation (GO:0045948),0.5950396791581015,1.31614925704498,0.15796178343949044,0.47514974662767684,1.0,3/18,8.61%,MTOR;YTHDF3;LARP1
prerank,positive regulation of cell death (GO:0010942),0.5330636759427234,1.3155409118573609,0.1126461211477152,0.47635044682425437,1.0,15/59,16.38%,CALCR;ITGB2;FCGR2B;TNF;SNCA;TYROBP;MAP3K5;C1QA;ITGAM;FYN;DDIT4;LRRK2;LRP1;CD36;FAF1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5219225232304638,-1.3153517816514206,0.14482758620689656,0.8586712460789602,1.0,9/11,30.49%,GPLD1;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1
prerank,regulation of glucose metabolic process (GO:0010906),-0.3660424571863751,-1.3152910007188874,0.06870229007633588,0.849310481567341,1.0,13/34,21.57%,OGT;IRS1;RORA;PDK3;GPLD1;SELENOS;ZNF692;MLYCD;DGKQ;AKT1;BCKDK;IRS2;PDK2
prerank,sodium ion transport (GO:0006814),0.5253809431687636,1.3144151533532036,0.08359133126934984,0.47899835115523937,1.0,7/85,4.10%,SLC6A3;SLC6A4;SCN4B;HCN4;FGF13;SLC8A1;PKD2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5126663451836526,-1.3143742545567385,0.1718213058419244,0.8429980901054076,1.0,6/12,18.57%,SEC61G;SGTB;CHMP4B;CHMP4A;SEC61B;SEC61A1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6695812998130686,1.3143614240978896,0.18732782369146006,0.478610067680121,1.0,5/11,18.40%,TGFB1;MYOCD;MEF2C;SOX6;GREM1
prerank,positive regulation of secretion (GO:0051047),0.6573376981091411,1.3141284314093207,0.16956521739130434,0.4787010621309085,1.0,1/11,1.86%,AQP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6962829910580154,1.3139604222390295,0.17055393586005832,0.4786766610266277,1.0,1/10,0.11%,PTPRC
prerank,cellular response to lectin (GO:1990858),0.5227069796706632,1.3138762070484353,0.06578947368421052,0.47785077485895466,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5227069796706632,1.3138762070484353,0.06578947368421052,0.47785077485895466,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.589845646699627,1.3135418819743763,0.16428571428571428,0.47830596044030915,1.0,5/24,8.26%,CD74;CD44;BCL2L1;SNAI1;TPT1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6704200124716867,1.3133591677703496,0.17130307467057102,0.47825712532236003,1.0,5/11,16.91%,PRDX1;PRDX3;PRDX2;PXDN;PRDX5
prerank,carbohydrate derivative transport (GO:1901264),0.6192113245183621,1.3132335320852146,0.17879948914431673,0.4780609512588978,1.0,4/18,4.53%,SLC15A3;NPC2;ABCG1;CLN3
prerank,autonomic nervous system development (GO:0048483),0.6222260877845192,1.3131902683757215,0.17866323907455012,0.4776635454211538,1.0,6/17,16.02%,ASCL1;EDNRB;TFAP2B;NRP1;SOX4;NF1
prerank,positive regulation of JNK cascade (GO:0046330),0.5331993781927901,1.3113901162795487,0.08722741433021806,0.482137863153468,1.0,14/70,12.29%,PTK2B;SLAMF1;FCGR2B;TAOK3;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;NOD2;SDCBP
prerank,sodium ion transmembrane transport (GO:0035725),0.5238790372748623,1.3112900709064252,0.09484536082474226,0.4818984894477533,1.0,10/84,9.15%,SLC6A3;SLC6A4;SCN4B;HCN4;SLC9A4;SLC8A1;PKD2;SLC9A9;SLC9A1;SLC6A15
prerank,positive regulation of signal transduction (GO:0009967),0.5093026348277494,1.3108861870682942,0.016,0.48247944749487015,1.0,53/238,13.41%,PTPRC;CD226;PTK2B;TREM2;SCIMP;SHH;CD74;SMOC2;P2RY6;ITGB3;SNX5;RAB34;TGFBR1;MGAT5;TLR2;BMP2K;DSTYK;LY86;MAML3;ERN1;PRKD2;PKD2;SKI;TNFAIP3;LGR6;FGFBP3;PRKCB;MACF1;CD80;CRADD;ASXL2;DISC1;CD180;CSNK2A1;TSPAN14;SULF2;LY96;NTF3;BAK1;POGLUT1;ATP6AP2;LIMS1;NRP1;CD63;PHIP;NOD2;CCBE1;SORL1;SMARCB1;TXNDC15;NPTN;GPS2;GAS6
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.6557943447648704,1.3107918769803013,0.1844380403458213,0.48219397837183686,1.0,4/12,14.96%,TREM2;APOE;IAPP;PFDN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.45229378374567325,-1.310430092169475,0.1415525114155251,0.8494655776263539,1.0,4/18,4.76%,UNC13B;GRIK4;GRIA2;SLC17A6
prerank,regulation of T cell chemotaxis (GO:0010819),0.6575271310106754,1.3101484280859337,0.18523676880222842,0.48345274647550185,1.0,2/11,7.31%,CCR2;WNK1
prerank,regulation of autophagy (GO:0010506),0.5080984296874312,1.309427297858934,0.017,0.4849304683719463,1.0,57/216,15.64%,TREM2;ATP6V0D2;IL10RA;ATP6V0E1;SNX5;DRAM2;CTSA;MTOR;PIK3CB;ATP6V1C1;PSAP;ERN1;TRIM5;SREBF2;ATP6V1E1;GPR137B;PIP4K2A;FOXO3;DDIT3;ATP6V0A2;DCAF12;HMGB1;TFEB;PIM2;SVIP;ATP6V0D1;TICAM1;PLK2;MTMR3;CSNK2A2;FLCN;RAB39B;TRIM27;TRIM8;GFAP;ATP6V0A1;EIF4G3;MID2;HDAC6;DAP;EXOC8;EXOC7;EXOC1;TAB2;FOXK1;LAMTOR3;VPS29;BMF;LRRK2;ATP6V0B;TAB3;SREBF1;VDAC1;RNF152;TBC1D14;MTDH;GSK3A
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6560719069446741,1.3078824267418487,0.18156028368794327,0.48882657714699196,1.0,4/12,5.85%,CD74;LPL;TNF;HMGB1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5033077023877351,1.3073400210038126,0.003,0.4897976701244961,1.0,60/348,13.41%,PTPRC;LCP2;PTK2B;TREM2;GPNMB;LYN;CALCR;TGFB1;CX3CR1;HCLS1;GATA1;CD74;LAT;FNIP2;ITGB3;CSF1R;PLCG2;NIBAN1;TGFBR1;MMD;PTPRJ;ANGPT4;MAD2L2;TEC;OSM;SNX9;RAP2A;SEMA4D;CCND3;TNF;FNIP1;SNCA;PRKD2;IL6R;BRAT1;CCND2;CD44;XRCC5;MAP2K3;TP53;CD80;VEGFB;TNIK;HFE;FLCN;NTF3;PFN2;INHBA;DUSP19;SOX9;NRP1;RPS6KA4;HDAC6;SDCBP;TAB2;LRP8;CAMKK2;NPTN;BRAF;GAS6
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5402787847815197,1.306930111449699,0.1372972972972973,0.4904469269362414,1.0,10/50,13.66%,CD86;LAPTM5;TLR2;TLR7;TNF;CD14;ACTN4;LIMS1;NOD2;TRADD
prerank,protein K63-linked ubiquitination (GO:0070534),0.5521729224196177,1.3067265955249212,0.1422319474835886,0.49044147756178036,1.0,16/41,14.99%,UBE2V2;TRIM5;UBE2V1;TRAF2;TRAF3;HECTD1;UBE2S;TRIM27;UBE2E3;RNF4;TRAF5;TRIM56;RNF135;ITCH;STUB1;RNF152
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6046267400152262,1.3064435186012573,0.16791044776119404,0.49074945352138366,1.0,13/20,28.34%,CNOT8;TNRC6A;MOV10;AGO4;AGO3;NRDE2;AGO2;CNOT7;CNOT1;AGO1;LIMD1;EIF6;TNRC6C
prerank,lipoprotein transport (GO:0042953),0.6697232344015653,1.3063645586855355,0.17510853835021709,0.49044067751250875,1.0,4/10,16.03%,PRKCB;VMP1;LRP1;CD36
prerank,negative regulation of kinase activity (GO:0033673),0.5346731062699435,1.3060554844988261,0.09544008483563096,0.4908094117209905,1.0,11/62,11.96%,PTPRC;UBASH3B;THY1;GNAQ;SNCA;RB1;TRIM27;QARS1;DUSP19;DTNBP1;PRDX3
prerank,cellular response to interleukin-6 (GO:0071354),0.5836269792005968,1.305943950086716,0.162874251497006,0.49060946365568603,1.0,11/26,16.43%,CBL;IL6R;CEBPA;SPI1;ST18;NFKB1;PID1;PTPRT;SRC;SELPLG;SBNO2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5258782271708619,1.3057988834939431,0.09603340292275574,0.4904835052045712,1.0,19/69,16.30%,PTK2B;CX3CR1;LGMN;ADAM8;MDK;APOE;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;HIF1A
prerank,gene silencing by miRNA (GO:0035195),0.5687764697134228,1.3046210345992941,0.1463963963963964,0.49340701319721186,1.0,19/32,26.28%,CNOT8;TNRC6A;MOV10;ADAR;PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;CNOT7;CNOT1;ZC3H7B;AGO1;PUM1;LIMD1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.47356049406630085,-1.3043596506826634,0.13214285714285715,0.863984573996487,1.0,4/13,11.64%,SESN3;CASTOR2;KPTN;ATM
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5963030719130711,1.304121108801821,0.16113161131611317,0.494312489425198,1.0,6/22,5.21%,ADAM8;SNX9;TNF;APOE;SNX33;TIMP1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5528082209524959,1.304079561006264,0.1270718232044199,0.4938952181365647,1.0,14/45,17.77%,PTK2B;TGFB1;CBL;GRB2;NCK2;ERBIN;DGKD;BCAR1;SOX9;BRAF;SRC;IQGAP1;RPS6KA5;PDPK1
prerank,cell-matrix adhesion (GO:0007160),0.515690759874494,1.3040026055985943,0.059123343527013254,0.49358537567855315,1.0,10/95,3.09%,ITGAL;FERMT3;HPSE;ITGB2;ITGA4;ITGB3;ITGB5;THY1;ITGA2;ANGPTL3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.532666685121061,1.302739549967367,0.08695652173913043,0.4966358583955415,1.0,16/75,10.93%,LYN;CD300A;PRKAR2B;PRKCD;PTPRJ;PTPN1;PIK3CB;SLC8A1;PKIB;APOE;CEBPA;PYCARD;MYOCD;RB1;LRP5;SH2B3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5561846555816159,1.3019165470238612,0.15324384787472037,0.49845736051962963,1.0,5/34,3.37%,UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18
prerank,mesoderm formation (GO:0001707),0.6077906369583652,1.3019019723045302,0.17866004962779156,0.49795556885562875,1.0,3/17,8.05%,ITGB3;ITGA2;SNAI1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5357296797859806,1.3014130068142844,0.12111468381564845,0.49881050326747817,1.0,18/49,21.15%,TREM2;NLRC3;HMGB1;TFIP11;SVIP;KIF14;HSF1;IMPACT;HDAC6;IAPP;SORL1;SRC;LDLRAD4;CDC42;DACT1;RIOK3;GSK3B;CRYAB
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5790080084530274,1.3008360314996206,0.16219512195121952,0.49990970984141764,1.0,9/25,17.39%,CBL;NUP62;ARAP1;DOK1;DGKD;BCAR3;RBPJ;RTN4;PDE6H
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5263421762757579,1.3005813255970968,0.11443298969072165,0.5001234752555104,1.0,20/71,16.53%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;TNFAIP3;DDI2;ATXN3;LONP1;MALT1;CTSZ;HDAC6;CASP8;STUB1;USP9X;CAPN2;PDCD6IP;IDE;YME1L1
prerank,regulation of coagulation (GO:0050818),0.6457962545453658,1.300004771927367,0.2076271186440678,0.5012519445430427,1.0,1/11,0.82%,GP1BA
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5887487796737255,1.299990637400311,0.15903614457831325,0.5007531463754696,1.0,9/25,16.37%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;PSME3IP1;EPHA4;RPL11
prerank,lymphocyte mediated immunity (GO:0002449),0.6488982240522899,1.2993771963825231,0.18948824343015214,0.5019169805241017,1.0,2/12,6.12%,MYO1G;BTN3A3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.615522534597807,1.2991390088029011,0.174496644295302,0.5020497386036696,1.0,4/16,9.18%,TREM2;TMSB4X;FLCN;PPARGC1A
prerank,rRNA 3'-end processing (GO:0031125),-0.5277736520409937,-1.2982616078266322,0.16451612903225807,0.8785894260586543,1.0,5/10,19.27%,RPS21;ERI1;EXOSC7;EXOSC8;EXOSC9
prerank,ear morphogenesis (GO:0042471),-0.4289703242913231,-1.2980977884158658,0.1152073732718894,0.8700116892343611,1.0,7/20,15.28%,NIPBL;MYO6;ZIC1;EPHB2;SIX1;TBX1;PAX2
prerank,heme catabolic process (GO:0042167),0.6276868943753897,1.297982427747474,0.1821705426356589,0.504207237946855,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6276868943753897,1.297982427747474,0.1821705426356589,0.504207237946855,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.45832433744929335,-1.2976604526864304,0.13636363636363635,0.8624217954341007,1.0,4/15,9.80%,TJP1;BMPER;SMAD1;KLF4
prerank,ERBB signaling pathway (GO:0038127),0.5263607218037172,1.297388306130325,0.12,0.5053438064297395,1.0,19/64,17.77%,PTK2B;TGFB1;CBL;GRB2;PTPN18;NCK2;ERBIN;DGKD;BCAR1;SOX9;NRG1;BRAF;STUB1;SRC;HSP90AA1;PTPN12;IQGAP1;RPS6KA5;PDPK1
prerank,secondary alcohol metabolic process (GO:1902652),0.5483288879484028,1.2973363245043283,0.13067552602436322,0.5049367447637537,1.0,7/42,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;SOAT2
prerank,blood circulation (GO:0008015),-0.3339818625647165,-1.2971920620263078,0.09090909090909091,0.8553297652863456,1.0,15/49,12.62%,SGCD;ELN;SGCZ;SERPING1;COL4A3;ACVRL1;SOD1;HTR7;SCPEP1;ROCK1;ACE;CYB5R3;CXCL12;GUCY1A1;NOS3
prerank,regulation of protein transport (GO:0051223),0.5744081364680773,1.2971271001562936,0.17253521126760563,0.5049629384060732,1.0,5/27,7.13%,LCP1;PTPN1;TNF;RHBDF2;GAPVD1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.665405668417772,1.296906603320541,0.1781767955801105,0.5050098000231256,1.0,3/11,8.10%,TGFB1;MYOCD;MEF2C
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6606237856055277,1.2966992084221927,0.18285714285714286,0.505062009755315,1.0,3/11,9.78%,CRTAP;P4HB;P3H2
prerank,Rap protein signal transduction (GO:0032486),0.6720019104020369,1.2962714323351026,0.19420289855072465,0.5056615768708189,1.0,6/10,14.54%,RAP2A;RAP1B;PLK2;RAP2B;RAPGEF1;RAP1A
prerank,negative regulation of platelet activation (GO:0010544),0.6254346056298221,1.2961962084943481,0.17195767195767195,0.505328097048993,1.0,4/16,4.14%,ALOX12;PRKCD;CD9;APOE
prerank,protein localization to synapse (GO:0035418),-0.5027192971363934,-1.2958849143897007,0.19083969465648856,0.851619121049197,1.0,3/12,11.11%,NLGN1;BSN;SHANK1
prerank,modulation by host of viral genome replication (GO:0044827),-0.478252579261568,-1.295326408292221,0.16363636363636364,0.8452228024878,1.0,10/13,19.11%,NUCKS1;PPIB;IFI27;CCNK;FMR1;FBXL2;TBC1D20;EIF2AK4;ZC3H12A;VAPA
prerank,membrane raft organization (GO:0031579),0.6216947275684644,1.2951069833645643,0.19414893617021275,0.5078213511623891,1.0,3/15,5.51%,RFTN1;CLN3;NPC1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6723941824324204,1.294847782497815,0.20625889046941678,0.5080450378511844,1.0,2/10,10.81%,LYN;MAP2K2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5423472210733961,1.2948476361758468,0.1425414364640884,0.5075074240545164,1.0,8/39,7.56%,LGMN;CBL;PTPRJ;DUSP3;GRB2;PTPN18;ZFYVE28;SH3KBP1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.6063054821999525,1.29316884157568,0.17193426042983564,0.5117476144845062,1.0,4/19,8.10%,RUNX1;TGFBR1;PIM1;MEF2C
prerank,regulation of ion transport (GO:0043269),0.5205650506079917,1.2931287887282408,0.10164271047227925,0.5113164588404358,1.0,16/76,14.28%,KCNJ11;SYT17;ITGB3;VAMP3;P2RX7;SNCA;P2RX4;WNK1;SYT2;HFE;SYT10;NEDD4L;DTNBP1;B2M;TOR1A;KCNA5
prerank,long-term memory (GO:0007616),0.6093037686164091,1.2929213843408658,0.15714285714285714,0.511341048369847,1.0,3/19,9.89%,NPAS4;APOE;CPEB3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6233906573018819,1.2929092610594404,0.17723156532988357,0.5108378420803685,1.0,4/17,8.05%,CD74;RFFL;CD44;SNAI1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3964282805465295,-1.2927224268723638,0.1337579617834395,0.8465329532904668,1.0,16/24,31.28%,LEPR;NDUFS1;SLC25A13;NDUFS4;COQ10B;GFPT1;COX15;SDHAF4;GFPT2;MRAP2;ACADVL;LYRM7;CYCS;COX10;MTLN;NR4A3
prerank,cellular response to peptide (GO:1901653),0.5343693732341749,1.2921459642613344,0.12085561497326203,0.512447683365339,1.0,16/56,17.28%,TREM2;FCGR2B;LGMN;ITGA4;RPL23;TP53;CACNA1A;ABCC1;NOD2;FYN;CACNB1;LRP1;SRC;CD36;EPHA4;ARHGEF2
prerank,glutathione derivative metabolic process (GO:1901685),0.59359893739808,1.2920670044081024,0.16959798994974876,0.5116077952326026,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.59359893739808,1.2920670044081024,0.16959798994974876,0.5116077952326026,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,membrane fusion (GO:0061025),0.5554062363850454,1.2919236477355183,0.1518987341772152,0.5115180317136908,1.0,17/33,23.88%,VAMP3;RABEP1;STX11;DNM2;SNAP29;DYSF;SNAP23;HUWE1;VPS33B;UBXN2A;DNM1L;USO1;NSFL1C;RIMS1;CHP1;NAPA;NSF
prerank,cellular response to fatty acid (GO:0071398),0.6480938127290977,1.2917270829925882,0.1901595744680851,0.5115401081501934,1.0,3/12,3.77%,LPL;FFAR2;NR1H4
prerank,endochondral bone morphogenesis (GO:0060350),-0.4963931657144519,-1.2899754379256336,0.17465753424657535,0.8482576459830258,1.0,8/11,25.38%,FOXC1;BMP4;INPPL1;TMEM119;COL13A1;TRPV4;BMPR2;FGFR3
prerank,negative regulation of calcium ion transport (GO:0051926),0.6143118876774649,1.2896463795930726,0.18218623481781376,0.516988738228097,1.0,3/15,8.56%,LILRB1;EPO;TRIM27
prerank,calcium import into the mitochondrion (GO:0036444),-0.5245854349934042,-1.2889961768708178,0.205607476635514,0.843158096506906,1.0,4/10,17.88%,AFG3L2;MICU1;MCUR1;SLC25A23
prerank,cilium-dependent cell motility (GO:0060285),-0.4088375144067769,-1.288420537896254,0.1511627906976744,0.8369400081628996,1.0,15/22,48.20%,CCDC39;CFAP54;DNAH2;CFAP44;GAS8;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH8;DNAH17;TEKT5;EFHC2;DNAH1
prerank,collagen fibril organization (GO:0030199),-0.2976659375661131,-1.2883465825929612,0.05555555555555555,0.8291053542351462,1.0,33/88,17.78%,COL5A2;COL8A1;COL12A1;COL25A1;SERPINH1;PLOD2;COL4A1;COL4A5;COL3A1;TLL1;COL6A3;PLOD1;COL4A2;COL4A3;PPIB;PLEC;COL4A6;ITGB4;COL5A3;COL1A2;COL20A1;LOXL1;ADAMTS2;COL6A2;COL1A1;COL16A1;COL6A1;COL26A1;COL9A2;COL14A1;DPT;PLOD3;CD151
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5795852872851057,1.2883213721853408,0.17191283292978207,0.5202950965988038,1.0,3/24,2.62%,RUNX1;CTSK;CTSL
prerank,regulation of myoblast fusion (GO:1901739),0.6436738982336319,1.2882185111883597,0.1919191919191919,0.520028607768268,1.0,4/11,11.09%,MAPK14;RIPOR2;CFLAR;CD53
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5443661484141225,1.2877923353628715,0.16758544652701213,0.5207451709800434,1.0,6/38,5.09%,TREM2;NLRC3;NR1H4;TANK;PYCARD;TNFAIP3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5626381460636719,1.2875939162977024,0.17806603773584906,0.52075537473455,1.0,7/29,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5149527693976184,1.2865952218606023,0.08299180327868852,0.5231019913361633,1.0,28/87,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;FMOD;TGFBRAP1;ZFYVE9;SMAD3;F11R;NLK;BAMBI;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,regulation of cell junction assembly (GO:1901888),0.580974524134434,1.2863864570181163,0.16627906976744186,0.5231310364829554,1.0,12/27,21.22%,RUNX1;RAP1B;SNAI1;MEF2C;PRKCH;F11R;RAPGEF1;RAP1A;MYO1C;FLOT1;ROCK2;SETD5
prerank,cellular response to mechanical stimulus (GO:0071260),0.5329910188038047,1.2863343620760779,0.14038876889848811,0.5227277746140745,1.0,14/46,13.88%,AQP1;TLR8;TLR7;CASP1;MAP3K14;CRADD;SLC9A1;MAP3K1;BAK1;F11R;SOX9;CASP8;NFKB1;IRF1
prerank,cellular response to organic cyclic compound (GO:0071407),0.5036000480126778,1.2863164238025409,0.05527638190954774,0.5222349492445384,1.0,34/141,14.54%,CYP1A1;TGFB1;P2RY6;AQP1;HCN4;P2RX7;P2RY2;NR1H4;TNF;PKD2;ADCY6;SPP1;IL18;RAP1B;P2RX4;TAF1;ABCB4;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;DIAPH1;RAPGEF1;CCL2;CASP7;NRIP1;TIPARP;ADCY3;ADCY8;GNG2;LRRK2;RAP1A
prerank,calcium ion transport into cytosol (GO:0060402),-0.40336284787933846,-1.2860786737493202,0.11282051282051282,0.8285834714506976,1.0,13/21,27.72%,CACNA1C;RYR2;JPH1;ITPR3;GRIN2B;CACNA2D1;GRIN1;TRPV4;JPH2;JPH4;TRPM2;CACNB3;GRIN2D
prerank,glycerophospholipid metabolic process (GO:0006650),0.5074740996014829,1.2857479375452823,0.11295336787564766,0.5233283039240225,1.0,18/75,15.84%,PLCB2;PLEK;PIGM;CSF1R;ABHD12;CLN3;PIGL;PIGX;PIGV;PLA2G7;AGK;PIGH;PRDX6;ABHD3;SYNJ1;GDE1;ABCA3;GDPD3
prerank,cellular response to organic substance (GO:0071310),0.5091302208346915,1.2856505810811085,0.06976744186046512,0.5230608811072889,1.0,26/116,14.53%,PTPN7;CYP1A1;TGFB1;HCLS1;FLT3;CSF1R;TGFBR1;PTPN18;NR1H4;TNF;LDLRAP1;CXCR4;IL18;CASP1;CTNNB1;TGFBR2;RAMP1;SMAD3;STAT5B;IL18BP;HDAC6;CCL2;TWF2;TIPARP;PID1;LRRK2
prerank,icosanoid metabolic process (GO:0006690),0.5403080952311566,1.2848308530019217,0.16979051819184124,0.5248710189828749,1.0,6/40,10.31%,TBXAS1;ALOX12;DAGLB;HPGD;PON3;ABCC1
prerank,cellular response to interleukin-15 (GO:0071350),0.6419731020152207,1.284808554525336,0.17264276228419656,0.5238585219807355,1.0,4/13,14.01%,STAT5A;GRB2;STAT5B;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6419731020152207,1.284808554525336,0.17264276228419656,0.5238585219807355,1.0,4/13,14.01%,STAT5A;GRB2;STAT5B;IL2RG
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3302077426329699,-1.2842408255392104,0.05263157894736842,0.8194612033356928,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3302077426329699,-1.2842408255392104,0.05263157894736842,0.8194612033356928,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5788785252060431,1.2833778789909704,0.17560975609756097,0.5273829568034896,1.0,3/23,3.02%,ITGAX;PIK3CD;MDK
prerank,negative regulation of multicellular organismal process (GO:0051241),0.49519436395279187,1.2829848947966607,0.03003003003003003,0.5280112746055007,1.0,43/199,13.91%,SLC6A4;GPNMB;SHH;SLC11A1;TGFB1;PLCL2;FCGR2B;SRGN;SLAMF8;MAD2L2;MDK;TLE3;MAP2K6;NR1H4;TNF;RGCC;DDIT3;SPI1;TIMP1;WWC2;PPP1R11;NKX2-1;MYOCD;MEF2C;FLCN;RB1;ATP2B1;DUSP10;ARHGDIB;PFN2;SOX9;RPS6KA4;PTPRO;ADIPOR1;GRN;HDAC9;CHSY1;PPP2CA;RAB11FIP5;NPTN;VASN;GAS6;TRPV3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.505666672751455,1.2828385510458418,0.07049345417925479,0.5279157747082167,1.0,15/113,6.88%,LGALS3;TGFB1;PLEK;SYK;LCP1;FNIP2;ABCA1;GTF2H1;TNF;FNIP1;SNCA;ASAP1;RAP1B;TP53;TAL1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4976610452502384,1.2828003584831182,0.013,0.5274843430171718,1.0,52/308,13.61%,CLEC9A;TREM2;FGR;PIK3CG;SHH;ITGAX;IRF4;SLC11A1;TGFB1;SYK;CCR2;IL1A;PIK3CD;ABCA1;TGFBR1;CRTAM;FABP4;RREB1;MAD2L2;MTOR;MDK;TNF;RGCC;APOE;CXCR4;CCDC88B;IL18;NFAM1;CTNNB1;TGFBR2;ACADL;CEBPB;SNAI1;FABP5;SMAD3;LURAP1;HSF1;PPARGC1A;PRKCH;INHBA;CMKLR1;TXK;SOX9;ADIPOR1;NR2C2;DYNC1H1;SDCBP;SORL1;BAMBI;PRLR;GAS6;SOX6
prerank,glycolipid metabolic process (GO:0006664),0.5361703972250182,1.2826175290803343,0.13852813852813853,0.5274337906262301,1.0,13/47,12.72%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;FUCA1;CERK;ST6GALNAC4;PGAP1;B3GALNT1;ARSA;SUMF2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5607104648346394,1.2811454393264732,0.19014084507042253,0.531082624841087,1.0,5/26,8.46%,ANAPC15;ESPL1;NEK6;CDC23;RB1
prerank,embryonic skeletal system development (GO:0048706),-0.36211608838464476,-1.2810038733717013,0.09565217391304348,0.8230643376302701,1.0,11/35,14.20%,PCSK5;HOXC4;WNT5A;SULF1;HOXB9;DSCAML1;HOXA3;PDGFRA;SIX1;HOXC9;COL1A1
prerank,steroid catabolic process (GO:0006706),0.6594715716208401,1.2809872440069112,0.19519094766619519,0.5310022243123439,1.0,3/10,15.73%,SPP1;HSD17B11;YWHAH
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6159921522092178,1.2803900588778725,0.1829105473965287,0.532210621406895,1.0,4/15,9.24%,BMP2K;PIK3CB;DGKD;SCYL2
prerank,plasma membrane repair (GO:0001778),0.6245096497131817,1.2800728312628855,0.2105978260869565,0.5325789521371127,1.0,6/13,19.88%,MYH9;SYTL4;DYSF;AHNAK2;ARL8B;SMPD1
prerank,protein-containing complex assembly (GO:0065003),0.4931380832137907,1.279474665674903,0.022,0.5337413767023012,1.0,62/259,15.85%,NCKAP1L;PTK2B;FERMT3;CD3E;BIN2;AIM2;CD74;SH3PXD2B;VAMP3;CTSC;P2RX7;SKAP2;DHX9;TLE3;SNX9;WIPF1;TNF;PPP6R1;MITF;TRAF2;TEAD1;CTNNB1;TRAPPC9;TP53;LEO1;SLC9A1;CAPZA1;HFE;MCFD2;CTSZ;PDCD6;HSF1;PPARGC1A;EPRS1;AMER1;TUBGCP4;RAB1B;RBBP5;SOX9;PYGO2;DET1;SEC24D;SEC16A;MDN1;CSNK1A1;F5;SEC16B;RANBP9;IKBKG;CASP8;STX5;TRAPPC6A;ADCY8;DARS1;TRADD;TSPAN4;PDZD11;LRRK2;CAPN3;AP2M1;GRIA1;BCL9
prerank,atrial septum development (GO:0003283),-0.4857769467938186,-1.2794118228016829,0.18450184501845018,0.8209363589800164,1.0,6/13,26.25%,ANK2;NPHP3;HEY2;BMPR2;DAND5;TGFB2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6254559352204208,1.2786940290617437,0.2054794520547945,0.5353868446246118,1.0,3/12,10.17%,MCM5;MCM6;MCM2
prerank,cellular glucose homeostasis (GO:0001678),0.5422172630703099,1.278459567250163,0.1627384960718294,0.5354999846552118,1.0,12/41,16.81%,HK3;LRRC8D;ERN1;PPARGC1A;TRA2B;GAS6;FOXK1;ADCY8;HK2;SOX4;HIF1A;GCK
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.592609237192709,1.2783684290125907,0.19975031210986266,0.5352182518920775,1.0,9/20,13.76%,SLC8A1;KCNMA1;SLC9A1;TFAP2B;NEDD4L;ATP6AP1;ATP1B3;LACC1;ATP1B2
prerank,hexose metabolic process (GO:0019318),0.5403147744350772,1.2783071499094876,0.15766262403528114,0.5348693002862845,1.0,11/39,17.26%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;FUCA1;TFAP2B;CHST15;PMM1;GALM;PPARD
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5202774704915698,1.276697239343299,0.11642411642411643,0.5389606057912325,1.0,9/75,8.19%,MRAP;CALCR;PLEK;GUCY2F;MGRN1;SAG;YWHAB;CNGB1;ZDHHC7
prerank,response to alcohol (GO:0097305),0.5664625974730197,1.2753516893567998,0.1957547169811321,0.542285861353089,1.0,4/27,6.68%,TGFB1;TGFBR1;SDF4;TGFBR2
prerank,regulation of integrin activation (GO:0033623),0.6060599395606842,1.2752165398760018,0.2064935064935065,0.542102362177378,1.0,7/15,22.43%,PLEK;RAP1B;KIF14;SRC;FBLIM1;PIEZO1;SELP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6428318795209703,1.2747845427775193,0.2268041237113402,0.5422656961909667,1.0,6/10,17.85%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6428318795209703,1.2747845427775193,0.2268041237113402,0.5422656961909667,1.0,6/10,17.85%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,microvillus organization (GO:0032528),0.6403811608285628,1.2747171771071943,0.21089385474860337,0.5419148405732442,1.0,9/13,22.13%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4319586277198749,-1.2745971446234943,0.15546218487394958,0.8306221888014532,1.0,6/17,8.42%,PIK3R3;EPHB4;EFNB2;ROBO1;SLIT2;GPLD1
prerank,rRNA catabolic process (GO:0016075),0.6090018714082108,1.27414526912026,0.21156373193166886,0.5430310781461349,1.0,1/16,0.36%,SLFN14
prerank,regulation of cell division (GO:0051302),0.5130564200787454,1.2733822963875412,0.11366006256517205,0.5446457759477719,1.0,14/72,11.28%,SHH;SMYD5;ZFYVE26;KLHL21;BCL2L1;TAL1;PLK4;PLK2;FLCN;MYO19;UVRAG;RAB11A;SETD2;BECN1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5416735218437008,1.2728631223516815,0.18055555555555555,0.5456019812760551,1.0,10/32,16.72%,TREM2;P2RX7;MLXIPL;PFKFB4;TMSB4X;PPARGC1A;PID1;PFKFB3;HIF1A;GAPDHS
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.37814558986134883,-1.2728075373356416,0.14634146341463414,0.8294178046397849,1.0,9/28,15.11%,SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5762266184547792,1.2726243562166695,0.19730392156862744,0.5457550776550522,1.0,6/23,19.98%,GUCY2F;SAG;CNGB1;GRK4;METAP2;NMT1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5327745597851002,1.2723028106679204,0.14859002169197397,0.5461378701493417,1.0,8/46,7.75%,LCP1;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,basement membrane organization (GO:0071711),0.6093203685454318,1.2714388910602412,0.1989389920424403,0.5481231520905652,1.0,1/14,0.14%,CTSS
prerank,positive regulation of catabolic process (GO:0009896),0.5164954355795282,1.2713414085338823,0.12849740932642487,0.5478471075237571,1.0,25/65,20.78%,VSIR;ANGPTL3;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CSNK2A1;NEDD4L;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;VPS28;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5753133961701019,1.2712435380122722,0.20730117340286833,0.5475839569053873,1.0,4/20,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,glucose homeostasis (GO:0042593),0.5088077359735476,1.2712419940692667,0.10020661157024793,0.547038834341962,1.0,20/83,16.81%,HK3;LRRC8D;MLXIPL;FFAR2;CEBPA;USF1;TFAP2B;PPARGC1A;SLC8B1;ADIPOR1;FOXK1;ADCY8;MBD5;WFS1;HK2;SOX4;HIF1A;ADIPOR2;APPL2;GCK
prerank,positive regulation of protein processing (GO:0010954),0.5826422901768252,1.2712298682417975,0.20822622107969152,0.5465225127635328,1.0,5/19,15.23%,BAG2;ADAM8;MYH9;CCBE1;PLGRKT
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.567810253992026,1.2707358320478261,0.1872749099639856,0.5473871649358123,1.0,8/26,18.32%,TREML4;TLR1;TLR2;HMGB1;WDFY1;NINJ1;RTN4;FLOT1
prerank,piRNA metabolic process (GO:0034587),-0.40491144328601936,-1.2704791005881537,0.18981481481481483,0.8302919306547218,1.0,19/19,59.56%,TDRKH;MYBL1;EXD1;TEX15;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,zinc ion transmembrane transport (GO:0071577),-0.3949062611156453,-1.2692706458824357,0.12637362637362637,0.8273096702390084,1.0,9/22,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;TRPM2;SLC39A12
prerank,phosphate ion homeostasis (GO:0055062),0.6442308520776974,1.2688599974442634,0.21669106881405564,0.5522116558554134,1.0,2/10,9.60%,TFAP2B;XPR1
prerank,placenta development (GO:0001890),-0.47259345197941627,-1.2688152740164462,0.1827956989247312,0.8214626959399681,1.0,8/12,43.89%,SOD1;PPARG;PTK2;ADAM19;ANG;E2F7;PLAC1;E2F8
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5146546745033068,1.2683039927335966,0.1385099685204617,0.5533431057809124,1.0,25/64,20.53%,PTK2B;CD3E;THY1;DUSP3;PIK3CB;MACF1;SLC9A1;CASK;ACTG1;VCL;NF2;THBS1;CDK6;PTPRA;RASA1;NF1;CD36;CCL25;CORO1C;RHOA;MINK1;PLEKHA2;ROCK2;GSK3B;MAP4K4
prerank,regulation of protein localization (GO:0032880),0.5196517510419756,1.268250143038965,0.14680851063829786,0.5529298790084661,1.0,11/58,10.11%,PLEKHM2;CTSD;ITGB3;MMD;TRIM25;TRIM5;RAB14;ZDHHC7;TRIM27;ATCAY;TPR
prerank,inhibitory synapse assembly (GO:1904862),0.6367465919464023,1.2678626958918058,0.20028612303290416,0.5535641313022516,1.0,2/11,2.79%,NPAS4;FGF13
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6565526463348121,1.2675167941561527,0.21820809248554912,0.55397983674653,1.0,4/10,10.93%,ALOX12;PRKCD;CD9;SH2B3
prerank,blood vessel morphogenesis (GO:0048514),0.5234945496164078,1.2667536038238332,0.14636752136752137,0.5556675643445724,1.0,14/54,16.11%,SHH;TGFB1;SYK;TGFBR1;ANGPTL3;CCM2;TGFBR2;LOX;LRP5;NRP1;CCBE1;RASA1;NF1;RBPJ
prerank,negative regulation of protein binding (GO:0032091),0.5066640282116244,1.266536266953192,0.12681912681912683,0.5557657651722152,1.0,15/71,15.37%,ARRB2;BAG2;ITGA4;PRKCD;ACTB;TFIP11;HFE;DISC1;CTSZ;PSME3IP1;SORL1;B2M;ATP2A3;LRRK2;TLE5
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6222919708553457,1.2659833554696345,0.21311475409836064,0.5568391418577732,1.0,5/13,14.39%,ZMIZ2;SPI1;ARID1A;ARID1B;ELOF1
prerank,dendritic spine organization (GO:0097061),0.5645983289184242,1.2651315236386533,0.18629807692307693,0.5588461817438143,1.0,3/26,6.43%,TREM2;LGMN;DOCK10
prerank,regulation of kinase activity (GO:0043549),0.5039255353563448,1.2647033860989223,0.11510791366906475,0.5595205366221766,1.0,9/89,4.28%,TREM2;FGR;FLT3;CD74;NLRC5;SLAMF8;CSF1R;DSTYK;TTN
prerank,cellular response to tumor necrosis factor (GO:0071356),0.49013876714702725,1.264550650899439,0.052104208416833664,0.5593975270555633,1.0,42/175,18.27%,PTK2B;AIM2;NFE2L2;TNFRSF11A;DHX9;CCL8;TNF;OCSTAMP;TNFSF8;TANK;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ERBIN;ST18;CCL14;TRAF5;TNFRSF21;PSMA2;CCL13;LIMS1;GBP3;CCL2;TNFRSF1B;PSME3;TRADD;PSMB5;PID1;PSMD8;PSMD7;PSMB9;ASAH1;CCL25;ARHGEF2;PSMD2;BIRC2
prerank,positive regulation of cell population proliferation (GO:0008284),0.4879576537287199,1.264149853143054,0.005,0.560017324119601,1.0,74/423,13.41%,PTPRC;CD86;PTK2B;SLAMF1;LYN;SHH;HCK;ITGAX;HPSE;TGFB1;CXCL5;HCLS1;FLT3;LGMN;CD74;RPL23;AQP1;CSF1R;TGFBR1;TCIRG1;MLXIPL;S100B;TNFRSF11A;DHX9;MDK;OSM;IL12RB2;TNF;IL6R;CNOT8;IL18;TIMP1;CCND2;FZD9;AIF1;GAB2;CCAR1;TGFBR2;RPS15A;PIM1;CCKBR;EPO;FLT3LG;MEF2C;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;PRKCH;ACER3;LRP5;HDAC4;NAP1L1;SOX9;THBS1;GRN;PHIP;PRDX3;CIAO1;NOD2;SDCBP;CDK6;TBC1D8;NRG1;STX3;BAMBI;PRLR;GAS6
prerank,microvillus assembly (GO:0030033),0.6253960756887711,1.2640788767210502,0.21828103683492497,0.5596724287403027,1.0,9/14,22.13%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,phosphorylation (GO:0016310),0.48725841160530314,1.2639313515655652,0.008,0.559557721897206,1.0,104/385,17.40%,PTK2B;BTK;FGR;LYN;GMFG;PIK3CG;HCK;TGFB1;SYK;DGKZ;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;TGFBR1;TYK2;PRKCD;MTOR;BMP2K;PIK3CB;TEC;GRK3;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;DGKK;MORC3;TLK1;DGKE;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;NADK;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;CERK;TNIK;PLK2;CSNK1G2;CHEK2;DGKG;DGKD;CSNK2A1;MAP3K1;STRADB;PRKCH;AGK;CDK7;STK17B;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;POMK;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;DGKI;LIPE;MERTK;CAMKK2;SHPK;BRAF;GAS6;STK3;STK24;BMX;LRRK2;NIM1K;WNK4;TESK2;STRADA;SGK3;GSK3A;CDK15;XYLB;MAP3K11;GNPTAB;COQ8B;STK4;GK;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,regulation of cholesterol esterification (GO:0010872),0.6477138078334282,1.2639134234535947,0.22507552870090636,0.5590553822546408,1.0,5/10,21.23%,ABCG1;APOE;STARD4;LAMTOR1;ABCA2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5513023235821539,1.2638570099084612,0.19929245283018868,0.558670073708559,1.0,11/26,20.84%,TREM2;TLR2;GPS2;IRF1;LGR4;CD36;APPL2;BIRC2;FLOT1;NFKBIL1;BIRC3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5203084646184681,1.2638031239692515,0.17067833698030635,0.5582845155825557,1.0,8/46,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,regulation of protein export from nucleus (GO:0046825),-0.3939454558565439,-1.263772510413069,0.1791907514450867,0.8327217746667797,1.0,7/23,7.63%,RAPGEF3;PTPN14;TCF7L2;SP100;ANP32B;BAG3;IFI27
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5658128664274387,1.2636570259497668,0.21428571428571427,0.5581867306616997,1.0,6/21,15.26%,TREM2;APOE;EEPD1;GPS2;LRP1;ABCA3
prerank,entry into host (GO:0044409),0.6187261389928307,1.263480867135116,0.23529411764705882,0.5581746547238596,1.0,4/13,6.29%,CBL;GRB2;CXCR4;CTNNB1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6009726222861553,1.2620350244250045,0.21352785145888595,0.561807071575754,1.0,5/16,9.74%,PIGM;PIGL;PIGX;PIGV;PIGH
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.43925946300670277,-1.2612755494331098,0.18702290076335878,0.8340349994963792,1.0,4/16,3.14%,ANK2;RYR2;UBAC2;BCAP31
prerank,inner ear morphogenesis (GO:0042472),-0.4006140202607041,-1.2612708754834008,0.17391304347826086,0.8268678397544765,1.0,8/22,15.28%,MYO6;TTC39C;ZIC1;EPHB2;TBX18;SIX1;TBX1;PAX2
prerank,lipoprotein catabolic process (GO:0042159),0.6461035625436142,1.261190201030032,0.22720897615708274,0.5637253822207122,1.0,4/11,11.66%,CTSD;APOE;ABHD17B;ABHD17C
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6005792159908255,1.2609379577395277,0.22733245729303547,0.5639065357188991,1.0,3/15,10.88%,NPAS4;CLN3;ZDHHC3
prerank,positive regulation of programmed cell death (GO:0043068),0.48392728253709105,1.259144392226386,0.02,0.568517809546305,1.0,63/272,17.55%,FGD2;VAV1;LILRB1;IRF5;PREX1;SYK;ABR;PLEKHN1;CTSD;LAPTM5;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;ITSN1;BAK1;STK17B;ARHGEF17;HDAC6;TRIM35;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;LRRK2;SOX4;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5374566234711813,1.2588502710100962,0.1981981981981982,0.5688330859343703,1.0,9/36,9.43%,CX3CR1;TGFBR1;TNF;PYCARD;CRADD;CSNK2A2;CSNK2A1;RB1;QARS1
prerank,positive regulation of coagulation (GO:0050820),0.6536317092490049,1.2586563084845186,0.22696011004126548,0.5683057071721268,1.0,2/10,11.24%,HPSE;THBS1
prerank,positive regulation of hemostasis (GO:1900048),0.6536317092490049,1.2586563084845186,0.22696011004126548,0.5683057071721268,1.0,2/10,11.24%,HPSE;THBS1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.33290701368311554,-1.2582085680413169,0.1111111111111111,0.8302503912872868,1.0,14/52,15.39%,RBFOX2;FXR2;YTHDC1;MBNL2;RBFOX3;REST;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;HNRNPU;KHDRBS2;PUF60
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6133780963646744,1.258062721072112,0.2248995983935743,0.5694547938504452,1.0,2/14,3.38%,PRKAR2B;PKIB
prerank,negative regulation of apoptotic process (GO:0043066),0.4832773932214159,1.2578663102743284,0.008,0.5694886959719316,1.0,97/444,16.32%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CX3CR1;CLEC5A;HCLS1;GATA1;PCID2;LGMN;CD74;CBL;AQP1;ALOX12;ADAM8;PRKCD;ANGPT4;TNFAIP8;DSTYK;NUP62;MDK;SEMA4D;NR1H4;TNF;FNIP1;SNCA;APOE;DNAJC3;CLN3;CCND2;CD44;FZD9;FZD3;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;CSNK2A2;CSNK2A1;TFAP2B;RB1;TRIM27;ARHGAP10;NTF3;PPARGC1A;PRKCH;QARS1;BABAM2;MGMT;ANXA4;SON;BNIP1;MAEA;SOX9;THBS1;CCL2;GRN;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;MERTK;PRLR;BRAF;GAS6;NFKB1;RETREG1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;CPEB4;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38
prerank,digestive tract development (GO:0048565),-0.35782653492698313,-1.2574703397029574,0.10687022900763359,0.8257916081840261,1.0,13/33,14.15%,COBL;PCSK5;NIPBL;GLI2;SALL1;GLI3;SMO;GLI1;PKDCC;CCDC39;CHD8;RARB;STRA6
prerank,mesonephros development (GO:0001823),-0.49767331101711915,-1.2572442074459362,0.20134228187919462,0.8197558951492925,1.0,7/11,35.32%,BMP4;PAX2;ZBTB16;FGF10;BMP7;FGF1;OSR1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5461126378138995,1.2571701618031403,0.1823394495412844,0.5709701474035965,1.0,4/32,2.52%,TGFB1;CD300A;PRKCD;MTOR
prerank,negative regulation of cell adhesion (GO:0007162),0.505211684078939,1.2570127169313636,0.15447991761071062,0.570889043838835,1.0,14/72,11.30%,PTPRC;TGFB1;PLXNC1;MDK;SEMA4D;TGFBI;PLXNB2;RIPOR2;SIPA1;SPINT2;PODXL;ARHGDIB;NF2;PTPRO
prerank,vasculogenesis (GO:0001570),0.5512393348900684,1.2566178778828703,0.1920374707259953,0.5714961945358101,1.0,4/32,6.68%,SHH;TGFB1;CCM2;TGFBR2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.29564392015817975,-1.2564808763018593,0.06666666666666667,0.8151723950433712,1.0,25/61,22.04%,CAV1;PANK2;PSME4;PSMD11;PSMA5;PSMA4;PPARA;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;FGFR4;PSMB4;PSMC4;PDK2;PSMB6
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5751090982402155,1.2557973974041339,0.22382671480144403,0.5733876206325851,1.0,9/22,18.16%,CCR2;EDNRB;AKAP5;CAP1;LTB4R2;GNAI3;NF1;CACNA1D;GNAI2
prerank,striated muscle tissue development (GO:0014706),-0.3700872709681818,-1.2552619610877531,0.15555555555555556,0.8123110742572789,1.0,6/29,10.33%,SGCD;CAV1;SGCZ;PGM5;BMP5;SIX1
prerank,chemical homeostasis (GO:0048878),0.5087943975271801,1.2552372901959965,0.15164369034994699,0.5743752449390928,1.0,13/61,11.13%,TREM2;ANGPTL3;CLN8;CEBPA;TENT4B;ABCB4;USF1;WNK1;AQP11;ABHD4;NEDD4L;VGF;SLC66A1
prerank,positive regulation of gene expression (GO:0010628),0.48455349370177553,1.2547938643704941,0.009,0.5750912767884926,1.0,83/442,14.37%,CLEC9A;LILRB1;TREM2;FGR;PF4;CALCR;PIK3CG;ITGAX;SLC11A1;TGFB1;CD3E;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;PLCG2;NIBAN1;TGFBR1;CRTAM;TLR2;TAF1A;P2RX7;MTOR;PIK3CB;MAPK14;POLR1E;ERN1;TNF;SF3B1;RGCC;MITF;TTN;PDCL3;PLXNB2;TENT4B;CCDC88B;NFAM1;CIRBP;ACTB;TYROBP;TP53;NKX2-1;TNRC6A;YTHDF3;TICAM1;HFE;MEF2C;LARP4B;MOV10;SMAD3;LURAP1;PPARGC1A;AGO4;NOS1AP;ACTG1;CPEB3;RPL26;INHBA;MAP2K2;POLR1B;POLR2L;TXK;LIMS1;DTNBP1;SOX9;THBS1;AGO3;ZCCHC4;METTL3;VSTM2A;SEC16B;BRAF;GAS6;PCIF1;POLDIP3;HCFC1;UPF3B;PID1;CADM1;HNRNPD
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6000960346856871,1.2543280206100473,0.23341836734693877,0.5759039844360216,1.0,4/17,10.79%,MYO1G;IL18;BTN3A3;IL18BP
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6168004470906461,1.253817871249547,0.2212041884816754,0.5769239179158575,1.0,2/15,2.77%,PTK2B;TEC
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6322734549631607,1.2537334703429008,0.22099447513812154,0.5766171575163447,1.0,2/11,7.45%,IL12RB2;STAT4
prerank,eye development (GO:0001654),-0.3211979666118699,-1.253589218021327,0.13157894736842105,0.8112524146667748,1.0,13/54,11.18%,COL5A2;CACNA1C;FOXC1;PBX1;NIPBL;EFEMP1;SHROOM2;MEIS2;FBN1;PBX4;SMG9;PBX3;PBX2
prerank,cellular response to heat (GO:0034605),0.5379580099779182,1.2535398893712806,0.18376550169109357,0.5766072829495903,1.0,12/35,18.36%,IL1A;ATXN3;HSBP1;PDCD6;HSF1;TPR;THBS1;RBBP7;STUB1;IER5;HSP90AA1;SLU7
prerank,glycosphingolipid metabolic process (GO:0006687),0.5329672216520285,1.253488186013723,0.18688524590163935,0.5762066958522725,1.0,19/42,21.48%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;CERK;B3GALNT1;ST8SIA1;ARSA;SUMF2;LARGE1;ASAH1;B4GALNT1;GBA2;SMPD1;ABCA2;SUMF1;B4GALT6
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4822822227807302,1.252679780883546,0.016,0.5779587637914108,1.0,56/348,11.72%,ARRB2;LILRB1;TREM2;PF4;CALCR;ITGAX;SLC11A1;TGFB1;CD3E;PCSK9;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;LAPTM5;VAMP3;PLCG2;TGFBR1;TLR2;P2RX7;MTOR;PTPN1;PIK3CB;MAPK14;TNF;SNCA;RGCC;MITF;TTN;PDCL3;TYROBP;TP53;NKX2-1;TNRC6A;TICAM1;RESF1;HFE;MEF2C;MOV10;SMAD3;NTF3;PPARGC1A;SCYL2;AGO4;NOS1AP;ACTG1;ATF7IP;INHBA;LIMS1;DTNBP1;SOX9;CD63;AGO3
prerank,negative regulation of hydrolase activity (GO:0051346),0.5190862896557364,1.252611465638678,0.17207792207792208,0.5775763587218927,1.0,8/49,9.97%,KLRK1;FZD10;RASA4;CST7;ARFGEF1;WNK1;ATP5IF1;F11R
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5391462088672382,1.2524188113157573,0.1844769403824522,0.5775744553460073,1.0,11/36,17.82%,CD74;NLRC5;LAPTM5;CXCR4;CD300LF;CASP1;TXK;GAS6;IRGM;HIF1A;UBE2K
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.521953745388598,1.2521044548063274,0.17937219730941703,0.5779047785782224,1.0,11/45,11.59%,TGFB1;NABP1;NME6;AURKAIP1;RGCC;FZD3;CTNNB1;PLK2;SMAD3;ANGEL2;TRIM35
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5202769827335286,-1.2517663970233177,0.19230769230769232,0.8105764648290144,1.0,8/10,42.94%,BMP5;LIN7C;ARHGAP12;BMP7;SOX11;DLL4;LRP6;TBX20
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6141190928250959,1.25149554889118,0.24166666666666667,0.5791182375888171,1.0,2/12,3.81%,TGFB1;TNF
prerank,nitrogen compound transport (GO:0071705),0.49229876969818054,1.2511631378005201,0.07669021190716448,0.579545532842912,1.0,18/141,9.15%,SLC6A3;SLC6A4;SLC11A1;SLC16A10;SLC15A3;AQP1;SLC52A1;LRRC8D;SLC7A7;SLC7A8;MYH9;RAB7A;SLC36A1;SLC38A4;RAMP1;SLC43A2;SLC44A2;SLC6A15
prerank,cellular iron ion homeostasis (GO:0006879),0.5101043083358068,1.250993751064905,0.160676532769556,0.5794849073640729,1.0,9/55,11.45%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1
prerank,synaptic vesicle membrane organization (GO:0048499),0.5861843539508802,1.2505810765584273,0.2306684141546527,0.5801215521904617,1.0,9/17,17.72%,STX11;AP3D1;SNAP29;SYNGR1;SYNGR2;STX3;SNAP23;TOR1A;STX2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.41610158163753164,-1.250247952582935,0.20304568527918782,0.808887751819989,1.0,9/18,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,bicellular tight junction assembly (GO:0070830),-0.3288663032809658,-1.249316427226253,0.039473684210526314,0.8056887399871697,1.0,10/46,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1
prerank,positive regulation of cell motility (GO:2000147),0.4846096887165783,1.2489301869965224,0.04312938816449348,0.5844027852983793,1.0,36/205,12.62%,PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;F10;VSIR;PIK3CD;CSF1R;TGFBR1;MGAT5;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;SEMA4A;THBS1;GRN;SDCBP;NUMB
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4871160844340725,1.2485326188164625,0.04909819639278557,0.5850129996250247,1.0,66/208,20.84%,TREM2;CARD11;CD74;PLCG2;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;NLRC3;TRIM5;NEK6;NR1H4;TNF;UBE2V1;TANK;TRAF2;PYCARD;TNFAIP3;CASP1;TRAF3;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;NLRX1;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;CAPN3;MTDH;UBE2N;TRIM62;REL;RHOA;PDPK1;BIRC2;TNFSF10;PER1;RIOK3;EDA2R;OPTN;HSPB1;ZMYND11;PRKN;CARD19;BIRC3
prerank,positive regulation of innate immune response (GO:0045089),0.5437943318033168,1.2481301805150267,0.21807909604519773,0.5856425538634821,1.0,5/30,4.97%,NLRC5;ADAM8;DHX9;TLR8;SPI1
prerank,regulation of cellular component movement (GO:0051270),0.5122312568142265,1.2478973616472486,0.17330462863293863,0.5857451579341558,1.0,13/49,14.01%,LYN;TGFBR1;CD9;ARAP1;ACTN4;ACTN1;PKN1;DIAPH1;HDAC6;CDK6;NRG1;ZSWIM6;ARHGAP18
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5450679854849744,1.2477129309120765,0.20276497695852536,0.5857881227888558,1.0,3/29,8.12%,RUNX1;VPS18;VPS11
prerank,retinoic acid metabolic process (GO:0042573),-0.4387756306269434,-1.2475360420152128,0.16877637130801687,0.8051569917520727,1.0,5/14,37.01%,SCPEP1;ALDH1A2;ADH1A;CYP2S1;BCO2
prerank,mRNA stabilization (GO:0048255),0.5265417113788847,1.2468423814776932,0.19243604004449388,0.5877859243144437,1.0,7/40,9.54%,SLC11A1;DHX9;MAPK14;CIRBP;LARP1;TENT5C;ANGEL2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5326927725789217,1.2463909958529475,0.20200892857142858,0.5886108176399157,1.0,11/38,16.71%,CX3CR1;SIRPA;TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;CD47;HSP90AA1
prerank,positive regulation of type I interferon production (GO:0032481),0.5019272883568919,1.2453136554790183,0.14644351464435146,0.591232794878954,1.0,21/73,19.16%,IRF5;TLR2;DHX9;TLR8;TLR7;LRRFIP1;CD14;XRCC5;CTNNB1;SETD2;TRIM56;POLR2L;RNF135;NFKB1;IRF1;HSP90AA1;DDX41;FLOT1;POLR2E;RIOK3;CRCP
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.49624755333396625,1.2449468809876747,0.138860103626943,0.5917625891004503,1.0,22/73,18.19%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;OSM;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;BRAF;GAS6;BCAR3;IRGM;HSP90AA1;STK4;AKAP9;CREBL2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5070280301968961,1.2449172625174287,0.1540880503144654,0.5912846474203064,1.0,13/70,12.01%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;SPI1;MEF2C;KIF14;RB1;ACTN1;PARVB;NRP1;METTL3
prerank,positive regulation of protein secretion (GO:0050714),0.494100328412929,1.2448117191720098,0.1626442812172088,0.5910411293389043,1.0,7/69,4.28%,TREM2;TGFB1;IL1A;ADAM8;TLR2;ABCG1;TTN
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.49840238580318763,1.2447189725442256,0.16049382716049382,0.5907961355066305,1.0,25/80,17.08%,GSAP;NIBAN1;PRKCD;MTOR;TNF;ABCG1;PLXNB2;SMPD3;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;NSMAF;UPF3B;HNRNPD;SOX4;GSK3A;EPHA4;RPS4X
prerank,negative regulation of heart contraction (GO:0045822),0.6280069674812692,1.2446688043425167,0.23709902370990238,0.5903900937128883,1.0,1/11,0.66%,PIK3CG
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48886468270937705,1.2444720304766694,0.13109756097560976,0.5903886968492238,1.0,31/93,19.10%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;NSD1;MLXIPL;OSM;NCK2;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;DDIT4;BRAF;GAS6;BCAR3;IRGM;PTEN;HSP90AA1;STK4;AKAP9;SPTBN4;CREBL2;PAQR3;CNKSR3;RPTOR
prerank,actin filament polymerization (GO:0030041),0.5391987839118126,1.2443753524359225,0.2151029748283753,0.5901063984008176,1.0,6/29,10.92%,PREX1;PSTPIP1;MICALL2;AIF1;WASHC3;DIAPH1
prerank,regulation of lipid catabolic process (GO:0050994),0.5769648346095175,1.2442236418078738,0.23026315789473684,0.5900069027416702,1.0,3/19,7.24%,ANGPTL3;TNF;ABCD1
prerank,cellular response to increased oxygen levels (GO:0036295),0.6287356149906561,1.2441725776967494,0.25615050651230103,0.5896021678243603,1.0,4/11,11.02%,ATG7;ATP6V0A2;ATP6V0D1;ATP6AP1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4915973773228541,1.2438564123025309,0.09837728194726167,0.5900115778948861,1.0,39/122,17.20%,CIITA;SMOC2;PPP1R3E;NLRC5;NIBAN1;TLR2;MTOR;DHX9;RGCC;PRKD2;PLXNB2;SLC25A37;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;BRPF3;THBS1;CCL2;STN1;ZCCHC4;METTL3;NOD2;KAT7;DNA2;PCIF1;NFKB1;POLDIP3;UPF3B;HNRNPD;TMEM106A;SOX4;BCAR3;FAF1;NOX1;GCK;RPS4X;IL33
prerank,cardiac atrium morphogenesis (GO:0003209),-0.43920628923763083,-1.2437501301652218,0.18846153846153846,0.8115189552482069,1.0,12/16,49.50%,HEY2;BMPR2;TGFB2;PROX1;DLL4;TBX20;NOG;MYH6;GATA4;NOTCH2;ZFPM1;ISL1
prerank,positive regulation of cellular respiration (GO:1901857),0.6316811847815897,1.243678997875169,0.24472573839662448,0.5899932327447146,1.0,2/11,4.57%,IL10RB;IFNAR1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.48235663363240877,-1.2435096520662285,0.20350877192982456,0.80594338035658,1.0,8/11,31.11%,UQCRC2;UQCRH;UQCRC1;UQCRQ;CYC1;UQCRFS1;CYCS;UQCC3
prerank,dopamine metabolic process (GO:0042417),0.583263989755167,1.243153551310832,0.21311475409836064,0.590937622457073,1.0,5/18,14.71%,SNCA;GCH1;ATP7A;COMT;MAOA
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.514713553014455,1.2430639391205152,0.19132369299221358,0.5906400790509433,1.0,13/44,18.46%,PCID2;AQP1;CST7;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;SRC;DNAJB6;MAP2K5
prerank,phosphatidic acid metabolic process (GO:0046473),0.5106701028178926,1.242956746452809,0.19629225736095965,0.5904159752974798,1.0,8/48,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,response to muramyl dipeptide (GO:0032495),0.6258497432947908,1.2428999821445768,0.22388059701492538,0.5900322910282515,1.0,3/12,12.25%,IRF5;ERBIN;NOD2
prerank,protein dephosphorylation (GO:0006470),0.4857396459611578,1.2427759704019503,0.10638297872340426,0.5898283179302845,1.0,32/135,18.68%,PTPRC;PTPN7;PPM1H;UBASH3B;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;DUSP10;RPAP2;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;PPP2R5C;PTPN3;PPP4R2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4909231561243354,1.2421589238218371,0.12962962962962962,0.5910543844528496,1.0,20/86,13.97%,VAV1;LYN;RASAL3;GRB2;NUP62;ARHGEF18;MYO9B;EPO;ERBIN;DENND1A;KIF14;FLCN;DENND4B;ARHGDIB;DENND4C;RAPGEF1;DENND4A;SYNGAP1;ARHGDIA;ARF6
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.48493836458481904,1.2421382859174448,0.08016032064128256,0.5905727720525743,1.0,46/158,18.51%,CARD11;CD74;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;TRIM5;NEK6;TNF;UBE2V1;TRAF2;CASP1;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;MTDH;UBE2N;TRIM62;REL;RHOA;BIRC2;TNFSF10
prerank,protein autophosphorylation (GO:0046777),0.488338892424999,1.242032940609768,0.0783132530120482,0.5903583659117845,1.0,40/157,18.94%,PTK2B;FGR;LYN;HCK;FLT3;MAPKAPK3;MAP4K1;TAOK3;CSF1R;MTOR;TEC;ERN1;NEK6;PRKD2;TAF1;MKNK1;STK10;PIM1;PIM2;TNIK;CHEK2;SMG1;STK17B;MAP2K2;TXK;MAP3K12;CAMKK2;STK24;BMX;LRRK2;SRC;MAP3K11;EPHA4;STK4;EPHA8;SIK2;PDPK1;VRK1;MINK1;TAOK1
prerank,dephosphorylation (GO:0016311),0.4828250831758352,1.2414660867699199,0.09246231155778895,0.5914412852925763,1.0,35/147,18.68%,PTPRC;PTPN7;PPM1H;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;PLPPR1;DUSP10;FRA10AC1;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;THNSL2;PXYLP1;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;DUSP23;PPP2R5C;PTPN3;PPP4R2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5226960027118485,1.2414263779788457,0.20507166482910694,0.5910073410417866,1.0,6/39,5.28%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A;PI4K2A;TTC7A
prerank,regulation of immune effector process (GO:0002697),0.520887313898627,1.24130741709041,0.18602029312288612,0.590791225113681,1.0,5/41,8.94%,IRF4;FCGR2B;C1QC;C1QA;C1QB
prerank,cellular response to chemical stress (GO:0062197),0.4905412108233109,1.2405378135980187,0.13831967213114754,0.5924013650756339,1.0,29/96,18.38%,CYBB;NCF4;NFE2L2;LRRC8D;NCF2;ATG7;SNCA;PKD2;FOXO3;TXNRD1;AIF1;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;LRRK2;CPEB2;NOX1;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,protein localization to microtubule organizing center (GO:1905508),0.6009464320903045,1.2403141609136654,0.25133689839572193,0.5924864835824633,1.0,2/15,6.40%,HOOK3;CEP192
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4976551702437429,1.24029010450059,0.14179894179894179,0.5920161604227793,1.0,21/70,16.54%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;FCER1G;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,apical junction assembly (GO:0043297),-0.30158595552573064,-1.2402371740578477,0.029411764705882353,0.8107792958180617,1.0,11/53,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;WDR1;PARD6G;CLDN14;DLG1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5941240912772878,1.240208912783046,0.24146981627296588,0.5916936985053803,1.0,4/16,8.78%,MAPK14;RIPOR2;MEF2C;AKIRIN1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6314640680296333,1.2401731652900743,0.24437781109445278,0.591237295702033,1.0,2/10,11.69%,TGFB1;TNFRSF1B
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5907251129552838,1.239872770935477,0.23221476510067113,0.591589161960765,1.0,3/15,8.57%,ABCG1;APOE;LIPC
prerank,epithelial tube morphogenesis (GO:0060562),0.5322850447028956,1.23957661263162,0.22287047841306884,0.5919309214462348,1.0,9/32,9.61%,SHH;CSF1R;CCM2;PRKD2;PKD2;CTNNB1;MTSS1;MEF2C;PODXL
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5198935796477764,1.2390321453557207,0.18777292576419213,0.5930061793988237,1.0,8/46,11.24%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;KIF14;PARVB;NRP1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4954964577911963,1.2389192002764762,0.16233090530697192,0.5927852941191355,1.0,15/76,12.25%,CD86;LAPTM5;TLR2;TLR7;TSPAN6;NLRC3;TNF;SPI1;CD14;ADGRG3;ACTN4;TMSB4X;LIMS1;ADIPOR1;NOD2
prerank,endomembrane system organization (GO:0010256),0.4832448229370552,1.2387543600086501,0.06318956870611836,0.5927232539036383,1.0,63/178,20.78%,HOOK3;PLEKHM2;SPTBN5;ATP8B4;SRGN;LMAN1L;TMED3;REEP6;PI4K2A;SNX33;VPS18;ARFGEF1;AP3D1;SYNE1;USP6NL;VMP1;VPS11;DNAJC13;ARHGAP21;ARFGEF2;VAPB;WASHC4;SYNGR1;SYNGR2;DYSF;TMCC1;BNIP1;ATL1;EXOC8;SEC16A;CSNK1A1;PI4K2B;SEC16B;TOR1AIP2;TOR1A;HUWE1;TRAPPC11;HOOK2;LRRK2;GAK;USP8;ALS2;LAMTOR1;LMAN2;CDC42;SNX10;VPS33B;LYSMD3;GOLGB1;GOLPH3;UBXN2A;TMEM170A;ATL2;LAPTM4B;RAB29;DNM1L;OPTN;ATL3;TRAPPC12;SEC31A;NSFL1C;COG7;SPTSSB
prerank,regulation of dendrite extension (GO:1903859),0.5788022517558329,1.2385604461071653,0.23567708333333334,0.592740474097531,1.0,9/18,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.560429952720858,1.238249889872719,0.21534653465346534,0.5930617191297627,1.0,9/22,13.44%,CYRIB;PRKCD;ARFGEF1;TMSB4X;PFN2;PFN1;TWF2;TMSB10;SSH2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5489382947566346,1.2381334245561602,0.23803827751196172,0.5928519395384181,1.0,9/26,16.71%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;TMEM106A;CD36;HSP90AA1
prerank,regulation of intracellular signal transduction (GO:1902531),0.4752167439248067,1.2376756278379046,0.015,0.5935436443963933,1.0,101/420,18.94%,ARHGAP45;ARHGAP30;FGD2;VAV1;TREM2;LYN;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;PRKAR2B;TAOK3;ARHGAP22;PLCG2;MTOR;ARHGAP24;RFFL;VAV2;MAPK14;ARHGEF18;MAP2K6;ARAP1;TNF;PIP5K1C;PRKD2;TRAF2;PIP4K2A;PYCARD;AKAP5;RMI1;EXO1;VAV3;TRAF3;FAM13B;WWC2;TAGAP;TAF1;BRIP1;MYO9B;GNA13;TP53;GNA12;TMSB4X;TNIK;CHEK2;CSNK2A2;CSNK2A1;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1;ATP6AP2;ARHGDIB;TRAF5;ARHGEF17;CMKLR1;USP7;NF2;RBBP7;DDIT4;PIP4P1;IKBKG;RRS1;ARHGEF3;DNA2;ARHGDIA;STK3;ARHGAP18;BRD7;ARHGEF11;LBH;LRRK2;NOC2L;TMEM127;CAPN3;PHLPP1;A2M;TAF3;TTI1;RPL11;ARHGEF26;PTEN;STK4;ARHGAP23;SGMS1;ARHGEF2;MEAF6;RHOA;PDPK1;CDC42;PTPMT1;BIRC2;PPP2R5C;CHN2;MINK1;CHD4;TAF11;TAOK1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4972018236794843,1.237611744148976,0.15279241306638566,0.5931976870245657,1.0,20/67,16.54%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.573234699313042,1.23741995656762,0.24521072796934865,0.5932462826175949,1.0,5/18,11.55%,ITGA4;MDK;HMGB1;MEF2C;CCL2
prerank,amino acid transport (GO:0006865),0.5141428364071606,1.2372403669056298,0.20065430752453653,0.5931710993361453,1.0,13/49,16.72%,SLC16A10;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC36A4;SLC38A10;SLC25A45;SLC1A4;SLC43A1
prerank,embryonic eye morphogenesis (GO:0048048),-0.5022210738778687,-1.2364179074985904,0.24584717607973422,0.817480090166297,1.0,3/11,8.21%,EFEMP1;MFAP5;FBN1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4852015187634477,1.2363710295247978,0.10873983739837398,0.5951566045377966,1.0,25/114,15.61%,PTK2B;AIM2;TNFRSF11A;TNF;TNFSF8;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ST18;TRAF5;PSMA2;LIMS1;TNFRSF1B;PSME3;TRADD;PSMB5;PSMD8;PSMD7;PSMB9
prerank,prostanoid metabolic process (GO:0006692),0.6153913864092095,1.2363042978884085,0.25237449118046135,0.5948066965798281,1.0,2/13,4.51%,HPGDS;HPGD
prerank,RNA catabolic process (GO:0006401),0.5155428647282455,1.2357244154751454,0.18221734357848518,0.5959862367373365,1.0,24/46,26.89%,SLFN14;ERN1;SND1;ZC3H12D;AGO4;AGO3;RNASEH1;METTL3;DNA2;HNRNPD;PABPC4;RNASEH2A;DIS3L2;RNASE6;NUDT12;ZPR1;DCP2;SIDT2;XRN2;NCBP1;DXO;RNASE3;SUPV3L1;LSM6
prerank,metal ion export (GO:0070839),0.5387469856813344,1.2346521197256106,0.19794050343249428,0.5985229892792285,1.0,7/31,14.28%,SLC11A1;ATP7A;KCNIP2;SLC9A1;ATP1B3;ATP1B2;KCNA5
prerank,presynapse assembly (GO:0099054),-0.42774258209322147,-1.2345322761642505,0.2,0.8174976889059355,1.0,5/16,8.58%,NLGN1;IL1RAPL1;WNT5A;BSN;LRRTM3
prerank,regulation of translational initiation (GO:0006446),0.49959271959374807,1.234442838508128,0.17714884696016772,0.5985813937692236,1.0,15/63,10.94%,NCK2;DNAJC3;ATF3;EIF5B;YTHDF3;CEBPB;EIF4EBP2;EIF1;LARP1;EIF4H;IMPACT;TPR;EIF2B2;CTIF;EIF4G3
prerank,mesenchyme morphogenesis (GO:0072132),-0.41889696031217727,-1.2337699303496807,0.2032520325203252,0.8139289601723549,1.0,4/17,12.62%,BMPR1A;ACVR1;ACVRL1;NOS3
prerank,negative regulation of biosynthetic process (GO:0009890),0.5919499121880828,1.2332658503632061,0.22631578947368422,0.601410317759523,1.0,3/16,7.84%,CIITA;ABCD1;TRAP1
prerank,protein localization to membrane (GO:0072657),0.48055096029484196,1.2330826568335007,0.07307307307307308,0.6013896424845624,1.0,42/187,14.80%,MRAP;ITGAL;FYB1;RFTN1;ITGB2;RAB8B;ITGA4;SH3PXD2B;RAB34;MYO5A;THY1;RAB32;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;NPC1;AP3D1;TSPAN32;AGRN;RAMP1;TNIK;PACS1;TSPAN14;ARL5B;RAB11A;RAB40C;F11R;CACNB2;DENND4C;TM9SF2;ZDHHC3;SEC16A;ATP1B3;BRAF;GAS6;PDZD11;RAP1A;GAK;CAPN3
prerank,cellular response to organonitrogen compound (GO:0071417),0.48723333798032725,1.2328409348084968,0.1346938775510204,0.6015466799220732,1.0,36/99,21.78%,P2RY6;AQP1;HCN4;P2RX7;MTOR;P2RY2;NR1H4;PKD2;RAP1B;P2RX4;TAF1;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;CPEB3;DIAPH1;RAPGEF1;SOX9;GLRA2;LAMTOR3;CAPN2;RAP1A;CPEB4;LAMTOR1;AKAP9;GOLPH3;RPTOR;INPP5K;P2RY1;HCN1;ZFP36L1;RRAGA;RRAGB
prerank,response to tumor necrosis factor (GO:0034612),0.4857316112224961,1.2320466976563509,0.1489795918367347,0.6034237374654593,1.0,26/91,21.76%,NFE2L2;TNFRSF11A;DHX9;CCL8;OCSTAMP;GCH1;TANK;PYCARD;ERBIN;CCL14;TNFRSF21;CCL13;GBP3;CCL2;CASP8;TRADD;PID1;CXCL16;ASAH1;CCL25;ARHGEF2;SMPD1;INPP5K;BAG4;ZFP36L1;CX3CL1
prerank,regulation of keratinocyte migration (GO:0051547),0.6061809511708447,1.2314759653625602,0.2503597122302158,0.6045434091224858,1.0,6/12,20.53%,MTOR;ARF6;PTEN;MAPRE2;IQSEC1;MAP4K4
prerank,positive regulation of cellular process (GO:0048522),0.47474141330786573,1.231312015012296,0.008,0.6044568866281791,1.0,109/565,16.67%,CD86;DOCK2;PTK2B;SLAMF1;TREM2;LYN;CALCR;SHH;HCK;ITGAX;SLC11A1;TGFB1;CXCL5;FCGR2B;HCLS1;FLT3;LGMN;SIRPA;RPL23;CSF1R;TGFBR1;ADAM8;PRKCD;PTPRJ;TLR2;CAMK1D;TCIRG1;P2RX7;MLXIPL;S100B;TNFRSF11A;MDK;OSM;IL12RB2;CST7;TNF;FCER1G;PRKD2;IL6R;CNOT8;BRAT1;PYCARD;TIMP1;P2RX4;CCND2;AIF1;GAB2;CCAR1;TGFBR2;ACTN4;TAL1;RPS15A;CCKBR;P4HB;EPO;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;FLCN;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;ACER3;LRP5;HDAC4;RNF10;NAP1L1;SOX9;THBS1;GRN;TNFRSF1B;PHIP;PRDX3;CIAO1;DYNC1H1;SDCBP;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;MERTK;PRLR;GAS6;HCFC1;CDC6;ZFHX3;INO80;IL2RG;SOX4;MEIS1;LRP1;FASN;IER5;ACACA;IL13RA1;CD36;CXCL16;COPS9;EPHA4;FAF1;PTEN;CD47;NOX1
prerank,regulation of myoblast differentiation (GO:0045661),0.5351052648374118,1.2306211317337254,0.21052631578947367,0.6059202457756535,1.0,7/32,11.20%,TGFB1;MAPK14;RIPOR2;MEF2C;AKIRIN1;SOX9;SRA1
prerank,positive regulation of protein catabolic process (GO:0045732),0.49272281922370725,1.2299223593867634,0.1473899692937564,0.6073670682389655,1.0,33/84,20.78%,ADAM8;SNX9;ATG7;TNF;APOE;SNX33;TNFAIP3;RAB7A;PLK2;VPS11;CSNK2A1;AMER1;NEDD4L;FZR1;TNFRSF1B;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;HSP90AA1;VPS28;FURIN;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6207658762486703,1.2293130434066595,0.22701149425287356,0.6085679506012179,1.0,5/10,22.05%,ZEB2;ATP7A;CTNS;GIPC1;CDH3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5260047553918075,1.2289409236872724,0.21064814814814814,0.609066000827646,1.0,10/30,20.45%,RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;CASP8;TRADD;ARHGEF2;TNFSF10;GSK3B
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6089542233508679,1.2288720881281825,0.2507163323782235,0.6087098148676096,1.0,3/12,11.21%,CIITA;TRIM5;MID2
prerank,positive regulation of autophagy (GO:0010508),0.48958090033694546,1.2288074736978085,0.16376663254861823,0.608337662192847,1.0,24/81,16.29%,PIK3CB;TRIM5;FOXO3;HMGB1;TFEB;SCOC;PIM2;SVIP;TICAM1;PLK2;FLCN;TRIM27;LARP1;PAFAH1B2;TRIM8;MID2;IKBKG;CAMKK2;GNAI3;LRRK2;RNF152;MTDH;GSK3A;IRGM
prerank,defense response to tumor cell (GO:0002357),0.6321384746728587,1.2285199238576314,0.23504273504273504,0.6086308430070975,1.0,3/10,12.89%,LAPTM5;SPI1;PRDX2
prerank,presynaptic endocytosis (GO:0140238),0.5523402285832671,1.2281843713945981,0.22972972972972974,0.6090745461651907,1.0,7/24,12.52%,SNCA;PIP5K1C;CEL;SYT2;STON2;STON1;SYNJ1
prerank,heart morphogenesis (GO:0003007),-0.31193543534746254,-1.2281552990470412,0.1388888888888889,0.8258300266261908,1.0,14/50,13.76%,BMPR1A;RYR2;NIPBL;EPHB4;ACVR1;TGFBR3;ACVRL1;TBX3;FKBP1A;HES1;OLFM1;TBX1;NOS3;SOX17
prerank,glycerophospholipid catabolic process (GO:0046475),0.5413349028524272,1.2280363522418498,0.23647058823529413,0.6089469237278567,1.0,12/27,23.51%,ABHD12;PLA2G7;LIPC;PRDX6;GDE1;ABHD16A;GDPD3;PLA2G5;GPCPD1;PLA2G6;INPP5F;PLA2G4E
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6367727961258804,1.2277677269135132,0.25663716814159293,0.6091891215261498,1.0,3/10,6.13%,ITGB3;PRKD2;PRKCB
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6037493825149863,1.2276067144696372,0.24570673712021135,0.609129598417214,1.0,3/13,11.20%,TGFB1;SOX9;SRA1
prerank,detection of visible light (GO:0009584),0.5890228625546446,1.2271714446767235,0.2536327608982827,0.6098860468282727,1.0,4/16,12.70%,GNAQ;REEP6;CNGB1;ABCA4
prerank,protein depolymerization (GO:0051261),-0.36394841082775853,-1.2271537765402272,0.15789473684210525,0.8229694136332298,1.0,11/27,18.47%,NCKAP5;GSN;CFL2;STMN2;WDR1;MICAL3;MICAL2;KIF24;STMN4;STMN3;KIF18A
prerank,regulation of ruffle assembly (GO:1900027),0.5630326025094904,1.226983459444117,0.23621103117505995,0.6098617659237471,1.0,7/23,11.10%,STAP1;ARHGAP24;PLEKHM1;P2RX4;P2RY12;PFN2;PFN1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6337845064751491,1.2266634555959293,0.26576576576576577,0.6097099084778473,1.0,2/10,6.71%,REEP6;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6337845064751491,1.2266634555959293,0.26576576576576577,0.6097099084778473,1.0,2/10,6.71%,REEP6;CNGB1
prerank,glycoprotein metabolic process (GO:0009100),0.5049636939122861,1.2266276584009435,0.1893048128342246,0.6092661147490126,1.0,18/53,19.21%,HPSE;MAN1C1;GCNT1;ST8SIA4;OGA;MAN2B1;ST8SIA1;MAN2A2;STT3B;B4GALT7;LARGE1;HIF1A;MGAT4B;ERP44;FBXO44;GOLPH3;MAN1A2;GANC
prerank,regulation of mRNA metabolic process (GO:1903311),0.6137013607615247,1.226389619186975,0.2603129445234708,0.6093941377198341,1.0,4/11,13.52%,DHX9;CDK11B;SRPK3;SAFB2
prerank,chondrocyte differentiation (GO:0002062),0.5260712206565197,1.2259821823442751,0.21892816419612315,0.610055935445747,1.0,8/32,13.61%,RUNX1;TGFB1;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,positive regulation of organelle organization (GO:0010638),0.5292616610140325,1.225783233971417,0.22686230248307,0.6101164501725828,1.0,7/32,12.52%,TREM2;P2RX7;RAB3GAP2;ANXA1;PPARGC1A;UVRAG;SYNJ1
prerank,positive regulation of dendrite extension (GO:1903861),0.5819854074040722,1.225671007519227,0.25100133511348466,0.6098925624076605,1.0,9/17,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6288427886690426,1.2254945579096288,0.260806916426513,0.6098657172016052,1.0,3/10,9.08%,ATP7A;KYNU;QDPR
prerank,positive regulation of calcium ion transport (GO:0051928),0.5227632012414253,1.2253104248003739,0.20457142857142857,0.6098962233977204,1.0,8/36,16.60%,LGALS3;P2RX7;P2RX4;ATP2B1;CACNB2;CCL2;WFS1;CACNA1D
prerank,microtubule-based transport (GO:0099111),-0.4588707340759828,-1.225287673634249,0.203125,0.8231155976816366,1.0,11/13,46.05%,DYNC1I1;SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;DYNC1I2;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5429489551958528,1.2251881221394914,0.23515151515151514,0.609691302532462,1.0,11/26,22.05%,PIK3CB;TNF;GCH1;ATP7A;APOE;NOS1AP;POR;HIF1A;GDNF;TERF2;CDH3
prerank,neutral amino acid transport (GO:0015804),0.540804095818249,1.2250987638254367,0.22943221320973348,0.6093932240799657,1.0,9/28,16.72%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC6A15;SLC36A4;CTNS;SLC1A4;SLC43A1
prerank,cellular response to sterol (GO:0036315),-0.4528483441763309,-1.2250078382069278,0.19540229885057472,0.8179058776659323,1.0,6/13,20.76%,RORA;GPLD1;SMO;INSIG2;INSIG1;PTCH1
prerank,organic hydroxy compound transport (GO:0015850),0.523666786321703,1.2249725718492581,0.2325315005727377,0.6092054407402293,1.0,9/36,18.30%,SLCO2B1;ABCC3;NPC2;NR1H4;SLC16A1;OSBP;SLCO1B1;STARD5;RXRA
prerank,actin cytoskeleton reorganization (GO:0031532),0.5033262123499005,1.224707041062976,0.1684322033898305,0.6094086322525087,1.0,16/63,11.24%,PLEK;CASS4;GRB2;PTPN1;RAP2A;MICALL2;MYH9;ANXA1;NEDD9;TNIK;THSD7B;ATP2C1;BCAR1;PARVB;DTNBP1;NRP1
prerank,neural tube development (GO:0021915),0.5964262488682441,1.224702123042114,0.24594594594594596,0.6088806761528255,1.0,2/15,4.10%,TGFB1;PKD2
prerank,regulation of transport (GO:0051049),0.5224198226638015,1.2243721287518243,0.23707865168539327,0.6093018431439676,1.0,11/36,14.59%,SNCA;REEP6;ACTB;GAPVD1;ACTG1;RAB11A;EPB41;NRP1;ICA1L;LRRK2;YRDC
prerank,carboxylic acid metabolic process (GO:0019752),0.525949352300188,1.224185739082696,0.22595596755504055,0.6092603414912561,1.0,5/33,11.56%,TBXAS1;SLC2A3;PON3;ST3GAL1;CYB5A
prerank,regulation of RNA metabolic process (GO:0051252),0.5002975143570095,1.2240957966504253,0.18027571580063625,0.6090066690136335,1.0,20/59,15.97%,RBM38;ZNF326;MITF;RC3H2;GRSF1;METTL4;RC3H1;PCBP3;HNRNPL;SON;PTBP2;TNFRSF1B;TRA2B;PRX;BRDT;FAM50A;PCBP1;IGF2BP3;RASA1;AHNAK2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5593548230280699,1.2238997402371843,0.2334963325183374,0.6090214475156137,1.0,3/21,6.19%,LPIN2;CEL;NUDT19
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5130050821295966,1.2237913176206108,0.19135135135135134,0.6088306406798207,1.0,9/46,14.53%,PTK2B;CCR2;DGKZ;TNF;CLN3;MEF2C;CCL2;DGKI;LRRK2
prerank,regulation of aerobic respiration (GO:1903715),0.5765142462477526,1.223085956184627,0.25745257452574527,0.6103264352876209,1.0,3/15,7.24%,CBFA2T3;ATP7A;ABCD1
prerank,histone lysine demethylation (GO:0070076),-0.37310871175674815,-1.222644563591732,0.18292682926829268,0.8196118007894391,1.0,11/25,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM1B;KDM2A;KDM4D;KDM6A;KDM8
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6252516912287609,1.2222775830818182,0.26187050359712233,0.6121696977641332,1.0,3/11,10.81%,TGFB1;TP53;MAP2K2
prerank,negative regulation of blood coagulation (GO:0030195),0.518098850812515,1.2215176610959761,0.24004424778761063,0.613821790533797,1.0,3/38,4.14%,GP1BA;F10;APOE
prerank,regulation of blood coagulation (GO:0030193),0.5423485323595506,1.221222463544655,0.2544589774078478,0.6141485216401237,1.0,3/27,4.14%,HPSE;GP1BA;APOE
prerank,intestinal lipid absorption (GO:0098856),0.6310767607935845,1.2211359097856733,0.23020527859237536,0.6138768616885493,1.0,3/11,16.03%,CEL;SOAT2;CD36
prerank,bile acid and bile salt transport (GO:0015721),0.5531297580050002,1.2207565561305904,0.25492610837438423,0.6144496031250772,1.0,3/24,3.77%,SLCO2B1;ABCC3;NR1H4
prerank,iron ion homeostasis (GO:0055072),0.4945430688795584,1.2201798002075888,0.19915700737618547,0.6156055699228329,1.0,11/58,14.05%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;B2M;FTH1
prerank,pentose-phosphate shunt (GO:0006098),0.6276493669231872,1.219938348882054,0.2593103448275862,0.6157621836440851,1.0,5/11,19.36%,RPE;SHPK;PGLS;PGD;RBKS
prerank,negative regulation of potassium ion transport (GO:0043267),0.6076880980466539,1.2198836977490441,0.24694708276797828,0.615385408158512,1.0,1/13,0.31%,PTK2B
prerank,protein localization to centrosome (GO:0071539),0.5862598766340488,1.2188036354608103,0.2609271523178808,0.6180085769773374,1.0,6/17,18.33%,HOOK3;CEP192;PCM1;NUDCD3;SNX10;GOLGB1
prerank,protein-containing complex disassembly (GO:0032984),0.49138247489254333,1.218587897799406,0.21251348435814454,0.6180716072129222,1.0,18/54,21.74%,RPL23;LIX1;FRAT2;MAP1LC3B;CLN3;CTNNB1;TECPR1;SNAP29;UVRAG;AMER1;CSNK1A1;SNX14;VPS33B;PYM1;FZD2;GSK3B;EPG5;VAMP8
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5761541099566707,1.2185188291947209,0.26975476839237056,0.6177410886858804,1.0,5/16,9.57%,PIK3CB;TNF;GCH1;APOE;NOS1AP
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5142773872032174,1.218015157439682,0.2215909090909091,0.6186760071146378,1.0,8/39,10.93%,TGFB1;MAD2L2;RGCC;AKNA;WNK1;SPINT2;PODXL;NF2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6173681947693797,1.2178508715888474,0.25895316804407714,0.6185779845036948,1.0,3/12,9.69%,APOBEC1;RESF1;ATF7IP
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.561009063199722,1.217795371235823,0.2506112469437653,0.6182176334035367,1.0,6/21,13.49%,ADCY7;GUCY2F;ADCY6;NPR2;ADCY3;ADCY8
prerank,nuclear membrane reassembly (GO:0031468),-0.3037755189407997,-1.2176974159012286,0.11764705882352941,0.829826843785698,1.0,20/54,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5678189103063261,1.2172257156872788,0.2506631299734748,0.6193879699732705,1.0,7/17,19.71%,LPL;ANGPTL3;LIPC;HDAC9;ANGPTL4;FURIN;SORT1
prerank,response to nutrient levels (GO:0031667),0.584343524740603,1.2170745871242072,0.25,0.6192922497698314,1.0,2/17,4.87%,MTOR;CD68
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.576181732741051,1.2166271320476019,0.26448362720403024,0.6200194202437066,1.0,3/18,5.85%,PYCARD;IL18;HMGB1
prerank,stabilization of membrane potential (GO:0030322),0.5778060739313607,1.2165019474288885,0.2503293807641634,0.6198426252987198,1.0,3/16,7.52%,KCNN4;KCNK6;KCNK13
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6176578260139524,1.2163579895307823,0.2624633431085044,0.6196856277380985,1.0,2/10,5.56%,PLS1;WHRN
prerank,ureteric bud morphogenesis (GO:0060675),0.5824054232497067,1.2158369097493198,0.25,0.6207088891706656,1.0,2/16,4.10%,SHH;PKD2
prerank,fatty acid metabolic process (GO:0006631),0.4749898810082672,1.215053898501616,0.162134944612286,0.6225661862712937,1.0,24/115,17.99%,CYP1A1;LPL;LPIN2;SGPL1;ALOX12;ANGPTL3;CEL;HPGD;NUDT19;PON3;ACSF2;LIPC;PPARGC1A;ADIPOR1;NDUFAB1;FASN;ACACA;CD36;ADIPOR2;CPT2;PNPLA3;PPARD;ACOT2;ABCD2
prerank,positive regulation of ERAD pathway (GO:1904294),0.6043846975548894,1.2149907807378515,0.28005657708628007,0.6222296245889317,1.0,3/13,6.40%,NFE2L2;HERPUD1;ATXN3
prerank,regulation of inclusion body assembly (GO:0090083),-0.4712639049636359,-1.2143152155962993,0.2627986348122867,0.8352845257802481,1.0,9/11,39.13%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.5615852198182807,1.2142305543655314,0.2641975308641975,0.6228566549913491,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.5615852198182807,1.2142305543655314,0.2641975308641975,0.6228566549913491,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.5615852198182807,1.2142305543655314,0.2641975308641975,0.6228566549913491,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4855557916441295,1.2142082512423518,0.19690721649484536,0.6223889043443471,1.0,21/80,15.16%,TBC1D10C;VAMP3;SNX5;TMEM87B;HEATR5A;RBSN;RAB7A;RAB7B;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;YKT6;STX5;VPS29;VTI1A;SNX2;TBC1D14;HEATR5B
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5422651842316234,1.214138545301355,0.2527075812274368,0.6220389825720926,1.0,3/25,2.08%,PCSK9;ITGB3;RIN3
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5473715494710784,1.2128583170190692,0.28501228501228504,0.6253072950465982,1.0,10/21,22.61%,PCID2;AIM2;PYCARD;FYN;SOX2;PSMB9;BIRC2;BIRC3;MT3;DELE1
prerank,embryonic hemopoiesis (GO:0035162),0.6177774217570515,1.2128575408418578,0.2612859097127223,0.6247718892963803,1.0,4/12,10.93%,TGFBR2;TAL1;FLT3LG;SH2B3
prerank,regulation of apoptotic process (GO:0042981),0.46374688700354333,1.2128432662858022,0.001,0.6242830377078713,1.0,143/676,16.74%,NCKAP1L;FGD2;VAV1;PTK2B;LILRB1;IRF5;ASCL1;SHH;HCK;PREX1;CD3E;CLEC5A;ABR;CTSB;PCSK9;FLT3;GATA1;PCID2;CD74;PLEKHN1;CTSD;CBL;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;VAV2;ARHGEF18;MTCH1;SEMA4D;NR1H4;ATG7;TNF;TMEM219;SNCA;ITGA6;TRAF2;DNAJC3;CLN3;FOXO3;PYCARD;VAV3;CASP1;CCND2;CD44;HMGB1;ANP32A;FZD9;APAF1;CFLAR;CTNNB1;ANXA1;BCL2L1;DNM2;GNA13;CCAR1;TP53;ACTN4;CRADD;MAP3K5;PIM1;KCNMA1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;FLCN;GADD45B;TFAP2B;ITSN1;ARHGAP10;NTF3;BAK1;BABAM2;BCAR1;MGMT;ANXA4;STK17B;ACTN1;SON;ARHGEF17;LGALS1;BNIP1;NF2;TRIM24;SOX9;SRA1;THBS1;TRIM35;IAPP;PHIP;PRDX3;ANGPTL4;UTP11;CTNNBL1;PRDX2;CASP8;ITCH;LRP8;ARHGEF3;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;STK3;TRADD;RNF144B;ATAD3A;WFS1;BAG1;ARHGEF11;MIEN1;BMF;AREL1;SOX4;CAPN3;VDAC1;PHLPP1;ERCC5;SRC;AHI1;PTPA;STEAP3;MTDH;RPS6KA2;TOP2A;FANK1;RASA1;NF1;MAP3K11;RTN4;TXNDC5;NAA38;FAF1;ARHGEF26;YME1L1;HSP90AA1;STK4
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5390737945778552,1.212669103199236,0.2571090047393365,0.6242492445737534,1.0,5/26,9.15%,LGMN;SMOC2;DUSP3;TAL1;HSF1
prerank,skeletal muscle contraction (GO:0003009),0.5672872357002645,1.2121068333360834,0.24632352941176472,0.625320303060851,1.0,4/19,15.11%,STAC;TNNT3;STAC3;RCSD1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6129443053272762,1.2120098556710308,0.28955223880597014,0.6250685878142181,1.0,2/10,5.96%,CD200R1;RIPOR2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.41068684521744986,-1.211435151242384,0.1825726141078838,0.8387690377935956,1.0,8/17,20.79%,SPRED2;PARD3;CALM3;SPRY2;DGKQ;DMTN;PPEF2;SMAD7
prerank,positive regulation of vasculature development (GO:1904018),0.47804362030106373,1.2108921913679827,0.18331616889804325,0.6277578044156795,1.0,24/94,18.59%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB;PDCD6;THBS1;GRN;ANGPTL4;NINJ1;HK2;MTDH;HIF1A;PDPK1;AGO2;ITGB1;VEGFD
prerank,negative regulation of programmed cell death (GO:0043069),0.46583977925002235,1.2108466736182435,0.032,0.6273646177375852,1.0,73/355,16.53%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CLEC5A;GATA1;PCID2;CD74;CBL;LAPTM5;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;SEMA4D;NR1H4;SNCA;DNAJC3;CLN3;RAB7A;CCND2;CD44;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;KIF14;TPT1;TFAP2B;ARHGAP10;BABAM2;MGMT;ANXA4;SON;BNIP1;SOX9;THBS1;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38;YME1L1
prerank,sensory perception (GO:0007600),0.5050434892135063,1.2106895258429031,0.21878335112059766,0.6272768264435179,1.0,10/45,13.51%,CCR2;P2RX7;PRDM12;WHRN;P2RX4;MYO7A;CCL2;SCN9A;CDH23;RETREG1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5495121258619651,1.2102896814459447,0.27649208282582216,0.6278897169105432,1.0,4/21,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5281607664010096,1.2102558818832085,0.24125874125874125,0.6274547109330476,1.0,9/28,16.71%,ERN1;TRAF2;DDIT3;MAP3K5;CEBPB;BAK1;ATP2A3;SELENOK;ERO1A
prerank,regulation of stem cell population maintenance (GO:2000036),-0.40502591738486293,-1.2101389820622463,0.23529411764705882,0.8371027362570845,1.0,3/18,6.04%,PTN;CNOT3;REST
prerank,positive regulation of hydrolase activity (GO:0051345),0.47296397935529405,1.2099944385821049,0.13897280966767372,0.6276762400765225,1.0,38/137,18.52%,DOCK8;RGS10;FZD10;THY1;SNX9;CCL8;PSAP;ARAP1;SEMA4D;ITGA6;RASGRP2;USP6NL;DOCK11;DOCK10;AGRN;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;MMUT;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;SNX13;CCL25;SNX18;RHOA;PICALM;MAPRE2;ITGB1
prerank,primary alcohol metabolic process (GO:0034308),0.5456747249097031,1.2096271269586074,0.2641509433962264,0.6282132645623222,1.0,5/25,15.84%,CYP1A1;DHRS3;RETSAT;GDE1;GDPD3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33046952878051,-1.209558282448099,0.16071428571428573,0.8330761566593538,1.0,7/35,9.28%,RBFOX2;UBR5;NR3C2;AR;KDM3A;TADA3;CALCOCO1
prerank,ventricular septum development (GO:0003281),-0.3295412788975892,-1.208742682322855,0.1724137931034483,0.829944232821152,1.0,9/37,7.15%,ZFPM2;BMPR1A;ROBO2;ACVR1;SALL1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6034213657036045,1.2083962498783882,0.27520435967302453,0.6313489774401565,1.0,3/13,8.05%,CD74;CD44;SNAI1
prerank,positive regulation of cholesterol transport (GO:0032376),0.5254168928474922,1.2080359749207337,0.25882352941176473,0.6319028244710677,1.0,7/27,15.26%,TREM2;APOE;ABCB4;EEPD1;GPS2;LRP1;ABCA3
prerank,regulation of postsynapse organization (GO:0099175),0.5273640995557609,1.2073284011015228,0.23352601156069364,0.6333549371367604,1.0,8/28,16.34%,FCGR2B;ARHGAP22;ABHD17B;ABHD17C;LZTS3;TANC2;LRRK2;EPHA4
prerank,tRNA modification (GO:0006400),-0.29776668107111104,-1.207250966992539,0.16981132075471697,0.8292125688805515,1.0,23/62,22.88%,NSUN6;DTWD2;METTL6;SSB;THADA;TYW5;THUMPD3;TPRKB;NSUN2;TRMT6;QTRT2;PUS10;TARBP1;DUS2;TYW1;URM1;MTO1;ANKRD16;TRMT5;WDR4;LCMT2;WDR6;DTWD1
prerank,regulation of cell migration (GO:0030334),0.46616016319593273,1.2069878863792847,0.022,0.6338411059918027,1.0,62/382,9.76%,PTK2B;FERMT3;GPNMB;FGR;SHH;ITGAX;TGFB1;CASS4;F10;TMIGD3;CD74;VSIR;PIK3CD;CYRIB;CSF1R;TGFBR1;MGAT5;PTPRJ;THY1;DUSP3;SLURP1;ARSB;RFFL;PLXNC1;MDK;ANGPTL3;RAP2A;SEMA4D;ITGA6;MITF;CLN3;PLXNB2;FOXO3;MCTP1;LGR6;ADGRG3;MACF1;ANXA1;DOCK10;AIF1;MAPRE1;CCAR1;ACTN4;NKX2-1;GNA12;RIPOR1;NEDD9;YTHDF3;TMSB4X;RAP2B;SNAI1;KIF14;FLCN;FAM89B;PTP4A1;DUSP10;PODN;NTF3;PODXL;ACTG1;BCAR1;VCL
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.584646118915736,1.2065836759870203,0.274025974025974,0.6344477607209987,1.0,5/15,13.79%,PTTG1;NEK6;CDC23;TPR;CDC6
prerank,cellular response to starvation (GO:0009267),0.47034472817157935,1.2065346763348137,0.1268882175226586,0.6340577695111286,1.0,44/147,19.42%,ATP6V0D2;PCSK9;ATP6V0E1;GAS2L1;TCIRG1;MTOR;ATP6V1C1;ATG7;FNIP1;SREBF2;MAP1LC3B;ATP6V1E1;FOXO3;TFEB;TP53;MAP3K5;RIPOR1;SEH1L;ATP6V0D1;MTMR3;CEBPB;FLCN;XPR1;IMPACT;BECN1;DAP;TBL2;STK24;LAMTOR3;LRRK2;NIM1K;ATP6V0B;SREBF1;RNF152;CPEB4;FADS1;GCN1;PIK3R4;LAMTOR1;SIK2;ATP6V1F;ATG14;RPTOR;SEC13
prerank,fatty acid biosynthetic process (GO:0006633),0.48990023810764183,1.206206587737299,0.1928345626975764,0.634488481324719,1.0,12/63,16.13%,CYP1A1;LPL;ALOX12;HPGD;ABCD1;LIPC;HACD4;ABHD3;NDUFAB1;DEGS1;ACACA;FADS1
prerank,negative regulation of viral life cycle (GO:1903901),0.5718913948359724,1.205967515250519,0.26595744680851063,0.6346211485102321,1.0,2/15,3.63%,CIITA;TRIM5
prerank,regulation of ion transmembrane transport (GO:0034765),0.5258857289237119,1.2053857370737304,0.250561797752809,0.6357872815016784,1.0,4/33,10.05%,KCNJ11;P2RX7;WNK1;NEDD4L
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5004395972722882,1.2050574563149756,0.24837310195227766,0.6362033679475121,1.0,10/47,13.46%,PLEK;WDTC1;SIRPA;ERLIN1;ERLIN2;ACADL;SNAI1;PRMT3;FYN;NFKB1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6271086722881483,1.2048669843839686,0.27631578947368424,0.636218733460143,1.0,2/10,4.05%,MAD2L2;RGCC
prerank,phosphate ion transport (GO:0006817),0.5641141164227281,1.20466390187749,0.2747688243064729,0.6362840336287402,1.0,4/16,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,cAMP biosynthetic process (GO:0006171),0.6209782150931364,1.2045820915493106,0.28067700987306066,0.6359972124275906,1.0,4/10,13.49%,ADCY7;ADCY6;ADCY3;ADCY8
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.47725844919275157,1.2038953562604366,0.2065775950668037,0.637444514880703,1.0,19/77,15.27%,LGALS3;CX3CR1;TGFBR1;TNF;ITGA6;HERPUD1;FZD9;CFLAR;BCL2L1;CSNK2A2;CSNK2A1;RB1;QARS1;THBS1;PHIP;PSME3;NOC2L;PIH1D1;SRC
prerank,mRNA catabolic process (GO:0006402),0.4997691728461887,1.203810018487749,0.22366992399565688,0.6371391577441557,1.0,9/44,16.57%,SLFN14;ERN1;ZC3H12D;RC3H1;AGO4;AGO3;METTL3;THRAP3;TUT7
prerank,neuron projection organization (GO:0106027),0.5640207415003932,1.2030236369987324,0.27224435590969454,0.6388062866229561,1.0,3/15,7.24%,LGMN;PLS1;ABCD1
prerank,regulation of actin filament-based movement (GO:1903115),-0.4730656550360285,-1.2025975968375446,0.25573770491803277,0.8387345163945584,1.0,2/10,5.88%,ANK2;SRI
prerank,regulation of oxidoreductase activity (GO:0051341),0.5907334569691388,1.2025101800443672,0.2726027397260274,0.6397449404219634,1.0,4/13,12.25%,SLAMF8;ATP7A;HDAC6;NOD2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5519833459351855,1.2016444104245005,0.2506297229219144,0.641678787528638,1.0,3/21,4.32%,P2RY6;ERN1;LDLRAP1
prerank,positive regulation of cell division (GO:0051781),0.5093374263653212,1.201527234155954,0.22576966932725198,0.6414916561338557,1.0,9/38,17.93%,SHH;TAL1;KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42
prerank,actin filament network formation (GO:0051639),0.6138709100500184,1.2012878738044646,0.28798842257597684,0.6416411003846626,1.0,4/11,10.21%,LCP1;PLS1;FHOD1;ACTN1
prerank,negative regulation of hippo signaling (GO:0035331),0.6048452453585096,1.2009519744328667,0.27097661623108665,0.642097210266965,1.0,3/12,6.25%,MAPK14;WWC2;MAP2K3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5369974771694483,1.2006393964849522,0.27088305489260145,0.6424090531026312,1.0,5/25,10.39%,STAP1;PRKCD;ARHGAP24;CAPZB;PFN2
prerank,regulation of intracellular protein transport (GO:0033157),0.5283672534783967,1.2006294635336345,0.2451539338654504,0.6419138263448381,1.0,7/32,12.40%,TGFB1;LCP1;PTPN1;RIPOR1;KIF20B;TPR;PCM1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.33280630771908676,-1.2006230956945008,0.2047244094488189,0.8397579106598709,1.0,11/33,13.59%,TJP1;SEMA6A;BMPER;EPN2;SYNJ2BP;KLF2;SMAD1;RHOJ;KLF4;ADAMTS9;GLUL
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5941612378489282,1.2005985997250088,0.2753623188405797,0.6414697383720385,1.0,5/11,18.96%,VAPB;BNIP1;ATL1;RTN4;ATL2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4865195482762123,1.2005030481839674,0.21956295525494277,0.6412010640314542,1.0,14/59,13.46%,CSF1R;MED17;MITF;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;MED27;SOX9;AGO3;NFKB1
prerank,transcription by RNA polymerase I (GO:0006360),0.5196539038294623,1.2004893481274683,0.2566168009205984,0.6407072250367966,1.0,8/34,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;TTF1;CDK7;POLR1B;POLR2L
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5787582479633868,1.1999948132176665,0.2754569190600522,0.6416288479478993,1.0,2/15,5.65%,CD74;CD44
prerank,positive regulation of apoptotic process (GO:0043065),0.4604346159798497,1.199993996526507,0.06006006006006006,0.6411006256271647,1.0,65/293,17.55%,FGD2;VAV1;LILRB1;IRF5;PREX1;ABR;PCSK9;PLEKHN1;CTSD;TGFBR1;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;DDIT3;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;TFAP2B;ITSN1;BAK1;STK17B;ARHGEF17;TRIM35;GRN;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;SOX4;TLE5;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,lipid transport (GO:0006869),0.47179273111445746,1.1997635242228224,0.18666666666666668,0.6412280477178847,1.0,25/97,18.30%,ABCA1;SLCO2B1;ABCC3;ATP8A1;GM2A;MFSD2B;NPC2;CLN8;NR1H4;ABCG1;APOE;CLN3;PRELID3B;ABCD1;FABP5;ABCA4;OSBP;SLCO1B1;OSBPL8;ABCA3;CD36;PPARD;ABCD2;STARD5;RXRA
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5007638064403886,1.1991229642167216,0.2435064935064935,0.6424931536016094,1.0,15/47,18.19%,LPL;METRNL;RREB1;PIM1;CEBPB;ASXL2;LRP5;CMKLR1;VSTM2A;CREB1;SYAP1;WDFY2;ZBTB7B;PPARD;CREBL2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5828073220918679,1.1990360100457533,0.28211920529801326,0.6421724004801265,1.0,6/16,16.20%,METRNL;RREB1;PIM1;FLCN;VSTM2A;ZBTB7B
prerank,regulation of macrophage activation (GO:0043030),0.5243578454189993,1.1989517384160053,0.26477272727272727,0.6418902991943828,1.0,4/30,4.57%,FCGR2B;CD74;GPR137B;CEBPA
prerank,negative regulation of transposition (GO:0010529),0.5667917002647812,1.1983389181460753,0.2595520421607378,0.6431220957976382,1.0,2/16,8.46%,SMYD5;MOV10
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5805961051276118,1.19832107879529,0.2900662251655629,0.6426493848433772,1.0,3/15,11.89%,SLFN14;ZC3H12D;RNASEH1
prerank,protein transport (GO:0015031),0.4612491800631867,1.1982572559414146,0.054,0.6423008299985418,1.0,100/332,19.53%,ATP6V0D2;IL10RA;TBC1D9;RAB8B;CD74;ABCA1;LAPTM5;TBC1D10C;ATP6V0E1;RAB34;UNC93B1;CTSA;TCIRG1;RAB32;ATP6V1C1;TMED3;SNX9;ABCG1;APOE;ATP6V1E1;SEL1L;RAB14;ATP6V0A2;SNX33;RAB3GAP2;MYH9;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;PRKCB;MACF1;DNM2;STXBP3;ATP6V0D1;RAMP1;VMP1;TBC1D10A;HFE;RAB28;PPY;SNX27;RAB31;ARHGAP1;PDCD6;SYNRG;ARL5B;ARL4A;RAB1B;TBC1D2;ATP6V0A1;TBC1D17;COPA;ATP6AP1;CLTC;HDAC6;TBC1D2B;WDR11;ARRDC4;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;SCAMP2;NEURL1B;ATP6V0B;LRP1;TBC1D14;STEAP3;TBC1D22B;YWHAH;SVBP;CD36;SNX13;ARFIP2;IFT27;ARHGEF2;MON1A;STX2;VLDLR;VPS33B;LRP1B;SLU7;GOLPH3;ATP6V1F;TBC1D12;LTBP2;TBC1D5;MCOLN1;RAB29;SEC13;OPTN
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.30898911902644294,-1.1981178116313502,0.14285714285714285,0.8426742775214475,1.0,10/51,9.52%,FSTL1;CRIM1;BMPR1A;BMPER;NBL1;SMAD9;SMAD4;SMAD5;FBN1;SMAD1
prerank,mitotic chromosome condensation (GO:0007076),0.5336324813413476,1.1974341097143597,0.2615933412604043,0.6441844532682619,1.0,8/26,19.91%,TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;SMC4;MCPH1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5177183272555951,1.1973501254287204,0.2562076749435666,0.6438984818774689,1.0,5/34,7.37%,PIK3CG;HCN4;SLC8A1;P2RX4;SLC9A1
prerank,vesicle transport along microtubule (GO:0047496),-0.3676408430644324,-1.1969347928445355,0.21052631578947367,0.8407506881525675,1.0,8/23,11.16%,KIF5B;DYNC1I1;PAFAH1B1;NDEL1;KIF3B;NDE1;KIF5A;KIFAP3
prerank,proteolysis (GO:0006508),0.46019582998657926,1.19671665436113,0.082,0.6452162815807109,1.0,49/252,17.05%,CTSS;KLK3;MMP12;CTSB;NAPSA;LGMN;FAM111A;SRGN;CTSD;CTSC;CTSA;CTSK;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CAPN15;CASP1;DDI2;LONP1;MALT1;ZMPSTE24;CTSZ;SPPL3;SPCS1;NLN;TINAGL1;CTSE;TBL1X;MMP19;CASP7;PARL;CASP8;LRP8;PCSK7;ERAP1;PSMB5;CAPN2;ECEL1;CAPN3;SPPL2A;METAP2;PRCP;SVBP;IDE;YME1L1;FURIN;ATG4A;PITRM1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4760367341030889,1.19671511479705,0.17868020304568527,0.6446898873947587,1.0,36/110,21.23%,CD86;TGFB1;ATG7;TNF;APOE;SLC25A37;IL18;TNFAIP3;RAB7A;CD80;PLK2;CSNK2A1;NEDD4L;RAB1B;INHBA;FZR1;RANBP9;SORL1;ITCH;STX5;TIPARP;HUWE1;WFS1;AREL1;GSK3A;SMURF1;IDE;VPS28;MAP2K5;DACT1;ROCK2;SEC22B;WWP1;GSK3B;PRKN;ABCA2
prerank,autophagosome maturation (GO:0097352),0.5144614084106492,1.1964347715776704,0.25791324736225085,0.6449495427826283,1.0,12/32,21.74%,LIX1;MAP1LC3B;CLN3;VMP1;TECPR1;SNAP29;UVRAG;SNX14;VPS33B;ATG14;EPG5;VAMP8
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5668125364103994,1.196267360254207,0.28516129032258064,0.644920350402741,1.0,3/17,4.58%,TGFB1;MDK;CXCR4
prerank,axonal fasciculation (GO:0007413),-0.4678139935203732,-1.1962594382100658,0.24305555555555555,0.837273336360619,1.0,4/12,4.78%,SEMA5A;ARHGAP35;EPHA3;EPHB2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5342851293103466,1.1961804742907225,0.2719614921780987,0.6446147837640381,1.0,8/25,16.71%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;HSP90AA1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5427008144860906,1.195251747594875,0.28132387706855794,0.6467904412628974,1.0,4/22,7.31%,THY1;TNF;CD44;WNK1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.5544320974417714,1.195070414763086,0.2805194805194805,0.6468252403010937,1.0,1/18,0.63%,KCNJ11
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5099646549661311,1.1948341127275708,0.24720357941834453,0.6469739675567313,1.0,7/41,11.17%,PTPRC;PLCG2;SLC8A1;PKD2;ITPR2;IBTK;CHERP
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5278303460036815,1.194434775987832,0.27379553466509987,0.6475872313273859,1.0,5/28,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.465955897010459,1.1941613379893758,0.1628140703517588,0.6478673005933901,1.0,43/119,23.29%,INPP5D;PIK3CG;PIK3R5;PIK3CD;PIGM;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14;TTC7A;PIGL;MTMR3;PIGV;SMG1;PIGH;PI4K2B;SYNJ1;BMX;PLEKHA1;EFR3A;PTEN;PIK3R4;PGAP2;PLEKHA2;INPP5K;PIGU;PIGC;SOCS3;PIGN;PIK3CA;ITPKB;SOCS4;SOCS7;FGF2;MTMR9;MTMR14;DPM2;PIGP;OCRL;INPP5F
prerank,RNA interference (GO:0016246),0.5571093427637058,1.1937625426874532,0.2750642673521851,0.6484453909172849,1.0,10/17,25.04%,DHX9;AGO4;AGO3;PRKRA;NRDE2;TARBP2;AGO2;DICER1;DROSHA;AGO1
prerank,synaptic vesicle recycling (GO:0036465),0.5133979034228873,1.1933109924868095,0.2511574074074074,0.6492405754383358,1.0,8/31,12.52%,SNCA;PIP5K1C;CEL;PLD2;SYT2;STON2;STON1;SYNJ1
prerank,chromosome condensation (GO:0030261),0.5138136901258633,1.1929222680830298,0.24971363115693013,0.6498675216321198,1.0,11/36,19.91%,ACIN1;TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;TOP2A;INCENP;SMC4;MCPH1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5143420144498234,1.19278694633355,0.24018475750577367,0.6497086233978117,1.0,9/35,18.32%,CBL;BMP2K;PIK3CB;LDLRAP1;HFE;B2M;ARF6;PICALM;FLOT1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4158043572140029,-1.1915454358517346,0.21008403361344538,0.8471352156225509,1.0,8/17,14.15%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.32877949675665297,-1.191443810000088,0.20634920634920634,0.8419862254206757,1.0,13/33,22.05%,WDR33;SCAF8;FIP1L1;CPSF7;CSTF2;PAPOLA;SNRPD3;MAZ;CSTF3;SNRPG;SNRPF;CSTF2T;NCBP2
prerank,negative regulation of response to wounding (GO:1903035),0.5627318868128945,1.1911496362804512,0.2900763358778626,0.6538667499901823,1.0,7/19,23.29%,MDK;RTN4RL1;CASK;EPHA4;CRK;FGF2;INPP5F
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5716108709209774,1.1910279289185999,0.2935064935064935,0.6536857071960217,1.0,4/16,11.24%,PTPRJ;PTPN1;BCAR1;NRP1
prerank,negative regulation of cellular component organization (GO:0051129),0.47423886180462554,1.1909844074866518,0.21318228630278063,0.653286142906038,1.0,15/74,12.78%,LILRB1;LGALS3;NR1H4;TNF;MCTP1;SNX33;XRCC5;DNM2;TFIP11;SVIP;HSF1;IMPACT;HDAC6;IAPP;SORL1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5312831201011097,1.1905900368469475,0.26321974148061106,0.6539205621081374,1.0,7/25,17.77%,CALCR;THY1;SNCA;CACNB2;CAPN3;CEMIP;PDPK1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.48936558357511356,1.1905834373421802,0.24193548387096775,0.6534084871886958,1.0,5/50,5.94%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;TAF1
prerank,regulation of exit from mitosis (GO:0007096),0.5036497040800604,1.1901115978969352,0.24887892376681614,0.6542318435012587,1.0,4/38,6.58%,ANAPC15;RGCC;CDC23;UBE2S
prerank,cartilage development (GO:0051216),0.4902859630672923,1.1900776945116465,0.23422459893048128,0.6537991296718901,1.0,10/49,13.61%,RUNX1;TGFB1;ATP7A;CD44;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.534620912973923,1.1897466181991687,0.30238393977415307,0.6541907771519667,1.0,5/20,9.69%,WDTC1;ERLIN1;ERLIN2;ACADL;PRMT3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5096281349347107,1.1896949585396503,0.27534562211981567,0.6538018502176842,1.0,5/33,8.24%,CBL;NUP62;ARAP1;DOK1;DGKD
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5228094645978743,1.1890492308461766,0.26586826347305387,0.6552153984942977,1.0,2/27,1.05%,TREM2;FCGR2B
prerank,regulation of ERAD pathway (GO:1904292),0.6016454091409366,1.1884601418482095,0.29619181946403383,0.6563530516269286,1.0,3/11,8.14%,HERPUD1;ATXN3;AQP11
prerank,regulation of dopamine secretion (GO:0014059),0.5321867316099734,1.1879791169004588,0.25448028673835127,0.6571733531482468,1.0,5/25,11.08%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,Ras protein signal transduction (GO:0007265),0.4662757313082447,1.1878028734354433,0.15863453815261044,0.6571843694967447,1.0,33/137,14.79%,GRAP2;LAT;RREB1;GRB2;ELMO1;MAPK14;RAP2A;RASGRP2;RAP1B;RGL2;SHC2;MYO9B;AIF1;GNA13;TP53;GNA12;RIPOR1;PLK2;RAP2B;RASGRP3;RB1;ARHGAP1;ARHGDIB;RAPGEF1;CYFIP1;RASSF1;ADGRG1;ARHGEF3;RRAS2;ARHGDIA;ARHGEF11;RAP1A;USP8
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.47207727623555473,1.1876658112549574,0.1811740890688259,0.6570477593596814,1.0,24/108,13.66%,SYK;CTSD;LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;HMGB1;APAF1;CFLAR;CRADD;MAP3K5;MALT1;ST18;SMAD3;GRAMD4;PDCD6;DAP;CASP8;ATP2A3;TRADD
prerank,ncRNA catabolic process (GO:0034661),0.5186908283814102,1.1873674188778482,0.2867132867132867,0.6573637266086966,1.0,3/28,6.86%,SLFN14;TENT4B;SND1
prerank,positive regulation of organelle assembly (GO:1902117),0.500957607730574,1.186999090554631,0.25379609544468545,0.6578924216320511,1.0,10/44,12.29%,LCP1;NUP62;KCTD17;TNF;ASAP1;PIP4K2A;RAB3GAP2;PLK4;DYNC1H1;SDCBP
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5576257419255005,1.1869560502397185,0.28309305373525556,0.6574915036189719,1.0,3/18,4.11%,GSAP;TNF;ABCG1
prerank,tight junction assembly (GO:0120192),-0.30188577470847977,-1.1866227518491461,0.09859154929577464,0.8517047350895272,1.0,11/49,11.61%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1;CLDN12
prerank,embryonic heart tube development (GO:0035050),-0.44651302316955943,-1.186092575596354,0.2690909090909091,0.8478203578998719,1.0,6/14,25.28%,RYR2;ACVR1;HES1;SOX17;SOX18;IFT122
prerank,regulation of protein secretion (GO:0050708),0.4623902368896558,1.1856634233799856,0.18383838383838383,0.6607383658339548,1.0,26/119,16.82%,TREM2;KCNJ11;TGFB1;IL1A;ADAM8;TNF;ABCG1;APOE;TTN;RHBDF2;CACNA1A;TFAP2B;ITPR2;SYTL4;ENSA;SLC8B1;EXOC1;ARF6;MYH10;KCNA5;RAP1A;CD33;RHBDF1;CACNA1D;GCK;PPP3CB
prerank,nucleoside salvage (GO:0043174),0.6101816484144634,1.1856049744161352,0.29455081001472755,0.6603719468302562,1.0,4/10,16.32%,UCK1;CDA;UCK2;DCK
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5506214671736924,1.1851390370685213,0.2872777017783858,0.6611509431279553,1.0,3/16,7.24%,MLXIPL;ATP7A;ABCD1
prerank,alcohol catabolic process (GO:0046164),0.6220363100791493,1.1845861954086367,0.29829545454545453,0.6622296350579829,1.0,2/10,4.47%,APOE;CEL
prerank,transition metal ion homeostasis (GO:0055076),0.5149063868648528,1.1845487030992163,0.2668213457076566,0.6618153800149386,1.0,10/28,22.07%,SLC11A1;IREB2;HFE;FTL;B2M;PICALM;ATP13A2;HMOX2;PRKN;MT3
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4778611276542616,-1.184302123145231,0.22972972972972974,0.8479474073609187,1.0,3/10,6.22%,SLC25A12;ARL6IP5;SLC25A13
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4770605565217345,1.1842376791241258,0.22419186652763295,0.662231946288244,1.0,15/80,9.02%,SYK;CTSD;AQP1;TNF;FNIP1;SNCA;PYCARD;CASP1;CD44;HMGB1;MAP3K5;MALT1;CSNK2A1;GRAMD4;PDCD6
prerank,cellular response to oxygen levels (GO:0071453),0.6111813679654098,1.1841359405784242,0.29394387001477107,0.6619819598213739,1.0,4/10,15.08%,ATP6V0A2;ATP6V0D1;ATP6AP1;CPEB4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.522006353580744,1.184101877227906,0.26706586826347306,0.6615664421043375,1.0,8/29,12.01%,NLRC5;PTPN1;SAMHD1;YTHDF3;RNASEL;TTLL12;USP18;METTL3
prerank,organic cation transport (GO:0015695),-0.3844985521317634,-1.1838780679522358,0.21182266009852216,0.8437677349734245,1.0,9/20,28.74%,SLC47A1;RALBP1;SEC14L1;SLC25A42;SLC5A7;SLC25A19;SLC22A2;SLC25A29;SLC25A26
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.46876587231676714,1.1838742964574243,0.2342436974789916,0.6616742998439835,1.0,11/75,9.02%,STAT5A;ITGA4;PIK3CD;ITGB3;TGFBR1;MDK;PRKD2;PDCL3;HMGB1;VEGFB;PDCD6
prerank,mitochondrial fusion (GO:0008053),-0.3916896868062434,-1.1832647572491195,0.23553719008264462,0.8402406091553886,1.0,9/18,25.71%,AFG3L2;SPG7;GDAP1;BAX;MFN2;MIGA2;MIEF1;STOML2;MIEF2
prerank,cardiac muscle tissue development (GO:0048738),-0.30429469614155397,-1.1829800297076154,0.19718309859154928,0.8358207792166534,1.0,12/50,10.26%,SGCD;BMPR1A;BMP4;SGCZ;AKAP13;BMP5;CACNA1G;SMAD4;SIK1;SMAD5;SMAD1;TBX18
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5979480400756817,1.1822611646949484,0.2972972972972973,0.6658044828717611,1.0,5/10,20.53%,MTOR;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,regulation of phosphorylation (GO:0042325),0.46483641731142267,1.1821861917874243,0.1700404858299595,0.6654994446853583,1.0,21/120,12.34%,NCKAP1L;LYN;STAP1;FNIP2;NLRC5;SLAMF8;PTGES3;NUP62;FNIP1;ITGA6;PLXNB2;SEH1L;FLCN;TPR;INHBA;NRP1;THBS1;NUP205;PHIP;SDCBP;PPP2CA
prerank,myelin maintenance (GO:0043217),0.6177549220855763,1.1821482262057104,0.2966360856269113,0.6650751177983705,1.0,6/10,17.99%,CXCR4;ABCD1;PRX;DEGS1;PTEN;ABCD2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4618024701336257,1.181986151881229,0.1636546184738956,0.6650414394041614,1.0,42/150,20.08%,PTPRC;LYN;UBASH3B;TGFB1;SIRPA;NIBAN1;PRKCD;THY1;GNAQ;MLXIPL;NCK2;SEMA4D;SNCA;DNAJC3;XDH;SAMSN1;RB1;TRIM27;NTF3;QARS1;IBTK;IMPACT;DUSP19;DTNBP1;SNX25;DDIT4;PID1;RTRAF;LRRK2;NF1;PTEN;TARBP2;CORO1C;LDLRAD4;PDPK1;PAQR3;GREM1;ATG14;CNKSR3;INPP5K;HSPB1;PTPN6
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4830173711787279,1.1815331614070854,0.24758842443729903,0.6658302580255029,1.0,12/54,16.98%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;CTNNB1;PRMT3;SOX4;CAPN3;SVBP;COPS9;RPL11;VPS28
prerank,regulation of catecholamine secretion (GO:0050433),0.5169146017796304,1.1814658721507192,0.27972027972027974,0.6654863381353348,1.0,5/29,11.08%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5967421332403657,1.1814045480205675,0.3009845288326301,0.6651437759216718,1.0,3/12,9.57%,MDK;WNK1;FUT9
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5916639155324037,1.1812465164018389,0.296551724137931,0.6651036573793747,1.0,5/13,16.20%,METRNL;RREB1;PIM1;VSTM2A;ZBTB7B
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5159551020388508,1.1809323504439164,0.2808460634547591,0.6655087967212474,1.0,7/30,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CDK7;POLR1B;POLR2L
prerank,positive regulation of ATPase activity (GO:0032781),0.4949647974005349,1.180345299901889,0.28683035714285715,0.6666822480164162,1.0,12/41,13.76%,MYL3;DHX9;ALDOB;VMP1;TNNT3;AHSA1;PFN2;PFN1;ATP1B3;TOR1AIP2;DNAJC9;ATP1B2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5447421449938101,1.1803329307106567,0.29875,0.6661876119402791,1.0,3/19,8.87%,TREM2;TNF;CCT8
prerank,regulation of JNK cascade (GO:0046328),0.47210715433777173,1.179628498880165,0.21508664627930682,0.667700879014238,1.0,20/101,13.36%,PTK2B;SLAMF1;FCGR2B;SIRPA;TAOK3;DUSP3;RAP2A;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;DUSP10;TRAF5;DUSP19;NOD2;SDCBP;ITCH;GPS2
prerank,actin filament depolymerization (GO:0030042),-0.47652335614397434,-1.1793709938936856,0.26282051282051283,0.8421686714216449,1.0,5/11,8.53%,GSN;CFL2;WDR1;MICAL3;MICAL2
prerank,regulation of cell-cell adhesion (GO:0022407),0.49507153875027204,1.1793572249662738,0.26853932584269663,0.6679402093365296,1.0,7/39,10.93%,FERMT3;TGFB1;ADAM8;SPINT2;FUT9;PODXL;NF2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5233093946773103,1.1789381221423008,0.27532777115613827,0.668658948470448,1.0,10/27,21.91%,SLFN14;ERN1;ZC3H12D;RNASEH1;ZC3H12C;PCF11;TRIR;DICER1;TOE1;RNASE6
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.49841443588841533,1.1788876194434674,0.2705749718151071,0.6682781127687026,1.0,12/36,17.89%,PLCB2;NFATC1;FZD3;CTNNB1;TNRC6A;MOV10;AGO4;NLK;AGO3;GNG2;PPP3CB;AGO2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.28996203172534374,-1.178458429063428,0.18571428571428572,0.8400653346935176,1.0,20/50,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5453106213837681,1.1784487017719922,0.29800498753117205,0.6690252925790975,1.0,13/20,25.87%,PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;DROSHA;ZC3H7B;AGO1;PUM1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4940494941490616,1.177689315790442,0.254071661237785,0.6706939543134682,1.0,15/41,24.03%,CD3E;THY1;MDK;TNF;CD44;PODXL;PTPRU;DENND6A;CD47;FLOT1;PIEZO1;MEGF10;CX3CL1;PTPN23;MAGI1
prerank,miRNA metabolic process (GO:0010586),0.5453001110436111,1.1774109281214145,0.30828025477707005,0.6709501203514859,1.0,10/20,21.57%,TENT4B;SND1;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DIS3L2;DICER1;LIN28B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5775760365525945,1.1773608411029561,0.2955801104972376,0.6705662678390949,1.0,4/14,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5499713031073296,1.177072124030836,0.3018134715025907,0.6707964066126197,1.0,4/18,10.81%,TGFB1;TNF;TP53;MAP2K2
prerank,transition metal ion transport (GO:0000041),0.4895981537651985,1.1767956797675803,0.2911392405063291,0.6710856275854411,1.0,7/35,14.34%,SLC11A1;ATP7A;ATOX1;IREB2;ATP2C1;FTH1;SLC31A2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.31887206885269914,-1.176650933970984,0.19,0.8406603056667874,1.0,6/39,3.85%,UTRN;ANK2;FHL1;TCAF1;AHCYL1;FGF12
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.4411089058571662,-1.176198329296726,0.24521072796934865,0.8369061377408252,1.0,6/13,16.05%,RHOT1;BNIP3;BCL2L11;BLOC1S2;BAD;BAX
prerank,regulation of angiogenesis (GO:0045765),0.4537057066556688,1.176146906936716,0.11923847695390781,0.6724066120961162,1.0,20/192,7.43%,RUNX1;KLK3;GPNMB;PF4;ITGAX;CCR2;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;RGCC;PRKD2;PDCL3;TNFAIP3;PRKCB;CTNNB1;STAB1;VEGFB
prerank,regulation of anoikis (GO:2000209),-0.3867835557663403,-1.1757623110898912,0.22119815668202766,0.8331493459108192,1.0,4/19,7.55%,ANKRD13C;CAV1;TLE1;SIK1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5676703258291799,1.1754974200527544,0.30993377483443707,0.6737864818794724,1.0,6/16,17.06%,TRIM25;TRIM5;TRIM27;EXOC7;EXOC2;TRIM62
prerank,positive regulation of vascular permeability (GO:0043117),0.5818175631907836,1.1753817188028766,0.30520393811533053,0.673562993334093,1.0,2/12,5.38%,TGFB1;FGFBP3
prerank,transcription by RNA polymerase III (GO:0006383),0.5152495658271283,1.1748146157507138,0.3005917159763314,0.6747139829115777,1.0,10/27,19.16%,IVNS1ABP;GTF3C4;GTF3A;POLR2L;SNAPC3;ELL;RO60;SNAPC4;ICE2;CRCP
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5760119395238095,1.174628433291231,0.3058659217877095,0.674734964448687,1.0,3/12,8.96%,PTPN1;ERN1;BAK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5967779692987651,1.1741318783190442,0.3002832861189802,0.6756489815780896,1.0,3/12,12.25%,MUC13;SOX9;NOD2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.32725744675414176,-1.1741111164192464,0.2222222222222222,0.8332025571037358,1.0,13/37,16.40%,EFNA5;PHLDB2;CYLD;EPHA3;STMN2;PHLDB1;ROCK1;MAP6;MAPT;TPPP;STMN4;TRIM36;STMN3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5770574873779479,1.1734546869613327,0.3245492371705964,0.6769841910869866,1.0,4/14,7.23%,CREB3;HERPUD1;BCL2L1;CREB3L1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5830297457305622,1.173332218961487,0.30327868852459017,0.6768197502389999,1.0,2/13,2.10%,TGFB1;TGFBR1
prerank,response to exogenous dsRNA (GO:0043330),0.5511423302741961,1.1729879775187668,0.3031446540880503,0.6772841184503917,1.0,3/18,7.53%,RFTN1;DHX9;TICAM1
prerank,response to chemokine (GO:1990868),0.581826908065947,1.172840834791627,0.30357142857142855,0.6772009977301675,1.0,4/13,10.93%,DOCK8;RIPOR2;WNK1;SH2B3
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5687414027824731,1.1727540642281173,0.31090174966352624,0.6769053633500085,1.0,6/15,23.23%,TGFB1;LRP1;DPP4;CLASP1;DDR1;PDPN
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.516807961621544,1.1720814319182262,0.2813953488372093,0.678375265362766,1.0,3/27,2.82%,CD74;AQP1;DHX9
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.47129623130971254,1.1715228499634427,0.24025289778714437,0.679431777480116,1.0,20/65,18.68%,CBL;PTPRJ;DUSP3;GRB2;NUP62;ARAP1;DOK1;ZFYVE28;RHBDF2;SH3KBP1;DGKD;MVB12B;EPS15;BCAR3;RHBDF1;EPN1;PTPN12;PDE6H;CDC42;PTPN3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.45752533584810834,1.1714153370598572,0.1905717151454363,0.6792185295267301,1.0,26/142,13.98%,CALCR;CX3CR1;CCR2;CD52;SLC8A1;CLN3;CXCR4;S1PR4;HMGB1;FZD9;CCKBR;TMEM178A;CACNA1A;ATP2B1;SMAD3;SPPL3;CYSLTR1;SLC8B1;CMKLR1;ATP2B3;TACR1;IAPP;NPTN;CDH23;ADCY8;C3AR1
prerank,chloride transport (GO:0006821),-0.268143634344421,-1.1712183058254488,0.19607843137254902,0.8375443198058198,1.0,17/74,17.41%,SLC12A2;CLIC4;SLC12A7;SLC4A10;GABRB2;CLCN6;GABRB1;SLC26A7;GABRA2;CLIC5;CLCN2;GABRB3;TTYH3;ANO4;TTYH1;SLC12A8;GLRB
prerank,ceramide metabolic process (GO:0006672),0.483778227086313,1.1707913849718,0.24756756756756756,0.6804617090868966,1.0,16/49,21.23%,CERS6;SGPL1;CLN8;CERK;AGK;ACER3;ORMDL2;PPP2CA;NSMAF;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;ABCA2
prerank,organelle fission (GO:0048285),0.5308973534374803,1.170682847593137,0.2975609756097561,0.6802424403993915,1.0,13/24,25.18%,PEX11A;MTFR2;DNM2;TMCC1;SEC16B;CORO1C;DNM1L;FIS1;PRKN;ACOT8;MTFR1;MFF;WASHC5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.35713191886874507,-1.1704698948756853,0.2265193370165746,0.8347281129611179,1.0,7/22,7.97%,SCAF8;CDK12;THOC1;BRD4;THOC5;CCNK;CCNT1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5336330763731807,1.170373988677908,0.29647630619684084,0.6806196342795247,1.0,5/21,10.29%,HPSE;SULF2;HS3ST4;XYLT1;EXTL3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4513871989513858,1.1703258224860813,0.046,0.6802215671434976,1.0,98/476,14.80%,CD86;RUNX1;NFE2;CIITA;SHH;IRF4;TGFB1;GATA1;PCID2;CD74;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;NSD1;MLXIPL;SS18L1;ELF4;NUP62;YAF2;RXRB;NR1H4;TNF;APOE;UBE2V1;MITF;FOXO3;DDIT3;CXXC1;SPP1;NDP;HIVEP3;RNF111;FLI1;TEAD1;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;TBL1XR1;NKX2-1;TAL1;MAP3K5;MYOCD;PIM2;ZFP90;EPO;CEBPB;CHEK2;SNAI1;MEF2C;TFAP2B;BICRA;SMAD3;MMS19;ARID1A;MDFIC;PPARGC1A;RNF4;ATF7IP;LRP5;HDAC4;ARID1B;RNF10;ATAD2;SEC14L2;TBL1X;INHBA;TRIM56;MAP2K2;CREB3L2;ELF2;SOX9;PHIP;MAP3K12;CREB1;BAMBI;SMARCD3;CAMKK2;NFKB1;FOXK1;GPATCH3;HCFC1;ZFHX3;IRF1;SOX2;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;CAPN3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.465428540790697,1.1699157647167626,0.26834381551362685,0.6808617609099691,1.0,15/63,16.01%,TREM2;IL10RA;MTOR;TIMP1;EIF4G3;NELL1;DAP;TAB2;SORL1;FOXK1;BMF;TAB3;TBC1D14;GSK3A;NRDE2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.46392513022024895,1.169896333018328,0.2189409368635438,0.680385824406125,1.0,31/104,20.69%,CSF1R;GTF2H1;THY1;SLC8A1;CCND3;SNCA;BCCIP;PYCARD;CCND2;ACTB;RB1;UVRAG;CDK7;LRP5;DUSP19;MAP2K2;PARP16;PPP2CA;CDC6;CCNE2;PIH1D1;SRC;SYAP1;INCENP;IRGM;KSR1;RHOA;RPTOR;CNPPD1;CDK5R1;TELO2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5394902523849027,1.1698450182677542,0.3097686375321337,0.6799943910226671,1.0,5/21,7.23%,CREB3;HERPUD1;DDIT3;BCL2L1;CREB3L1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5188149373637059,1.169686847379117,0.28738317757009346,0.6799194256297992,1.0,18/29,25.87%,ADAR;SMAD3;PUM2;AGO4;SNIP1;AGO3;METTL3;PRKRA;TUT7;TARBP2;AGO2;ZC3H7A;DICER1;LIN28B;DROSHA;ZC3H7B;AGO1;PUM1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4670956462486571,-1.1695809107486004,0.2876712328767123,0.8324715440987455,1.0,3/11,15.95%,MLLT3;RSPO3;WNT5B
prerank,regulation of macroautophagy (GO:0016241),0.460438604967806,1.1686400763340035,0.24141414141414141,0.6823837470568701,1.0,24/105,14.61%,ATP6V0D2;ATP6V0E1;SNX5;MTOR;ATP6V1C1;ERN1;ATP6V1E1;CLN3;ATP6V0A2;SCOC;ATP6V0D1;LARP1;PAFAH1B2;SMG1;ATP6V0A1;HDAC6;EXOC8;EXOC7;EXOC1;IKBKG;LAMTOR3;GNAI3;LRRK2;ATP6V0B
prerank,camera-type eye development (GO:0043010),-0.3669604406632546,-1.1685561801021531,0.21301775147928995,0.8307328895491313,1.0,7/25,15.28%,CACNA1C;EFEMP1;SHROOM2;FBN1;TENM3;STRA6;PAX2
prerank,cellular response to cAMP (GO:0071320),0.5134086251169597,1.1684242478552946,0.2890716803760282,0.6824852463144047,1.0,10/30,21.24%,AQP1;HCN4;PKD2;RAP1B;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5627594048767028,1.1683517001575416,0.3125,0.6821903065598789,1.0,5/15,13.75%,PRKCD;TNF;SMPD3;ORMDL2;NSMAF
prerank,action potential (GO:0001508),0.491212667247381,1.1681544086961526,0.2802617230098146,0.6822414155508933,1.0,3/44,4.53%,GNA15;GNAQ;CLN3
prerank,cytoskeleton organization (GO:0007010),0.4594228092500266,1.1677779818219287,0.22154471544715448,0.6827541969564679,1.0,30/114,17.75%,FGD2;THY1;NCKIPSD;MDK;APOE;TNFAIP3;PLD2;FMNL3;FGD6;CAPZB;NEDD9;RANBP10;MICAL1;TNIK;SH3KBP1;SIPA1;ARHGAP10;DIAPH1;CCL13;CCL2;PHIP;RANBP9;DES;SIPA1L3;DST;PDZD8;WDPCP;BIN1;ANK1;RHOA
prerank,homeostasis of number of cells (GO:0048872),0.5929446685802239,1.167756954039287,0.29929078014184396,0.6822962367013793,1.0,2/12,7.72%,CX3CR1;OCIAD1
prerank,protein localization to mitochondrion (GO:0070585),-0.46654015187106657,-1.1672444972210887,0.2757352941176471,0.8299488927115163,1.0,6/11,16.31%,HK1;PINK1;COX18;DNAJA1;AKT1;MTCH2
prerank,positive regulation of phosphorylation (GO:0042327),0.45154109411778287,1.1671734638456162,0.125250501002004,0.6834239604423944,1.0,23/240,5.61%,NCKAP1L;TREM2;GPNMB;LYN;TGFB1;FLT3;CD74;ITGB3;CSF1R;NIBAN1;P2RX7;MLXIPL;DSTYK;PTGES3;RAP2A;SEMA4D;CCND3;TNF;FNIP1;ITGA6;BRAT1;PFKFB4;CCND2
prerank,regulation of cholesterol transport (GO:0032374),0.5443351151417054,1.1670446111594301,0.2901960784313726,0.6832738383112232,1.0,9/20,21.23%,TSPO;ABCB4;TTC39B;NFKB1;ARV1;LRP1;LAMTOR1;NAXE;ABCA2
prerank,organic substance transport (GO:0071702),0.4565582589399149,1.1669794482962874,0.18346774193548387,0.6829325965880725,1.0,25/121,18.21%,SLC6A3;SLC6A4;ABCA1;SLCO2B1;ATP8A1;GM2A;MFSD2B;CLN8;ABCG1;MYH9;RAB7A;ABCD1;RAMP1;TAP1;ARRDC4;ABCA4;CUBN;SCAMP2;SLCO1B1;ABCA3;SLC18A1;TAP2;ABCD2;VPS33B;LRP1B
prerank,regulation of endothelial cell migration (GO:0010594),0.45834443669023994,1.1668446368576482,0.25,0.6827830801249324,1.0,16/85,11.64%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;PRKD2;APOE;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34314910600873694,-1.1667077514109543,0.22033898305084745,0.8269261141268603,1.0,11/31,13.30%,DLG2;PRKCI;LIN7A;SYNJ2BP;PARD3;MYO9A;WDR1;DLG1;LIN7C;MTCL1;EZR
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4863793105906894,1.1665148494670186,0.26609442060085836,0.683193651652706,1.0,4/48,3.87%,PTK2B;UBASH3B;THY1;SNCA
prerank,positive regulation of cell cycle (GO:0045787),0.4704691562276706,1.16581163882618,0.2761904761904762,0.6846504764030957,1.0,10/62,9.15%,LGMN;SMOC2;DUSP3;CCND3;RGCC;PKD2;CCND2;TAL1;RPS15A;HSF1
prerank,smooth muscle tissue development (GO:0048745),0.6100729033132054,1.1650008906539377,0.3058823529411765,0.686445170716667,1.0,1/10,0.68%,SHH
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4790737462149369,1.1646120301264338,0.2553191489361702,0.6870066925669073,1.0,9/54,9.39%,HPSE;GUSB;GNS;IDS;HEXA;FUCA1;AGRN;NDST1;XYLT1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.49402322422976375,1.1645583447315937,0.2956120092378753,0.686632940923315,1.0,7/33,8.66%,PLCG2;CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,phosphate ion transmembrane transport (GO:0035435),0.5784342043834543,1.1644933409344906,0.33286516853932585,0.686294860312817,1.0,4/12,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,regulation of intracellular transport (GO:0032386),0.5000202302667861,1.1640912569502389,0.28475336322869954,0.6869596601265714,1.0,4/38,4.64%,LCP1;NEFH;PTPN1;REEP6
prerank,positive regulation of blood coagulation (GO:0030194),0.5549312792708079,1.16377416115108,0.3054862842892768,0.6873640911440871,1.0,3/17,11.24%,HPSE;USF1;THBS1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4513934960309574,1.163415665843619,0.15245737211634905,0.6878900943606142,1.0,43/170,19.71%,PTPRC;TREM2;ASCL1;SHH;CAVIN4;SIRPA;SLC8A1;PRDM12;TRIM5;APOE;ZUP1;TBC1D16;TFEB;AIF1;NFKBID;MTMR3;TRIM27;PCBP3;TXK;NELL1;AFF1;CDK6;ZFP64;COQ7;ZNF445;MEGF8;PCBP1;SOX2;HNRNPD;RO60;IGF2BP3;C1D;RASA1;HIF1A;MARF1;LAMTOR1;FLOT1;PRDM10;FUBP3;GDNF;ROCK2;ATRAID;SORT1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5517577982001501,1.1634136028899984,0.33066666666666666,0.6873771104495666,1.0,7/17,19.60%,CBFA2T3;MLXIPL;FLCN;HDAC4;PID1;TIGAR;FIS1
prerank,copper ion transport (GO:0006825),0.5823088722502548,1.1625872043003496,0.3039647577092511,0.6892116839371439,1.0,4/11,15.44%,ATP7A;ATOX1;SLC31A2;STEAP3
prerank,membrane lipid catabolic process (GO:0046466),0.5911603707184907,1.1622237629094452,0.3229901269393512,0.6897048069233047,1.0,2/10,6.72%,SGPL1;FUCA1
prerank,sterol metabolic process (GO:0016125),0.4780590949679303,1.1621619825967957,0.26526315789473687,0.6893739510106849,1.0,8/60,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;LIPA;SOAT2
prerank,tRNA aminoacylation (GO:0043039),0.5025849104548644,1.1620349727288644,0.2927927927927928,0.6892304467803777,1.0,17/37,22.57%,VARS1;FARSB;GATB;GARS1;PPA2;RARS1;EPRS1;QARS1;LARS2;DARS1;DARS2;FARS2;AIMP1;TARS1;YARS1;SARS2;SARS1
prerank,brain morphogenesis (GO:0048854),0.5820239073463361,1.1608592887836933,0.3179916317991632,0.6920373235202463,1.0,1/12,0.40%,SLC6A4
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4902598479928384,1.1604221212948265,0.2747747747747748,0.6927126139581754,1.0,8/36,11.24%,TGFB1;ANGPT4;TNF;RGCC;APOE;HMGB1;MEF2C;THBS1
prerank,positive regulation of sodium ion transport (GO:0010765),0.5780417808974553,1.1596792284855286,0.31163434903047094,0.6942555895303053,1.0,3/12,8.16%,SCN4B;PKP2;PRSS8
prerank,regulation of actin filament bundle assembly (GO:0032231),0.5129048844096848,1.1592676399063666,0.2977461447212337,0.6949134999965779,1.0,11/26,21.76%,PLEK;FHOD1;SLC9A1;ACTG1;PFN2;PFN1;SYNPO;CDC42;ROCK2;PRKN;CX3CL1
prerank,regulation of centrosome cycle (GO:0046605),-0.36190183139275645,-1.1587544940659869,0.23737373737373738,0.8471013387591918,1.0,12/21,37.49%,NAT10;CHMP5;CHMP4B;MARK4;CHMP2A;NPM1;ATF5;CHMP4C;CHMP1B;GEN1;CEP131;XRCC3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.39060957373119165,-1.1586104623220008,0.2540983606557377,0.8426114717668587,1.0,4/18,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4667658472318871,1.1580018740373026,0.2810526315789474,0.6979377961534982,1.0,14/60,13.46%,CSF1R;MED17;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;ATF7IP;MED27;SOX9;AGO3;NFKB1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.45688513347905235,1.1576451743107927,0.23076923076923078,0.6984946922984298,1.0,31/112,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;TGFBRAP1;MEF2C;ZFYVE9;SMAD3;F11R;LIMS1;SOX9;NLK;BAMBI;SOX6;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,protein export from nucleus (GO:0006611),0.506014195116586,1.1574043417867657,0.2967289719626168,0.6986396854175854,1.0,11/27,22.38%,TGFB1;XPO1;CSE1L;STRADB;TPR;XPO6;STRADA;SMURF1;DESI1;CHP1;XPO7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.45908286233218737,1.157400559767776,0.25103734439834025,0.6981286394658482,1.0,8/87,3.02%,PTK2B;IQGAP2;CORO1A;FZD10;CSF1R;PRKCD;MTOR;MDK
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.523067170338237,1.1570485870608869,0.30324909747292417,0.6986402420931678,1.0,12/24,22.83%,SMYD5;DNMT3A;SPI1;TRIM27;RBBP7;MTF2;TASOR;PHF1;RBBP4;EED;AEBP2;H3-3A
prerank,cellular response to ketone (GO:1901655),0.49727962317688285,1.1567398880945265,0.30371203599550056,0.6989271545774426,1.0,12/35,19.65%,MAP4K1;AQP1;ADCY6;SPP1;LARP1;ADCY3;ADCY8;GNG2;SRC;NCOA4;GOLPH3;ROCK2
prerank,response to UV-B (GO:0010224),-0.4357296276310798,-1.156535219916728,0.2972972972972973,0.8442161176943193,1.0,5/12,22.36%,MSH2;MME;RELA;HYAL1;CDKN1A
prerank,genitalia development (GO:0048806),0.583947802084833,1.1564050440304892,0.3153526970954357,0.699391254848966,1.0,2/12,6.22%,SHH;CHD7
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4876691459488739,1.1561336381784473,0.2956043956043956,0.6996595017560063,1.0,5/41,9.57%,CTSS;KCNN4;STAC;KCNMA1;NOS1AP
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5729314673904027,1.1560416381600576,0.32763532763532766,0.699409877035605,1.0,3/12,8.46%,ESPL1;CTNNB1;RB1
prerank,regulation of MAPK cascade (GO:0043408),0.45178076129297473,1.1558565656661441,0.17771084337349397,0.6994084266327626,1.0,32/157,17.35%,PTPRC;LYN;SYK;FLT3;CD74;LAPTM5;TAOK3;PLCG2;PTPRJ;DUSP3;P2RX7;OSM;TRIM5;HMGB1;TNIK;ATP6AP2;DUSP19;MAP2K2;GPR37;IAPP;STK3;SOX2;LBH;TMEM106A;PHLPP1;BCAR3;NF1;STK4;EPHA8;IQGAP1;KSR1;LAMTOR1
prerank,cGMP-mediated signaling (GO:0019934),0.5664160063042053,1.1556610739654463,0.3136729222520107,0.6994491419237057,1.0,2/13,4.14%,AQP1;APOE
prerank,generation of neurons (GO:0048699),0.4512902958520181,1.1551306528908156,0.16132264529058116,0.7004649602900871,1.0,28/190,13.00%,RUNX1;ASCL1;SHH;CX3CR1;PCSK9;FZD10;HES7;FGF13;IER2;PLXNB2;MYT1L;BHLHE41;THOC2;FZD3;CTNNB1;LRP12;DISC1;MEF2C;PEX13;FUT9;MAP1B;OLIG1;ARTN;NRP1;CDK6;DDIT4;TAFA1;NAV1
prerank,mRNA 3'-end processing (GO:0031124),-0.2739389703628221,-1.1551049788307945,0.16129032258064516,0.8437437048017857,1.0,24/78,15.25%,WDR33;APP;SARNP;SRRM1;RPRD2;CPSF6;SCAF8;AHCYL1;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;PAF1;SRSF11;PAPOLG;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.49490740567123515,1.1550514756045918,0.3178206583427923,0.7001596010024136,1.0,4/32,4.10%,P2RY6;THY1;SNCA;PKD2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.534830227866589,1.1550198186543115,0.30076142131979694,0.6997162523761441,1.0,8/18,20.80%,CAMK1D;PRKD2;RPS6KA4;LRP8;ADCY8;RPS6KA5;RELN;CRTC3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5462971637500067,1.1547433006319248,0.3087674714104193,0.7000096066968885,1.0,6/18,16.02%,MDK;CXCR4;TMEM98;TNFRSF21;TNFRSF1B;NF1
prerank,regulation of sensory perception of pain (GO:0051930),-0.4545354175171884,-1.1547426074859968,0.27936507936507937,0.8399534040310014,1.0,7/11,39.42%,ATPSCKMT;CCN3;ZFHX2;ACP3;SPX;F2R;TMEM100
prerank,neuropeptide signaling pathway (GO:0007218),0.4632855266289007,1.1547371478263817,0.27024185068349105,0.6995112773101417,1.0,9/58,12.78%,CYSLTR2;GALR1;SORCS3;PPY;CYSLTR1;GPR37;GLRA2;LTB4R2;SORL1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.369341241580455,-1.15461952837277,0.25595238095238093,0.8356019708265862,1.0,6/20,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5986769768355631,1.1540785037688062,0.32595870206489674,0.7007857992781823,1.0,3/10,8.33%,DIP2B;MYOCD;FLCN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3482635355776724,-1.1536684896818612,0.24074074074074073,0.8337741673578705,1.0,10/25,10.73%,CACNA1C;ANK2;CAV1;RYR2;CXADR;JUP;CALM3;TBX18;DLG1;CTNNA3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5015355619669404,1.1536418162833595,0.3159117305458769,0.7015184926750563,1.0,7/32,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;CDK7;POLR1B;POLR2L
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4499703931000206,1.153323890584608,0.19798994974874373,0.7019186055927172,1.0,47/166,17.08%,SMOC2;PPP1R3E;NIBAN1;MTOR;MLXIPL;DHX9;ZEB2;TNF;SNCA;RGCC;ATP7A;PRKD2;PKD2;PLXNB2;SLC25A37;P2RX4;CIRBP;YTHDF3;LARP4B;SMAD3;PPARGC1A;NOS1AP;CPEB3;RPL26;BRPF3;THBS1;STN1;ZCCHC4;METTL3;KAT7;DNA2;PCIF1;DDAH1;POLDIP3;UPF3B;HNRNPD;STARD4;SOX4;SREBF1;BCAR3;PAOX;CD36;HIF1A;FAF1;HSP90AA1;GCK;RPS4X
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.47122569645984047,1.1524147418640458,0.28308026030368766,0.7040421137494459,1.0,10/51,14.53%,NCKAP1L;TAOK3;ATP7A;DNM2;TNIK;KIF20B;NTF3;DTNBP1;LRRK2;SNX2
prerank,regulation of gluconeogenesis (GO:0006111),-0.3452984062954143,-1.152366018935391,0.2471264367816092,0.8331224161111676,1.0,11/27,23.11%,OGT;DDB1;SIK1;SELENOS;ZNF692;DGKQ;ARPP19;C1QTNF3;NNMT;PDK2;CRY1
prerank,nuclear migration (GO:0007097),0.5664521024149304,1.1522695814675785,0.320109439124487,0.7039466849460846,1.0,1/13,0.15%,HOOK3
prerank,quinone biosynthetic process (GO:1901663),0.5573543316863965,1.1519687982111755,0.3249001331557923,0.7043015245249126,1.0,8/14,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,metanephros development (GO:0001656),0.5080732771617091,1.151788598716012,0.32335329341317365,0.7043139343479433,1.0,3/26,4.10%,SHH;BASP1;PKD2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4572584962907702,1.1510125873898955,0.2441505595116989,0.706042167181771,1.0,31/101,17.08%,TGFB1;NIBAN1;MTOR;ATG7;AURKAIP1;PLXNB2;ASPH;CIRBP;YTHDF3;TBC1D10A;VPS11;LARP4B;BAK1;CPEB3;AMER1;RPL26;INHBA;THBS1;ZCCHC4;METTL3;CASP8;PCIF1;STUB1;POLDIP3;UPF3B;HNRNPD;SOX4;CAPN3;FAF1;HSP90AA1;RPS4X
prerank,regulation of neuron migration (GO:2001222),-0.3482626255150426,-1.1509800165681983,0.2413793103448276,0.8327008364601303,1.0,8/26,4.32%,SEMA6A;NIPBL;COL3A1;NTNG1;SEMA3A;ULK4;DAB2IP;NEXMIF
prerank,cellular response to insulin stimulus (GO:0032869),0.4531459122074725,1.1509582600152963,0.23356926188068755,0.7056731808574822,1.0,32/124,16.81%,ATP6V0D2;PCSK9;RAB8B;LPIN2;ATP6V0E1;MYO5A;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;HDAC5;USF1;ATP6V0D1;ZDHHC7;RAB31;AP3S1;EPRS1;BCAR1;DENND4C;ATP6V0A1;ATP6AP1;ZNF106;PHIP;HDAC9;ATP6V0B;BCAR3;GSK3A;SYAP1;IDE;CPEB2;GCK
prerank,regulation of microtubule-based movement (GO:0060632),0.5844701588065037,1.1509540247994898,0.34236804564907275,0.7051599440718815,1.0,2/11,11.27%,NEFH;HDAC6
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.45749584649125846,1.15083071295917,0.2647362978283351,0.7049898733260835,1.0,21/83,18.10%,TUBB;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;TP53;CEP70;PLK4;CEP76;KIF14;HAUS1;DYNC1H1;PCM1;CEP152;HAUS8;NINL;HSP90AA1;AKAP9;CEP63
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4490174269582121,1.1506445320055565,0.23935091277890466,0.7050100552816362,1.0,33/107,20.86%,NIBAN1;ERN1;HERPUD1;TRAF2;ATF3;SEL1L;DDIT3;TP53;MAP3K5;CREB3L1;P4HB;CEBPB;TMX1;BAK1;DERL1;CREB3L2;THBS1;SEC16A;ATF6B;ATP2A3;WFS1;CCDC47;SELENOK;PDIA3;ERO1A;ERP44;FLOT1;ERLEC1;OS9;QRICH1;GSK3B;PRKN;TMEM259
prerank,cAMP metabolic process (GO:0046058),0.5626447615440351,1.1504723530612766,0.3310719131614654,0.7049553220208844,1.0,4/13,13.49%,ADCY7;ADCY6;ADCY3;ADCY8
prerank,lipoprotein biosynthetic process (GO:0042158),0.5811270075804718,1.1500548062321294,0.34008683068017365,0.7056323420219266,1.0,2/11,4.14%,ATG7;APOE
prerank,pyruvate metabolic process (GO:0006090),0.4752692493450566,1.1499699621204307,0.29978354978354976,0.7053385549612698,1.0,15/52,16.87%,HK3;PFKL;ALDOB;ENO3;SLC16A1;GPI;PDHA1;HK2;VDAC1;ME3;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,peptidyl-amino acid modification (GO:0018193),0.6037672568924911,1.1496970854907642,0.3185840707964602,0.7056044676654745,1.0,5/10,28.72%,ATP7A;METAP2;TTLL4;METAP1D;FKBP10
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48565386154832935,1.1490698336530412,0.3160220994475138,0.7068730617126182,1.0,10/40,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC36A4;SLC16A1;ABCC1;SLC25A30;SLC38A10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45270131948551856,1.1490353759562115,0.23286290322580644,0.7064403413389799,1.0,32/128,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;RNF111;TGFBR2;HFE;TGFBRAP1;ZFYVE9;SMAD3;F11R;INHBA;NLK;BAMBI;MEGF8;STUB1;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5532531281225054,1.148630888334898,0.3232588699080158,0.7071054964778593,1.0,1/13,2.15%,TYK2
prerank,organelle organization (GO:0006996),0.44139584153466543,1.1484017490915042,0.095,0.7072368845062181,1.0,113/388,20.78%,FGD2;PLEKHM2;SPTBN5;ATP8B4;LMAN1L;PEX11A;RAB34;THY1;RAB32;NCKIPSD;MTFR2;MDK;TMED3;ATXN7;ATP7A;PKD2;APOE;PYROXD2;REEP6;PI4K2A;RAB14;VPS18;ARFGEF1;TNFAIP3;NDP;PLD2;RAB7A;FMNL3;SYNE1;TTC29;FGD6;USP6NL;CAPZB;LONP1;NEDD9;ABCD1;YTHDF3;IRAG2;RANBP10;VMP1;MICAL1;TNIK;SH3KBP1;VPS11;MSTO1;RAB31;SIPA1;ARHGAP21;ARHGAP10;PPARGC1A;VAPB;TMCC1;BNIP1;DIAPH1;CCL13;ATL1;CCL2;PEX7;PHIP;PRDX3;SEC16A;CSNK1A1;PI4K2B;WDR81;SEC16B;RANBP9;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HCFC1;ATAD3A;DES;HUWE1;TRAPPC11;LRRK2;GAK;EPS15;ABCA3;SIPA1L3;AGTPBP1;TWNK;DST;PDCD6IP;PDZD8;YME1L1;PLAAT3;WDPCP;PNPLA3;BIN1;LMAN2;ANK1;CDC42;ABCD2;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;MCOLN1;RAB29;DNM1L;PALLD;OPTN;SORT1;ATL3;TRAPPC12;SEC31A;KIF3A;NSFL1C;COG7;PRKN;SPTSSB
prerank,regulation of amyloid fibril formation (GO:1905906),0.5556432261623023,1.1483168441491949,0.3168044077134986,0.7069304300042295,1.0,2/15,4.14%,TREM2;APOE
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.28742557658195356,-1.1482294669121702,0.22388059701492538,0.8366372464907356,1.0,21/53,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;BCKDK;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,negative regulation of chemokine production (GO:0032682),0.5568949598252365,1.1480961481032705,0.31409395973154364,0.7069993855279173,1.0,1/14,1.41%,SIRPA
prerank,negative regulation of viral release from host cell (GO:1902187),0.5681579501252785,1.1477437537027457,0.3476454293628809,0.7074271570697883,1.0,4/13,11.59%,TRIM5;TRIM8;MID2;TRIM35
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5119862842554188,1.1475403075124029,0.3252720677146312,0.7075181573338896,1.0,2/21,2.09%,SHH;RAB34
prerank,cellular response to nitrogen compound (GO:1901699),0.5282589796062708,1.1470435954652367,0.3274336283185841,0.7084375238298818,1.0,10/20,24.44%,NR1H4;DDI2;HSF1;ATRX;RIOK3;ROCK2;SPIDR;EPG5;ATP2B4;DDX11
prerank,neuron differentiation (GO:0030182),0.44866041742538265,1.1466499610406586,0.19678714859437751,0.7090633475701353,1.0,18/165,11.07%,RUNX1;ASCL1;SHH;PCSK9;FZD10;TGFBR1;IER2;ATP8A2;MYT1L;THOC2;FZD3;CTNNB1;WNK1;MEF2C;MYO7A;FUT9;INHBA;OLIG1
prerank,cardiac muscle cell development (GO:0055013),0.5358690301214201,1.1465767653855845,0.35687263556116017,0.7087696295439667,1.0,3/20,4.39%,SLC8A1;TTN;MYLK3
prerank,positive regulation of chromatin organization (GO:1905269),0.5656515488186247,1.1465585808241852,0.32336182336182334,0.7083005300110763,1.0,7/12,22.85%,TAL1;ATRX;UBE2N;TINF2;TERF2;H3-3A;TERF2IP
prerank,regulation of hippo signaling (GO:0035330),0.5400387760061102,1.145654823277388,0.3337612323491656,0.7103350270465034,1.0,4/17,10.93%,MAPK14;WWC2;MAP2K3;NF2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5071589326824829,1.1454624306285086,0.315606936416185,0.7103607568101398,1.0,4/31,3.69%,TGFB1;TGFBR1;MYL3;PKP2
prerank,positive regulation of signaling (GO:0023056),0.4839585359799157,1.1453885716006906,0.3054298642533937,0.7100706819431019,1.0,5/37,6.74%,CLSTN1;VAMP3;TNF;SNCA;CD80
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5774743915442446,1.1452558870833331,0.35694444444444445,0.7099496144728997,1.0,4/12,14.71%,ATP7A;DDC;AMD1;MAOA
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5870929467402224,1.1450619545017824,0.3440702781844802,0.7099964399799674,1.0,5/10,22.07%,SNCA;HDAC6;ETFBKMT;PRKN;MT3
prerank,activin receptor signaling pathway (GO:0032924),0.5455718683943349,1.14467380796297,0.3328981723237598,0.7105497060309874,1.0,3/15,10.55%,TGFBR1;SMAD3;INHBA
prerank,negative regulation of JNK cascade (GO:0046329),0.5025401950667142,1.1442909086553446,0.3162193698949825,0.7111244976464516,1.0,11/31,20.78%,SIRPA;TAOK3;DUSP3;DUSP10;DUSP19;ITCH;GPS2;DACT1;PER1;ZMYND11;PRKN
prerank,cellular response to metal ion (GO:0071248),0.44619327345957166,1.1440071775296607,0.2527693856998993,0.7113540825163155,1.0,42/123,22.28%,SLFN14;SYT17;ADCY7;LGMN;AQP1;PLCG2;RASA4;SNCA;PKD2;RASGRP2;P2RX4;MEF2A;SYT2;HFE;MEF2C;SYT10;HSF1;GLRA2;B2M;BRAF;ADCY8;LRRK2;CAPN3;IQGAP1;SCN5A;ADD1;TIGAR;MCOLN1;HVCN1;SMPD1;ATP13A2;PRKN;ITPKB;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,ubiquinone biosynthetic process (GO:0006744),0.5497248332990328,1.1438735552429868,0.33201058201058203,0.7112094824174544,1.0,8/15,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,negative regulation of angiogenesis (GO:0016525),0.45536859746608177,1.1437986901007449,0.2696629213483146,0.710919521842055,1.0,10/84,7.23%,KLK3;PF4;CCR2;ANGPT4;PIK3CB;TNF;RGCC;CTNNB1;STAB1;CREB3L1
prerank,positive regulation of dephosphorylation (GO:0035306),0.50888699085369,1.1436473446912154,0.3123543123543124,0.7108281400559798,1.0,13/27,24.55%,TGFB1;PRKCD;SPPL3;SRC;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;MTMR9;PPP1R16B;CAMTA1;PPIA
prerank,response to amino acid starvation (GO:1990928),0.4645378576960375,1.143585036778844,0.27632950990615224,0.710494377775988,1.0,23/72,19.42%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;LARP1;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,protein phosphorylation (GO:0006468),0.4424537215445584,1.142920243947259,0.09,0.7117840918095211,1.0,107/479,17.40%,PTK2B;BTK;FGR;LYN;GMFG;HCK;TGFB1;SYK;FLT3;MAPKAPK3;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;CSF1R;TGFBR1;TYK2;PRKCD;GTF2H1;TLR2;CAMK1D;MTOR;BMP2K;TEC;TLR7;MAPK14;GRK3;MAP2K6;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;MORC3;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;PLK2;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;STRADB;ABI1;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;LIPE;MERTK;CAMKK2;BRAF;GAS6;STK3;STK24;BMX;LRRK2;NIM1K;WNK4;TESK2;SRC;STRADA;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11;INCENP;EPHA4;COQ8B;STK4;EPHA8;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4541546784418327,1.142640631368087,0.26038500506585616,0.7120366420996834,1.0,25/102,16.81%,PCSK9;ADCY7;RAB8B;LPIN2;PRKAR2B;MYO5A;CYSLTR2;PRKCD;ADCY6;HDAC5;USF1;RAB31;EPRS1;DENND4C;PRKACB;HDAC9;NR4A1;NFKB1;ADCY3;ADCY8;SRC;GSK3A;SYAP1;CPEB2;GCK
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4514167550095661,1.142313564547853,0.27253886010362693,0.7124531122918475,1.0,17/78,15.64%,BAG2;NFE2L2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;TAF1;HECTD1;FZR1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5907209180242885,1.142198317687485,0.3087818696883853,0.7122396771559518,1.0,4/10,17.20%,TLR2;CCL2;NOD2;IL33
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4603605977493987,1.141549807224884,0.2985386221294363,0.7135155423878797,1.0,10/67,12.44%,PTK2B;CD3E;CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1;CDK6
prerank,regulation of cellular pH (GO:0030641),0.49644246918679813,1.141472734466944,0.32590855803048063,0.7132049158401954,1.0,10/29,22.06%,SLC9A4;CLN3;SLC9A9;SLC9A1;ATP6AP1;LACC1;SLC9A8;SLC9B1;SLC9A7;CHP1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5658340155932229,1.1414222424062803,0.32142857142857145,0.7128157827304004,1.0,2/13,2.82%,CD74;DHX9
prerank,regulation of peptide hormone secretion (GO:0090276),0.45862938585254653,1.1413886761639465,0.3074501573976915,0.7123947661744903,1.0,16/67,16.82%,KCNJ11;FFAR2;TNF;RASL10B;CHD7;CACNA1A;HFE;TFAP2B;ITPR2;ENSA;SLC8B1;KCNA5;RAP1A;CACNA1D;GCK;PPP3CB
prerank,regulation of vasculogenesis (GO:2001212),0.5459924504496125,1.1412785603432938,0.3235685752330226,0.712197614145027,1.0,2/14,5.36%,RIN2;XDH
prerank,sensory perception of light stimulus (GO:0050953),0.44995441717571105,1.1408838638932015,0.28105906313645623,0.7127988924399392,1.0,14/87,14.21%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;WHRN;RP2;CNGB1;MYO7A;CRYBB1;RPGR;CDH23;OAT;WFS1
prerank,cytosolic calcium ion transport (GO:0060401),-0.337958100557765,-1.1404047343301291,0.2215568862275449,0.8570921327644254,1.0,9/28,12.43%,CACNA1C;RYR2;AFG3L2;MICU1;JPH1;ITPR3;SLC35G1;MCUR1;CACNA2D1
prerank,positive regulation of angiogenesis (GO:0045766),0.4461021292969784,1.1403445348068384,0.24288617886178862,0.7137613051223194,1.0,13/108,7.43%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;MDK;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4871473375225516,1.140285735311056,0.31101021566401815,0.7133959618009927,1.0,11/36,16.71%,IL1A;PIK3CB;TNF;GCH1;APOE;DNM2;NOS1AP;SPR;DDAH1;HIF1A;HSP90AA1
prerank,negative regulation of blood pressure (GO:0045776),-0.4160078056173294,-1.1400401567358487,0.2801556420233463,0.8534525917418351,1.0,6/13,26.64%,SCPEP1;NOS3;NOS1;DRD2;BMPR2;GPR37L1
prerank,positive regulation of metabolic process (GO:0009893),0.45188863259691575,1.1399868995436355,0.2517694641051567,0.7137063441364205,1.0,24/103,16.91%,IRF4;SYK;CCR2;FABP4;CAMK1D;TNF;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;FASN;ACACA;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5811906076216331,1.139659407198451,0.35827338129496406,0.7141065864297805,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,extracellular matrix organization (GO:0030198),0.4419322199047744,1.1394949940521824,0.141,0.7140249739118845,1.0,34/276,7.70%,CTSS;ITGAL;MMP12;ITGA2B;ITGAX;TGFB1;ITGB2;LCP1;SMOC2;ITGA4;SH3PXD2B;ITGB3;TGFBR1;ITGB5;ADAM8;ITGA2;CTSK;CTSL;ADAMTS8;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;SPP1;TIMP1;CD44;ITGAE;TNR;AGRN;CREB3L1;P4HB;LOX
prerank,negative regulation of cell motility (GO:2000146),0.4479024363616227,1.139465697551834,0.2560483870967742,0.7135945057359867,1.0,26/108,16.50%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;NKX2-1;RAP2B;FLCN;SPINT2;DUSP10;PODN;VCL;NF2;PTPRU;ADARB1;STK24;PTPRT;NF1;EPHA4;PTEN
prerank,regulation of regulated secretory pathway (GO:1903305),0.4888334210005754,1.1394539614814123,0.32265446224256294,0.7131155684518984,1.0,6/34,11.08%,SYT17;UNC13D;VPS18;SYT2;SYT10;DTNBP1
prerank,cardiac myofibril assembly (GO:0055003),0.5504017144084516,1.1393087562235333,0.34893048128342247,0.7130128766965145,1.0,3/15,6.76%,TTN;MYLK3;MEF2A
prerank,plasma membrane organization (GO:0007009),0.4619171179567401,1.1391311077636042,0.30406852248394006,0.7130171400598634,1.0,20/61,17.99%,BIN2;P2RX7;SNX9;CLN3;CXCR4;SNX33;MYH9;MICALL1;ABCD1;SYTL4;DYSF;BIN3;FNBP1L;ARV1;DEGS1;AHNAK2;ARL8B;BIN1;STX2;ABCD2
prerank,carbohydrate homeostasis (GO:0033500),0.4588631156623024,1.1390441653201278,0.27991675338189387,0.7127377529162572,1.0,19/67,20.09%,MLXIPL;FFAR2;CEBPA;TENT4B;USF1;TFAP2B;VGF;SLC8B1;ADIPOR1;ADCY8;MBD5;WFS1;SOX4;ADIPOR2;APPL2;GCK;KLF7;INPP5K;PYGL
prerank,cellular component assembly (GO:0022607),0.4412978297068648,1.1390237634995475,0.17,0.7122732120208491,1.0,44/253,14.80%,NCKAP1L;PTK2B;TGFB1;CD3E;LCP1;NEFH;CD74;VAMP3;SKAP2;SNX9;PLS1;WIPF1;PKP2;MITF;TRAF2;TEAD1;AIF1;ACTB;TP53;NEDD9;YTHDF3;VMP1;MICAL1;CAPZA1;HFE;TRIP13;PPARGC1A;EPRS1;ACTG1;TUBGCP4;PARVB;LIMS1;SOX9;CYFIP1;DET1;MDN1;RANBP9;IKBKG;GAS6;DARS1;TSPAN4;NOC2L;JHY;CAPN3
prerank,central nervous system neuron differentiation (GO:0021953),0.4876619364793382,1.1387978682517108,0.31046511627906975,0.7124159635095592,1.0,3/33,6.29%,DRAXIN;ATP7A;CTNNB1
prerank,regulation of lymphocyte migration (GO:2000401),0.5846111097756217,1.1385562193344498,0.33238636363636365,0.7125774781354698,1.0,2/10,10.60%,STK10;SLC8B1
prerank,apical protein localization (GO:0045176),-0.4647762943819239,-1.1384180947661044,0.3,0.8541006641647055,1.0,6/10,21.37%,SHROOM3;SHROOM2;ATP8B1;JAM3;GOPC;VANGL2
prerank,positive regulation of peptidase activity (GO:0010952),0.5148732049410181,1.1380414251471114,0.32129514321295144,0.7135464517043819,1.0,4/20,12.47%,VSIR;TANK;GRN;PSME3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5078023818382618,1.1376461373251416,0.3491484184914842,0.714132343011242,1.0,3/24,5.78%,LPCAT1;PGS1;CDS2
prerank,regulation of protein localization to cell surface (GO:2000008),0.4859745087099418,1.1376282851828483,0.3325526932084309,0.7136655500569937,1.0,15/33,25.14%,TNF;SNX33;CTNNB1;TYROBP;HFE;NEDD4L;RAB11FIP5;STX3;TOR1A;PICALM;LEPROTL1;ABCA2;GPM6B;GPD1L;HSP90AB1
prerank,macrophage differentiation (GO:0030225),0.5621252845059822,1.1375837138240479,0.32483221476510066,0.713281617251161,1.0,6/13,24.08%,CSF1R;CASP8;CDC42;PARP1;VEGFA;IL15
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5120833931434208,1.1370303579214383,0.33658536585365856,0.7143469244160214,1.0,7/23,20.70%,PLEK;CBFA2T3;HDAC4;GSK3A;GCK;TIGAR;CLK2
prerank,respiratory system development (GO:0060541),0.4866539947849491,1.136273894569101,0.32837528604118993,0.7159751147319442,1.0,5/32,6.82%,SHH;BASP1;CEBPA;CHD7;NKX2-1
prerank,N-glycan processing (GO:0006491),0.5286755161193639,1.135958017072561,0.3442838370565046,0.7163365468123665,1.0,8/18,19.21%,MAN1C1;ST8SIA4;ST8SIA1;MAN2A2;GNPTAB;MGAT4B;MAN1A2;GANC
prerank,protein localization to cell periphery (GO:1990778),0.44560680640653877,1.1355508672108023,0.24064711830131447,0.7169462610501481,1.0,40/133,19.95%,MRAP;FYB1;RAB8B;RAB34;MYO5A;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;PDZD11;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;RAB29;ROCK2;FCHO2;INPP5K;P2RY1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.46053533698494764,1.1350448333719407,0.2921589688506982,0.7178827372014234,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;CLN3;AKAP5;STAC;ATP2C1;PRKCH;STX3;STAC3;ARF6;LRP1
prerank,protein kinase B signaling (GO:0043491),0.5150708332382238,1.1349301525586182,0.3495630461922597,0.7176944664672104,1.0,9/23,24.65%,TGFB1;TNF;CCL2;GAS6;PTEN;ZFP36L1;MT3;IGF1;KDR
prerank,organophosphate biosynthetic process (GO:0090407),-0.30654402554347354,-1.1342963692305468,0.22413793103448276,0.8623619646617089,1.0,12/37,20.85%,PPIP5K2;IP6K1;AGPAT4;GK5;AGPAT3;AGPAT5;IP6K2;GPHN;MBOAT1;ITPKC;IPMK;NFS1
prerank,glucose metabolic process (GO:0006006),0.46450485822569915,1.133762743436431,0.31045406546990495,0.7204501946456163,1.0,14/58,17.26%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;ENO3;TFAP2B;PPARGC1A;LRP5;GPI;GAPDHS;PGAM1;GALM;PPARD
prerank,membrane protein proteolysis (GO:0033619),0.4842202755543366,1.1336832164251487,0.30101465614430667,0.7201815371473733,1.0,9/37,14.82%,TGFB1;NAPSA;MYH9;PRKCQ;SPPL3;PARL;NFKB1;ERAP1;SPPL2A
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5091845208091933,1.1329814114739798,0.326007326007326,0.7216233747424405,1.0,6/27,8.09%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4710864176807268,1.1329671679242903,0.32751091703056767,0.7211462527383015,1.0,10/47,14.70%,TGFB1;EDNRB;WDR91;APOE;FOXO3;INHBA;CYFIP1;PCIF1;NFKB1;PUM3
prerank,regulation of glycogen metabolic process (GO:0070873),0.5576235085937067,1.132885107366469,0.3555858310626703,0.7208574631655061,1.0,1/12,1.62%,PPP1R3E
prerank,respiratory chain complex IV assembly (GO:0008535),-0.35651681613590824,-1.1328176013057678,0.25396825396825395,0.8623748969486854,1.0,13/21,30.05%,COX16;OXA1L;COX18;COX15;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;COX10;SURF1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4569640752954338,1.1324099378665713,0.3012684989429176,0.7216884770527222,1.0,9/60,8.87%,SMOC2;PTGES3;PKIB;RGCC;PRKD2;XRCC5;CTNNB1;PRKCQ;CCT8
prerank,lung epithelium development (GO:0060428),0.588375276953938,1.1323022250384005,0.35444947209653094,0.7214703461734547,1.0,1/10,0.60%,ASCL1
prerank,regulation of amyloid-beta formation (GO:1902003),0.47787726558319865,1.1315005872660835,0.3249714937286203,0.7231590141452386,1.0,18/34,25.48%,GSAP;TNF;ABCG1;APOE;SORL1;RTN1;GSK3A;RTN4;EPHA4;BIN1;PICALM;ROCK2;ABCA2;PIN1;EFNA1;IGF1;IFNGR1;GGA3
prerank,protein deneddylation (GO:0000338),0.5759675066415095,1.131462387309167,0.3377777777777778,0.7227551832093833,1.0,3/10,13.52%,COPS6;COPS4;TOR1A
prerank,response to ethanol (GO:0045471),0.5513404544839399,1.1314511330881414,0.33557046979865773,0.7222828729152304,1.0,2/14,2.97%,ADCY7;SDF4
prerank,purine ribonucleotide transport (GO:0015868),0.5372280832047002,1.1314160988856328,0.3346883468834688,0.7218759112154074,1.0,2/16,2.47%,ABCC6;LRRC8D
prerank,negative regulation of peptidase activity (GO:0010466),-0.29581095257742496,-1.1313259611175712,0.2222222222222222,0.8627164613029406,1.0,12/47,18.09%,SERPINH1;SERPINE2;SERPING1;TIMP2;SPOCK2;TIMP3;SERPINB9;SERPINF1;ECM1;AKT1;GAPDH;PARK7
prerank,glutamate metabolic process (GO:0006536),0.5170943057228553,1.130751028329697,0.34047919293820933,0.7233017148450019,1.0,2/19,2.77%,DGLUCY;MTHFS
prerank,regulation of protein dephosphorylation (GO:0035304),0.4809157480930165,1.1306913000073044,0.3370288248337029,0.7229563336964269,1.0,18/37,26.62%,TGFB1;PRKCD;PPP6R1;YWHAB;ENSA;SPPL3;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;PPP1R16B;CAMTA1;PPIA;HTT;MFHAS1;TIPRL;TSC1
prerank,regulation of microtubule-based process (GO:0032886),-0.31980065413015435,-1.130075622135121,0.2231404958677686,0.8618885115580895,1.0,11/36,14.99%,EFNA5;PHLDB2;CYLD;EPHA3;PHLDB1;ROCK1;MAP6;MAPT;TPPP;MARK4;TRIM36
prerank,proteoglycan metabolic process (GO:0006029),0.5001609972480031,1.1299393276413887,0.3364817001180638,0.724557254386818,1.0,5/26,12.61%,HPSE;SULF2;HS3ST4;XYLT1;B4GALT7
prerank,cellular response to reactive oxygen species (GO:0034614),0.46405179245114675,1.1297641925948503,0.31023454157782515,0.7245268340160503,1.0,12/59,13.08%,NFE2L2;SIRPA;AQP1;PRKCD;PKD2;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6;PRDX3;CAMKK2
prerank,striated muscle contraction (GO:0006941),0.468906214810001,1.1297261222061084,0.29014989293361887,0.7241211584896423,1.0,10/53,15.11%,SCN4B;MYL3;SLC8A1;TTN;STAC;TNNT3;DTNA;STAC3;ARHGEF11;RCSD1
prerank,negative regulation of nuclear division (GO:0051784),0.5604749532091478,1.1296696286978694,0.33676470588235297,0.7237826115783718,1.0,2/11,4.03%,NME6;AURKAIP1
prerank,amino acid transmembrane transport (GO:0003333),0.47632610385602125,1.1288038736655734,0.31135135135135134,0.7257353765392583,1.0,10/45,13.28%,LRRC8D;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC25A18;SLC38A10
prerank,positive regulation of lipid metabolic process (GO:0045834),0.49826984905860877,1.1287835485639028,0.336144578313253,0.7252882533136785,1.0,4/22,4.14%,MTOR;MLXIPL;ANGPTL3;APOE
prerank,endodermal cell differentiation (GO:0035987),0.48959296236973704,1.1287817968957612,0.340522133938706,0.7247874730338558,1.0,6/31,10.55%,ITGB2;ITGA4;ITGB5;LEO1;SETD2;INHBA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5029288668608258,1.128752284180649,0.32689987937273823,0.7243694686733401,1.0,9/28,16.66%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;PID1;GSK3A;APPL2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4008099089505902,-1.1287234903007684,0.29767441860465116,0.861682217294712,1.0,5/15,19.88%,RSPO3;NPHP3;GPC3;WNT5B;SPEF1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5118859216776989,1.1286753076566343,0.3316892725030826,0.7240790004415143,1.0,2/22,3.44%,GPNMB;RAP2A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5345657686532826,1.1281107178695535,0.3541114058355438,0.7251459707994724,1.0,3/15,15.56%,DDC;SMOX;PAOX
prerank,positive regulation of heart contraction (GO:0045823),-0.3653888415428681,-1.1277448239887835,0.271356783919598,0.860188704362487,1.0,8/19,29.71%,RYR2;ATP1A2;EDN1;EDN3;TGFB2;CHGA;ATP2A2;SCN3B
prerank,limb development (GO:0060173),-0.3393612737021992,-1.1276675843702235,0.2684563758389262,0.8558473199030828,1.0,13/28,26.28%,PCSK5;KREMEN1;SALL1;GLI3;MAP3K20;RSPO2;PTCH1;FGF10;KAT2B;LRP4;IFT122;SMOC1;KAT2A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.43159760592401386,1.1272671876158349,0.057,0.7269621502169953,1.0,145/834,13.98%,RUNX1;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;NFATC1;MED17;RREB1;TLR2;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;SPI1;IL18;FIZ1;HDAC5;GALR1;HMGB1;RNF111;TEAD1;MRTFA;CTNNB1;TFEB;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MYOCD;AGRN;LEO1;YY1;TCF20;SLC9A1;CEBPB;ASXL2;ST18;LMO2;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;SMAD3;AKIRIN1;IRF2;HSF1;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;RNF10;NFIC;ATAD2;TBL1X;INHBA;ACTR3;RNASEL;TXK;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;ELL;CREB1;LAGE3;IKBKG;ZFP64;KAT7;SMARCD3;NR4A1;MAX;SMARCB1;GPS2;NFKB1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF
prerank,glycerolipid metabolic process (GO:0046486),0.5714106821300353,1.1266198676474066,0.3630862329803328,0.7282491196447075,1.0,2/11,8.19%,DGKZ;DGKG
prerank,positive regulation of protein import (GO:1904591),0.49761166056319023,1.126538762605133,0.352803738317757,0.7279709889321923,1.0,5/30,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5294224406635885,1.1264437599204717,0.352258064516129,0.7277643192125168,1.0,10/19,20.78%,SREBF2;CSNK2A2;HDAC6;CAMKK2;SREBF1;VDAC1;GSK3A;DNM1L;ATP13A2;PRKN
prerank,anion transport (GO:0006820),0.48872763155928656,1.125808219677753,0.33102652825836215,0.729021065125391,1.0,8/33,17.03%,TSPO;SLCO2B1;LRRC8D;VDAC2;VDAC1;SLCO1B1;LRRC8C;SLC13A3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.564498857186826,1.1253116586209866,0.36541143654114366,0.7299382212454102,1.0,1/13,1.91%,CYRIB
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4394388709613494,1.1251907076637335,0.2593340060544904,0.7297944531207329,1.0,33/124,17.93%,ARRB2;PLCB2;FZD10;NFATC1;FZD9;FZD3;CTNNB1;PSMB10;TNRC6A;AP2S1;MOV10;DAAM1;AGO4;PSMA2;PFN1;CLTC;NLK;AGO3;PSME3;PSMB5;PSMD8;GNG2;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;FZD8;PPP3CB;RHOA;PSMD2;AGO2;CDC42
prerank,cellular response to amino acid starvation (GO:0034198),0.45663653523788283,1.1251890648913516,0.3076923076923077,0.7292936577495458,1.0,22/71,19.42%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5435839913731406,1.1249792771213214,0.353494623655914,0.7293566472146911,1.0,2/16,4.10%,SHH;PKD2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4304713499755644,1.1249440644137627,0.034,0.7289509843283418,1.0,199/1082,14.68%,CD86;RUNX1;NFE2;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;PCID2;CD74;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;TLR2;MTOR;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;YAF2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;APOE;UBE2V1;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;CXXC1;SPP1;SPI1;IL18;FIZ1;NDP;HIVEP3;HDAC5;GALR1;HMGB1;RNF111;FLI1;TEAD1;MRTFA;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;AGRN;YY1;TCF20;SLC9A1;PIM2;ZFP90;EPO;CEBPB;ASXL2;ST18;LMO2;CHEK2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;BICRA;SMAD3;MMS19;AKIRIN1;ARID1A;IRF2;HSF1;MDFIC;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;ATF7IP;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;ARID1B;RNF10;DDX39B;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;ACTR3;TRIM56;RNASEL;MAP2K2;CREB3L2;TXK;ELF2;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;MAP3K12;ELL;HEATR1;CREB1;LAGE3;IKBKG;ZFP64;KAT7;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;GPS2;NFKB1;FOXK1;GPATCH3;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;SOX2;BRD7;HNRNPD;ELOF1;ARHGEF11;LBH;SOX4;SREBF1;MEIS1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5644260306140411,1.1244688558262297,0.3553008595988539,0.7297631686928823,1.0,5/11,15.93%,PCBP3;ZNF445;PCBP1;IGF2BP3;RASA1
prerank,I-kappaB phosphorylation (GO:0007252),0.5713696707603958,1.1243492145910925,0.3668555240793201,0.729576901110185,1.0,2/10,2.91%,TLR2;TLR7
prerank,negative regulation of signal transduction (GO:0009968),0.434030710611036,1.1242411040040023,0.208,0.7293626369229792,1.0,30/249,9.43%,PTPRC;SLAMF1;LYN;UBASH3B;PLEK;CX3CR1;LGMN;NFATC1;PRKCD;PTPRJ;PTPN1;PIK3CB;PTPN18;TNF;SNCA;PTPRE;PIP4K2A;MGRN1;TNFAIP3;XDH;PRKCB;YWHAB;CREB3L1;PRKCQ;CSNK2A2;CSNK2A1;RB1;SULF2;PDCD6;QARS1
prerank,regulation of organelle assembly (GO:1902115),0.45094115149325,1.1237987398668257,0.31974921630094044,0.7300945088628719,1.0,27/73,19.79%,HCK;TBC1D10C;TBC1D16;TBC1D22A;USP6NL;PLK2;MTMR3;TBC1D10A;CEP76;VPS11;RNF4;RAB1B;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;ATXN2L;TBC1D14;TBC1D22B;PDCD6IP;ATG3;RABEP2;DYNC2LI1;TBC1D12;TBC1D5;TRAPPC12;SENP6
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5662676661516013,1.1230789288197816,0.3561253561253561,0.7315765866689552,1.0,4/11,14.39%,ZMIZ2;ARID1A;ARID1B;ELOF1
prerank,epithelium development (GO:0060429),0.4461052403354009,1.1225699266172073,0.2901921132457027,0.7325173914334492,1.0,7/107,5.05%,LGALS3;MEOX1;SHH;TGFB1;CTSB;PKD2;DMBT1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4842625981363902,1.1225381740163767,0.3344594594594595,0.7321002373856863,1.0,11/36,19.92%,CCR2;TAF1;HFE;NRP1;HDAC6;CCL2;BUD31;HIF1A;GREM1;ITGB1;RELN
prerank,melanosome organization (GO:0032438),0.4948785978648496,1.1221034143319073,0.3545347467608952,0.7327873889646228,1.0,5/26,13.34%,LYST;RAB32;AP3D1;DTNBP1;TRAPPC6A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.47717119521147267,1.1220070098166741,0.32662192393736017,0.7325598444630591,1.0,18/42,22.57%,VARS1;FARSB;GARS1;PPA2;RARS1;EPRS1;QARS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;AIMP1;TARS1;YARS1;SARS2;SARS1
prerank,synaptic vesicle endocytosis (GO:0048488),0.47796503256134876,1.1219815460527647,0.35494880546075086,0.7321252436490004,1.0,10/33,14.65%,SNCA;PIP5K1C;CEL;DNM2;SYT2;STON2;ITSN1;STON1;SYNJ1;GAK
prerank,alanine transport (GO:0032328),0.5846285800739979,1.121850458268063,0.3739130434782609,0.7319708190613281,1.0,3/10,15.11%,SLC36A1;SLC36A4;SLC1A4
prerank,regulation of cytoplasmic transport (GO:1903649),0.5789063766979481,1.1214310262592009,0.3713892709766162,0.7326091427186787,1.0,5/11,15.27%,DNAJC13;MAP2K2;USP7;LRRK2;SRC
prerank,sphingolipid metabolic process (GO:0006665),0.44493706250112386,1.120701998210042,0.281947261663286,0.7340961087027342,1.0,33/108,21.46%,HEXB;CERS6;SGPL1;CTSA;GM2A;PSAP;CLN8;PRKD2;HEXA;SMPD3;CERK;CSNK1G2;HACD4;AGK;B3GALNT1;ACER3;VAPB;ORMDL2;PPP2CA;ARSA;SUMF2;NSMAF;ARV1;DEGS1;ASAH1;SGMS1;B4GALNT1;GBA2;SPTSSA;SMPD1;SPTSSB;ABCA2;SUMF1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4158250530425768,-1.1204228684716497,0.3044982698961938,0.8745677971579506,1.0,7/13,23.42%,NOS3;GLUL;NOS1;GAD1;GLS;GLS2;ALDH4A1
prerank,protein localization to plasma membrane (GO:0072659),0.4396750318731308,1.120355359358736,0.2696969696969697,0.7345785804702635,1.0,37/129,19.95%,MRAP;FYB1;RAB8B;RAB34;MYO5A;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;ROCK2;FCHO2;INPP5K;P2RY1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.39980927986855364,-1.12031897589227,0.30991735537190085,0.8703442731702946,1.0,4/15,7.60%,ATF2;RAD17;TIPIN;MRE11
prerank,DNA replication initiation (GO:0006270),0.474566661586133,1.120110959803042,0.34615384615384615,0.7347465500526988,1.0,10/37,16.90%,MCM5;ORC3;MCM6;MCM2;DBF4;ORC4;CDC34;CDC6;NOC3L;LRWD1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5695091013047218,1.1200855815461415,0.36429608127721336,0.7343178374284113,1.0,1/10,1.10%,RIN2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4720465188528588,1.1200125431120147,0.3506787330316742,0.7340044421765487,1.0,8/39,13.41%,NFE2L2;ITGA4;TNF;RGCC;TNFAIP3;THBS1;CCL2;GAS6
prerank,transcription preinitiation complex assembly (GO:0070897),0.5579797961617435,1.119817286289001,0.3787878787878788,0.734052912570941,1.0,5/12,18.83%,POLR1E;TAF1;BDP1;GTF2B;TAF11
prerank,ion transport (GO:0006811),0.44431470402361223,1.1197894138451379,0.2907801418439716,0.7336388243606462,1.0,21/111,14.90%,P2RX1;TSPO;SLC15A3;HCN4;SLC9A4;KCNN4;SLC8A1;SLC36A1;SLC9A9;CNGB1;WNK1;SLC9A1;AQP11;SLC8B1;SLC20A2;SLC25A18;CTNS;WNK4;SLC9A8;VDAC2;VDAC1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4540662621328403,1.119577615489871,0.3215767634854772,0.7337174984766524,1.0,17/66,16.66%,GPNMB;CCND3;RGCC;PKD2;CCND2;ANXA1;AIF1;KIF14;RB1;LSM11;CCL2;CDK6;PSME3;INO80;BRD7;PTEN;APPL2
prerank,negative regulation of defense response (GO:0031348),0.44151244700596365,1.1195060823001448,0.3237113402061856,0.7334276917869978,1.0,9/77,5.09%,SIRPA;METRNL;PRKCD;NLRC3;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3
prerank,regulation of cellular catabolic process (GO:0031329),0.4517650264519253,1.1191563523786667,0.32948583420776495,0.7338947442401749,1.0,21/62,21.78%,DRAM2;WDR91;PSAP;GPR137B;PIP4K2A;DDIT3;DCAF12;ABCD1;MTMR3;RAB39B;HDAC6;VPS29;LRRK2;KEAP1;RPTOR;HSPB1;OSBPL7;PRKN;RRAGA;SCARB2;RRAGB
prerank,ceramide transport (GO:0035627),0.5534238274215864,1.1191543434412075,0.3472222222222222,0.7334031601238334,1.0,2/12,6.00%,PSAP;ABCB4
prerank,regulation of protein import into nucleus (GO:0042306),0.4802695969921297,1.1184441882618243,0.34467120181405897,0.7349042283496262,1.0,6/36,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;MDFIC;TPR
prerank,cation transmembrane transport (GO:0098655),0.46607559731395787,1.118332384092142,0.34517203107658156,0.7347180744116558,1.0,6/44,10.22%,KCNJ11;SLC25A20;SLC7A8;PKD2;SLC25A38;SLC36A4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.36898883244662084,-1.1182693857767827,0.27802690582959644,0.8720642984339702,1.0,6/19,9.80%,APP;MAPK8;MTPN;KLF2;CHRNA7;KLF4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5276255997962326,1.1182108800965274,0.34509803921568627,0.7345252201376026,1.0,3/17,11.19%,GMFG;WASF2;CYFIP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4476030188631026,1.1181879931007304,0.33194154488517746,0.7341019415293666,1.0,15/72,13.44%,TREM2;CORO1A;CYRIB;PRKCD;FGF13;SNCA;ATXN7;APOE;ARFGEF1;MAPRE1;PFN2;PFN1;IAPP;TWF2;SSH2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4885528020847474,1.11782152985621,0.3624856156501726,0.734604132769891,1.0,5/30,13.12%,LPAR6;GPR17;F11R;ADGRG1;ARHGEF3
prerank,organonitrogen compound catabolic process (GO:1901565),0.45209718960995143,1.1177843985100449,0.3315508021390374,0.7342202324143434,1.0,15/57,17.55%,SGPL1;NPL;MTOR;CLN8;RENBP;NAGK;PLA2G7;LIPC;TXN2;NAALADL1;TRIM24;ERAP1;CAPN3;IDE;USE1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45438337215696784,1.1177523442637622,0.32085561497326204,0.7338084214282715,1.0,10/56,9.82%,ESPL1;CCND3;RGCC;CDC23;CCND2;ANXA1;AIF1;RB1;LSM11;RAB11A
prerank,negative regulation of protein modification process (GO:0031400),0.4492762210216668,1.1172098924392633,0.32502596053997923,0.7347962476699899,1.0,24/79,20.78%,LYN;TGFB1;SIRPA;DBI;NIBAN1;CRTAP;XDH;YWHAB;ENSA;IBTK;IMPACT;CDYL;PID1;LRRK2;PTPA;PTEN;CORO1C;PAQR3;ATG14;TINF2;INPP5K;FXYD1;GSK3B;PRKN
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4409840614254487,1.117054805943962,0.2777212614445575,0.7347426205838341,1.0,46/110,25.69%,RPL23;RPL17;RPL10A;PNRC2;RPS2;RPL18A;RPS15A;GSPT1;CASC3;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;RPS11;RPL11;SMG7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;EIF3E;RPLP1;RPS15;RPS5;RPL41;RPL10;NCBP1;RPS8;RPL5;RPL18
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4505842890406726,1.1165015702050873,0.33581296493092455,0.7357423211189392,1.0,20/52,25.39%,EDEM1;ERN1;DNAJC3;CXXC1;ATP6V0D1;VAPB;EXTL3;PARP16;TLN1;TATDN2;WFS1;GSK3A;ADD1;SEC31A;HYOU1;DDX11;PPP2R5B;PDIA6;EXTL2;XBP1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4985434915648816,1.116443626846512,0.35826296743063935,0.7353900682155149,1.0,6/23,11.48%,TSPAN6;NLRC3;SPI1;ADGRG3;TMSB4X;ADIPOR1
prerank,inner dynein arm assembly (GO:0036159),-0.44365832810155525,-1.1163459494582846,0.33881578947368424,0.8736705862024275,1.0,9/11,52.94%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,retinoid metabolic process (GO:0001523),0.4487873876858024,1.1162463530512123,0.32053941908713696,0.7354073309140067,1.0,10/71,15.03%,CYP1A1;LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;RETSAT;LRP1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.43685559755148184,1.1159970007577769,0.2661290322580645,0.7355841036814041,1.0,48/153,21.32%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;ERN1;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;PRKCQ;CSNK2A2;CSNK2A1;SMG1;PRKCH;STK32C;MAP2K2;PKN1;RPS6KA4;NLK;CSNK1A1;MAP3K12;GAS6;LRRK2;SGK3;RPS6KA2;STK4;RPS6KA5;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5562954418706657,1.115988545639455,0.35825105782792666,0.7351105120275504,1.0,6/12,19.31%,ACTB;ZDHHC7;ACTG1;AHI1;LAMA3;SCRIB
prerank,epithelial cell differentiation (GO:0030855),0.44609823702678575,1.1159057446006369,0.3221202854230377,0.7348472240991171,1.0,9/88,9.80%,LGALS3;ASCL1;CTSB;BASP1;DMBT1;ANXA1;ZDHHC7;TDRD7;ANXA4
prerank,regulation of protein localization to membrane (GO:1905475),-0.3392943308292185,-1.1158120777661886,0.2981366459627329,0.8708801278152143,1.0,6/28,4.10%,SPTBN1;GPC6;GPC5;GSN;MMP14;AR
prerank,regulation of gene expression (GO:0010468),0.4265451723292511,1.1157354610004018,0.042,0.7348179382467526,1.0,175/903,16.43%,PTPRC;RUNX1;LILRB1;TREM2;PF4;LYN;CALCR;ASCL1;SHH;ITGAX;SLC11A1;TGFB1;CD3E;HCLS1;STAP1;LGMN;CD74;CAVIN4;NFE2L2;IL1A;SIRPA;VSIR;PIK3CD;RPL23;RBM38;HAVCR2;PLCG2;TGFBR1;RREB1;TLR2;P2RX7;MTOR;NSD1;MLXIPL;PIK3CB;MAPK14;MSR1;SLC8A1;PRDM12;YAF2;TRIM5;TNF;RGCC;APOE;UBE2V1;ZNF326;MITF;TTN;PDCL3;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;TRAF3;WWC2;XDH;ZUP1;HDAC5;TAF1;BACH1;BTN3A3;CHD7;SBNO1;TFEB;CDK11B;AIF1;TYROBP;DNM2;CCAR1;TP53;NKX2-1;TNRC6A;YY1;CREB3L1;NFKBID;GCFC2;TICAM1;CEBPB;HINT1;FOXN2;HFE;TGFBRAP1;CHEK2;GRSF1;PRKCQ;MEF2C;FLCN;MOV10;RB1;METTL4;TRIM27;LARP1;SMAD3;RC3H1;GTF2IRD1;IRF2;PPARGC1A;TDRD7;PCBP3;PUM2;ATRX;AGO4;RPL6;NOS1AP;ACTG1;HNRNPL;HDAC4;NFX1;SON;INHBA;MAP2K2;TXK;HCFC2;ZSCAN26;LIMS1;DTNBP1;SOX9;NELL1;RPS6KA4;HDAC6;NLK;AFF1;DENND4A;NR2C2;PTBP2;AGO3;ZNF628;GZF1;VSTM2A;TRA2B;PRX;MTF2;PPP2CA;CDK6;BRDT;SEC16B;ZFP64;KAT7;CASP8;COQ7;TIPARP;BRAF;FOXN3;FAM50A;GAS6;NFKB1;MEGF8;SOX6;HCFC1;PCBP1;ZFHX3;PID1;SOX2;HNRNPD;RO60;SOX4;IGF2BP3;ZBTB11;C1D;ICOSLG;SPTY2D1;TLE5;REXO4;GSK3A;AHNAK2;OGG1;CD36;RBPJ;FADS1;ZBTB7B;HIF1A;RPL11;SBNO2
prerank,mRNA destabilization (GO:0061157),0.4780022792643234,1.1156714156206282,0.3690078037904125,0.7344835698604916,1.0,15/38,22.43%,PLEKHN1;YTHDF3;RC3H2;ZC3H12D;MOV10;RC3H1;CPEB3;METTL3;MEX3D;TUT7;ROCK2;FTO;DIS3L2;ZFP36L1;CNOT1
prerank,negative regulation of myotube differentiation (GO:0010832),0.5683739559465102,1.1156405531090299,0.38285714285714284,0.7340780677016129,1.0,3/12,9.96%,BHLHE41;HDAC5;HDAC4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.32694298079872275,-1.1155853758990866,0.296551724137931,0.867173513254099,1.0,10/29,17.36%,RAB6A;GOSR1;COG2;COPZ2;TRAPPC3;COG1;RAB6B;COPB1;VTI1B;COPG2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4789363050182803,1.115382216832639,0.37133182844243795,0.7342784073572277,1.0,7/34,11.24%,CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4418819540538717,1.1152008659843264,0.3278520041109969,0.7342653915296153,1.0,7/75,6.60%,KLK3;PF4;CCR2;ANGPT4;RGCC;CTNNB1;STAB1
prerank,negative regulation of macroautophagy (GO:0016242),-0.34122541389502914,-1.115165199913729,0.29936305732484075,0.8639814453724873,1.0,16/26,23.76%,MTM1;FEZ1;NRBP2;TMEM39A;LZTS1;PINK1;CHMP4B;CHMP4A;AKT1;NUPR1;CLEC16A;PHF23;USP36;SMCR8;FEZ2;UBQLN4
prerank,nucleosome organization (GO:0034728),0.44893965269923736,1.1146427369886667,0.35654008438818563,0.7353150506948017,1.0,13/55,15.28%,NFE2;BPTF;SRCAP;ARID1A;ATRX;SETD2;NAP1L1;SOX9;BRDT;SMARCD3;SMARCB1;INO80;SPTY2D1
prerank,Golgi organization (GO:0007030),0.4361815713063649,1.1145451079318613,0.30253807106598984,0.735085124308314,1.0,36/112,20.57%,PLEKHM2;SPTBN5;ATP8B4;LMAN1L;TMED3;PI4K2A;ARFGEF1;SYNE1;USP6NL;VMP1;ARHGAP21;SEC16A;CSNK1A1;PI4K2B;SEC16B;STX5;HUWE1;TRAPPC11;VTI1A;LRRK2;GAK;LMAN2;CDC42;VRK1;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;RAB29;OPTN;ATL3;TRAPPC12;SEC22B;NSFL1C;COG7
prerank,regulation of biomineral tissue development (GO:0070167),0.4970537558603823,1.1145033180615196,0.3632075471698113,0.7347169349705022,1.0,5/26,13.41%,TGFB1;BMP2K;CEBPB;SOX9;GAS6
prerank,establishment of spindle orientation (GO:0051294),-0.3237473826031445,-1.1142495022317485,0.3227848101265823,0.8624415777328447,1.0,6/28,11.09%,PAFAH1B1;MAP4;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.30355625247963797,-1.1137720777675948,0.28735632183908044,0.8596974248751267,1.0,8/38,10.54%,ANK2;KCNN2;FHL1;KIF5B;ACTN2;GABBR2;DLG1;KCNJ3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.33136119012831644,-1.1136867780320276,0.27702702702702703,0.8556342539415315,1.0,4/26,4.70%,ANK2;FHL1;ATP1B1;ACTN2
prerank,cardiac cell development (GO:0055006),0.5598034689635323,1.1134673356953502,0.3588652482269504,0.7369727835365367,1.0,2/11,4.28%,SLC8A1;TTN
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5516577793025691,1.1134629389784994,0.359504132231405,0.7364942117723946,1.0,2/11,4.62%,FBL;TENT4B
prerank,regulation of protein phosphorylation (GO:0001932),0.4320125885103048,1.1132672777658246,0.22622622622622623,0.7365605520577996,1.0,56/256,18.59%,TREM2;GPNMB;FGR;LYN;TGFB1;ITGB2;CD74;SIRPA;FNIP2;ITGB3;CSF1R;NIBAN1;NSD1;RAP2A;SEMA4D;CCND3;TNF;FNIP1;TTN;PDCL3;ATF3;PLXNB2;BRAT1;XDH;CCND2;VEGFB;TNIK;CEBPB;FLCN;IBTK;IMPACT;SOX9;PHIP;FYN;PPP2CA;PPIL4;CAMKK2;NPTN;GAS6;MOB1B;PID1;LRRK2;AKAP8L;WDFY2;IRGM;PTEN;HSP90AA1;STK4;PECAM1;CORO1C;SPTBN4;FLOT1;PAQR3;ANGPT1;PPP2R5C;VEGFD
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.27222874200629416,-1.1130363047210192,0.24561403508771928,0.8533041751561036,1.0,28/57,26.66%,DLG2;APP;DLGAP1;NLGN1;GRIA3;GRIA2;DLGAP2;ACTN2;NEFL;GRIN2B;DLG1;SHANK1;PRRT1;GRIN1;CACNG8;CAMK2A;OPRM1;DLG3;SHISA9;GSG1L;DLGAP3;SHISA7;GRIA4;CAMK2B;CACNG2;LRRC7;NPTX1;NPTXR
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.540741107250863,1.1129313492724544,0.37642045454545453,0.736974357933088,1.0,4/13,8.99%,CNOT8;GTPBP1;MOV10;RC3H1
prerank,regulation of monooxygenase activity (GO:0032768),0.5048045326644454,1.112821240498714,0.3557692307692308,0.7367811648756251,1.0,10/23,20.68%,IL1A;SNCA;DNM2;NOS1AP;SPR;DDAH1;POR;HSP90AA1;GDNF;ZDHHC21
prerank,response to estradiol (GO:0032355),0.4793919046710524,1.1126796115249227,0.3480278422273782,0.7366668032189363,1.0,5/31,11.82%,TGFB1;CTNNB1;ANXA1;STAT5B;NRIP1
prerank,positive regulation of nervous system process (GO:0031646),0.5194898412491038,1.1126551385870371,0.3713188220230474,0.7362412401955151,1.0,4/18,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,cardiac muscle contraction (GO:0060048),0.4777375284065243,1.1125579195576218,0.35051546391752575,0.7360127577385875,1.0,4/34,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4469370525983313,1.1125115063344218,0.33298647242455776,0.7356441113433407,1.0,16/73,13.66%,LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;APAF1;CFLAR;CRADD;SMAD3;DAP;CASP8;ATP2A3;TRADD
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4404263106185141,1.1124291699148054,0.30879345603271985,0.7353543200222362,1.0,26/88,16.83%,MYO5A;RABEP1;AP1S3;EXOC6;CCDC93;RAB14;RP2;DNM2;VPS35L;CLINT1;AP1B1;FTL;ARFGEF2;DTNBP1;CLTC;EXOC8;EXOC1;SORL1;EXOC2;SNAP23;EXOC5;FTH1;SCAMP2;EPS15;TXNDC5;MON2
prerank,regulation of microtubule nucleation (GO:0010968),-0.46422483893529576,-1.112427866165792,0.3474025974025974,0.850896414240812,1.0,2/10,4.47%,EML2;PAK1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4437919119428792,1.111624073124753,0.31237322515212984,0.7369845898829143,1.0,20/90,16.91%,IRF4;SYK;CCR2;FABP4;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,regulation of cell population proliferation (GO:0042127),0.42514161816619583,1.1115639687691259,0.112,0.7366623083029075,1.0,110/691,14.77%,CD86;RUNX1;PTK2B;SLAMF1;GPNMB;PF4;LYN;SHH;HCK;ITGAX;TGFB1;CXCL5;HCLS1;FLT3;TMIGD3;LGMN;STAT5A;IL1A;TSPO;CBFA2T3;RPL23;CSF1R;TGFBR1;PTPRJ;TCIRG1;SLURP1;MLXIPL;S100B;TNFRSF11A;ADAMTS8;NUP62;OSM;UTP20;NCK2;IL12RB2;RGCC;PKD2;SKI;IL6R;CNOT8;CEBPA;ATP8A2;TIMP1;CCND2;XRCC5;SPEG;CTNNB1;AIF1;GAB2;CCAR1;TGFBR2;TP53;RPS15A;MYOCD;CCKBR;PIM2;STAT4;EPO;ST18;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;PODN;NTF3;HSF1;CCL14;ABI1;STRN;P3H2;ACER3;STAT5B;LRP5;HDAC4;NAP1L1;INHBA;SH2B3;NF2;LIMS1;CHERP;SOX9;THBS1;PTPRU;AGO3;PHIP;PRDX3;CIAO1;SDCBP;CDK6;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;ADARB1;PRLR;DDAH1;CDC6;RAB33B;IRF1;FTH1;BRD7;SOX4;MEIS1;TMEM127;PRKRA
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5014020339479941,1.1115340931487798,0.3681710213776722,0.7362595260046695,1.0,9/24,20.53%,PTPRJ;THY1;DUSP3;LIMS1;NRP1;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,limb morphogenesis (GO:0035108),0.5137676116522465,1.1113606508172176,0.36107711138310894,0.7362358276862317,1.0,4/20,13.51%,SHH;SKI;TFAP2B;MEGF8
prerank,regulation of dephosphorylation (GO:0035303),0.5396777908825156,1.1110804797370637,0.36375321336760924,0.7365164295320569,1.0,7/15,26.03%,MTMR3;SRC;SMG7;INPP5K;MTMR9;PPP1R16B;CDK5RAP3
prerank,positive regulation of response to stimulus (GO:0048584),0.4783685565391051,1.1103802947452759,0.3556531284302964,0.7379077260798357,1.0,7/40,15.19%,FCGR2B;PRKCD;DHX9;CD80;YPEL3;B2M;IER5
prerank,positive regulation of cell cycle process (GO:0090068),0.4402810010457148,1.110344778215901,0.3018292682926829,0.7375038294311547,1.0,16/91,13.89%,PCID2;IL1A;NUP62;RGCC;PLK4;KIF14;KIF20B;KIF23;ATRX;LRP5;TPR;DBF4;PHIP;DYNC1H1;CDC6;INO80
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4884854875905691,1.1101632906156609,0.3659976387249115,0.7375227510124995,1.0,4/27,9.11%,SYT17;SDF4;SYT2;SYT10
prerank,regulation of vasculature development (GO:1901342),0.490840015372431,1.1099826568158269,0.3663003663003663,0.7375152299585449,1.0,2/26,6.29%,GPNMB;CTNNB1
prerank,cellular response to purine-containing compound (GO:0071415),0.5718993729343353,1.1099701075664432,0.37010159651669083,0.7370690702611808,1.0,2/10,3.19%,P2RY6;SLC8A1
prerank,visual perception (GO:0007601),0.43890305641835825,1.109774472938288,0.32440782698249226,0.7371396539671371,1.0,13/84,14.21%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;REEP6;RP2;CNGB1;MYO7A;CRYBB1;RPGR;OAT;WFS1
prerank,positive regulation of vacuole organization (GO:0044090),0.5702684907410477,1.109715651042735,0.37202380952380953,0.7367964121770764,1.0,3/10,11.64%,PIP4K2A;RAB3GAP2;GRN
prerank,long-chain fatty acid transport (GO:0015909),0.4739243775954117,1.1097064286588436,0.3704994192799071,0.7363360710286203,1.0,9/30,17.99%,FABP4;SLC25A20;APOE;ABCD1;FABP5;ACACA;CD36;CPT2;ABCD2
prerank,BMP signaling pathway (GO:0030509),-0.2660302666144867,-1.109354447220578,0.20408163265306123,0.8560924321625787,1.0,15/62,14.77%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1;RGMB;SMAD6;TGFB3
prerank,intracellular lipid transport (GO:0032365),0.5090125015004491,1.109330716154,0.35294117647058826,0.7369106542114209,1.0,7/21,17.99%,SLC25A20;NPC2;ABCD1;ARV1;ACACA;CPT2;ABCD2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2552097251088373,-1.1092661799314623,0.1935483870967742,0.8521661631243234,1.0,21/84,15.79%,RBFOX2;FXR2;YTHDC1;DAZAP1;MBNL2;RBFOX3;REST;NUP98;U2AF2;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;METTL16;QKI;HNRNPU;SNW1;KHDRBS2;PUF60;LARP7
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.44355870425114674,1.107826774270819,0.32849740932642485,0.740465967128416,1.0,16/74,13.31%,TGFB1;TGFBR1;MAD2L2;MTOR;MDK;RGCC;CTNNB1;TGFBR2;NKX2-1;SNAI1;SMAD3;ADIPOR1;SDCBP;PPP2CA;BAMBI;VASN
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4980383854327551,1.107723821596424,0.36757425742574257,0.7402583127533592,1.0,7/24,14.53%,CREB3;HERPUD1;BCL2L1;CREB3L1;AQP11;WFS1;LRRK2
prerank,oligodendrocyte differentiation (GO:0048709),0.507341938858008,1.1070195607586715,0.3478818998716303,0.7417125455955598,1.0,4/19,13.61%,SHH;EIF2B2;SOX9;SOX6
prerank,renal filtration (GO:0097205),0.5720293313946011,1.1066739678755309,0.3965014577259475,0.7421514498013339,1.0,2/10,8.85%,MYO1E;SULF2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4418376934478883,1.10663780477046,0.31392931392931395,0.7417587161491993,1.0,17/76,16.50%,BAG2;CBFA2T3;LAPTM5;RNF180;RNF19B;CEBPA;TAF1;HECTD1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;SMURF1;PTEN
prerank,neuron projection fasciculation (GO:0106030),-0.4618677805388835,-1.1065827792307976,0.38198757763975155,0.8561340167139843,1.0,3/10,4.78%,SEMA5A;ARHGAP35;EPHB2
prerank,glycogen metabolic process (GO:0005977),-0.33272794198081906,-1.1064891618882549,0.25609756097560976,0.8522372499874425,1.0,11/27,21.94%,PGM1;PHKA2;PYGB;PHKG2;UGP2;PHKB;PYGM;PER2;AGL;PPP1R3C;PHKA1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4528814953643021,1.1061420912967532,0.34303534303534305,0.7426327820953683,1.0,6/64,7.24%,CYP1A1;ALOX12;DAGLB;HPGD;ACADL;ABCD1
prerank,protein localization to cell junction (GO:1902414),-0.35319797779366563,-1.1058086174618924,0.26063829787234044,0.8503081795648624,1.0,6/22,12.45%,NLGN1;TJP1;BSN;SHANK1;JAM3;HEG1
prerank,rRNA metabolic process (GO:0016072),0.4306012373456613,1.1057845889654674,0.28256513026052105,0.7431636321683015,1.0,45/160,21.04%,SLFN14;RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;TRIR;RPL22;IMP4;RPS7
prerank,smooth muscle cell differentiation (GO:0051145),0.557245916759894,1.1054790843288136,0.3853459972862958,0.7435144687931937,1.0,4/12,8.10%,EDNRB;MRTFA;MYOCD;MEF2C
prerank,regulation of lipid kinase activity (GO:0043550),0.5536111862425845,1.1053288165120505,0.38825214899713467,0.7434084567469207,1.0,3/11,12.33%,WDR91;RB1;WDR81
prerank,regulation of receptor binding (GO:1900120),0.5659621701738964,1.1051985376325295,0.3760932944606414,0.7432744132872913,1.0,3/10,13.41%,HFE;B2M;ATP2A3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5121350184997324,1.1043535152963186,0.38254172015404364,0.7450682751734434,1.0,5/19,11.83%,SULT4A1;SLC35B3;BPNT1;PAPSS1;TPST1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5550699871879461,1.1038589087861201,0.3825214899713467,0.7458911973036567,1.0,3/11,8.99%,ANXA1;RC3H2;RC3H1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5470710480896583,1.1037961701425147,0.3788732394366197,0.7455911202347785,1.0,3/11,6.70%,FZD3;BCL2L1;TP53
prerank,secretion (GO:0046903),0.5408843386577307,1.1030841614338842,0.3813443072702332,0.747062193955302,1.0,1/14,1.60%,TPD52
prerank,regulation of p38MAPK cascade (GO:1900744),0.4717423878298104,1.1029014523827507,0.3690078037904125,0.7470625834589717,1.0,6/35,10.77%,TREM2;SPI1;XDH;GADD45B;DUSP10;RELL1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5519716348137074,1.1027164561598206,0.36666666666666664,0.7470823472219219,1.0,3/10,14.53%,NFE2L2;GPR37;LRRK2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4399440170874784,1.1022818284255482,0.3523908523908524,0.7477510506438377,1.0,13/70,13.66%,TGFB1;P2RX7;TNF;TRAF2;IL6R;BCL2L1;CRADD;SMAD3;BAK1;INHBA;TNFRSF1B;CASP8;TRADD
prerank,negative regulation of insulin secretion (GO:0046676),0.5255889493743294,1.1014450344610311,0.3643724696356275,0.7494277269097435,1.0,1/17,0.63%,KCNJ11
prerank,glial cell development (GO:0021782),0.4882451790852478,1.101054863066,0.3657635467980296,0.749994014100919,1.0,7/25,16.02%,NRROS;TLR2;MDK;EIF2B2;CDK6;SOX4;NF1
prerank,protein stabilization (GO:0050821),0.428248075255444,1.100670959566609,0.28542713567839195,0.7505435718572186,1.0,63/168,22.44%,BAG2;RPL23;PRKCD;GNAQ;PTGES3;PDCL3;SEL1L;CRTAP;MORC3;TAF1;OTUD3;TYROBP;PIM2;CHEK2;CCT8;PPARGC1A;CDK7;ATF7IP;PFN2;TBL1X;USP7;PFN1;NLK;GRN;SEC16A;WDR81;CREB1;ATP1B3;STK3;HCFC1;ATP1B2;CCT5;USP9X;WFS1;BAG1;SOX4;PRKRA;RTN4;IRGM;EPHA4;RPL11;PTEN;STXBP4;HSP90AA1;STK4;VHL;CREBL2;FLOT1;TESC;COG7;TELO2;NAA15;PRKN;BAG4;RPS7;CRYAB;PIN1;FLNA;WIZ;CHP1;MT3;MTMR9;MDM4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.4270144080724056,1.1006355680619173,0.3073073073073073,0.7501461377271359,1.0,23/151,10.55%,CERS6;LPIN2;SGPL1;LPCAT1;ESD;AKR1A1;HPGDS;GCNT1;GCH1;PRKD2;APOE;PCYT1A;CHKB;LPCAT2;CSNK1G2;CSNK2A2;CSNK2A1;SLC44A2;HACD4;ACER3;VAPB;STARD10;INHBA
prerank,positive regulation of biomineral tissue development (GO:0070169),0.46001505283636346,1.1004112101646006,0.36281179138321995,0.7502636444446278,1.0,8/40,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;CEBPB;MEF2C;ATP2B1;NELL1
prerank,positive regulation of synaptic transmission (GO:0050806),0.4402248480851223,1.1003945180525276,0.3496868475991649,0.7498283348331837,1.0,12/72,13.49%,PTK2B;CCR2;LGMN;CLSTN1;TNF;AKAP5;PLK2;ZDHHC3;DTNBP1;CCL2;NPTN;ADCY8
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.50703438640161,1.1000540850541063,0.37944162436548223,0.7497796915305251,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.50703438640161,1.1000540850541063,0.37944162436548223,0.7497796915305251,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,glutamate receptor signaling pathway (GO:0007215),0.46800076771258003,1.099918561237138,0.36017897091722595,0.7496641493994325,1.0,4/37,4.53%,PTK2B;DAGLB;GNAQ;CLN3
prerank,negative regulation of gene expression (GO:0010629),0.4228434249376596,1.0997584759697658,0.229,0.7496482572865706,1.0,48/302,13.46%,RUNX1;SLFN14;GPNMB;SLC11A1;SMYD5;TGFB1;CD3E;FCGR2B;LGMN;SRGN;HAVCR2;MSR1;ERN1;DNMT3A;TNF;RGCC;APOE;CNOT8;SPI1;XDH;PPP1R11;TAF1;TNRC6A;YY1;CREB3L1;ZC3H12D;MEF2C;FLCN;MOV10;RB1;ATP2B1;TRIM27;LARP1;EPRS1;AGO4;CPEB3;MAP2K2;RPS6KA4;PTBP2;AGO3;RBBP7;METTL3;HDAC9;MTF2;NPTN;TIPARP;PCIF1;NFKB1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2734437248054001,-1.099719460825927,0.3076923076923077,0.8651417955248999,1.0,25/55,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;PINX1;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,regulation of cellular protein localization (GO:1903827),0.45668152361727354,1.0991817042568426,0.3767643865363735,0.7507003278569178,1.0,14/45,21.61%,SHH;LCP1;PTPN1;CTNNB1;HFE;SETD2;RAB11FIP5;TOR1A;HSP90AA1;CCDC66;ATP13A2;SPIDR;ABCA2;PIN1
prerank,adenine nucleotide transport (GO:0051503),0.5181293408392843,1.0991662084346443,0.3790322580645161,0.7502564880513389,1.0,2/17,2.47%,ABCC6;LRRC8D
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5662091847804253,1.0988773214781957,0.38928067700987307,0.7505692823722808,1.0,3/11,13.59%,PRKCD;MAP3K5;STK24
prerank,anterior/posterior pattern specification (GO:0009952),0.45413101027805064,1.0988718380315314,0.3714902807775378,0.7501029439005881,1.0,9/53,10.28%,BASP1;TGFBR1;HES7;SKI;DDIT3;BHLHE41;ATP6AP2;LRP5;HOXA6
prerank,response to interferon-beta (GO:0035456),0.4926725342269369,1.0987616510325164,0.3780487804878049,0.7499274719333385,1.0,7/22,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,glucan catabolic process (GO:0009251),0.5296658506973135,1.0987420449374705,0.39577836411609496,0.7494932053526995,1.0,1/15,0.75%,MGAM
prerank,response to muscle stretch (GO:0035994),0.5345555231691509,1.09869071806143,0.385752688172043,0.7491446828603281,1.0,4/15,7.37%,SLC8A1;TTN;CTNNB1;SLC9A1
prerank,negative regulation of cell population proliferation (GO:0008285),0.4205450877658021,1.0984992422851376,0.224,0.7491641829439533,1.0,62/351,14.77%,PTK2B;TREM2;GPNMB;LYN;TGFB1;TMIGD3;IL1A;CD300A;CBFA2T3;PTPRJ;SLURP1;ADAMTS8;NUP62;OSM;UTP20;NCK2;NLRC3;RGCC;PKD2;SKI;CEBPA;ATP8A2;TNFAIP3;MORC3;SPEG;CTNNB1;MTSS1;AIF1;TP53;MYOCD;PIM2;SLC16A2;ST18;AQP11;FLCN;TFAP2B;DUSP10;PODN;ABI1;STRN;P3H2;INHBA;SH2B3;NF2;CHERP;SOX9;NELL1;PTPRU;CDK6;ADGRG1;B4GALT7;ADARB1;B2M;DDAH1;CDC6;IRF1;FTH1;SOX2;BRD7;SOX4;TMEM127;PRKRA
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5136969852835203,1.0982256878482293,0.38751625487646296,0.7493940357018626,1.0,1/17,2.53%,LPCAT1
prerank,protein oxidation (GO:0018158),0.548561788469199,1.0980669303478687,0.36541143654114366,0.7493764424718503,1.0,5/11,21.46%,LOX;CHCHD4;PRDX3;LOXL3;SUMF1
prerank,cellular response to calcium ion (GO:0071277),0.4435836988946441,1.0979082419190864,0.35337552742616035,0.749335160711888,1.0,18/67,19.88%,SYT17;LGMN;PLCG2;RASA4;PKD2;RASGRP2;MEF2A;SYT2;MEF2C;SYT10;BRAF;ADCY8;CAPN3;IQGAP1;SCN5A;ADD1;MCOLN1;SMPD1
prerank,positive regulation of telomere capping (GO:1904355),0.5195264852628705,1.0976439306248484,0.3934010152284264,0.7495638022060862,1.0,4/17,14.37%,PKIB;PRKCQ;TNKS2;HNRNPD
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5183218613334261,1.0974007220667077,0.3843137254901961,0.7497257124847816,1.0,5/18,15.64%,BHLHE41;HDAC5;HDAC4;SOX6;GSK3A
prerank,AMP metabolic process (GO:0046033),-0.4122637665098431,-1.0973719618340763,0.3295880149812734,0.8680428543281983,1.0,10/13,29.58%,ADSS2;NT5E;AK3;AMPD3;AMPD2;ADSL;AK4;NUDT2;NT5C1A;ADSS1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5497008982421666,1.0970010220681925,0.37669376693766937,0.7503324578132289,1.0,3/12,15.71%,CTPS1;CDA;DPYSL5
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4799223541321167,1.0960480594031552,0.381468110709988,0.7523837221622022,1.0,6/26,8.66%,CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.42211381740570003,1.095507104122358,0.2845691382765531,0.7533412001041554,1.0,21/182,8.46%,RUNX1;APOBEC1;TGFB1;CD3E;PCSK9;LGMN;HAVCR2;RIN3;MSR1;TNF;APOE;SPI1;XDH;TAF1;TNRC6A;YY1;CREB3L1;MEF2C;FLCN;MOV10;RB1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.44848188680008116,1.0951295767837017,0.37418655097613884,0.7538112725607277,1.0,13/50,18.46%,AQP1;RFFL;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;PIH1D1;SRC;DNAJB6;MAP2K5
prerank,regulation of cell differentiation (GO:0045595),0.426659054646457,1.0943442928856817,0.30482897384305835,0.7554209908392389,1.0,31/148,19.30%,RUNX1;LGALS3;SHH;SMYD5;TGFB1;TGFBR1;MDK;TNF;PRKCB;TRPS1;CEBPB;OCIAD1;TFAP2B;NTF3;TAF8;PPP2CA;CDK6;GPS2;ZFHX3;YWHAH;NF1;FADS1;MCRIP1;TRIP4;BIN1;VHL;CASZ1;BIRC2;GREM1;MAFB;GDNF
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4329062927062653,1.0942423453135373,0.3452868852459016,0.7552076481711008,1.0,38/87,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,organic acid transport (GO:0015849),0.43282707615282834,1.0942013152115846,0.36382322713257964,0.7548203873875614,1.0,21/94,18.30%,SLC16A10;SLCO2B1;LRRC8D;ABCC3;SLC7A7;SLC7A8;NR1H4;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC16A1;SLC25A30;SLC25A45;SLCO1B1;SLC1A4;SLC43A1;SLC13A3;PPARD;STARD5;RXRA
prerank,positive regulation of protein modification process (GO:0031401),0.4217376078316843,1.0941507284016405,0.2978936810431294,0.7544617621977264,1.0,25/203,9.57%,TREM2;GPNMB;LYN;TGFB1;CD74;ITGB3;CSF1R;NIBAN1;PRKCD;RAP2A;SEMA4D;CCND3;ATG7;TNF;FNIP1;BRAT1;RAB3GAP2;CCND2;SVIP;VEGFB;RAMP1;TNIK;FLCN;SPPL3;NOS1AP
prerank,regulation of transferase activity (GO:0051338),0.5136399020998625,1.0938413960271753,0.3859416445623342,0.7548197434068349,1.0,2/17,1.96%,NLRC5;SLAMF8
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5311389168241788,1.0937475520263007,0.37935656836461124,0.7545922962341505,1.0,6/15,23.66%,TNF;TICAM1;NOD2;HIF1A;GBP5;STAT3
prerank,extracellular transport (GO:0006858),-0.4067779363755404,-1.0935930082448702,0.3594306049822064,0.8756905368130965,1.0,9/13,46.05%,SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,primary neural tube formation (GO:0014020),0.4768549707959636,1.0933287359077162,0.3644859813084112,0.7552175424454909,1.0,3/30,4.59%,TGFB1;SKI;PLXNB2
prerank,regulation of synapse organization (GO:0050807),0.4964478881021886,1.0932795799657296,0.3973902728351127,0.7548550090425606,1.0,6/26,11.66%,ARHGAP22;TNF;CLN3;ABHD17B;MEF2C;ABHD17C
prerank,response to cAMP (GO:0051591),0.46432615537886723,1.0929556292195546,0.3711691259931896,0.755222265330013,1.0,11/37,21.24%,AQP1;HCN4;PKD2;RAP1B;VGF;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,V(D)J recombination (GO:0033151),0.5610327370419913,1.0929399929761137,0.3946629213483146,0.7547747869338267,1.0,2/11,6.22%,HMGB1;LIG3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5376410508880468,1.092448257892392,0.3952180028129395,0.7556016005088676,1.0,3/13,11.83%,SULT4A1;BPNT1;TPST1
prerank,regulation of histone acetylation (GO:0035065),0.4720900964346562,1.0923199829381995,0.37133182844243795,0.7554624232124904,1.0,13/33,21.79%,SNCA;SPI1;HDAC5;MYOCD;FLCN;PPARGC1A;RPS6KA4;BRD7;NOC2L;RPS6KA5;SETD5;IWS1;CTBP1
prerank,insulin receptor signaling pathway (GO:0008286),0.43848879368908816,1.0922592398787698,0.36231884057971014,0.7551236601059309,1.0,18/69,16.08%,ATP6V0D2;ATP6V0E1;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;AP3S1;BCAR1;ATP6V0A1;ATP6AP1;ZNF106;PHIP;ATP6V0B;BCAR3;GSK3A;IDE
prerank,muscle tissue development (GO:0060537),0.5475855757223793,1.092199210505889,0.4084124830393487,0.7548093875181259,1.0,5/13,16.02%,SHH;SRPK3;POGLUT1;CSRP1;NF1
prerank,positive regulation of cilium assembly (GO:0045724),-0.3518238455768168,-1.091787733650256,0.3333333333333333,0.8768095207472393,1.0,10/18,22.65%,ARHGAP35;CEP135;CCP110;BBS4;MARK4;CEP120;FUZ;CCDC88A;WRAP73;CROCC
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.44130788061494647,1.0916788144175942,0.35833333333333334,0.7556646243729044,1.0,26/73,22.83%,SMYD5;TAF1A;POLR1E;DNMT3A;SF3B1;SPI1;HDAC5;ACTB;TRIM27;HDAC4;POLR1B;POLR2L;HDAC6;RBBP7;MTF2;ERCC6;TASOR;MYO1C;PHF1;POLR2E;RBBP4;EED;TAF1C;SMARCA5;AEBP2;H3-3A
prerank,cell-substrate junction assembly (GO:0007044),-0.30571996730531825,-1.0915912096684042,0.33043478260869563,0.8733266313584584,1.0,9/33,8.60%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM;PLEC;ITGB4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5335057953902987,1.0907678369166895,0.40654843110504774,0.7576046650929142,1.0,3/14,13.41%,RFFL;GPS2;GAS6
prerank,cellular response to light stimulus (GO:0071482),0.4448087350327009,1.0906664052733188,0.36392075078206465,0.757393913702752,1.0,14/66,16.15%,AQP1;PRKCD;SAG;TAF1;TP53;CNGB1;YY1;BAK1;RPL26;METTL3;INO80;BMF;NOC2L;COPS9
prerank,regulation of protein catabolic process (GO:0042176),0.4327020116101267,1.0905619866362348,0.33975659229208927,0.7571827806232219,1.0,38/99,22.74%,CTSA;MAD2L2;WDR91;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CHEK2;CSNK2A1;NEDD4L;GFAP;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;VPS28;FURIN;DACT1;SEC22B;WWP1;SF3B3;ATP13A2;GSK3B;PRKN;AZIN2;ZDHHC2;PIN1;FLNA;MDM4;NKD1
prerank,fat cell differentiation (GO:0045444),0.4490880874626226,1.0904076542542822,0.362962962962963,0.7571177646841902,1.0,13/57,15.24%,METRNL;SDF4;FFAR2;CEBPA;OSBPL11;BBS9;TFAP2B;PPARGC1A;NR4A1;TMEM120A;ERAP1;PID1;OSBPL8
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4301778101107323,1.0903429120692205,0.35190918472652216,0.7568118450405674,1.0,16/85,15.64%,TREM2;BAG2;CBFA2T3;RNF180;RNF19B;CEBPA;TAF1;HECTD1;ATXN3;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,positive regulation of bone mineralization (GO:0030501),0.46235657945351033,1.0903231588923676,0.3870220162224797,0.7563846005323958,1.0,7/35,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,regulation of signal transduction (GO:0009966),0.4222366733546856,1.089961078660169,0.2992992992992993,0.7568727442508271,1.0,26/190,12.36%,RUNX1;TREM2;UBASH3B;TGFB1;CD3E;IRAK2;LFNG;PTPN1;NUP62;DHRS3;GRK3;NCK2;MTCH1;TRIM5;SREBF2;TIMP1;CD80;ZDHHC7;MDFIC;ZDHHC3;DTNBP1;CD63;WDR11;FYN;PPP2CA;GRK4
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3385985513944223,-1.0899467111438206,0.3181818181818182,0.8744794731043064,1.0,8/22,18.42%,SP100;GDI1;LMAN1;RAB23;INSIG1;DMTN;PARK7;CABP1
prerank,tube closure (GO:0060606),0.47416206131994443,1.089626976549214,0.37514518002322883,0.7573007858263584,1.0,3/31,4.59%,TGFB1;SKI;PLXNB2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5169292603388381,1.0894075268465815,0.40312093628088425,0.7574258765248711,1.0,1/16,0.75%,MGAM
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.344024739312647,-1.089128773326579,0.30246913580246915,0.8730390973566712,1.0,10/23,26.44%,FAR1;ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.47615888198024076,1.0890932124274968,0.38559814169570267,0.7577807033915797,1.0,4/29,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5361647859699704,1.0888155121678362,0.3806970509383378,0.7580008476908097,1.0,3/13,11.24%,PLXNC1;PLXNB2;NRP1
prerank,sodium ion homeostasis (GO:0055078),0.5025755114863791,1.0887714922357545,0.38957816377171217,0.7576518634468116,1.0,6/21,13.76%,SLC8A1;SLC9A1;TFAP2B;NEDD4L;ATP1B3;ATP1B2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.31885403038551763,-1.0876140849445564,0.32231404958677684,0.8736223093646353,1.0,10/30,10.62%,FSTL1;LTBP4;LATS1;TGFBR3;XIAP;PCSK6;SMAD4;FKBP1A;LATS2;TWSG1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2771448155630426,-1.087094970634753,0.2708333333333333,0.8712030307841878,1.0,6/43,4.03%,SUCO;BMPR1A;WNT4;PRKD1;BMP4;ACVR1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.44746694895234135,1.0867259812559766,0.3773987206823028,0.7625899193212264,1.0,10/55,13.92%,GRB2;MAPK14;SNCA;XDH;TGFBR2;TP53;THBS1;PARL;COQ7;PID1
prerank,negative regulation of response to external stimulus (GO:0032102),0.4250479904395584,1.086505413749386,0.3488372093023256,0.7627029162708141,1.0,16/105,13.40%,SIRPA;METRNL;PRKCD;DUSP3;NLRC3;RTN4RL1;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3;RB1;CASK;ITCH;GPS2;FNDC4
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45974496433512313,1.0864012920640298,0.38095238095238093,0.762487463790414,1.0,8/41,16.11%,TGFB1;MYL3;PKP2;TGFBR2;MEF2C;SOX4;GSK3A;RBPJ
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.43409382654655415,-1.0863084141702017,0.3368421052631579,0.869495837089715,1.0,4/10,17.08%,SOX5;ACVRL1;PKDCC;ZBTB16
prerank,positive regulation of telomerase activity (GO:0051973),0.4674686926805891,1.0852277201104272,0.39085714285714285,0.765193668988109,1.0,5/33,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;PRKCQ
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4300151057755269,1.0851139315967053,0.3564862104187947,0.7649994260572905,1.0,23/95,18.10%,TUBB;MKS1;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;CEP70;PLK4;CEP76;HAUS1;RAB11A;DYNC1H1;PCM1;CEP152;HAUS8;CEP162;AHI1;NINL;HSP90AA1;AKAP9;CEP63
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4931385536035388,1.0841001997905817,0.38686131386861317,0.7672406095346949,1.0,4/22,13.13%,CYRIB;TRAF2;MALT1;B2M
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.45792530575460744,-1.083819169656761,0.3575949367088608,0.8731664357412583,1.0,4/10,13.26%,OGT;SELENOS;ZNF692;DGKQ
prerank,negative regulation of cellular process (GO:0048523),0.41495539488447336,1.0838091744601894,0.188,0.7675237103739583,1.0,88/521,14.77%,PTK2B;LILRB1;TREM2;GPNMB;LYN;SHH;SMYD5;TGFB1;FCGR2B;TMIGD3;IL1A;SIRPA;CBFA2T3;VAMP3;PTPRJ;TLR2;SLURP1;ADAMTS8;PLXNC1;NUP62;MDK;OSM;CD9;UTP20;NCK2;SEMA4D;NME6;RGCC;PKD2;SKI;TGFBI;HPGD;CEBPA;PLXNB2;ATP8A2;MYH9;RIPOR2;SPEG;CTNNB1;CDA;TP53;MYOCD;PIM2;EPO;ST18;AQP11;FLCN;TFAP2B;RB1;SMAD3;SIPA1;PODN;TMEM98;CASK;ABI1;STRN;PODXL;P3H2;IMPACT;ARHGDIB;ACTN1;INHBA;TNFRSF21;DYSF;SH2B3;NF2;CHERP;BECN1;PTPRU;PARP16;TNFRSF1B;RBBP7;PPP2CA;CDK6;ADGRG1;NR4A1;ADARB1;ARHGDIA;DDAH1;CTTNBP2NL;CDC6;IRF1;FTH1;WFS1;BRD7;SOX4;TMEM127;PRKRA
prerank,vasodilation (GO:0042311),-0.3985080136230429,-1.0836587559641102,0.36538461538461536,0.8696058735557848,1.0,7/13,26.87%,SOD2;SOD1;KLF2;NOS3;NOS1;GPER1;ADRB2
prerank,regulation of viral release from host cell (GO:1902186),0.49152083374467537,1.0835431015875323,0.3906633906633907,0.7677454927423741,1.0,5/21,11.59%,TRIM25;TRIM5;TRIM8;MID2;TRIM35
prerank,fatty acid transport (GO:0015908),0.5008274554497614,1.083382684453524,0.3828647925033467,0.7676822506557878,1.0,5/17,17.26%,FABP4;APOE;FABP5;CD36;PPARD
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.47408090584294493,1.083059948318707,0.3778801843317972,0.7680600407378262,1.0,6/30,10.33%,CD74;CD44;BCL2L1;SNAI1;TPT1;DDX39B
prerank,fatty acid oxidation (GO:0019395),0.44383994219301315,1.0822039314106433,0.3759318423855165,0.7698362523450751,1.0,16/57,18.65%,ALOX12;EHHADH;ACAD10;ACADL;ABCD1;PEX13;PPARGC1A;ECHS1;ILVBL;ECI1;ADIPOR1;ADIPOR2;CPT2;PPARD;ABCD2;ECHDC1
prerank,carboxylic acid transport (GO:0046942),0.44492686426748185,1.08174217146672,0.3959227467811159,0.7705438055456751,1.0,14/55,17.42%,PSAP;SLC7A8;SLC38A6;CLN3;SLC36A1;SLC16A2;SLC6A15;SLC36A4;SLC16A1;SLC66A1;SLC1A4;SLC16A6;SLC13A3;SLC16A13
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5310009774717129,1.0816988720359586,0.3937677053824363,0.7701757467550688,1.0,5/13,13.26%,EDEM1;SEC16A;SEC16B;SORL1;SAR1A
prerank,O-glycan processing (GO:0016266),0.4514387403629548,1.0807476011601538,0.37323177366702937,0.7722132684877052,1.0,8/54,8.51%,GCNT1;GALNT10;MUC13;GALNT15;GALNT7;ST6GALNAC4;GALNT6;ST3GAL1
prerank,negative regulation of hormone secretion (GO:0046888),0.5644832909858619,1.0805381616351613,0.4005891016200295,0.7722624817532319,1.0,2/10,12.59%,OSM;RAB11FIP5
prerank,GPI anchor biosynthetic process (GO:0006506),0.4679617458992249,1.0802552501723863,0.39315230224321135,0.7725740664549902,1.0,13/30,24.47%,PIGM;PIGL;PIGX;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP;PIGK
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5330565773759322,1.0802147274940126,0.39266304347826086,0.7722018312360337,1.0,5/13,17.43%,GCH1;QDPR;SPR;HSP90AA1;FPGS
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4129364368912881,-1.080122608381458,0.35,0.8727630627536047,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4129364368912881,-1.080122608381458,0.35,0.8727630627536047,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,protein K11-linked ubiquitination (GO:0070979),0.47713441337548385,1.0798796896632354,0.3971797884841363,0.7726329584384876,1.0,7/27,11.25%,CDC23;UBE2D3;UBE2S;UBE2E3;RNF4;UBE2H;FZR1
prerank,actin polymerization or depolymerization (GO:0008154),0.4419243742819598,1.0797389035598128,0.38536060279870826,0.7725128954311179,1.0,10/50,12.18%,PREX1;PSTPIP1;MICALL2;FLII;AIF1;MICAL1;WASHC3;ABI1;DIAPH1;TWF2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49605547835119984,1.0796501824778066,0.39719029374201786,0.772257314758137,1.0,10/20,22.31%,KCTD17;HERPUD1;BAK1;WFS1;CCDC47;SELENOK;PACS2;FIS1;RAP1GDS1;TGM2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.44047390993962116,1.0795127025748936,0.364124597207304,0.7721172652251816,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;AKAP5;STAC;PRKCH;EPB41;STX3;EPB41L2;STAC3;ARF6;LRP1
prerank,protein targeting to ER (GO:0045047),0.4230703153100707,1.0793806344562686,0.35634517766497464,0.7719602138047522,1.0,41/99,25.69%,RPL23;RPL17;EDEM1;RPL10A;RPS2;RPL18A;RPS15A;SPCS2;SPCS1;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,t-circle formation (GO:0090656),0.5574260407961559,1.0792224461300068,0.41228070175438597,0.7709498770748133,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5574260407961559,1.0792224461300068,0.41228070175438597,0.7709498770748133,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5574260407961559,1.0792224461300068,0.41228070175438597,0.7709498770748133,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4865165782549286,1.0788095653205911,0.39338235294117646,0.7715865116948136,1.0,5/22,7.50%,P2RY6;PKD2;STAC;SLC9A1;VMP1
prerank,intermediate filament organization (GO:0045109),0.5166275806739893,1.0786350323250835,0.4134366925064599,0.771562817414805,1.0,5/17,17.62%,BFSP2;PKP2;GFAP;DES;DNAJB6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.46373181356610255,1.0785504486691813,0.3955056179775281,0.7713103574744883,1.0,6/35,11.85%,CD300A;MTOR;PPP6R1;PPP1R11;BOD1L1;PPP4R4
prerank,regulation of stem cell differentiation (GO:2000736),0.4304470701329277,1.0785318084378064,0.36512820512820515,0.7708726267637058,1.0,18/89,16.29%,RUNX1;SMYD5;GATA1;OSM;SP7;PSMB10;TAL1;OCIAD1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5330926075476707,1.0783742611093126,0.38514442916093533,0.7708247307200145,1.0,3/13,14.21%,PTPN1;ATF6B;WFS1
prerank,histone lysine methylation (GO:0034968),0.4627936360442814,1.077928106421101,0.3969732246798603,0.7714955350867296,1.0,10/33,18.42%,WDR5B;CXXC1;SETD6;DPY30;DOT1L;RBBP5;SMYD3;SUV39H1;SETD1B;WDR82
prerank,embryonic axis specification (GO:0000578),-0.3895111916619983,-1.0779033847348274,0.3562753036437247,0.8756344859010281,1.0,10/15,44.05%,COBL;TBX3;SMAD6;PTCH1;STIL;FZD5;CXXC4;RIPPLY2;WNT7A;HOXD8
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3176230261168465,-1.0778646023319305,0.3712121212121212,0.871813277334666,1.0,12/27,26.75%,ANK2;DMD;JPH1;FKBP1A;SELENON;AHNAK;NOS1;JPH2;JPH4;PDE4D;CALM2;CACNB3
prerank,macroautophagy (GO:0016236),0.4231019524473474,1.0775524830222083,0.3481781376518219,0.7719973417827302,1.0,40/118,22.54%,LIX1;TCIRG1;VTA1;ATG7;MAP1LC3B;CLN3;PIP4K2A;PLEKHM1;MTMR3;FUNDC1;CSNK2A2;CSNK2A1;TECPR1;SNAP29;UVRAG;VPS37C;BECN1;TOMM40;VDAC1;VPS39;SRC;SNX14;ATG3;ARL8B;VPS28;PIK3R4;VPS33B;ATG14;PLAA;TBC1D5;TOMM20;MFN1;ATP13A2;EPG5;STAM2;PRKN;VAMP8;RB1CC1;ATG10;MTMR14
prerank,sulfate transport (GO:0008272),-0.38924371369191474,-1.0773927944466406,0.3584905660377358,0.8693465979804313,1.0,7/14,30.79%,SLC26A2;SLC26A7;SLC25A14;SLC25A11;SLC26A6;RACGAP1;SLC26A8
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4560948247828415,-1.0770426194622378,0.37003058103975534,0.8665005498668018,1.0,2/10,5.30%,UPP2;NT5E
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5518454261956612,1.076548419294245,0.4168975069252078,0.7741892962946034,1.0,7/11,23.23%,RREB1;CD44;SRC;CORO1C;ARPIN;ARHGEF7;PDPN
prerank,nuclear body organization (GO:0030575),-0.41620398470541015,-1.0764519099272847,0.3333333333333333,0.8645495365730262,1.0,4/12,22.96%,AFF2;PML;WRAP53;USP50
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5115650542831454,1.0764447558022803,0.4147651006711409,0.7740093976087257,1.0,4/15,9.46%,EDEM1;RAB3GAP2;SPCS2;SPCS1
prerank,negative regulation of cell differentiation (GO:0045596),0.41598514665745884,1.0764346304645582,0.34769539078156314,0.7735577390838301,1.0,31/181,14.68%,PTK2B;ASCL1;SHH;TGFB1;ABCA1;ITGB3;TGFBR1;MAD2L2;SEMA4D;PKP2;TNF;ABCG1;SKI;XDH;NKX2-1;MYOCD;LEO1;RB1;SMAD3;LRP5;SOX9;SRA1;ADIPOR1;PPP2CA;CDK6;BAMBI;VASN;GPS2;SOX2;BBS12;MEIS1
prerank,regulation of membrane depolarization (GO:0003254),0.49956904667537183,1.0762411403285983,0.40992167101827676,0.7735790004149599,1.0,6/18,18.68%,HCN4;ABCD1;NEDD4L;LRRK2;SCN5A;PTPN3
prerank,peptidyl-serine modification (GO:0018209),0.4197725432856885,1.0760776017477665,0.3380281690140845,0.7735321663157759,1.0,51/166,21.32%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;POGLUT2;PRKCQ;CSNK2A2;CSNK2A1;POGLUT1;SMG1;PRKCH;HPF1;STK32C;PKN1;RPS6KA4;CSNK1A1;MAP3K12;GAS6;GALNT2;LRRK2;MGAT5B;SGK3;RPS6KA2;STK4;RPS6KA5;GALNT1;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4588827236656607,1.0757267692686971,0.4155251141552511,0.7739666206862863,1.0,7/32,14.05%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.48358254335431183,1.0751141645659021,0.42034313725490197,0.7750728429263266,1.0,6/25,16.71%,PTGES3;SDF2L1;DNAJC7;BAG1;GAK;ERO1A
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5198287113037048,1.0750213637157322,0.3975069252077562,0.7748465104344499,1.0,2/12,7.57%,SOAT2;P4HB
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.42896086985920706,-1.0747392773121727,0.3944636678200692,0.8658999234925253,1.0,4/11,11.24%,BMPR1A;CD200;CD46;PTGS2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.49186825546537294,1.0747202050968405,0.38366336633663367,0.7751718461755803,1.0,3/21,8.40%,TGFB1;TGFBR1;FAM89B
prerank,neural tube closure (GO:0001843),0.46069039803700274,1.0739936019094993,0.39265212399540755,0.7766692606985854,1.0,3/34,4.59%,TGFB1;SKI;PLXNB2
prerank,ubiquinone metabolic process (GO:0006743),0.5148257734968885,1.0739658551296056,0.4066225165562914,0.7762690508670113,1.0,8/15,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,negative regulation of protein polymerization (GO:0032272),0.4711546119961047,1.0737942023271225,0.4100467289719626,0.7762069628473651,1.0,9/27,13.44%,CYRIB;PRKCD;SNCA;ARFGEF1;MAPRE1;PFN2;PFN1;TWF2;SSH2
prerank,DNA strand elongation (GO:0022616),-0.36975776060981186,-1.0735768504118028,0.36792452830188677,0.8658249224588638,1.0,13/18,37.93%,MRE11;POLA1;GINS3;TERT;MCM4;DCLRE1B;MCMDC2;POLD2;RFC3;GINS1;RFC4;MCM3;MCM7
prerank,negative regulation of neuron differentiation (GO:0045665),0.48291495020474234,1.0730991986057403,0.39927184466019416,0.7775159735145531,1.0,6/22,20.45%,ASCL1;SOX9;B2M;SOX2;CNTN4;GSK3B
prerank,positive regulation of neuron differentiation (GO:0045666),0.45565565500217703,1.0722188729673414,0.3943820224719101,0.7793223143234503,1.0,5/40,9.84%,ASCL1;GPRC5B;MMD;MEF2C;IMPACT
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4522311736842653,1.0718530635052765,0.4101433296582139,0.7798072132743822,1.0,7/43,6.51%,P2RY6;ERN1;TNF;LDLRAP1;IL6R;IL18;AIF1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.48311194301330956,1.071670875227267,0.4138335287221571,0.7797706598284185,1.0,5/27,10.81%,TGFB1;DHX9;TP53;PUM2;MAP2K2
prerank,pulmonary valve development (GO:0003177),-0.36621753735099855,-1.0711162315768554,0.36324786324786323,0.8694621153790748,1.0,8/18,14.15%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,cholesterol metabolic process (GO:0008203),0.4368688795733596,1.0709279041075417,0.39539748953974896,0.7812313333079375,1.0,8/68,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;CEL;SOAT2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5505655643619314,1.0704015295613911,0.43213296398891965,0.7821312329971524,1.0,2/11,6.70%,MAD2L2;TP53
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4605813132874356,1.0703846435338866,0.4139908256880734,0.7816959001823905,1.0,11/32,17.93%,RREB1;ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2;SRC;CORO1C;CDC42
prerank,histone H2A acetylation (GO:0043968),0.5035980795903783,1.0699809013490447,0.41184387617765816,0.7823333755371252,1.0,7/16,25.07%,BRD8;EP400;NAA40;MEAF6;MORF4L2;MORF4L1;SPHK2
prerank,negative regulation of transmembrane transport (GO:0034763),0.5618224360256289,1.0698035700768513,0.4291970802919708,0.7823484447479778,1.0,4/10,19.95%,PRKCB;THBS1;CTTNBP2NL;INPP5K
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5437644345258451,1.0689479422762125,0.4294032023289665,0.7840663211210095,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,carnitine metabolic process (GO:0009437),0.5410969419352133,1.068942559761927,0.41904761904761906,0.7836046890067022,1.0,5/12,23.85%,ALDH9A1;ACADL;CPT2;CROT;CPT1A
prerank,cellular response to alcohol (GO:0097306),0.4424460401166357,1.0687620534565279,0.4092373791621912,0.7835653805495115,1.0,13/42,20.41%,ADCY7;MAP4K1;ADCY6;CTNNB1;LARP1;GLRA2;ADCY3;ADCY8;GNG2;GOLPH3;GRAMD1C;SPIDR;OSBPL7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.445774146799889,1.068522161088634,0.4090909090909091,0.7836936014574369,1.0,7/43,7.56%,CBL;PTPRJ;DUSP3;GRB2;ZFYVE28;RAB7A;SH3KBP1
prerank,cellular respiration (GO:0045333),-0.28140133792144384,-1.0683879898381854,0.32989690721649484,0.874341660883983,1.0,27/41,32.99%,UQCRC2;UQCRH;NDUFS1;SLC25A13;NDUFS4;OXA1L;SLC25A14;COQ10B;MTFR1L;COX15;ATP5F1D;UQCRC1;ETFA;NDUFS7;ETFRF1;ETFB;SDHAF4;UQCRFS1;LYRM7;MDH2;CYCS;COX10;MTLN;SURF1;NR4A3;NDUFS8;SIRT3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5044831203136655,1.0683623690997301,0.4,0.7836567756646653,1.0,1/18,0.31%,PTK2B
prerank,autophagosome organization (GO:1905037),0.4401845871514845,1.0683496729732387,0.39358288770053473,0.7832052192868546,1.0,18/50,22.33%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;ATP13A2;NSFL1C;TP53INP2;RB1CC1
prerank,regulation of cell communication (GO:0010646),0.4540930472772601,1.0682207955940615,0.4041095890410959,0.7830481684437172,1.0,6/35,6.34%,PTPN1;NUP62;SLC8A1;GRK3;MTCH1;ANXA1
prerank,neurotrophin signaling pathway (GO:0038179),0.4863116775731937,1.068101124520908,0.41605839416058393,0.782886339298182,1.0,8/21,19.71%,GRB2;NTF3;BCAR1;RAPGEF1;DDIT4;RAP1A;KIDINS220;SORT1
prerank,regulation of muscle contraction (GO:0006937),-0.3227180520178967,-1.0677075627905697,0.35294117647058826,0.8726097601776236,1.0,7/26,13.05%,CHRM2;CAV1;SRI;KCNA1;ATP1A2;PLCE1;KCNB2
prerank,regulation of cell cycle (GO:0051726),0.41044121861655414,1.0674494711441744,0.317,0.784173470032133,1.0,47/271,14.24%,PTPRC;LILRB1;TGFB1;RPL23;GAS2L1;TGFBR1;MLXIPL;MAP2K6;ERN1;NEK6;RGCC;PKD2;HPGD;FBXL22;FZD9;CDK11B;TP53;SND1;RPS15A;PIM2;CSNK2A2;CSNK2A1;GADD45B;KIF20B;RB1;SMAD3;SIPA1;CDK7;SON;INHBA;NF2;MAEA;TTLL12;SOX9;SRA1;THBS1;RASSF1;RNF40;METTL3;SDCBP;CDK6;FBXL3;NR4A1;ADARB1;HCFC1;IRF1;SOX2
prerank,regulation of sodium ion transport (GO:0002028),0.4572846821337283,1.0674363193795526,0.3945885005636979,0.7837307592054713,1.0,12/34,18.95%,SCN4B;P2RX7;PKP2;P2RX4;WNK1;PRSS8;WNK4;YWHAH;SCN5A;SPTBN4;PER1;CNKSR3
prerank,regulation of TOR signaling (GO:0032006),0.42983802303693575,1.0673531515185544,0.39810924369747897,0.7834565961941488,1.0,23/67,21.95%,TREM2;RFFL;FNIP1;GNA12;SEH1L;FLCN;PDCD6;DDIT4;GAS6;LAMTOR3;TMEM127;PIH1D1;GSK3A;TTI1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB;NPRL3
prerank,actin filament bundle assembly (GO:0051017),0.4623551674823148,1.0673043943116058,0.4061784897025172,0.7831053155418409,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,cellular protein-containing complex assembly (GO:0034622),0.41787630877680565,1.0669638941627921,0.3672032193158954,0.7835191966625863,1.0,47/160,21.81%,TGFB1;CD3E;VAMP3;TBCEL;DHX9;PTGES3;NCK2;SNX9;SNCA;TRAF2;DNAI4;FMOD;LONP1;AP2S1;TBCC;PSMG3;CHCHD4;SMAD3;HSF1;UVRAG;EIF4H;TPR;IMMP2L;CLTC;NUP205;NRG1;PRLR;BBS12;SRP19;EPS15;SRC;AP2M1;RTN4;HSP90AA1;GTF2B;BIN1;MIS12;PICALM;ANGPT1;TMEM170A;FCHO2;GPX4;CYBA;PDE4DIP;DNAJB14;VAMP8;PSMG2
prerank,muscle filament sliding (GO:0030049),0.45476046507828316,1.0669165192285284,0.4040632054176072,0.7826830055265672,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,actin-myosin filament sliding (GO:0033275),0.45476046507828316,1.0669165192285284,0.4040632054176072,0.7826830055265672,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,positive regulation of exocytosis (GO:0045921),0.4553706521412911,1.0658614214215525,0.40404040404040403,0.7849364733507757,1.0,11/35,19.99%,UNC13D;SNCA;SMPD3;RAB7A;SYTL4;ATP6AP1;SDCBP;PDCD6IP;RAB27B;STXBP5;ATP13A2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.43829631928375073,1.0650375349162537,0.42628205128205127,0.7866936595227445,1.0,14/57,20.78%,TREM2;DDHD1;PYCARD;TP53;BAK1;PPARGC1A;CAMKK2;BMF;GSK3A;TNFSF10;DNM1L;FIS1;GSK3B;PRKN
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5093423536461504,1.0650203733384966,0.401894451962111,0.7862602073827728,1.0,4/16,11.27%,TNF;CLN3;GSPT1;HDAC6
prerank,peptide cross-linking (GO:0018149),0.47715665180335076,1.0647415150304183,0.41617819460726846,0.7864960860749862,1.0,3/25,11.24%,F13A1;ANXA1;THBS1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5458713697980009,1.0642195634188696,0.43333333333333335,0.787364939886457,1.0,4/10,20.02%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.46778671030648866,1.063739999309003,0.4224343675417661,0.7881785190569114,1.0,7/24,12.18%,ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,potassium ion transport (GO:0006813),0.4174729727547075,1.0637214024564048,0.3850806451612903,0.7877482959611299,1.0,13/120,7.52%,KCNJ11;AQP1;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;KCNMA1;SLC9A1;KCNK13
prerank,diol biosynthetic process (GO:0034312),0.5107928557925353,1.0636953642973586,0.41948051948051945,0.7873302844409197,1.0,6/15,21.23%,GCH1;QDPR;ACER3;SPR;ASAH1;ABCA2
prerank,cellular response to oxidative stress (GO:0034599),0.41816662469315274,1.0636027425365682,0.4012158054711246,0.7870911625350558,1.0,30/118,18.38%,CYBB;NCF4;NFE2L2;PRKCD;NCF2;SNCA;PKD2;FOXO3;TXNRD1;AIF1;TP53;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;CAMKK2;LRRK2;HIF1A;CPEB2;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,regulation of wound healing (GO:0061041),0.44361510284833666,1.0635397544241985,0.4010989010989011,0.7867920812025047,1.0,6/42,9.65%,GP1BA;ARFGEF1;TNFAIP3;ANXA1;CASK;ACTG1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3715920177736799,-1.0633414213483696,0.35944700460829493,0.8822339266676008,1.0,4/15,10.54%,KCNN2;ATP1B1;KCND3;KCNJ3
prerank,proteasome assembly (GO:0043248),-0.4282929591793011,-1.0632535150741165,0.36363636363636365,0.8787199581289635,1.0,8/11,40.65%,PSMD11;PSMD5;OTUD6B;PSMG1;ADRM1;PSMD10;PSMD9;POMP
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4837131919797219,1.0629133311656476,0.4105392156862745,0.7878972428100802,1.0,5/24,9.02%,ITGB3;PTPN1;PRKD2;PRKCB;PDCD6
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.44620264030785173,1.0624528501251234,0.4178935447338618,0.7886394197620562,1.0,7/39,11.24%,SHH;PKD2;CTNNB1;TGFBR2;NKX2-1;LRP5;NRP1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4319832372398874,-1.0623451702190256,0.3614457831325301,0.8778087407026154,1.0,6/10,28.89%,ACSL1;SLC27A1;SLC27A4;ACSL3;SLC2A1;SLC27A2
prerank,determination of left/right symmetry (GO:0007368),0.45263146840972546,1.0619805736597532,0.41352549889135254,0.7893954350682071,1.0,3/37,5.50%,SHH;PKD2;ODAD2
prerank,ncRNA export from nucleus (GO:0097064),-0.2953600046847243,-1.0619380116617156,0.3018867924528302,0.8753532866623931,1.0,17/36,22.05%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;PHAX;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43;NPM1;NCBP2
prerank,regulation of protein metabolic process (GO:0051246),0.4438820348986844,1.0608458249347226,0.42444444444444446,0.7918603907965596,1.0,13/44,19.65%,GSAP;SHH;APOE;TRAF3;CHEK2;NEDD4L;SPOP;PARL;WFS1;FAF1;FURIN;MAP2K5;ROCK2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5558965284481612,1.0606901699527416,0.4449275362318841,0.7917916471655561,1.0,2/10,9.48%,PRDM12;ATRX
prerank,cell junction maintenance (GO:0034331),0.5139167550173942,1.0600216261149251,0.4361111111111111,0.7930222128035751,1.0,1/14,2.01%,CSF1R
prerank,negative regulation of phosphorylation (GO:0042326),0.42507338876022605,1.0596671027727613,0.40615384615384614,0.7934438315634248,1.0,22/85,20.78%,LYN;TGFB1;STAP1;SIRPA;CBFA2T3;NIBAN1;XDH;IBTK;IMPACT;HDAC4;INHBA;PRDX3;PID1;LRRK2;PTEN;CORO1C;PAQR3;TIGAR;ATG14;INPP5K;ANKLE2;PRKN
prerank,modulation of chemical synaptic transmission (GO:0050804),0.41529653964024216,1.0595167806111263,0.3983656792645557,0.7933626406054004,1.0,14/107,8.95%,NPAS4;CX3CR1;ABR;DGKZ;CLSTN1;TNF;CEL;CLN3;MCTP1;BTBD9;CACNA1A;MEF2C;EIF4EBP2;NTF3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.49928597233387495,1.0594460193409767,0.42451612903225805,0.7930748741626164,1.0,4/17,11.24%,MDK;AIF1;DOCK4;NRP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4292165965333524,1.0593240752409576,0.40767634854771784,0.7929206691856232,1.0,16/73,16.29%,RUNX1;GATA1;OSM;SPI1;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,pseudouridine synthesis (GO:0001522),-0.39241358964965184,-1.0591756509409873,0.34285714285714286,0.8798281098204019,1.0,10/13,40.34%,PUS10;TRUB2;GAR1;NOP10;PUS1;PUS7L;NHP2;TRUB1;PUSL1;RPUSD2
prerank,thyroid hormone generation (GO:0006590),0.5397243429192702,1.0586213737301953,0.42962962962962964,0.7942519377932976,1.0,2/10,14.25%,CTSK;TG
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4628125315487325,1.058484122164167,0.4352078239608802,0.7941167467827442,1.0,3/27,4.09%,SMOC2;RGCC;PRKD2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.442721685395716,1.058318919382865,0.4288990825688073,0.7940372268255826,1.0,12/38,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;ATP5IF1;PARL;HUWE1;LRRK2;SREBF1;UBE2J2;GSK3A
prerank,glutamine family amino acid metabolic process (GO:0009064),0.45702566655465476,1.058194754374896,0.42214532871972316,0.793873671618147,1.0,6/33,14.00%,DGLUCY;MTHFS;ART4;PYCR2;DDAH1;OAT
prerank,nuclear membrane disassembly (GO:0051081),0.5043460245088159,1.0578890188195533,0.40027137042062416,0.7941770152057884,1.0,5/14,20.90%,NEK6;PRKCB;AKAP8L;VRK1;LPIN1
prerank,eye photoreceptor cell development (GO:0042462),0.5112494653602798,1.0574704549321712,0.4429530201342282,0.7947759294206679,1.0,3/15,8.12%,THY1;NRL;MYO7A
prerank,autophagosome assembly (GO:0000045),0.43406872998744955,1.057253948863344,0.4068522483940043,0.7948556469880723,1.0,18/52,22.33%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;SMURF1;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;NSFL1C;TP53INP2;RB1CC1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.38598039557984404,-1.0571623769348277,0.3782771535580524,0.8820724915974945,1.0,8/14,25.56%,ECE1;ACE;NOS3;ENPEP;EDN1;EDN3;AGTR1;ACE2
prerank,fatty acid catabolic process (GO:0009062),0.4250881808885587,1.056627508256264,0.40042149631190727,0.7959764894638777,1.0,25/67,24.25%,LPIN2;EHHADH;CEL;ACAD10;NUDT19;ACADL;ABCD1;PEX13;ECHS1;ILVBL;ECI1;ABHD3;MMUT;CPT2;PPARD;PCCA;ABCD2;ECHDC1;LPIN1;ACOT8;CROT;MMAA;ABHD2;HADHA;HADH
prerank,positive regulation of vasoconstriction (GO:0045907),-0.39224952678726455,-1.0563567491418329,0.3667953667953668,0.880634357643502,1.0,1/13,1.12%,CAV1
prerank,microtubule depolymerization (GO:0007019),-0.3545156647827986,-1.0558981061140842,0.35964912280701755,0.8784045975497092,1.0,7/17,21.12%,NCKAP5;STMN2;KIF24;STMN4;STMN3;KIF18A;STMN1
prerank,cell cycle checkpoint signaling (GO:0000075),0.5334179393808769,1.055795411892249,0.43706777316735823,0.7976837713034607,1.0,7/12,27.37%,NABP1;PLK2;PRCC;ZWINT;BUB1B;ZWILCH;WEE1
prerank,regulation of protein acetylation (GO:1901983),-0.4070295082840932,-1.0556294380022149,0.3602941176470588,0.875496418818846,1.0,2/12,1.83%,CEP295;RAPGEF3
prerank,cotranslational protein targeting to membrane (GO:0006613),0.416835709629956,1.0548981565237512,0.4069529652351738,0.7995026243298949,1.0,38/91,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,cytoplasmic translation (GO:0002181),0.4187749796437802,1.0548135475358038,0.42008196721311475,0.7992448348336444,1.0,40/91,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;GSPT1;EIF4A1;RPL6;RPL26;RPS20;RPS16;RPS14;RPL19;RWDD1;RPL9;TMA7;RPS11;RPL11;RPS23;RPS4X;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;RPL22L1;RPLP1;EIF3M;RPS15;RPS5;RPL41;DRG2;RPL10;RPS8;RPL5;RPL18
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.40767755417561063,1.0547679728215995,0.41051567239635994,0.7988896643787972,1.0,16/113,12.99%,MMP12;STAT5A;PIK3CD;ITGB3;TGFBR1;RREB1;MDK;PRKD2;PDCL3;VEGFB;PDCD6;SOX9;NRP1;GRN;NOD2;NR4A1
prerank,outer dynein arm assembly (GO:0036158),0.5089107870360519,1.054566175242955,0.4314516129032258,0.798943013999622,1.0,3/15,13.03%,ODAD2;ODAD1;CCDC63
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4904574480737723,1.0544859502921013,0.42857142857142855,0.7986605599983603,1.0,4/20,20.61%,TSPO;FDXR;FDX1;STARD3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5318172244233866,1.054327735141614,0.4283727399165508,0.798555296105575,1.0,4/11,17.23%,NOS1AP;CACNB2;CACNB1;BIN1
prerank,regulation of vasoconstriction (GO:0019229),-0.32638838417690075,-1.0537949780786187,0.3782051282051282,0.8772770251653316,1.0,11/27,27.30%,CAV1;ECE1;ACE;CHRM3;PER2;TBXA2R;BMPR2;KCNMB2;AGTR1;ACE2;AGT
prerank,artery morphogenesis (GO:0048844),0.4634011307581156,1.0536139458858034,0.4342258440046566,0.7999113832140027,1.0,8/30,16.02%,TGFBR1;ANGPTL3;PKD2;HPGD;TFAP2B;NRP1;LRP1;NF1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3258140044129263,-1.0535363744044934,0.3674698795180723,0.874357425446565,1.0,13/24,30.41%,DMD;JPH1;SRI;FKBP1A;CALM3;SELENON;NOS1;JPH2;JPH4;PDE4D;CALM2;GSTO1;CASQ2
prerank,positive regulation of cell killing (GO:0031343),0.5124201489671348,1.0534928122611182,0.4279835390946502,0.7997486390005253,1.0,1/13,0.95%,SYK
prerank,chromosome organization (GO:0051276),-0.22876112437851923,-1.0533763146544413,0.2631578947368421,0.8713053262960887,1.0,19/99,10.95%,SMARCA4;COPS5;LATS1;DDB2;TCF7L2;HMG20A;DDB1;EZH1;NUCKS1;ABL1;MSH2;HMGN3;HDAC2;RBX1;EZH2;PWWP3A;TOP2B;SETD7;RAE1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.43776620034606223,1.0530561074224292,0.41857923497267757,0.80038476188558,1.0,7/46,10.11%,TGFB1;HCLS1;PRKCD;DHX9;TP53;SMAD3;TPR
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.43526792282704757,1.0529886902014698,0.4406417112299465,0.8000817462631814,1.0,8/50,14.42%,GTF2H1;CCND3;BCCIP;CCND2;ACTB;CDK7;CDC6;CCNE2
prerank,anterograde axonal transport (GO:0008089),-0.29449159442096695,-1.05292136889514,0.375,0.8691453269947602,1.0,8/37,10.38%,DLG2;KIF5B;SPAST;SOD1;NEFL;MAPK8IP3;KIF3B;KIF5A
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3356652680090676,-1.0528647464272185,0.3407821229050279,0.8657675018038246,1.0,11/22,22.13%,NTRK3;STMN2;NGF;EHD1;MAPT;RAPGEF2;AKT1;MAGI2;WASF1;BDNF;NTRK2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.33880291794062484,-1.0523492413847406,0.39351851851851855,0.8636801197735245,1.0,10/20,19.35%,NLGN1;CAPRIN1;DLG5;FMR1;SHANK3;SHANK1;DBN1;DHX36;CAPRIN2;CAMK1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4328848780783648,1.0522951049345866,0.41865509761388287,0.8012894063205976,1.0,5/53,6.99%,TREM2;BAG2;APOE;XPO1;GNA12
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4913036379471733,1.0520485114003952,0.43902439024390244,0.8014358445313019,1.0,1/18,0.35%,LILRB1
prerank,ephrin receptor signaling pathway (GO:0048013),0.41760147189016217,1.052044521512989,0.4176954732510288,0.8009759198913255,1.0,25/82,17.93%,LYN;VAV2;NCK2;VAV3;ARPC2;EFNA2;ACTB;AP2S1;ARPC3;ITSN1;ACTG1;ACTR2;ACTR3;YES1;ARPC4;SDCBP;FYN;EFNB3;SRC;AP2M1;RASA1;EPHA4;EPHA8;RHOA;CDC42
prerank,sphingoid metabolic process (GO:0046519),-0.40287473952502817,-1.0520351469481357,0.3805970149253731,0.8610650479572617,1.0,7/12,40.93%,SGPP1;SPHK1;PLPP3;PLPP1;PLPP2;ASAH2;SPTLC3
prerank,neuron development (GO:0048666),0.41509850113847785,1.0514142804405318,0.40963855421686746,0.802095923689146,1.0,19/141,9.82%,RUNX1;LYN;ASCL1;PRDM12;MICALL2;ATP7A;APOE;ATP8A2;MYT1L;THOC2;HMGB1;GPRIN3;MICALL1;LRP12;WNK1;MEF2C;RB1;ATCAY;RAB11A
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5449146539939006,1.0512000572778557,0.45809248554913296,0.802203673770184,1.0,6/10,24.65%,FZD9;ABCD1;LRRK2;SRC;RACK1;KDR
prerank,"transcription, DNA-templated (GO:0006351)",0.40842789728346085,1.0509501563859405,0.39478957915831664,0.802386560997847,1.0,70/207,25.39%,ARRB2;IVNS1ABP;RREB1;GTF2H1;TAF1A;FOXO3;EAF1;TAF1;GTF3C4;BTF3;TP53;MEF2A;TTF1;LEO1;GTF3A;TRIP13;GMEB2;MMS19;HSF1;CDK7;NFX1;NFIC;KLF13;POLR2L;TRIM24;MBD1;PMF1;SNAPC3;ELL;MLLT1;NFKB1;RO60;TWNK;MAF;ERCC6;TAF3;ZBTB7B;GTF2B;RSF1;NFYA;TCEA1;CREBL2;GTF2H5;POLR2E;TAF11;FUBP3;ELOB;MED4;CRCP;GLIS3;IWS1;TAF1C;IRF9;SMARCA5;ELOC;POLR3A;NELFE;GTF2A1;CTR9;PARP1;MNT;TFAM;MRPL12;PAX8;PWP1;THRA;NCBP1;XAB2;NFIX;XBP1
prerank,protein insertion into ER membrane (GO:0045048),-0.28485334968513915,-1.0508247641876949,0.33070866141732286,0.8610264006306615,1.0,13/37,19.11%,APP;EMC7;ALDH3A2;TRAM1;SEC61G;EMC10;EMC4;EMD;SERP1;SEC61B;EMC1;GET4;VAPA
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4140405241102152,1.0507356858154073,0.4294478527607362,0.8024573065281696,1.0,17/94,13.59%,FNIP2;PRKCD;ERN1;TRAF2;PYCARD;DDIT3;APAF1;BCL2L1;TP53;MAP3K5;CEBPB;HINT1;CHEK2;BAK1;TNFRSF1B;ATP2A3;STK24
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4722280096448096,1.0501173789774745,0.42460796139927626,0.8036032785717374,1.0,3/22,4.59%,EDEM1;MAN1C1;SEL1L
prerank,regulation of cellular localization (GO:0060341),0.4415921529542488,1.0500239229777237,0.42733188720173537,0.803379313267728,1.0,9/46,16.71%,LYN;UNC13D;NR1H4;REEP6;LRP5;DYNC1H1;LRRK2;STXBP4;HSP90AA1
prerank,extracellular structure organization (GO:0043062),0.4067212489954894,1.0499184000955804,0.382,0.8031898504723897,1.0,26/204,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;TGFBR1;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,cellular transition metal ion homeostasis (GO:0046916),0.4145802060062876,1.049774884037285,0.4268292682926829,0.8030804558098198,1.0,25/91,22.28%,SLC11A1;FRRS1;ATP7A;ATOX1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;FTH1;SLC31A2;ATP13A2;SLC39A6;HMOX2;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,epiboly involved in wound healing (GO:0090505),0.4981926901299386,1.0496649292368658,0.44805194805194803,0.8028715902631011,1.0,8/16,23.23%,LCP1;CD44;MRTFA;TOR1A;RHOA;FLNA;DDR1;PDPN
prerank,endoderm formation (GO:0001706),0.4535434202671574,1.049537965408395,0.44004524886877827,0.8027235332354943,1.0,5/35,10.55%,ITGB2;ITGA4;ITGB5;SETD2;INHBA
prerank,SNARE complex assembly (GO:0035493),0.5459085683258702,1.0494410063658448,0.4221879815100154,0.8024911492814996,1.0,3/10,9.42%,VAMP3;SNCA;UVRAG
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.30622851092526193,-1.0493709498067065,0.3819444444444444,0.8616953894622047,1.0,14/29,23.27%,ARRDC3;ABL1;DCUN1D4;TOPORS;PINK1;FBXW7;DTX3L;UBE2L3;FEM1A;DCUN1D3;PARK7;BMI1;SMAD7;BAG5
prerank,negative regulation of chemotaxis (GO:0050922),-0.30324920805342903,-1.0489672291238492,0.3826086956521739,0.859477347432131,1.0,9/31,8.55%,SEMA6A;ROBO2;SEMA5A;SEMA3A;SEMA6D;ROBO1;SLIT2;SEMA3C;SEMA3D
prerank,regulation of histone modification (GO:0031056),0.5164830629175154,1.0485792067946966,0.42971887550200805,0.80422476375331,1.0,6/13,21.22%,MYOCD;FLCN;HPF1;AKAP8L;UBE2N;SETD5
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3684985293488937,-1.0485292718301524,0.41596638655462187,0.857203004594099,1.0,3/16,1.09%,SOX5;FOXC1;PTN
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.26371687125373966,-1.0485290106119105,0.35185185185185186,0.8503998061449396,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.26371687125373966,-1.0485290106119105,0.35185185185185186,0.8503998061449396,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,regulation of intracellular pH (GO:0051453),0.44964427577726845,1.0484439555770402,0.4425287356321839,0.8040977247549992,1.0,11/34,22.06%,SLC9A4;CLN3;SLC9A9;SLC9A1;LRRK2;SLC9A8;NOX1;TMEM165;SLC9B1;SLC9A7;CHP1
prerank,negative regulation of cell migration (GO:0030336),0.4092130678023738,1.0477300089832045,0.42412060301507537,0.8054197762745647,1.0,34/137,17.38%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;TIMP1;NKX2-1;RAP2B;FLCN;DUSP10;PODN;VCL;ARHGDIB;PFN2;NF2;PTPRU;ADIPOR1;ADGRG1;ADARB1;STK24;ATP1B2;PTPRT;LRP1;NF1;EPHA4;PTEN;CORO1C;LDLRAD4
prerank,regulation of response to interferon-gamma (GO:0060330),0.5123594185327772,1.0475798589890248,0.4377564979480164,0.805335834157067,1.0,9/14,30.33%,IFNGR2;PIAS1;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37;SUMO1;JAK2
prerank,regulation of filopodium assembly (GO:0051489),0.4444328319359612,1.04711986092853,0.4653014789533561,0.806030589726533,1.0,10/38,14.40%,PRKCD;ARAP1;RIPOR2;DOCK11;CAPZB;AGRN;NRP1;FNBP1L;ARF6;MIEN1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.50172822210464,1.0465628757198302,0.42597402597402595,0.8069711768293475,1.0,2/14,5.17%,LPIN2;CHKB
prerank,positive regulation of cell projection organization (GO:0031346),0.40903403983698416,1.0460726394273157,0.42697768762677485,0.8077262418024358,1.0,20/115,14.54%,PTK2B;LYN;CAMK1D;ARSB;SS18L1;PLXNC1;MDK;SLITRK1;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;NPTN;ARHGDIA;CUX1;ATP1B2;RAP1A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.38544823972872455,-1.0460605907440228,0.39590443686006827,0.8541636277226977,1.0,7/14,21.50%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1;KMT2E;PRDM9
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.49390633255653604,1.0456875113900777,0.43112244897959184,0.8082382483080053,1.0,3/18,5.80%,PCID2;NXF1;THOC2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47980560010357487,1.0456582535197954,0.44125,0.8078494682275479,1.0,3/20,10.05%,PCSK9;EPO;NEDD4L
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3646629216987361,-1.0438929665234866,0.3807531380753138,0.8569503848839132,1.0,8/17,23.34%,SOD2;PRKG1;TGFB3;PPARG;TAFA5;PDCD4;CDKN1A;GPER1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4859212915914479,1.043643692235756,0.46964064436183395,0.8125147658793486,1.0,5/20,13.13%,TRAF2;IL18;MALT1;DENND1B;B2M
prerank,ceramide biosynthetic process (GO:0046513),0.4433302538995467,1.0435975811602838,0.4330357142857143,0.8121495562786412,1.0,14/40,22.59%,CERS6;CLN8;ST8SIA4;ST6GALNAC4;AGK;DEGS1;ASAH1;SGMS1;B4GALNT1;SPTSSA;SMPD1;SPTSSB;B4GALT6;CERS4
prerank,positive regulation of neurogenesis (GO:0050769),0.42304125990205477,1.0434780274172346,0.4328824141519251,0.8120073435336126,1.0,14/68,13.64%,CX3CR1;SS18L1;PLXNC1;SLITRK1;PLXNB2;FZD3;CTNNB1;DISC1;NAP1L1;NUMB;SMARCD3;NPTN;ARHGDIA;CUX1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4249243377597425,1.0431550078695382,0.4264859228362878,0.8123524108554285,1.0,15/70,16.29%,RUNX1;GATA1;OSM;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of axonogenesis (GO:0050771),0.46354681592986796,1.043113032334473,0.4395734597156398,0.8119813927176392,1.0,8/27,17.75%,THY1;FGF13;DIP2B;ARHGDIA;EFNB3;RTN4;PTEN;RHOA
prerank,nucleoside catabolic process (GO:0009164),-0.42589694779212994,-1.0431080329252969,0.4290322580645161,0.8558920391185632,1.0,2/11,5.30%,UPP2;NT5E
prerank,'de novo' posttranslational protein folding (GO:0051084),0.45831308726641745,1.0428991920630437,0.46533490011750883,0.8120545811835777,1.0,7/30,16.71%,PTGES3;SDF2L1;DNAJC7;CHCHD4;BAG1;GAK;ERO1A
prerank,cellular sodium ion homeostasis (GO:0006883),0.5038339537607874,1.0422855533519781,0.43359375,0.8130830019995539,1.0,5/15,13.76%,SLC8A1;SLC9A1;NEDD4L;ATP1B3;ATP1B2
prerank,apoptotic process (GO:0006915),0.4018750446908164,1.042081028971506,0.409,0.8131335120025497,1.0,38/203,14.99%,PTK2B;ITGB2;IL1A;PRKCD;TLR2;MTOR;ELMO1;ESPL1;CXCR4;BRAT1;PYCARD;CD14;CASP1;APAF1;CFLAR;BCL2L1;CDK11B;TGFBR2;BAK1;ATCAY;MCM2;TNFRSF21;BNIP1;CASP7;DAP;IAPP;PPP2CA;DDIT4;IKBKG;CASP8;STK3;TRADD;IRF1;HK2;BMF;CAPN3;VDAC1;RNF152
prerank,maintenance of blood-brain barrier (GO:0035633),-0.29414918116992866,-1.0413476626686864,0.36879432624113473,0.8575725141046213,1.0,9/30,15.11%,SLC12A2;TJP1;CDH5;DMD;CLDN5;CLDN12;JAM3;LAMC1;OCLN
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.43032319655677265,1.041049947731726,0.4320441988950276,0.8152780086315232,1.0,8/43,11.18%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3;SOX9
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4516924801791137,1.0408808487851495,0.4448315911730546,0.8152116128858561,1.0,8/29,13.44%,CORO1A;CYRIB;PRKCD;ARFGEF1;PFN2;PFN1;TWF2;SSH2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5237560184636575,1.0407577036093403,0.4618705035971223,0.8150315608390424,1.0,4/12,16.32%,UCK1;CDA;UCK2;DCK
prerank,response to histamine (GO:0034776),-0.424507605540397,-1.0402476392302111,0.3993993993993994,0.8573122956110877,1.0,3/10,10.55%,GABRB2;GABRB1;GABRB3
prerank,positive regulation of filopodium assembly (GO:0051491),0.4673818058344974,1.0400809225479066,0.4504950495049505,0.8162281576559989,1.0,8/24,17.93%,ARAP1;RIPOR2;DOCK11;AGRN;NRP1;FNBP1L;MIEN1;CDC42
prerank,negative regulation of DNA binding (GO:0043392),0.4603198734453465,1.0400081813698665,0.4576470588235294,0.8159560166802279,1.0,2/28,2.40%,GATA1;MAD2L2
prerank,striated muscle cell differentiation (GO:0051146),0.5030294577510119,1.0398811558544283,0.43820224719101125,0.8158125094085215,1.0,5/16,12.63%,SKI;PLD3;MYOCD;MEF2C;NRG1
prerank,mRNA metabolic process (GO:0016071),0.40813414258595615,1.039827080920202,0.444672131147541,0.8154830050637528,1.0,16/90,12.06%,SLFN14;ERN1;SF3B2;AURKAIP1;SCAF11;TP53;ZC3H12D;LSM11;HSF1;PPARGC1A;PCBP3;AGO4;SON;AGO3;METTL3;PRPF8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5118897791209089,1.039479913536371,0.45690834473324216,0.8158478966834946,1.0,4/12,20.61%,TSPO;FDXR;FDX1;STARD3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.40941541076392934,1.0393112879513324,0.4351378958120531,0.815790295022298,1.0,16/88,13.07%,STAT5A;PIK3CD;ITGB3;TGFBR1;RGCC;PRKD2;APOE;PDCL3;XDH;VEGFB;ATP5IF1;PDCD6;NRP1;THBS1;NR4A1;ATP5F1A
prerank,mitochondrial genome maintenance (GO:0000002),0.5183016621843989,1.0384569856221726,0.4352773826458037,0.8175150632212284,1.0,7/11,27.01%,MEF2A;LONP1;MGME1;MPV17;PARP1;AKT3;TOP3A
prerank,regulation of axon guidance (GO:1902667),0.5363243929506433,1.0382424112010362,0.4606413994169096,0.8175721359032263,1.0,5/10,28.44%,NRP1;ZSWIM6;MYCBP2;VEGFA;ZSWIM5
prerank,cardiac muscle cell action potential (GO:0086001),0.4600770244592589,1.0378433491452133,0.45664739884393063,0.8181206128191943,1.0,5/30,4.32%,SCN4B;HCN4;SLC8A1;PKP2;KCNIP2
prerank,rRNA transcription (GO:0009303),0.483337547018808,1.0375621381523865,0.43905635648754915,0.8183875280770897,1.0,3/17,7.94%,POLR1E;GTF3C4;GTF3A
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.45224332175324217,1.03695259231774,0.44221698113207547,0.8194369946330335,1.0,4/31,9.11%,SYT17;SYT2;STXBP3;SYT10
prerank,regulation of interleukin-1 production (GO:0032652),0.5019680015377406,1.0367102522015745,0.4451697127937337,0.8195840152031466,1.0,3/15,6.34%,SIRPA;HMGB1;ANXA1
prerank,regulation of protein sumoylation (GO:0033233),0.49123521543295845,1.0361196654010258,0.43546284224250326,0.8206462884967922,1.0,6/17,20.01%,CTNNB1;HDAC4;UBA2;CAPN3;PIAS1;RWDD3
prerank,regulation of heart contraction (GO:0008016),0.4112921646546276,1.0358292948212446,0.43979591836734694,0.8208911637049707,1.0,15/90,13.93%,KCNJ11;TMIGD3;HCN4;SLC8A1;KCNIP2;P2RX4;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2;DES
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4083808492143308,1.0352260904181754,0.44410569105691056,0.8219273914154254,1.0,19/108,12.34%,RUNX1;NFATC1;TLR2;GNAQ;CDK14;OTULIN;SKI;TNFAIP3;LGR6;MACF1;CTNNB1;DISC1;CSNK2A1;SULF2;MDFIC;ATP6AP2;AMER1;NLK;PPP2CA
prerank,intracellular protein transport (GO:0006886),0.3986261674909576,1.0351620245453592,0.403,0.8216295167706651,1.0,79/304,19.42%,MMP12;TBC1D9;TGFB1;SYK;CD74;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;NUP62;AP1S3;TMED3;SNX9;XPO1;RAB14;RAB3GAP2;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;STXBP3;TBC1D10A;RAB28;SNX27;CSE1L;RAB31;STRADB;PDCD6;SYNRG;ARL5B;ARL4A;TPR;RAB1B;TBC1D2;TBC1D17;COPA;CLTC;HDAC6;TBC1D2B;WDR11;XPO6;SEC16A;TBC1D8;STX3;SORL1;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;TBC1D14;STRADA;TBC1D22B;YWHAH;SMURF1;RPL11;SNX13;APPL2;ARFIP2;VPS28;IFT27;ARHGEF2;MYO1C;STX2;GIPC1;VPS33B;SLU7;TBC1D12;LTBP2;TBC1D5;DESI1;RAB29;SEC13
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.31714542542340574,-1.035117945543093,0.36363636363636365,0.8687697089081063,1.0,5/23,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47798788910947854,1.0348488899029629,0.43439490445859874,0.821972542211115,1.0,4/20,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4649599129989103,1.0342864241078702,0.4439140811455847,0.8229389519792212,1.0,4/24,11.77%,PRKAR2B;MGRN1;PDE11A;CDC34
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.42952088459214427,1.0342807710712403,0.42950108459869846,0.8224845688992515,1.0,17/48,21.97%,TAF1A;POLR1E;SF3B1;ZMIZ2;ACTB;ARID1A;ARID1B;ATAD2;POLR1B;POLR2L;ELOF1;ERCC6;MYO1C;POLR2E;PADI2;TAF1C;SMARCA5
prerank,peroxisome organization (GO:0007031),0.4622501179450289,1.0340651452833727,0.4326923076923077,0.8225249401778236,1.0,11/25,25.04%,PEX11A;ABCD1;PEX7;SEC16B;PLAAT3;ABCD2;DNM1L;FIS1;ACOT8;TMEM135;MFF
prerank,regulation of small molecule metabolic process (GO:0062012),0.4608540632607177,1.0339739144042628,0.453781512605042,0.8222814182938508,1.0,8/28,14.79%,NR1H4;APOE;FMO5;ACADL;ADIPOR1;TTC39B;FOXK1;ARV1
prerank,DNA geometric change (GO:0032392),0.4709678588255713,1.0338883941444177,0.46117084826762245,0.8220247214624413,1.0,6/24,14.15%,DHX9;HMGB1;ANXA1;MCM9;DNA2;DDX1
prerank,tRNA transport (GO:0051031),-0.2841837223181176,-1.0335968553180221,0.36036036036036034,0.8700100237233387,1.0,11/35,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;YBX1;NDC1;RAE1;NUP153;NUP37
prerank,gland development (GO:0048732),0.42485871318165463,1.0331715315605199,0.4369747899159664,0.8233472776983253,1.0,14/59,16.02%,SHH;PCSK9;TGFBR1;MDK;PKD2;CEBPA;ANXA1;NKX2-1;SOX9;NRG1;SOX2;TG;IGSF3;NF1
prerank,regulation of centriole replication (GO:0046599),0.4851858305369837,1.0331427335337395,0.44923857868020306,0.82295647245691,1.0,5/18,7.73%,NUP62;MDM1;PLK4;PLK2;CEP76
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.47653713752098026,1.032830053058413,0.4589963280293758,0.8232522152224809,1.0,2/21,4.27%,MED17;MITF
prerank,mitotic sister chromatid segregation (GO:0000070),0.409939703310516,1.0322926892258908,0.4651639344262295,0.8241061110504223,1.0,26/98,20.56%,NUP62;ESPL1;CDC23;TTN;NCAPG2;SEH1L;KIF14;CSNK2A2;CSNK2A1;RB1;KIF23;RAB11A;BECN1;PDS5A;RRS1;INO80;AKAP8L;PDCD6IP;NAA50;EML4;CENPK;MIS12;SMC4;MCPH1;DIS3L2;CUL3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4725367912538673,1.0320449622859764,0.46463414634146344,0.824265547852439,1.0,6/21,17.70%,SCN4B;NOS1AP;KCNA5;CACNA1D;SCN5A;AKAP9
prerank,acute-phase response (GO:0006953),0.5138800870063673,1.0320353644484976,0.4625668449197861,0.8238191493740996,1.0,2/12,7.68%,IL6R;CEBPB
prerank,positive regulation of cell differentiation (GO:0045597),0.3994487004338986,1.031339344948575,0.418,0.8250790773881413,1.0,38/237,13.61%,PF4;ASCL1;TGFB1;RIN2;LPL;TGFBR1;GPRC5B;MMD;MTOR;MDK;MAPK14;SP7;MSR1;RGCC;IL6R;IL18;RIPOR2;CTNNB1;TGFBR2;MEF2A;CEBPB;ASXL2;SNAI1;MEF2C;SMAD3;AKIRIN1;PRKCH;IMPACT;LRP5;CMKLR1;ATP6AP1;SOX9;NELL1;SDCBP;CREB1;BAMBI;NFKB1;SOX6
prerank,mitotic cell cycle phase transition (GO:0044772),0.4021177891746737,1.0309823015911996,0.445,0.8254921354983502,1.0,37/204,14.42%,TUBB;GPR132;PRKAR2B;HAUS2;CDK14;CCND3;CDC23;TUBA4A;FBXL22;CCND2;CNTRL;CEP192;MAPRE1;UBE2S;DNM2;CEP70;GSPT1;PLK4;PIM2;PLK2;CEP76;CHEK2;RB1;ENSA;HAUS1;CDK7;DBF4;INHBA;CDC34;DYNC1H1;PCM1;CDK6;FBXL3;MAX;CEP152;HAUS8;CCNE2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4055212781203564,1.0301221517481356,0.4433094994892748,0.8272338438994753,1.0,29/100,20.78%,BAG2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;XPO1;TAF1;HECTD1;GNA12;HFE;USP7;DET1;CSNK1A1;SDCBP;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;RPL11;GIPC1;KEAP1;ELOB;DESI1;TLK2;RAD23B;GSK3B;PRKN
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3936411591601233,1.0298988857945173,0.315,0.8273334739122681,1.0,270/1667,14.33%,RUNX1;BATF3;SPIC;NFE2;LILRB1;IRF5;NPAS4;MMP12;AHRR;PF4;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;SLC11A1;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;STAT5A;NFE2L2;POU2F2;BRD8;FNIP2;LPIN2;NLRC5;RPL23;CSF1R;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;EDNRB;TLR2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;MAPK14;IER2;OSM;MED13L;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;PRDM12;SEMA4D;RXRB;FOXD2;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;TET3;ITGA6;RGCC;RFX1;PRKD2;PKD2;MLXIP;APOE;CIR1;BPTF;UBE2D3;MITF;ZFP30;CRYM;SKI;ATF3;CEBPA;CDK8;FOXO3;SRCAP;FHOD1;ZMIZ2;LRRFIP1;DDIT3;SPI1;IL18;FIZ1;MYT1L;ZBTB12;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;GALR1;HMGB1;TAF1;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;MRTFA;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;ZNF177;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;PHF21A;NRL;TAL1;USF1;MYOCD;RCOR1;TNRC6A;AGRN;KDM7A;HSBP1;YY1;TCF20;CREB3L1;SLC9A1;STAT4;ZFP90;EPO;CEBPB;ASXL2;DBX2;ST18;LMO2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;MOV10;RB1;TRIM27;GMEB2;SMAD3;AKIRIN1;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;PPARGC1A;ZNF32;ARID3B;ATRX;AGO4;CDK7;CREBRF;RNF4;ARID4A;ANXA4;IMPACT;GMEB1;CPEB3;STAT5B;MCRS1;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;NEDD4L;TPR;ACTR2;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;RPAP2;NFIC;ATAD2;TBL1X;INHBA;MED27;ACTR3;KLF13;CHD1;RNASEL;CREB3L2;PKN1;BAZ1A;TXK;HCFC2;ZSCAN26;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;PTOV1;JDP2;NR2C2;AGO3;ETV6;ZNF740;NRIP1;E2F6;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;NOD2;SDCBP;MTF2;CREB1;RPS14;LAGE3;IKBKG;ZFP64;KAT7;ZSCAN18;SMARCD3;NR4A1;PPIL4;MAX;SMARCB1;ZFX;ZNF445;GPS2;NFKB1;FOXK1;SAFB2;RFX7;SOX6;CUX1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;USP9X;WFS1;SOX2;KDM3B;BRD7
prerank,negative regulation of cell division (GO:0051782),-0.4169659035181552,-1.0294895142643736,0.3951048951048951,0.8785741148212268,1.0,7/11,43.89%,ZFYVE19;VPS4A;ORC6;CHMP4C;E2F7;MYC;E2F8
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40994481434169666,1.029414304904604,0.46018614270941055,0.8280776145802458,1.0,14/72,13.58%,LPAR6;ABCA1;ARHGEF18;APOE;GPR17;RIPOR2;MYO9B;FLCN;ARHGDIB;F11R;NRP1;ADGRG1;ARHGEF3;ARHGDIA
prerank,protein catabolic process (GO:0030163),0.41957270869124974,1.0291709005530172,0.4504792332268371,0.8282335847053276,1.0,15/59,18.32%,CTSD;MTOR;CLN8;APOE;DDI2;OGA;CHEK2;TRIM24;STT3B;UBE2G2;CAPN3;IDE;HSP90AA1;USE1;FBXO44
prerank,positive regulation of translation (GO:0045727),0.40866745787063125,1.0291504108933427,0.46279306829765543,0.8278139967123886,1.0,24/94,17.95%,NIBAN1;MTOR;DHX9;PLXNB2;CIRBP;FASTKD3;YTHDF3;LARP4B;LARP1;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;RCC1L;HNRNPD;SOX4;USP16;RPS4X;AGO2;CNBP
prerank,protein import into peroxisome membrane (GO:0045046),0.4621366118440763,1.0289985928474403,0.4431818181818182,0.8277012708443582,1.0,4/22,9.10%,RAB8B;ABCD1;PEX13;PXMP2
prerank,cardiac muscle cell differentiation (GO:0055007),0.4701040659349902,1.028859880691483,0.4622754491017964,0.8275770736546318,1.0,5/21,12.63%,SLC8A1;TTN;MYOCD;MEF2C;NRG1
prerank,actin filament bundle organization (GO:0061572),0.4476418738191952,1.0285261537901873,0.44815668202764974,0.8279387394301313,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,organic anion transport (GO:0015711),0.4088538722380745,1.0284238646204191,0.4423676012461059,0.827717806463784,1.0,12/76,15.17%,AQP1;ABCC6;SLC52A1;SLCO2B1;LRRC8D;CYB5R1;SLC16A2;CYB5RL;MGST1;SLC35A3;SLCO1B1;LRRC8C
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.45870107325184967,1.0283170003742372,0.43896424167694204,0.8275040708685183,1.0,7/23,16.72%,P2RX7;MLXIPL;PFKFB4;NFKB1;PFKFB3;HIF1A;GAPDHS
prerank,long-term synaptic potentiation (GO:0060291),0.47073325419635526,1.0280784734131225,0.4550063371356147,0.8276406531253407,1.0,2/21,7.63%,PTK2B;PLK2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3825926717349539,-1.0273172899985823,0.39325842696629215,0.881608019337368,1.0,7/14,29.97%,UPP2;NT5E;DHODH;NT5C1A;UMPS;UPB1;CAD
prerank,triglyceride biosynthetic process (GO:0019432),0.47804519689153624,1.0272500029673086,0.4475703324808184,0.8292031981698357,1.0,7/18,20.90%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,positive regulation of neuron projection development (GO:0010976),0.4069493245677203,1.027203727921955,0.451081359423275,0.8288583614509574,1.0,16/85,14.54%,PTK2B;LYN;CAMK1D;ARSB;MDK;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;LRP8;NPTN;ATP1B2;RAP1A
prerank,myoblast differentiation (GO:0045445),-0.36996913630133926,-1.0265385602240134,0.41245136186770426,0.8804804724120641,1.0,6/14,13.26%,TCF7L2;REST;HINFP;EPAS1;JAG1;MAPK12
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3080258450707011,-1.0263827967275718,0.3974358974358974,0.8776253337426191,1.0,10/25,26.87%,NLGN1;SHANK3;SHANK1;PRRT1;CACNG8;SHISA9;GSG1L;SHISA7;CACNG2;ADRB2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3518270426068343,-1.0263233925733781,0.397196261682243,0.8745013339508421,1.0,6/18,12.66%,SLC25A12;FOLH1;MTHFD1;SLC25A13;SMS;GOT1
prerank,neuron projection development (GO:0031175),0.3977447912806625,1.0261605144754011,0.45190380761523047,0.8310053591400306,1.0,42/168,20.53%,NCKAP1L;LYN;NEFH;TAOK3;PRDM12;MICALL2;ATP7A;APOE;WHRN;HMGB1;DOCK10;DNM2;GPRIN3;MICALL1;LRP12;TNIK;KIF20B;RB1;NTF3;ATCAY;RAB11A;DTNBP1;STX3;TOR1A;LRRK2;ERCC6;SVBP;CAMSAP2;ALS2;EPHA4;PTEN;EPHA8;TBC1D23;MANF;CDC42;MINK1;TAOK1;GDNF;CNTN4;CDK5R1;GSK3B;MAP4K4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5037636548470912,1.026087990851049,0.46825396825396826,0.8307257113759557,1.0,4/13,13.41%,IL18;TYROBP;TICAM1;GAS6
prerank,regulation of cellular protein catabolic process (GO:1903362),0.47863142590880464,1.0259715338096727,0.4494949494949495,0.8305335070088983,1.0,8/18,19.66%,WDR91;VPS11;AMER1;NELL1;FAF1;HSP90AA1;DACT1;ATRAID
prerank,negative regulation of proteolysis (GO:0045861),0.4400397414260519,1.02570916985898,0.4596774193548387,0.8307238603967447,1.0,9/34,19.16%,CST7;CLN8;CLN3;TIMP1;HDAC6;LRRK2;EPHA4;PTPN3;TMEM59
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5216849172221627,1.0255724000610258,0.4764621968616263,0.8305941201891194,1.0,4/11,16.71%,GCH1;QDPR;SPR;HSP90AA1
prerank,cellular protein localization (GO:0034613),0.3940189601268036,1.0255353088434975,0.439,0.8302248953463456,1.0,97/285,23.15%,TBC1D9;CD74;SH3PXD2B;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;TMED3;SNX9;RAP2A;RAB14;RAB3GAP2;TBC1D16;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;CTNNB1;STXBP3;TBC1D10A;MYO7A;RAB28;SNX27;RAB31;ITSN1;PDCD6;SYNRG;ARL5B;ARL4A;VCL;RAB1B;TBC1D2;TM9SF2;TBC1D17;COPA;CLTC;HDAC6;PTPRU;CD63;TBC1D2B;BICD2;WDR11;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;LAMTOR3;VPS29;LRRK2;CAPN3;TBC1D14;AHI1;TBC1D22B;YWHAH;SMURF1;SNX13;MESD;ARFIP2;IFT27;ARHGEF2;LAMTOR1;STX2;VPS33B;SLU7;ANGPT1;TBC1D12;PACS2;TBC1D5;RAB29;SEC13;HHEX;SEC31A;USO1;ARCN1;COG7;AMOT;PIGU;HERC2;RRAGA;RRAGB;ERP29;UNC50;FLNA;NAPA;ABHD17A;NPHP1;ADPRH;ARL5A;CEP68;TBC1D9B;STX7
prerank,chordate embryonic development (GO:0043009),0.4193541002889258,1.0255277160988903,0.4582881906825569,0.8297726074666198,1.0,7/55,9.39%,TGFB1;TGFBR1;PKD2;CHD7;FLCN;SULF2;XYLT1
prerank,external encapsulating structure organization (GO:0045229),0.3971647627236701,1.0245924889140468,0.438,0.8316684100191697,1.0,25/205,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5183117839085972,1.023967561659474,0.4566145092460882,0.8327949472963714,1.0,5/12,17.27%,CLN3;ATP6AP2;GRN;LRRK2;TMEM165
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4782449167112699,1.023591167690861,0.4700122399020808,0.8332196096907454,1.0,5/19,12.46%,SMOC2;PIK3CB;XDH;CD63;CCBE1
prerank,regulation of histone methylation (GO:0031060),0.5048612735042081,1.0234195127866452,0.4549237170596394,0.8331848344134685,1.0,3/13,15.10%,NSD1;TTLL12;PIH1D1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5282154955887635,1.022675151833466,0.47746478873239434,0.8345365440617043,1.0,3/10,9.69%,HMGB1;TP53;ATF7IP
prerank,odontogenesis (GO:0042476),-0.28517569183232216,-1.0222333698020578,0.4166666666666667,0.8825742106787877,1.0,9/35,14.77%,FOXC1;EDA;BMP4;GLI2;WNT6;HDAC2;COL1A2;TBX1;TGFB3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.424611022326611,1.0220891590363315,0.47282608695652173,0.835544768649061,1.0,9/48,13.64%,CASS4;RREB1;SS18L1;MDK;NEDD9;P4HB;LIMS1;NRP1;CUX1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4288088334629616,1.021694666652625,0.46420581655480986,0.8360139635927412,1.0,11/39,20.21%,PCSK9;SCN4B;FGF13;WNK1;NEDD4L;WNK4;FXYD5;YWHAH;FXYD6;PTPN3;FXYD1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4747836406700784,1.0215732431242872,0.4714104193138501,0.8358688070013169,1.0,7/19,20.99%,PRDX1;PRDX3;PRDX2;PXDN;NOX1;PRDX5;CYBA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.40938893631587997,1.0215558014633923,0.47253886010362695,0.8354488623633315,1.0,19/80,14.40%,P2RX7;KCTD17;ARAP1;ARPC2;PLEKHM1;RIPOR2;DOCK11;AGRN;WASF2;P2RY12;AKIRIN1;ACTR2;ACTR3;PFN1;CYFIP1;NRP1;TWF2;FNBP1L;MIEN1
prerank,regulation of osteoblast proliferation (GO:0033688),0.478675019222552,1.0214487260526717,0.45897435897435895,0.8352612469359485,1.0,5/17,19.66%,HPSE;NELL1;RHOA;GREM1;ATRAID
prerank,skin development (GO:0043588),-0.24519246878381237,-1.0211858047737328,0.40384615384615385,0.882175783286297,1.0,14/65,15.14%,COL5A2;ERRFI1;CLIC4;COL3A1;WNT5A;BCR;ITGB4;COL5A3;COL1A2;MET;JAG1;CASP3;COL1A1;UGCG
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39363723293670405,1.0209743794205361,0.424,0.8359332455031445,1.0,98/572,14.24%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;UXT;GATA1;FNIP2;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;ZEB2;PRDM12;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;BHLHE41;HDAC5;HMGB1;TAF1;BACH1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;HSBP1;YY1;ZFP90;EPO;CEBPB;SNAI1;MEF2C;FLCN;TFAP2B;RB1;TRIM27;SMAD3;GTF2IRD1;IRF2;HSF1;ATRX;IMPACT;CPEB3;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;HCFC2;SOX9;JDP2;NR2C2;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;RPS14;MAX;GPS2;NFKB1;CUX1;HCFC1;ZFHX3;USP9X;WFS1;SOX2
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2779763954517428,-1.0208020597615088,0.3870967741935484,0.8798555892063618,1.0,30/42,35.85%,REV1;RFC1;WRNIP1;PRIMPOL;ZBTB1;WRN;USP10;RFC2;POLN;POLA1;UBC;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;UBA52;USP43;POLD2;RPA2;RFC3;RPS27A;PCLAF;POLE;RFC4;PCNA;CDKN2D;POLD4;POLD1
prerank,polyol biosynthetic process (GO:0046173),-0.36196791078508483,-1.0206817756001905,0.4194915254237288,0.8768784360843451,1.0,7/16,23.13%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK;ISYNA1;CYP2R1
prerank,negative regulation of cell cycle (GO:0045786),0.4076065331783198,1.0205635747756125,0.4653567735263702,0.8364804013620087,1.0,21/73,20.95%,LILRB1;TGFB1;HPGD;CEBPA;MYOCD;RB1;SMAD3;SIPA1;ANGEL2;INHBA;TRIM35;CDK6;NR4A1;RPS6KA2;PTEN;PTPN3;SCRIB;HHEX;NPPC;HEXIM1;TFAP4
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4566387423325449,1.0204184426935474,0.4543147208121827,0.8363759684625268,1.0,6/21,20.45%,FRAT2;CTNNB1;AMER1;CSNK1A1;FZD2;GSK3B
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.39998381923481113,1.0203415482699438,0.48185483870967744,0.8361037145478651,1.0,27/124,17.60%,LYN;PLEK;CSF1R;PRDM12;MICALL2;PKD2;APOE;HMGB1;TTC29;GPRIN3;MICALL1;LRP12;RB1;ATCAY;RAB11A;DTNBP1;CYFIP1;STX3;TOR1A;ATP1B2;PLEKHA1;ERCC6;EPHA8;ARFIP2;WDPCP;TBC1D23;MANF
prerank,cGMP biosynthetic process (GO:0006182),0.5274536682586797,1.0202034823006627,0.4666666666666667,0.8359762012418156,1.0,2/10,10.24%,GUCY2F;NPR2
prerank,negative regulation of locomotion (GO:0040013),0.5056035578321967,1.020137267468849,0.4793152639087018,0.8356468448511095,1.0,2/12,8.85%,DUSP3;SPINT2
prerank,response to estrogen (GO:0043627),0.4447277765747877,1.0201097929547205,0.4695752009184845,0.8352488535424637,1.0,6/31,15.48%,TRIM25;OCSTAMP;TRIM24;RBBP5;SRA1;NCOA4
prerank,muscle cell migration (GO:0014812),0.5253487710254066,1.020108652602693,0.48265460030165913,0.8347886112880388,1.0,1/10,1.74%,ITGB3
prerank,bone morphogenesis (GO:0060349),0.4946416480247785,1.0193657651806185,0.4666666666666667,0.8361402965168648,1.0,2/14,9.91%,SKI;LRP5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.39923270872612915,1.019176621318866,0.4788732394366197,0.8361201477241921,1.0,23/129,14.27%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;BACH1;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.4087345202335606,-1.0190222725646283,0.428125,0.8782391134028672,1.0,2/10,13.44%,CAV1;ANK3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4632160310834773,1.0188326105091945,0.4725943970767357,0.8364789717273179,1.0,11/21,27.83%,PPP1R11;YWHAB;ENSA;BOD1L1;PPP4R4;PTPA;GSK3B;PPP1R16B;MFHAS1;TIPRL;CRY2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.23589453009420322,-1.018644014524096,0.3793103448275862,0.8760441637200892,1.0,12/85,7.32%,PIEZO2;ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43445086857573906,1.0183966367541593,0.4598870056497175,0.83709273398328,1.0,9/36,13.05%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,cellular protein modification process (GO:0006464),0.3909817788810805,1.0183870571067464,0.398,0.8366583218587091,1.0,210/983,18.94%,PTPRC;PTK2B;BTK;PTPN7;FGR;LYN;GMFG;PPM1H;HCK;DAPP1;TGFB1;SYK;PCSK9;WDTC1;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;COPS6;F13A1;TGFBR1;TYK2;PPP2CB;PRKCD;PTPRJ;MTOR;PTPN1;DUSP29;BMP2K;TEC;GRK3;PTPN18;ERN1;NEK6;CDK14;ATG7;ART4;PTPRE;PRKD2;ST8SIA4;APOE;UBE2D3;MYLK3;DNAJC3;CEL;CDK8;FBXL22;SPP1;RNF7;TIMP1;OARD1;NPC1;MORC3;FBXL18;TLK1;PARP8;TAF1;PTP4A2;KLHL21;PRKCB;ANXA1;MKNK1;CDK11B;UBE2S;STK10;TGFBR2;PSMB10;MAP3K5;OGA;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;P4HB;PLK2;MTMR3;CSNK1G2;LOX;CHEK2;CSNK2A1;ST3GAL1;MAP3K1;STRADB;DUSP10;MAN2B1;CHML;PRKCH;PGAP1;FUT9;CDK7;B3GALNT1;PIGH;RAB11A;MCRS1;STK17B;RAB1B;VGF;ST8SIA1;FAM20C;MSRA;RNASEL;LGALS1;CHGB;PKN1;PSMA2;TXK;YES1;RBBP5;THBS1;RPS6KA4;PTPRU;PTPRO;TIMM50;NLK;FBXO40;PRKACB;PARP16;CCL2;CDC34;KLHL11;RBBP7;FBXO32;MAN2A2;CSNK1A1;F5;FYN;PPP2CA;TNKS2;GRK4;MAP3K12;CDK6;PSME3;CREB1;STT3B;B4GALT7;SUMF2;FBXL3;LIPE;ILKAP;MERTK;CAMKK2;COPS4;TIPARP;BRAF;GAS6;SSH2;STK3;STK24;PSMB5;CTTNBP2NL;PTPRT;BMX;WFS1;PSMD8;LRRK2;NIM1K;WNK4;PPP1CC;CCDC8;DCAF17;TESK2;LARGE1;METAP2;PTPRA;PSMD7;STRADA;GAN;PSMB9;SGK3;GSK3A;CDK15;MAP3K11;HIF1A;ATG3;APLP2;COQ8B;PTEN;WSB2;ERO1A;STK4;PTPN12;PPP3CB;MACROD1;DCAF5;FEM1B;PIK3R4;RPS6KA5;CDK18;SIK2;VHL;PPM1M;PDPK1;PSMD2;KEAP1;DDOST;VRK1;FBXO44;PPP2R5C;CSK;MINK1;PTPN3;PPP4R2;MXRA8;SPSB2;IGFBP4;ELOB;TAOK1
prerank,liver development (GO:0001889),0.4425321272300343,1.0183124541666326,0.45662100456621,0.8363726521027517,1.0,5/32,7.68%,PCSK9;PKD2;CEBPA;ANXA1;CEBPB
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4271034907543853,1.0182427232692768,0.4682981090100111,0.8360844603889499,1.0,9/39,18.76%,RAB8B;ABCA1;SEL1L;PPY;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4443782757490943,1.017970460162159,0.45560747663551404,0.8362919443033159,1.0,12/27,27.02%,CHSY3;BCAN;XYLT1;CHSY1;CHST15;PXYLP1;CHPF;CSPG4;B3GAT2;CHST3;CHST11;CHST9
prerank,protein deacetylation (GO:0006476),0.42638357063461085,1.017904523704282,0.4727272727272727,0.8359672546505384,1.0,10/41,13.99%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11
prerank,manganese ion transport (GO:0006828),0.49354808995198224,1.0176942355553622,0.4725568942436412,0.8360362769193717,1.0,2/14,8.01%,SLC11A1;ATP2C1
prerank,amino acid import (GO:0043090),0.4714689957935806,1.017450659092463,0.4628930817610063,0.8361715006371501,1.0,4/21,9.26%,SLC7A8;SLC36A1;SLC16A2;SLC25A38
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.40134894566229135,-1.017448135088653,0.41233766233766234,0.876256169428845,1.0,5/10,30.15%,MAPT;PPM1F;DNAJA1;TERF1;NDFIP2
prerank,mesenchymal to epithelial transition (GO:0060231),0.5327616465847826,1.0173189531653677,0.481638418079096,0.8359985817531626,1.0,1/10,1.62%,BASP1
prerank,sodium-independent organic anion transport (GO:0043252),0.5327007631910773,1.017242044434652,0.48633093525179855,0.8357217373575371,1.0,3/10,14.98%,SLCO2B1;SLC16A2;SLCO1B1
prerank,regulation of chromosome segregation (GO:0051983),0.497102025735965,1.0169516110309678,0.4789272030651341,0.835955314459808,1.0,4/16,13.79%,CSNK2A2;CSNK2A1;PUM2;CDC6
prerank,myofibril assembly (GO:0030239),0.4257796815181467,1.0164505442556684,0.4857456140350877,0.8367289902185324,1.0,7/42,14.80%,TTN;MYLK3;FLII;CFLAR;TNNT3;CSRP1;CAPN3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4512253654372638,1.0161951587018756,0.47044917257683216,0.8368917046603818,1.0,4/26,7.84%,PLCG2;SNCA;ABCD1;TRAP1
prerank,regulation of cellular component organization (GO:0051128),0.401954327156317,1.0160564985997538,0.4839357429718876,0.8367832301445034,1.0,36/135,19.65%,CD22;MAD2L2;MTOR;PTPN1;SEMA4D;TNF;APOE;TRAF2;RASGRP2;RAP1B;CDK11B;AP2S1;PRKCQ;STON2;KIF14;METTL4;BCAR1;GFAP;RAPGEF1;STON1;ITCH;HCFC1;RAB33B;ATAD3A;ARHGEF11;RAP1A;SGK3;CAMSAP2;CD36;IRGM;HSP90AA1;LAMTOR1;PICALM;DCUN1D5;RPTOR;ROCK2
prerank,protein polymerization (GO:0051258),0.4213733870996978,1.0157838740926473,0.472193074501574,0.8370162719239626,1.0,9/56,12.84%,PREX1;FGF13;PSTPIP1;MICALL2;AIF1;UBE2S;WASHC3;DIAPH1;RNF135
prerank,regulation of viral life cycle (GO:1903900),0.46553264908049113,1.0152788392905987,0.4766009852216749,0.837756640344256,1.0,3/21,8.56%,TRIM25;TRIM5;TRIM27
prerank,cytoplasmic microtubule organization (GO:0031122),0.41363028883550773,1.0152717642314768,0.49626467449306294,0.8373102299464918,1.0,13/54,16.12%,HOOK3;CCDC88B;CLIP2;RAB11A;TUBGCP6;TUBGCP4;DYNC1H1;PCM1;KATNA1;HOOK2;DST;CAMSAP2;FIGN
prerank,regulation of programmed cell death (GO:0043067),0.3940862075310803,1.0150472827917685,0.4914572864321608,0.8374231647583132,1.0,34/161,16.74%,CD3E;CTSB;FLT3;NUP62;TNF;TMEM219;TRAF2;CASP1;ANP32A;APAF1;TP53;ACTN4;CRADD;MALT1;TPT1;NTF3;BCAR1;ACER3;ACTN1;LGALS1;NF2;TRIM24;SOX9;SRA1;PRDX2;LRP8;WFS1;LRRK2;PHLPP1;STEAP3;FANK1;RTN4;HSP90AA1;ASAH1
prerank,regulation of protein modification process (GO:0031399),0.4178291635766651,1.0144618839430857,0.47811816192560175,0.8383929394578036,1.0,21/50,24.71%,LYN;FNIP2;ATG7;FNIP1;PLXNB2;FLCN;HPF1;PHIP;PPP2CA;PUM3;CORO1C;ATG14;HSPB1;ABCA2;PIN1;MT3;ATG10;FKTN;PPP1R16B;SPRED3;SPRED1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4879653168049173,1.013707449005487,0.4606896551724138,0.8396942289449373,1.0,2/13,4.54%,CBL;ZFYVE28
prerank,negative regulation of fat cell differentiation (GO:0045599),0.43577984746618537,1.0133360484081761,0.49067599067599066,0.8401498774611077,1.0,6/34,14.32%,TGFB1;TNF;FLCN;SMAD3;GPS2;BBS12
prerank,renal absorption (GO:0070293),-0.4260480046481872,-1.0129968099931985,0.4383116883116883,0.8854467937307382,1.0,2/10,5.50%,GSN;KLHL3
prerank,regulation of urine volume (GO:0035809),0.5223910214761438,1.0129751853153683,0.45714285714285713,0.840571298362247,1.0,4/10,19.95%,ADCY6;TFAP2B;ADM;INPP5K
prerank,positive regulation of neuron migration (GO:2001224),-0.385904476860379,-1.0129066780243996,0.3952702702702703,0.8824487953130569,1.0,6/11,11.99%,SEMA6A;NIPBL;SEMA3A;DAB2IP;RAPGEF2;NSMF
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2460454852733852,-1.012543692595309,0.46938775510204084,0.8802705248887494,1.0,28/65,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;NABP2;PINX1;PSMC3;ZFYVE19;PSMB3;VPS4A;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4125979522891743,1.0124835196826083,0.48757763975155277,0.8413226046447522,1.0,15/64,18.91%,PCID2;GTF2H1;POLR1E;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.40923326039535207,1.012249329686674,0.48628691983122363,0.8414441983503685,1.0,15/65,17.77%,TGFB1;NRROS;TGFBR1;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1
prerank,protein maturation (GO:0051604),0.39916013895119545,1.0121011015905945,0.4789311408016444,0.8413512803413694,1.0,22/95,17.05%,CTSS;SRGN;ECE2;EEF1AKMT4-ECE2;CLN3;DDI2;TSPAN32;TSPAN14;MMS19;CIAO2A;CIAO1;NAA40;SORL1;NDUFAB1;STUB1;PCSK7;GALNT2;ECEL1;METAP2;NAA50;FURIN;PITRM1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.516423035743418,1.0116683984256243,0.47186147186147187,0.8419135869203994,1.0,2/10,7.24%,MLXIPL;ABCD1
prerank,regulation of cytoplasmic translation (GO:2000765),0.49675008433015605,1.0112896727589027,0.4961832061068702,0.842391750660485,1.0,6/14,20.49%,DHX9;CPEB3;CPEB4;CPEB2;CNBP;PKM
prerank,error-free translesion synthesis (GO:0070987),-0.32673345386257313,-1.0109784328790226,0.391812865497076,0.8814224981238755,1.0,15/22,39.93%,REV1;RFC1;RCHY1;RFC2;UBC;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA;POLD1;UFD1;RFC5
prerank,muscle cell development (GO:0055001),-0.2949219560116563,-1.0108625343808224,0.4161073825503356,0.8785131868743626,1.0,5/30,3.14%,ANK2;NEBL;CXADR;DMD;SGCZ
prerank,COPII-coated vesicle budding (GO:0090114),0.4082450296551262,1.010479509398918,0.47848898216159497,0.8439070282377492,1.0,27/68,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;VAPB;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,cellular senescence (GO:0090398),0.4518528806622642,1.0103736027713643,0.5,0.843692012765083,1.0,3/27,4.97%,PRKCD;MAPK14;SPI1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4815732264216174,1.0102295527165286,0.48026315789473684,0.8431323552521194,1.0,3/15,11.08%,AP3D1;AP3S1;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4815732264216174,1.0102295527165286,0.48026315789473684,0.8431323552521194,1.0,3/15,11.08%,AP3D1;AP3S1;DTNBP1
prerank,regulation of RNA export from nucleus (GO:0046831),0.5157387819822412,1.0100708348600023,0.49213161659513593,0.8430483747453772,1.0,5/11,16.01%,DHX9;TPR;SETD2;AKAP8L;NRDE2
prerank,artery development (GO:0060840),0.4553066704979794,1.0099538682715221,0.47665847665847666,0.8428711744798539,1.0,5/23,11.24%,TGFBR1;ANGPTL3;PKD2;HECTD1;NRP1
prerank,regulation of water loss via skin (GO:0033561),0.4836082065227028,1.009783745012639,0.4634146341463415,0.8423783760298659,1.0,1/15,1.99%,ALOX12
prerank,establishment of skin barrier (GO:0061436),0.4836082065227028,1.009783745012639,0.4634146341463415,0.8423783760298659,1.0,1/15,1.99%,ALOX12
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4620078641479004,1.0095588821089063,0.49097472924187724,0.8424478367221511,1.0,13/23,28.04%,SNCA;ADCY6;SLC9A1;GNG2;LRRK2;PRKN;TGM2;GABPA;ATP2B4;MAPK1;MAPK3;PRKACA;APLP1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4241114690354296,1.0092657637895126,0.48777777777777775,0.8427157039592214,1.0,12/43,17.40%,SNX5;PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;SORL1;PID1;GSK3A;ZBTB7B;SIK2
prerank,T-helper cell differentiation (GO:0042093),0.49459764236419546,1.0091500665928679,0.47908232118758437,0.8425486396605575,1.0,4/14,9.45%,ATP7A;HMGB1;TMEM98;GPR183
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.41067643364577183,1.0089223533030023,0.4825765575501584,0.8417197489420095,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,vesicle coating (GO:0006901),0.41067643364577183,1.0089223533030023,0.4825765575501584,0.8417197489420095,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,COPII vesicle coating (GO:0048208),0.41067643364577183,1.0089223533030023,0.4825765575501584,0.8417197489420095,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,protein import (GO:0017038),0.40107136004197214,1.0088913739543215,0.5,0.8413372960377002,1.0,11/84,10.11%,MMP12;SYK;RAB8B;NUP62;APOE;SNX33;ABCD1;CSE1L;PEX13;PXMP2;TPR
prerank,purine nucleotide catabolic process (GO:0006195),0.4966937777084497,1.0084685460255232,0.460431654676259,0.8418960905946674,1.0,3/13,8.29%,XDH;HINT1;PNP
prerank,epithelial to mesenchymal transition (GO:0001837),0.42166818627319175,1.008465967040764,0.4955555555555556,0.8414434188167136,1.0,13/47,20.45%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;LIMS1;SOX9;RBPJ;HIF1A;TASOR;LOXL3;ROCK2;GSK3B
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4481615612381919,1.0083260197543906,0.4713763702801462,0.8413070991363365,1.0,2/25,3.66%,LYST;VTA1
prerank,peptide hormone secretion (GO:0030072),-0.311588052166907,-1.0082041882989041,0.3939393939393939,0.8829091059566846,1.0,9/26,24.67%,LTBP4;CDK16;RIMS2;CAMK2G;PARK7;PTPRN;EDN1;EDN3;ADCYAP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4638992460123647,1.008189471141139,0.47307692307692306,0.8411909005230741,1.0,8/20,25.14%,PTGES3;LONP1;PSMG3;BBS12;HSP90AA1;PSMG2;HSPA4;HSP90AB1
prerank,regulation of fat cell differentiation (GO:0045598),0.40287433306105397,1.0081564836496921,0.4792099792099792,0.8408031150954458,1.0,16/74,18.19%,TGFB1;LPL;TNF;CEBPB;ASXL2;SMAD3;LRP5;CMKLR1;TAF8;CREB1;GPS2;BBS12;SYAP1;WDFY2;PPARD;CREBL2
prerank,Golgi to plasma membrane transport (GO:0006893),0.41630611001379225,1.0080483378802838,0.4890829694323144,0.8406063994900577,1.0,13/47,13.78%,RAB34;RABEP1;EXOC6;CCDC93;MACF1;VPS35L;RAB31;ARFGEF2;EXOC8;EXOC1;EXOC2;EXOC5;GGA2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4095166369671909,1.0077242562183604,0.49117341640706125,0.8408918034010286,1.0,16/66,14.24%,TGFB1;NLRC3;RGCC;APOE;XDH;MTSS1;AQP11;ATP5IF1;DUSP10;CASK;SOX9;THBS1;CDK6;ATP5F1A;B2M;SOX2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3318237830946229,-1.0073612335628825,0.4264705882352941,0.8822286145034537,1.0,6/20,14.96%,CHRM2;CAV1;SETD3;PLCE1;KCNB2;CHRM3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.45949464793506,1.0071173561447633,0.4963942307692308,0.8419010289848976,1.0,6/25,14.62%,CTSS;STAC;WNK1;ATP1B3;ATP1B2;WNK4
prerank,regulation of lamellipodium assembly (GO:0010591),0.424695572193113,1.005274260057446,0.4869762174405436,0.8458605584960536,1.0,8/34,12.18%,ARPC2;CAPZB;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.38813206922152443,-1.0051696261767649,0.4234527687296417,0.8849968143687461,1.0,6/12,18.49%,ANKRD13C;RER1;KDELR3;INSIG2;INSIG1;KDELR1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5048804708635348,1.0049241273625644,0.472992700729927,0.8462720694036351,1.0,1/11,0.91%,PLEK
prerank,cellular response to BMP stimulus (GO:0071773),-0.24008705462714078,-1.0048944881194806,0.4117647058823529,0.88261685957939,1.0,12/66,9.52%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1
prerank,spindle assembly (GO:0051225),0.39743169719462695,1.0043407066515444,0.49476987447698745,0.8471894277403478,1.0,18/67,18.47%,HAUS2;NEK6;BCCIP;CEP192;MAPRE1;STARD9;CHEK2;HAUS1;RAB11A;TUBGCP6;TUBGCP4;STAG2;INO80;HAUS8;KIF2A;RHOA;CEP63;MAPRE2
prerank,establishment of protein localization to organelle (GO:0072594),0.4060243110244407,1.0037531790136445,0.48704663212435234,0.8481676677362271,1.0,8/72,10.11%,MMP12;IL10RA;SYK;NUP62;CD68;CSE1L;RAB11A;TPR
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.44964804035320866,1.003696813312613,0.4867358708189158,0.8478341103010786,1.0,8/31,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,membrane organization (GO:0061024),0.3862948251646052,1.0036804758750644,0.5095095095095095,0.8474236565695458,1.0,63/227,21.09%,ARRB2;CBL;VAMP3;GRB2;RABEP1;SNX9;MTCH1;PIP5K1C;LDLRAP1;CLN3;ARPC2;NPC1;STX11;AP3D1;LPCAT2;ACTB;DNM2;GAPVD1;AP2S1;SYT2;ARPC3;SH3KBP1;ATP2C1;STON2;ITSN1;SNAP29;ACTG1;VAPB;SYNGR1;ACTR2;SYNGR2;ACTR3;DYSF;TMCC1;CLTC;TIMM50;ARPC4;SYNJ1;SNAP23;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HUWE1;GAK;EPS15;AP2M1;PDCD6IP;EPN1;CORO1C;BIN1;VPS33B;PICALM;UBXN2A;TMEM170A;DNM1L;FCHO2;FNBP1;USO1;NSFL1C;STAM2;AZIN2;RIMS1
prerank,response to metal ion (GO:0010038),0.40477987743783755,1.003336312505959,0.4947257383966245,0.8477885438549896,1.0,12/67,12.34%,IL1A;PPP2CB;SNCA;TTN;HAAO;KCNMA1;HFE;PDCD6;ALG2;NEDD4L;THBS1;PPP2CA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3166665149920967,-1.0032900645141483,0.45751633986928103,0.8839868435292845,1.0,18/24,35.85%,RFC1;XRCC1;RFC2;LIG1;UBC;POLK;RPA3;UBA52;POLD2;RPA2;RFC3;RPS27A;LIG4;POLE;RFC4;PCNA;POLD4;POLD1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.32185056141825363,-1.0029694715898687,0.45251396648044695,0.8817492574742614,1.0,7/21,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST8SIA6;ST3GAL3;B3GALT1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.33770539404154254,-1.0028168238643165,0.4336734693877551,0.8790104271200728,1.0,4/21,3.95%,AFG3L2;BCAP31;MICU1;SLC8A3
prerank,regulation of biosynthetic process (GO:0009889),0.5159853388918333,1.0027171808354742,0.48011363636363635,0.8487571893676064,1.0,1/11,3.87%,SNCA
prerank,neuron apoptotic process (GO:0051402),-0.33559589256858335,-1.002657800138355,0.4533333333333333,0.8764119339608563,1.0,5/19,18.04%,APP;BNIP3;ATN1;NAE1;GAPDH
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.48889161777851353,1.0025958896302387,0.4702627939142462,0.8485843549465772,1.0,2/12,6.13%,NEK6;PRKCB
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.45710816283631,1.0023619330297275,0.49029126213592233,0.8487162102570716,1.0,6/24,12.63%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;NRG1
prerank,negative regulation of receptor internalization (GO:0002091),0.491401305917926,1.0017519479632788,0.4854771784232365,0.8497202191963165,1.0,3/12,15.22%,RIN3;SDCBP;ANKRD13A
prerank,cardiac conduction system development (GO:0003161),-0.31426861347898755,-1.0012544034701731,0.40860215053763443,0.8772895902613345,1.0,7/24,10.26%,BMPR1A;BMP4;CACNA1G;SMAD4;SMAD5;SMAD1;TBX18
prerank,phasic smooth muscle contraction (GO:0014821),0.5126900647236601,1.0012251656859874,0.5021645021645021,0.850488279009457,1.0,1/10,2.42%,EDNRB
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.44066730687262107,1.0009777304523477,0.4951338199513382,0.8506342931166222,1.0,9/25,20.34%,BCAS2;SF3B1;SCAF11;PRPF8;TRA2B;WDR83;SLU7;SF3B3;SRSF10
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.44991266042588823,1.000176571346866,0.5036407766990292,0.8520609378803161,1.0,10/23,25.59%,NLRC5;IFNGR2;TXK;PIAS1;IRGM;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37
prerank,acute inflammatory response (GO:0002526),0.45604451151647235,0.999910933414424,0.5047961630695443,0.8521993621909151,1.0,3/23,7.68%,MYLK3;IL6R;CEBPB
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3293321834571056,-0.999824370631538,0.44549763033175355,0.878312133583427,1.0,12/20,25.78%,ADSS2;NT5C2;GMPS;PFAS;AK3;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;AK4;PPAT
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43718275398107664,0.9993362498295728,0.5029515938606848,0.8530830027762678,1.0,10/28,22.65%,TNF;SPI1;CRADD;ZDHHC3;CASP8;TRADD;SORT1;DEDD;DELE1;BID
prerank,regulation of protein ubiquitination (GO:0031396),0.39256166379551366,0.9992186644311833,0.49646107178968657,0.8529239520671571,1.0,22/108,18.47%,ARRB2;BAG2;IVNS1ABP;LAPTM5;TGFBR1;TNFAIP3;MALT1;DERL1;PRMT3;AMER1;STUB1;HUWE1;WFS1;LRRK2;SOX4;GSK3A;SVBP;HSP90AA1;VPS28;UBE2N;BIRC2;ANGPT1
prerank,regulation of cytokinesis (GO:0032465),0.39673398832253864,0.9990099393681412,0.5197505197505198,0.8529328458606933,1.0,20/78,18.00%,ZFYVE26;KLHL21;BCL2L1;PLK4;PLK2;KIF14;FLCN;KIF20B;MYO19;KIF23;UVRAG;RAB11A;SETD2;BECN1;CDC6;PIK3R4;RHOA;GIPC1;CDC42;ENTR1
prerank,cell cycle G1/S phase transition (GO:0044843),0.4073573973870698,0.998613920574689,0.5120925341745531,0.8534535512891547,1.0,14/61,16.10%,GPR132;GSPT1;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CCNE2;USP29;MAP3K11
prerank,regulation of epithelial cell migration (GO:0010632),0.41450442160418566,0.9983216561988099,0.490280777537797,0.853686707453357,1.0,15/51,17.23%,PLCG2;RREB1;ARSB;MACF1;DUSP10;RAB11A;PFN2;PFN1;SOX9;HDAC6;ADIPOR1;SRC;RTN4;HIF1A;CORO1C
prerank,positive regulation of DNA replication (GO:0045740),0.47293216831844953,0.9982731758455466,0.4935400516795866,0.8533311565748852,1.0,7/16,16.38%,DHX9;BRPF3;STN1;KAT7;DNA2;BCAR3;FAF1
prerank,potassium ion homeostasis (GO:0055075),-0.2981944915335554,-0.9981885230690957,0.4074074074074074,0.8801875412284651,1.0,3/23,1.49%,SLC12A2;SLC12A7;ATP1B1
prerank,extracellular matrix assembly (GO:0085029),0.45238105918392796,0.9980238150002444,0.4878048780487805,0.8534552540928078,1.0,6/23,18.76%,TGFB1;ATP7A;GAS6;PXDN;MFAP4;LTBP3
prerank,positive regulation of transferase activity (GO:0051347),0.39040919099142973,0.997604336306461,0.5090361445783133,0.8540155799387794,1.0,12/142,6.29%,TREM2;TGFB1;FLT3;CD74;DBI;CSF1R;DSTYK;PTGES3;PKIB;RPS2;XRCC5;CTNNB1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48860467514819295,0.9974531421321403,0.48554913294797686,0.8539249414838694,1.0,5/12,17.72%,STX11;SNAP29;STX3;SNAP23;STX2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.46486460993733436,0.9974411318568852,0.4830508474576271,0.8535006502333056,1.0,4/19,11.24%,PTPRJ;THY1;LIMS1;NRP1
prerank,regulation of G0 to G1 transition (GO:0070316),0.42681189329900954,0.9973909460890586,0.4897959183673469,0.8531521515429101,1.0,9/38,13.05%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5099312912523736,0.997337573250143,0.50480109739369,0.8523760993267275,1.0,4/11,17.89%,TNRC6A;AGO4;AGO3;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5099312912523736,0.997337573250143,0.50480109739369,0.8523760993267275,1.0,4/11,17.89%,TNRC6A;AGO4;AGO3;AGO2
prerank,regulation of humoral immune response (GO:0002920),0.4138426546753204,0.9972104635917931,0.49944506104328523,0.8522298870998426,1.0,6/44,14.89%,FCGR2B;C1QC;C1QA;C1QB;C3AR1;C4B
prerank,heart looping (GO:0001947),0.4292087716474715,0.9970636789901378,0.5033185840707964,0.8521295921118036,1.0,4/40,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,response to hexose (GO:0009746),0.4401018614205299,0.996870012323006,0.48645465253239106,0.8521208784949117,1.0,4/25,11.24%,LPL;PFKL;EIF2B2;THBS1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.27010988016467335,-0.9965424572358024,0.45544554455445546,0.8818724029555178,1.0,24/42,33.29%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;SEC61G;C2CD5;PEX14;TOMM70;SEC61B;TIMM23;SEC61A1;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;ZFAND2B;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5124180596642629,0.9964547345260054,0.4956268221574344,0.8526531120502037,1.0,3/10,11.77%,MGRN1;PDE11A;CDC34
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3590654908257554,-0.996425656783522,0.4493927125506073,0.8791259551293367,1.0,3/15,7.10%,PIEZO2;SCN1A;KCNA1
prerank,positive regulation of cellular protein localization (GO:1903829),0.3983973074060409,0.9962735186777127,0.5036496350364964,0.8526550079464008,1.0,16/69,20.78%,TGFB1;NUP62;TNF;GPR137B;SNX33;TYROBP;FYN;STX3;KAT7;CENPQ;RTN4;VPS28;ENTR1;TRAPPC12;GSK3B;PRKN
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.40098335677506547,0.9961898347818511,0.508994708994709,0.8523894381229922,1.0,18/69,19.86%,TRIM25;EDEM1;HERPUD1;SEL1L;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;STUB1;WFS1;UBE2J2;FAM8A1;FBXO44;EDEM2;OS9;TMEM67
prerank,positive regulation of ossification (GO:0045778),0.42141035265642696,0.9960279024880565,0.5039727582292849,0.8523164913782133,1.0,7/39,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,negative regulation of neuron projection development (GO:0010977),0.4074967714421912,0.9957512820723717,0.5133976420150054,0.8524885370594363,1.0,18/56,19.41%,MYLIP;THY1;BCL11A;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;ARHGDIA;EFNB3;GAK;RTN4;EPHA4;PTEN;RHOA;DENND5A;PAQR3;RAB29
prerank,regulation of pH (GO:0006885),0.5002736894150257,0.995566303005331,0.49646393210749645,0.852497029285743,1.0,4/11,20.59%,SLC9A1;ATP6AP1;LACC1;SLC9A7
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3799080288748299,0.9945513743592759,0.549,0.8544171897358682,1.0,336/1645,18.79%,CD86;RUNX1;BATF3;SPIC;NFE2;IRF5;NPAS4;AHRR;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;PCID2;CD74;STAT5A;NFE2L2;POU2F2;BASP1;CBFA2T3;SNX5;TGFBR1;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;MAPK14;MED13L;SP7;CREB3L4;CREB3;BARX2;YAF2;RXRB;FOXD2;CDK14;NR1H4;TNF;SREBF2;RFX1;MLXIP;APOE;UBE2V1;CIR1;BPTF;ZNF326;MITF;ZFP30;PPIE;NFXL1;ATF3;CEBPA;FOXO3;SRCAP;ZMIZ2;LRRFIP1;DDIT3;CXXC1;SPP1;SPI1;MYT1L;ZBTB12;NDP;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;CHD7;SBNO1;MAP2K3;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;CDK11B;DNM2;CCAR1;ZNF177;TP53;KLF6;CD80;MEF2A;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;RCOR1;KDM7A;YY1;TCF20;CREB3L1;GCFC2;CDK17;PIM2;STAT4;ZFP90;EPO;CBFA2T2;CEBPB;HINT1;DBX2;FOXN2;TGFBRAP1;ST18;CHEK2;SNAI1;PRKCQ;MEF2C;NKRF;CDC5L;TFAP2B;RB1;METTL4;RBM15B;GMEB2;CIART;BICRA;SMAD3;MMS19;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;MDFIC;PPARGC1A;ZNF32;ARID3B;QARS1;ATRX;RPL6;CREBRF;RNF4;RING1;ATF7IP;ARID4A;ANXA4;GMEB1;STAT5B;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;PHC1;MED27;TRIM56;KLF13;CHD1;MAP2K2;CREB3L2;PKN1;BAZ1A;ZMYND15;POLR2L;HCFC2;ZSCAN26;LIMS1;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;HDAC6;NLK;JDP2;DENND4A;NR2C2;DAP;ETV6;ZNF740;E2F6;ZNF628;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;MTF2;PPP2CA;MBD1;MAP3K12;CREB1;NRG1;BRDT;KAT7;ZSCAN18;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;ZFX;ZNF445;FOXN3;GAS6;NFKB1;FOXK1;SAFB2;RFX7;GPATCH3;SOX6;CUX1;HCFC1;CDC6;ZFHX3;IRF1;SOX2;KDM3B;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;SREBF1;MEIS1;CAPN3;ZBTB11;POU6F1;IFRD1;PIAS1;SPTY2D1;TLE5;EID1;NR2C1;MTDH;REXO4;MAF;FOSL2;ERCC6;YWHAH;THRAP3;FANK1;CDK15;USP21;USP16;OGG1;MED29;RBPJ;FADS1;ZBTB7B;HIF1A;SIX5;SBNO2;SUV39H1;PPP3CB;PBXIP1;REL;TRIP4;ZNF568;ZKSCAN2;PPARD;RSF1;ZSCAN2;RPS6KA5;ZGPAT;CDK18;BACH2;VHL;NFYA;PCGF1;CASZ1;KDM4C;NPAS2;CNBP;PROX2;ZNF35;HSF2;CREBL2;PICALM;LOXL3;SFMBT1;RXRA;TESC;JUNB;PHF1;KLF5;CUX2;CIPC;POU2F3;KLF7;CHD4;CTBP2;PER1;MAFB
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3283605034643806,-0.9943483349229293,0.484304932735426,0.8816904268140352,1.0,11/18,30.05%,COX16;OXA1L;COX18;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;SURF1
prerank,histone H2A monoubiquitination (GO:0035518),-0.3270580474980058,-0.9937441382800782,0.4369747899159664,0.8804508049996493,1.0,6/17,10.90%,DDB2;RYBP;DDB1;TRIM37;PCGF2;PCGF3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.48057703079699415,0.9936930417688297,0.5027932960893855,0.8559736788011095,1.0,4/13,17.60%,FCGR2B;AQP11;WFS1;MANF
prerank,regulation of multicellular organismal development (GO:2000026),0.45151911507787457,0.9932099581257338,0.49702734839476814,0.8566192132160521,1.0,2/25,4.84%,HPSE;RAB14
prerank,negative regulation of catalytic activity (GO:0043086),0.4393247144500957,0.9928215290040734,0.4891304347826087,0.8570620432164207,1.0,5/24,11.27%,CLN3;TIMP1;TP53;ATP5IF1;HDAC6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5030296820116285,0.9923364166292075,0.5200534759358288,0.8577231011333842,1.0,2/12,10.11%,TGFB1;TPR
prerank,muscle cell differentiation (GO:0042692),0.4281168926883233,0.9920872964637505,0.503954802259887,0.8578516174901624,1.0,8/32,13.14%,DUSP29;SYNE1;SPEG;MRTFA;MYOCD;MEF2C;FBXO40;NINJ1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3912658786513448,0.9919173715661075,0.5288169868554095,0.8577847855215276,1.0,23/118,16.34%,GPNMB;TGFB1;CYRIB;LFNG;RAP2A;SEMA4D;TNFAIP3;CTNNB1;CAPZB;TNIK;MEF2C;MYO19;RC3H1;POGLUT1;NEDD4L;PHIP;LZTS3;PID1;TANC2;LRRK2;PDZD8;NF1;EPHA4
prerank,axonal transport of mitochondrion (GO:0019896),-0.38468254411732467,-0.9915419826691875,0.4519230769230769,0.8836029723992875,1.0,4/11,11.34%,SPAST;NEFL;SYBU;MAPT
prerank,MAPK cascade (GO:0000165),0.3840650632339373,0.9913618573927795,0.5545545545545546,0.8586281752503216,1.0,69/295,18.94%,PTPN7;TGFB1;RASAL3;FLT3;SPTBN5;LAT;CSF2RB;TAOK3;GRB2;PIK3CB;FGF13;CCM2;RASA4;TNF;RASA3;IL18;RGL2;SHC2;BCL2L1;YWHAB;MEF2A;PSMB10;MAP3K5;ABHD17B;TNIK;FLT3LG;PRKCQ;MEF2C;RASGRP3;HSF1;MAP2K2;PSMA2;ARTN;SOX9;CCL2;ABHD17C;SYNGAP1;FYN;PSME3;NRG1;RANBP9;IKBKG;CAMKK2;BRAF;NFKB1;PSMB5;LAMTOR3;IL2RG;PSMD8;WDR83;LRRK2;PPP1CC;IL3RA;PTPRA;PSMD7;PSMB9;RASA1;NF1;RASGRP4;RASAL1;KSR1;SPTBN4;PSMD2;PAQR3;ANGPT1;CSF2RA;MINK1;PTPN3;TAOK1
prerank,substantia nigra development (GO:0021762),0.41719879987766445,0.9911368260771193,0.5005834305717619,0.8587284614762408,1.0,12/37,23.03%,BASP1;CKB;ACTB;SEC16A;YWHAH;COX6B1;RHOA;CDC42;GNB4;PADI2;RAD1;NDRG2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4875618038868992,0.9910682521667735,0.493844049247606,0.8584523316734968,1.0,8/13,23.94%,ATG7;UBA2;DESI1;DESI2;SENP6;ATG10;UBA7;UBA5
prerank,negative regulation of RNA metabolic process (GO:0051253),0.46035787997391064,0.9909765750847143,0.5046113306982872,0.8582142659276999,1.0,2/18,3.81%,TGFB1;TNF
prerank,positive regulation of cell development (GO:0010720),0.4285016787903558,0.990771671128449,0.5028248587570622,0.8582175320367059,1.0,5/31,12.62%,CX3CR1;TYROBP;NAP1L1;ATP6AP1;NUMB
prerank,positive regulation of glycolytic process (GO:0045821),0.4526917263198688,0.9907478848134922,0.4789808917197452,0.8573625703701965,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.4526917263198688,0.9907478848134922,0.4789808917197452,0.8573625703701965,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,monocarboxylic acid metabolic process (GO:0032787),0.38884762095633824,0.9906941744818137,0.537917087967644,0.8570431906967039,1.0,22/117,17.81%,CYP1A1;LPL;SGPL1;ALOX12;MTHFS;ANGPTL3;CKB;NPC1;KYNU;ACSF2;SLC16A1;MCCC2;PDHA1;PDZD11;VDAC1;FASN;ME3;CD36;LDHA;PPARD;ACOT2;PCCA
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4339940186448322,0.9906633811631538,0.5017301038062284,0.8566644067336011,1.0,8/32,17.23%,MMP12;CASK;NF2;THBS1;SRC;RASA1;PTEN;CORO1C
prerank,cellular response to interleukin-1 (GO:0071347),0.3846856042050203,0.9905076458298869,0.535678391959799,0.8565673502342277,1.0,34/143,17.85%,IL1A;SIRPA;IRAK2;CCL8;UBE2V1;MYLK3;TANK;PYCARD;PSMB10;ST18;RC3H1;CCL14;PSMA2;CCL13;SOX9;RPS6KA4;GBP3;CCL2;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;HIF1A;CD47;CCL25;UBE2N;RPS6KA5;PSMD2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4039991000527496,0.9901492414222103,0.5172786177105831,0.8569537274283034,1.0,2/53,6.34%,CNR2;ANXA1
prerank,endothelial cell migration (GO:0043542),-0.2786751289464353,-0.9900952952188736,0.42990654205607476,0.8846336919371529,1.0,10/37,16.08%,FSTL1;CDH5;STARD13;ID1;ABL1;FAP;CCN3;NOS3;SCG2;STAT1
prerank,regulation of telomere capping (GO:1904353),0.45117834347715224,0.9899906874884022,0.5060532687651331,0.8568684426911236,1.0,5/23,14.37%,PKIB;PRKCQ;USP7;TNKS2;HNRNPD
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3667058400424654,-0.9899665494528086,0.4418604651162791,0.8819575411792713,1.0,3/13,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,ncRNA processing (GO:0034470),0.38253399226230234,0.9898304572570827,0.5355355355355356,0.8567891551551459,1.0,74/200,25.69%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;ADAR;SMAD3;INTS8;KRR1;AGO4;RPL6;DDX27;RPLP2;RPL26;RPS16;AGO3;METTL3;MDN1;UTP11;HEATR1;RPS14;INTS6;RPL19;PRKRA;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;TUT7;FARS2;TARBP2;WDR12;RPS27;AGO2;INTS1;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7;DICER1;LIN28B;SARS1;EXOSC2;RPLP1;ZCCHC8;ADAT1;RPS15;INTS3;RPL41;XRN2;DROSHA;DDX10;RPL10;AGO1;UTP6;RPL5;RPL18
prerank,aortic valve development (GO:0003176),0.4222527434144831,0.9897904369293801,0.5108077360637088,0.8564335052367772,1.0,6/34,11.69%,TGFB1;NFATC1;SNAI1;RB1;SOX9;TNFRSF1B
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5057010749205837,0.9896795715627248,0.4985632183908046,0.8562434718244054,1.0,4/10,16.89%,ATP5MC2;ATP5F1A;ATP5PD;ATP5MG
prerank,carbohydrate derivative catabolic process (GO:1901136),0.4636685189303198,0.9894394485759852,0.4961636828644501,0.8563319383223319,1.0,5/18,18.32%,SAMHD1;FUCA1;OGA;STT3B;FBXO44
prerank,GPI anchor metabolic process (GO:0006505),0.43401085673616474,0.9891564977481118,0.486810551558753,0.8565671610772803,1.0,11/26,23.19%,PIGM;PIGL;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP
prerank,negative regulation of cell cycle process (GO:0010948),0.3980789603684136,0.9890790234843286,0.5249734325185972,0.8563066482327837,1.0,12/61,13.05%,UXT;YAF2;ESPL1;NME6;AURKAIP1;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.48480139369923303,0.9889893430085364,0.5183175033921302,0.8560549738986742,1.0,4/13,14.19%,UTP20;NOP9;RRS1;TSR1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.45175922029090315,0.9885403964201421,0.49875,0.8566356502717832,1.0,6/20,17.33%,DIP2B;PPARGC1A;RPS6KA4;BRD7;SOX4;RPS6KA5
prerank,proteasomal protein catabolic process (GO:0010498),0.38520742257169044,0.9882980447646225,0.5320641282565131,0.8567290292459441,1.0,58/201,20.78%,ARRB2;NFE2L2;RFFL;KCTD17;UBE2D3;SEL1L;FBXL22;DDIT3;DDI2;CTNNB1;ATXN3;PSMB10;TBL1XR1;KIF14;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;CDC34;SPOP;PSME3;RNF216;RMND5B;ITCH;STUB1;PSMB5;HUWE1;PSMD8;AREL1;ZNRF1;CCDC47;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;ERLEC1;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,nuclear export (GO:0051168),0.3921388080352254,0.987736331410341,0.52218782249742,0.8575931261971088,1.0,23/80,19.39%,TGFB1;NUP62;DHX38;XPO1;NXF1;THOC2;CASC3;MALT1;CSE1L;STRADB;WASHC4;TPR;DDX39B;XPO6;POLDIP3;UPF3B;THOC3;STRADA;SMURF1;SLU7;SRSF6;DESI1;SRSF2
prerank,establishment of protein localization to membrane (GO:0090150),0.3990675879207579,0.9875611372477483,0.5131717597471022,0.8575507386726288,1.0,18/66,17.92%,RFTN1;RAB3GAP2;NPC1;MICALL1;ZDHHC14;AQP11;ZDHHC7;RAB11A;ZDHHC3;VPS37C;SDCBP;BRAF;ZDHHC1;ZDHHC24;RABGEF1;ATG3;MYO1C;SEC63
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39974775787208855,0.987380290241282,0.5335429769392034,0.8575292209064697,1.0,12/63,13.66%,LGALS3;TGFBR1;TNF;ITGA6;TRAF2;PYCARD;CFLAR;THBS1;PHIP;PSME3;CASP8;TRADD
prerank,cellular response to inorganic substance (GO:0071241),0.45357131269237577,0.9866729724250694,0.5158831003811944,0.858708574007334,1.0,7/21,24.44%,AQP1;DDI2;ATRX;MTR;SPIDR;MT3;DDX11
prerank,cation transport (GO:0006812),0.3870421060291067,0.9866600648666788,0.5345345345345346,0.8582880015805741,1.0,19/167,12.02%,SLC6A3;SCN4B;AQP1;HCN4;KCNN4;FGF13;KCNK6;SLC8A1;SLC7A8;KCNIP2;CLN3;SLC36A1;CNGB1;KCNMA1;NEDD4L;SLC36A4;SLC8B1;SLC66A1;SCN9A
prerank,polarized epithelial cell differentiation (GO:0030859),0.5050004990306944,0.9866048291779055,0.5096952908587258,0.8579702327358172,1.0,5/13,19.31%,RAP2A;ZDHHC7;RHOA;CDC42;SCRIB
prerank,cellular protein metabolic process (GO:0044267),0.38037823232502394,0.9862799624307841,0.559,0.8582352295140934,1.0,89/396,18.78%,KLK3;PCSK9;NAPSA;LGMN;CSF2RB;RPL23;RPL17;RPL10A;SFTPA1;SFTPA2;ST8SIA4;APOE;UBE2D3;DNAJC3;RPS2;SPP1;DMBT1;RRBP1;TIMP1;RPL18A;FARSB;MRPL41;UBE2S;TTF1;RPS15A;SPCS2;GSPT1;P4HB;ATP23;LOX;SEC11C;CHEK2;EIF4EBP2;ST3GAL1;MRPL51;MAN2B1;SPPL3;SPCS1;RPL6;PIGH;MCRS1;VGF;RPLP2;RPL26;FAM20C;RPS20;MSRA;LGALS1;CHGB;YES1;RPS16;CDC34;LMCD1;PARL;F5;RPS14;B4GALT7;UBE2G2;GAS6;DARS1;RPL19;WFS1;IGF2BP3;RPL9;ABCA3;IDE;RPS11;ATG3;RPL11;APLP2;YME1L1;RPS23;ERO1A;FURIN;RPS4X;MRPS21;FDXR;RPS27;FDX1;AGO2;RPL4;MRPS14;PABPC4;CSF2RA;MRPL3;MSRB2;PPP4R2;MXRA8;IGFBP4
prerank,neuromuscular process controlling balance (GO:0050885),0.49058614970605824,0.9862099954324204,0.5231416549789621,0.8579385900147166,1.0,3/12,13.32%,CLN3;MYO7A;CDH23
prerank,response to calcium ion (GO:0051592),0.387856980377115,0.9861835054293157,0.5355691056910569,0.8575560224756321,1.0,15/102,9.11%,SYT17;LGMN;PLCG2;RASA4;PKD2;TTN;KCNIP2;RASGRP2;MEF2A;KCNMA1;SYT2;MEF2C;PDCD6;ALG2;SYT10
prerank,mRNA methylation (GO:0080009),-0.3491417124357051,-0.9860337207237939,0.5062240663900415,0.8898116733357945,1.0,6/15,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;CMTR1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.43755736588861566,0.9859560267202477,0.4889705882352941,0.857661739421413,1.0,12/24,20.11%,FCER1G;HFE;TAPBPL;TAP1;SEC24D;B2M;ERAP1;IDE;PDIA3;TAP2;SEC13;SEC31A
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3479759303223792,-0.9854103864360235,0.4308300395256917,0.8884613242211857,1.0,7/15,23.15%,GNAS;GNAL;UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,regulation of trophoblast cell migration (GO:1901163),0.4763282542991038,0.9853530590529731,0.5067204301075269,0.8585905275712484,1.0,7/14,25.36%,TIMP1;YTHDF3;ARHGDIB;AGO2;VEGFA;GJA1;C1QBP
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4871665119978745,0.985176861599055,0.4879356568364611,0.858538807010389,1.0,4/13,17.20%,TLR2;CCL2;NOD2;IL33
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4752465990463567,0.9846396960649804,0.5087719298245614,0.8593163730096054,1.0,3/15,9.59%,HERPUD1;SEL1L;DERL1
prerank,protein lipidation (GO:0006497),0.39818113715047826,0.9840732397228149,0.5463258785942492,0.8601478200187419,1.0,21/59,23.19%,PIGM;ATG7;PIGL;PIGV;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;PIGH;ZDHHC3;ZDHHC1;SELENOK;PGAP2;ZDHHC21;PIGU;PIGC;ZDHHC2;PIGN;ATG10;DPM2;PIGP
prerank,mesenchymal cell differentiation (GO:0048762),0.40690957388182886,0.9827720362514576,0.5308775731310943,0.8626606247135952,1.0,8/51,11.18%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;MEF2C;LIMS1;SOX9
prerank,regulation of myotube differentiation (GO:0010830),0.43868553637899493,0.9823840790295073,0.5138539042821159,0.8630763019746036,1.0,5/24,12.14%,MAPK14;BHLHE41;HDAC5;HDAC4;HDAC9
prerank,regulation of secretion (GO:0051046),-0.37943360785241964,-0.9823426375912939,0.4889705882352941,0.8939375165077338,1.0,7/13,27.26%,MYO6;GPLD1;FGF10;EGF;ERBB3;ACSL3;POFUT2
prerank,negative regulation of histone acetylation (GO:0035067),0.5021886224208495,0.9821564840624085,0.5221745350500715,0.8631141040581625,1.0,3/11,14.67%,SNCA;SPI1;NOC2L
prerank,histone modification (GO:0016570),0.38448460222798825,0.9821132350113284,0.5429726996966633,0.862774087578467,1.0,24/109,17.33%,BRD8;PRKCD;NSD1;ATXN7;HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;PHC1;RPS6KA4;HDAC6;HDAC9;MAP3K12;HUWE1;HDAC11;USP21;USP16;INCENP;NAA50;UBE2N;RPS6KA5
prerank,cell junction organization (GO:0034330),0.3965204451069149,0.9815863407416254,0.5276907001044933,0.8635004491194053,1.0,12/71,11.06%,TGFB1;RAB8B;SNCA;ACTB;AGRN;VMP1;C1QA;CAPZA1;RAB39B;SMAD3;ACTG1;LIMS1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2542040392513082,-0.9814307240132407,0.48484848484848486,0.8934697908784427,1.0,12/53,11.86%,SMCHD1;EYA2;EGFR;FXR2;SPRED2;NACC2;EYA1;FMR1;CEBPG;EYA4;ATM;CCAR2
prerank,inorganic cation transmembrane transport (GO:0098662),0.38176214957294674,0.9809061795971563,0.568,0.8646209156914423,1.0,22/268,8.01%,SLC6A3;SLC6A4;KCNJ11;SLC11A1;SCN4B;ATP6V0E1;HCN4;SLC9A4;KCNN4;P2RX7;KCNK6;SLC8A1;PKD2;SLC36A1;P2RX4;SLC9A9;CCDC51;SLC9A1;ATP6V0D1;KCNK13;CACNA1A;ATP2C1
prerank,cell cycle G2/M phase transition (GO:0044839),0.3838248711791744,0.9807368241693618,0.5502008032128514,0.864565262649355,1.0,27/130,18.10%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8;AKAP8L;NINL;HSP90AA1;AKAP9;CEP63
prerank,zinc ion transport (GO:0006829),-0.3105775589469076,-0.9806752457697105,0.49230769230769234,0.892474531085667,1.0,7/21,25.80%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;TRPM2
prerank,ion homeostasis (GO:0050801),0.42728473038418685,0.9803803878901236,0.5223004694835681,0.8649638640044813,1.0,5/30,10.05%,HCN4;P2RY2;AP3D1;WNK1;NEDD4L
prerank,cellular potassium ion homeostasis (GO:0030007),-0.3690429878794813,-0.9802598923959429,0.4844961240310077,0.8907160719224583,1.0,3/13,7.58%,SLC12A2;ATP1B1;ATP1A2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.35131647056539245,-0.979807873188812,0.4528985507246377,0.8891010810644372,1.0,7/15,17.54%,NTRK3;F3;VEGFC;CXCL12;IL16;SCG2;PGF
prerank,axon extension (GO:0048675),-0.3003630423233317,-0.9795924845105851,0.49171270718232046,0.8867904261244237,1.0,5/23,6.36%,SEMA5A;AUTS2;SEMA3A;ULK2;SLIT2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3882569030432682,0.9786827431568703,0.5358606557377049,0.8682877080102602,1.0,19/78,20.95%,GTF2H1;CCND3;RGCC;PKD2;BCCIP;CEBPA;CCND2;ACTB;MYOCD;CDK7;CDC6;CCNE2;PTEN;CCNYL1;CNPPD1;HHEX;CDK5R1;HEXIM1;TFAP4
prerank,negative regulation of viral process (GO:0048525),0.3988582825895469,0.9786179722816,0.5550802139037433,0.8679978396190631,1.0,17/57,24.55%,FAM111A;TRIM5;TNF;TRIM27;TRIM8;RNASEL;MID2;TRIM35;TRIM62;PARP10;IFITM2;HEXIM1;ILF3;IFIT1;IFITM1;UBP1;PPIA
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42229453844967163,0.9778332165662914,0.5107142857142857,0.8692883739507774,1.0,8/30,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;HUWE1;UBE2J2;GSK3A
prerank,ribosome biogenesis (GO:0042254),0.37935852946021026,0.9771140732617797,0.5761523046092184,0.8704308887204113,1.0,50/187,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;XPO1;LAS1L;URB2;RPL18A;GTF3A;KRR1;SURF6;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RRS1;RPL19;NOC2L;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;DDX31;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4747207999029541,0.9769756825191115,0.5173745173745173,0.870290143124041,1.0,3/17,3.19%,SCN4B;HCN4;SLC8A1
prerank,ERAD pathway (GO:0036503),0.38825859126274653,0.9768952794630117,0.5612033195020747,0.8700219798438775,1.0,23/83,21.28%,TRIM25;EDEM1;HERPUD1;SEL1L;ATXN3;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;TOR1A;STUB1;WFS1;UBE2J2;CCDC47;FAM8A1;FBXO44;ERLEC1;OS9;TMEM67;PRKN;DNAJB14
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2749455971633371,-0.9768219477450555,0.4666666666666667,0.8915934888441296,1.0,8/33,8.31%,NR2F2;MCC;DAB2IP;SYNJ2BP;ACVRL1;SP100;SLIT2;KRIT1
prerank,cristae formation (GO:0042407),-0.29389502590894767,-0.976673636092574,0.49019607843137253,0.8890752636936569,1.0,10/27,16.24%,AFG3L2;APOOL;IMMT;ATP5PO;ATP5PF;ATP5MC3;SPG7;DMAC2L;SAMM50;ATP5F1D
prerank,response to reactive oxygen species (GO:0000302),-0.2529267043201938,-0.9764626281431737,0.45714285714285713,0.8867325086741843,1.0,16/54,17.20%,MAPK8;EGFR;SOD2;AGAP3;MAPK9;PTPRK;SOD1;PDGFRA;STK25;CHUK;MAPT;AKT1;GLRX2;HYAL1;COA8;ERCC6L2
prerank,cellular response to estrogen stimulus (GO:0071391),0.4771918620633844,0.9764396279075701,0.5080213903743316,0.8705954668845974,1.0,5/14,20.44%,OCSTAMP;TRIM24;SRA1;NCOA4;SFR1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5028592834741721,0.9757768109140933,0.5144429160935351,0.8716243790252071,1.0,2/11,9.43%,DHX9;PUM2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.41165177267286857,0.9754377333422646,0.5145739910313901,0.8719222481236389,1.0,2/37,2.20%,ITGAL;CRTAM
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.44621171914581576,0.9754222653025134,0.5203452527743526,0.871508085787019,1.0,11/21,23.67%,DUSP3;MACF1;SLC9A1;ACTG1;VCL;PTPRA;CORO1C;RHOA;ROCK2;CLASP1;GPM6B
prerank,histone H3-K4 methylation (GO:0051568),0.4302706354431225,0.9754098254066348,0.5114873035066505,0.8710917198432174,1.0,8/26,19.48%,WDR5B;TET3;CXXC1;DPY30;RBBP5;SETD1B;WDR82;TET2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.42219834766057646,0.9751857988490578,0.5234741784037559,0.8711240286307915,1.0,5/30,14.30%,KLK3;PKN1;HDAC6;SAFB2;KLK2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.30471685959884487,-0.9751339433146006,0.5172413793103449,0.8874643539497035,1.0,12/25,21.12%,NCKAP5;STMN2;MAPT;KIF24;TPPP;STMN4;STMN3;HDGFL3;MAP7D3;KIF18A;TRPV4;STMN1
prerank,positive regulation of DNA binding (GO:0043388),0.4240879201421135,0.9744290964634337,0.5208816705336426,0.8723685254069192,1.0,4/31,8.46%,TGFB1;SKI;HMGB1;RB1
prerank,ether lipid metabolic process (GO:0046485),0.4661136105375773,0.9742950395662406,0.5176151761517616,0.8722305856616182,1.0,7/14,16.78%,DHRS7B;PLA2G7;PEX7;LIPE;AGMO;NCEH1;PLAAT3
prerank,regulation of dendritic spine development (GO:0060998),-0.3155968993546662,-0.9739546929248984,0.4975124378109453,0.8877262805279021,1.0,7/19,11.45%,NLGN1;GRIN3A;DLG5;FMR1;SHANK3;SHANK1;PPFIA2
prerank,signal transduction in response to DNA damage (GO:0042770),0.40795194203711127,0.9739297631934505,0.5403930131004366,0.8726012095807599,1.0,9/49,9.48%,MAD2L2;GRB2;MAPK14;BRIP1;TP53;CHEK2;DOT1L;CDC5L;ATRX
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3450318000712257,-0.9738887812850102,0.4763779527559055,0.8849985992594418,1.0,8/16,26.86%,PSIP1;DCPS;SRSF1;SNRPC;NCBP2;DDX23;SRSF12;CACTIN
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.38935489218179836,0.9737829128960129,0.555327868852459,0.8724926594164628,1.0,23/83,20.73%,GPR132;CDK14;BACH1;GSPT1;CDK17;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CDC6;CCNE2;USP29;CDK15;CDK18;CRLF3;CDC45;CUL3;NPAT
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4392810060627552,0.973697677353268,0.5199516324062878,0.872239030638699,1.0,4/22,10.77%,SPI1;XDH;GADD45B;RELL1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3948577068861328,0.9735150625259964,0.5421940928270043,0.8721967859762613,1.0,21/67,19.20%,TBC1D10C;TBC1D16;P2RX4;TBC1D22A;USP6NL;CAPZB;TBC1D10A;PODXL;TBC1D2;TBC1D17;TBC1D2B;TWF2;TBC1D8;ARF6;TBC1D14;TBC1D22B;ATG3;RABEP2;CDC42;DYNC2LI1;TBC1D5
prerank,regulation of viral genome replication (GO:0045069),0.392527211899956,0.9728482465393352,0.5468085106382978,0.8732756435151116,1.0,17/56,24.55%,FAM111A;TNF;PPIE;ADAR;LARP1;VAPB;RNASEL;ADARB1;TARBP2;PPIH;PARP10;IFITM2;CNOT7;ILF3;IFIT1;IFITM1;PPIA
prerank,adipose tissue development (GO:0060612),0.49725414587089,0.9725874779989109,0.5286713286713287,0.8734275974552721,1.0,2/11,9.91%,SH3PXD2B;LRP5
prerank,cellular response to glucose stimulus (GO:0071333),0.42188226423411374,0.9719919121388557,0.544392523364486,0.8742991540178523,1.0,7/30,14.60%,MLXIPL;ERN1;TRA2B;RAB11FIP5;GAS6;ADCY8;SOX4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4638604376844497,0.9717110997307816,0.5178082191780822,0.8745006203876725,1.0,3/13,14.53%,NFE2L2;GPR37;LRRK2
prerank,steroid biosynthetic process (GO:0006694),-0.24744982844784896,-0.9712262801069184,0.5471698113207547,0.8894346310697023,1.0,25/56,33.94%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;CYP51A1;INSIG2;INSIG1;SQLE;AMACR;LSS;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;OSBPL2;CH25H
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.41205782919290646,0.9708488260573775,0.5316027088036117,0.8759507662812205,1.0,7/35,14.05%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,heart contraction (GO:0060047),0.4071939966618349,0.9707606112634951,0.518232044198895,0.8757098586876417,1.0,4/41,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3761627010625968,0.9704028649830831,0.5815815815815816,0.8760820404002126,1.0,38/185,18.10%,TUBB;ANAPC15;PRKAR2B;HAUS2;NEK6;RGCC;CDC23;TUBA4A;CNTRL;CEP192;MAPRE1;UBE2S;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;PSMA2;FZR1;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;CDC6;INO80;HAUS8;PSMD8;PSMD7;PSMB9;NINL;APPL2;HSP90AA1;ANAPC11;AKAP9;PSMD2;CEP63
prerank,cellular response to radiation (GO:0071478),0.41076133178940694,0.970293347864399,0.5294771968854283,0.8758700074918908,1.0,4/40,6.70%,GRB2;MAPK14;TANK;TP53
prerank,linoleic acid metabolic process (GO:0043651),0.45789929230461474,0.9695932062864722,0.5301047120418848,0.8769832758051782,1.0,4/17,17.83%,ALOX12;ABCD1;FADS1;GSTM2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3732972333363903,0.9688357439215037,0.611,0.878249691085374,1.0,77/327,19.05%,HCLS1;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;ACTN4;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2;PHF1;MAFB;TULP3
prerank,aortic valve morphogenesis (GO:0003180),0.4186167127282496,0.968543249387612,0.5326340326340326,0.8784520773587505,1.0,5/30,11.18%,TGFB1;NFATC1;SNAI1;RB1;SOX9
prerank,positive regulation of intracellular protein transport (GO:0090316),0.37531217536266354,0.9675635745887169,0.5633802816901409,0.8801793485301418,1.0,29/144,15.73%,TGFB1;ITGB2;HCLS1;PRKCD;SREBF2;MICALL2;UBE2D3;AKAP5;YWHAB;TP53;RIPOR1;VPS11;CSNK2A2;KIF20B;SMAD3;ITGAM;TPR;SEC16A;FYN;PCM1;SEC16B;SORL1;CASP8;SAR1A;GAS6;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3717002679978543,0.9674953008366158,0.654,0.8798726168383045,1.0,136/807,14.43%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;TGFB1;IKZF1;UXT;GATA1;FNIP2;BASP1;CBFA2T3;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;MLXIPL;ZEB2;PRDM12;YAF2;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;TAF1;BACH1;PCGF6;CTNNB1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;RCOR1;HSBP1;YY1;CREB3L1;GCFC2;ZFP90;EPO;CBFA2T2;CEBPB;SNAI1;MEF2C;NKRF;FLCN;TFAP2B;RB1;RBM15B;TRIM27;CIART;SMAD3;GTF2IRD1;IRF2;HSF1;MDFIC;QARS1;RING1;ATF7IP;ARID4A;IMPACT;CPEB3;MIDEAS;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;PHC1;ZMYND15;HCFC2;LIMS1;SOX9;HDAC6;JDP2;NR2C2;DAP;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;MBD1;CREB1;RPS14;NRG1;KAT7;MAX;GPS2;FOXN3;GAS6;NFKB1;FOXK1;CUX1;HCFC1;ZFHX3;IRF1;USP9X;WFS1;SOX2;BRD7;LBH
prerank,supramolecular fiber organization (GO:0097435),0.3741982055695605,0.9670598628530513,0.616,0.8803604773456242,1.0,75/334,18.76%,MYO1F;HOOK3;ARHGAP25;MYO1G;MYO1E;CORO1A;BFSP2;TGFBR1;MYO5A;MAD2L2;FGF13;ELMO1;SNCA;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;CCDC88B;FLII;CLIP2;P4HB;LOX;MYO7A;KIF14;TSPAN14;MYO19;TPM4;BCAR1;P3H2;TUBGCP6;TUBGCP4;ACTN1;GFAP;BIN3;IAPP;DYNC1H1;ITM2B;PCM1;B4GALT7;TPM3;SORL1;KATNA1;B2M;PXDN;GGA2;DES;USP9X;KIF2A;HOOK2;CAPN3;LAMA3;DST;CAMSAP2;COL22A1;NF1;CD36;FIGN;COL23A1;MFAP4;FURIN;CORO1C;ARHGEF2;MARCKS;MYO1C;DNAJB6;RHOA;CDC42;MYO15A;ELMO2;LOXL3;GREM1;LTBP2;LTBP3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.39273132056158994,0.9670580572260334,0.5408271474019088,0.8799208723642793,1.0,14/59,20.03%,CD84;PCDHB6;PLXNB2;EMB;TRO;NPTN;PTPRT;CADM1;KIRREL3;PECAM1;ITGB1;VSTM2L;PALLD;CNTN4
prerank,nucleotide catabolic process (GO:0009166),0.45808706737755645,0.9667856821814708,0.504054054054054,0.8800798073305306,1.0,3/16,8.29%,XDH;SAMHD1;PNP
prerank,protein targeting to lysosome (GO:0006622),0.4465857442853615,0.9667713257559986,0.5278121137206427,0.8796683169361451,1.0,5/20,16.46%,LAPTM5;RAB7A;SORL1;NCOA4;GNPTAB
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3318670195671882,-0.9667609446791986,0.5294117647058824,0.8990883294584109,1.0,3/16,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4475295977930548,0.9665521571312945,0.5401002506265664,0.8797202835725566,1.0,7/22,16.04%,STAC;CACNB4;NOS1AP;CACNB2;CACNB1;STAC3;GNB5
prerank,epithelial cell migration (GO:0010631),-0.26364532773157473,-0.9664393665800655,0.4864864864864865,0.8969938288400284,1.0,10/37,16.08%,FSTL1;STARD13;KANK1;KANK2;ABL1;FAP;ROCK1;NOS3;SCG2;STAT1
prerank,detection of mechanical stimulus (GO:0050982),0.45045429144639965,0.9663191204638846,0.5211970074812967,0.8797939888406879,1.0,3/19,6.29%,PKD2;TTN;CTNNB1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.49900224917620883,0.9662593416088936,0.5547445255474452,0.8794703892102643,1.0,5/10,17.74%,POGLUT2;POGLUT1;GALNT2;MGAT5B;GALNT1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43398073941760273,0.9661906178129321,0.5324825986078886,0.8791761427456531,1.0,4/26,8.51%,PRELP;B4GALT1;FMOD;ST3GAL1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4774768007068295,0.9659579001865758,0.5407303370786517,0.8792572641438393,1.0,4/14,18.40%,TGFBR1;SOX9;RFLNA;GREM1
prerank,fatty acid transmembrane transport (GO:1902001),0.4418937713972605,0.9657391022336985,0.5370843989769821,0.8792870422246541,1.0,6/19,17.99%,SLC25A20;ABCD1;ACACA;CD36;CPT2;ABCD2
prerank,ameboidal-type cell migration (GO:0001667),0.4006984883308157,0.9653025509311497,0.5626326963906582,0.8798043027205475,1.0,4/51,3.56%,SHH;ITGA4;SGPL1;SEMA4D
prerank,clathrin-dependent endocytosis (GO:0072583),0.42845753960718946,0.9652824241595029,0.5347137637028014,0.8794111666277414,1.0,13/26,23.29%,PIP5K1C;AP2S1;GPR107;ITSN1;CLTC;FNBP1L;SIGLEC1;GAK;AP2M1;PICALM;FCHO2;ITSN2;INPP5F
prerank,microtubule anchoring (GO:0034453),0.490514121129902,0.965098004205868,0.5364145658263305,0.8793730940447232,1.0,3/12,12.40%,BCCIP;BICD2;PCM1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.25888457222414163,-0.9650958302353224,0.5384615384615384,0.8976476331548113,1.0,16/38,24.79%,PRPF3;SNRPD3;SNRPD1;TGS1;SNRPC;WDR77;SNRPG;COIL;SNRPF;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRMT7;PRPF31
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.35877388431356516,-0.9646451860697638,0.4732510288065844,0.8959372327699312,1.0,9/14,29.63%,IRS1;PPARA;LONP2;AKT1;IRS2;MFSD2A;TWIST1;TYSND1;MTLN
prerank,regulation of secretion by cell (GO:1903530),0.39834019601421466,0.9646431701899298,0.542518837459634,0.879887461203342,1.0,6/54,8.10%,RAB8B;VAMP3;MCTP1;RHBDF2;ANXA1;MEF2C
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5031395781245409,0.964587526085736,0.5308988764044944,0.8795584056227811,1.0,3/10,13.89%,ATRX;DBF4;INO80
prerank,positive regulation of protein binding (GO:0032092),0.3947609158248117,0.9645817954159396,0.5437837837837838,0.8791295341119792,1.0,23/56,22.55%,PPP2CB;APOE;TAF1;HFE;SPPL3;DERL1;EPB41;PPP2CA;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.39558813611326754,-0.9642928293815841,0.49085365853658536,0.8939457682459845,1.0,2/10,3.69%,DLGAP1;DLGAP2
prerank,endocrine system development (GO:0035270),0.44881723444338595,0.9639713260505136,0.5273189326556544,0.8799837834124388,1.0,6/21,16.02%,TGFBR1;MDK;NKX2-1;SOX2;TG;NF1
prerank,cellular response to UV-A (GO:0071492),0.4764496000089087,0.9638292453669288,0.5204513399153737,0.8798511443251859,1.0,1/11,5.21%,TIMP1
prerank,positive regulation of viral genome replication (GO:0045070),0.4169384571198403,0.9632971743954374,0.5443786982248521,0.8806139676518085,1.0,13/29,26.38%,PPIE;ADAR;LARP1;VAPB;ADARB1;TOP2A;TARBP2;PPIH;CNOT7;IFIT1;PPIA;PKN2;HACD3
prerank,central nervous system myelination (GO:0022010),0.4876934681191193,0.9628097898346919,0.5269286754002911,0.8811998298482939,1.0,6/11,27.98%,PTEN;ABCA2;B4GALT6;TENM4;CNTNAP1;B4GALT5
prerank,synapse assembly (GO:0007416),0.3875562284088914,0.9627386668969178,0.5462097611630322,0.880918480387268,1.0,5/67,4.59%,NPAS4;PCDHB6;FGF13;SLITRK1;PLXNB2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3742749100298476,0.9623871447470063,0.5955955955955956,0.8812328851309791,1.0,63/168,25.69%,RPL23;RPL17;RPL10A;PNRC2;RPS2;CNOT8;TENT4B;RPL18A;RPS15A;GSPT1;RC3H2;CASC3;RC3H1;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;THRAP3;RPS11;RPL11;SMG7;TUT7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;DIS3L2;RPL22;RPS7;ZFP36L1;DCP1B;RPS13;PNLDC1;CNOT7;CNOT1;EIF3E;RPLP1;RPS15;DCP2;RPS5;CNOT2;RPL41;XRN2;RPL10;AGO1;NCBP1;RPS8;RPL5;DXO;RPL18
prerank,regulation of mitotic cell cycle (GO:0007346),0.37421002915270185,0.9617908136602966,0.5989949748743718,0.8821143682690744,1.0,36/171,17.85%,ANAPC15;TGFB1;LGMN;SMOC2;DUSP3;NEK6;CDC23;CDK11B;UBE2S;PSMB10;TAL1;PIM2;KIF20B;RB1;SMAD3;HSF1;ANGEL2;PSMA2;MAEA;TTLL12;SRA1;FZR1;RNF40;TRIM35;SDCBP;PSME3;PSMB5;PSMD8;CCDC8;INTS13;PSMD7;PSMB9;DYNLT3;IQGAP1;ANAPC11;PSMD2
prerank,nuclear membrane organization (GO:0071763),-0.3165275060190177,-0.961412947327775,0.49019607843137253,0.8990468502399199,1.0,8/19,23.34%,SPAST;VPS4A;EMD;CHMP4B;TMEM43;TARDBP;CHMP2A;GPER1
prerank,ATP transport (GO:0015867),0.49116892288345665,0.9609790282498173,0.5161290322580645,0.8833985755102783,1.0,1/10,1.90%,ABCC6
prerank,energy reserve metabolic process (GO:0006112),-0.3202757968566773,-0.9606949554112695,0.5023696682464455,0.8981432744767442,1.0,10/19,25.51%,LEPR;PHKG2;UGP2;PHKB;PYGM;GFPT1;PPP1R3C;PHKA1;GFPT2;MRAP2
prerank,response to ketone (GO:1901654),0.4407613104900775,0.9604609724872175,0.5437125748502994,0.8840437518595787,1.0,3/24,11.24%,TGFB1;ABCB4;THBS1
prerank,stress-activated MAPK cascade (GO:0051403),0.38834716087289556,0.960450116351822,0.5567338282078473,0.8836255680945218,1.0,15/61,17.04%,IRAK2;MAPK14;CCM2;UBE2V1;MAP2K3;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;NFKB1;TAB3;MAP3K11;UBE2N
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.30017715283139074,-0.9603031907318588,0.5168539325842697,0.8963583482452183,1.0,3/23,1.33%,MTM1;SACM1L;MTMR7
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4110048141505328,0.9602292495132159,0.5661016949152542,0.8836898660599182,1.0,8/37,12.29%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;USP7;SDCBP
prerank,regulation of cell cycle process (GO:0010564),0.3736564002925509,0.9599986385034015,0.5747474747474748,0.8837623095407209,1.0,19/104,12.21%,ZFYVE26;KLHL21;CTNNB1;BCL2L1;SND1;PLK4;PLK2;CSNK2A2;CSNK2A1;FLCN;KIF20B;MYO19;UVRAG;RAB11A;SETD2;DBF4;SOX9;BECN1;DYNC1H1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.464606811215363,0.959928748626805,0.5409153952843273,0.8834690081213906,1.0,3/13,6.91%,RENBP;NAGK;OGA
prerank,RNA 3'-end processing (GO:0031123),-0.23148203011838375,-0.9594869449924137,0.5161290322580645,0.895787687519428,1.0,18/69,15.25%,WDR33;SARNP;SRRM1;RPRD2;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;SRSF11;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,peptide catabolic process (GO:0043171),-0.29431574147120176,-0.9589762875370028,0.48514851485148514,0.8943474046647782,1.0,9/23,23.98%,LTA4H;ECE1;CPQ;ACE;NPEPPS;CHAC2;ENPEP;GGT7;TPP1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3239282433659554,-0.9588393694217691,0.5,0.8919492394405519,1.0,3/16,8.91%,RBFOX2;AR;TADA3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.39487775389750046,0.9587843195166302,0.5674518201284796,0.8855668028619159,1.0,15/51,21.76%,PLEK;TGFBR1;RGCC;FHOD1;PFN2;NF2;PFN1;NRP1;SYNPO;CD47;RHOA;CDC42;ROCK2;EVL;CX3CL1
prerank,negative regulation of glycolytic process (GO:0045820),0.4986070494803231,0.9582185948086935,0.5440956651718983,0.8858529097537557,1.0,2/10,9.96%,CBFA2T3;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4986070494803231,0.9582185948086935,0.5440956651718983,0.8858529097537557,1.0,2/10,9.96%,CBFA2T3;HDAC4
prerank,ERBB2 signaling pathway (GO:0038128),0.41104731476186596,0.957664431819937,0.5525114155251142,0.8866258228147769,1.0,8/31,16.79%,GRB2;PTPN18;ERBIN;NRG1;STUB1;SRC;HSP90AA1;PTPN12
prerank,response to progesterone (GO:0032570),0.46103333492675,0.9573176997147014,0.5489199491740788,0.8869508397010579,1.0,3/18,15.27%,TGFB1;THBS1;SRC
prerank,regulation of acrosome reaction (GO:0060046),-0.39263071997991333,-0.9572082317198722,0.483974358974359,0.8936659048069868,1.0,8/10,60.76%,CACNA1H;PLCB1;SPINK13;SERPINA10;FAM170B;PRSS37;PLA2G10;GLRA1
prerank,positive regulation of developmental growth (GO:0048639),0.39483278748684286,0.9569786512888692,0.5556756756756757,0.887229001195229,1.0,13/49,21.68%,SYT17;SEMA4D;MACF1;AGRN;SYT2;NEDD4L;TWF2;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,protein localization to Golgi apparatus (GO:0034067),0.4259825875398924,0.956794182095403,0.5544794188861986,0.8871864423119398,1.0,14/27,23.02%,RIPOR1;ARL5B;BICD2;SORL1;RAB33B;GAK;PAQR3;GOLPH3;OPTN;COG7;VPS13C;GBP5;VPS13A;ARL5A
prerank,protein localization to vacuole (GO:0072665),-0.3553092125281785,-0.9567895216495297,0.5055762081784386,0.8919992509840333,1.0,5/13,20.93%,LMBRD1;KPTN;CD81;LAMTOR5;GLMP
prerank,modulation by symbiont of host process (GO:0044003),0.48121014260121464,0.9562190402038963,0.5310245310245311,0.8879862649300053,1.0,3/10,20.10%,TLR2;B2M;ENO1
prerank,cardiocyte differentiation (GO:0035051),0.5019997589053959,0.9560742304065551,0.5457142857142857,0.8878581068817968,1.0,3/10,12.63%,EEF1AKMT4-ECE2;MYOCD;NRG1
prerank,snRNA metabolic process (GO:0016073),-0.3222195456196427,-0.9556647900579617,0.5122950819672131,0.892286015284029,1.0,7/17,19.34%,INTS9;INTS10;MTREX;TUT1;INTS4;INTS2;MEPCE
prerank,modification-dependent protein catabolic process (GO:0019941),0.37210392577663143,0.9554441371383109,0.6022044088176353,0.8888292822697096,1.0,33/193,13.69%,ANAPC15;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;RNF19B;HERPUD1;CDC23;RNF7;PPP1R11;TAF1;RNF111;ATXN3;UBE2S;LONP1;RNF150;RC3H2;RNF114;RC3H1;UBE4B;NEDD4L;UBE2H;FZR1;RNF40;CDC34;WDR81;ITCH;UBE2G2;STUB1;RNF144B
prerank,regulation of catabolic process (GO:0009894),0.452148264480784,0.9545846087012302,0.5608194622279129,0.8902105946222821,1.0,8/18,21.35%,HPGD;CHEK2;ZDHHC7;NEDD4L;FAF1;FURIN;ITGB1;ZDHHC2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.31679209350336757,-0.9544973961712012,0.4908256880733945,0.8926390256232136,1.0,5/19,13.22%,BMPR1A;ACVR1;SMAD4;OLFM1;SMAD6
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4991715653662261,0.954136927320704,0.5701078582434514,0.890735085702759,1.0,1/10,0.91%,PLEK
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4583222826404683,0.954088884251349,0.5345501955671447,0.8903969006851307,1.0,6/15,22.43%,TENT4B;TNRC6A;CPEB3;AGO2;CNOT7;CNOT1
prerank,neurotransmitter transport (GO:0006836),0.3853259310301863,0.9540386227025086,0.5800636267232238,0.8900702564713171,1.0,10/73,15.92%,SLC6A3;SLC6A4;APBA1;STXBP3;SLC6A15;CASK;SYNJ1;PPFIA1;PDZD11;DNAJC5
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.2911553496842884,-0.9539956066338873,0.5031446540880503,0.891248582178052,1.0,6/24,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3689387551498636,0.9539851860452633,0.655,0.8897347742173256,1.0,79/341,18.89%,ARRB2;ANAPC15;NFE2L2;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;KCTD17;RNF19B;HERPUD1;CDC23;UBE2D3;FBXL22;DDIT3;RNF7;TNFAIP3;PPP1R11;TAF1;RNF111;CTNNB1;ATXN3;UBE2S;PSMB10;TBL1XR1;RNF150;RC3H2;KIF14;RNF114;GID8;RC3H1;RNF4;UBE4B;NEDD4L;UBE2H;APPBP2;TBL1X;PSMA2;MAEA;VPS37C;FZR1;RNF40;CDC34;SPOP;WDR81;PSME3;RNF216;RMND5B;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;ZNRF1;MVB12B;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;VPS28;FEM1B;ZNRF3;ANAPC11;UBE2K;PSMD2;KEAP1;BIRC2;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3896285275491443,0.9538970784558181,0.5733471074380165,0.889479504998824,1.0,18/62,23.31%,PCID2;GTF2H1;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB;IWS1;ELOC;NELFE;CTR9
prerank,embryonic digit morphogenesis (GO:0042733),0.45428412848716837,0.9537494089230389,0.522697795071336,0.8893561999432883,1.0,1/18,0.68%,SHH
prerank,cell differentiation in hindbrain (GO:0021533),0.4814609836043671,0.9533329769476278,0.5433526011560693,0.8898185593181013,1.0,2/11,15.48%,ATP7A;AGTPBP1
prerank,positive regulation of protein sumoylation (GO:0033235),0.495793592175477,0.9532409488846559,0.5812220566318927,0.8895768372078148,1.0,4/10,20.01%,HDAC4;UBA2;PIAS1;RWDD3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4387002434707561,0.9524454612138078,0.5514250309789344,0.8908140073018856,1.0,2/20,3.31%,NFE2L2;CREB3
prerank,glycerolipid catabolic process (GO:0046503),0.4459796253465092,0.9523136926975765,0.5478589420654912,0.8906446078913386,1.0,7/19,23.89%,ABHD12;PRDX6;GDE1;GDPD3;GPCPD1;PLA2G4E;ABHD2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4614809929977935,0.9522892385339113,0.5660130718954248,0.8902465947992024,1.0,4/16,15.83%,RMI1;HFM1;SLX4;TOP2A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3640338626159406,-0.952173093658493,0.5076335877862596,0.8934980826109896,1.0,7/12,35.78%,BDH2;GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39468422189079255,0.9517663424468698,0.5631284916201117,0.8909811623751338,1.0,8/48,12.48%,FNIP2;PYCARD;BCL2L1;TP53;CHEK2;BAK1;TNFRSF1B;DDIT4
prerank,membrane depolarization (GO:0051899),0.41589913301204434,0.9517187825557089,0.5782710280373832,0.890638614999767,1.0,9/32,17.43%,P2RX7;P2RX4;CACNA1A;CACNB4;ATP5IF1;SCN9A;CACNA1B;YWHAH;SCN5A
prerank,regulation of actin filament depolymerization (GO:0030834),0.4787009581777747,0.9516978794211811,0.5482456140350878,0.8902361301614601,1.0,1/12,0.91%,PLEK
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.36673936148149666,0.9512440679180412,0.656,0.8907888741226914,1.0,78/314,20.78%,ARRB2;ANAPC15;NFE2L2;TRIM25;EDEM1;PTTG1;RFFL;KCTD17;HERPUD1;CDC23;UBE2D3;SEL1L;FBXL22;DDIT3;DCAF12;FBXL18;TAF1;CTNNB1;ATXN3;ERLIN1;ERLIN2;UBE2S;PSMB10;TBL1XR1;KIF14;RB1;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;FZR1;CDC34;SPOP;PSME3;RNF216;STT3B;FBXL3;RMND5B;ITCH;UBE2G2;STUB1;PSMB5;HUWE1;WFS1;PSMD8;AREL1;UBE2J2;ZNRF1;FAM8A1;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;OS9;TMEM67;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,regulation of dendrite morphogenesis (GO:0048814),0.40909341383603703,0.9511471238438868,0.561849710982659,0.8905592665572698,1.0,9/32,20.45%,SS18L1;RAP2A;SEMA4D;TNIK;NEDD4L;CUX1;YWHAH;CUX2;GSK3B
prerank,glucose import (GO:0046323),0.4728822237399225,0.9508516230192697,0.5437158469945356,0.8907284348761334,1.0,2/13,8.19%,SLC2A3;ZDHHC7
prerank,regulation of DNA metabolic process (GO:0051052),0.3936042684660906,0.9507663648775193,0.5806451612903226,0.8904636971694965,1.0,14/44,22.85%,UBE2V2;UBE2V1;XRCC5;POLH;SMG1;KAT7;HNRNPD;SMARCAD1;KPNA1;UBE2N;MPV17;TERF2;WDR70;TERF2IP
prerank,mRNA modification (GO:0016556),-0.29761167683059797,-0.9507457587230269,0.5164835164835165,0.8945504178198107,1.0,7/22,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;TRUB2;CMTR1
prerank,positive regulation of response to wounding (GO:1903036),0.4265339658637003,0.9504234801327124,0.5487364620938628,0.8907166211969525,1.0,5/24,11.64%,MDK;ARFGEF1;ANXA1;ACTG1;GRN
prerank,keratinocyte differentiation (GO:0030216),-0.2815404327537063,-0.9500768866341824,0.5102040816326531,0.8934436737306358,1.0,6/29,15.14%,CLIC4;WNT5A;BCR;JAG1;CASP3;UGCG
prerank,positive regulation of protein acetylation (GO:1901985),-0.3597026837193631,-0.9499105039085997,0.5517241379310345,0.891194237723154,1.0,3/12,6.31%,CEP295;RAPGEF3;DIP2A
prerank,neuron projection morphogenesis (GO:0048812),0.36904215466679396,0.949495091652584,0.6,0.8922813502204862,1.0,19/137,11.42%,NCKAP1L;NEFH;TAOK3;S100B;SLITRK1;ATP7A;CTNNB1;DOCK10;ACTB;DNM2;MEF2A;TNIK;KIF20B;NTF3;IMPACT;FLRT1;MAP1B;DTNBP1;ATL1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4522213417129082,0.9490769022943687,0.5218543046357615,0.8927158579762835,1.0,5/16,16.66%,ACADL;ABCD1;PPARGC1A;SOX9;APPL2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.44994732374461277,0.9489568637195988,0.5420439844760673,0.892539964215219,1.0,4/17,17.70%,SCN4B;NOS1AP;SCN5A;AKAP9
prerank,response to interferon-alpha (GO:0035455),0.44870248170769245,0.9487206252005596,0.5316129032258065,0.8926199130271998,1.0,5/16,14.38%,IFNAR1;ADAR;TPR;GAS6;RO60
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3927986216773812,0.9483780224474407,0.5665938864628821,0.8928963551051644,1.0,7/46,6.51%,TNF;IL6R;IL18;TNFAIP3;XRCC5;CTNNB1;AIF1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4936411776868208,0.9478940679500475,0.5392749244712991,0.8934470868168208,1.0,3/10,16.71%,RB1;SORL1;HSP90AA1
prerank,nuclear pore complex assembly (GO:0051292),-0.39142155344304563,-0.9477994138209422,0.535593220338983,0.8939802554077043,1.0,5/10,11.37%,NUP93;NUP98;AHCTF1;NDC1;NUP153
prerank,positive regulation of hormone secretion (GO:0046887),0.44159465691190375,0.9471240131160042,0.5434782608695652,0.8946231710703864,1.0,4/17,14.06%,SPP1;RASL10B;HFE;NMB
prerank,positive regulation of cell communication (GO:0010647),0.413610376458733,0.946992558795175,0.5520094562647754,0.8944528116774897,1.0,3/28,6.74%,CLSTN1;TNF;CD80
prerank,response to interleukin-6 (GO:0070741),0.4878019381686831,0.9469634996956124,0.5454545454545454,0.894073354817538,1.0,5/10,16.43%,NFKB1;PID1;PTPRT;SELPLG;SBNO2
prerank,histone methylation (GO:0016571),0.4223912462950652,0.9467107818705529,0.5612121212121212,0.8941714215223238,1.0,5/26,16.48%,NSD1;FBL;SETD6;SMYD3;SUV39H1
prerank,connective tissue development (GO:0061448),0.4049827490324243,0.9465132738112242,0.5947786606129398,0.894143252752701,1.0,8/35,13.61%,SH3PXD2B;ATP7A;CD44;SULF2;LRP5;CREB3L2;SOX9;SOX6
prerank,respiratory tube development (GO:0030323),0.41514071167111344,0.9461018646272213,0.562874251497006,0.8945822508833383,1.0,3/28,6.82%,SHH;CEBPA;NKX2-1
prerank,sarcomere organization (GO:0045214),0.4237321035128329,0.9459532877350433,0.5575117370892019,0.894471571476557,1.0,5/27,14.80%,TTN;MYLK3;TNNT3;CSRP1;CAPN3
prerank,sensory perception of sound (GO:0007605),-0.21464219147038407,-0.945865578425101,0.5862068965517241,0.8964937804719807,1.0,14/88,12.21%,ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1;CLIC5;ATP6V0A4;TBX1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.37132542763441356,0.9458562003131088,0.5983606557377049,0.8942340430814327,1.0,21/98,17.77%,TREM2;LGALS3;ITGB2;PLS1;TNF;AKAP5;STAC;YWHAB;TP53;PRKCH;ITGAM;FYN;STX3;CASP8;STAC3;ARF6;LRP1;YWHAH;CEMIP;MYO1C;PDPK1
prerank,tRNA export from nucleus (GO:0006409),-0.2744694879242926,-0.9454384897245758,0.5641025641025641,0.8922635762588895,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2744694879242926,-0.9454384897245758,0.5641025641025641,0.8922635762588895,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,heterocycle biosynthetic process (GO:0018130),0.45683560212980706,0.9453244799763091,0.5447042640990372,0.894953226706252,1.0,2/14,10.15%,GCH1;PYCR2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.38843989725000605,0.9453032173645738,0.574761399787911,0.8945637960805415,1.0,8/55,6.86%,TGFBR1;TNF;TRAF2;PYCARD;DDIT3;BCL2L1;TP53;CRADD
prerank,membrane depolarization during action potential (GO:0086010),0.4216719021982945,0.9452382704035179,0.5586854460093896,0.8942579243833132,1.0,7/26,17.43%,SCN4B;HCN4;SLC8A1;SCN9A;YWHAH;CACNA1D;SCN5A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.44145490429311596,0.945126596145867,0.5455729166666666,0.8940329849014877,1.0,2/17,8.05%,TGFB1;SNAI1
prerank,protein import into nucleus (GO:0006606),0.3850908865710506,0.944793789199864,0.5875,0.8942833173974795,1.0,4/66,2.92%,MMP12;SYK;RPL23;NUP62
prerank,protein localization to kinetochore (GO:0034501),0.45999017190074776,0.9443048874668261,0.5561643835616439,0.8948986514804693,1.0,5/14,23.99%,IK;MIS12;KNL1;BUB3;CENPT
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39235471117317466,0.944150337556392,0.6045016077170418,0.8947897502013904,1.0,8/47,11.24%,CASS4;RREB1;MDK;ACTN4;NEDD9;P4HB;LIMS1;NRP1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4009095844299766,0.9441366192853571,0.5863192182410424,0.8943740480257372,1.0,11/47,18.94%,SCIMP;TAOK3;RAP2A;QARS1;MAP2K2;NOD2;KLHDC10;PHLPP1;GREM1;PER1;TAOK1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.44473089904352653,0.94386539159972,0.5503355704697986,0.8944873335251531,1.0,3/15,6.91%,RENBP;NAGK;OGA
prerank,isotype switching (GO:0045190),-0.39605992286600367,-0.9438644521865484,0.5333333333333333,0.8937778854367362,1.0,6/10,36.40%,MSH2;MSH6;BATF;HSPD1;LIG4;RNF8
prerank,negative regulation of viral genome replication (GO:0045071),0.39690122290412255,0.9436793959321577,0.5882352941176471,0.8944661803313949,1.0,12/40,23.80%,FAM111A;TNF;RESF1;RNASEL;TASOR;PARP10;INPP5K;IFITM2;SETDB1;ILF3;IFIT1;IFITM1
prerank,peptide biosynthetic process (GO:0043043),0.3669979725813567,0.9431438742993091,0.6395582329317269,0.8951448112977595,1.0,59/153,26.27%,RPL23;RPL17;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;RPS15A;GSPT1;EIF4EBP2;MRPL51;RPL6;RPLP2;RPL26;RPS20;GGTA1;RPS16;RPS14;DARS1;RPL19;IGF2BP3;RPL9;RPS11;RPL11;RPS23;FURIN;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;RPL22;RPS7;RPS13;SARS1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;RPL10;MRPL37;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1;RPL28;MRPS15
prerank,regulation of axon regeneration (GO:0048679),0.4789143135181904,0.9431065151843382,0.5359195402298851,0.8947916066106039,1.0,4/12,16.34%,RTN4RL1;GRN;STK24;EPHA4
prerank,epidermal cell differentiation (GO:0009913),-0.2564344160157268,-0.9425640406147627,0.6020408163265306,0.8944621843469236,1.0,8/41,15.14%,CLIC4;WNT5A;BCR;HDAC2;GLI1;JAG1;CASP3;UGCG
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4391635839281704,0.9425472797081479,0.5645569620253165,0.8955127993429091,1.0,2/18,6.34%,AQP1;ANXA1
prerank,positive regulation of histone acetylation (GO:0035066),0.42555426003837826,0.9425338087450613,0.5697399527186762,0.8951129107306083,1.0,11/23,27.11%,PPARGC1A;RPS6KA4;KAT7;SMARCB1;BRD7;PIH1D1;RPS6KA5;ARRB1;SPHK2;GLYR1;MAPK3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.33365999211096087,-0.9424894396982256,0.5338645418326693,0.8919522564443726,1.0,2/15,2.48%,FOXC1;BMP4
prerank,monocyte differentiation (GO:0030224),0.48513793819560525,0.9423452276513697,0.5579399141630901,0.895073073270283,1.0,2/10,5.26%,CSF1R;MYH9
prerank,regulation of neuron projection arborization (GO:0150011),-0.3371486140970398,-0.9421544974022154,0.5019305019305019,0.8902131606232505,1.0,5/15,12.28%,NTNG1;WNT5A;MYO9A;FZD4;GRIP1
prerank,regulation of cell motility (GO:2000145),0.36775662833480643,0.9419509474572831,0.6212121212121212,0.8954624685309673,1.0,29/121,22.04%,TGFB1;CYRIB;CSF1R;PLXNC1;PLXNB2;ADGRG3;MACF1;DOCK10;TMSB4X;KIF14;SPINT2;PKN1;DIAPH1;CDK6;NRG1;TMSB10;ARHGAP18;KIF2A;SGK3;RHOA;MINK1;ROCK2;CRK;SPATA13;AMOT;MEMO1;PIN1;FLNA;FGF2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.37929632127357626,0.9414474715519631,0.6072186836518046,0.8960933495504801,1.0,13/65,16.48%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;TP53;P4HB;TBL2;STUB1;CPEB4;HIF1A;CPEB2;SUV39H1
prerank,chloride transmembrane transport (GO:1902476),-0.24239490074629777,-0.9413745988469403,0.5609756097560976,0.8896266409241721,1.0,9/48,17.41%,SLC12A2;SLC12A7;GABRB2;GABRB1;GABRA2;GABRB3;ANO4;SLC12A8;GLRB
prerank,DNA double-strand break processing (GO:0000729),0.44088164710143807,0.9412498618163481,0.5444015444015444,0.8960371764826748,1.0,5/18,17.04%,UBE2V2;DNA2;SLX4;SMARCAD1;UBE2N
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4872829917431332,0.9411340292233752,0.5552367288378766,0.8958254406889281,1.0,5/10,25.36%,TSPAN6;GPATCH3;RIOK3;RNF125;C1QBP
prerank,RNA stabilization (GO:0043489),0.40831978025700433,0.9410442184771928,0.568649885583524,0.8955741552824604,1.0,4/33,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,regulation of vacuole organization (GO:0044088),0.42644619525394,0.9406575865365508,0.5594936708860759,0.8959246143062142,1.0,11/20,24.20%,ENO3;MTMR3;RAB1B;TBC1D14;TBC1D12;LAPTM4B;ENO1;SCARB2;NPRL3;ADPRH;IFT88
prerank,negative regulation of protein secretion (GO:0050709),0.4025307527161538,0.9405536480207674,0.5741789354473387,0.8957201913741512,1.0,3/38,4.68%,KCNJ11;APOE;RHBDF2
prerank,in utero embryonic development (GO:0001701),0.4227101330833847,0.9405064985133212,0.5607701564380265,0.8953814919288021,1.0,3/25,8.33%,TGFBR1;CHD7;FLCN
prerank,cellular response to glucose starvation (GO:0042149),0.39116860424689576,0.9402166526757202,0.5722222222222222,0.8955777825726942,1.0,22/41,28.84%,FOXO3;TP53;MTMR3;IMPACT;BECN1;TBL2;NIM1K;CPEB4;PIK3R4;SIK2;ATG14;BRSK1;NUAK1;PRKAG1;NUAK2;XBP1;SH3GLB1;PRKAA1;ITFG2;SESN1;SESN2;PMAIP1
prerank,hepaticobiliary system development (GO:0061008),0.4404861237489853,0.9400664602153069,0.5744949494949495,0.8954407486967915,1.0,3/20,4.57%,PCSK9;PKD2;CEBPA
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.41736881577942764,0.9399487527778946,0.5783718104495748,0.8952419104092681,1.0,3/26,4.54%,CBL;NCK2;ZFYVE28
prerank,determination of heart left/right asymmetry (GO:0061371),0.4016757302246025,0.9396364747628626,0.6010989010989011,0.8954454126411563,1.0,4/43,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,sulfation (GO:0051923),0.48356243715728103,0.9394245983066967,0.5693430656934306,0.8954319006861863,1.0,1/11,4.99%,SULT4A1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4121962918472754,0.9393140911256975,0.5634118967452301,0.8952298913990616,1.0,8/33,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,protein localization to condensed chromosome (GO:1903083),0.4661958683204014,0.938829762413365,0.5561877667140825,0.8957501041523661,1.0,1/12,2.30%,IK
prerank,sensory organ development (GO:0007423),0.3838540381639577,0.9382453920717676,0.572354211663067,0.8965021359269069,1.0,9/51,15.38%,ASCL1;SH3PXD2B;CHD7;MYO7A;ZDHHC16;SOX2;MEIS1;SIPA1L3;AHI1
prerank,rRNA processing (GO:0006364),0.36459297850667094,0.937295419410874,0.656312625250501,0.8980054043448362,1.0,46/172,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;RIOK3;WDR75;RPL7A;RPL15;EXOSC3;SART1;RPL29;RRP7A;UTP3;SRFBP1;RPL22;IMP4;RPS7
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.44358867301576194,0.9370707498514089,0.5525238744884038,0.8980380977110611,1.0,8/14,24.65%,PIK3CD;VEGFB;NRP1;MYO1C;VEGFD;PIK3CA;VEGFA;KDR
prerank,regulation of telomerase activity (GO:0051972),0.3903284292023354,0.9367607681069626,0.5969664138678223,0.8982563477824781,1.0,6/45,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;TP53;PRKCQ
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.45797076907642,0.9365535894089015,0.5855354659248957,0.898275075031958,1.0,5/14,20.83%,PKD2;TMSB4X;FAF1;KEAP1;NFKBIE
prerank,regulation of muscle cell differentiation (GO:0051147),0.40898864435304866,0.9363786521681876,0.5845799769850403,0.8982217901306367,1.0,10/31,22.04%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;HDAC9;CDC42;MEGF10;PTBP1;CDH15
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.43015303936231125,0.9363321363169806,0.5641646489104116,0.8978782542608253,1.0,5/22,15.61%,NFE2L2;PSMB10;PSMA2;PSMB5;PSMB9
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4237810009630498,0.9363028604803407,0.5667074663402693,0.8974961306270058,1.0,9/21,27.02%,CHSY3;BCAN;CHSY1;CHST15;CHPF;CSPG4;CHST3;CHST11;CHST9
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.45267794335553363,0.9361783173326638,0.5638998682476943,0.8973167504823758,1.0,3/15,12.48%,GRB2;BCAR1;DDIT4
prerank,lamellipodium organization (GO:0097581),0.4020987726476891,0.9361085841909339,0.5710982658959538,0.8970204080458941,1.0,12/29,20.63%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;SNX2;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13
prerank,lysine metabolic process (GO:0006553),0.4695277757624202,0.9356925394631583,0.5692520775623269,0.8970186047887282,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.4695277757624202,0.9356925394631583,0.5692520775623269,0.8970186047887282,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,oogenesis (GO:0048477),0.4555008239073017,0.9356679429864511,0.5565789473684211,0.8966481309935771,1.0,4/15,17.07%,MDK;TRIP13;METTL3;MARF1
prerank,positive regulation of exosomal secretion (GO:1903543),0.4582092253336796,0.9355283388511924,0.5716162943495401,0.8964838330642186,1.0,5/15,19.99%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35977269718593474,0.9353846723853843,0.734,0.8963530794952405,1.0,79/366,18.19%,HCLS1;GATA1;ORC3;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;FOXO3;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;CYFIP1;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;PCIF1;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;PUM3;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.38044645930351745,0.9352031344788161,0.6198083067092651,0.8962975356157216,1.0,17/58,21.91%,UBE2V2;HMGB1;XRCC5;LIG3;ATP23;UVRAG;BABAM2;ERCC6;BABAM1;MDC1;UBE2N;ERCC1;POLM;HERC2;DCLRE1C;NSMCE2;ERCC4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4125503392797924,0.9351589372333904,0.5533742331288344,0.8959570571230682,1.0,9/26,21.22%,SMYD5;TET3;SETD2;ETFBKMT;SUV39H1;SETD1B;WDR82;TET2;SETD5
prerank,signal peptide processing (GO:0006465),0.47776946529494063,0.9348601221119807,0.5774240231548481,0.8961346379439336,1.0,6/11,17.02%,SPCS2;SEC11C;SPPL3;SPCS1;PARL;FURIN
prerank,regulation of monocyte differentiation (GO:0045655),0.4559326873030502,0.9347853105583973,0.5656836461126006,0.895853858436954,1.0,2/14,3.61%,CD74;ACIN1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3957474813061065,0.9345969814934864,0.5905598243688255,0.8958104149704423,1.0,8/45,13.46%,TGFB1;ERN1;TP53;GRSF1;ZC3H18;MAP2K2;HEATR1;NFKB1
prerank,primary miRNA processing (GO:0031053),-0.3691657782982941,-0.9345010744206995,0.5236593059936908,0.9044865549484585,1.0,4/10,11.19%,DGCR8;HNRNPA2B1;SMAD1;PUS10
prerank,DNA methylation (GO:0006306),0.41889174984293265,0.9343376139595229,0.5555555555555556,0.8959295518404826,1.0,4/23,9.69%,DNMT3A;METTL4;ATRX;ATF7IP
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4173250427730357,0.933906257898113,0.5648038049940547,0.8963950281531414,1.0,11/24,23.84%,TENT4B;STN1;TNKS2;SLX4;SRC;TINF2;TERF2;ERCC4;TEN1;PARP1;DCP2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.38317744754056204,0.9337811647841552,0.5936170212765958,0.8962183513538236,1.0,10/51,15.27%,PKIB;TENT4B;XRCC5;CTNNB1;PRKCQ;CCT8;STN1;TNKS2;CCT5;SRC
prerank,sphingolipid biosynthetic process (GO:0030148),0.37788168820159457,0.9336592482293206,0.619644723092999,0.8960521095663162,1.0,20/71,22.59%,CERS6;SGPL1;CLN8;PRKD2;CSNK1G2;HACD4;AGK;ACER3;VAPB;ST8SIA1;LARGE1;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;B4GALT6;PRKD3;CERS4
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.37521805171911643,-0.9333455903698388,0.5393939393939394,0.9048181805013236,1.0,8/10,41.35%,GAR1;NOP10;TSR3;RPUSD1;NHP2;NAF1;RPUSD2;RPUSD3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.38349186155386417,-0.93308658486816,0.5379746835443038,0.902847198477388,1.0,6/10,24.58%,APP;SHANK3;RAB5A;SYP;DRD2;CAMK2B
prerank,regulation of protein binding (GO:0043393),0.3650233697748778,0.9330137700367813,0.6255060728744939,0.8968760118705666,1.0,29/114,18.54%,BAG2;PRKCD;LDLRAP1;HDAC5;TAF1;ACTB;TFIP11;HFE;DISC1;CTSZ;SPPL3;DERL1;EPB41;HDAC4;PPP2CA;PSME3IP1;SORL1;BAMBI;B2M;STK3;LRRK2;LRP1;TLE5;IDE;RPL11;STK4;ADD1;FLOT1;DACT1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.45055986505921997,0.9326560923512829,0.5676392572944297,0.897140878738948,1.0,4/15,14.15%,TSEN15;ERN1;RTRAF;DDX1
prerank,regulation of feeding behavior (GO:0060259),-0.3754824530206419,-0.9325286804781089,0.54375,0.9016506695188551,1.0,5/11,36.27%,LEPR;EIF2AK4;NR4A3;AGRP;CFAP20
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.4590177723658198,0.9324897603243986,0.5618279569892473,0.8970398503438055,1.0,2/14,9.43%,TLR2;PUM2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4213373984242181,0.9324397983129702,0.5848375451263538,0.8967090975222645,1.0,5/24,13.61%,TGFBR1;MDK;TRPS1;SOX9;SOX6
prerank,tRNA wobble base modification (GO:0002097),-0.33651612636476314,-0.9320117869693354,0.5189393939393939,0.9004277081707086,1.0,5/14,20.80%,ELP3;ELP4;URM1;MTO1;DPH3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3632169638364929,-0.9318884114423287,0.5539568345323741,0.8981253696203942,1.0,4/12,4.64%,CDH5;STMN2;EML2;DYRK1A
prerank,dicarboxylic acid transport (GO:0006835),-0.2767789639576365,-0.9315959112834893,0.5524475524475524,0.8962247444860457,1.0,4/28,6.22%,SLC25A12;ARL6IP5;SLC26A7;SLC25A13
prerank,skeletal muscle organ development (GO:0060538),0.41858992760437497,0.931593971992583,0.5726290516206483,0.8980110239459042,1.0,3/26,8.10%,BASP1;CFLAR;MEF2C
prerank,histone H4 deacetylation (GO:0070933),0.4762859318609864,0.9313697210124704,0.5695067264573991,0.8980403696290042,1.0,4/10,16.17%,RCOR1;HDAC4;HDAC9;SMARCAD1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.34535107959869105,-0.9312689853494125,0.5134099616858238,0.8945363706390037,1.0,4/14,6.34%,CPSF6;FIP1L1;CPSF7;CSTF2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3965237283982941,0.9310945348828051,0.5988888888888889,0.898116950215536,1.0,16/38,23.99%,CENPO;ASF1B;ATRX;RBBP7;CENPI;CENPQ;CENPK;RSF1;UBN1;RBBP4;IPO4;ITGB3BP;SMARCA5;H3-3A;KNL1;CENPT
prerank,cellular copper ion homeostasis (GO:0006878),0.4411948191445949,0.9307954578011163,0.5664893617021277,0.8983268997887495,1.0,2/14,4.49%,ATP7A;ATOX1
prerank,JNK cascade (GO:0007254),0.3907316128240539,0.9306582491676197,0.5758582502768549,0.898171076163832,1.0,12/40,18.63%,IRAK2;UBE2V1;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;TAB3;MAP3K11;UBE2N;MINK1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.423289848838411,0.9302857722617591,0.5677339901477833,0.8984712990716409,1.0,2/20,8.46%,TGFB1;RB1
prerank,carnitine shuttle (GO:0006853),0.47056310826840575,0.93027468920601,0.5654008438818565,0.8980636410100733,1.0,3/11,16.91%,SLC25A20;ACACA;CPT2
prerank,RNA splicing (GO:0008380),0.36393563235189075,0.9297589815827946,0.6286876907426246,0.8986897958949366,1.0,24/95,21.65%,IVNS1ABP;BCAS2;SF3B2;SF3B1;SNRNP25;SCAF11;ZMAT5;SNRPD2;PPARGC1A;DDX39B;LUC7L3;PRPF8;TRA2B;PPP2CA;WDR83;PPIG;NRDE2;SLU7;SNRNP35;SRSF2;SF3B3;SRSF10;PTBP1;PDCD7
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3650603529364228,0.9289427880911972,0.6663316582914572,0.8998570892363689,1.0,57/148,28.29%,RPL23;MTOR;RFFL;MAPK14;MAP2K6;PIP4K2A;RMI1;EXO1;TAF1;BRIP1;TP53;CHEK2;CSNK2A2;CSNK2A1;RPS20;USP7;RBBP7;PIP4P1;RRS1;DNA2;BRD7;NOC2L;TAF3;RPL11;MEAF6;PDPK1;PPP2R5C;CHD4;TAF11;RBBP4;CDK5R1;HEXIM1;TTC5;PHF20;PIN1;RAD1;MDM4;SGK1;NUAK1;RPS15;CHD5;ATR;RPA1;PRKAG1;RPL5;CDK5RAP3;ING5;MTA2;TAF6;TOP3A;PAK1IP1;TAF15;PRKAA1;KAT5;RHNO1;HDAC1;RAD9B
prerank,modulation by host of symbiont process (GO:0051851),0.40494979541742443,0.9287167456835045,0.58274231678487,0.8998786494785722,1.0,2/31,1.86%,CX3CR1;AQP1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.41914373369618907,0.9285356604011403,0.5835380835380836,0.8998157299902583,1.0,7/24,22.06%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;CHP1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.3537237310617123,-0.9279700670402066,0.5403225806451613,0.9005574272459581,1.0,3/13,5.64%,KCNK5;KCND3;KCNT2
prerank,regulation of spindle organization (GO:0090224),0.4266502868709181,0.9277433440772016,0.5620998719590269,0.9009657908763662,1.0,4/18,12.21%,NUP62;RNF4;CLTC;DYNC1H1
prerank,endothelial tube morphogenesis (GO:0061154),0.48070889078875034,0.9276804042445403,0.5514705882352942,0.9006681908891255,1.0,3/10,6.29%,CCM2;PRKD2;CTNNB1
prerank,heme biosynthetic process (GO:0006783),0.4232540465174765,0.9272972569007147,0.5731559854897219,0.9010189286307738,1.0,4/22,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,regulation of NMDA receptor activity (GO:2000310),0.40284291936517996,0.9272715397810284,0.5932203389830508,0.9006474596498987,1.0,2/32,1.16%,PTK2B;CCR2
prerank,epithelial cell-cell adhesion (GO:0090136),0.47105625684895014,0.9271970289750322,0.586552217453505,0.9003741605872556,1.0,2/11,9.76%,ITGB5;VCL
prerank,nuclear transport (GO:0051169),0.4427924683526808,0.9265829270382074,0.5729166666666666,0.9011921051529592,1.0,4/16,11.71%,XPO1;ANP32A;RBM15B;NUP205
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.38565611522337123,0.9262982111387141,0.6123778501628665,0.9013295474748296,1.0,13/48,20.17%,ADCY7;SLC25A16;GUCY2F;ADCY6;SLC35B3;NPR2;PAPSS1;ADCY3;ADCY8;IMPDH2;PPCDC;ADCY9;NPPC
prerank,cellular calcium ion homeostasis (GO:0006874),0.36208485485277925,0.9262065733981442,0.6512562814070352,0.9010877451914031,1.0,33/133,19.99%,CCR2;KCTD17;SLC8A1;CCL8;HERPUD1;CLN3;FZD9;TMEM178A;ATP2C1;TPT1;ATP2B1;BAK1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;CDH23;ATP2A3;ADCY8;WFS1;CCDC47;SELENOK;PDZD8;TMEM165;MICU2;PACS2;CALCA;ATP13A5;ATP13A2
prerank,potassium ion import across plasma membrane (GO:1990573),0.39787952505574264,0.9257478438400849,0.6052921719955898,0.9016141930162647,1.0,2/41,2.24%,KCNJ11;HCN4
prerank,regulation of synapse maturation (GO:0090128),-0.37790270862578335,-0.9256139848794762,0.5517241379310345,0.9041425802469156,1.0,5/10,28.16%,DAB2IP;ARHGEF15;ANAPC2;CAMK2B;YWHAZ
prerank,negative regulation of developmental process (GO:0051093),0.37382782165980755,0.9255986498787996,0.6132368148914168,0.9014951941730919,1.0,18/69,21.54%,SHH;TGFB1;THY1;BCL11A;SPI1;RC3H1;SOX9;CDK6;GAS6;HUWE1;VAT1;SFMBT1;GREM1;KLF7;ROCK2;PRKN;ARPIN;PARP3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4107557182938929,0.9255458250400782,0.5911799761620977,0.9011691516534335,1.0,3/27,8.05%,CD74;CD44;SNAI1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.360597750233808,0.9253413362239672,0.6579739217652959,0.9011556931131965,1.0,31/146,18.10%,TUBB;GPR132;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;RAB11A;PSMA2;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;HAUS8;PSMD8;PSMD7;PSMB9;NINL;RAD51B;HSP90AA1;AKAP9;PSMD2;CEP63
prerank,histone monoubiquitination (GO:0010390),-0.2826910918035765,-0.9248494534305179,0.5555555555555556,0.9034538101841856,1.0,7/24,12.26%,DDB2;RYBP;DDB1;TRIM37;PAF1;WAC;DTX3L
prerank,UV protection (GO:0009650),0.4765967687542536,0.9247892731015558,0.5736994219653179,0.9018055829334712,1.0,3/10,16.44%,SDF4;ERCC5;MFAP4
prerank,positive regulation of viral life cycle (GO:1903902),0.4299361731056389,0.9245669129679877,0.5985130111524164,0.9018270379418022,1.0,3/22,10.78%,CD74;P4HB;LGALS1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.38679988130424225,0.9244396535337054,0.6,0.9016455625862795,1.0,5/45,12.29%,TGFB1;TGFBR1;HFE;INHBA;SDCBP
prerank,positive regulation of TORC1 signaling (GO:1904263),0.44303437576612514,0.924416939812081,0.5683646112600537,0.9012701146356508,1.0,8/16,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;PIH1D1;TELO2;RRAGA;RRAGB
prerank,response to nitric oxide (GO:0071731),0.45993003276574296,0.9243172560495451,0.5750708215297451,0.9010466981086522,1.0,1/13,1.86%,AQP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.38286672375570235,0.9232929806410393,0.5947089947089947,0.9027106391804443,1.0,15/54,17.75%,PTPRJ;THY1;DUSP3;MACF1;SLC9A1;ACTG1;VCL;LIMS1;NRP1;THBS1;SRC;PTPRA;PTEN;CORO1C;RHOA
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3891944512301746,0.9230258547883143,0.5963511972633979,0.9028297562312345,1.0,9/35,16.35%,PCDHB6;ATP2C1;CDH8;CDH9;CDH12;CDH23;DCHS1;CDH19;PCDHGB4
prerank,regulation of protein localization to nucleus (GO:1900180),0.3901014603106052,0.9226735529054311,0.6077777777777778,0.9030877243432697,1.0,2/43,0.90%,SHH;TGFB1
prerank,regulation of dendrite development (GO:0050773),0.3919988187491073,0.9225589581843108,0.6083995459704881,0.9028720446963154,1.0,8/37,12.93%,CAMK1D;BCL11A;RAP2A;SEMA4D;TNIK;NEDD4L;CSMD3;LRP8
prerank,regulation of exosomal secretion (GO:1903541),0.4337541744788086,0.9219923111995252,0.5895522388059702,0.9035736308222562,1.0,6/19,20.78%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2;PRKN
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3488001057729636,-0.9214181463236539,0.5758928571428571,0.9096093368906623,1.0,3/14,4.70%,ANK2;ATP1B1;ACTN2
prerank,regulation of mitochondrial fission (GO:0090140),0.41645072264444805,0.9212719501559353,0.5726290516206483,0.9046034716027489,1.0,8/24,20.78%,CYRIB;DDHD1;MYO19;LRRK2;DNM1L;FIS1;INF2;PRKN
prerank,RNA processing (GO:0006396),0.3561066503118759,0.9211243538234337,0.6857429718875502,0.9044564961234665,1.0,45/176,21.65%,APOBEC1;IVNS1ABP;BCAS2;SF3B2;SF3B1;AURKAIP1;RBM39;TENT4B;SNRNP25;SCAF11;TFIP11;ZMAT5;SNRPD2;ADAR;PPARGC1A;HNRNPL;DDX39B;SON;RNASEL;LUC7L3;METTL3;PRPF8;PPP2CA;ADARB1;HNRNPD;ALKBH5;PPIG;AKAP8L;NUFIP1;NRDE2;TUT7;PABPC4;SLU7;RBMS2;HNRNPF;SNRNP35;SRSF2;PABPN1;SF3B3;TSEN2;DICER1;PTBP1;HNRNPA0;LIN28B;PDCD7
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38552676729857566,0.9204997745107569,0.6048298572996706,0.9053141803273701,1.0,15/44,22.43%,CNOT8;GTPBP1;TNRC6A;YTHDF3;MOV10;RC3H1;CPEB3;METTL3;MEX3D;AGO2;ROCK2;FTO;ZFP36L1;CNOT7;CNOT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.37000520698550887,-0.9200306054794223,0.5531914893617021,0.9104835437382959,1.0,3/10,11.92%,NEXMIF;ACER2;JAM3
prerank,regulation of cellular response to stress (GO:0080135),0.3634845442912826,0.9198831118423838,0.6595744680851063,0.9060507095070028,1.0,33/115,21.26%,BAG2;MTOR;PTGES3;NUP62;NEK6;DNAJC7;ATF3;CLN3;HSBP1;ABCD1;SEH1L;CEBPB;HSF1;SMG1;TPR;NUP205;ADCY8;CHORDC1;BAG1;HSP90AA1;MANF;DNAJB6;NPAS2;CORO2B;RPTOR;SEC13;ROCK2;GSK3B;PRKN;NUP54;BAG4;CRYAB;NEK4
prerank,calcium ion homeostasis (GO:0055074),0.3642851734249342,0.9196894228937087,0.6448979591836734,0.9059847382571403,1.0,18/95,14.21%,CCR2;SLC8A1;CCL8;SNCA;ATP2C1;TPT1;TFAP2B;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;WFS1
prerank,protein localization to cell-cell junction (GO:0150105),0.4428235129477421,0.9195256021062208,0.5681818181818182,0.9058795473339891,1.0,4/15,9.97%,ARHGEF18;ACTB;ACTG1;F11R
prerank,peroxisomal membrane transport (GO:0015919),0.4026002915884948,0.9192244280213976,0.5841346153846154,0.9060229609660934,1.0,5/27,11.57%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3647178817474631,0.9192087082354945,0.6490335707019329,0.9056283013663682,1.0,21/95,17.77%,TGFB1;TGFBR1;ZEB2;SKI;RNF111;TGFBR2;NKX2-1;FLCN;FAM89B;SMAD3;THBS1;SNX25;SDCBP;BAMBI;VASN;STUB1;BCL9;SMURF1;LDLRAD4;GIPC1;PDPK1
prerank,pre-replicative complex assembly (GO:0036388),0.37043094267179766,0.919121340042686,0.6231732776617954,0.9053808700426911,1.0,13/64,15.61%,MCM5;ORC3;PSMB10;MCM6;MCM2;PSMA2;ORC4;PSME3;PSMB5;CDC6;PSMD8;PSMD7;PSMB9
prerank,stress granule assembly (GO:0034063),0.4247448050206722,0.9190577938781279,0.5822942643391521,0.9050805954604574,1.0,5/20,16.67%,CIRBP;YTHDF3;DYNC1H1;ATXN2L;RPS23
prerank,histone deacetylation (GO:0016575),0.38093864444883613,0.9189311195963286,0.619750283768445,0.9049039054067575,1.0,11/43,16.17%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11;SMARCAD1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4473860796669801,0.9188482321732033,0.571041948579161,0.9046394832477752,1.0,2/14,4.53%,ABCG1;CLN3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3881899630587692,0.9187397226216706,0.6013001083423619,0.9044459743790578,1.0,10/42,18.63%,THY1;PIK3CB;ATXN3;LIMS1;PTPRO;NF1;CORO1C;RHOA;CORO2B;MINK1
prerank,protein complex oligomerization (GO:0051259),0.36300396086567055,0.9186594111632377,0.6434426229508197,0.9041648308430079,1.0,18/85,16.53%,CARD11;LRRC8D;SNCA;PKD2;PYCARD;SLC9A1;AQP11;ATL1;RNF135;NINJ1;TMEM120A;ADCY8;LRRC8C;TWNK;PDCD6IP;ALS2;ZNHIT6;YME1L1
prerank,mitochondrion disassembly (GO:0061726),0.39645922139163875,0.9178218515133374,0.6138952164009112,0.9053322220136739,1.0,10/34,22.33%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;FIS1;PRKN;RB1CC1
prerank,transcription by RNA polymerase II (GO:0006366),0.3556665050471208,0.9169577495291529,0.751,0.9065729087631571,1.0,68/305,19.13%,ARRB2;PCID2;POU2F2;MED17;RREB1;GTF2H1;TAF1A;MAML3;NABP1;RXRB;NR1H4;EAF1;HDAC5;ELL2;TAF1;BTF3;TEAD1;TBL1XR1;LEO1;CSTF1;TRIP13;GMEB2;LSM11;INTS8;PPARGC1A;CDK7;NFX1;SETD2;RPAP2;NFIC;TBL1X;MED27;KLF13;POLR2L;TRIM24;TAF8;NR2C2;HDAC9;MBD1;PMF1;SNAPC3;ELL;NR4A1;MLLT1;NFKB1;INTS6;ELOF1;INTS13;NR2C1;MAF;ERCC6;TAF3;RBPJ;ZBTB7B;SNAPC4;GTF2B;ICE2;PPARD;NFYA;PCF11;INTS1;TCEA1;GTF2H5;RXRA;POLR2E;TAF11;ELOB;MED4
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3432630083412158,-0.9164144829154137,0.5899280575539568,0.9169973233765766,1.0,3/12,7.48%,UNC13B;RIMS2;SYT7
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.44077394636340195,0.9162571086758978,0.5833333333333334,0.9075255341214693,1.0,2/14,9.54%,MAPK14;ANGEL2
prerank,nucleotide-excision repair (GO:0006289),0.3638168455300595,0.9159025531672907,0.6730964467005076,0.907770820198572,1.0,23/101,18.79%,COPS6;GTF2H1;PPIE;RNF111;BRIP1;LIG3;UVSSA;ATXN3;TP53;MMS19;CDK7;USP7;POLR2L;COPS4;SLX4;POLD3;ERCC5;ERCC6;OGG1;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2149110365870422,-0.9157236656668759,0.7575757575757576,0.916077674170385,1.0,30/82,26.38%,SUCO;CRIM1;BMPR1A;TMEM64;WNT4;PRKD1;BMP4;ACVR1;RORB;REST;CTNNBIP1;CCN1;ATF4;SMAD6;PPARG;TWIST2;HDAC7;FERMT2;RANBP3L;TMEM119;PTK2;PTCH1;CHRD;BMPR2;MEN1;TWIST1;ACVR2B;FGFR2;SMOC1;HGF
prerank,cellular response to UV (GO:0034644),0.36860627566796333,0.9154712463477309,0.6297435897435898,0.9081615789197346,1.0,15/76,16.44%,AQP1;PRKCD;TIMP1;TAF1;TP53;YY1;BAK1;IMPACT;RPL26;METTL3;INO80;BMF;NOC2L;COPS9;MFAP4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2853941090669988,-0.9148667370981842,0.5573770491803278,0.9156711979021546,1.0,6/26,10.09%,SRI;THADA;ATP1A2;FKBP1A;FMR1;CALM3
prerank,RNA transport (GO:0050658),0.3673334460827641,0.9147415497949694,0.6367432150313153,0.9091935211896631,1.0,20/71,21.24%,RFTN1;NUP62;DHX38;NXF1;THOC2;TGFBR2;CASC3;TPR;DDX39B;POLDIP3;UPF3B;RTRAF;THOC3;FLOT1;SLU7;SRSF6;SRSF2;SLBP;SRSF3;ZFP36L1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.25171275078267524,-0.9145788873362364,0.6074766355140186,0.9138168988237605,1.0,17/37,26.84%,KIF3C;IFT46;IFT57;IFT172;KIF3B;IFT81;KIFAP3;IFT74;WDR35;IFT20;IFT43;DYNC2I2;DYNLL2;IFT22;IFT122;WDR19;TRAF3IP1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3716143037508021,0.9145707696936812,0.6448202959830867,0.9091118336505507,1.0,8/62,8.26%,NFE2L2;CREB3;HERPUD1;BCL2L1;CREB3L1;EPO;SNAI1;TPT1
prerank,histone exchange (GO:0043486),0.39148862764324543,0.9144760796931232,0.6320541760722348,0.9088823467586478,1.0,14/37,23.99%,CENPO;SRCAP;RBBP7;CENPI;SPTY2D1;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;VPS72;SMARCA5;KNL1;CENPT
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4206147710485746,0.9142107286772373,0.5903307888040712,0.908954389156431,1.0,10/22,26.03%,RPL23;RPS20;HEXIM1;RPS7;RPS15;CHD5;SPRED3;ATR;SPRED1;CDK5RAP3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3953235929528883,0.9140518927052116,0.5920281359906213,0.9088187714231153,1.0,7/31,13.60%,PTPN1;ERN1;ATXN3;BAK1;HSF1;HDAC6;STUB1
prerank,protein deacylation (GO:0035601),0.4143610670857097,0.9139014448940209,0.5968137254901961,0.9087032219455972,1.0,5/23,11.66%,HDAC5;ABHD17B;HDAC4;HDAC6;ABHD17C
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4630513289254584,0.9137017521751125,0.5764872521246459,0.9086774792633757,1.0,1/12,2.02%,PLCG2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.391527987183797,0.9131180505599577,0.5986078886310905,0.909367602554686,1.0,5/31,17.14%,GCH1;DHRS11;PYCR2;PRLR;FDXR
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4821395400801016,0.912406608075047,0.6022408963585434,0.9103159793891263,1.0,2/10,5.36%,PIK3CB;XDH
prerank,Rho protein signal transduction (GO:0007266),0.37200022543274286,0.9123570392415171,0.6239316239316239,0.9099753020963675,1.0,19/53,23.93%,MYO9B;GNA13;GNA12;RIPOR1;ARHGAP1;ARHGDIB;ADGRG1;ARHGEF3;ARHGDIA;ARHGEF11;RHOA;CDC42;CDC42EP3;RHOD;ROCK2;CFL1;RHOG;PDPN;EPS8L1
prerank,DNA replication (GO:0006260),0.36148272943210275,0.9122240421872241,0.6567926455566905,0.9097964796807374,1.0,18/105,13.79%,MCM5;FAM111A;ORC3;RMI1;EXO1;BRIP1;MCM6;MCM2;NAP1L1;DBF4;BAZ1A;ORC4;WDHD1;MCM9;KAT7;DNA2;MCMBP;CDC6
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4007902618893461,0.9119117370237665,0.5997610513739546,0.9099819475932711,1.0,4/28,6.55%,LGMN;APOE;AKAP5;TYROBP
prerank,proton transmembrane transport (GO:1902600),0.39939270240752756,0.9119011350458862,0.6255707762557078,0.9095851026612172,1.0,4/36,7.43%,ATP6V0E1;SLC36A1;SLC9A1;ATP6V0D1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.35233030482284305,-0.910986053873416,0.5666666666666667,0.9204858316876114,1.0,3/12,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,autophagy of mitochondrion (GO:0000422),0.3887754419120275,0.9099393088412271,0.6297968397291196,0.9129495078519376,1.0,11/38,22.33%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;ATG14;FIS1;PRKN;RB1CC1
prerank,cellular glucan metabolic process (GO:0006073),-0.3612188129175334,-0.9097516814512264,0.5728476821192053,0.920988950605126,1.0,6/11,21.94%,PHKG2;UGP2;PHKB;PYGM;PPP1R3C;PHKA1
prerank,cellular metal ion homeostasis (GO:0006875),0.3585452063085508,0.9094897055583585,0.668693009118541,0.9133786716693355,1.0,20/102,13.76%,CCR2;SLC8A1;CCL8;KCNMA1;SLC9A1;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;NEDD4L;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP1B3;ATP2A3;ATP1B2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4515876338314021,0.9093805526658443,0.5902964959568733,0.9131656071780365,1.0,3/12,16.50%,UBE2S;FZR1;PTEN
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3997482821980516,0.9090308767981985,0.6013986013986014,0.913410034537379,1.0,3/29,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3719010391409828,0.908774838930112,0.6577319587628866,0.9135045507960008,1.0,6/75,7.37%,KCNJ11;HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.27927149269298834,-0.9083340529007081,0.6273291925465838,0.9218192019163796,1.0,13/25,27.03%,ADK;DGUOK;GMPS;MTHFD1;PRPS2;AMPD3;GMPR;AMPD2;PAICS;ADSL;PPAT;PRPS1;PRPS1L1
prerank,bicarbonate transport (GO:0015701),0.4012828904105677,0.9080734938690493,0.6107711138310894,0.9144315475355345,1.0,3/25,12.09%,AQP1;CYB5R1;CYB5RL
prerank,negative regulation of cellular senescence (GO:2000773),-0.33752373271711644,-0.9079918591938102,0.5498281786941581,0.9200985745714939,1.0,6/13,24.19%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1
prerank,regulation of striated muscle contraction (GO:0006942),0.403367632116534,0.9078638164403254,0.6016548463356974,0.9144080380325874,1.0,4/27,8.17%,HCN4;MYL3;P2RX4;TNNT3
prerank,rRNA methylation (GO:0031167),0.41566111122244054,0.9075199737608254,0.6027227722772277,0.9146306953582446,1.0,3/22,11.99%,EMG1;FBL;ZCCHC4
prerank,translation (GO:0006412),0.35508457569229723,0.9075073758410775,0.757271815446339,0.9142258135241853,1.0,77/208,25.74%,RPL23;RPL17;VARS1;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;GTPBP1;RPS15A;GSPT1;GATB;EIF4EBP2;GARS1;PPA2;MRPL51;RARS1;EPRS1;QARS1;RPL6;LARS2;RPLP2;RPL26;RPS20;RPS16;RPS14;DARS1;RPL19;RWDD1;DARS2;IGF2BP3;RPL9;TMA7;RPS11;RPL11;RPS23;FARS2;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;AIMP1;RPL22;RPS7;TARS1;YARS1;RPS13;EEF1G;SARS2;SARS1;RPL22L1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;DRG2;GATC;RPL10;MRPL37;MRPS34;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1
prerank,cellular response to virus (GO:0098586),0.3927093345632782,0.9073350529653327,0.5983701979045402,0.9141157470979113,1.0,6/30,18.99%,POU2F2;MAPK14;IRGM;HIF1A;HSP90AA1;RIOK3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.34531258003481236,-0.9070665094223436,0.5728813559322034,0.9199154219413583,1.0,7/12,25.95%,RAD17;TOPBP1;STK33;NAE1;CLSPN;SETMAR;ORC1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4578235368202284,0.9065447078921338,0.5892617449664429,0.9151853665639333,1.0,1/13,1.72%,NEIL2
prerank,aorta morphogenesis (GO:0035909),-0.31479347892850557,-0.9064080279534527,0.5867768595041323,0.919073997998341,1.0,5/17,13.17%,BMPR1A;ACVRL1;TBX1;ADAMTS9;JAG1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.37049004558429655,0.9062720313154224,0.6264550264550265,0.9152651133077014,1.0,15/57,23.07%,ADCY7;PSAP;ADCY6;AKAP5;P2RY12;GPR37;ADCY3;ADCY8;GNAI3;RGS1;GNAI2;ADCY9;FLNA;MTNR1A;HTR1F
prerank,protein targeting to peroxisome (GO:0006625),0.3949617379419965,0.9059433331409323,0.5954653937947494,0.9154736926865991,1.0,5/29,11.57%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3360747578932907,-0.905803332898522,0.5830388692579506,0.9180180678807813,1.0,7/13,24.79%,PRPF3;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRPF31
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4150576863258629,0.9057557086685002,0.5901639344262295,0.9154173334550858,1.0,1/20,0.90%,TGFB1
prerank,protein neddylation (GO:0045116),-0.3410334327604625,-0.905511441977236,0.5824175824175825,0.9162418799298326,1.0,6/13,18.17%,DCUN1D4;RBX1;NAE1;UBA3;DCUN1D3;UBE2M
prerank,membrane lipid metabolic process (GO:0006643),0.40367624405783054,0.9055092793317533,0.6119221411192214,0.9154658421233914,1.0,5/22,14.79%,CERK;ST6GALNAC4;AGK;AGMO;ARV1
prerank,regulation of cilium assembly (GO:1902017),0.369469124485251,0.9054848597311594,0.6361702127659574,0.9151013414868779,1.0,18/62,19.20%,TBC1D10C;KCTD17;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;TBC1D14;TBC1D22B;ATG3;RABEP2;ENTR1;DYNC2LI1;TAPT1;TBC1D5
prerank,mitochondrion transport along microtubule (GO:0047497),0.4407738137465913,0.9051602528868175,0.5910987482614742,0.9153086742237397,1.0,1/13,1.14%,UXT
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2579516217289233,-0.9050327229062594,0.6496350364963503,0.9149718946913551,1.0,19/31,33.29%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;PEX14;TOMM70;TIMM23;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,response to ionizing radiation (GO:0010212),0.363433904996303,0.9047952397160833,0.6576482830385015,0.9155514899105383,1.0,18/70,21.96%,GRB2;MAPK14;NABP1;TANK;BRAT1;ANXA1;TP53;BABAM2;INO80;IKBIP;BABAM1;SWI5;SMPD1;SPIDR;CLK2;BRSK1;RAD1;RFWD3
prerank,regulation of translation (GO:0006417),0.3553678315381091,0.9045752448495932,0.7074148296593187,0.9155285349436635,1.0,34/173,14.82%,NIBAN1;MTOR;DHX9;CNOT8;PLXNB2;FOXO3;EIF5B;CIRBP;GSPT1;YTHDF3;TRAP1;LARP4B;EIF1;LARP1;EPRS1;EIF4H;IMPACT;CPEB3;EIF2B2;RPL26;CTIF;EIF4G3;CYFIP1;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;DDX1;HNRNPD;SOX4;PUM3;IGF2BP3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4255554756655915,0.9045265867567007,0.6020806241872562,0.9151965618939724,1.0,5/17,23.61%,IK;RB1;MIS12;KNL1;BUB3
prerank,regulation of mRNA stability (GO:0043488),0.3533773321825482,0.9042596050893321,0.6973947895791583,0.9153134739958101,1.0,35/145,20.12%,SLC11A1;PCID2;PRKCD;EXOSC1;XPO1;ANP32A;CIRBP;YWHAB;FASTKD3;PSMB10;YTHDF3;RC3H2;LARP1;TENT5C;RC3H1;PUM2;FASTKD1;PSMA2;METTL3;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9;THRAP3;MEX3D;PSMD2;GDNF;SERBP1;ROCK2;FTO;HSPB1;EXOSC3
prerank,protein palmitoylation (GO:0018345),0.3954564276791961,0.9039642357004752,0.6113074204946997,0.9154415236744171,1.0,8/30,15.36%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;ZDHHC24;SELENOK
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.426959705614171,0.9034984559789955,0.5955497382198953,0.9158710468093838,1.0,3/17,9.59%,HERPUD1;SEL1L;DERL1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3249975471654989,-0.9032220115930845,0.5833333333333334,0.9170102287496787,1.0,4/17,15.59%,VEZF1;BMP4;ATOH8;BAD
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.37170404847048655,-0.9031851610000963,0.5523809523809524,0.9146010740057605,1.0,3/10,25.44%,FBXW7;HBEGF;EGF
prerank,diterpenoid metabolic process (GO:0016101),0.3663682186218999,0.902809799368295,0.624332977588047,0.9167561011594761,1.0,8/55,15.03%,LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;LRP1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4179380939486615,0.9026931145662678,0.6048593350383632,0.916578726143399,1.0,8/17,25.04%,FZD9;BCL2L1;BAK1;TIMM50;DNM1L;FIS1;BID;MFF
prerank,synaptic vesicle exocytosis (GO:0016079),0.3760794490399207,0.902202439427501,0.6015712682379349,0.9170871126428205,1.0,12/40,21.09%,SNCA;PIP5K1C;STX11;SYT2;SYT10;SNAP29;STX3;SNAP23;DNAJC5;STX2;UNC13A;RIMS1
prerank,atrioventricular valve development (GO:0003171),-0.3338853204002165,-0.9017646568005397,0.5483870967741935,0.9155965021606938,1.0,2/14,4.03%,BMPR1A;ACVR1
prerank,RNA destabilization (GO:0050779),0.4239988185927048,0.9011174298896821,0.6119592875318066,0.9186832664759286,1.0,9/18,25.87%,YTHDF3;ZC3H18;METTL3;MEX3D;ROCK2;FTO;LIN28B;DXO;PUM1
prerank,regulation of necroptotic process (GO:0060544),0.4037547760774175,0.9010113390733189,0.6185696361355082,0.9184505879450253,1.0,11/23,20.84%,FZD9;CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ARHGEF2;BIRC2;FLOT1;BIRC3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3602745971722797,-0.9006567202022112,0.5874125874125874,0.915719402684609,1.0,4/11,18.09%,REST;PINK1;ATF4;PARK7
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4389166951491982,0.9000302617697444,0.5913978494623656,0.9198587875969151,1.0,2/14,7.24%,EHHADH;ABCD1
prerank,myelin assembly (GO:0032288),0.4661299915697002,0.8996028894353599,0.6,0.9202433805304662,1.0,7/10,28.62%,CD9;DICER1;ABCA2;TENM4;CNTNAP1;PMP22;GPC1
prerank,regulation of blood circulation (GO:1903522),0.3848141528658945,0.8990573024974234,0.5988505747126437,0.9208352607051683,1.0,2/34,4.32%,TMIGD3;KCNIP2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.38986487114338453,0.8987529486634018,0.6272321428571429,0.9209965911484955,1.0,9/35,16.02%,RGCC;APOE;XDH;MEF2C;ATP5IF1;THBS1;CCL2;ATP5F1A;NF1
prerank,response to glucose (GO:0009749),0.37044212084868977,0.8987176292848578,0.6426229508196721,0.9206501082602353,1.0,10/46,16.81%,LPL;PFKL;ERN1;EIF2B2;THBS1;TRA2B;GAS6;ADCY8;SOX4;GCK
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4249483743255522,0.8985087097286962,0.6008064516129032,0.920599828193431,1.0,1/15,2.36%,ABHD12
prerank,circulatory system development (GO:0072359),0.3506309675659624,0.8984623955582521,0.6923076923076923,0.9202566353781527,1.0,24/118,16.50%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;TGFBR2;MEF2A;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;SOX4;PDLIM1;POU6F1;NF1;PTEN
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.35021028784807384,0.898114236455736,0.7250755287009063,0.9204994051872768,1.0,34/152,15.71%,TGFB1;GPRC5B;TLR2;ZEB2;DKK2;SKI;TNFAIP3;LGR6;FZD9;MACF1;PSMB10;TBL1XR1;WNK1;CSNK1G2;DISC1;CSNK2A1;GID8;SULF2;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.26090127401387364,-0.8978046223892516,0.6129032258064516,0.9202132532212975,1.0,12/29,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ACLY;PPT1;CBR4;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,endoplasmic reticulum organization (GO:0007029),0.35536740164862596,0.897521465758137,0.6511387163561076,0.9211626122907519,1.0,23/72,20.78%,LMAN1L;REEP6;VAPB;TMCC1;BNIP1;ATL1;CYB5A;SEC16A;SEC16B;STX5;TOR1AIP2;LRRK2;GAK;UBE2J2;CCDC47;RTN4;LMAN2;TMEM170A;ATL2;DNM1L;ATL3;SEC31A;SPTSSB
prerank,cell-cell junction maintenance (GO:0045217),0.45602427525591305,0.8974485295512614,0.6225352112676056,0.9208847480110361,1.0,1/11,2.01%,CSF1R
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3621914190926424,0.8973298665010643,0.6649269311064718,0.9206917490793944,1.0,9/66,14.05%,TGFB1;HCLS1;PRKCD;SMAD3;CCT8;MCRS1;TPR;KAT7;CCT5
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4511341134253505,0.896930526088924,0.6196581196581197,0.9210263554018054,1.0,2/11,5.93%,RENBP;NAGK
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3992924990935899,0.8967052119569153,0.6064593301435407,0.9210220483745886,1.0,1/26,0.31%,PTK2B
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.45786341400464214,0.896659158622747,0.6069986541049798,0.9206867172927258,1.0,2/12,5.36%,PIK3CB;XDH
prerank,muscle contraction (GO:0006936),0.35276566178076874,0.8953446332706434,0.6996966632962589,0.92268222187532,1.0,18/126,14.40%,ITGB5;HCN4;MYL3;SLC8A1;TTN;KCNIP2;ASPH;MYL12A;TNNT3;TPM4;VCL;DTNA;DYSF;TLN1;TPM3;SMTN;DES;ARHGEF11
prerank,synaptic vesicle localization (GO:0097479),-0.33217203630632935,-0.8952596932247339,0.5693950177935944,0.9240395633518131,1.0,5/13,15.76%,NLGN1;KIF5B;SYNDIG1;KIF5A;RAB27A
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4403161115373323,0.8948152174977619,0.6051502145922747,0.9232449284227024,1.0,6/13,19.44%,EDEM1;SVIP;UBE2G2;EDEM2;ERLEC1;OS9
prerank,regulation of exocytosis (GO:0017157),0.3736780305532536,0.8947297008428734,0.6244541484716157,0.9229878659976685,1.0,6/46,11.02%,RAB8B;UNC13D;SNCA;ANXA1;SYTL4;ATP6AP1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2905701737461435,-0.8945047981091965,0.6192893401015228,0.9234354214307616,1.0,10/19,21.39%,PML;HK1;BBS4;TOPORS;PINK1;HNRNPU;AKT1;SUPT7L;BCL3;SKP1
prerank,regulation of actin filament-based process (GO:0032970),0.3604761099872614,0.8941856366812414,0.6670157068062827,0.9236287088765079,1.0,17/70,20.48%,IQGAP2;CORO1A;FZD10;PRKCD;MTOR;F11R;TWF2;ARHGAP18;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;CRK
prerank,negative regulation of cell death (GO:0060548),0.3544200907675486,0.8937244684154171,0.6724667349027635,0.9240392125102669,1.0,25/88,22.07%,GPNMB;CD200R1;NUP62;SNCA;TRAF2;PPARGC1A;IMPACT;BECN1;PARP16;TNFRSF1B;FYN;SORL1;IKBKG;WFS1;LRRK2;SOX4;NPAS2;TIGAR;SRSF6;NENF;ATP13A2;GSK3B;PRKN;FGF2;MT3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37843801732620447,0.8936245730374998,0.6380090497737556,0.9238089945428081,1.0,11/41,24.89%,ALOX12;DAGLB;ABCD1;DEGS1;FADS1;GSTM2;GPX4;ACOT8;SCD;FADS2;PTGS1
prerank,regulation of centrosome duplication (GO:0010824),-0.24762517273793205,-0.893321247705316,0.6338028169014085,0.9237586701292794,1.0,15/30,32.21%,CEP295;SPICE1;NAT10;CHMP5;CHMP4B;CENATAC;ALMS1;CEP120;CHMP2A;NPM1;STIL;CHMP4C;CEP295NL;CCNF;CHMP1B
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.34684600797893245,0.8932537850918816,0.776,0.924073724545839,1.0,68/260,20.63%,FGD2;MKS1;RAB8B;P2RX7;RAP2A;EXOC6;ASAP1;IFT52;RAP1B;FGD6;RP2;MTSS1;AIF1;CNGB1;ABLIM2;BBS9;PLK4;ATP6V0D1;TNIK;P2RY12;DISC1;RAP2B;SNAP29;VCL;RAB11A;ACTR2;ACTR3;PARVB;CYFIP1;NRP1;HDAC6;PTPRO;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;SDCBP;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;ARF6;EXOC3;RAP1A;CEP162;FXYD5;AHI1;WDR90;ARFIP2;WDPCP;NUDCD3;SNX10;GOLPH3;ITGB1;MINK1;CCDC66;CLUAP1;RHOD;TMEM67;INPP5K;KIF3A;AIF1L;MAP4K4;SPATA13
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3735459056160038,-0.8930141457065988,0.6192052980132451,0.9196083539440522,1.0,4/10,22.82%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3735459056160038,-0.8930141457065988,0.6192052980132451,0.9196083539440522,1.0,4/10,22.82%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,lamellipodium assembly (GO:0030032),0.3900549766994629,0.8929769604485053,0.6059171597633136,0.924187871303571,1.0,13/26,24.54%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13;ARHGEF7;SRGAP2
prerank,regulation of cardiac conduction (GO:1903779),0.36894046348003023,0.8928885994403737,0.6406417112299465,0.9239375529398305,1.0,10/54,13.76%,KCNJ11;SLC8A1;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.4605233408210448,0.8928838083215117,0.6150506512301013,0.9235293950258499,1.0,4/10,23.25%,PLA2G7;LIPC;PLA2G5;PLA2G6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3675496414883851,0.8922631132124266,0.6863354037267081,0.9242866968474096,1.0,9/62,11.71%,TGFB1;DHX9;NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3456141975404152,0.892066821649831,0.808,0.9242172218262943,1.0,100/306,26.27%,MCM5;FAM111A;ORC3;RPL23;RPL17;RPL10A;GCNT1;APOE;RPS2;RMI1;EXO1;RRBP1;RPL18A;BRIP1;FARSB;MRPL41;MEF2A;GTPBP1;RPS15A;GSPT1;EIF4EBP2;MMS19;MRPL51;RPL6;FUT9;MCM6;MCM2;NAP1L1;DBF4;RPLP2;RPL26;INHBA;RPS20;POLR2L;RPS16;ORC4;MCM9;RPS14;KAT7;DNA2;DARS1;RPL19;CDC6;POLD3;IGF2BP3;RPL9;LARGE1;RPS11;RPL11;RPS23;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;GOLPH3;RNASEH2A;MRPL3;POLR2E;TOP1;FUBP3;RPL7A;RPL15;MRPL10;RPL29;CDC45;RPL22;RPS7;RAD1;RPS13;EEF1G;SARS1;RPLP1;POLR3A;RPS15;MRPL18;MRPL52;RPS5;ATR;RPL41;PAX8;PWP1;RPA1;RPL10;MRPL37;XAB2;MRPS12;ABCF1;RPS8;RPL5;EXT2;RPL18;EEF1A1;ING5;RPL28;PTMA;MRPS15
prerank,heterochromatin assembly (GO:0031507),-0.29031007905233597,-0.891633676267852,0.625,0.9203975968684629,1.0,2/20,4.79%,SMCHD1;EZH1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.43547426103891484,0.89159371612479,0.611878453038674,0.9246190569623478,1.0,2/13,4.79%,LGMN;AKAP5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2053111052028801,-0.891563638291408,0.72,0.9181208712285684,1.0,29/88,22.47%,FBXL7;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;FBXL2;PSMC6;SKP2;PSMC3;FBXW7;PSMB3;PSMC1;PSMD5;CUL2;PSMA3;PSMD3;PSMD6;PSMC5;FBXO31;PSME2;FBXO17;PSMB4;FBXO38;PSMC4;SKP1;PSMB6;CUL1
prerank,peptidyl-threonine modification (GO:0018210),0.3608584045814565,0.8914822939233032,0.650893796004206,0.924412936113902,1.0,19/66,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;GALNT2;LRRK2;GSK3A;GALNTL6;GALNT1;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.34551496972821194,0.8914601595771426,0.7317317317317318,0.9240290011226214,1.0,24/159,16.35%,CD84;ITGAL;ITGB2;PCDHB6;CRTAM;SLITRK1;PLXNB2;EMB;TGFBR2;TRO;ATP2C1;ITGAM;CDH8;CDH9;CDH12;NPTN;CDH23;PTPRT;CADM1;KIRREL3;MPZ;DCHS1;CDH19;PCDHGB4
prerank,apoptotic nuclear changes (GO:0030262),0.4018154166445099,0.8912571016236907,0.6245443499392467,0.9239800481396172,1.0,11/24,27.66%,ACIN1;HMGB1;TOP2A;KPNA1;DICER1;DNASE2;DFFB;CECR2;CDK5RAP3;KPNB1;HMGB2
prerank,response to UV (GO:0009411),0.35672592419901683,0.8911295345062544,0.6826042726347915,0.9238025970973858,1.0,21/95,16.44%,AQP1;PRKCD;SDF4;TAF1;CIRBP;UVSSA;TP53;USF1;POLH;YY1;BAK1;UBE4B;RPL26;METTL3;INO80;BMF;NOC2L;ERCC5;ERCC6;COPS9;MFAP4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.42403536957144594,0.8910701122357462,0.6288265306122449,0.9235018870190372,1.0,6/17,22.85%,NEIL2;ERCC5;OGG1;TINF2;TERF2;TERF2IP
prerank,monocarboxylic acid transport (GO:0015718),0.370486915908525,0.8909343236209041,0.6652173913043479,0.9233482862096716,1.0,12/51,18.30%,SLCO2B1;ABCC3;NR1H4;ABCB4;SLC16A2;SLC16A1;SLCO1B1;CD36;SLC16A6;SLC16A13;STARD5;RXRA
prerank,spliceosomal complex assembly (GO:0000245),0.3739158213274431,0.8908415517726017,0.6644736842105263,0.9230968213703424,1.0,12/46,20.34%,SF3B1;SCAF11;GCFC2;SRPK3;SNRPD2;DDX39B;LUC7L3;DDX1;CRNKL1;SNRNP200;SRSF6;SRSF10
prerank,positive regulation of actin nucleation (GO:0051127),-0.3458748913926918,-0.8906992619762891,0.5733788395904437,0.9176075124862503,1.0,3/11,5.31%,GSN;BRK1;WHAMM
prerank,positive regulation of axonogenesis (GO:0050772),0.37266402407221544,0.8906050049178433,0.6301969365426696,0.9230989855300638,1.0,5/43,6.19%,PLXNC1;SLITRK1;SEMA4D;PLXNB2;MACF1
prerank,cellular response to pH (GO:0071467),0.42023292335912427,0.8900668303394196,0.6002570694087404,0.9236536956517919,1.0,6/17,22.06%,SLC9A1;IMPACT;RAB11FIP5;MCOLN1;HVCN1;CHP1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.39323391322028434,0.8894848954855069,0.6267942583732058,0.9242984264408118,1.0,15/27,31.18%,BRD8;KAT7;NAA50;PHF20;MORF4L2;MORF4L1;TAF6;KAT5;CREBBP;EP300;SGF29;MRGBP;KAT6A;BAG6;KAT8
prerank,amino sugar biosynthetic process (GO:0046349),0.4383477207708898,0.8893698453881936,0.6328233657858137,0.9240906180126576,1.0,2/12,5.93%,RENBP;NAGK
prerank,regulation of mRNA processing (GO:0050684),0.3839756156248036,0.8892229381162237,0.6261363636363636,0.9239541520821299,1.0,15/32,25.80%,DHX9;RBM39;CDK11B;SRPK3;SON;SAFB2;PABPN1;SRSF10;SRSF3;ZFP36L1;IWS1;NCBP1;HNRNPK;CPSF4;JMJD6
prerank,negative regulation of DNA replication (GO:0008156),-0.3339957826550617,-0.8890579801612152,0.5807692307692308,0.919053404192772,1.0,5/13,18.91%,RAD17;WAPL;TSPYL2;S100A11;CDAN1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.36104856836021787,0.8887816902929273,0.6958333333333333,0.9243138432475393,1.0,16/72,18.79%,COPS6;GTF2H1;PPIE;LIG3;UVSSA;CDK7;USP7;POLR2L;COPS4;POLD3;ERCC5;ERCC6;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,oligosaccharide metabolic process (GO:0009311),0.3708402049921227,0.8887797039750676,0.6466083150984683,0.9239017442407873,1.0,7/46,10.45%,ST8SIA4;B4GALT1;ST6GALNAC4;MAN2B1;MAN2B2;FUT9;ST8SIA1
prerank,regulation of cellular metabolic process (GO:0031323),0.36931053212697706,0.8884022266931998,0.6619411123227917,0.9241634857612512,1.0,14/45,21.23%,NPC2;ABCG1;TBC1D16;PARL;COQ7;STUB1;PID1;FASN;ACACA;LAMTOR1;FLOT1;MPV17;PRKN;ABCA2
prerank,steroid hormone biosynthetic process (GO:0120178),0.3870226441748921,0.8883397013598704,0.6083916083916084,0.9238732592301285,1.0,8/29,26.30%,TSPO;HSD17B11;FDXR;FDX1;STARD3;HSD17B8;MED1;STARD3NL
prerank,regulation of organelle organization (GO:0033043),0.35472451198659644,0.8883268224550566,0.6827515400410678,0.9234852705033223,1.0,24/80,21.44%,MYO5A;ZEB2;ARMH3;RBSN;CLN3;USP6NL;VPS11;F11R;DIAPH1;PARL;STX5;SAR1A;RAB33B;CAPN2;CAMSAP2;AKAP9;GOLPH3;TAOK1;DNM1L;FIS1;ATP13A2;PRKN;PDE4DIP;SCARB2
prerank,snRNA transcription (GO:0009301),0.354874023058816,0.888195480958641,0.6757322175732218,0.9233215129032577,1.0,18/70,18.83%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3554388856077081,0.8881372904269818,0.6750524109014675,0.9230128309030389,1.0,18/69,18.83%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,mitochondrion localization (GO:0051646),0.4111330677535571,0.8879877497989964,0.6083123425692695,0.9228860251467467,1.0,9/19,25.46%,BRAT1;MEF2A;MSTO1;ATCAY;LRRK2;MFN1;MARK1;MARK2;TRAK1
prerank,pharyngeal system development (GO:0060037),-0.32005999854486367,-0.8877799014943576,0.5868725868725869,0.9196404118503092,1.0,5/15,12.21%,BMPR1A;BMP4;BMP5;HES1;TBX1
prerank,gliogenesis (GO:0042063),0.4278216216738641,0.8877129139067289,0.6121919584954605,0.9229742296801958,1.0,4/15,12.44%,CD9;ANXA1;METTL3;CDK6
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.40623382392064633,0.8876537939950528,0.6124523506988564,0.9226665729006448,1.0,5/18,19.30%,TNF;ATP7A;NOD2;POR;GDNF
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3455142477930516,-0.8876342901682149,0.6123188405797102,0.9176100167885917,1.0,3/11,10.54%,ATP1B1;KCND3;KCNJ3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.45337119499829526,0.8866653737305222,0.6289120715350224,0.9240119650916925,1.0,3/10,9.89%,LEO1;HSF1;CPEB3
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.31678066437640534,-0.886545978849887,0.6,0.9178553154695649,1.0,4/15,6.77%,RAPGEF3;TCF7L2;ANP32B;BAG3
prerank,positive regulation of ion transport (GO:0043270),0.3658965363721843,0.8863352621826199,0.6488222698072805,0.9241698685781113,1.0,12/48,19.30%,SCN4B;P2RX7;PKP2;P2RX4;PRSS8;ATP2B1;CACNB2;WFS1;CACNA1D;SCN5A;CNKSR3;GDNF
prerank,negative regulation of cellular component movement (GO:0051271),0.42727527824515643,0.8862472131096684,0.6141522029372497,0.9239237060146643,1.0,3/15,10.21%,CD9;SPINT2;ACTN1
prerank,glutathione metabolic process (GO:0006749),0.37258935124476156,0.8859534165659737,0.6478555304740407,0.9240126205112953,1.0,2/38,3.21%,GSTT4;HPGDS
prerank,myoblast fusion (GO:0007520),-0.3304349587336912,-0.885781849637526,0.5977443609022557,0.9172639913514108,1.0,7/12,23.87%,ADAMTS5;ADAM12;ADAMTS15;CD81;KCNH1;NOS1;CACNA1H
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3857411857157751,0.8852970928653033,0.6459054209919262,0.9243360691781852,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,CENP-A containing chromatin organization (GO:0061641),0.3857411857157751,0.8852970928653033,0.6459054209919262,0.9243360691781852,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,regulation of cell aging (GO:0090342),0.45049707186843313,0.8852138761661641,0.6208393632416788,0.9240752358718554,1.0,1/11,3.66%,NEK6
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.4012629359593042,0.8841906804053642,0.6455089820359281,0.9254873116856799,1.0,4/24,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,negative regulation of cell projection organization (GO:0031345),0.36499615208686975,0.8841620664831673,0.6520342612419701,0.9251333386479813,1.0,14/48,19.41%,MYLIP;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;FYN;GAK;YWHAH;EPHA4;PTEN;DENND5A;PAQR3;RAB29
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.35136983995271365,0.8839389792794345,0.7066666666666667,0.925113190323979,1.0,19/85,17.93%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42
prerank,regulation of cation channel activity (GO:2001257),0.35376352836916697,0.8829732035152945,0.6993865030674846,0.9264165029449282,1.0,7/89,8.10%,CTSS;PTK2B;FGF13;STAC;EPO;CACNB4;MEF2C
prerank,regulation of protein polymerization (GO:0032271),0.3826426142186134,0.8829678123090297,0.6311010215664018,0.926013038556126,1.0,9/35,18.71%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1;CAMSAP2;HSP90AA1;GBA2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3884742358344062,0.8829239534814344,0.6339393939393939,0.9256771815728599,1.0,3/26,5.09%,NLRC3;TRAFD1;TNFAIP3
prerank,negative regulation of cartilage development (GO:0061037),0.4387773691517505,0.8829075840848711,0.6289398280802292,0.9252871201012824,1.0,3/13,18.40%,TGFBR1;SOX9;GREM1
prerank,glycerol metabolic process (GO:0006071),0.4450389588415726,0.8828655067815541,0.5985401459854015,0.9249573304566387,1.0,3/10,19.85%,ANGPTL3;GK;COQ3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.38602266383667055,0.8823682523131595,0.6336056009334889,0.9254224086815483,1.0,5/29,11.24%,TNF;TRAF2;PYCARD;INHBA;THBS1
prerank,protein acetylation (GO:0006473),-0.2600766010543485,-0.882091508808663,0.6402877697841727,0.923421568765606,1.0,10/30,22.07%,ESCO1;CLOCK;NAT10;HAT1;MAPT;NAA60;ING4;NAA35;SPHK1;KAT2B
prerank,regulation of fibrinolysis (GO:0051917),0.437796929308202,0.8820905187071455,0.6259842519685039,0.9255006222980786,1.0,2/13,11.24%,USF1;THBS1
prerank,cellular response to cadmium ion (GO:0071276),-0.27591885662130516,-0.8820391813638963,0.639344262295082,0.9211384890553576,1.0,4/24,9.25%,MAPK8;EGFR;MAPK9;CHUK
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3840733464067949,0.8817632611437831,0.6458569807037458,0.9256680829533,1.0,8/33,16.66%,PLCG2;TAF1;KIF14;PSME3;INO80;PTEN;STXBP4;APPL2
prerank,response to insulin (GO:0032868),0.35181732746768035,0.8815488858793853,0.6917525773195876,0.9256541227950972,1.0,21/80,21.24%,PCSK9;RAB8B;LPIN2;MYO5A;HDAC5;USF1;RAB31;EPRS1;DENND4C;HDAC9;GSK3A;SYAP1;ZBTB7B;CPEB2;GCK;PDPK1;SORT1;INPP5K;PKM;LPIN1;ZFP36L1
prerank,ncRNA transcription (GO:0098781),0.4301839698396976,0.881328772837141,0.6152796725784447,0.9256279444955484,1.0,3/13,12.43%,GTF3A;RPAP2;SNAPC3
prerank,acylglycerol biosynthetic process (GO:0046463),0.3903015786014561,0.8807986406542334,0.6299019607843137,0.9261487486142249,1.0,7/23,20.90%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,axonemal dynein complex assembly (GO:0070286),0.38738345033285976,0.8807728045596067,0.6318874560375146,0.9257942538182845,1.0,4/28,13.03%,DNAI4;ODAD2;ODAD1;CCDC63
prerank,regulation of neuron projection development (GO:0010975),0.34351688229648913,0.8805588623286679,0.7727727727727728,0.925756738790185,1.0,42/163,22.07%,PTK2B;LYN;MYLIP;CAMK1D;ARSB;MDK;RTN4RL1;ITGA6;APOE;PLXNB2;ADCY6;CBFA2T2;DISC1;FUT9;RAPGEF1;PTPRO;CSMD3;TWF2;NPTN;LZTS3;ATP1B2;TANC2;LRRK2;RAP1A;GAK;GSK3A;CAMSAP2;EPHA4;PTEN;DENND5A;PAQR3;KIDINS220;RAB29;RELN;CDK5R1;GSK3B;MARK1;BRSK1;SCARB2;CX3CL1;CFL1;MT3
prerank,organelle assembly (GO:0070925),0.3402694456047745,0.8804572648639797,0.846,0.9255288886260518,1.0,84/385,19.47%,BIN2;MKS1;RAB8B;SH3PXD2B;CORO1A;RAB32;NUP62;HAUS2;VTA1;NEK6;ATG7;EXOC6;ASAP1;MAP1LC3B;IFT52;RAB7A;CDS2;FLII;CIRBP;RP2;MAPRE1;CNGB1;BBS9;PLK4;YTHDF3;ATP6V0D1;VMP1;STARD9;DISC1;RC3H1;HAUS1;SNAP29;EMC6;RAB11A;TUBGCP6;TUBGCP4;ACTR2;RAB1B;ACTR3;VPS37C;HDAC6;BECN1;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;TRAPPC6A;INO80;SYNPO;EXOC3;HAUS8;CAPN3;CEP162;ATXN2L;ABCA3;AHI1;WDR90;PDCD6IP;ATG2B;IRGM;ATG3;RPS23;VPS28;WDPCP;NUDCD3;MIS12;CEP63;SNX10;MAPRE2;UBXN2A;ATG14;PACS2;TMEM41B;CCDC66;CLUAP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3616545498231827,0.8800867271329466,0.6774541531823085,0.9257577409755221,1.0,16/59,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;LRRK2;GSK3A;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,regulation of actomyosin structure organization (GO:0110020),0.43046680425841083,0.8797389964878812,0.6382978723404256,0.9259746450884215,1.0,5/13,19.65%,FHOD1;SLC9A1;ACTG1;CDC42;ROCK2
prerank,regulation of cellular response to heat (GO:1900034),0.3537559753289797,0.879738554344506,0.7017543859649122,0.9255677217752777,1.0,21/77,21.15%,BAG2;MTOR;PTGES3;NUP62;DNAJC7;HSBP1;SEH1L;HSF1;TPR;NUP205;CHORDC1;BAG1;IER5;HSP90AA1;DNAJB6;RPTOR;SEC13;GSK3B;NUP54;BAG4;CRYAB
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3469498848180521,0.879178707004677,0.7244174265450861,0.9261573616275506,1.0,30/107,22.28%,SLC11A1;CCR2;SLC8A1;CCL8;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;TMEM165;ATP13A5;ATP13A2;SLC39A6;SLC10A7;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,cellular response to gamma radiation (GO:0071480),0.41660904846452784,0.8785735052391402,0.6304347826086957,0.9267505426397039,1.0,4/17,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,dorsal/ventral pattern formation (GO:0009953),0.40923307309143436,0.8784991615035526,0.618925831202046,0.9264836210276103,1.0,1/20,0.68%,SHH
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.37650190180398785,0.878168233585091,0.6602272727272728,0.9266496908433741,1.0,4/37,8.10%,P2RY6;ERN1;LDLRAP1;MEF2C
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3314028720123051,-0.8779938620791701,0.6210526315789474,0.9283392782054078,1.0,3/13,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4137614575920952,0.8779480259616607,0.6310432569974554,0.926624564520255,1.0,5/18,20.78%,NFE2L2;TRAP1;HIF1A;HSPB1;PRKN
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3837975658068467,0.8776157224961285,0.6378316032295271,0.9267652043714154,1.0,3/31,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3800121041080434,0.8775822165619909,0.6400449943757031,0.9264091571138249,1.0,8/32,18.19%,MTOR;MLXIPL;APOE;ADIPOR1;CREB1;ADIPOR2;ASAH1;CREBL2
prerank,histone H4-K16 acetylation (GO:0043984),0.40245713496785485,0.8773647699976276,0.6195372750642674,0.9263616698056751,1.0,8/19,21.52%,MSL2;MCRS1;KAT7;HCFC1;JADE2;MEAF6;MSL1;PHF20
prerank,purine-containing compound salvage (GO:0043101),-0.33607740486262594,-0.8770328606952039,0.6089965397923875,0.9281219931317977,1.0,5/12,18.07%,ADK;DGUOK;AMPD3;GMPR;AMPD2
prerank,cellular response to growth factor stimulus (GO:0071363),0.3420885205164404,0.8769736766592167,0.7469879518072289,0.926656970366456,1.0,27/151,13.61%,TGFB1;LGMN;TGFBR1;DUSP3;DSTYK;MAPK14;ERN1;PRKD2;CD44;MAP2K3;CTNNB1;ANXA1;TGFBR2;MEF2C;SMAD3;ACAP2;BCAR1;STAT5B;RAPGEF1;LIMS1;SOX9;NRP1;CCL2;VSTM2A;TWF2;NR4A1;SOX6
prerank,protein modification by small protein conjugation (GO:0032446),0.33826416084081196,0.8766069965744524,0.841,0.9268805251600549,1.0,98/361,23.54%,ARRB2;NFE2L2;CBL;MYLIP;BCL11A;UBE2V2;NUP62;TRIM5;ATG7;MKRN1;CDC23;UBE2D3;OTULIN;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;KLHL21;UVSSA;UBE2S;LEO1;KLHL7;SEH1L;VPS11;TRIM27;UBE2E3;PEX13;DERL1;NFX1;NEDD4L;UBE2H;TPR;USP7;TRIM24;RNF40;TRIM35;NUP205;CDC34;DET1;FBXO32;ARRDC4;FBXL3;RNF135;ITCH;UBE2G2;STUB1;HUWE1;UBA2;USP9X;AREL1;UBE2J2;DTX4;RNF152;PIAS1;GAN;SMURF1;HIF1A;ATG3;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;KEAP1;DCUN1D5;SPSB2;ELOB;OS9;WWP1;FBXW11;CUL3;LZTR1;PRKN;UBE2R2;NUP54;HERC2;NSMCE2;RRAGA;CDC16;RFWD3;ELOC;UBE2E1;ATG10;TNFAIP1;SPSB1;UBA7;EIPR1;FBXO4;CTR9;RACK1;MYCBP2;NUP85;RNF181;UBE2I
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.25724116496352706,-0.8763180100550239,0.6375838926174496,0.9272384498030535,1.0,11/30,19.99%,OGT;RYBP;N4BP1;USP14;TRIM39;WAC;CCAR2;NOP53;PARK7;UCHL5;DDRGK1
prerank,tRNA methylation (GO:0030488),-0.24658775195345178,-0.875856583240167,0.7265625,0.9257914905817437,1.0,17/34,32.92%,NSUN6;METTL6;THADA;THUMPD3;NSUN2;TARBP1;DALRD3;MTO1;TRMT5;LCMT2;WDR6;TRMT44;TRMT13;TRMT10C;TYW3;TRMT12;TRMT112
prerank,phospholipid biosynthetic process (GO:0008654),-0.24406073858947325,-0.8757334465800531,0.6730769230769231,0.9237106812362113,1.0,12/36,16.30%,FAR1;SAMD8;AGPAT4;AGPAT3;SGMS2;AGPAT5;NUS1;CPNE3;HDHD5;SRD5A3;CRLS1;MBOAT1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3441893591141444,-0.8755769341260439,0.6205673758865248,0.9217399928404592,1.0,2/11,4.70%,CAV1;ACTN2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4446357656122595,0.8753952765480012,0.6463768115942029,0.9285599507032565,1.0,2/10,6.77%,RXRB;ACTN4
prerank,positive regulation of synapse assembly (GO:0051965),0.38275975339785845,0.8735838242419789,0.6568396226415094,0.9313155489047003,1.0,4/27,10.78%,CLSTN1;SEMA4D;AGRN;SEMA4A
prerank,response to prostaglandin E (GO:0034695),0.4461064688972186,0.8735666652249459,0.6217391304347826,0.9309328497805319,1.0,2/10,14.48%,ADCY6;GNG2
prerank,positive regulation of ruffle assembly (GO:1900029),0.43610925072903584,0.8732153690949875,0.6307901907356949,0.9311402257846225,1.0,3/13,11.10%,PLEKHM1;P2RY12;PFN1
prerank,cellular amide metabolic process (GO:0043603),0.3454483649764353,0.8725801993707258,0.7169042769857433,0.9318036625751944,1.0,21/102,17.81%,DBI;SGPL1;MTHFS;CLN8;SMPD3;CERK;ST3GAL1;ACSF2;ABHD4;NLN;MCCC2;DNPEP;ORMDL2;PPP2CA;NSMAF;PDZD11;ACOT9;PLAAT3;FPGS;ACOT2;PCCA
prerank,negative regulation of cell aging (GO:0090344),-0.30591967601927306,-0.8722147744514038,0.622568093385214,0.9273520810557926,1.0,7/16,27.98%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1;MIF
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35420766077196564,0.8722028997500922,0.6670281995661606,0.9320450040292524,1.0,12/52,15.73%,SREBF2;MICALL2;UBE2D3;YWHAB;TP53;VPS11;CSNK2A2;CASP8;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,protein import into mitochondrial matrix (GO:0030150),-0.29261676219081567,-0.8720613861257194,0.6535087719298246,0.9252922099674289,1.0,11/18,33.29%,DNAJC19;TIMM17A;GRPEL2;TOMM70;TIMM23;PAM16;TIMM21;ROMO1;GRPEL1;DNLZ;TOMM40L
prerank,regulation of cellular component biogenesis (GO:0044087),0.36879482043203166,0.871951698543382,0.6476399560922064,0.9320839855249479,1.0,14/39,19.65%,APOE;TRAF2;RAP1B;VPS11;GFAP;RAPGEF1;HCFC1;RAP1A;SPTY2D1;CD36;IRGM;HSP90AA1;PARP10;ROCK2
prerank,glucan biosynthetic process (GO:0009250),0.4309528326323909,0.8717987071495746,0.6199158485273493,0.9315165212751632,1.0,2/12,9.01%,GYG1;GBE1
prerank,glycogen biosynthetic process (GO:0005978),0.4309528326323909,0.8717987071495746,0.6199158485273493,0.9315165212751632,1.0,2/12,9.01%,GYG1;GBE1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3994903836110633,0.8717002374878384,0.6276202219482121,0.9312759103781182,1.0,4/21,8.29%,XDH;NUDT4;HINT1;PNP
prerank,regulation of protein autophosphorylation (GO:0031952),0.3697604289910289,0.8716996686660844,0.6532438478747203,0.9308699568919703,1.0,2/36,3.44%,GPNMB;RAP2A
prerank,cellular response to ionizing radiation (GO:0071479),0.36051730825674044,0.871666137056105,0.6655879180151025,0.9305148965979761,1.0,7/47,10.47%,GRB2;MAPK14;TANK;XRCC5;TP53;HSF1;RPL26
prerank,mRNA splice site selection (GO:0006376),-0.2509593110917916,-0.8715795022262538,0.7109375,0.9240480502903774,1.0,16/30,34.39%,PSIP1;YTHDC1;SF3A1;SRSF1;PUF60;SNRPC;SRSF12;CELF4;CELF6;LUC7L;SF3A2;CELF5;LUC7L2;SF3A3;CELF2;SRSF9
prerank,negative regulation of protein processing (GO:0010955),0.431119782289615,0.8712578587335513,0.6224627875507442,0.9307819920514963,1.0,4/12,19.16%,CTSZ;THBS1;LRRK2;TMEM59
prerank,protein glycosylation (GO:0006486),0.341564738430226,0.8708418824212286,0.7630522088353414,0.9310930930233661,1.0,35/125,20.62%,MGAT5;MAN1C1;GALNT10;TET3;ST8SIA4;NPC1;B4GALT1;GALNT7;OGA;GALNT6;AQP11;ST3GAL1;ALG2;POGLUT1;FUT9;B3GALNT1;ST8SIA1;POMK;DPAGT1;STT3B;B4GALT7;GALNT2;LARGE1;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;GALNT1;DDOST;TET2;MGAT1;STT3A;COG7;TUSC3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3611748785519989,0.8707895611034177,0.6768893756845564,0.9307844058845772,1.0,14/49,19.60%,HERPUD1;PYCARD;DDIT3;BCL2L1;TP53;P4HB;BECN1;BMF;NOC2L;SRC;SGMS1;PTPMT1;DNM1L;FIS1
prerank,motile cilium assembly (GO:0044458),-0.32976882614046277,-0.8703827443246448,0.6156583629893239,0.9243964403493287,1.0,4/12,17.61%,BBOF1;BBS5;CCDC39;E2F4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4280596572633814,0.8703287241273894,0.6256906077348067,0.9311644366208637,1.0,1/13,2.77%,MTHFS
prerank,DNA methylation or demethylation (GO:0044728),0.40277637747528133,0.8702063710250955,0.6359102244389028,0.9305598509206103,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,DNA alkylation (GO:0006305),0.40277637747528133,0.8702063710250955,0.6359102244389028,0.9305598509206103,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,ganglioside biosynthetic process (GO:0001574),0.4220194576376437,0.8701932322231751,0.6490514905149052,0.9301752418228907,1.0,3/15,8.51%,ST8SIA4;ST6GALNAC4;ST3GAL1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.231295141506447,-0.869948723178954,0.6956521739130435,0.9230180243204067,1.0,10/41,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,Rac protein signal transduction (GO:0016601),0.4098032110200832,0.8697392499396092,0.6348387096774194,0.9305678010881593,1.0,3/18,11.19%,ELMO1;AIF1;CYFIP1
prerank,regulation of peptidase activity (GO:0052547),-0.2969456892402892,-0.8696147911574217,0.6238532110091743,0.9213549660356769,1.0,6/19,13.60%,CAV1;NRDC;PINK1;ECM1;MAPK12;PSMA3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.34394155188068365,-0.8695240269747317,0.6262975778546713,0.919211802859142,1.0,4/10,11.86%,THOC1;THOC5;WDR76;CCAR2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4072084486048693,0.8694826783023644,0.6708701134930644,0.9305938229288852,1.0,8/19,22.92%,MTOR;CEBPA;ELL;PRDX5;ICE2;RPTOR;ZC3H8;TENM1
prerank,regulation of potassium ion transport (GO:0043266),0.3805478937508642,0.8693075881139539,0.6451977401129944,0.930500036407705,1.0,2/31,4.32%,PTK2B;KCNIP2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.40194067542928863,0.8688770173777327,0.6161745827984596,0.9308193903317872,1.0,5/18,17.23%,SLC43A2;EPO;NEDD4L;SLC43A1;BIN1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.37280099999585337,0.868819348193566,0.6369942196531792,0.9305173679064874,1.0,8/34,12.99%,MAPK14;ERN1;PRKD2;MAP2K3;ANXA1;VEGFB;NRP1;NR4A1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.39413433929029396,0.8685834869730604,0.6629766297662977,0.930139929307267,1.0,7/22,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.39413433929029396,0.8685834869730604,0.6629766297662977,0.930139929307267,1.0,7/22,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,regulation of RNA splicing (GO:0043484),0.3504618399234437,0.8685414571471421,0.6882168925964547,0.9298066026855399,1.0,13/69,13.39%,RBM38;ERN1;ZNF326;RBM39;GRSF1;METTL4;HNRNPL;SON;PTBP2;TRA2B;PRX;BRDT;FAM50A
prerank,positive regulation of cytokinesis (GO:0032467),0.37236195643297476,0.8676490217734403,0.681924882629108,0.9309267961377663,1.0,8/32,20.56%,KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42;CUL3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.28747281780980916,-0.867526483544737,0.6363636363636364,0.9213296077111811,1.0,6/20,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST3GAL3;B3GALT1
prerank,regulation of viral transcription (GO:0046782),0.3699174971917296,0.8673950563644316,0.6763392857142857,0.9309343702230647,1.0,12/39,24.49%,DHX9;TRIM27;MDFIC;POLR2L;MID2;TARBP2;TRIM62;RSF1;POLR2E;HEXIM1;NELFE;UBP1
prerank,gene expression (GO:0010467),0.33471924925836777,0.8670139573583248,0.869,0.9311700286507422,1.0,125/348,26.37%,APOBEC1;RPL23;RPL17;NUP62;RPL10A;RBM39;RPS2;DHX38;RRBP1;NXF1;THOC2;RPL18A;FARSB;MRPL41;MEF2A;TSPAN32;RPS15A;GSPT1;TFIP11;SEH1L;CASC3;EIF4EBP2;TSPAN14;RBM15B;ADAR;MMS19;MRPL51;SMG1;RPL6;HNRNPL;TPR;DDX39B;RPLP2;RPL26;RPS20;RNASEL;POLR2L;RPS16;NUP205;RPS14;SORL1;ADARB1;DARS1;STUB1;RPL19;POLDIP3;GALNT2;UPF3B;THOC3;HNRNPD;ALKBH5;IGF2BP3;RPL9;NUFIP1;RPS11;RPL11;SMG7;RPS23;RPS4X;MRPS21;UPF2;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;TESC;SLU7;FYTTD1;GOLPH3;MRPL3;POLR2E;RBMS2;FUBP3;HNRNPF;SRSF6;SRSF2;SEC13;PABPN1;RPL7A;RPL15;HHEX;MRPL10;RPL29;SLBP;SRSF3;RPL22;NUP54;RPS7;RPS13;SARS1;TASP1;RPLP1;POLR3A;NUP85;RPS15;MRPL18;ATXN1;MRPL52;RPS5;NUP155;RPL41;PAX8;PWP1;DDX20;XRN2;DROSHA;RPL10;MRPL37;NCBP1;XAB2;MRPS12;ABCF1;HNRNPK;RPS8;RPL5;RPL18;CPSF4;EEF1A1;MCM3AP;RPL28;PTMA;MRPS15;NOVA1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4147078435648357,0.8669342621505318,0.6336760925449871,0.9309082472192478,1.0,3/16,8.26%,BCL2L1;SNAI1;TPT1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.44297791196888936,0.8668410423715713,0.6349431818181818,0.9306675309421317,1.0,3/12,16.29%,TNF;UVRAG;IRGM
prerank,ribosomal small subunit assembly (GO:0000028),0.415778755932723,0.866646407023615,0.6544502617801047,0.9305954316030215,1.0,7/16,23.92%,XRCC5;ERAL1;RPS14;RPS27;RRP7A;RPS15;RPS5
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3357878562174425,0.8663295463501767,0.7865731462925851,0.930751090918349,1.0,51/173,20.57%,F10;SPTBN5;LMAN1L;CTSC;TMED3;KDELR2;CAPZB;CAPZA1;ACTR10;MCFD2;CTSZ;PDCD6;PGAP1;VAPB;RAB1B;COG6;COPA;YKT6;DCTN5;SEC24D;SEC16A;DYNC1H1;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GAS6;TRAPPC11;VTI1A;GRIA1;LMAN2;ANK1;USE1;SPTBN4;DCTN6;ERGIC1;GOLGB1;TRAPPC2L;ATL2;COG5;RAB29;SEC13;ATL3;TRAPPC12;SEC22B;SEC31A;USO1;ARCN1;CUL3;COG7
prerank,regulation of establishment of planar polarity (GO:0090175),0.3436698087733142,0.8662541350503309,0.7254098360655737,0.9304678034552202,1.0,22/88,20.27%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42;DACT1;ARHGEF19;FZD2
prerank,microtubule bundle formation (GO:0001578),-0.22721536257777586,-0.8656067956722202,0.75,0.9232490109499001,1.0,19/42,32.13%,NCKAP5;SPAST;CLIP1;MAP1S;CDK5RAP2;MTCL1;TPPP;MARK4;CFAP74;RP1;SPEF1;NUMA1;SPAG16;GAS8;CFAP46;TTLL3;AAAS;LRGUK;CAPN6
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33297779291859897,0.8646190232823648,0.827,0.932800562320537,1.0,48/248,15.71%,DRAXIN;TGFB1;TMEM131L;GPRC5B;MAD2L2;GNAQ;ZEB2;MDK;TLE3;CDK14;DKK2;APOE;OTULIN;TPBGL;DDIT3;LGR6;FZD9;CTNNB1;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;SCYL2;ATP6AP2;AMER1;TBL1X;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;TNKS2;PSME3;BAMBI;NFKB1;STK3;PSMB5;SOX2;PSMD8;LRRK2;SOX4;USP8;TLE5;PSMD7;PSMB9;GSK3A;LGR4
prerank,spinal cord development (GO:0021510),0.4328812373084837,0.8642732764643375,0.6498637602179836,0.932967012577219,1.0,6/12,22.80%,PKD2;SOX4;NF1;LOXL3;RELN;ZPR1
prerank,chromatin remodeling at centromere (GO:0031055),0.3751745342151631,0.864189865792349,0.6647531572904707,0.9327021509013577,1.0,11/31,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,mucosal immune response (GO:0002385),0.41826534194795917,0.8641333944131573,0.645326504481434,0.9323964087879228,1.0,2/15,12.30%,FFAR2;DEFA6
prerank,cellular response to leucine starvation (GO:1990253),0.44848929517542035,0.8633594996573566,0.6246376811594203,0.9332786023909071,1.0,4/10,21.78%,MTOR;IMPACT;GCN1;RRAGB
prerank,aspartate family amino acid catabolic process (GO:0009068),0.402374904827657,0.8632406747063581,0.6392405063291139,0.9330885881297324,1.0,3/19,12.95%,CRYM;OGDH;ALDH7A1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4457235939532829,0.8629533954823835,0.6545718432510885,0.9331825973110774,1.0,1/10,2.77%,MTHFS
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4487950647937988,0.8629134250658869,0.6462686567164179,0.9328506988445576,1.0,5/10,19.95%,PRKCB;PID1;GSK3A;APPL2;INPP5K
prerank,establishment of vesicle localization (GO:0051650),0.39926586291829835,0.8628006939138565,0.6572528883183568,0.9326355316589043,1.0,5/18,13.52%,DNM2;RAB11A;SYNJ1;IKBKG;TOR1A
prerank,ether lipid biosynthetic process (GO:0008611),0.4435952314464817,0.8625067636051066,0.6395864106351551,0.9327287326819808,1.0,3/10,11.57%,LPCAT2;DHRS7B;PEX7
prerank,cellular response to acid chemical (GO:0071229),0.38047423252263285,0.862269458385386,0.6549295774647887,0.9327367981075902,1.0,12/27,25.39%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB;VEGFA;XBP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.381445625767013,0.8618502358716459,0.6646778042959427,0.9330483693313637,1.0,8/28,22.06%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;INPP5K;CHP1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3481664572056638,0.8618234701312111,0.7054429028815368,0.9326912629942724,1.0,14/61,18.57%,SMOC2;DHX9;RGCC;PRKD2;HMGB1;ATRX;BABAM2;USP7;USP9X;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,neuromuscular process (GO:0050905),0.40914466790909976,0.8618059042105292,0.6402116402116402,0.9323208194477287,1.0,2/16,4.53%,GCH1;CLN3
prerank,membrane lipid biosynthetic process (GO:0046467),0.3526254413521605,0.8613901708171393,0.7009544008483564,0.9325974122487681,1.0,7/58,9.81%,CERS6;SGPL1;PRKD2;CSNK1G2;HACD4;ACER3;VAPB
prerank,epidermis development (GO:0008544),-0.22247790684829247,-0.8607383365146916,0.7962962962962963,0.9318978067843345,1.0,19/56,32.28%,PLOD1;EMP1;YBX1;HDAC2;ALDH3A2;GLI1;FLOT2;UGCG;GATA6;PTHLH;FGF7;LAMC2;FGFR2;ATP2A2;SCEL;KRTDAP;CCN2;EDAR;DSP
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3048524346698366,-0.8606166415401573,0.6360153256704981,0.92989920998976,1.0,4/15,12.89%,SMARCA4;NUCKS1;CCNT1;SNW1
prerank,protein secretion (GO:0009306),0.34901135393245336,0.8605453335078533,0.6965811965811965,0.9336160746196909,1.0,11/56,18.76%,RAB8B;ABCA1;SEL1L;ANXA1;PPY;SNX19;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,negative regulation of defense response to virus (GO:0050687),0.4337928206871905,0.8604312790421487,0.621897810218978,0.9334303291168788,1.0,5/10,25.36%,TSPAN6;ITCH;TARBP2;ILRUN;C1QBP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4089220498649445,0.8603837264498646,0.625,0.9330997482191533,1.0,7/14,24.50%,XRCC5;ATRX;TNKS2;TINF2;TERF2;TERF2IP;ATR
prerank,positive regulation of viral process (GO:0048524),0.35287855644085886,0.8596663535731597,0.7002118644067796,0.9338981682707005,1.0,13/60,18.79%,DHX9;PPIE;RAB7A;ADAR;LARP1;MDFIC;VAPB;POLR2L;ADARB1;TARBP2;RSF1;PPIH;POLR2E
prerank,cellular response to unfolded protein (GO:0034620),0.3852561581202997,0.8595991238501899,0.6521739130434783,0.9336067413629796,1.0,4/26,9.15%,PTPN1;ERN1;BAK1;HSF1
prerank,clathrin coat assembly (GO:0048268),0.41478834881487675,0.8593596778447583,0.6586345381526104,0.9335999152107863,1.0,5/15,19.79%,AP2S1;CLTC;EPS15;PICALM;FCHO2
prerank,protein modification by small protein removal (GO:0070646),0.33269784040843065,0.8593137274145755,0.851,0.9332720211177545,1.0,61/252,20.84%,ARRB2;COPS6;OTULINL;TGFBR1;ATXN7;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;COPS4;FOXK1;TOR1A;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2;DESI1;DESI2;TOMM20;SENP6;RAD23B;STAM2;SENP7;PRKN;BIRC3
prerank,mitotic metaphase plate congression (GO:0007080),0.36034693582681887,0.8589810847523978,0.696969696969697,0.9334223047674834,1.0,10/51,17.53%,NUP62;CDC23;SEH1L;KIF14;RAB11A;BECN1;RRS1;PDCD6IP;EML4;MIS12
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.43606694069979884,0.8585791933790214,0.6309859154929578,0.9337074408103714,1.0,6/11,21.25%,SH2B3;NF2;ADIPOR1;PTPRT;VHL;SOCS3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3092907672569642,-0.8585603730599121,0.6533333333333333,0.9323136200008244,1.0,4/14,16.40%,CAV1;SPRED2;SPRY2;NOTCH4
prerank,cell-cell junction assembly (GO:0007043),0.3503060434751561,0.8582713491020145,0.6962962962962963,0.9338241169112435,1.0,13/63,12.03%,CD9;PKP2;PIP5K1C;CTNNB1;ACTB;GJB6;FLCN;ACTG1;CDH8;VCL;CDH9;CDH12;TLN1
prerank,positive regulation of viral transcription (GO:0050434),0.38602939704354544,0.8577693366838253,0.6532066508313539,0.9342564013270971,1.0,5/25,18.79%,DHX9;MDFIC;POLR2L;RSF1;POLR2E
prerank,regulation of lamellipodium organization (GO:1902743),0.4139504040992786,0.8576941985357741,0.6557377049180327,0.9339757599458832,1.0,4/14,17.93%,CD44;CAPZB;TWF2;CDC42
prerank,protein targeting to mitochondrion (GO:0006626),0.3543243517211104,0.8573864338839023,0.7164502164502164,0.9340904219038214,1.0,18/52,23.68%,TSPO;AIP;CHCHD4;TIMM22;AGK;IMMP2L;TIMM50;TOMM40;PMPCB;HSP90AA1;PITRM1;TOMM20;FIS1;PMPCA;DNAJC15;TIMM29;TIMM8B;HSPA4
prerank,morphogenesis of an epithelium (GO:0002009),0.384243814489027,0.8568423862267156,0.677536231884058,0.9345452165362703,1.0,6/25,15.66%,ACTB;ACTG1;VCL;SOX9;AHI1;LAMA3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3920774060179366,0.8566173252810007,0.6704834605597965,0.9345336447832537,1.0,9/21,23.21%,ABCD1;TRAP1;HDAC6;ABCD2;PRKN;SIRT5;MT3;AATF;SLC30A10
prerank,lung development (GO:0030324),0.3655095353466553,0.8559560141456256,0.6709451575262544,0.9352168194929906,1.0,3/33,6.82%,SHH;CEBPA;NKX2-1
prerank,regulation of response to oxidative stress (GO:1902882),0.4400681671649076,0.8558328401430015,0.6642547033285094,0.9350293957326969,1.0,2/11,7.24%,MCTP1;ABCD1
prerank,negative regulation of axon extension (GO:0030517),-0.25135891728118975,-0.8554453501501037,0.7105263157894737,0.9368814942643712,1.0,6/30,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3853669686176656,0.8553224243471497,0.6674528301886793,0.9354865072321459,1.0,7/26,18.43%,GCNT1;ALG2;LARGE1;RRM2B;GK;ALG11;GOLPH3
prerank,nucleic acid metabolic process (GO:0090304),-0.2109061461429143,-0.8550056541118127,0.7727272727272727,0.9355901581434217,1.0,27/69,28.29%,RBFOX2;NT5E;TOPBP1;DUSP11;HNRNPR;HNRNPA2B1;DDX24;METTL14;ATXN2;HNRNPA1;WRN;HNRNPU;EXD2;RBMX;HNRNPH2;POLG;RAN;POLR2C;DDX54;NCBP2;GTF2F1;PCBP2;SETMAR;POLR2J;PDE12;POLR2D;KPNA2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.42472911997940765,0.8548601203651283,0.6359773371104815,0.935875589878443,1.0,5/11,20.84%,FZD9;CASP8;ARHGEF2;BIRC2;BIRC3
prerank,heart trabecula morphogenesis (GO:0061384),-0.284783038691375,-0.8543575230612778,0.6666666666666666,0.934757914746214,1.0,8/18,20.15%,BMPR1A;ADGRG6;TGFBR3;BMP5;FKBP1A;S1PR1;TEK;RBP4
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3837798320960848,0.854280752457417,0.6427688504326329,0.9364497247858347,1.0,10/20,20.84%,CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ASAH1;BIRC2;FLOT1;BIRC3
prerank,sister chromatid segregation (GO:0000819),0.3653799580534876,0.8534935386637463,0.6812428078250863,0.937285849598,1.0,8/31,19.63%,ESPL1;NCAPG2;RB1;INO80;TOP2A;CENPK;MIS12;SMC4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3677037444707039,0.8534686453287998,0.6670454545454545,0.936924049736413,1.0,9/29,20.34%,UTP20;RPS16;NOP9;HEATR1;RPS14;RRS1;TSR1;NGDN;UTP3
prerank,smoothened signaling pathway (GO:0007224),0.368437245896033,0.852489978884859,0.6728110599078341,0.9381260706148354,1.0,2/32,7.36%,SHH;PTCHD1
prerank,sodium ion export across plasma membrane (GO:0036376),0.4212697979927569,0.852194270519125,0.6652949245541838,0.9382114335122522,1.0,3/13,13.76%,SLC9A1;ATP1B3;ATP1B2
prerank,mammary gland epithelium development (GO:0061180),0.41442235860962495,0.8519373275084691,0.6574585635359116,0.9382101051244941,1.0,1/14,2.01%,CSF1R
prerank,nuclear envelope organization (GO:0006998),-0.28510115409533837,-0.8519092896939446,0.69,0.9378487097658983,1.0,5/20,16.34%,NUP93;VPS4A;CTDNEP1;EMD;TMEM43
prerank,female gamete generation (GO:0007292),0.3730124684254717,0.851557000512938,0.6678700361010831,0.9384232748127825,1.0,6/29,17.07%,MDK;TRIP13;METTL3;MCM9;USP9X;MARF1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3297647664160012,0.8515087497642159,0.8018018018018018,0.9381069897556629,1.0,32/166,19.16%,MED17;GTF2H1;TAF1A;MAML3;POLR1E;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR1B;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;RSF1;GTF2H5;RXRA;POLR2E;TAF11;CRCP
prerank,sulfur compound biosynthetic process (GO:0044272),0.3352241012426298,0.8510717845782384,0.7790224032586558,0.9383869684766544,1.0,25/104,21.76%,PRELP;ESD;AKR1A1;HPGDS;SLC35B3;B4GALT1;CHSY3;FMOD;ST3GAL1;BCAN;GGTA1;PAPSS1;CHSY1;CHST15;MGST1;CBS;GSTM2;ANGPT1;CHPF;CSPG4;CNDP2;SLC10A7;B4GALT6;B4GALT2;GCLM
prerank,epithelial structure maintenance (GO:0010669),0.42942632068135306,0.8505900609704862,0.6539007092198581,0.9387649137011158,1.0,3/11,20.89%,MUC13;NOD2;STRAP
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4456772199487615,0.850299239825106,0.6436781609195402,0.9388458793410671,1.0,3/10,17.93%,RAP2A;RHOA;CDC42
prerank,ovarian follicle development (GO:0001541),0.41931263085053305,0.8502714623232618,0.6648721399730821,0.9384904426175957,1.0,3/13,10.55%,CEBPB;EIF2B2;INHBA
prerank,antibacterial humoral response (GO:0019731),0.4054618353693642,0.8500895613565046,0.6512549537648613,0.9383987323267674,1.0,5/16,26.04%,DMBT1;DEFA6;RNASE6;PLA2G6;RNASE3
prerank,contractile actin filament bundle assembly (GO:0030038),0.4077183650642133,0.8498213208902891,0.6609724047306176,0.9380546748540021,1.0,10/15,24.82%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,stress fiber assembly (GO:0043149),0.4077183650642133,0.8498213208902891,0.6609724047306176,0.9380546748540021,1.0,10/15,24.82%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3339395657883746,0.849642912505257,0.7933467741935484,0.9379532965656735,1.0,26/125,19.42%,ERCC6L;CENPO;ESPL1;NEK6;BCCIP;XPO1;MAPRE1;SEH1L;PLK2;SETD2;DYNC1H1;PMF1;CENPI;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;DCTN6;TAOK1;SEC13
prerank,nerve growth factor signaling pathway (GO:0038180),0.4315342350069486,0.8491374170176691,0.6455696202531646,0.9383558675441966,1.0,4/10,19.06%,NTF3;RAPGEF1;RAP1A;KIDINS220
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3316099161921212,0.8486032029233552,0.8016112789526687,0.9388100654542847,1.0,27/138,18.83%,MED17;GTF2H1;MAML3;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;GTF2H5;RXRA;POLR2E;TAF11
prerank,neuron projection extension (GO:1990138),0.36284896236518616,0.8484464545924655,0.6804597701149425,0.9386686716280643,1.0,10/32,17.31%,CTNNB1;IMPACT;FLRT1;MAP1B;CYFIP1;NRP1;USP9X;HSP90AA1;PPP3CB;IQGAP1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3606041407260057,0.8484051190997668,0.7105549510337323,0.9383365785490466,1.0,4/44,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,oxoacid metabolic process (GO:0043436),0.38060039414828595,0.8481224846408373,0.6789099526066351,0.9383715368020638,1.0,4/27,11.83%,SULT4A1;BPNT1;PPA2;TPST1
prerank,response to unfolded protein (GO:0006986),0.35090897965756873,0.8478722063139265,0.6943231441048034,0.938365394171037,1.0,13/48,20.78%,PTPN1;ERN1;HERPUD1;DDIT3;BAK1;HSF1;DERL1;STT3B;HSP90AA1;ERP44;OPTN;HSPB1;PRKN
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4202861750944078,0.8471927121607129,0.645293315143247,0.9390766220762676,1.0,1/13,1.25%,NRROS
prerank,telomere organization (GO:0032200),0.3512481687450639,0.8471410375540465,0.6892778993435449,0.9387647876118961,1.0,16/43,24.85%,PTGES3;XRCC5;DOT1L;STN1;DNA2;POLD3;TINF2;RAD51D;TERF2;PARP3;ERCC4;H3-3A;TERF2IP;PARP1;ATR;RPA1
prerank,regulation of isotype switching (GO:0045191),0.4117085190183282,0.8470726989996594,0.6675531914893617,0.9384678967136614,1.0,4/14,21.54%,MAD2L2;SHLD1;SHLD2;PARP3
prerank,endothelial cell proliferation (GO:0001935),0.3959933262879215,0.8467505121813917,0.6710353866317169,0.9385886146627559,1.0,2/17,3.63%,ANGPT4;ERN1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4229913031973011,0.8464675497420415,0.6546961325966851,0.9386535777745972,1.0,7/12,23.59%,PARP8;PARP16;TNKS2;TIPARP;PARP10;PARP3;PARP1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4274117117135059,0.8460189158587214,0.6694915254237288,0.9389957722261855,1.0,6/11,26.06%,VPS11;SORL1;PRKN;EIPR1;PTPN23;RAB21
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.35647174977448104,0.8454710481402107,0.7141316073354909,0.9394730303827251,1.0,13/44,21.96%,KCNN4;KCNIP2;KCNMA1;WNK1;NOS1AP;ATP1B3;ATP1B2;GNG2;WNK4;AKAP9;KCNJ2;KCNJ10;FLNA
prerank,regulation of gastrulation (GO:0010470),-0.30819965662152315,-0.844858025865132,0.6779026217228464,0.9510387083027646,1.0,2/14,6.23%,PHLDB2;PHLDB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.33088783802008137,0.8441262892744329,0.7844129554655871,0.9411895148562253,1.0,22/121,15.61%,PCID2;PRKCD;CNOT8;EXOSC1;XPO1;ANP32A;YWHAB;PSMB10;GTPBP1;YTHDF3;RC3H2;MOV10;RC3H1;PUM2;PSMA2;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9
prerank,error-prone translesion synthesis (GO:0042276),-0.2703561045695584,-0.8439325216424213,0.6839080459770115,0.9506003415550051,1.0,16/21,35.26%,REV3L;REV1;RFC1;PRIMPOL;RFC2;POLE2;UBC;POLK;POLI;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA
prerank,apoptotic DNA fragmentation (GO:0006309),0.4004094578980693,0.8436436345213598,0.6644736842105263,0.9415732805899082,1.0,9/16,29.28%,HMGB1;KPNA1;DICER1;DNASE2;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.26901372166887544,-0.8432131679187679,0.6850828729281768,0.9497934185379303,1.0,12/23,27.12%,GLIS2;GLI3;HHIP;GPC3;KCTD21;GPR161;PTCH1;KIF7;RFX4;IFT122;ULK3;PTCH2
prerank,positive regulation of macroautophagy (GO:0016239),0.34756380821386734,0.843136095604942,0.6953210010881393,0.9420010665289998,1.0,10/48,16.29%,PIP4K2A;RAB3GAP2;SCOC;LARP1;PAFAH1B2;UVRAG;IKBKG;GNAI3;VDAC1;IRGM
prerank,protein O-linked glycosylation (GO:0006493),0.33658047039981326,0.8430059078004275,0.7625383828045036,0.9417894498813912,1.0,19/96,16.62%,SDF2L1;GCNT1;GALNT10;TET3;MUC13;GALNT15;GALNT7;OGA;ST6GALNAC4;GALNT6;POGLUT2;ST3GAL1;POGLUT1;TMTC4;POMK;GALNT2;LARGE1;MGAT5B;GALNTL6
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2617698289664757,-0.8429785546445975,0.7074468085106383,0.9480315428133694,1.0,2/23,1.03%,SLC12A2;SLC12A7
prerank,nitric oxide metabolic process (GO:0046209),0.40586376882307007,0.8416508812622049,0.6496062992125984,0.9434435772624165,1.0,2/14,11.59%,GCH1;SPR
prerank,nervous system development (GO:0007399),0.3253845969353931,0.8416339714692043,0.916,0.9430707236513907,1.0,63/429,16.23%,PCDHA6;ASCL1;SHH;TGFB1;PCSK9;PCDHB6;TGFBR1;DAGLB;MYLIP;EDNRB;S100B;FGF13;ZEB2;MDK;NAV2;SLITRK1;PRDM12;CLN8;SREBF2;PKD2;ST8SIA4;CXCR4;NRGN;MYT1L;NDP;FZD9;APAF1;TEAD1;CHD7;ATXN3;APBA1;MEF2C;BPNT1;NTF3;BCAN;HDAC4;EIF2B2;INHBA;ARTN;CHERP;NELL1;SNTG2;NR2C2;PRX;UTP11;ITM2B;NRG1;NAV1;MERTK;NINJ1;SH3GL3;SOX6;MBD5;EFNB3;KIRREL3;IGF2BP3;MPZ;AHI1;ERCC6;DPYSL5;MTR;NF1;DCHS1
prerank,nitric oxide biosynthetic process (GO:0006809),0.41069783365303003,0.8411352454096085,0.6578599735799208,0.943480401320139,1.0,2/13,11.59%,GCH1;SPR
prerank,negative regulation of metabolic process (GO:0009892),0.34788825186447525,0.8410365880516217,0.7249190938511327,0.9432384465061375,1.0,7/54,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;ZDHHC7;FLCN;RB1
prerank,negative regulation of catabolic process (GO:0009895),0.34880726629890996,0.8405756225134069,0.7350993377483444,0.9435571005983976,1.0,5/47,9.96%,CBFA2T3;MAD2L2;TNF;ZDHHC7;HDAC4
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3534093860440419,0.8401676259778051,0.7056179775280899,0.9437965056034749,1.0,16/39,26.92%,EMG1;NOB1;ERAL1;SURF6;RPS16;RPS14;RPS27;RIOK3;RRP7A;SRFBP1;RPS7;RPS15;RPS5;NOP14;LSM6;RPS6
prerank,NAD biosynthetic process (GO:0009435),0.3859994537455401,0.8400232805873612,0.6817610062893081,0.9436220864560392,1.0,7/20,19.31%,HAAO;KYNU;NMNAT3;PARP16;NAXD;NAXE;PARP10
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.38648481490869946,0.8399307803960322,0.6737235367372354,0.9433821931559783,1.0,6/20,20.78%,TGFBR1;ITCH;HIF1A;HSP90AA1;DCUN1D5;PRKN
prerank,metal ion transport (GO:0030001),0.33091251033955144,0.839925522396084,0.7476923076923077,0.942996310277363,1.0,14/86,13.80%,SLC11A1;KCNN4;SLC8A1;CCL8;PKD2;RAMP1;CACNA1A;ATP2C1;TPT1;NIPAL3;FYN;CDH23;ATP2A3;CACNA1B
prerank,nitric oxide mediated signal transduction (GO:0007263),0.3988523064479601,0.8398537976411089,0.6554508748317631,0.9427230255671206,1.0,3/16,16.03%,APOE;DDAH1;CD36
prerank,necroptotic process (GO:0070266),0.4022801208780948,0.8398128735973072,0.6671052631578948,0.942395568712279,1.0,3/16,8.92%,CD14;TICAM1;LY96
prerank,response to hydroxyurea (GO:0072710),0.4305527651523408,0.8396298598790061,0.6942028985507246,0.9422841849432091,1.0,3/11,12.85%,DDI2;ATRX;KAT7
prerank,glycine metabolic process (GO:0006544),-0.32075007614888884,-0.8396205286485235,0.6843971631205674,0.9530985268291091,1.0,6/12,40.87%,DLD;RIDA;GCSH;SHMT2;GLDC;SHMT1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3647889925372776,0.8395858183426179,0.6851211072664359,0.9419576131467153,1.0,10/32,22.80%,CDK14;BACH1;CDK17;RB1;CDC6;CDK15;CDK18;CDC45;NPAT;ZPR1
prerank,centromere complex assembly (GO:0034508),0.358988976369096,0.8393814294181895,0.7098976109215017,0.9418944207042418,1.0,12/36,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;MIS12;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,homologous chromosome segregation (GO:0045143),0.390040074181778,0.8393164927381247,0.6721311475409836,0.9416084822252153,1.0,1/20,2.80%,PTTG1
prerank,positive regulation of heart rate (GO:0010460),-0.2728446031866828,-0.8384998025385597,0.6968325791855203,0.9532007197193912,1.0,6/17,29.71%,RYR2;EDN1;EDN3;PDE4D;ATP2A2;SCN3B
prerank,regulation of telomere maintenance (GO:0032204),0.37068569330497025,0.8384726387752605,0.6858147713950762,0.9425029950294722,1.0,10/26,22.85%,XRCC5;SMG1;ATRX;USP7;HNRNPD;ERCC1;TINF2;TERF2;ERCC4;TERF2IP
prerank,potassium ion transmembrane transport (GO:0071805),0.3291304346650618,0.8384523443716344,0.7867203219315896,0.9421401308307834,1.0,11/135,7.52%,KCNJ11;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;SLC9A1;KCNK13
prerank,mitotic cytokinesis (GO:0000281),0.34330989074798696,0.8384068283105817,0.7277657266811279,0.9418202794584727,1.0,12/47,17.17%,SNX9;ESPL1;SNX33;CNTROB;KIF23;SON;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18
prerank,chromatin remodeling (GO:0006338),0.33141487123221197,0.8379060961072311,0.7833163784333672,0.9421880421227542,1.0,28/100,19.97%,NPM3;BPTF;SRCAP;HDAC5;ACTB;RB1;ARID1A;ATRX;HDAC4;ARID1B;BAZ1A;HCFC2;SOX9;BRDT;SMARCD3;SMARCB1;HCFC1;INO80;PIH1D1;ERCC6;SMARCAD1;RSF1;KDM4C;CHD4;TOP1;KDM5A;RBBP4;KDM5B
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.2847501765622226,-0.8377991475863175,0.7233009708737864,0.9523078069483611,1.0,5/20,16.59%,WNT4;NCOR1;SIK1;C1QTNF3;BCKDK
prerank,negative regulation of phosphatase activity (GO:0010923),0.37482280624757025,0.836780124397481,0.6793802145411204,0.9435933444812877,1.0,7/25,22.06%,SEMA4D;PPP1R11;BOD1L1;PPP4R4;PTPA;GSK3B;CHP1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.38660890486193017,0.8362918357716982,0.6805194805194805,0.9439549435163054,1.0,8/17,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PIN1;IGF1;GGA3
prerank,RNA methylation (GO:0001510),-0.20513329591771634,-0.8362895789748244,0.8163265306122449,0.9532886475115886,1.0,21/60,23.10%,NSUN6;METTL6;THADA;CBLL1;THUMPD3;METTL14;NSUN2;METTL5;METTL16;TRMT6;TARBP1;TGS1;CMTR1;MTO1;MTERF4;MEPCE;NOP2;TRMT5;LCMT2;WDR6;NSUN5
prerank,lipid biosynthetic process (GO:0008610),0.33300576887183697,0.836078725003076,0.7590861889927311,0.9438808966367579,1.0,12/77,17.14%,LPL;LPCAT1;CLN8;DHRS11;LIPC;PDSS1;PRLR;NDUFAB1;SREBF1;ACACA;FADS1;FDXR
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3242194155450365,-0.8357775700823312,0.6515679442508711,0.9520536023511889,1.0,2/12,10.90%,SERPINE2;HES1
prerank,protein targeting to membrane (GO:0006612),0.33038264869633893,0.8352307913256524,0.7783505154639175,0.9448033978212101,1.0,23/83,21.72%,RAB8B;MICALL1;ABCD1;ZDHHC14;AQP11;ZDHHC7;PEX13;PXMP2;ZDHHC3;VPS37C;SDCBP;ZDHHC1;ZDHHC24;SRP19;RABGEF1;ATG3;MYO1C;SEC63;ABCD2;FIS1;ZDHHC21;ZDHHC2;SRP14
prerank,protein deubiquitination (GO:0016579),0.32417845357711145,0.8349111627538248,0.877,0.9449131071171389,1.0,51/242,18.27%,ARRB2;OTULINL;TGFBR1;ATXN7;OTULIN;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;FOXK1;MINDY1;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2
prerank,regulation of actin nucleation (GO:0051125),0.41934295784642284,0.8348370347923479,0.6880984952120383,0.9446364712929205,1.0,1/12,1.76%,CORO1A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3613952271530068,0.834603525338616,0.7082847141190198,0.94460312970341,1.0,7/29,17.38%,MAD2L2;NKX2-1;ADIPOR1;PPP2CA;VASN;PTEN;LDLRAD4
prerank,heart development (GO:0007507),0.3260436473241141,0.8343132135757675,0.802020202020202,0.9446532147780135,1.0,25/150,14.97%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;CHD7;TGFBR2;MEF2A;MYOCD;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;MEGF8;SOX4;PDLIM1;POU6F1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3594900925191434,0.8342345757253877,0.7110609480812641,0.9443910673588892,1.0,5/40,9.29%,PRKCD;UBE2V2;UBE2V1;POLH;SMG1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33425715483186935,0.833621874682966,0.7663934426229508,0.9449530814515299,1.0,16/87,16.50%,GPNMB;GPR132;RGCC;PKD2;PSMB10;RB1;PSMA2;CCL2;CDK6;PSME3;PSMB5;BRD7;PSMD8;PSMD7;PSMB9;PTEN
prerank,protein N-linked glycosylation (GO:0006487),0.3329623481027755,0.8333088547083458,0.7456410256410256,0.9450361070389336,1.0,20/66,21.39%,MGAT5;MAN1C1;B4GALT1;OSTC;ST3GAL1;MCFD2;ALG2;DPAGT1;STT3B;B4GALT7;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;DDOST;MGAT1;STT3A;TUSC3;MAGT1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.30000708467806564,-0.8333000319908876,0.6818181818181818,0.9549649542647228,1.0,4/16,12.86%,RAD17;TIPIN;TOPBP1;NAE1
prerank,protein localization to lysosome (GO:0061462),0.3689202502623136,0.8329268076157441,0.7074030552291422,0.9452499018336944,1.0,13/28,27.24%,LAPTM5;RAB7A;SORL1;NCOA4;RTN4;ATP13A2;SCARB2;RNF128;MFSD1;GGA3;HGS;SNX16;NAGPA
prerank,protein K48-linked ubiquitination (GO:0070936),0.3457414041278408,0.8329202601876533,0.7387096774193549,0.9448673488836955,1.0,19/54,22.14%,RFFL;UBE2D3;TNFAIP3;UBE2E3;RNF4;NEDD4L;UBE2H;CDC34;RNF216;ITCH;UBE2G2;ZNRF1;RNF152;UBE2K;CUL3;PRKN;UBE2R2;RNF146;UBE2E1
prerank,interstrand cross-link repair (GO:0036297),-0.20292408018963076,-0.8327800890945773,0.8307692307692308,0.953763520928654,1.0,28/53,34.32%,NUCKS1;FAN1;FANCM;ATRIP;XPA;FANCI;POLN;ERCC6L2;DCLRE1A;MSH6;UBC;DCLRE1B;MUS81;FAAP20;RPA3;FANCB;UBA52;FANCC;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RPS27A;RAD51;RAD51AP2;CENPX
prerank,polyamine metabolic process (GO:0006595),0.4077833556159788,0.8325512200452179,0.6648122392211405,0.945053871813492,1.0,4/13,15.56%,SMOX;AMD1;HDAC6;PAOX
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3561685688219598,0.832367659401753,0.7073732718894009,0.9449610698640953,1.0,3/33,5.09%,NFE2L2;MDK;TNFAIP3
prerank,mitochondrial transcription (GO:0006390),0.4176162496653005,0.8322989565614037,0.6800573888091822,0.9446719886179857,1.0,4/10,24.33%,FOXO3;TWNK;TFAM;MRPL12
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.41157541516240337,0.8312446936486444,0.680327868852459,0.945905866682062,1.0,6/14,22.06%,ACTN4;WNK1;SLC9A1;WNK4;TESC;CHP1
prerank,barbed-end actin filament capping (GO:0051016),0.38178120240535407,0.8310950273690116,0.6902536715620827,0.9453483949335059,1.0,4/18,12.18%,FLII;CAPZB;CAPZA1;TWF2
prerank,actin filament capping (GO:0051693),0.38178120240535407,0.8310950273690116,0.6902536715620827,0.9453483949335059,1.0,4/18,12.18%,FLII;CAPZB;CAPZA1;TWF2
prerank,microtubule nucleation (GO:0007020),-0.2632590049744913,-0.8304938324651496,0.735,0.9563848134925742,1.0,6/20,13.95%,SLAIN2;TUBGCP2;NDEL1;NDE1;GOLGA2;TPPP
prerank,negative regulation of protein catabolic process (GO:0042177),0.35026497999820627,0.8303133673617474,0.7174638487208009,0.9461642667561164,1.0,4/40,5.21%,CTSA;MAD2L2;SNCA;TIMP1
prerank,maturation of LSU-rRNA (GO:0000470),0.3678881982211123,0.8300574990981764,0.6993006993006993,0.9461541870026281,1.0,7/26,19.82%,RPL10A;LAS1L;DDX18;PES1;ZNHIT6;WDR12;RPL7A
prerank,magnesium ion transport (GO:0015693),-0.32523399904525463,-0.8299309827035756,0.6643356643356644,0.9552951235399485,1.0,5/12,19.16%,SLC41A1;NIPA2;NIPAL2;MRS2;CNNM4
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42062810214227125,0.8292152273894605,0.6826923076923077,0.9470198173132164,1.0,4/11,17.99%,ABCD1;TRAP1;FYN;ABCD2
prerank,skeletal muscle tissue development (GO:0007519),0.3584076566815663,0.8291115110085048,0.7131608548931384,0.9467763914646591,1.0,3/32,8.10%,SKI;CFLAR;MEF2C
prerank,regulation of epithelial cell proliferation (GO:0050678),0.32733837820454487,0.8289967911179075,0.7661538461538462,0.946553455911496,1.0,14/85,14.24%,TGFB1;NLRC3;MTSS1;AQP11;DUSP10;LIMS1;SOX9;GRN;NOD2;CDK6;NR4A1;B2M;RAB33B;SOX2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.42278640971168896,0.8289658365716698,0.6724386724386724,0.946209863364699,1.0,6/11,24.90%,MTOR;SMARCB1;PIH1D1;DDX11;PWP1;SIRT7
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.36099860084428326,0.8281298282059467,0.6986143187066974,0.9471192339489785,1.0,10/30,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,protein ubiquitination (GO:0016567),0.31866554275613473,0.8280017497346378,0.94,0.9469247183108104,1.0,93/471,18.32%,ARRB2;NFE2L2;CBL;MYLIP;TRIM25;UBE2V2;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;OTULIN;TRAF2;FBXL22;MSL2;VPS18;MGRN1;RNF7;FBXL18;HLTF;TAF1;RNF111;KLHL21;CTNNB1;UVSSA;UBE2S;PSMB10;LEO1;KLHL7;LONRF1;RC3H2;VPS11;TRIM27;RNF114;UBE2E3;PEX13;RC3H1;DERL1;RNF4;UBE4B;NFX1;NEDD4L;UBE2H;RNF10;PHC1;USP7;PSMA2;TRIM24;RNF40;FBXO40;TRIM35;CDC34;SPOP;DET1;FBXO32;TNKS2;ARRDC4;PSME3;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;UBE2J2;DTX4;ZNRF1;RNF152;PSMD7;GAN;PSMB9;SMURF1;HIF1A;ATG3;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;PSMD2;KEAP1;BIRC2;FBXO44
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3657738257309849,0.8277890506195661,0.6875,0.9468489445364613,1.0,3/27,9.00%,LPIN2;CHKB;ABHD4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40854653176753336,0.8274394740972604,0.6702269692923899,0.9470069240444982,1.0,4/14,19.31%,RAP2A;RHOA;CDC42;SCRIB
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3665666095964164,0.8273923447220134,0.7165259348612787,0.9466824047243271,1.0,8/25,21.22%,ZNF326;EAF1;DDX39B;ELL;KAT7;ERCC6;ZMYND11;SETD5
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.30278937306363995,-0.8272385577298798,0.6690909090909091,0.9585656020148935,1.0,8/14,32.76%,ENPP3;AK3;AK4;SMPDL3A;CMPK2;NME2;CMPK1;AK7
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2623743889066473,-0.8269562085531533,0.7447916666666666,0.9568561439080235,1.0,4/22,12.20%,VPS37A;UBAP1;SNF8;VPS4A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4019057350596116,0.826870944582995,0.6942590120160214,0.9471117542443853,1.0,5/14,22.04%,CREB3L1;SULF2;THBS1;SPRY4;FGF2
prerank,leukotriene metabolic process (GO:0006691),0.3812258960028196,0.8267077342624681,0.6705128205128205,0.9469821012852213,1.0,5/19,23.78%,ALOX12;ABCC1;ABCC10;PLA2G5;DPEP2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4035740146604329,0.8261759088557793,0.6970108695652174,0.9473810741990405,1.0,5/13,23.91%,RENBP;NAGK;SLC35A3;GNPNAT1;GNPDA2
prerank,myotube differentiation (GO:0014902),0.3911094520784398,0.82566082257639,0.6840796019900498,0.9478028718232023,1.0,3/17,8.10%,SKI;PLD3;MEF2C
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.34364131987674174,0.8255773760903824,0.7142857142857143,0.9475279239545731,1.0,6/46,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;FLCN;RB1
prerank,mRNA processing (GO:0006397),0.31969925512565234,0.8253984126065305,0.905,0.9474155581593194,1.0,75/287,21.69%,IK;SNRNP27;GTF2H1;DHX9;ERN1;BCAS2;SF3B2;SF3B1;AURKAIP1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;THOC2;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;PPARGC1A;CDK7;HNRNPL;RBMX2;DDX39B;SON;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;POLDIP3;PCBP1;UPF3B;THOC3;HNRNPD;WDR83;ALKBH5;BUD31;AKAP8L;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;GTF2H5;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,protein K63-linked deubiquitination (GO:0070536),0.3648166332694391,0.8253515626022928,0.7092198581560284,0.9471035759201492,1.0,8/31,16.40%,TNFAIP3;ATXN3;STAMBPL1;BABAM2;USP7;USP8;USP16;BABAM1
prerank,gluconeogenesis (GO:0006094),-0.22427516772810258,-0.8252584884700018,0.7706422018348624,0.9580916943123686,1.0,15/39,23.11%,SLC25A12;PGM1;MDH1;SLC25A13;PGK1;GOT1;ATF4;SLC39A14;SLC25A11;PER2;GAPDH;ALDOC;RBP4;ENO2;CRY1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3946419651681165,0.8252417983754606,0.7018716577540107,0.946879685488786,1.0,5/14,24.33%,FOXO3;FASTKD1;TWNK;TFAM;MRPL12
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.38552571390026724,0.82514694664681,0.6790757381258024,0.9462392911812074,1.0,6/19,22.85%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.38552571390026724,0.82514694664681,0.6790757381258024,0.9462392911812074,1.0,6/19,22.85%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,positive regulation of cellular senescence (GO:2000774),0.42844795306525074,0.8250963140799014,0.6809728183118741,0.9459287222150811,1.0,2/10,13.13%,YPEL3;B2M
prerank,DNA modification (GO:0006304),0.37597334493088164,0.8249044267124277,0.7059538274605103,0.945834910040802,1.0,8/22,23.59%,NEIL2;OGG1;TINF2;EXOSC3;TERF2;PARP3;TERF2IP;PARP1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.38117647920520786,0.8245570902316511,0.6657963446475196,0.9459869468164802,1.0,9/18,23.15%,LDLRAP1;CLN3;ACTB;ZDHHC7;STX8;ABCA2;ZDHHC2;VAMP8;STX7
prerank,amino acid import across plasma membrane (GO:0089718),0.37573310463978576,0.8245362189197522,0.6950617283950618,0.9456290697692691,1.0,3/24,7.47%,SLC7A8;SLC36A1;SLC16A2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3405389577434148,0.8240878295478078,0.7570194384449244,0.9459126521744841,1.0,12/54,17.60%,RPL10A;LAS1L;GTF3A;SURF6;RPL6;RPL26;MDN1;RRS1;NOC2L;PES1;RPL11;WDR12
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.33410144366695016,0.8236409187352175,0.7505307855626328,0.94620396155342,1.0,13/57,18.07%,EMG1;XPO1;URB2;GTF3A;SURF6;RPL26;RPS16;RRS1;NOC2L;PES1;RPL11;WDR12;DDX31
prerank,regulation of epithelial cell differentiation (GO:0030856),0.39031390584891223,0.8233766380520693,0.68359375,0.9461960663176159,1.0,3/17,11.18%,MAFG;CEBPB;SOX9
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2801991122333821,-0.8232980224704127,0.746268656716418,0.9599528246509799,1.0,5/18,14.42%,UBTF;EIF2AK3;ATF4;DHX33;UTP15
prerank,methylguanosine-cap decapping (GO:0110156),0.42998980249349456,0.8232320742425918,0.6813655761024182,0.9460111311540288,1.0,1/10,4.01%,PNRC2
prerank,histone mRNA catabolic process (GO:0071044),-0.29114651712899753,-0.8231959637201459,0.7253218884120172,0.9578696567004693,1.0,5/15,14.46%,SSB;ERI1;ATM;UPF1;TUT1
prerank,embryonic limb morphogenesis (GO:0030326),0.35633922668595347,0.8231007756792096,0.7178899082568807,0.9458221632973863,1.0,3/34,6.29%,SHH;SKI;CTNNB1
prerank,protein localization to chromatin (GO:0071168),-0.27179127878410425,-0.8230514864752652,0.7135922330097088,0.9559207375137578,1.0,3/18,6.33%,NIPBL;WAPL;MSH2
prerank,regulation of mitochondrial fusion (GO:0010635),0.41865128482276437,0.8224428836795822,0.6671270718232044,0.9464116340157496,1.0,4/11,20.78%,PID1;HUWE1;VAT1;PRKN
prerank,Notch signaling pathway (GO:0007219),0.3339329493978748,0.822398204382422,0.7331223628691983,0.9460947376706685,1.0,3/59,3.24%,ASCL1;MDK;MAML3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3575458913517443,0.8223601874921868,0.7185761957730812,0.9457701604513038,1.0,9/38,17.70%,SCN4B;HCN4;PKP2;CACNB2;KCNA5;CACNA1D;BIN1;SCN5A;AKAP9
prerank,canonical Wnt signaling pathway (GO:0060070),0.32772951494782404,0.8223425969142129,0.7567849686847599,0.9454095084354405,1.0,13/68,16.50%,FZD10;FRAT2;FZD9;FZD3;CTNNB1;SCYL2;LRP5;AMER1;CSNK1A1;LRRK2;BCL9;FZD8;PTEN
prerank,negative regulation of anoikis (GO:2000811),-0.2935831775693566,-0.8221075463487769,0.7318840579710145,0.9554894331421686,1.0,2/14,6.60%,CAV1;TLE1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.38238816614370214,0.8220040789190655,0.680628272251309,0.9455259647025563,1.0,2/17,9.11%,UNC13D;SYT10
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2882952774922028,-0.8219678331225844,0.6890756302521008,0.95352425099235,1.0,4/15,15.28%,BMP4;SMO;SIX1;PAX2
prerank,calcineurin-mediated signaling (GO:0097720),0.42575429322971814,0.8218597943944317,0.6938775510204082,0.9449659402536973,1.0,1/10,2.16%,NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.42575429322971814,0.8218597943944317,0.6938775510204082,0.9449659402536973,1.0,1/10,2.16%,NFATC1
prerank,cGMP metabolic process (GO:0046068),0.4179722076816801,0.8215724434387854,0.6810584958217271,0.9449965296637736,1.0,2/12,10.24%,GUCY2F;NPR2
prerank,peripheral nervous system development (GO:0007422),-0.2610245077910849,-0.8215636789812526,0.7318435754189944,0.9522170119617965,1.0,5/23,11.59%,ADGRG6;NFASC;NGF;ALDH3A2;SCN8A
prerank,purine-containing compound catabolic process (GO:0072523),0.4021358245084573,0.8215066637731016,0.6666666666666666,0.9447023712444917,1.0,2/13,8.29%,XDH;PNP
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.36842664497938393,0.8213009766386749,0.7054545454545454,0.9446159569596845,1.0,6/24,21.35%,NFE2L2;TNFAIP3;GAS6;PDPK1;ANGPT1;RAMP2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21530495205500846,-0.821282781504337,0.8117647058823529,0.9505295733821182,1.0,22/44,33.94%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;INSIG2;INSIG1;SQLE;PER2;PARK7;AMACR;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;TM7SF2;OSBPL2;CH25H
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3161215942875261,-0.8206638386700287,0.6655405405405406,0.9495592751561001,1.0,3/12,9.85%,SORBS1;IRS1;PRKCZ
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3737816562104529,0.820662345417801,0.6993630573248407,0.9451622868322523,1.0,9/19,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PICALM;PIN1;IGF1;GGA3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3834832116280645,0.8201956047624496,0.6888604353393086,0.9454841829498821,1.0,5/17,18.46%,ANXA1;TMSB4X;ANXA4;CD33;MAP2K5
prerank,regulation of protein localization to centrosome (GO:1904779),0.42862498879678584,0.8196794206680736,0.6884272997032641,0.9458382786004598,1.0,1/10,2.92%,NUP62
prerank,protein localization to chromosome (GO:0034502),0.34919060941289054,0.8195779306317185,0.7041619797525309,0.9456146795648513,1.0,12/34,24.85%,XRCC5;RB1;ATRX;TNKS2;MCM9;SLF2;TINF2;TERF2;PARP3;TERF2IP;ATR;RPA1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.35515645790786704,0.8195279634296917,0.7213302752293578,0.9453184917744201,1.0,9/32,18.57%,PRKCD;NR1H4;FOXO3;CYFIP1;PCIF1;PUM3;PGAM1;PICALM;TIGAR
prerank,ketone body metabolic process (GO:1902224),0.427161426798292,0.8194932347735739,0.6966759002770083,0.9449863818330663,1.0,1/10,3.39%,OXCT1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.30513122687987504,-0.8194885122484971,0.7209302325581395,0.9496897173839699,1.0,9/14,25.78%,ADK;ADSS2;GMPS;PFAS;RFK;PAICS;ADSL;IMPDH1;PPAT
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.281356533175932,-0.8192302707445513,0.7035398230088495,0.9480116854039892,1.0,7/16,17.69%,SMCHD1;KMT5B;DTX3L;KMT5C;WRAP53;KDM4D;PRKDC
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3467181382134907,0.8191605303435605,0.7288135593220338,0.9450966259246452,1.0,17/37,26.64%,SND1;ADPRM;ENTPD1;RNASEH1;HNRNPD;ENTPD2;PABPC4;RNASEH2A;ENTPD3;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32043132196596286,0.8191529242136445,0.82744702320888,0.9447245888248782,1.0,27/129,15.71%,TGFB1;GPRC5B;ZEB2;DKK2;LGR6;FZD9;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,protein localization to cilium (GO:0061512),-0.21936218497649987,-0.8188733408307186,0.803030303030303,0.9465592318855149,1.0,15/32,26.97%,ZNF423;ATP6V1D;ARL3;BBS4;ARL6;EHD1;WDR35;IFT20;TCTN2;BBS1;TUB;IFT122;WDR19;TULP2;NPHP4
prerank,protein targeting (GO:0006605),0.3184735243744328,0.8188547483256535,0.8159757330637007,0.9447908431044636,1.0,28/118,19.60%,TSPO;EDEM1;AP1S3;AIP;MICALL1;SPCS2;ZDHHC14;AQP11;ZDHHC7;TIMM22;SPCS1;ZDHHC3;VPS37C;SDCBP;SORL1;TOMM40;ZDHHC1;ZDHHC24;RABGEF1;ATG3;RPL11;PITRM1;MYO1C;GIPC1;SEC63;LTBP2;TOMM20;FIS1
prerank,glutathione biosynthetic process (GO:0006750),-0.3207559912272401,-0.8187905170394733,0.6866197183098591,0.9445427375142654,1.0,6/11,35.78%,GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21276931221404627,-0.8187052510229319,0.835820895522388,0.9425213294879795,1.0,18/57,18.76%,RINT1;ATF2;RAD17;TAOK2;TIPIN;TOPBP1;TRIM39;MRE11;WAC;ATM;STK33;NOP53;MRNIP;SDE2;PRKDC;FBXO31;CDK2;HMGA2
prerank,double-strand break repair (GO:0006302),0.3188111708440023,0.8181306630918032,0.839,0.945456701299854,1.0,41/158,21.97%,ZFYVE26;MAD2L2;UBE2V2;NABP1;RMI1;HMGB1;XRCC5;SAMHD1;BRIP1;LIG3;YY1;ATP23;CHEK2;TRIP13;BABAM2;HPF1;APTX;MCM9;DNA2;INO80;SLX4;DDX1;ERCC5;SMARCAD1;RAD51B;BABAM1;MDC1;UBE2N;ERCC1;SWI5;RAD51D;POLM;SPIDR;SFR1;HERC2;DCLRE1C;NSMCE2;PARP3;ERCC4;RFWD3;SMARCA5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36811083654174637,0.8180232718598213,0.7006060606060606,0.9452322314701506,1.0,1/23,0.90%,TGFB1
prerank,regulation of synapse assembly (GO:0051963),0.3426199405663319,0.8180060146688495,0.758957654723127,0.9448698643012705,1.0,5/46,8.10%,CLSTN1;TLR2;SLITRK1;SNCA;MEF2C
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.31374128064907025,-0.8177755419536091,0.7027027027027027,0.942122562943212,1.0,5/11,14.33%,PARP6;PARP14;PARP12;PARP11;PARP4
prerank,negative regulation of translational initiation (GO:0045947),0.4106503127357039,0.8172152650197572,0.7190860215053764,0.9456389176272365,1.0,5/13,22.55%,EIF4EBP2;LARP1;TPR;AGO2;EIF3E
prerank,neuron cell-cell adhesion (GO:0007158),-0.29591448554782257,-0.8169878986553917,0.7427385892116183,0.9414230505433088,1.0,3/14,8.33%,NLGN1;ASTN1;NINJ2
prerank,regulation of neuron differentiation (GO:0045664),0.3269805298480491,0.8166443508280304,0.7732919254658385,0.9460986829780335,1.0,17/76,20.23%,ASCL1;GPRC5B;MMD;MEF2C;NTF3;IMPACT;ZFHX3;SOX2;LRRK2;YWHAH;BIN1;ARHGEF2;CASZ1;RHOA;BEND6;CNTN4;CDK5R1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.37468462323002605,0.8164088817923768,0.709832134292566,0.9460552997053437,1.0,2/23,8.71%,TGFB1;SMAD3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.38922629799368147,0.8163359103217256,0.7093333333333334,0.9457772239794029,1.0,6/16,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,oligodendrocyte development (GO:0014003),-0.2887912721837317,-0.8159438278116529,0.7350746268656716,0.9413345174767183,1.0,7/15,30.94%,EIF2B3;TPPP;EIF2B5;EIF2B4;NSUN5;SOX10;EIF2B1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28801455193644676,-0.8155379808778224,0.731404958677686,0.9399432285518494,1.0,10/16,25.78%,ADSS2;GMPS;PFAS;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;NUDT2;PPAT
prerank,double-strand break repair via homologous recombination (GO:0000724),0.32346983778044935,0.8153427134764301,0.789795918367347,0.946801232621899,1.0,28/95,24.14%,MCM5;ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;RAD54L;MCM6;MCM2;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;CDC45;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1;GINS4
prerank,cellular response to interleukin-7 (GO:0098761),0.3871410836807111,0.8152062925908964,0.6993548387096774,0.94623481545795,1.0,3/17,14.01%,STAT5A;STAT5B;IL2RG
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3871410836807111,0.8152062925908964,0.6993548387096774,0.94623481545795,1.0,3/17,14.01%,STAT5A;STAT5B;IL2RG
prerank,gonad development (GO:0008406),0.3456773474617646,0.8146097634423489,0.7339246119733924,0.946721332402758,1.0,2/41,1.62%,GATA1;BASP1
prerank,regulation of embryonic development (GO:0045995),-0.22730977425730972,-0.8145827857111568,0.7578125,0.9396360853011787,1.0,10/34,20.43%,PHLDB2;NIPBL;PHLDB1;TDG;NPHP3;ZBED3;SOX17;DHX36;RBM19;RPS6KA6
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.26442185507877686,-0.8143888421254091,0.730593607305936,0.9379311448128153,1.0,4/18,10.47%,OTUD7B;LATS1;RAB23;LATS2
prerank,striated muscle cell development (GO:0055002),0.3933419457366634,0.8141619399076143,0.707774798927614,0.9469591557615537,1.0,2/14,14.80%,FLII;CAPN3
prerank,regulation of stress fiber assembly (GO:0051492),0.32728961216821195,0.813875936081175,0.7839248434237995,0.9469874064892801,1.0,13/74,11.24%,TGFBR1;ARHGEF18;ARAP1;RGCC;FHOD1;SLC9A1;WASF2;ACTG1;F11R;PFN2;NF2;PFN1;NRP1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3162456871468589,-0.8136629635961983,0.738562091503268,0.9370695394198344,1.0,8/11,44.28%,MFN2;WDR45B;WIPI1;WDR45;ATG9A;STX17;ATG13;WIPI2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3155317532694443,-0.8135908095575843,0.7152542372881356,0.9351134438115535,1.0,4/12,18.76%,REST;PSMC3;TARDBP;HMGA2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.37143581338358383,0.8128746382693246,0.7272727272727273,0.9480286787714262,1.0,5/21,14.82%,MYH9;PRKCQ;SPPL3;ERAP1;SPPL2A
prerank,synaptic membrane adhesion (GO:0099560),-0.293877676712069,-0.8126518600623982,0.6770428015564203,0.9348298721978252,1.0,2/14,2.95%,GPC6;NTNG1
prerank,programmed necrotic cell death (GO:0097300),0.37800086661475507,0.8126440745979583,0.6975546975546976,0.9479908649218022,1.0,3/18,8.92%,CD14;TICAM1;LY96
prerank,positive regulation of nervous system development (GO:0051962),0.34078264259215063,0.812595177697737,0.7475728155339806,0.9476692946108048,1.0,2/42,1.58%,CX3CR1;CLSTN1
prerank,RNA metabolic process (GO:0016070),0.31814631102762775,0.8124563655683703,0.8277945619335347,0.9475009520530949,1.0,33/127,21.19%,APOBEC1;DHX9;RBM39;SND1;TFIP11;ADAR;PCBP3;AGO4;FASTKD1;HNRNPL;DDX39B;RNASEL;POLR2L;AGO3;RNASEH1;METTL3;LAGE3;ADARB1;PCBP1;HNRNPD;NUFIP1;LSM8;AGO2;PABPC4;RNASEH2A;POLR2E;RBMS2;HNRNPF;FTO;PABPN1;DICER1;PTBP1;HNRNPA0
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3956606992943953,0.812254559471345,0.6943699731903485,0.9474011617181947,1.0,4/14,17.60%,DDX18;PES1;ZNHIT6;WDR12
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2654292401460139,-0.8122244486920656,0.7373737373737373,0.9335571370723709,1.0,5/18,12.45%,KANK1;ARHGAP35;SCAI;MET;HEG1
prerank,fatty acid elongation (GO:0030497),0.40145379487518223,0.8117540936836625,0.694708276797829,0.9477402137977187,1.0,2/13,8.77%,ABCD1;HACD4
prerank,protein localization to cell surface (GO:0034394),0.3611456919056226,0.8117263805144022,0.7243047158403869,0.9474064951285784,1.0,13/26,25.48%,CTNNB1;VCL;PTPRU;GGA2;ARF6;SMURF1;MESD;ANGPT1;PIGU;UNC50;FLNA;PIGK;GGA3
prerank,positive regulation of DNA recombination (GO:0045911),0.3557585039527489,0.8114405169116785,0.731995277449823,0.9474328286109838,1.0,6/27,19.13%,MAD2L2;MMS19;ACTR2;ERCC6;SHLD1;SHLD2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.32400995669416055,0.8114156362845691,0.7952674897119342,0.9470867455077154,1.0,20/86,18.91%,NFE2L2;ATF3;DDIT3;BACH1;TP53;PSMB10;EPO;IMPACT;PSMA2;PSME3;PSMB5;INO80;PSMD8;PSMD7;PSMB9;HIF1A;GCN1;VHL;PSMD2;ELOB
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.36855812676814625,0.8110755826718014,0.6932668329177057,0.9471670693559773,1.0,10/22,28.08%,UTP20;NOP9;RRS1;PES1;WDR12;EXOSC3;EXOSC2;URB1;NOP14;EXOSC10
prerank,aorta development (GO:0035904),0.40041236352051135,0.8110291878343201,0.7111716621253406,0.9468542633096609,1.0,4/14,15.03%,PKD2;HECTD1;TFAP2B;LRP1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.29101374454723977,-0.8109085328549761,0.7171314741035857,0.9339246206569723,1.0,2/14,4.64%,NIPBL;DYRK1A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4098359904631689,0.810424122775373,0.7067039106145251,0.9473320445605784,1.0,4/11,16.59%,RESF1;ATF7IP;TPR;TASOR
prerank,acyl-CoA metabolic process (GO:0006637),0.34385849820874015,0.81020534756941,0.7460496613995485,0.947260578401397,1.0,6/35,17.50%,DBI;OGDH;ACSF2;ACOT9;ACACA;ACOT2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4223266047398402,0.8091870466865625,0.7118155619596542,0.9483464142377185,1.0,7/10,26.03%,NELL1;EPHA4;FURIN;ATRAID;EFNA1;RIC1;CDK5RAP3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38274913019303763,0.8088201382824324,0.6941323345817728,0.9485114556382384,1.0,8/18,27.11%,VPS11;DNAJC13;MAP2K2;SRC;PTPN23;RAB21;MAPK1;MAPK3
prerank,negative regulation of cellular protein localization (GO:1903828),0.3525879128926148,0.8088013654941888,0.7517162471395881,0.948161807651865,1.0,11/34,20.55%,SNX33;SPI1;RIPOR2;FLCN;NEDD4L;ANKRD13A;PICALM;ROCK2;LEPROTL1;GSK3B;NSFL1C
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4139191810204955,0.8087908471511481,0.7044476327116213,0.9477927516406335,1.0,5/11,23.67%,SNX33;NEDD4L;PICALM;LEPROTL1;GPM6B
prerank,UV-damage excision repair (GO:0070914),-0.3121988951829478,-0.808582084561278,0.7050359712230215,0.9361835925016331,1.0,5/12,20.71%,DDB2;DDB1;XPA;POLA1;ACTR5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3412899583253845,0.8084883456124484,0.7244094488188977,0.9478647455399452,1.0,5/35,12.10%,RASAL3;ARHGAP24;RIPOR2;FLCN;SYNGAP1
prerank,development of primary male sexual characteristics (GO:0046546),0.35261461807351735,0.8084710807554727,0.7211981566820277,0.9475104481659183,1.0,4/34,11.18%,GATA1;LHFPL2;INHBA;SOX9
prerank,axon guidance (GO:0007411),0.31681883795345583,0.8082806553694,0.8918918918918919,0.9474288688476147,1.0,46/201,20.56%,SHH;DRAXIN;SPTBN5;PIK3CD;GRB2;PIK3CB;PLXNC1;SEMA4D;TUBB3;DOK1;CXCR4;PLXNB2;EMB;LGR6;EFNA2;TNR;GAB2;SH3KBP1;PRKCQ;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;FYN;RANBP9;NPTN;EFNB3;SRC;PTPRA;LAMA3;EPHA4;EPHA8;SEMA4B;RPS6KA5;SPTBN4;VLDLR;TMEFF1;KLF7;VSTM2L;GDNF;PALLD;RELN;CNTN4;CDK5R1;DOK5
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.25314683212161415,-0.8081307952312226,0.7344632768361582,0.9349832572392968,1.0,4/24,8.48%,SORBS1;IRS1;EPM2AIP1;SELENOS
prerank,skeletal system morphogenesis (GO:0048705),0.33844231875618813,0.8077580906878903,0.7386489479512736,0.9477937231868638,1.0,8/42,13.95%,TGFBR1;SKI;LRP5;DYNC2I1;MEGF8;RFLNA;RAB33B;ANKRD11
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.396278466825937,0.80757491400262,0.7203274215552524,0.9476543777024382,1.0,5/14,21.96%,TIMP1;LIMS1;CD63;LOXL3;FLNA
prerank,mitochondrial fission (GO:0000266),0.38816902389848185,0.8075665555947914,0.7135348226018396,0.9472872274629215,1.0,7/16,25.04%,MTFR2;DNM2;DNM1L;FIS1;PRKN;MTFR1;MFF
prerank,dendritic spine morphogenesis (GO:0060997),-0.2912274853004859,-0.8075661647402461,0.6861924686192469,0.9338864301309006,1.0,4/15,11.11%,EPHB2;DIP2A;SHANK3;SHANK1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.36554791969505085,0.8073430321381112,0.722877358490566,0.947223046519324,1.0,3/27,3.69%,HCN4;FGF13;PKP2
prerank,regulation of glycolytic process (GO:0006110),0.3256326162455756,0.8073076388828763,0.781799379524302,0.9468898879906467,1.0,14/68,16.87%,CBFA2T3;P2RX7;MLXIPL;NUP62;PFKFB4;SEH1L;HDAC4;TPR;NUP205;PFKFB3;HIF1A;GAPDHS;GCK;PGAM1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.31177845893162753,-0.8069465663907337,0.7245901639344262,0.9328649969946042,1.0,5/11,22.05%,AHCYL1;PAPOLA;PAF1;DHX36;NCBP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.31176762648774764,0.8068430360495166,0.943,0.9471863860332453,1.0,58/336,16.97%,LYN;EID3;FAM111A;FNIP2;TAOK3;GTF2H1;GRB2;MAPK14;MAP2K6;NABP1;TANK;BRAT1;DDIT3;EXO1;VAV3;OARD1;XRCC5;TAF1;SAMHD1;BACH1;BCL2L1;TP53;POLH;YY1;CHEK2;DOT1L;ENDOV;MMS19;BAK1;UVRAG;RAD54L;ZDHHC16;BABAM2;MGMT;HPF1;RBBP5;APTX;BOD1L1;WDHD1;TNFRSF1B;METTL3;PDS5A;MCM9;IKBKG;RNF169;INO80;SLX4;SLF2;REXO4;TOP2A;USP16;OGG1;NRDE2;RAD51B;SUV39H1;STXBP4;FANCL;MACROD1
prerank,protein methylation (GO:0006479),-0.21987347721015066,-0.8067286832403879,0.8118811881188119,0.931208964518583,1.0,21/40,32.92%,RAB6A;SETD3;FAM98B;SNRPD3;ATPSCKMT;EZH2;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;PRMT7;EEF1AKMT2;N6AMT1;CAMKMT;ICMT;NTMT1;VCPKMT;EHMT1;TRMT112
prerank,midbody abscission (GO:0061952),-0.2740731346624444,-0.8065136848564979,0.7522522522522522,0.9295037038576222,1.0,5/17,20.05%,VPS4A;CHMP5;CHMP4B;CHMP4A;CHMP2A
prerank,myotube cell development (GO:0014904),0.41399838055911,0.8056119648996339,0.7,0.9485505507805493,1.0,1/10,4.36%,SKI
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2204607387899276,-0.8055269490408368,0.8317757009345794,0.929304310032154,1.0,23/37,35.85%,RFC1;DDB2;DDB1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,L-amino acid transport (GO:0015807),0.35906074545752814,0.805352414124874,0.7094907407407407,0.9485227217216361,1.0,6/28,15.11%,SLC7A8;SLC36A1;SLC36A4;SLC25A18;CTNS;SLC1A4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3821508690200437,0.8049160038549374,0.712401055408971,0.948742696236142,1.0,6/17,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,protein polyubiquitination (GO:0000209),0.31151995472475125,0.8047810620288798,0.9229229229229229,0.9485536354430044,1.0,64/297,18.32%,MYLIP;UBE2V2;RFFL;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;TRAF2;FBXL22;TNFAIP3;TRAF3;FBXL18;TAF1;HECTD1;CTNNB1;UBE2S;PSMB10;LONRF1;RC3H2;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;UBE4B;TRAF5;NEDD4L;UBE2H;TRIM56;PSMA2;FZR1;FBXO40;CDC34;SPOP;FBXO32;TNKS2;PSME3;RNF216;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;PSMD8;AREL1;UBE2J2;ZNRF1;RNF152;PSMD7;PSMB9;SMURF1;UBE2N;TRIM62;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44
prerank,visual system development (GO:0150063),0.3410626536790605,0.8047049693139167,0.7281001137656428,0.9482831489481828,1.0,7/37,15.34%,SH3PXD2B;C1QA;ITGAM;ZDHHC16;SOX2;MEIS1;SIPA1L3
prerank,regulation of DNA binding (GO:0051101),0.33239788152033456,0.8039586617869329,0.7350705754614549,0.9489420695591576,1.0,4/44,8.18%,TGFB1;SKI;HMGB1;DOT1L
prerank,cellular response to leucine (GO:0071233),0.40543430085540183,0.8031884833686687,0.691970802919708,0.949258184173339,1.0,1/10,2.52%,MTOR
prerank,response to leucine (GO:0043201),0.40543430085540183,0.8031884833686687,0.691970802919708,0.949258184173339,1.0,1/10,2.52%,MTOR
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.3404339537361825,0.8030458935026613,0.7688838782412627,0.94907133044481,1.0,8/38,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;NDUFAB1;NDUFB11
prerank,protein acylation (GO:0043543),0.34297803108372676,0.8029008946641993,0.7385474860335196,0.9489045717209683,1.0,12/38,21.35%,ZDHHC14;ZDHHC7;ZDHHC13;NAT9;ZDHHC16;ZDHHC3;ZDHHC1;SELENOK;GTF2B;ZDHHC21;NAA80;ZDHHC2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3516146492174539,0.8024935863592072,0.7069988137603797,0.9490903288138987,1.0,8/27,20.21%,SCN4B;NEDD4L;FXYD5;YWHAH;SCN5A;FXYD6;PTPN3;FXYD1
prerank,neuron remodeling (GO:0016322),-0.3259503940853416,-0.8024217655695796,0.67003367003367,0.9328938708556966,1.0,1/10,0.14%,APP
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.20395715898870095,-0.8024169516485404,0.8695652173913043,0.9308532413572433,1.0,10/48,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.27782381753361174,-0.802291678884265,0.6818181818181818,0.9290728639082259,1.0,9/16,32.04%,DIP2A;ACLY;MLYCD;PPT1;CBR4;ACSS1;PPCS;GCDH;SLC25A1
prerank,electron transport chain (GO:0022900),0.3820004071677346,0.8019221121823754,0.7144772117962467,0.9495342230480507,1.0,5/15,20.75%,PPARGC1A;POR;SDHB;ETFDH;SDHA
prerank,positive regulation of cyclase activity (GO:0031281),0.3893545565838525,0.8013240623820077,0.7152406417112299,0.9499907755993502,1.0,4/14,16.60%,MAPK14;AKAP5;NF1;CACNA1D
prerank,protein mannosylation (GO:0035268),-0.24050527989792356,-0.7997796050938721,0.7228915662650602,0.931476263696939,1.0,10/22,24.25%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2;DPY19L4
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2849705905986012,-0.7996551350591897,0.7429718875502008,0.9296830540087064,1.0,7/16,29.99%,UPP2;NT5E;CRMP1;DPYSL2;NT5C1A;UPB1;DPYSL3
prerank,negative regulation of T cell differentiation (GO:0045581),0.4173531085717961,0.7989430494571623,0.7082728592162555,0.9529574512983127,1.0,2/10,13.88%,MDK;IRF1
prerank,copper ion homeostasis (GO:0055070),0.3717735711707142,0.7988985178194075,0.7182175622542595,0.9526513522227421,1.0,2/17,4.49%,ATP7A;ATOX1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.39729069034716635,0.798846204503069,0.6869806094182825,0.9523454958902927,1.0,5/12,22.41%,SREBF2;SEC14L2;SREBF1;ABCA2;MBTPS2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.21545680817911703,-0.7986872210772414,0.8431372549019608,0.9294897168116163,1.0,24/39,35.85%,RFC1;DDB2;DDB1;FAN1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,negative regulation of vascular permeability (GO:0043116),0.40437114990405565,0.7977653523503265,0.7049180327868853,0.9534890930089508,1.0,6/12,24.84%,PTPRJ;DDAH1;ANGPT1;RAMP2;VEGFA;SH3GL2
prerank,phosphatidylserine metabolic process (GO:0006658),0.3467912022209225,0.7977308420955974,0.7531718569780853,0.9531551482619575,1.0,6/32,20.31%,ABHD12;OSBPL10;OSBPL8;ABHD16A;PLAAT3;PLA2G5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.34447894932289336,0.7974061172770631,0.7372685185185185,0.9532287104231764,1.0,4/32,6.54%,FGF13;SNCA;ATXN7;MAPRE1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.36390758502388004,0.7969999601880186,0.7403245942571786,0.9534193920896329,1.0,5/21,18.94%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1
prerank,relaxation of muscle (GO:0090075),0.3934577985758294,0.7969626114612829,0.7162726008344924,0.9530911402626885,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,establishment of epithelial cell polarity (GO:0090162),0.37157901314420033,0.7968983882794879,0.7227101631116688,0.952811359617892,1.0,6/19,18.43%,RAP2A;CYTH1;SIPA1L3;RHOA;CDC42;GOLPH3
prerank,negative regulation of stress fiber assembly (GO:0051497),0.3522072142711532,0.796626078345758,0.7072879330943848,0.9528035407159207,1.0,6/24,13.26%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3442142035913842,0.7963663922294933,0.7370838117106774,0.9527710340787546,1.0,6/31,12.94%,SEMA4D;SKI;LRP5;SOX9;CDK6;BAMBI
prerank,axonogenesis (GO:0007409),0.31039913442972555,0.7959395402280193,0.911,0.9529959158411735,1.0,45/237,17.85%,SHH;DRAXIN;NEFH;SPTBN5;PIK3CD;GRB2;PIK3CB;S100B;SLITRK1;SEMA4D;TUBB3;DOK1;CXCR4;EMB;LGR6;EFNA2;TNR;ACTB;GAB2;SH3KBP1;PRKCQ;MAP1B;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;ATL1;FYN;RANBP9;NPTN;USP9X;EFNB3;SRC;PTPRA;LAMA3;EPHA4;PTEN;HSP90AA1;EPHA8;PPP3CB;SEMA4B;RPS6KA5;SPTBN4;VLDLR
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.37642952246166195,0.795631362803244,0.7142857142857143,0.9530454721058798,1.0,9/18,25.87%,PUM2;GPATCH3;BIRC2;BIRC3;RNF125;DDX60;C1QBP;USP15;PUM1
prerank,activation of protein kinase B activity (GO:0032148),0.3402890310594354,0.7954284603744864,0.7420867526377491,0.9529449795308415,1.0,7/29,17.77%,MTOR;IL18;NTF3;NRG1;GAS6;OSBPL8;PDPK1
prerank,histone H3-K9 demethylation (GO:0033169),-0.3162720365696836,-0.7952621105118274,0.7269372693726938,0.9335302875903133,1.0,5/11,16.80%,JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3263262338603179,0.795246947498062,0.7808510638297872,0.9528263782036265,1.0,7/54,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.22270791825435043,-0.7951980423783408,0.788235294117647,0.9316295642718374,1.0,20/35,36.18%,RFC1;TDG;XRCC1;SMUG1;RFC2;POLG;LIG1;RPA3;NEIL1;POLD2;RPA2;RFC3;POLE;RFC4;MUTYH;PCNA;NTHL1;POLD4;POLD1;MPG
prerank,calcium ion transport (GO:0006816),0.31150422039240216,0.7949555402868301,0.8306451612903226,0.9528561457284935,1.0,22/113,17.27%,KCNN4;P2RX7;SLC8A1;CCL8;PKD2;ORAI2;P2RX4;RAMP1;CACNA1A;ATP2C1;TPT1;CACNB2;FYN;CDH23;GAS6;ATP2A3;CACNA1B;TRPV3;SELENOK;CACNA1D;CRACR2B;TMEM165
prerank,cellular macromolecule catabolic process (GO:0044265),0.3282065301254654,0.7948034071370423,0.7654054054054054,0.9526823440725618,1.0,20/49,26.64%,SND1;OGA;CHEK2;RNASEH1;STT3B;UBE2G2;HNRNPD;IDE;PABPC4;FBXO44;RNASEH2A;PRKN;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2873861996957119,-0.7947860820730058,0.7201492537313433,0.9303151891344006,1.0,2/13,6.00%,RANBP2;IPO5
prerank,L-serine metabolic process (GO:0006563),0.4128215905064914,0.7946713060081791,0.7208333333333333,0.952482035141897,1.0,5/10,24.97%,CBS;PHGDH;PSAT1;SERINC3;PSPH
prerank,mitochondrion organization (GO:0007005),0.3089730932936545,0.7945815950373663,0.8793969849246231,0.9522310377325078,1.0,38/165,19.75%,TSPO;RAB32;MTFR2;AIP;ATP7A;PYROXD2;BCL2L1;DNM2;MEF2A;LONP1;ATP23;CHCHD4;MSTO1;TIMM22;PPARGC1A;ATCAY;IMMP2L;MGME1;TIMM50;PRDX3;WDR81;HCFC1;TOMM40;ATAD3A;PID1;MIGA1;HK2;LRRK2;AGTPBP1;TWNK;YME1L1;PITRM1;RAB29;DNM1L;TOMM20;FIS1;MPV17;MFN1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.373292612884571,0.7944663596095028,0.7519083969465649,0.9520286440371505,1.0,5/19,18.32%,MAD2L2;RGCC;PTPRU;DENND6A;FLOT1
prerank,amyloid fibril formation (GO:1990000),0.3279685282267323,0.7939975645991245,0.7710583153347732,0.9523010049724026,1.0,12/51,17.02%,SNCA;TTR;TGFBI;TSPAN14;IAPP;ITM2B;SORL1;B2M;GGA2;USP9X;CD36;FURIN
prerank,neural crest cell migration (GO:0001755),0.3386591743156249,0.7939331054150954,0.7453347969264544,0.9520096654940828,1.0,4/36,11.24%,SHH;SEMA4D;SEMA4A;NRP1
prerank,peptidyl-asparagine modification (GO:0018196),0.34533506956760873,0.793919682690323,0.753757225433526,0.9516540900724687,1.0,10/31,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,sphingolipid catabolic process (GO:0030149),0.38774528159853816,0.7937115091893694,0.7256410256410256,0.9515770937475947,1.0,4/15,19.88%,SGPL1;ACER3;ASAH1;SMPD1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.30026020194376213,-0.7933372921991253,0.7228070175438597,0.9307637596700752,1.0,2/13,3.80%,SORBS1;IRS1
prerank,response to amino acid (GO:0043200),0.34606654310468343,0.7929289626622115,0.7522935779816514,0.9522924561052796,1.0,10/31,21.78%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,snRNA processing (GO:0016180),-0.2785515887815111,-0.7925378138068967,0.8015564202334631,0.9300724389592103,1.0,6/16,18.93%,INTS9;INTS14;INTS10;TUT1;INTS4;INTS2
prerank,C4-dicarboxylate transport (GO:0015740),0.3896028806747025,0.7916278488080215,0.7259552042160737,0.9536728793742407,1.0,3/14,13.02%,LRRC8D;SLC25A18;SLC25A30
prerank,positive regulation of lyase activity (GO:0051349),-0.29258421953353597,-0.7915464203868406,0.716,0.9297177308253662,1.0,6/14,21.09%,CACNA1C;NOS3;PARK7;NOS1;FXN;ISCU
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3585609812578019,0.7908502188147384,0.7539975399753998,0.9543595019635686,1.0,4/22,12.07%,P2RX4;MEF2A;SLC9A1;LMCD1
prerank,import into nucleus (GO:0051170),0.3169700308242687,0.7900139126610409,0.8130841121495327,0.9551529504511839,1.0,6/73,10.11%,MMP12;SYK;NUP62;SNRPD2;CSE1L;TPR
prerank,regulation of cartilage development (GO:0061035),0.3710612023654333,0.7894175557244584,0.7410714285714286,0.9555884350192267,1.0,4/18,13.61%,MDK;TRPS1;SOX9;SOX6
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.27833667138190765,-0.7893587734647645,0.76,0.9314226156777997,1.0,5/16,17.04%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1
prerank,mitotic nuclear division (GO:0140014),0.31389592308815223,0.7877799999323579,0.7951933124346917,0.9574443455995865,1.0,14/71,17.75%,NUP62;ESPL1;BCCIP;NCAPG2;CEP192;UBE2S;CHEK2;RAB11A;STAG2;INO80;KIF2A;CENPK;MIS12;RHOA
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37216899987166807,0.7876968597988191,0.7349081364829396,0.9571656732524922,1.0,6/17,20.68%,TNF;VCL;F11R;ADD1;ROCK2;ZDHHC21
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.29969305332764645,-0.7871288245950674,0.7576923076923077,0.9333353807633185,1.0,4/13,14.30%,ADHFE1;D2HGDH;GOT1;DLST
prerank,negative regulation of double-strand break repair (GO:2000780),0.3466317018060214,0.7871176771449365,0.7519818799546999,0.9575829942890597,1.0,8/30,19.13%,MAD2L2;TFIP11;HSF1;RNF169;ERCC6;OGG1;SHLD1;SHLD2
prerank,regulation of chromatin organization (GO:1902275),0.3862992971270488,0.7869459986756043,0.714095744680851,0.9574361217507306,1.0,3/14,10.19%,TLK1;METTL4;HPF1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.39673752302144344,0.786783996015993,0.7116477272727273,0.9572677010217544,1.0,4/10,22.85%,TFIP11;TERF2;DCLRE1C;TERF2IP
prerank,monoacylglycerol metabolic process (GO:0046462),0.38976563330420655,0.7866233030254187,0.7254098360655737,0.9571002142090047,1.0,3/13,18.87%,ABHD12;ABHD16A;DGAT2
prerank,relaxation of cardiac muscle (GO:0055119),0.3853649548065553,0.7864640694658132,0.7148760330578512,0.9569412765037969,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,cilium assembly (GO:0060271),0.30418055639396446,0.7864325060323419,0.932,0.9566101619791859,1.0,56/297,18.14%,TUBB;MKS1;RAB8B;PRKAR2B;HAUS2;EXOC6;ASAP1;TUBA4A;IFT52;RP2;CNTRL;CEP192;MAPRE1;CNGB1;CEP70;SPATA6;BBS9;PLK4;ATP6V0D1;CEP76;DISC1;HAUS1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;CEP152;EXOC3;HAUS8;JHY;CEP162;AHI1;WDR90;NINL;HSP90AA1;WDPCP;IFT27;NUDCD3;AKAP9;DYNC2LI1;CEP63;SNX10
prerank,bile acid biosynthetic process (GO:0006699),-0.2503024519221367,-0.7860146668970279,0.7610062893081762,0.9331944632294249,1.0,12/24,37.86%,OSBPL9;OSBPL1A;CYP7B1;AMACR;CYP39A1;SCP2;HSD17B4;SLC27A2;OSBPL2;CH25H;CYP46A1;HSD3B7
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.33433857677279866,0.7859153030068172,0.7768052516411379,0.9569498166289251,1.0,8/40,14.53%,BCL2L1;ABCD1;ATP5IF1;PPA2;BAK1;PRDX3;PID1;LRRK2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.27384703332862503,-0.7858934163051046,0.7644444444444445,0.929435355617265,1.0,4/16,15.72%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.27384703332862503,-0.7858934163051046,0.7644444444444445,0.929435355617265,1.0,4/16,15.72%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35960836040688904,0.7857371034467399,0.7601977750309024,0.9568111434762289,1.0,2/22,6.70%,MED17;TP53
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.31318104642258365,0.7856609044464612,0.831275720164609,0.9565385014287666,1.0,15/84,17.85%,ANAPC15;PTTG1;CDC23;UBE2S;PSMB10;RB1;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,regulation of microtubule depolymerization (GO:0031114),0.3539993278907021,0.7855886229114388,0.7468982630272953,0.9562628717882397,1.0,6/25,18.94%,FGF13;ATXN7;MAP1B;CAMSAP2;ARHGEF2;TAOK1
prerank,regulation of rRNA processing (GO:2000232),-0.2654470750103661,-0.7855834610380876,0.7155172413793104,0.9279448864364808,1.0,8/16,32.92%,RIOK2;SHQ1;UTP15;USP36;KAT2B;RIOK1;NUDT16;TRMT112
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38603801582096864,0.7850029218749139,0.7181208053691275,0.9566217275297118,1.0,3/13,13.02%,XPO1;NOP9;RRS1
prerank,cellular response to superoxide (GO:0071451),0.40557788717568194,0.7848427275001236,0.729957805907173,0.9564610122713662,1.0,3/10,12.89%,ATP7A;PRDX1;PRDX2
prerank,DNA metabolic process (GO:0006259),0.30402837785918907,0.7845891391286371,0.945,0.9564442806009417,1.0,49/270,17.04%,MCM5;EID3;ORC3;GTF2H1;UBE2V2;PTGES3;NABP1;EXO1;HMGB1;XRCC5;SAMHD1;BACH1;LIG3;POLH;LONP1;DOT1L;ENDOV;MMS19;UVRAG;RAD54L;MGMT;MCM6;MCM2;DBF4;USP7;ORC4;WDHD1;STN1;CDC34;RNASEH1;PDS5A;SMARCB1;ZNF445;DNA2;CDC6;INO80;SLX4;POLD3;ERCC5;NOC3L;REXO4;TOP2A;OGG1;SMARCAD1;RAD51B;FANCL;CBS;LRWD1;UBE2N
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.38457087901959675,0.7841665531964351,0.7008547008547008,0.9565981272137735,1.0,4/13,13.26%,SEC16A;SEC16B;SORL1;SAR1A
prerank,alpha-amino acid catabolic process (GO:1901606),0.34604577290795774,0.7830443055418261,0.7461263408820024,0.9577612702657455,1.0,5/29,16.86%,HAAO;KYNU;KMO;THNSL2;CBS
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2705989534157474,-0.7829622277794643,0.7475247524752475,0.9304218342671017,1.0,10/19,33.39%,DRG1;CEP97;HNRNPU;CHMP5;CHMP4B;CHMP2A;CHMP4C;CHMP1B;HSPA1A;EML3
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3663683516071014,0.782708172963741,0.7297668038408779,0.957842239588692,1.0,3/15,16.45%,ATF3;HSF1;CPEB2
prerank,negative regulation of cell junction assembly (GO:1901889),0.350346481886332,0.782474324092438,0.7538461538461538,0.9577819057163847,1.0,7/25,19.65%,TLR2;TNF;THBS1;SRC;PTEN;CORO1C;ROCK2
prerank,GTP metabolic process (GO:0046039),0.3794648616601849,0.7822807824715882,0.7319316688567674,0.957669771193653,1.0,6/15,23.34%,GTPBP1;GNAI3;LRRK2;IMPDH2;MFN1;EFL1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3192775971972912,0.7822735847794445,0.7871657754010695,0.9573041681006491,1.0,6/56,12.29%,TGFB1;TGFBR1;HFE;INHBA;SNX25;SDCBP
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3030791881439034,0.781537786696034,0.938938938938939,0.9578940962673648,1.0,67/264,21.69%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;SRPK3;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;DDX1;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;CLNS1A;PABPN1;SF3B3;SART1;SRSF10;SRSF3;STRAP;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3041962603996905,0.7809892863446595,0.9278557114228457,0.9582007280653293,1.0,62/241,21.69%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,protein K48-linked deubiquitination (GO:0071108),0.35084356861650123,0.7808689084623301,0.7200488997555012,0.9579926370321903,1.0,5/23,14.79%,TNFAIP3;ATXN3;OTUD3;MINDY1;USP8
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.28204919869862344,-0.7807656522448267,0.7210144927536232,0.9320869543709263,1.0,4/13,17.10%,PTGIS;NAMPT;PTGS2;NNMT
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.38729400610327797,0.780747621994719,0.7353760445682451,0.9577735622656174,1.0,5/13,23.93%,RAMP1;IL33;ABCA2;CHP1;IGF1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3996731648302689,0.7806445354331795,0.7234352256186317,0.9575279985324286,1.0,5/10,23.29%,SH2B3;NF2;PPP2CA;SOCS3;INPP5F
prerank,glial cell differentiation (GO:0010001),0.34346866059287295,0.7802844133141565,0.7612121212121212,0.9576127528847935,1.0,4/28,14.60%,SHH;SOX9;SOX2;SOX4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.30853040313477104,0.779594927017356,0.8247950819672131,0.9581546692432732,1.0,10/87,13.58%,CBL;GRB2;DSTYK;RAB14;CD44;FLRT1;POLR2L;CCL2;NR4A1;FIBP
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.37505905077046675,0.7794793195048582,0.7379134860050891,0.9579378588221866,1.0,1/15,2.22%,DAGLB
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.40004299462587395,0.7792487512575358,0.7160839160839161,0.9578777452964122,1.0,6/11,22.83%,ASF1B;ATRX;UBN1;RBBP4;IPO4;H3-3A
prerank,atrial septum morphogenesis (GO:0060413),-0.32275402593801916,-0.7788255947283202,0.7325227963525835,0.9334400606153465,1.0,4/10,26.25%,ACVR1;HEY2;BMPR2;TGFB2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3720050748715692,0.7787097604605987,0.7390146471371505,0.9582100397722325,1.0,2/15,6.68%,TGFBR1;TGFBR2
prerank,positive regulation of telomere maintenance (GO:0032206),0.34104351024619606,0.7784207311452895,0.7488532110091743,0.9582280710269767,1.0,6/31,14.37%,PKIB;PRKCQ;ATRX;TNKS2;SLX4;HNRNPD
prerank,positive regulation of cell growth (GO:0030307),0.3073803600505764,0.7777165032033488,0.832995951417004,0.9587865560267704,1.0,24/96,22.97%,SYT17;TGFBR1;SEMA4D;BRAT1;MACF1;SYT2;CSNK2A1;NEDD4L;TWF2;SDCBP;INO80;SMURF1;CXCL16;RASAL1;CDC42;PLAA;RPTOR;UNC13A;RIMS1;PABIR1;ITSN2;EXOSC2;H3-3A;GOLGA4
prerank,sensory perception of smell (GO:0007608),-0.31003739718825274,-0.777627284267387,0.7789115646258503,0.9334605954324167,1.0,5/11,23.15%,UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,protein-DNA complex assembly (GO:0065004),0.30489968036697124,0.7772865967007343,0.8594539939332659,0.9589606362344618,1.0,23/116,18.25%,MCM5;ORC3;GTF2H1;PSMB10;ATRX;CDK7;MCM6;MCM2;NAP1L1;PSMA2;SOX9;ORC4;PSME3;PSMB5;CDC6;PSMD8;ERCC5;SPTY2D1;PSMD7;PSMB9;RSF1;PSMD2;GTF2H5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.32587766727578665,0.7770605284565312,0.756202804746494,0.9588950884525562,1.0,13/42,24.67%,MAD2L2;MMS19;ACTR2;SETD2;ERCC6;PPP4C;SHLD1;PPP4R2;SHLD2;SPIDR;TERF2IP;PARP1;KLHL15
prerank,transport across blood-brain barrier (GO:0150104),0.309192587859621,0.7769491636847918,0.8323045267489712,0.958657571827225,1.0,15/83,17.03%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;FABP5;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4;CD36;SLC13A3
prerank,selective autophagy (GO:0061912),0.31894183221476835,0.7766541877760945,0.799140708915145,0.9586607354884862,1.0,23/56,27.25%,MAP1LC3B;UBE2V1;RAB7A;HDAC6;BECN1;DYNC1H1;WDR81;TEX264;RETREG1;ATG2B;UBE2N;WDFY3;ATG14;PRKN;RB1CC1;UBA5;IFT88;DYNC1LI1;NBR1;AMBRA1;DYNLL1;ATG2A;UFM1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3304789942023226,0.776077267360734,0.7570303712035995,0.959007669778761,1.0,11/35,25.52%,ALOX12;HPGD;GGTA1;FASN;ACACA;PPT2;FAR2;HMGCL;SCD;ACSS3;HSD17B8
prerank,aminoglycan metabolic process (GO:0006022),0.3999904519557196,0.7758240811757471,0.7319884726224783,0.9589738770726147,1.0,3/10,20.94%,XYLT1;B4GALT7;B3GAT2
prerank,mitochondrion morphogenesis (GO:0070584),-0.30844468815412274,-0.7756699596038589,0.764505119453925,0.9347643894301729,1.0,6/11,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.37979430754403004,0.7748066164367257,0.728021978021978,0.9599326411049465,1.0,2/14,7.90%,TRAF2;MALT1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.37406959337433465,0.7739809170518971,0.7427055702917772,0.9606529130963745,1.0,2/14,8.96%,PTPN1;BAK1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3029740273579859,0.7738416565491717,0.8676767676767677,0.9604682570016658,1.0,41/132,25.14%,DHX9;PTGES3;SF3B1;SCAF11;XRCC5;GCFC2;SRPK3;SNRPD2;ERAL1;RPL6;EIF4H;DDX39B;LUC7L3;MDN1;RPS14;RRS1;DDX1;RPL11;HSP90AA1;TARBP2;CRNKL1;RPS27;SNRNP200;SRSF6;CLNS1A;SART1;RRP7A;SRSF10;STRAP;DICER1;EIF2S2;SNRPB;RPS15;GEMIN8;RPS5;DDX20;NUDT21;RPL10;NCBP1;XAB2;HSP90AB1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.2919668197854488,-0.7738091297835424,0.7517006802721088,0.9358409583431861,1.0,2/12,4.78%,ARHGAP35;EPHB2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.376570934988011,0.7723847029204524,0.7377963737796374,0.9619593677778177,1.0,3/13,12.13%,MMS19;CIAO2A;CIAO1
prerank,tRNA wobble uridine modification (GO:0002098),0.37406446539948646,0.7722378871499256,0.7335127860026918,0.9617676328337782,1.0,3/14,11.46%,ELP1;TRMU;CTU1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.403416184904943,0.7712747561069043,0.7312775330396476,0.96266619818954,1.0,4/10,26.08%,SNCA;NOC2L;CTBP1;KLF15
prerank,synaptic vesicle cycle (GO:0099504),0.3347205637094355,0.771273803225474,0.7570422535211268,0.9622962700371452,1.0,4/30,9.11%,SNCA;PIP5K1C;PLD2;SYT10
prerank,neural crest cell development (GO:0014032),0.32932883469187396,0.7710788351928523,0.7740174672489083,0.9621776424174598,1.0,9/44,19.30%,SHH;SEMA4D;PDCD6;SEMA4A;NRG1;SEMA4B;CORO1C;TAPT1;GDNF
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23374311910654377,-0.770804987801896,0.8452380952380952,0.9387387025196854,1.0,8/23,25.87%,ATAD1;SLC24A2;SLC30A1;PRRT1;SHANK2;DRD2;ARF1;STXBP1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3953669698105267,0.7707649923776833,0.7474747474747475,0.9621983739767099,1.0,3/11,11.18%,TGFBR2;LRP5;SOX9
prerank,cellular response to amino acid stimulus (GO:0071230),0.33067484704471894,0.770196743413287,0.7799315849486887,0.9625495753095668,1.0,11/33,21.78%,MTOR;CPEB3;GLRA2;FYN;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3668647744308144,0.7696562722250048,0.7463863337713534,0.9628602955752533,1.0,6/16,25.05%,RB1;PDS5A;NAA50;MAU2;SMC1A;PDS5B
prerank,protein O-linked mannosylation (GO:0035269),-0.25403190546130205,-0.7693346145720166,0.7761194029850746,0.9390111627270018,1.0,9/18,23.47%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2
prerank,hemidesmosome assembly (GO:0031581),0.38685286808790365,0.7689949899524536,0.7258522727272727,0.9633370746569975,1.0,3/11,15.77%,ITGA6;LAMA3;DST
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30588687360444233,0.7689065223646983,0.8343621399176955,0.9630898571519658,1.0,9/86,12.29%,TGFB1;TGFBR1;ZEB2;RNF111;HFE;FLCN;INHBA;THBS1;SDCBP
prerank,phospholipid dephosphorylation (GO:0046839),-0.2121649451063885,-0.7682966310460665,0.875,0.9386727905635627,1.0,3/37,1.33%,MTM1;SACM1L;MTMR7
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.33436860973478927,0.7682146185915457,0.7578947368421053,0.9636075269914877,1.0,5/29,11.41%,TLE3;CTNNB1;LEO1;RBBP5;PYGO2
prerank,inorganic anion transport (GO:0015698),0.31658858510172233,0.7680294194471435,0.8217391304347826,0.9634981613638873,1.0,6/53,15.59%,SLC11A1;PACC1;CLIC1;XPR1;SLC25A30;CLCN4
prerank,regulation of DNA repair (GO:0006282),0.31942657361339366,0.7679866753181928,0.775330396475771,0.9631693261043237,1.0,11/44,18.57%,DHX9;UBE2V2;UBE2V1;POLH;BABAM2;KAT7;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,negative regulation of cell growth (GO:0030308),0.3037113145858499,0.7678400224386682,0.8814070351758794,0.9629756501922527,1.0,14/121,12.34%,TGFB1;PTPRJ;FGF13;NME6;DIP2B;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.33982658424148915,0.767548829453194,0.7708578143360753,0.9625977835684956,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.33982658424148915,0.767548829453194,0.7708578143360753,0.9625977835684956,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,histone H3-K4 trimethylation (GO:0080182),0.3799058003845996,0.7673444489106238,0.7201704545454546,0.9624909793229525,1.0,5/11,23.31%,TET3;SETD1B;WDR82;TET2;CTR9
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3507688864479096,0.7670788817940265,0.7477707006369426,0.9624753659349125,1.0,7/21,19.95%,MLXIPL;NCK2;DDIT4;PTEN;PAQR3;CNKSR3;INPP5K
prerank,replicative senescence (GO:0090399),0.38762581287813325,0.7669711200238218,0.7551299589603283,0.9622336496792044,1.0,2/12,7.97%,TP53;CHEK2
prerank,amide biosynthetic process (GO:0043604),0.31757898455297146,0.7662628282367026,0.8063112078346029,0.96278674904609,1.0,10/47,20.78%,CERS6;CLN8;AGK;DEGS1;ASAH1;FURIN;SGMS1;SPTSSA;SMPD1;SPTSSB
prerank,regulation of axon extension (GO:0030516),0.32570967824543196,0.7660208993916225,0.796875,0.9627157316899105,1.0,10/37,22.97%,APOE;DIP2B;MACF1;DNM2;TWF2;RTN4;GSK3B;MT3;NRCAM;GOLGA4
prerank,protein heterotetramerization (GO:0051290),0.3760283677326336,0.7658595300538906,0.7724719101123596,0.9625585045980293,1.0,2/13,6.09%,PKD2;FARSB
prerank,protein modification process (GO:0036211),0.3096880037411516,0.765392034233444,0.8427672955974843,0.9628000207061973,1.0,23/76,24.58%,ST8SIA4;UBE2D3;UBE2S;LOX;ST3GAL1;MAN2B1;PIGH;MCRS1;MSRA;YES1;CDC34;B4GALT7;ATG3;ERO1A;PPP4R2;CSNK1G3;UBL5;ADPRH;UBA7;UBE2I;PARP1;BAP1;ABL2
prerank,cellular response to hydroxyurea (GO:0072711),0.3979397000096127,0.7643763074760636,0.7558823529411764,0.9637258433977263,1.0,2/10,9.48%,DDI2;ATRX
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.39107638622970786,0.7643691920286652,0.7510980966325037,0.9633667056247336,1.0,1/10,3.78%,DNMT3A
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3943745291437868,0.7640358304040445,0.7361516034985423,0.9634330223369391,1.0,2/10,10.14%,SETD6;SETD2
prerank,positive regulation of intracellular transport (GO:0032388),0.3246822574874802,0.7622591869666093,0.7856353591160221,0.9653320293459299,1.0,7/38,12.78%,RIPOR1;KIF20B;PGAP1;TPR;DYNC1H1;PCM1;SORL1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3782702032286157,0.7621739520254796,0.7466124661246613,0.9650669714384378,1.0,5/13,23.34%,GTPBP1;GNAI3;LRRK2;MFN1;EFL1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.40269281440343063,0.7619985327201974,0.7588757396449705,0.9649057472626547,1.0,2/10,10.57%,DUSP10;DUSP19
prerank,synapse organization (GO:0050808),0.29753949828411524,0.7613426752480417,0.8757575757575757,0.9653411783673356,1.0,17/125,14.72%,CX3CR1;PCDHB6;ARHGAP39;C1QC;SLITRK1;SNCA;AGRN;C1QA;CACNB4;RAB39B;C1QB;CACNB2;CYFIP1;CACNB1;PPFIA1;LRRK2;KIRREL3
prerank,DNA repair (GO:0006281),0.2967749481775758,0.7611068540725339,0.952,0.9652678943125947,1.0,51/284,17.21%,EID3;FAM111A;NEIL2;GTF2H1;MAD2L2;UBE2V2;NABP1;UBE2V1;EXO1;XRCC5;BRIP1;BACH1;LIG3;ATXN3;TP53;POLH;FAAP100;CHEK2;DOT1L;ENDOV;TRIP13;MMS19;UVRAG;RAD54L;BABAM2;MGMT;SETD2;HPF1;MGME1;APTX;WDHD1;PDS5A;TEX264;PMS1;DNA2;INO80;HUWE1;SLX4;POLD3;DDX1;ALKBH5;ERCC5;REXO4;ERCC6;OGG1;RAD51B;BABAM1;FANCL;MDC1;UBE2N;FANCE
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.34019634400067567,0.7610003536123318,0.7763313609467456,0.9650384204985407,1.0,7/25,16.53%,ATXN3;LONP1;DERL1;HDAC6;TOR1A;STUB1;YME1L1
prerank,hexose transmembrane transport (GO:0008645),0.3527061328809325,0.7606223758732417,0.7632911392405063,0.9651339887245354,1.0,3/21,17.26%,SLC2A3;SLC2A12;PPARD
prerank,replication fork processing (GO:0031297),0.32543481353449005,0.7605296021449921,0.7929125138427464,0.9648766380629777,1.0,5/38,13.34%,FAM111A;SAMHD1;ATRX;BOD1L1;DNA2
prerank,mitochondrial transport (GO:0006839),0.3105080165676524,0.7603938893837767,0.8069039913700108,0.9646752774635767,1.0,6/53,8.96%,TSPO;SLC25A16;AIP;BCL2L1;TIMM22;BAK1
prerank,negative regulation of telomere maintenance (GO:0032205),0.3688265049230936,0.7600917355234069,0.7506631299734748,0.9646944310441079,1.0,7/15,23.59%,TNKS2;SLX4;ERCC1;TERF2;ERCC4;TERF2IP;PARP1
prerank,protein ADP-ribosylation (GO:0006471),0.3289265463676563,0.7598290140793953,0.7827102803738317,0.9646418338362894,1.0,6/28,13.24%,ART4;PARP8;HPF1;PARP16;TNKS2;TIPARP
prerank,glycolipid biosynthetic process (GO:0009247),0.3201713974104013,0.7592306827105453,0.7800224466891134,0.9650284937266992,1.0,13/38,23.19%,PIGM;PIGL;PIGV;PIGH;ST8SIA1;LARGE1;PGAP2;PIGU;PIGC;B4GALT6;PIGN;DPM2;PIGP
prerank,protein monoubiquitination (GO:0006513),0.3267023036166887,0.7590354818932479,0.7833523375142531,0.9648904927370854,1.0,12/36,23.31%,TRIM25;UBE2D3;MGRN1;LEO1;RNF40;HUWE1;FANCL;CUL3;PRKN;UBE2R2;UBE2E1;CTR9
prerank,endothelial cell development (GO:0001885),-0.2249032697490006,-0.7581410007952449,0.8685714285714285,0.9524781473454299,1.0,8/25,17.19%,RAPGEF3;MYADM;RDX;MET;RAPGEF2;EZR;PDE2A;ROBO4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3526950713659451,0.7564202194431409,0.7710997442455243,0.9677013301114752,1.0,3/19,12.48%,PYCARD;TP53;DDIT4
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2986804903329322,0.7563718184769891,0.848730964467005,0.9673969749946291,1.0,20/94,17.85%,IL1A;IRAK2;UBE2V1;PSMB10;ST18;PSMA2;RPS6KA4;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;UBE2N;RPS6KA5;PSMD2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.31619478226889197,-0.7562184168883671,0.7639344262295082,0.953265394147136,1.0,7/10,45.23%,FMR1;CALM3;DRD2;CBARP;GPR35;CRHR1;DRD3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3443147411647337,0.7561708438575233,0.7596034696406444,0.9672702944536362,1.0,10/21,27.71%,MAP2K2;SOX9;ZFP36L1;MT3;IGF1;KDR;PTGER4;MAPK1;MAPK3;CTSH
prerank,organelle transport along microtubule (GO:0072384),0.3282542240820352,0.7559371670962142,0.8043728423475259,0.9671857202220546,1.0,5/31,11.77%,UXT;CLN3;ARHGAP21;BORCS5;BICD2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.24544380407771413,-0.7558015827041927,0.8379629629629629,0.9519013200333153,1.0,5/20,12.28%,AFG3L2;MICU1;SLC8A3;SPG7;MCUR1
prerank,cochlea morphogenesis (GO:0090103),-0.3071467854761393,-0.7557570561500897,0.7884615384615384,0.949994683346867,1.0,3/10,15.28%,TBX18;TBX1;PAX2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3627354921270276,0.7557453293089543,0.7789613848202397,0.9670588272382229,1.0,6/16,21.48%,ST8SIA4;ST6GALNAC4;ST8SIA1;LARGE1;B4GALNT1;B4GALT6
prerank,photoperiodism (GO:0009648),-0.21958814764956075,-0.755708770657745,0.8811188811188811,0.9481249891560131,1.0,10/28,23.11%,PPP1CB;CLOCK;PML;SIK1;RBM4B;USP2;PER2;PPP1CA;RBM4;CRY1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.2803911158359932,-0.7556869279539933,0.7773851590106007,0.9462031349334498,1.0,3/14,6.35%,WNT5A;ULK4;MYADM
prerank,neural crest cell differentiation (GO:0014033),0.3631760143190467,0.755456718875433,0.750924784217016,0.9670544669785381,1.0,4/18,19.08%,MEF2C;PDCD6;NRG1;TAPT1
prerank,determination of bilateral symmetry (GO:0009855),0.3339683351243242,0.7554105894944728,0.7684085510688836,0.9667416096127145,1.0,2/25,5.50%,PKD2;ODAD2
prerank,sulfur amino acid metabolic process (GO:0000096),0.3343469638536188,0.7552425192436375,0.7574626865671642,0.9665668687689214,1.0,5/24,16.86%,TXN2;MSRA;MMUT;MTR;CBS
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.24572963153547406,-0.7551852556159525,0.7942857142857143,0.9449679385915936,1.0,10/21,28.51%,PAN2;CNOT3;SAMD4B;SAMD4A;TNKS1BP1;PAN3;PARN;CNOT6L;CNOT9;ZFP36
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34058516161016394,0.7544875156445551,0.758364312267658,0.9671004192728682,1.0,11/23,29.28%,HMGB1;REXO4;KPNA1;DICER1;DNASE2;DNASE1L1;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,protein destabilization (GO:0031648),0.32916132259576997,0.7544186426377595,0.7878787878787878,0.966822052761743,1.0,16/32,29.05%,SNCA;DERL1;FBXL3;CAPN3;IRGM;FBXW11;CUL3;PRKN;HTT;GGA3;CTSH;PRNP;CREBBP;SENP2;EP300;CDC73
prerank,C-terminal protein amino acid modification (GO:0018410),-0.29562727363212815,-0.7544085087975119,0.7555555555555555,0.9441948064200084,1.0,8/11,28.45%,AGBL4;FOLH1;GPLD1;TTL;LCMT1;AGBL1;ATG5;ICMT
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.37164309541794577,0.7539835378861292,0.7506775067750677,0.9669621081704718,1.0,7/13,28.34%,TNRC6A;CPEB3;AGO2;CNOT7;CNOT1;BTG2;TNRC6C
prerank,postsynaptic membrane organization (GO:0001941),0.36066711318030487,0.7538578139540367,0.77431906614786,0.966735194958379,1.0,2/17,4.47%,APOE;CEL
prerank,dendrite self-avoidance (GO:0070593),0.36252948981924604,0.7536819491856368,0.7721179624664879,0.9665751305565611,1.0,6/16,24.11%,EMB;NPTN;VSTM2L;PALLD;CNTN4;BSG
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.28093815864638266,-0.7528781739770325,0.7859778597785978,0.9445244453109934,1.0,5/13,18.42%,SP100;RAB23;NUP153;PARK7;CABP1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.3749467281443933,0.75250192822178,0.7657784011220197,0.9676207324918573,1.0,1/12,1.96%,SLAMF8
prerank,DNA duplex unwinding (GO:0032508),0.3120485207009731,0.7521589281186917,0.8289054197662061,0.9676707928707264,1.0,8/50,15.51%,GTF2H1;DHX9;ANXA1;MCM6;MCM2;MCM9;DDX1;TWNK
prerank,cardiac muscle cell contraction (GO:0086003),0.3563755389909381,0.7518860339291932,0.7714646464646465,0.9676356275463351,1.0,2/19,3.69%,SCN4B;PKP2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3703952356541116,0.7516926235233314,0.765034965034965,0.9675106882925306,1.0,5/13,21.96%,PKD2;YWHAB;KEAP1;NFKBIE;FLNA
prerank,actomyosin structure organization (GO:0031032),0.3004716771961978,0.7515944890184996,0.8433981576253838,0.9672604797617009,1.0,15/75,15.27%,ITGB5;TTN;MYLK3;MYH9;FLII;TNNT3;EPB41;F11R;EPB41L2;ZYX;MYH10;CSRP1;PDLIM1;CAPN3;SRC
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.23289358789359096,-0.75076065662723,0.8538011695906432,0.9456730639498164,1.0,10/24,30.49%,DACH1;ACVRL1;MSH2;MSH6;H1-0;CDKN1A;BMPR2;NIBAN2;MSH3;RTEL1
prerank,neuromuscular synaptic transmission (GO:0007274),0.3535945268657802,0.7507498389420557,0.7608142493638677,0.967976246902175,1.0,4/18,18.37%,RIMBP2;DTNA;STAC3;KIF1B
prerank,regulation of cilium movement (GO:0003352),0.3888430959285341,0.7500794719203834,0.7547169811320755,0.9684154178164592,1.0,1/10,5.50%,ODAD2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2995863597699423,0.749398527242547,0.8699690402476781,0.9688554167417053,1.0,14/88,16.29%,EDNRB;CLN8;APOE;CNOT8;CLN3;LARP1;EPRS1;CPEB3;NELL1;HDAC6;PCIF1;NFKB1;IGF2BP3;PUS7
prerank,mRNA export from nucleus (GO:0006406),0.29745719719743136,0.7492882653338447,0.8853955375253549,0.968620532132934,1.0,28/102,20.95%,PCID2;NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;PABPN1;HHEX;SLBP;SRSF3;NUP54
prerank,nucleotide metabolic process (GO:0009117),-0.24303166049576297,-0.7490801356730012,0.8624338624338624,0.9460791376803601,1.0,11/23,28.83%,ME1;NUDT5;RNASEH2B;ENPP3;NMNAT1;PARK7;GUK1;AK4;CMPK2;NME2;CMPK1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3753780783859837,0.7488872815691775,0.7650273224043715,0.9687233594717213,1.0,2/13,9.02%,PTPN1;PDCD6
prerank,mitotic spindle organization (GO:0007052),0.29199593887671266,0.748629624979719,0.9236947791164659,0.9686655125487718,1.0,30/153,19.42%,ERCC6L;CENPO;NEK6;BCCIP;XPO1;CEP192;MAPRE1;SEH1L;PLK2;CHEK2;KIF23;RAB11A;DYNC1H1;PMF1;CENPI;STAG2;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;RHOA;DCTN6;TAOK1;SEC13
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3763915635010319,0.7478950516739865,0.7838235294117647,0.9684663970108996,1.0,1/11,3.26%,SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3763915635010319,0.7478950516739865,0.7838235294117647,0.9684663970108996,1.0,1/11,3.26%,SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.3763915635010319,0.7478950516739865,0.7838235294117647,0.9684663970108996,1.0,1/11,3.26%,SLC25A16
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.33163771267408165,0.7476371346901136,0.7939759036144578,0.9684133595097281,1.0,6/28,18.71%,GAS2L1;MAPRE1;MAP1B;CAMSAP2;MAPRE2;GBA2
prerank,cilium movement (GO:0003341),0.3108818731367801,0.7476306706532507,0.8064171122994652,0.9680571121946919,1.0,5/48,13.03%,DNAI4;ODAD2;TTC29;ODAD1;CCDC63
prerank,cellular response to hypoxia (GO:0071456),0.29212152518231094,0.7476053782201997,0.9071644803229062,0.9677253990966783,1.0,25/126,18.91%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;BACH1;TP53;PSMB10;P4HB;EPO;PSMA2;PSME3;TBL2;STUB1;PSMB5;PSMD8;PSMD7;PSMB9;HIF1A;CPEB2;SUV39H1;VHL;PSMD2;TIGAR;ELOB
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3395049141665337,0.7471926561849179,0.7959442332065906,0.9678617516496683,1.0,6/23,19.44%,HERPUD1;SEL1L;DERL1;SEC16A;SEC13;OS9
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28666876210051645,-0.7468353361337394,0.7526501766784452,0.9472754682186172,1.0,6/12,22.20%,WAC;SDE2;PRKDC;FBXO31;CDK2;PLK5
prerank,negative regulation of dephosphorylation (GO:0035305),0.34450080247253706,0.7467235647794377,0.7707006369426752,0.9680692062316021,1.0,7/18,26.12%,YWHAB;ENSA;PTPA;INPP5K;CHP1;PPP1R16B;MFHAS1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3786801797052902,0.7465940672274063,0.7631205673758865,0.9678586722459568,1.0,2/11,15.64%,P2RX4;GSK3A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.30888272262199723,0.7460564304433588,0.832258064516129,0.9681417384155274,1.0,4/52,6.93%,DGLUCY;MTHFS;HAAO;OGDH
prerank,negative regulation of protein transport (GO:0051224),0.332374876066851,0.7455900181484652,0.7822485207100591,0.9682911859049697,1.0,2/25,4.68%,APOE;RHBDF2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.30253236593422017,0.7452954684558454,0.8312101910828026,0.9682964044057844,1.0,17/68,23.34%,DBI;SULT4A1;GTPBP1;HINT1;BPNT1;ACSF2;TPST1;GNAI3;LRRK2;ACOT9;ACOT2;MFN1;GMPR2;ACOT8;CROT;TPST2;EFL1
prerank,organelle disassembly (GO:1903008),-0.2076396574161227,-0.7451165666221217,0.8846153846153846,0.9477249205966076,1.0,11/33,25.32%,KIF5B;GFM2;ULK2;EIF2D;GOLGA2;KIF9;DDRGK1;PLK5;KLC1;UFL1;MRRF
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3016548142282089,0.7449409338402377,0.8436170212765958,0.9683500240843418,1.0,13/56,17.75%,SNX9;ESPL1;SNX33;KIF23;SON;BIN3;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18;RHOA
prerank,cell part morphogenesis (GO:0032990),-0.28380393831055684,-0.7446498078965995,0.7747035573122529,0.9464916557528216,1.0,6/13,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,regulation of cell growth (GO:0001558),0.29114492420007443,0.7442521249274009,0.94994994994995,0.9688148925682937,1.0,31/204,16.17%,TGFB1;TGFBR1;PTPRJ;MAD2L2;MTOR;NME6;BRAT1;RASGRP2;CDA;CDK11B;TP53;PRKCQ;KIF14;CSNK2A1;FLCN;RB1;SMAD3;SIPA1;BCAR1;INHBA;RBBP7;SDCBP;PPP2CA;ITCH;RAB33B;INO80;ATAD3A;ARHGEF11;SGK3;CXCL16;RTN4
prerank,response to gamma radiation (GO:0010332),0.3332005188305476,0.744072125026913,0.7679425837320574,0.9686751863680344,1.0,4/24,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,negative regulation of TOR signaling (GO:0032007),0.31489576943632813,0.7439217882572061,0.8048220436280138,0.9684979787678982,1.0,7/36,15.64%,FNIP1;FLCN;PDCD6;DDIT4;TMEM127;RNF152;GSK3A
prerank,regulation of insulin secretion (GO:0050796),0.29133047596708384,0.7434940122398125,0.878323108384458,0.9686680545497761,1.0,16/101,16.82%,KCNJ11;NR1H4;TNF;CACNA1A;TFAP2B;ITPR2;ENSA;LRP5;SLC8B1;KCNA5;RAP1A;SOX4;STXBP4;CACNA1D;GCK;PPP3CB
prerank,chromatin organization (GO:0006325),0.2910962893047095,0.7426354330377494,0.9133937562940584,0.9693176967503895,1.0,34/132,19.97%,NPM3;BPTF;SPI1;HDAC5;SNAI1;RB1;ARID1A;ATRX;HDAC4;SETD2;CHD1;BAZ1A;HCFC2;SOX9;MTF2;BRDT;SMARCD3;SMARCB1;FAM50A;HCFC1;INO80;HDAC11;SOX2;PIH1D1;SMARCAD1;SUV39H1;LRWD1;RSF1;KDM4C;PHF1;TOP1;KDM5A;RBBP4;KDM5B
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.38684747711468614,0.7423485320562969,0.7726027397260274,0.9692960693789967,1.0,4/11,16.52%,PIK3CB;CREB3L1;THBS1;EPN1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3366875646021312,0.7420799351409718,0.770414201183432,0.9692549169607731,1.0,10/23,27.37%,NABP1;PLK2;PABIR1;PRCC;INTS3;ZWINT;BUB1B;CDK5RAP3;ZWILCH;WEE1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3194842166129324,0.7418035839017976,0.7944890929965557,0.9692026877984775,1.0,5/35,11.18%,AQP1;APOE;NUDT4;CAP1;SOX9
prerank,positive regulation of chromosome organization (GO:2001252),-0.26452319582534767,-0.7417737078340874,0.8362831858407079,0.9485934464199937,1.0,4/15,17.71%,PML;MRE11;GNL3;DHX36
prerank,cardiac ventricle development (GO:0003231),-0.2435288986951302,-0.7414729794708965,0.8285714285714286,0.9471394765108162,1.0,10/20,33.76%,SALL1;HES1;STRA6;PDE2A;HEY2;MATR3;DAND5;TMEM65;HEY1;DLL4
prerank,peptidyl-lysine acetylation (GO:0018394),-0.30098082019467526,-0.741135857999536,0.8082595870206489,0.9456576587815028,1.0,1/10,1.29%,ESCO1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.26637827833023603,-0.740869039058187,0.8145161290322581,0.9441375406308266,1.0,4/15,14.17%,REST;HNRNPU;UBE2L3;BCL2L11
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.34791938731518435,0.7401223804554515,0.7733499377334994,0.970847399135248,1.0,2/19,10.02%,APOE;RAPSN
prerank,positive regulation of binding (GO:0051099),0.29235782577847963,0.7399795377466275,0.8675564681724846,0.9706560649992003,1.0,29/84,25.12%,DHX9;APOE;SKI;HMGB1;TAF1;HFE;SPPL3;DERL1;EPB41;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN;AMFR;IGF1;DDX11;PARP9;NCBP1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.37443373192494456,0.7395958018595025,0.776551724137931,0.9707418681213126,1.0,1/12,2.82%,DHX9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3255049924131325,0.7395416116390785,0.7931844888366627,0.9704367473878416,1.0,7/27,23.58%,CTPS1;TXNRD1;RRM2B;AK8;GSR;AK5;AK1
prerank,regulation of autophagosome maturation (GO:1901096),0.3686233598654227,0.7388364627632311,0.785234899328859,0.9708872855791887,1.0,3/13,16.29%,CLN3;UVRAG;IRGM
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.29291267333782156,-0.7385682422520655,0.8066914498141264,0.9452556189851993,1.0,2/11,5.70%,GSN;CAAP1
prerank,zinc ion homeostasis (GO:0055069),0.32940086954487907,0.7380013687222012,0.8091872791519434,0.9715018165874847,1.0,13/28,23.21%,ATP13A2;SLC39A6;PRKN;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;SLC30A10
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29619432941849977,0.7379311244687117,0.8690228690228691,0.9712204389393823,1.0,19/76,20.84%,LAPTM5;TANK;MALT1;DERL1;HDAC4;AMER1;STUB1;HUWE1;UBA2;WFS1;LRRK2;PIAS1;GSK3A;BIRC2;ANGPT1;DCUN1D5;RWDD3;CUL3;BIRC3
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3010731742427247,-0.7373324198827073,0.8050541516245487,0.9450522792471888,1.0,9/11,33.00%,TRIM37;CDK5RAP2;RBM14;CENATAC;NPM1;KAT2B;KAT2A;CCNF;BRCA1
prerank,sprouting angiogenesis (GO:0002040),0.2998357165812707,0.7362331080628388,0.819848975188781,0.9728421571090201,1.0,11/51,18.59%,PTK2B;OTULIN;VEGFB;NRP1;THBS1;CCBE1;NR4A1;NAXE;GREM1;ANGPT1;VEGFD
prerank,mitochondrial protein processing (GO:0034982),0.3852274385186429,0.7361729704526437,0.7966339410939691,0.9725585809753837,1.0,5/11,19.72%,ATP23;IMMP2L;PMPCB;YME1L1;PMPCA
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2850700943545964,0.735592356244817,0.9306532663316583,0.972873550866717,1.0,33/161,18.78%,DRAXIN;TMEM131L;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,peptide metabolic process (GO:0006518),0.2911552294734059,0.7354904516451419,0.8611691022964509,0.9726218345292792,1.0,16/75,18.38%,GSTT4;HPGDS;SPCS2;SEC11C;SPPL3;SPCS1;NLN;NAALADL1;DNPEP;PARL;CTNS;ERAP1;IDE;FURIN;GSTM2;GSR
prerank,chromatin assembly or disassembly (GO:0006333),0.37137868668508134,0.7354007284949833,0.7596017069701281,0.9723664925513903,1.0,3/11,19.59%,TP53;NOC2L;RBBP4
prerank,positive regulation of reproductive process (GO:2000243),0.31370474916385743,0.7352329822644582,0.7941860465116279,0.9721910041109422,1.0,5/31,17.89%,LHFPL2;INHBA;TACR1;PGAM4;AGO2
prerank,negative regulation by host of viral process (GO:0044793),0.3805543123608152,0.7350808140921903,0.783744557329463,0.9720160272654247,1.0,1/10,3.44%,CCL8
prerank,brain development (GO:0007420),0.2867097659755482,0.734915240527892,0.9164149043303121,0.9718400379181643,1.0,30/136,20.41%,SLC6A4;CX3CR1;EEF1AKMT4-ECE2;BPTF;CXCR4;PLXNB2;TGFBR2;NKX2-1;PAFAH1B2;SCYL2;QARS1;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SOX6;ZFHX3;MEIS1;JHY;POU6F1;NF1;PTEN;TBC1D23;PHGDH;RELN;CNTN4;CDK5R1;UTP3;FBXW11
prerank,response to growth factor (GO:0070848),0.3118801791317521,0.7342726986532176,0.8140311804008908,0.9722196789112594,1.0,7/41,14.24%,TGFBR1;CTNNB1;TGFBR2;STAT5B;HDAC6;TWF2;SOX2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.31618605108003917,0.7339865887544703,0.8148584905660378,0.9721819019026285,1.0,3/29,4.14%,MTOR;MLXIPL;APOE
prerank,cellular response to hexose stimulus (GO:0071331),0.331618364476904,0.7338882124046779,0.7965686274509803,0.9719257706317694,1.0,5/23,14.60%,ERN1;TRA2B;GAS6;ADCY8;SOX4
prerank,regulation of cell death (GO:0010941),0.28955108585289147,0.7338158865943487,0.8892276422764228,0.9716451090577259,1.0,22/94,22.07%,CALCR;SNCA;CTSZ;ACER3;IMPACT;BECN1;PARP16;TNFRSF1B;RRAS2;LRRK2;SOX4;LRP1;CD36;FAF1;NPAS2;SRSF6;RAB29;PRKN;CRYAB;FGF2;CHP1;MT3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.38294282541442926,0.7333147117532801,0.7815750371471025,0.9718558413890833,1.0,3/10,15.10%,HDAC5;SMARCB1;PIH1D1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3283378676808285,0.7332749737451603,0.7988095238095239,0.9715396908966313,1.0,6/28,15.93%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1
prerank,positive regulation of transmembrane transport (GO:0034764),0.3664467186745218,0.7331708030798284,0.7817679558011049,0.9713039322634959,1.0,2/13,13.29%,P2RX7;BRAF
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2952938616632023,0.7327466785860102,0.8608515057113187,0.9714040489495666,1.0,9/68,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CSTF1;LSM11;CDK7;POLR1B;POLR2L
prerank,negative regulation of protein depolymerization (GO:1901880),0.3297974520030247,0.7323211735555996,0.816953316953317,0.9715511631756326,1.0,7/24,22.70%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1;PIK3CA;CLASP1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.36521058607942675,0.7322230082221111,0.7907608695652174,0.9713042782345471,1.0,5/14,21.54%,HDAC5;THBS1;RHOA;MAP2K5;MMRN2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.35632695003367443,0.7320965388553585,0.8015978695073236,0.9710871638907591,1.0,2/17,3.69%,SLC8A1;PKP2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.34358433909069064,0.732073048704825,0.8029100529100529,0.9707534200092353,1.0,7/18,21.09%,VPS18;RAP1B;DTNBP1;LRRK2;RAP1A;GSK3B;RIMS1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.32527795620095296,0.7320593838311491,0.8090277777777778,0.9704066564487784,1.0,8/28,21.54%,MAD2L2;TFIP11;HSF1;ACTR2;ERCC6;SHLD1;SHLD2;PARP3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.33784482910722774,0.7317382320775285,0.7845373891001267,0.9704170814871834,1.0,5/19,19.92%,SS18L1;LRP8;CUX1;CUX2;RELN
prerank,regulation of cell cycle phase transition (GO:1901987),0.29208849672765497,0.7315028194492429,0.8755102040816326,0.9703187922267551,1.0,16/91,17.85%,ANAPC15;CDC23;TAF1;UBE2S;TP53;PSMB10;DBF4;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35624717205466166,0.7312591096985879,0.7873485868102288,0.9702444292387676,1.0,3/14,14.15%,TSEN15;RTRAF;DDX1
prerank,nucleosome assembly (GO:0006334),0.31731925521498494,0.731225255297219,0.8274647887323944,0.9699301594069096,1.0,11/31,22.83%,ASF1B;ATRX;NAP1L1;SOX9;SPTY2D1;RSF1;UBN1;RBBP4;IPO4;SMARCA5;H3-3A
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3235418774763665,0.731220617649343,0.8258293838862559,0.969576016789182,1.0,5/27,13.46%,CCM2;MAP3K5;IKBKG;KAT7;NFKB1
prerank,reticulophagy (GO:0061709),0.36505328984739216,0.7308125942921031,0.8060941828254847,0.9696964099587956,1.0,7/12,27.25%,TEX264;RETREG1;ATG2B;RB1CC1;UBA5;ATG2A;UFM1
prerank,icosanoid biosynthetic process (GO:0046456),-0.2897184991339658,-0.7303433056873407,0.8204334365325078,0.9523872808936465,1.0,1/10,2.21%,LTA4H
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3045534262439436,0.7299735959682742,0.8203723986856517,0.9702688853740999,1.0,19/45,26.62%,FOXO3;LARP1;RC3H1;TDRD7;PUM2;CYFIP1;PCIF1;PUM3;MEX3D;PER1;ATG14;ZC3H7A;NUDT21;RPL10;ZC3H7B;EIF2A;PARP9;PUM1;TSC1
prerank,DNA-dependent DNA replication (GO:0006261),0.28621862549856664,0.7299508232182772,0.9271255060728745,0.9699316387249182,1.0,23/128,15.61%,MCM5;ORC3;PSMB10;MCM6;MCM2;DBF4;MGME1;BAZ1A;PSMA2;ORC4;WDHD1;CDC34;PSME3;DNA2;MCMBP;PSMB5;CDC6;POLD3;PSMD8;NOC3L;PSMD7;TWNK;PSMB9
prerank,cardiolipin metabolic process (GO:0032048),0.35683265381188894,0.729694269890595,0.7773167358229599,0.9698719391683391,1.0,7/13,25.79%,PGS1;LCLAT1;PTPMT1;PLA2G5;PLA2G6;HADHA;HADHB
prerank,positive regulation of insulin secretion (GO:0032024),-0.2009341688187682,-0.7292578785410445,0.9316239316239316,0.9519018835387998,1.0,18/36,40.99%,MYRIP;TCF7L2;GPLD1;BAD;IRS2;RBP4;GPER1;ACSL4;CAPN10;CFTR;AACS;GLUD1;C2CD2L;ANO1;PSMD9;DOC2B;LRRC8A;NLGN2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2926972723639743,0.7291771696883056,0.8693415637860082,0.9700951444525596,1.0,9/75,11.42%,NEFH;S100B;SLITRK1;ACTB;MEF2A;MEF2C;RB1;MAP1B;ATL1
prerank,regulation of axonogenesis (GO:0050770),0.3012085707040321,0.7289096634512323,0.8434125269978402,0.970040713807695,1.0,10/51,17.75%,THY1;PLXNC1;SLITRK1;PLXNB2;ARHGDIA;EFNB3;RTN4;EPHA4;PTEN;RHOA
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3652220945299699,0.7281557611294008,0.7745664739884393,0.9705301177512183,1.0,2/11,9.59%,TIMM22;AGK
prerank,regulation of DNA replication (GO:0006275),0.2984608552429246,0.7279484139572324,0.8364030335861322,0.9704061559366145,1.0,11/49,16.38%,ORC3;DHX9;BRPF3;STN1;PDS5A;PPP2CA;KAT7;DNA2;CDC6;BCAR3;FAF1
prerank,telomere capping (GO:0016233),0.3485183412006136,0.7278738112518489,0.799475753604194,0.9701404976469085,1.0,7/16,22.93%,TFIP11;STN1;TINF2;TERF2;DCLRE1C;TERF2IP;TEN1
prerank,kidney development (GO:0001822),0.29210531063404255,0.7275169494923702,0.8493723849372385,0.9701992173359255,1.0,3/65,2.10%,SHH;PCSK9;TGFBR1
prerank,Wnt signaling pathway (GO:0016055),0.28763584749033383,0.7267918980737181,0.8850457782299085,0.970640363701757,1.0,15/92,16.50%,FZD10;PLCG2;FZD9;FZD3;CTNNB1;CSNK1G2;STRN;LRP5;AMER1;CSNK1A1;VPS29;LRRK2;BCL9;FZD8;PTEN
prerank,vascular transport (GO:0010232),0.28974546436419946,0.7265694471248934,0.8827160493827161,0.9705233239270848,1.0,12/81,15.11%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4
prerank,embryonic organ development (GO:0048568),0.29708371926902943,0.72632302514614,0.8539682539682539,0.970430092265641,1.0,6/61,7.98%,TGFB1;TNF;TEAD1;TGFBR2;TAL1;FLT3LG
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.31705525094155057,0.7260044432846136,0.7831325301204819,0.9704261364449404,1.0,6/26,18.66%,NR1H4;LRP5;ADCY8;STXBP4;PPP3CB;KLF7
prerank,vascular process in circulatory system (GO:0003018),-0.2737144449380685,-0.725646188131499,0.8223938223938224,0.952461984662635,1.0,4/13,12.62%,SCPEP1;ROCK1;ACE;NOS3
prerank,regulation of tube diameter (GO:0035296),-0.2737144449380685,-0.725646188131499,0.8223938223938224,0.952461984662635,1.0,4/13,12.62%,SCPEP1;ROCK1;ACE;NOS3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.29415285608089325,-0.725561471423305,0.8302469135802469,0.9506649430700485,1.0,5/10,28.02%,FOXC1;TRIM16;NUMA1;NME2;ETV4
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.35075913725749475,0.7255596872959882,0.8005354752342704,0.9705546284180042,1.0,2/15,9.18%,MLXIPL;PPARGC1A
prerank,regulation of presynapse organization (GO:0099174),0.3438147500150578,0.723437820405456,0.8134920634920635,0.9721987236812206,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,regulation of presynapse assembly (GO:1905606),0.3438147500150578,0.723437820405456,0.8134920634920635,0.9721987236812206,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,protein homotetramerization (GO:0051289),0.30159433383716133,0.72296332184799,0.8308189655172413,0.9723523573302594,1.0,11/49,21.77%,ALDH9A1;PKD2;SAMHD1;B2M;ACACA;USP16;APPL2;MCOLN1;KCNJ2;HCN1;GBP5
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3047053855737498,0.7223699284998468,0.8337004405286343,0.9726580415299927,1.0,17/42,26.65%,SRCAP;ACTB;ARID1A;ARID1B;SMARCB1;INO80;SPTY2D1;ERCC6;SMARCAD1;CHD4;RBBP4;VPS72;SMARCA5;MBD2;SMARCC1;CECR2;MTA2
prerank,calcium ion transmembrane transport (GO:0070588),0.289314534177607,0.7213249675432721,0.8831967213114754,0.9734468652743318,1.0,21/86,19.72%,P2RX7;SLC8A1;PKD2;P2RX4;CACNA1A;ATP2C1;ATP2B1;SLC8B1;ATP2B3;PARL;GAS6;ATP2A3;TRPV3;PMPCB;YME1L1;CACNA1D;TMEM165;MICU2;MCOLN1;NALCN;PMPCA
prerank,regulation of smoothened signaling pathway (GO:0008589),0.29595414042465534,0.7210228136268079,0.8476605005440696,0.9734369330767737,1.0,3/50,5.02%,SHH;RAB34;MGRN1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3652764075263241,0.7209208795633936,0.7769784172661871,0.9731838145673098,1.0,1/10,6.29%,CTNNB1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2784562637457371,-0.7207067997746324,0.8152173913043478,0.954918261636822,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3017623516329716,0.7206145289984707,0.8333333333333334,0.9731784879370092,1.0,10/44,19.65%,TGFBR1;RGCC;FHOD1;PFN2;NF2;NRP1;CD47;RHOA;CDC42;ROCK2
prerank,regulation of cytoskeleton organization (GO:0051493),0.28297744877565745,0.7202397439507197,0.9018218623481782,0.9732489200369759,1.0,23/108,20.48%,IQGAP2;CORO1A;FZD10;PRKCD;P2RX7;MTOR;CLN3;F11R;DIAPH1;BICD2;TWF2;ARHGAP18;CAPN2;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;GSK3B;CRK
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3334317437457132,0.7200117572099392,0.815365551425031,0.9731442285165801,1.0,7/19,23.84%,TENT4B;STN1;SRC;TINF2;TERF2;TEN1;DCP2
prerank,establishment of spindle localization (GO:0051293),0.34744715032567564,0.7198774720815581,0.7771664374140302,0.9729271887690599,1.0,4/14,22.70%,ESPL1;DYNC1H1;CFL1;CLASP1
prerank,positive regulation of catalytic activity (GO:0043085),0.3095522164129239,0.7198422161354845,0.8424101969872537,0.9726136577940385,1.0,4/37,6.62%,MAPK14;ATP7A;XRCC5;YWHAB
prerank,response to cadmium ion (GO:0046686),0.3195533841241628,0.7198090002602352,0.8162291169451074,0.9723048497972477,1.0,11/26,22.28%,HAAO;HSF1;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,myelination (GO:0042552),0.29821628883690954,0.7194175210742727,0.849615806805708,0.9723739751415382,1.0,10/46,17.99%,SKI;CXCR4;ABCD1;ACER3;EIF2B2;TNFRSF21;MPZ;DEGS1;NF1;ABCD2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.35187488109803855,0.7190854176392404,0.793010752688172,0.9723839260916326,1.0,3/14,15.69%,MMS19;ACTR2;ERCC6
prerank,ESCRT III complex disassembly (GO:1904903),0.3700624603213351,0.7189856444872601,0.7867435158501441,0.9718010333743237,1.0,1/10,3.66%,VTA1
prerank,ESCRT complex disassembly (GO:1904896),0.3700624603213351,0.7189856444872601,0.7867435158501441,0.9718010333743237,1.0,1/10,3.66%,VTA1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.37076194940818485,0.7186177946095557,0.7824817518248175,0.9718474403635774,1.0,5/10,24.76%,PRKRA;TARBP2;AGO2;DICER1;DROSHA
prerank,positive regulation of behavior (GO:0048520),-0.2925283005463545,-0.7181193238863636,0.8201892744479495,0.9561973774281307,1.0,1/10,0.39%,NLGN1
prerank,regulation of chromosome organization (GO:0033044),0.3270785396761115,0.7180555744641876,0.8176328502415459,0.9721187542270189,1.0,4/22,14.37%,XRCC5;RB1;SMG1;HNRNPD
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.29899007685194745,0.7168100772917688,0.8577728776185226,0.9731757550882152,1.0,10/46,19.60%,TSPO;AIP;CHCHD4;TIMM22;TIMM50;TOMM40;HK2;PITRM1;TOMM20;FIS1
prerank,regulation of multicellular organism growth (GO:0040014),0.3446885542694168,0.7165685141576584,0.8005215123859192,0.973067776243265,1.0,3/15,14.18%,STAT5A;STAT5B;MBD5
prerank,signal transduction by p53 class mediator (GO:0072331),0.30935548252319867,0.7163597625323451,0.8109048723897911,0.9729412137405381,1.0,4/30,9.48%,PYCARD;TP53;HINT1;ATRX
prerank,negative chemotaxis (GO:0050919),0.31337917618233485,0.7160039218672133,0.8289920724801813,0.972955406379999,1.0,3/33,5.21%,ITGB3;SEMA4D;LGR6
prerank,fatty acid beta-oxidation (GO:0006635),0.29539509680799225,0.7159346549023576,0.8487124463519313,0.9726753111366784,1.0,11/51,18.65%,EHHADH;ACAD10;ACADL;ABCD1;ECHS1;ECI1;CPT2;PPARD;ABCD2;ETFDH;ECHDC1
prerank,protein homooligomerization (GO:0051260),0.28240181972350276,0.7158078632482487,0.9017223910840932,0.9724476173609395,1.0,22/114,20.98%,CARD11;ALDH9A1;PKD2;PYCARD;SAMHD1;AQP11;ATL1;RNF135;B2M;NINJ1;TMEM120A;ADCY8;PDCD6IP;ACACA;USP16;ALS2;APPL2;ATL2;MCOLN1;ATL3;KCNJ2;HCN1
prerank,recombinational repair (GO:0000725),0.2874550631759317,0.7152809254077974,0.8829015544041451,0.9726554074459264,1.0,22/77,23.59%,ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3636111772790258,0.7144131257525076,0.7916666666666666,0.9732352421006145,1.0,2/10,13.14%,WDFY1;NINJ1
prerank,positive regulation of tissue remodeling (GO:0034105),0.37549535282997115,0.7143736816649559,0.807799442896936,0.9729223059879172,1.0,1/10,5.08%,IL18
prerank,positive regulation of double-strand break repair (GO:2000781),0.30132402600864855,0.7141802126880769,0.836824696802646,0.972778620425948,1.0,13/39,25.10%,MAD2L2;MMS19;MGMT;ACTR2;SLF2;ERCC6;SHLD1;SHLD2;SPIDR;PARP3;PARP1;DDX11;PARP9
prerank,intestinal absorption (GO:0050892),0.35048416129916327,0.7138889471905843,0.8117489986648865,0.9727604579380048,1.0,2/13,16.03%,F11R;CD36
prerank,nucleus organization (GO:0006997),0.2947844415244847,0.7135820482563379,0.8656084656084656,0.9727378443209174,1.0,10/47,18.86%,ATXN7;SYNE1;SEH1L;IRAG2;TPR;NUP205;TOR1A;PDCD6IP;BIN1;TMEM170A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.31430010262547287,0.7131125381145836,0.829940119760479,0.9729112341575041,1.0,6/27,13.26%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,photoreceptor cell development (GO:0042461),-0.2567471423828354,-0.7129519001125528,0.864,0.960457764350704,1.0,5/14,21.11%,RORB;ARL3;TOPORS;RP1;MFSD2A
prerank,nucleocytoplasmic transport (GO:0006913),0.2935249852171219,0.7128053890800106,0.8316831683168316,0.9728900692562732,1.0,6/40,11.71%,XPO1;ANP32A;SNRPD2;MALT1;RBM15B;NUP205
prerank,mitochondrion distribution (GO:0048311),0.3592599360854893,0.712589980970459,0.7939560439560439,0.9727644939260109,1.0,5/12,19.49%,MEF2A;MSTO1;ATCAY;LRRK2;DNM1L
prerank,motor neuron axon guidance (GO:0008045),-0.24708734767390536,-0.7124446889724237,0.8652173913043478,0.9592081189409304,1.0,2/15,6.36%,SEMA3A;SLIT2
prerank,positive regulation of histone deacetylation (GO:0031065),0.3494704330310543,0.7106180300484436,0.7989347536617842,0.9745640565162295,1.0,5/12,23.95%,PRKD2;AKAP8L;ZBTB7B;CTBP1;VEGFA
prerank,response to X-ray (GO:0010165),0.34143908162152287,0.710592400222382,0.7955801104972375,0.9742370635699845,1.0,3/14,14.22%,XRCC5;ANXA1;IKBIP
prerank,telomere maintenance (GO:0000723),0.29302280573304923,0.7102623531492532,0.8595927116827439,0.9742451462416416,1.0,17/50,24.85%,PTGES3;XRCC5;STN1;DNA2;POLD3;TEP1;TINF2;RAD51D;TERF2;NSMCE2;PARP3;ERCC4;TERF2IP;TEN1;PARP1;ATR;RPA1
prerank,negative regulation of ATPase activity (GO:0032780),0.34149569531166807,0.7099724710094426,0.820615796519411,0.9741886545378456,1.0,2/16,8.60%,TP53;ATP5IF1
prerank,histone deubiquitination (GO:0016578),0.3339052917321252,0.7097228691910832,0.8055908513341804,0.9741017859341643,1.0,4/18,16.00%,ATXN7;USP7;USP21;USP16
prerank,androgen receptor signaling pathway (GO:0030521),-0.2816656481038668,-0.7094728675177318,0.8305084745762712,0.9606787084042958,1.0,5/11,25.09%,AR;KDM3A;RNF14;PMEPA1;PLPP1
prerank,aerobic electron transport chain (GO:0019646),0.2847310169348024,0.7091426516709637,0.8716356107660456,0.9743639168969265,1.0,15/68,19.52%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,positive regulation of cell aging (GO:0090343),0.3634675475834298,0.7090987795460004,0.8094575799721836,0.974063165077912,1.0,2/11,13.13%,YPEL3;B2M
prerank,positive regulation of cell junction assembly (GO:1901890),0.2917709328534424,0.7090673923971225,0.880085653104925,0.9737437330124131,1.0,3/56,2.38%,CLSTN1;PTPRJ;THY1
prerank,regulation of cellular senescence (GO:2000772),0.3105856895139128,0.7088012537584037,0.8133971291866029,0.9736930809925723,1.0,10/28,26.35%,NEK6;YPEL3;CDK6;B2M;TERF2;NEK4;NUAK1;SLC30A10;AKT3;FBXO5
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28424209216305807,0.7079681300489081,0.8752577319587629,0.9742489817577179,1.0,15/69,19.52%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,mitochondrial membrane organization (GO:0007006),-0.21511722121980426,-0.7077148803838799,0.9133858267716536,0.960832520106479,1.0,11/32,22.80%,APOOL;IMMT;SLC25A4;BNIP3;SPG7;SAMM50;BAD;MFN2;MTX3;SLC25A5;APOO
prerank,mitochondrial translation (GO:0032543),0.2820415357240512,0.7070825207792555,0.8970438328236493,0.9748507487986282,1.0,31/104,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GATB;ERAL1;MRPL51;MTRF1L;LARS2;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MTIF3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;GATC;MRPL37;MRPS34;MRPS12
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2718534586406461,0.7069925608538513,0.995995995995996,0.9745914355813727,1.0,88/417,21.25%,ASCL1;CIITA;TGFB1;IKZF1;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;CIART;MDFIC;QARS1;RING1;ATF7IP;ARID4A;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;MBD1;NRG1;KAT7;FOXN3;GAS6;FOXK1;IRF1;BRD7;LBH;CAPN3;TLE5;EID1;RBPJ;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT;LOXL3;SFMBT1;CIPC;CTBP2;PER1;CALCA;WWP1;INPP5K;HHEX;ENO1;ZMYND11;CDK5R1;FBXW11;POU2F1;YEATS2;HEXIM1;EED;SCMH1;TFAP4;CRYAB;PHC2
prerank,spermatid development (GO:0007286),-0.2048922342236047,-0.7068567187258001,0.9407407407407408,0.9599475701290238,1.0,8/32,24.01%,BBS4;RFX2;CEP57;ACRBP;NECTIN2;TDRD5;MKKS;NME5
prerank,positive regulation of growth (GO:0045927),0.2855796475995457,0.7055023475043743,0.8842544316996872,0.9757859275198558,1.0,14/64,22.83%,RFTN1;TGFBR1;BRAT1;CSNK2A1;SDCBP;INO80;WFS1;CXCL16;CDC42;RPTOR;PABIR1;EXOSC2;ZPR1;H3-3A
prerank,negative regulation of mitochondrion organization (GO:0010823),0.30210932261932594,0.7052363282873282,0.8317757009345794,0.9757250163368327,1.0,10/33,24.18%,FZD9;BCL2L1;FLCN;IAPP;HUWE1;VAT1;GHITM;PRKN;IGF1;PRELID1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3415976957673313,0.7040449664063744,0.8296398891966759,0.9766203311044588,1.0,1/15,2.02%,PLCG2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2809444101412286,0.7037121000307031,0.9089048106448311,0.9766304719218859,1.0,22/95,21.71%,PRELP;HEXA;B4GALT1;CHSY3;FMOD;AGRN;ST3GAL1;NDST1;BCAN;XYLT1;CHSY1;B4GALT7;CHST15;PXYLP1;NDST2;CEMIP;ANGPT1;CHPF;CSPG4;SLC10A7;B4GALT6;B4GALT2
prerank,meiosis I (GO:0007127),0.31609894997272986,0.7033827329337787,0.8242424242424242,0.9766409747691212,1.0,2/23,12.70%,PTTG1;BRDT
prerank,cell junction assembly (GO:0034329),0.27960398044589335,0.7033374911527333,0.9142857142857143,0.9763339489006729,1.0,22/100,19.64%,PCDHB6;SLITRK1;PKP2;ITGA6;ACTB;VMP1;CAPZA1;FLCN;ACTG1;CDH8;LIMS1;CDH9;CDH12;TLN1;KIRREL3;DCHS1;CDH19;PTEN;RHOA;CDC42;RAB29;FBLIM1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.3481069103129617,0.7032863844042281,0.8169014084507042,0.9760312041655417,1.0,6/12,23.95%,MYO7A;AGTPBP1;NKD1;PROM1;STAT3;VEGFA
prerank,membrane repolarization (GO:0086009),0.3398387013270883,0.7031302735057878,0.8113695090439277,0.975852273997227,1.0,3/15,13.76%,KCNIP2;ATP1B3;ATP1B2
prerank,telomere maintenance via recombination (GO:0000722),0.3575688137333084,0.703119297323789,0.8097902097902098,0.9755134083853977,1.0,5/11,21.91%,TEP1;ERCC1;RAD51D;NSMCE2;ERCC4
prerank,insulin secretion (GO:0030073),0.32883849117958963,0.7026813954252977,0.812743823146944,0.9756124087233545,1.0,3/19,12.59%,ANXA1;SNX19;RAB11FIP5
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3150958173474401,0.7025023428294388,0.8323057953144266,0.9754441417123406,1.0,10/26,22.80%,DUSP3;STAT5B;SOX9;SYAP1;PTPN12;IQGAP1;PDPK1;INPP5K;ZFP36L1;ZPR1
prerank,regulation of ossification (GO:0030278),0.3027789000905196,0.7024274060858505,0.864501679731243,0.9751680505208584,1.0,5/36,12.22%,BMP2K;MDK;MEF2C;SOX9;CHSY1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3212475291469803,0.7017032989183418,0.826946847960445,0.975577529382184,1.0,3/22,12.34%,PPP2CB;DUSP10;PPP2CA
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.34736758579513893,0.7013269395632172,0.8162692847124825,0.975263217107203,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.34736758579513893,0.7013269395632172,0.8162692847124825,0.975263217107203,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,cellular zinc ion homeostasis (GO:0006882),0.31530809334875404,0.7012610053174495,0.8381294964028777,0.974975447399096,1.0,12/26,23.21%,ATP13A2;SLC39A6;MT3;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;SLC30A10
prerank,mitochondrial translational elongation (GO:0070125),0.28086729913963876,0.7011981915471946,0.8935516888433982,0.9746930328807599,1.0,26/88,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3263667409927531,0.7010162496476054,0.8080939947780679,0.9745310329549249,1.0,2/17,12.78%,TNF;SORL1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.35292612174499643,0.7002602920389083,0.8045649072753209,0.9749622756311929,1.0,2/12,8.10%,DOCK4;MEF2C
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.32610339305091507,0.6999504571818016,0.8278688524590164,0.9749354825865512,1.0,6/16,26.35%,PHIP;IGFBP4;CDH3;IGFBP2;IGF1;IGFBP3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.26237172408200815,-0.6997609837515235,0.8745387453874539,0.9659186655117586,1.0,3/13,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,histone H4 acetylation (GO:0043967),0.2901315082476412,0.6997491225552109,0.8510405257393209,0.9747886262075312,1.0,16/47,24.77%,BRD8;MSL2;EP400;MCRS1;NAA40;KAT7;HCFC1;JADE2;MEAF6;PER1;MSL1;PHF20;MORF4L2;MORF4L1;CHD5;KANSL1
prerank,regulation of developmental growth (GO:0048638),0.3068033238091906,0.6994159329012369,0.8450867052023121,0.9747953200991392,1.0,4/29,9.89%,STAT5A;APOE;DNM2;STAT5B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.33310492186929636,0.6990831061647451,0.8166894664842681,0.9747924681880278,1.0,5/15,24.18%,BCL2L1;GHITM;PRKN;IGF1;PRELID1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2683365347653903,-0.6990048042608782,0.8444444444444444,0.9648489077796593,1.0,7/12,27.03%,MTHFD1;PRPS2;AMPD2;ADSL;PPAT;PRPS1;PRPS1L1
prerank,synaptic vesicle transport (GO:0048489),0.3496434175338782,0.6985029393928882,0.8218390804597702,0.9750394297772974,1.0,3/11,13.52%,DNM2;SYNJ1;TOR1A
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3516745496427228,0.6971666260295118,0.8026509572901326,0.9760232795029399,1.0,3/11,10.18%,RAP2B;F11R;RAB1B
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.30240460116238216,0.6964941218094516,0.851985559566787,0.9763539343752439,1.0,4/29,10.01%,APOE;CLN3;MCTP1;SYNGR1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3336279699959448,0.6963604456783695,0.8089005235602095,0.9757969349418325,1.0,5/15,22.43%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3336279699959448,0.6963604456783695,0.8089005235602095,0.9757969349418325,1.0,5/15,22.43%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,cytoplasmic translational initiation (GO:0002183),-0.23975617492412965,-0.6962113153046796,0.8957345971563981,0.9660392337126804,1.0,4/17,12.41%,EIF2B3;EIF4B;EIF2D;DHX29
prerank,mitotic spindle assembly (GO:0090307),0.28598806432507945,0.6960934626113514,0.8430939226519337,0.9757230593518358,1.0,7/42,14.27%,BCCIP;CEP192;CHEK2;KIF23;RAB11A;STAG2;KIF2A
prerank,camera-type eye morphogenesis (GO:0048593),0.36181385224537266,0.6956191620818303,0.8168812589413448,0.9758725232291903,1.0,4/10,23.95%,SKI;NF1;KDM2B;VEGFA
prerank,response to steroid hormone (GO:0048545),0.30677128951471666,0.6955632389658839,0.8568075117370892,0.9755835166177076,1.0,1/31,0.90%,TGFB1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3474799634579327,0.694951879416507,0.8131241084165478,0.9758543632779597,1.0,5/12,21.23%,APOE;RANBP9;PICALM;ROCK2;ABCA2
prerank,secondary palate development (GO:0062009),0.33687409210045766,0.6946744639653335,0.8190224570673712,0.9757845948522764,1.0,2/14,6.68%,CHD7;TGFBR2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.35897386625907957,0.6946414415822656,0.8174037089871612,0.9754696115267132,1.0,2/10,10.48%,NOS1AP;CACNB2
prerank,regulation of complement activation (GO:0030449),0.2928224272889972,0.6942330079872716,0.8778280542986425,0.97554399410491,1.0,5/40,14.89%,C1QC;C1QA;C1QB;C3AR1;C4B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24703986725032,-0.6931759199215081,0.8907563025210085,0.9673069450315632,1.0,6/17,18.67%,MPDU1;NUS1;ALG9;SRD5A3;ALG12;ALG1
prerank,histone H4-K8 acetylation (GO:0043982),0.3327064983328343,0.6929524968166252,0.8340192043895748,0.9761716510147385,1.0,7/15,24.77%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.3327064983328343,0.6929524968166252,0.8340192043895748,0.9761716510147385,1.0,7/15,24.77%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,early endosome to Golgi transport (GO:0034498),0.3484036321877006,0.6924967842535384,0.8194640338504936,0.9762635888805736,1.0,3/11,14.53%,RBSN;STX5;SNX2
prerank,Golgi ribbon formation (GO:0090161),-0.2626485804811788,-0.6919241431984455,0.8362989323843416,0.9667010620439266,1.0,3/13,11.76%,VAMP4;GCC2;GOLGA2
prerank,negative regulation of viral transcription (GO:0032897),0.34338907497646554,0.6912636184756265,0.8162692847124825,0.977156715918748,1.0,5/13,24.49%,TRIM27;MID2;TRIM62;HEXIM1;UBP1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33075882142429747,0.6911518305254225,0.8192771084337349,0.976925807217892,1.0,7/16,25.16%,CIRBP;TRA2B;PRDX6;THRAP3;RBMXL1;NCBP1;TRA2A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.25940415615154755,-0.6906694293755049,0.8794326241134752,0.9660634840171728,1.0,9/13,42.86%,CACNA1G;SYT4;CACNA1H;CACNA1I;KCNB1;SYT1;DOC2B;HYAL3;SCAMP5
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.2764813161055858,-0.6898580094826334,0.8361774744027304,0.9650428172982307,1.0,8/10,31.34%,IVD;ACAD11;ETFA;ETFB;ACADS;ACADVL;GCDH;ACADM
prerank,axoneme assembly (GO:0035082),-0.20081595570192795,-0.6888605221180594,0.9291338582677166,0.9641888128011721,1.0,12/31,31.01%,SPAG1;TTC12;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;CFAP46;TTLL3;DNAAF3;LRGUK
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.29456750412486393,0.688651844193999,0.8365714285714285,0.9791076891839448,1.0,4/32,12.48%,PYCARD;TP53;HINT1;DDIT4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23389434132341597,-0.6883044237875738,0.9184549356223176,0.9629134149571067,1.0,5/17,17.47%,EMC7;EMC10;EMC4;EMC1;GET4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2661887350524561,0.6882505500746714,0.9678714859437751,0.9791623677513468,1.0,36/186,18.78%,DRAXIN;TMEM131L;NFATC1;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;NLK;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;LRP1;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.30546651950884535,0.6873217265780288,0.8484848484848485,0.9797354787019558,1.0,4/26,16.74%,GCH1;ACER3;SPR;ASAH1
prerank,male gonad development (GO:0008584),0.2991053603932676,0.6873148933686033,0.854524627720504,0.9793943507955366,1.0,4/34,15.48%,GATA1;INHBA;SOX9;NCOA4
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.34664178343226926,0.6868960446890745,0.8117154811715481,0.9794630687245088,1.0,2/11,11.24%,BCAR1;NRP1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.32360472661188433,0.6863678292614745,0.8402684563758389,0.9796678597642001,1.0,6/15,23.58%,ENTPD1;ENTPD2;AK8;ENTPD3;AK5;AK1
prerank,cilium organization (GO:0044782),0.2669972412177129,0.6858414934082225,0.970970970970971,0.9798324836585053,1.0,34/210,15.62%,MKS1;RAB8B;EXOC6;ASAP1;PKD2;IFT52;TTC29;RP2;CNGB1;BBS9;PLK4;ATP6V0D1;DISC1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;EXOC3;CEP162;AHI1;WDR90
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3295754779023205,0.6853414364903926,0.833976833976834,0.9799988091521266,1.0,1/16,2.40%,MAD2L2
prerank,positive regulation of mRNA processing (GO:0050685),0.3155583148883086,0.6849980129791967,0.8589580686149937,0.9799966814130721,1.0,6/21,19.27%,CIRBP;LEO1;TRA2B;PRDX6;THRAP3;RBMXL1
prerank,peptidyl-proline modification (GO:0018208),0.30442008758419914,0.6843991838554231,0.8422301304863582,0.9802409714433011,1.0,9/25,25.25%,PPIE;CWC27;P3H2;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,lipid droplet formation (GO:0140042),0.3571644897188536,0.6842508702325043,0.8137829912023461,0.9800392983415522,1.0,1/10,5.78%,CDS2
prerank,tRNA 5'-leader removal (GO:0001682),0.3337688035162917,0.684083723897049,0.8319327731092437,0.9798486639117826,1.0,3/13,15.01%,RPP38;RPP14;PRORP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3367264776724368,0.6840237849096125,0.8452883263009845,0.9795692151066776,1.0,2/13,10.01%,CLN3;SYNGR1
prerank,protein alkylation (GO:0008213),-0.21294391672085086,-0.6835659465678439,0.9081081081081082,0.9658595321628128,1.0,11/22,30.42%,FAM98B;SNRPD3;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;EEF1AKMT2;CAMKMT;VCPKMT
prerank,tRNA metabolic process (GO:0006399),-0.2294325803350849,-0.6831668302967898,0.9087136929460581,0.9643936758823628,1.0,8/17,32.59%,SSB;DTD2;KARS1;RPP21;YARS2;POP5;RPP30;POP1
prerank,neuron migration (GO:0001764),0.2820177747395055,0.6831336820517728,0.8732394366197183,0.9800662730107932,1.0,10/48,14.17%,FGF13;LRP12;DISC1;MEF2C;PEX13;MAP1B;NRP1;DDIT4;NAV1;USP9X
prerank,inositol phosphate-mediated signaling (GO:0048016),0.31457385901102575,0.6827791921277591,0.8405438813349815,0.9800692051253241,1.0,1/19,2.16%,NFATC1
prerank,nuclear pore organization (GO:0006999),0.3352095999726319,0.6824722181644325,0.851006711409396,0.980013382037438,1.0,6/14,20.95%,SEH1L;TPR;NUP205;RTN4;TMEM170A;NUP54
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2771588304538202,0.6808307707279991,0.8955696202531646,0.9812928525756461,1.0,7/63,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3318939287569528,0.6804982229496609,0.8326474622770919,0.9812605555167887,1.0,2/12,12.85%,METTL4;KAT7
prerank,glucose transmembrane transport (GO:1904659),0.3213974946207841,0.6804224012766574,0.8380462724935732,0.9809906198877828,1.0,3/18,19.71%,SLC2A3;PPARD;SORT1
prerank,endodermal cell fate commitment (GO:0001711),0.3557834524112127,0.6802407982283112,0.8253968253968254,0.9808237287829457,1.0,2/10,14.24%,LEO1;SOX2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2953847000997117,0.6792329158441249,0.8716763005780347,0.9814823900461792,1.0,7/31,18.67%,RPS2;UBE2S;FZR1;ARRDC4;PTEN;UBE2N;DCUN1D5
prerank,blood vessel diameter maintenance (GO:0097746),0.28833746005678085,0.6791574703056437,0.8698553948832035,0.9812061478967111,1.0,2/34,4.66%,EDNRB;ADCY6
prerank,alpha-amino acid metabolic process (GO:1901605),0.2857035608106957,0.6782803255003188,0.882091212458287,0.9817194980124107,1.0,8/45,16.86%,ATP7A;ASPG;KMO;PYCR2;MMUT;DDAH1;OAT;CBS
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2282464013411541,-0.6772912299705807,0.9086538461538461,0.9680255321461034,1.0,2/18,7.36%,EGFR;CCDC62
prerank,Golgi to endosome transport (GO:0006895),0.32011093618459546,0.6768455089098109,0.8401048492791612,0.9827655563876507,1.0,6/16,22.22%,RAB14;EPS15;MON2;SORT1;VPS13C;VPS13A
prerank,cobalamin metabolic process (GO:0009235),0.31841790584279783,0.6762939410719225,0.855146124523507,0.982945393909673,1.0,6/17,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.32083404984399044,0.6758700307616591,0.8522292993630574,0.9830058445327563,1.0,4/17,19.52%,COX6C;COX7C;COX6B1;COX4I1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2677688996565321,0.6753671375338952,0.9310344827586207,0.9831370607276555,1.0,26/96,20.95%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3295885721963978,0.675274134378134,0.837465564738292,0.9828705703130657,1.0,2/14,12.34%,PPP2CB;PPP2CA
prerank,7-methylguanosine RNA capping (GO:0009452),0.29766101818184537,0.6752295972303939,0.8710045662100456,0.982220504532198,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,7-methylguanosine mRNA capping (GO:0006370),0.29766101818184537,0.6752295972303939,0.8710045662100456,0.982220504532198,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.34573827469653984,0.673767631186906,0.859882005899705,0.9832464908577057,1.0,3/10,20.94%,XYLT1;PXYLP1;B3GAT2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2589120813937736,0.6737159806195279,0.998,0.9829529293407541,1.0,78/497,17.35%,ASCL1;CIITA;TGFB1;IKZF1;DBI;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CNOT8;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;LARP1;CIART;MDFIC;EPRS1;QARS1;RING1;ATF7IP;ARID4A;CPEB3;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;PDS5A;MBD1;NRG1;KAT7;FOXN3;GAS6;PCIF1;FOXK1;CDC6;IRF1;BRD7;LBH;CAPN3;IGF2BP3;TLE5;EID1;GSK3A;RBPJ;PUS7;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT
prerank,calcium ion import across plasma membrane (GO:0098703),0.3309165475718354,0.6735556772632353,0.8331071913161465,0.9827666440082193,1.0,2/14,13.91%,SLC8A1;TRPV3
prerank,negative regulation of histone modification (GO:0031057),0.3282482117595384,0.6734860977654391,0.8342245989304813,0.9824871522312401,1.0,6/14,29.48%,SNCA;NOC2L;CTBP1;SPHK2;JARID2;PRMT6
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.318528750983423,0.673199362333024,0.8408796895213454,0.9824250877247408,1.0,1/16,2.22%,DAGLB
prerank,regulation of neurotransmitter secretion (GO:0046928),0.28800738616792887,0.6731270432567198,0.8685121107266436,0.9821531150566535,1.0,5/32,14.53%,MCTP1;VPS18;MEF2C;DTNBP1;LRRK2
prerank,N-terminal protein amino acid modification (GO:0031365),0.32814657480911574,0.6730691216794966,0.8301369863013699,0.9818690936980173,1.0,4/14,20.75%,NAA40;METAP2;NAA50;NAA15
prerank,metal ion homeostasis (GO:0055065),0.2842408818520593,0.6723497114765783,0.88998899889989,0.9822182834312122,1.0,4/40,8.42%,SLC8A1;SLC7A8;SNCA;TFAP2B
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26381278875520575,0.67209814875415,0.936105476673428,0.9821189872199002,1.0,18/104,18.40%,TGFB1;TGFBR1;UBE2D3;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;SORL1;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1;RBPMS2;GREM1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.31159995035321286,0.6717975056202771,0.835427135678392,0.982066870615593,1.0,2/20,8.05%,TGFBR1;SNAI1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.30041437360984824,0.671614479879508,0.8542168674698796,0.9819091001984367,1.0,4/26,14.53%,NFE2L2;GPR37;FYN;LRRK2
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.19558163073019458,-0.6710137672097765,0.95,0.9719608890992155,1.0,5/30,10.66%,ABCD4;ACSL1;HACD1;ELOVL5;ACSL6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2694817460103334,0.6709585738884437,0.9176225234619395,0.9821966937508698,1.0,15/74,18.91%,NFE2L2;BACH1;PSMB10;EPO;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;RBPJ;HIF1A;VHL;PSMD2;ELOB
prerank,central nervous system development (GO:0007417),0.2594909811931043,0.6706479945695107,0.988,0.9821510710324093,1.0,49/250,20.34%,SHH;CX3CR1;S100B;EEF1AKMT4-ECE2;PKD2;BPTF;CXCR4;PLXNB2;CHD7;TGFBR2;NKX2-1;C1QA;PAFAH1B2;BCAN;SCYL2;ITGAM;QARS1;ATP6AP2;EIF2B2;SOX9;SNTG2;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SH3GL3;SOX6;ZFHX3;SOX4;MEIS1;JHY;POU6F1;AHI1;NF1;PTEN;TBC1D23;MARCKS;PHGDH;NPAS2;LOXL3;GBA2;ZIC4;WWP1;RELN;CNTN4;ANKLE2;CDK5R1;UTP3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2768655598804325,0.6705523413727712,0.8956796628029505,0.9818943218600231,1.0,12/54,21.96%,KCNN4;KCNIP2;KCNMA1;NOS1AP;NEDD4L;CD63;GNG2;CACNA1D;BIN1;KCNJ2;KCNJ10;FLNA
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.34402164314699724,0.6702219963126205,0.8266666666666667,0.9818689403871675,1.0,1/10,3.87%,SNCA
prerank,histone H3-K36 demethylation (GO:0070544),0.35104006665407167,0.6696871491019887,0.8478581979320532,0.9820093706445553,1.0,4/10,21.86%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,histone H2B ubiquitination (GO:0033523),0.3442179120383845,0.6694471004890191,0.8340740740740741,0.9818856730855339,1.0,4/10,23.31%,LEO1;RNF40;UBE2E1;CTR9
prerank,protein heterooligomerization (GO:0051291),0.3101498888836001,0.6691728263035072,0.8463576158940397,0.9817946956636774,1.0,3/17,13.25%,PKD2;FARSB;TMEM120A
prerank,histone mRNA metabolic process (GO:0008334),-0.19809500364796911,-0.6688335593963841,0.9276315789473685,0.972122382246285,1.0,9/27,22.05%,SSB;SNRPD3;ERI1;ATM;UPF1;TUT1;SNRPG;SNRPF;NCBP2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.316568330103325,0.6674800132139632,0.8641160949868074,0.9830359104301436,1.0,9/17,25.12%,HSF1;CPEB3;RNF40;VIRMA;ZC3H3;NELFE;CTR9;NUDT21;NCBP1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2602076357357973,-0.6671529539632962,0.8831168831168831,0.9717480125354807,1.0,4/11,21.73%,ENPP3;SLC19A2;SLC19A3;SLC25A19
prerank,iron ion transmembrane transport (GO:0034755),0.3533265082884453,0.6671211134307922,0.8560830860534124,0.9830284502392039,1.0,1/10,4.91%,SLC25A37
prerank,peptidyl-arginine modification (GO:0018195),0.3191445583811239,0.6669413005045667,0.8560411311053985,0.9828551330405418,1.0,1/15,3.91%,ART4
prerank,neuron maturation (GO:0042551),0.31808144853308723,0.6658825836660552,0.8562091503267973,0.9835524987914034,1.0,5/18,21.76%,MTCH1;C1QA;EPHA8;B4GALT6;CX3CL1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2864204888030075,0.6636784027947,0.8714121699196326,0.9852556681706875,1.0,3/33,8.10%,TNFAIP3;AIF1;MEF2C
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3403961373136344,0.6635377920012484,0.8609077598828697,0.9850323700053201,1.0,2/10,14.05%,CCT8;CCT5
prerank,pigment granule transport (GO:0051904),0.3110943467437759,0.6630925693097927,0.8576826196473551,0.9847797075912309,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,melanosome transport (GO:0032402),0.3110943467437759,0.6630925693097927,0.8576826196473551,0.9847797075912309,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,calcium ion import into cytosol (GO:1902656),0.3215946505318096,0.6630126887951405,0.8600269179004038,0.9845024718798268,1.0,2/15,13.91%,SLC8A1;TRPV3
prerank,synaptonemal complex organization (GO:0070193),0.321140206534068,0.6627167065430513,0.864314789687924,0.9840918315423304,1.0,1/15,8.32%,TRIP13
prerank,synaptonemal complex assembly (GO:0007130),0.321140206534068,0.6627167065430513,0.864314789687924,0.9840918315423304,1.0,1/15,8.32%,TRIP13
prerank,autophagy of nucleus (GO:0044804),0.31665034384522606,0.6624715456020491,0.8436657681940701,0.9839872524920846,1.0,3/16,16.36%,ATG7;ATG2B;ATG3
prerank,regulation of protein neddylation (GO:2000434),0.3387993926550863,0.6623998499871407,0.8476052249637155,0.9837035398173113,1.0,4/10,18.67%,COPS9;HIF1A;RPL11;DCUN1D5
prerank,postreplication repair (GO:0006301),0.27622267407341417,0.6620417674534984,0.9044516829533116,0.9836823174876211,1.0,4/45,6.94%,TRIM25;UBE2V2;UBE2V1;POLH
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2973767302439941,0.66169254211694,0.8781065088757396,0.9836454135389084,1.0,3/25,8.42%,SLC8A1;SNCA;TFAP2B
prerank,covalent chromatin modification (GO:0016569),0.3223322430653577,0.6613331861604872,0.8432432432432433,0.9836285055735807,1.0,7/14,28.19%,CHD1;SETD5;MT3;MBD2;SIRT7;HELLS;HDAC1
prerank,translational elongation (GO:0006414),0.26472434627589003,0.6611503066368495,0.9375,0.9834565370578395,1.0,29/101,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GTPBP1;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;EEF1G;MRPL21;RACK1;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,neuromuscular junction development (GO:0007528),0.2970973924447584,0.6605073517689521,0.8648648648648649,0.983677757766085,1.0,5/24,14.53%,AGRN;CACNB4;CACNB2;CACNB1;LRRK2
prerank,mismatch repair (GO:0006298),0.2958697440754908,0.6599835802246532,0.8586326767091541,0.9838361263237535,1.0,7/27,18.75%,EXO1;SETD2;MCM9;PMS1;POLD3;RNASEH2A;ERCC1
prerank,membrane assembly (GO:0071709),0.2789872830716499,0.6591730714950267,0.8853575482406356,0.9842262164194429,1.0,8/34,18.49%,RFTN1;CEL;GAK;PTEN;STX2;PICALM;FLOT1;UBXN2A
prerank,nucleotide biosynthetic process (GO:0009165),0.30912048604927994,0.6590228858081945,0.8598484848484849,0.984031139733455,1.0,5/18,16.30%,GART;PNP;NMNAT3;PRPSAP1;RRM2B
prerank,membrane repolarization during action potential (GO:0086011),0.32604212479828193,0.6590108954750269,0.8580901856763926,0.9836991891387568,1.0,1/13,4.32%,KCNIP2
prerank,autophagy of peroxisome (GO:0030242),0.33186610856024945,0.6589899779514226,0.8555555555555555,0.9833742283032625,1.0,4/12,25.46%,MAP1LC3B;PIK3R4;RB1CC1;NBR1
prerank,base-excision repair (GO:0006284),0.2760564978965223,0.6586746055567114,0.9066523605150214,0.9833407472494652,1.0,8/48,16.00%,NEIL2;LIG3;DNA2;HUWE1;POLD3;ERCC5;ERCC6;OGG1
prerank,maturation of 5.8S rRNA (GO:0000460),0.3096108087181338,0.6583666860083849,0.8470437017994858,0.983293425008822,1.0,4/17,17.60%,LAS1L;PES1;C1D;WDR12
prerank,hexose biosynthetic process (GO:0019319),0.2802345899372103,0.6582743160021204,0.9138121546961326,0.9830403735749389,1.0,8/42,16.87%,ALDOB;SORD;ENO3;PPARGC1A;GPI;CHST15;GAPDHS;PGAM1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.28748108538360334,0.6581190731265979,0.8830409356725146,0.9828429169341563,1.0,11/32,25.24%,HDAC5;ANXA1;THBS1;HDAC9;RHOA;MAP2K5;MMRN2;FGF2;VEGFA;KDR;AKT3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3174861648574379,0.6579670068859332,0.8646112600536193,0.9826491485098118,1.0,4/15,18.96%,ATL1;RTN4;TMEM170A;ATL2
prerank,skeletal system development (GO:0001501),0.2558662312303866,0.6578910172178636,0.966900702106319,0.98237918827401,1.0,20/148,14.60%,SH3PXD2B;TGFBR1;PRELP;ATP7A;CD44;CHD7;TRPS1;SULF2;BCAN;XYLT1;PRDX1;CMKLR1;CREB3L2;PAPSS1;SOX9;SOX6;RFLNA;RAB33B;ANKRD11;SOX4
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2645735387600185,0.6574216422017863,0.918834547346514,0.9824575546485631,1.0,12/68,17.81%,SLC52A1;MTHFS;SLC2A3;ABCC1;MCCC2;CYB5A;MMUT;CUBN;PDZD11;MTR;FPGS;PCCA
prerank,tetrapyrrole metabolic process (GO:0033013),0.3050754909092176,0.6569142494238337,0.8598247809762203,0.9825791473767513,1.0,6/18,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,diol metabolic process (GO:0034311),0.3007474713603492,0.6566741689259059,0.8627450980392157,0.9824360970496366,1.0,3/19,16.71%,GCH1;SPR;HSP90AA1
prerank,mitotic DNA replication (GO:1902969),0.3342522169758241,0.6565990668582956,0.8629737609329446,0.9821609121159195,1.0,2/10,10.17%,MCM6;MCM2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28547360492544804,0.6563484466505007,0.8593200468933178,0.9820531902230192,1.0,6/25,23.09%,EAF1;LEO1;ELL;ZMYND11;HEXIM1;NELFE
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3430081636265297,0.6560876679146578,0.8549075391180654,0.9819448343153145,1.0,3/10,22.41%,MTMR3;ABCA3;MTMR9
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.27196275766373657,0.6557598250786213,0.8936627282491945,0.9819141113211262,1.0,5/52,8.99%,NT5C3B;CNOT8;EXOSC1;RC3H2;RC3H1
prerank,regulation of ATP metabolic process (GO:1903578),0.26987026133374514,0.654481998059404,0.9184549356223176,0.982705098356335,1.0,13/54,20.95%,NUP62;ATP7A;ABCD1;SEH1L;ATP5IF1;TPR;NUP205;HIF1A;GCK;PGAM1;SEC13;FIS1;NUP54
prerank,ncRNA 3'-end processing (GO:0043628),0.3201715481506195,0.6540253493777153,0.8594377510040161,0.9827707489391401,1.0,5/14,21.18%,ELAC2;INTS8;INTS6;INTS6L;TOE1
prerank,regulation of phosphatase activity (GO:0010921),0.2942878802504068,0.6536709651823494,0.8782816229116945,0.9827348195858023,1.0,8/24,26.62%,PPP6R1;PTPA;CHP1;MTMR9;HTT;CDK5RAP3;TIPRL;TSC1
prerank,pore complex assembly (GO:0046931),0.3053630456929233,0.6536123712632187,0.869182389937107,0.9824510015803977,1.0,6/19,18.86%,P2RX7;TPR;NUP205;PDZD11;RTN4;TMEM170A
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3285624607658505,0.6530292235572609,0.8696883852691218,0.9826191969784851,1.0,11/11,67.17%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,mRNA transport (GO:0051028),0.25887768985489196,0.6529309160443284,0.9472081218274112,0.9823681287196416,1.0,27/101,21.24%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54;ZFP36L1
prerank,sulfur compound transport (GO:0072348),0.29101635742729787,0.652930915212493,0.8726190476190476,0.9820292642392278,1.0,4/27,13.56%,LRRC8D;SLC36A1;SLC25A30;MGST1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2615454302708701,0.652774140491095,0.9349173553719008,0.9818280162252869,1.0,15/79,20.57%,GCNT1;ATP7A;ST8SIA4;NPC1;XYLT1;FUT9;B3GALNT1;ST8SIA1;B4GALT7;TMEM106A;LARGE1;DDOST;GOLPH3;MGAT1;COG7
prerank,detection of calcium ion (GO:0005513),0.3254717944087701,0.6527618299354639,0.8333333333333334,0.9814983977285923,1.0,1/13,4.32%,KCNIP2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.1876430244336115,-0.6526149477041603,0.9695121951219512,0.9820831587203065,1.0,5/28,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,protein polyglutamylation (GO:0018095),0.33101035613186003,0.65238149641769,0.8563218390804598,0.9815060504126003,1.0,4/11,25.34%,TPGS1;TTLL1;TTLL7;TTLL4
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.18628910171902413,-0.6515060136760072,0.937984496124031,0.9811448179407825,1.0,20/33,34.86%,RFC1;MRE11;PINX1;CTC1;SHQ1;TNKS1BP1;WRAP53;CDK2;TERT;DCLRE1B;GAR1;PPP6R3;TERF1;NOP10;RTEL1;ZBTB48;ACD;RAD51;PPP6C;NHP2
prerank,apoptotic mitochondrial changes (GO:0008637),0.2789079159331474,0.6514014313976633,0.8934707903780069,0.9820157380538805,1.0,8/32,19.60%,FZD9;BCL2L1;BAK1;TIMM50;HK2;ATG3;DNM1L;FIS1
prerank,smooth muscle contraction (GO:0006939),0.32152848231166037,0.6512076965718274,0.8812664907651715,0.9818257050596746,1.0,3/14,19.65%,SLC8A1;SMTN;ROCK2
prerank,negative regulation of binding (GO:0051100),0.25798001491686406,0.650831977624061,0.9268795056642637,0.9818134937430743,1.0,20/81,24.72%,BAG2;PRKCD;ACTB;TFIP11;DISC1;CTSZ;PSME3IP1;SORL1;LRRK2;TLE5;RSF1;DACT1;GSK3B;TFAP4;PIN1;MITD1;RACK1;IFIT1;DDX11;ILRUN
prerank,central nervous system neuron development (GO:0021954),0.3131005400106867,0.6507739460953866,0.8663967611336032,0.9815225108852522,1.0,8/15,28.35%,ATP7A;PTEN;HSP90AA1;GBA2;B4GALT6;HSP90AB1;B4GALT5;MAP2
prerank,positive regulation of developmental process (GO:0051094),0.2536621173860546,0.6507484420065083,0.973,0.9812088275102985,1.0,28/164,19.92%,SHH;BASP1;RREB1;MAD2L2;DDHD1;MDK;TNF;APOE;CEBPB;CPEB3;SOX9;NR2C2;SORL1;LRP8;SOX6;SRC;RTN4;CORO1C;VHL;VLDLR;AGO2;SHLD1;TAPT1;SHLD2;GDNF;DNM1L;FIS1;RELN
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.330997446351935,0.6505729342976201,0.8496551724137931,0.9810207421789849,1.0,1/12,3.05%,DHRS3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2989406557074188,0.6501690003536076,0.8708860759493671,0.9810253719596339,1.0,2/19,5.93%,RENBP;NAGK
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.24998321497537151,-0.6501341602190566,0.927536231884058,0.9803879792205632,1.0,3/12,16.07%,DSE;VCAN;DCN
prerank,RNA export from nucleus (GO:0006405),0.25732623198883914,0.6501304580875261,0.9452332657200812,0.9807209816933965,1.0,26/100,20.95%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,negative regulation of wound healing (GO:0061045),0.2847902094767451,0.6500594733850481,0.889018691588785,0.9804417808092635,1.0,8/28,22.70%,TNF;APOE;CASK;PTEN;CRK;FGF2;VTN;CLASP1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.3235631409994553,0.6499593373922183,0.8581081081081081,0.9801951293443214,1.0,3/14,15.03%,AIF1;MEF2C;LRP1
prerank,cellular response to alkaloid (GO:0071312),0.30337633858538277,0.6498088650211727,0.8615384615384616,0.9799922447517478,1.0,5/17,22.31%,SLC8A1;CASP7;GSTM2;SPIDR;TGM2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.29253320460167254,0.6489540311092352,0.8764988009592326,0.9804119568569535,1.0,8/22,25.95%,MDK;CASK;STXBP4;SRSF6;ZFP36L1;CDH3;EPB41L4B;MED1
prerank,mitochondrial translational termination (GO:0070126),0.2594060908194254,0.6485080485717067,0.9354508196721312,0.9804603535682771,1.0,26/88,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2722274388006719,0.6478782246630472,0.9004474272930649,0.9806846839363758,1.0,12/40,25.04%,PYCARD;BCL2L1;TP53;BMF;TNFSF10;GHITM;DNM1L;PRKN;BID;IGF1;PRELID1;MFF
prerank,Notch signaling involved in heart development (GO:0061314),0.32739282778838374,0.646889093446761,0.8459302325581395,0.9812044958147963,1.0,2/11,16.11%,SNAI1;RBPJ
prerank,peptidyl-lysine modification (GO:0018205),0.2557699113653211,0.6468072542901814,0.9388379204892966,0.9809429975408083,1.0,22/99,21.50%,BCL11A;NUP62;ATP7A;SEH1L;LOX;HDAC4;TPR;HDAC6;NUP205;HDAC9;NDUFAB1;ETFBKMT;UBA2;PIAS1;VPS33B;LOXL3;SENP6;SENP7;NUP54;SIRT5;NSMCE2;EEF1AKMT1
prerank,global genome nucleotide-excision repair (GO:0070911),0.2892095041377477,0.6467851483344238,0.8787515006002401,0.9806237848434813,1.0,8/26,24.19%,GTF2H1;RNF111;GTF2H5;ERCC1;RAD23B;ERCC4;PARP1;XPC
prerank,regulation of cell morphogenesis (GO:0022604),0.2832578731048865,0.6462295449375873,0.8896551724137931,0.9807565569140401,1.0,5/30,11.88%,CD44;MACF1;CAPZB;MOV10;PHIP
prerank,sensory perception of taste (GO:0050909),0.3285418366706423,0.6460329431469172,0.8633093525179856,0.9805743723167215,1.0,10/10,67.17%,CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;PKD1L3;PKD2L1
prerank,aggrephagy (GO:0035973),0.28341765675312325,0.6455292439148976,0.8730538922155688,0.9806558959566405,1.0,9/27,24.32%,UBE2V1;HDAC6;DYNC1H1;WDR81;UBE2N;WDFY3;PRKN;IFT88;DYNC1LI1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.30465548084365174,0.6449390175373798,0.8753315649867374,0.9808239101730168,1.0,1/16,2.82%,DHX9
prerank,xenobiotic transport (GO:0042908),0.30250782172016344,0.6449235842638398,0.8823529411764706,0.9805028321606443,1.0,3/17,15.26%,ABCC3;ABCC1;ABCA3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.24322451000470627,-0.6448645025290495,0.8843283582089553,0.982539089367105,1.0,6/12,36.40%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.2717048177298169,0.6446571726361087,0.8880266075388027,0.9803931144567999,1.0,7/39,16.11%,BMP2K;MAML3;TSPAN14;POGLUT1;NOD2;SRC;RBPJ
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.32716679483554334,0.6446097435489142,0.8587731811697575,0.9800965552694201,1.0,3/10,16.40%,PIH1D1;NUFIP1;ZNHIT6
prerank,DNA integrity checkpoint signaling (GO:0031570),0.27651213193370444,0.644107785117154,0.8914549653579676,0.9802015469477571,1.0,10/36,21.92%,BRIP1;CHEK2;DOT1L;CDC5L;DNA2;CDC6;ERCC6;CEP63;CDC45;RAD1
prerank,cellular response to dsRNA (GO:0071359),0.31122138508275454,0.6440931954510237,0.8588082901554405,0.9798797209552289,1.0,1/15,2.82%,DHX9
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.25174430225636013,-0.6436470914463279,0.8978102189781022,0.9815919274845673,1.0,3/12,14.87%,GMDS;UGP2;GFPT1
prerank,DNA conformation change (GO:0071103),0.3084327662665829,0.6433447018642457,0.871261378413524,0.9801854268974423,1.0,7/17,27.66%,HMGB1;TOP2A;TOP1;HHEX;NAA10;TOP3A;HMGB2
prerank,tRNA 5'-end processing (GO:0099116),0.30381982483157133,0.6432671347853811,0.8567567567567568,0.9799131130562068,1.0,3/15,15.01%,RPP38;RPP14;PRORP
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.27380980597952365,0.6425171061538937,0.8940397350993378,0.9802095137266386,1.0,4/40,12.53%,FAM111A;ATRX;BOD1L1;MCM9
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31998099316203144,0.6421126560902204,0.8741355463347165,0.9802189249593,1.0,4/12,14.16%,RBM15B;METTL3;CDYL;LRIF1
prerank,female gonad development (GO:0008585),0.2984138962776801,0.6420748870608778,0.8813349814585909,0.9799196409853135,1.0,3/19,10.55%,CEBPB;EIF2B2;INHBA
prerank,renal system development (GO:0072001),0.2657201517577443,0.6420430960287903,0.9164859002169198,0.97961497579908,1.0,6/52,11.41%,PCSK9;TGFBR1;MYOCD;TFAP2B;SULF2;PYGO2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.29668045619399275,0.6419328601436122,0.8813559322033898,0.9793719347429537,1.0,4/18,18.41%,ASH1L;SETD2;SUV39H1;SETD1B
prerank,kinetochore organization (GO:0051383),0.3134103465595179,0.6413073891033505,0.8682385575589459,0.9795741773705582,1.0,13/13,68.68%,MIS12;CENPT;CDT1;POGZ;CENPC;CENPW;NUF2;DLGAP5;CENPA;CENPF;NDC80;CENPH;CENPE
prerank,negative regulation of hemostasis (GO:1900047),0.323287028781345,0.6409365767826339,0.8686030428769018,0.9795513579539121,1.0,1/12,4.14%,APOE
prerank,folic acid metabolic process (GO:0046655),0.30303890851747384,0.6408547514242854,0.8821243523316062,0.979286624846248,1.0,1/18,2.77%,MTHFS
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.28001257448561734,0.6408036535938981,0.8877551020408163,0.9789976781100487,1.0,6/30,17.43%,SCN4B;PKP2;NEDD4L;KCNA5;CACNA1D;SCN5A
prerank,chromatin assembly (GO:0031497),0.268799032728308,0.64073246383453,0.8961187214611872,0.9787113664845706,1.0,11/38,22.83%,TP53;ATRX;NAP1L1;SOX9;NOC2L;SPTY2D1;RSF1;RBBP4;LIN54;SMARCA5;H3-3A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2579392664983343,0.6406515984282002,0.9332638164754953,0.9784363934216948,1.0,8/72,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;ATRX;RPL26
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2996522566602661,0.6401566959777307,0.8683229813664596,0.9785024238403123,1.0,7/18,27.11%,DDHD1;DNM1L;FIS1;PRKN;KDR;MFF;MCU
prerank,negative regulation of growth (GO:0045926),0.25246903445017543,0.6393007835829159,0.9657258064516129,0.9789192023914729,1.0,12/121,12.34%,TGFB1;PTPRJ;NME6;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.30347558811575986,0.6389023405152126,0.8809523809523809,0.9789175331543275,1.0,7/16,23.29%,SH2B3;NF2;ADIPOR1;PPP2CA;VHL;SOCS3;INPP5F
prerank,cell-cell junction organization (GO:0045216),0.25348597334976036,0.6384378538137966,0.9421487603305785,0.9789774208001225,1.0,13/79,16.24%,TGFB1;CSF1R;PKP2;FLCN;SMAD3;CDH8;LIMS1;CDH9;CDH12;TLN1;CADM1;DCHS1;CDH19
prerank,protein sumoylation (GO:0016925),0.26597298516424644,0.6381517835212827,0.9158576051779935,0.9788738701523668,1.0,7/49,15.15%,BCL11A;NUP62;SEH1L;TPR;NUP205;UBA2;PIAS1
prerank,response to UV-A (GO:0070141),0.30489617643478345,0.6380347493141876,0.8729508196721312,0.9786404111000893,1.0,1/14,5.21%,TIMP1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.32644533209827253,0.6378382201767244,0.8595271210013908,0.9784741622393214,1.0,5/12,20.21%,WNK1;ATP1B3;ATP1B2;WNK4;FXYD1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3112818612280177,0.6377520272659335,0.8676880222841226,0.9782128656869825,1.0,3/13,16.11%,TGFBR2;GSK3A;RBPJ
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2993361855820479,0.63763600177919,0.8893129770992366,0.97797118854125,1.0,3/19,17.43%,MTHFS;GGH;FPGS
prerank,neuron projection regeneration (GO:0031102),0.3279161620782974,0.6375444559367016,0.8657817109144543,0.9777140572413751,1.0,1/10,3.71%,RTN4RL1
prerank,epithelial cell development (GO:0002064),-0.20057685856446716,-0.6371606451065859,0.9315068493150684,0.9845629282821642,1.0,13/20,49.97%,WNT5B;ACTA2;PDZD7;EXPH5;RILPL2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,positive regulation of axon extension (GO:0045773),0.28946687914435704,0.637035985107714,0.8948685857321652,0.9777846189966448,1.0,4/22,13.51%,MACF1;NRP1;TWF2;MEGF8
prerank,positive regulation of DNA repair (GO:0045739),0.2610339717010344,0.63634390294253,0.9096774193548387,0.9780243862172936,1.0,11/46,20.14%,DHX9;HMGB1;BABAM2;MGMT;SLF2;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR;SPIDR
prerank,purine nucleotide metabolic process (GO:0006163),0.2853395767242409,0.6361107272620341,0.875609756097561,0.9778874607527108,1.0,4/24,14.45%,XDH;GART;PNP;PRPSAP1
prerank,coenzyme A metabolic process (GO:0015936),0.31037935383053017,0.6349257162096772,0.88268156424581,0.978511058926988,1.0,1/14,3.26%,SLC25A16
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.32474268080129765,0.6345504306405554,0.8640915593705293,0.9781706552995454,1.0,2/10,18.46%,WNK1;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.32474268080129765,0.6345504306405554,0.8640915593705293,0.9781706552995454,1.0,2/10,18.46%,WNK1;MAP2K5
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.3140416873171313,0.634511671392711,0.8585034013605443,0.9778704382915828,1.0,1/13,3.19%,SLC8A1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.2887166238123041,0.6339319035575203,0.8656898656898657,0.9779785081335552,1.0,5/21,23.51%,OSBPL10;OSBPL8;PLAAT3;PLA2G5;PLA2G4E
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.2900664089136295,0.6326418638382384,0.8848560700876095,0.9787221257551795,1.0,8/20,25.25%,PPIE;CWC27;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,muscle tissue morphogenesis (GO:0060415),0.298248341758725,0.632491707180344,0.8832684824902723,0.9785143802057393,1.0,1/16,4.28%,TTN
prerank,cellular response to misfolded protein (GO:0071218),0.2863095624843927,0.632415623473758,0.8829389788293898,0.9782345076204962,1.0,9/20,27.32%,ATXN3;DERL1;TOR1A;STUB1;CUL3;DNAJB14;KLHL15;UGGT2;VCP
prerank,sphingosine biosynthetic process (GO:0046512),0.321989610349683,0.6321538653996348,0.8557422969187675,0.9777755365459466,1.0,4/11,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.321989610349683,0.6321538653996348,0.8557422969187675,0.9777755365459466,1.0,4/11,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,calcium ion import (GO:0070509),0.27568606417551,0.6320851963781602,0.8919567827130852,0.9774986143126305,1.0,6/28,17.73%,SLC8A1;CACNA1A;CACNB2;CACNA1B;CACNA1D;MICU2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.31582421625287344,0.631788914018511,0.8680057388809183,0.9774100729134068,1.0,1/11,6.29%,CTNNB1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.25668442149158,-0.631190866709035,0.9015873015873016,0.9869962188707938,1.0,2/10,8.81%,ATP1A2;FKBP1A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.22053352152001088,-0.6311015494417123,0.9516129032258065,0.985222214839094,1.0,2/15,6.53%,DSE;VCAN
prerank,regulation of Notch signaling pathway (GO:0008593),0.2524261748885196,0.6309901625304625,0.9487704918032787,0.9777220161188951,1.0,8/76,12.25%,LFNG;BMP2K;MAML3;SREBF2;TSPAN14;POGLUT1;METTL3;NOD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.28605141937212414,0.6306388541391592,0.8920953575909661,0.9776721078038224,1.0,4/20,20.45%,BCL2L1;BAK1;GSK3A;GSK3B
prerank,negative regulation of histone methylation (GO:0031061),0.327124937466016,0.630540095574332,0.8766328011611031,0.9774142214052903,1.0,5/10,28.12%,MTF2;PHF1;DNMT3B;BCOR;JARID2
prerank,protein localization to nucleus (GO:0034504),0.2489673129100863,0.6299996056805366,0.961577350859454,0.977532734798675,1.0,14/102,16.66%,MMP12;SYK;NUP62;MORC3;CSE1L;TPR;TAF8;RRS1;TOR1AIP2;TOR1A;INTS13;TAF3;RPL11;APPL2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.267046926690372,0.6292156200995864,0.9165727170236753,0.9778342195884139,1.0,10/43,21.51%,TAOK3;NABP1;BABAM2;FZR1;FOXN3;CDC6;BABAM1;TAOK1;BRSK1;PABIR1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.2848808894448024,0.6289685457632374,0.9118012422360249,0.9777105934762955,1.0,1/22,3.81%,TNF
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.3062140466775203,0.6286294260954376,0.8663028649386084,0.9776411365966554,1.0,4/14,20.51%,ADPRM;ENTPD1;ENTPD2;ENTPD3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.31725856117339885,0.6285318336189835,0.8801169590643275,0.9773888599014148,1.0,3/11,21.23%,ITM2B;AGO2;ABCA2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28230468782682167,0.6285184502986764,0.8910648714810282,0.9770716865971302,1.0,9/24,26.38%,TPGS1;AGBL5;AGTPBP1;TTLL1;NAA80;TTLL7;PARP1;TTLL4;NAA10
prerank,protein tetramerization (GO:0051262),0.25505106466684935,0.6280604312140112,0.9525316455696202,0.9770988764108497,1.0,5/67,6.09%,ALDH9A1;SNCA;PKD2;SAMHD1;FARSB
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2492205381599951,-0.6280442775494026,0.9283489096573209,0.9854151583145542,1.0,7/10,39.13%,SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,cranial nerve development (GO:0021545),0.3194372758469217,0.6280148570063189,0.8788300835654597,0.9767999033837947,1.0,1/11,6.22%,CHD7
prerank,histone acetylation (GO:0016573),0.2526961322660333,0.6279062925809724,0.9510416666666667,0.9765520311322117,1.0,17/69,24.01%,BRD8;SPI1;EP400;TADA1;BRPF3;NAA40;KAT7;JADE2;NAA50;MEAF6;PER1;BRD1;YEATS2;PHF20;MORF4L2;MORF4L1;CHD5
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.22802280850728981,-0.6271956771124315,0.9288389513108615,0.9842449315277785,1.0,6/13,36.40%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,organelle fusion (GO:0048284),0.2807507999992689,0.6267393094696934,0.9041095890410958,0.9771865247870538,1.0,7/22,25.04%,VPS18;VPS11;MIGA1;FIS1;MFN1;EEA1;MFF
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.3160505061031506,0.6266312758945717,0.8626062322946175,0.9769417823461193,1.0,2/12,17.53%,SEH1L;MIS12
prerank,receptor recycling (GO:0001881),0.32533132786714924,0.6261587172882856,0.8949704142011834,0.9769954252318651,1.0,2/10,12.78%,ARFGEF2;SORL1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.21238034358860625,-0.6260050314094557,0.9099099099099099,0.9831970239232142,1.0,4/17,26.87%,AKAP13;RAPGEF2;DRD2;ADRB2
prerank,translational termination (GO:0006415),0.249432062171717,0.6259468807655012,0.9499489274770173,0.9768216632686995,1.0,27/95,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;GSPT1;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,post-translational protein modification (GO:0043687),0.241432109346536,0.6257268002185935,1.0,0.9766590047628885,1.0,55/332,18.91%,PCSK9;WDTC1;COPS6;APOE;DNAJC3;FBXL22;SPP1;RNF7;TIMP1;FBXL18;PTP4A2;KLHL21;PSMB10;P4HB;CHML;RAB11A;RAB1B;VGF;FAM20C;LGALS1;CHGB;PSMA2;RBBP5;FBXO40;KLHL11;RBBP7;FBXO32;F5;PSME3;STT3B;SUMF2;FBXL3;COPS4;GAS6;PSMB5;WFS1;PSMD8;CCDC8;DCAF17;PSMD7;GAN;PSMB9;HIF1A;APLP2;WSB2;DCAF5;FEM1B;VHL;PSMD2;KEAP1;FBXO44;MXRA8;SPSB2;IGFBP4;ELOB
prerank,inositol phosphate catabolic process (GO:0071545),0.31215478862622864,0.6253409044053686,0.8803418803418803,0.9766313436102919,1.0,5/12,23.28%,SYNJ1;PTEN;INPP5K;NUDT3;OCRL
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2026810994340514,-0.6244667571346537,0.9644444444444444,0.9823492547094403,1.0,10/20,32.04%,FAR1;ACLY;PPT1;CBR4;ACSL4;ACSL3;HSD17B4;FITM2;GCDH;SLC25A1
prerank,regulation of neurotransmitter transport (GO:0051588),0.29735669388497277,0.6238491658905048,0.891644908616188,0.9775105468682719,1.0,2/16,8.10%,MCTP1;MEF2C
prerank,maturation of SSU-rRNA (GO:0030490),0.2671933910305081,0.6237284385187266,0.9244444444444444,0.9772781926030925,1.0,9/34,20.88%,NOB1;RPS16;HEATR1;RPS14;TSR1;NGDN;RIOK3;UTP3;SRFBP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3142907109026809,0.6236924607578087,0.8939828080229226,0.976654220836205,1.0,1/11,4.10%,PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3142907109026809,0.6236924607578087,0.8939828080229226,0.976654220836205,1.0,1/11,4.10%,PKD2
prerank,DNA biosynthetic process (GO:0071897),-0.2142521471081723,-0.6236198508807098,0.9128630705394191,0.9810818367496437,1.0,11/16,35.85%,WRNIP1;WRN;POLA1;TERT;TYMS;POLD2;RFC3;POLE;CDKN2D;POLD4;POLD1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.265458557035192,0.623593893757351,0.9111111111111111,0.9764042256554422,1.0,12/39,21.76%,ACTN4;CASK;NF2;THBS1;PTPRO;RASA1;CORO1C;RHOA;SPRY4;CORO2B;MAP4K4;CX3CL1
prerank,amino sugar metabolic process (GO:0006040),0.31712307466197054,0.6234243212971742,0.8744650499286734,0.9762242755616511,1.0,3/10,19.34%,ST3GAL1;SLC35A3;FN3K
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.30165973150183845,0.6229777212252842,0.8839050131926122,0.9762362032559002,1.0,2/15,7.37%,MEF2A;SLC9A1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3175039338118895,0.6226317412328444,0.889367816091954,0.9761498801248296,1.0,4/10,21.27%,EMC6;EMC2;MMGT1;EMC3
prerank,vitamin transport (GO:0051180),0.2792407929580253,0.6222730994124879,0.9196217494089834,0.9761125485935248,1.0,1/29,1.98%,SLC52A1
prerank,DNA damage checkpoint signaling (GO:0000077),0.27874629257502404,0.6218259066214131,0.9157641395908543,0.9761282645433197,1.0,4/28,8.23%,BRIP1;CHEK2;DOT1L;CDC5L
prerank,regulation of endocytic recycling (GO:2001135),0.31434818548225624,0.6214028920900043,0.8764044943820225,0.9761309752633923,1.0,5/11,23.51%,ARHGAP1;SORL1;EIPR1;INPP5F;PLA2G4E
prerank,establishment of endothelial barrier (GO:0061028),0.27130336878963046,0.6208631711655803,0.8990610328638498,0.9762328214185136,1.0,7/29,17.18%,RAP1B;RAP2B;F11R;RAB1B;RAPGEF1;RAP1A;PECAM1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.28783515857263564,0.6204395670651226,0.8881748071979434,0.9762259267643765,1.0,5/18,22.65%,FZD9;BAK1;GSK3A;GSK3B;BID
prerank,regulation of TORC1 signaling (GO:1903432),0.26899875289326824,0.6202099013316418,0.9042056074766355,0.9760656473030155,1.0,9/33,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;RNF152;PIH1D1;TELO2;RRAGA;RRAGB
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.29098545827543854,0.6199422432688827,0.9080604534005038,0.9759454314705822,1.0,4/19,16.12%,NDST1;XYLT1;EXTL3;NDST2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.24899964349552833,0.6199103208609986,0.9400206825232679,0.975647769464658,1.0,19/80,21.61%,LAPTM5;RPS2;MALT1;PDCD6;DERL1;AMER1;ARRDC4;STUB1;HUWE1;WFS1;LRRK2;GSK3A;UBE2N;BIRC2;ANGPT1;DCUN1D5;CUL3;BIRC3;PIN1
prerank,modified amino acid transport (GO:0072337),0.30082729193185653,0.6190282901328503,0.8883048620236531,0.9759908940309326,1.0,3/15,15.11%,CTNS;MGST1;SLC1A4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.2944954052738108,0.6186335694508853,0.9108781127129751,0.9759520215330767,1.0,1/17,3.24%,MAML3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3172732300101726,0.6183217448419956,0.8834080717488789,0.9758596291780985,1.0,4/10,19.44%,SVIP;UBE2G2;ERLEC1;OS9
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.26615268682693066,0.6180339877718085,0.8931475029036005,0.9757659345673081,1.0,9/31,22.65%,YWHAB;TP53;BAK1;CASP8;GSK3A;YWHAH;NMT1;GSK3B;BID
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2569610076690019,0.6170685802570478,0.9372340425531915,0.9758407424523977,1.0,7/50,11.71%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,regulation of gene silencing by RNA (GO:0060966),0.2569610076690019,0.6170685802570478,0.9372340425531915,0.9758407424523977,1.0,7/50,11.71%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,histone ubiquitination (GO:0016574),0.28073737257017223,0.6168998583924503,0.895910780669145,0.9756432639810564,1.0,7/21,23.31%,LEO1;PHC1;RNF40;HUWE1;UBE2N;UBE2E1;CTR9
prerank,regulation of autophagosome assembly (GO:2000785),0.2645450112581296,0.6167297910034825,0.9095182138660399,0.9754438738791258,1.0,11/33,24.20%,PIP4K2A;RAB3GAP2;MTMR3;RAB1B;LRRK2;TBC1D14;TBC1D12;SEC22B;NPRL3;ADPRH;IFT88
prerank,organophosphate ester transport (GO:0015748),0.27673869548418967,0.616639914691386,0.8948626045400239,0.9751921984582014,1.0,4/24,15.26%,NPC2;PRELID3B;OSBPL8;ABCA3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.2870803153986477,0.616162575301712,0.8876262626262627,0.9752336563239036,1.0,3/18,19.95%,PRKCB;BRAF;INPP5K
prerank,positive regulation of cartilage development (GO:0061036),0.28831912102903956,0.6157680005872166,0.8877928483353884,0.9752090976394594,1.0,3/17,13.61%,MDK;SOX9;SOX6
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2778727431259516,0.6153557133555144,0.8914919852034525,0.9751957764706275,1.0,4/22,15.10%,MTOR;HEATR1;SMARCB1;PIH1D1
prerank,regulation of nuclear division (GO:0051783),0.27806300543059986,0.6153259787956469,0.9,0.9748955684897835,1.0,5/20,26.48%,KIF20B;CCDC8;PIN1;FBXO5;DAPK3
prerank,response to peptide hormone (GO:0043434),0.25794417301906225,0.6151013445213483,0.9289617486338798,0.9747342025976358,1.0,10/43,19.71%,STAT5A;ANXA1;STAT4;STAT5B;EIF2B2;CREB1;SRC;ZBTB7B;ROCK2;SORT1
prerank,icosanoid secretion (GO:0032309),0.29882183067789514,0.6149165668592858,0.8777173913043478,0.9745515427563511,1.0,3/12,21.31%,ANXA1;PLA2G5;ABCC4
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.2415622746967368,-0.6148138983418675,0.9055944055944056,0.9847577283199067,1.0,3/11,23.11%,SIK1;C1QTNF3;CRY1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30632254386429925,0.6147482186856286,0.8822674418604651,0.9743594956443405,1.0,1/11,3.77%,NR1H4
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2598520311593645,0.6127924140314258,0.9184597961494904,0.9754579130322598,1.0,4/36,8.53%,RAB34;RAB7A;MACF1;RAB31
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.30677356469430495,0.6124908169111993,0.8957142857142857,0.9753569808681118,1.0,1/11,6.22%,LIG3
prerank,maintenance of protein location in nucleus (GO:0051457),0.2815040856966326,0.6119971813688341,0.9149198520345253,0.9753982605611738,1.0,4/20,15.91%,MORC3;SYNE1;TAF8;TAF3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.23628892876770197,0.6114955725648189,0.99,0.9754259474823518,1.0,27/224,15.78%,PCDHB6;PRKAR2B;SNCA;KCNIP2;CEL;AKAP5;NRGN;ATXN3;APBA1;PTCHD1;CACNA1A;CACNB4;GABRA5;SYT10;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;GABRA4;CACNA1B;MPZ;GRIA1;RPS6KA2
prerank,regulation of lipid metabolic process (GO:0019216),0.24434428204292727,0.6109879971839842,0.9639917695473251,0.9754546331446867,1.0,15/88,18.30%,PSAP;NPC2;SREBF2;ZFP69;TBL1XR1;TBL1X;ADIPOR1;SMARCD3;GPS2;SREBF1;FASN;ACACA;PPARD;NFYA;RXRA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.26536981192017234,0.6106765948256481,0.9252873563218391,0.9753531578395592,1.0,9/30,23.84%,TENT4B;TP53;STN1;SRC;TINF2;TERF2;ERCC4;TEN1;DCP2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3030038119362703,0.6104353225276741,0.8970792767732962,0.9752039789682251,1.0,2/12,11.45%,IREB2;ACO1
prerank,acidic amino acid transport (GO:0015800),0.29382141514305454,0.609950839181814,0.8903061224489796,0.9752411767564997,1.0,5/17,24.22%,LRRC8D;SLC25A18;GIPC1;SLC6A6;GJA1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3062258681219988,0.609814641876606,0.909985935302391,0.9750088440097452,1.0,2/11,14.05%,CCT8;CCT5
prerank,arachidonic acid secretion (GO:0050482),0.31046100784667596,0.6097794111484416,0.8946608946608947,0.9743879822463385,1.0,1/10,6.34%,ANXA1
prerank,arachidonate transport (GO:1903963),0.31046100784667596,0.6097794111484416,0.8946608946608947,0.9743879822463385,1.0,1/10,6.34%,ANXA1
prerank,axon development (GO:0061564),0.24444452593327157,0.6095592468855475,0.9542619542619543,0.9742488391735982,1.0,15/78,20.23%,NEFH;S100B;SLITRK1;RTN4RL1;ACTB;MAP1B;ATL1;SVBP;MTR;CAMSAP2;RTN4;SPTBN4;KLF7;CNTN4;CDK5R1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19284034630515443,-0.60933577218397,0.9723756906077348,0.9862244630097381,1.0,6/21,22.53%,ATAD5;BRD4;CDK4;CDC7;NPM1;RAD51C
prerank,snRNA 3'-end processing (GO:0034472),0.2872050238853709,0.6090516340403247,0.912987012987013,0.9742754707887104,1.0,7/19,22.63%,INTS8;INTS6;INTS6L;INTS1;EXOSC3;TOE1;EXOSC2
prerank,DNA packaging (GO:0006323),0.290861769065656,0.6090020813352292,0.8940568475452196,0.9739870533556686,1.0,3/16,19.59%,TP53;NOC2L;RBBP4
prerank,sulfur amino acid catabolic process (GO:0000098),0.30741289165305796,0.6081719112938758,0.8727272727272727,0.9742536663730617,1.0,2/10,16.86%,TXN2;CBS
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.26254647391617836,0.6080391192105971,0.9286563614744352,0.974020844536083,1.0,5/30,13.78%,RAB34;MACF1;RAB31;SEC16A;GGA2
prerank,positive regulation of histone modification (GO:0031058),0.26479694596787123,0.6077203548908855,0.9336332958380202,0.973934392643172,1.0,12/33,27.11%,PPARGC1A;RPS6KA4;BRD7;AKAP8L;ZBTB7B;UBE2N;RPS6KA5;CTBP1;ARRB1;GLYR1;SART3;MAPK3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.2930859907914702,0.6076460785373189,0.8961748633879781,0.9736670597044362,1.0,6/14,25.83%,SEC24D;SAR1A;SEC13;SEC31A;SEC24C;SEC24A
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2916844998610093,0.6076379309079301,0.9034749034749034,0.9733533334890951,1.0,3/16,15.51%,MCM6;MCM2;TWNK
prerank,axonal transport (GO:0098930),0.25641249745104333,0.6074454464486929,0.9284903518728718,0.9731764401199074,1.0,9/36,20.41%,AP3D1;AP3S1;DTNBP1;DYNC1H1;DST;HIF1A;KIF1B;KIF3A;FBXW11
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2746303983062387,0.6071672903921403,0.914043583535109,0.9730556446681728,1.0,6/22,21.64%,APOE;MAP1B;CAMSAP2;GBA2;AEBP1;PIK3CA
prerank,histone H3 acetylation (GO:0043966),0.2571696084672208,0.6071265834934195,0.9219620958751393,0.9727663654918228,1.0,9/40,20.73%,SPI1;TADA1;BRPF3;KAT7;JADE2;MEAF6;PER1;BRD1;YEATS2
prerank,ncRNA metabolic process (GO:0034660),0.2601582685440553,0.6067558533811396,0.9229024943310657,0.9727155466955979,1.0,9/37,24.76%,TENT4B;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DICER1;ZCCHC8;DROSHA
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2826343393940617,0.6066941154300505,0.9144654088050315,0.9724457732768143,1.0,6/19,21.79%,CDA;PNP;POLD3;DCK;APRT;GMPR2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.3127944458578874,0.6062918137484428,0.8938053097345132,0.9724193424881108,1.0,3/10,19.03%,GABRA5;GABRA4;GABRG1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.2890146660787979,0.6062800310234356,0.9108527131782945,0.972110451872356,1.0,2/17,10.05%,PKP2;NEDD4L
prerank,tyrosine metabolic process (GO:0006570),-0.23655623228897038,-0.6062354626430015,0.9176829268292683,0.9861533342524148,1.0,5/11,41.92%,FAH;GSTZ1;TYR;HGD;IL4I1
prerank,negative regulation of coagulation (GO:0050819),0.30011664841716224,0.6051268141486235,0.8979591836734694,0.9726004509527905,1.0,1/14,4.14%,APOE
prerank,dermatan sulfate metabolic process (GO:0030205),-0.227437203135165,-0.6050429486270034,0.9347826086956522,0.9850211143751022,1.0,2/13,6.53%,DSE;VCAN
prerank,body fluid secretion (GO:0007589),0.2945706965106881,0.6046705444288697,0.907859078590786,0.9726211000772441,1.0,4/15,26.25%,PRLR;ZBTB7B;VEGFA;ERBB4
prerank,cellular amino acid catabolic process (GO:0009063),0.24162238247427176,0.6045414204763792,0.9713114754098361,0.9724046078373262,1.0,10/87,13.61%,CRYM;HAAO;OGDH;KYNU;KMO;QDPR;ECHS1;MCCC2;ALDH7A1;DDAH1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.30342721395755334,0.6044596646003466,0.8991596638655462,0.9721371491036487,1.0,2/12,8.14%,ATIC;GART
prerank,peptidyl-lysine methylation (GO:0018022),0.2677257819958878,0.6039209474723511,0.9108433734939759,0.9722033075959963,1.0,5/26,16.48%,SETD6;SETD2;ETFBKMT;SMYD3;SUV39H1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.24158019335532213,0.6017481418370211,0.950259067357513,0.97346027910668,1.0,14/79,18.40%,PTPN1;UBE2D3;SKI;CREB3L1;SULF2;PDCD6;CASK;THBS1;SORL1;BAMBI;SMURF1;RBPMS2;SPRY4;GREM1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.28999859426067853,0.6001117030061955,0.9174560216508796,0.9742461517808201,1.0,4/15,18.09%,LDLRAP1;PPARD;ADM;PPM1K
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.2848772793276945,0.599780230411711,0.9088507265521797,0.9741591004794031,1.0,4/16,23.95%,THBS1;FGF2;PPP1R16B;VEGFA
prerank,translesion synthesis (GO:0019985),0.2513355235359084,0.599770599899089,0.9407244785949506,0.9738475296096063,1.0,3/42,6.94%,TRIM25;MAD2L2;POLH
prerank,positive regulation of histone methylation (GO:0031062),0.2669973163109944,0.5984111082711374,0.9146039603960396,0.9744580012940143,1.0,3/24,12.31%,PRDM12;CTNNB1;MTF2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.29573128334234217,0.5975735825382129,0.8964088397790055,0.9743738645424557,1.0,2/11,14.05%,CCT8;CCT5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.29573128334234217,0.5975735825382129,0.8964088397790055,0.9743738645424557,1.0,2/11,14.05%,CCT8;CCT5
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2988560991621615,0.5971000311583341,0.9034090909090909,0.9743948645726109,1.0,2/12,9.18%,ABCD1;PPARGC1A
prerank,hippo signaling (GO:0035329),0.2584230126899407,0.5968382335299098,0.9148936170212766,0.9742469398948097,1.0,8/26,20.79%,TEAD1;YWHAB;STK3;MOB1B;DCHS1;STK4;MOB1A;AMOT
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27541183074599557,0.5955188670177745,0.9176904176904177,0.9748026774557245,1.0,7/20,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2370402025314984,0.5953164804058007,0.9675732217573222,0.9746242382978211,1.0,19/80,20.57%,KLC2;TMED3;KDELR2;KIF23;UVRAG;RAB1B;BNIP1;COPA;SCYL1;BICD2;KIF2A;LMAN2;USE1;ERGIC1;GOLPH3;SEC22B;KIF3A;ARCN1;COG7
prerank,negative regulation of reproductive process (GO:2000242),0.2791644618375667,0.5949274062839858,0.9238845144356955,0.9745771621582257,1.0,2/17,9.88%,TIMP1;ARHGDIB
prerank,negative regulation of endopeptidase activity (GO:0010951),0.24969479913747078,0.59447201869555,0.9394273127753304,0.9745552194905981,1.0,2/47,5.21%,PCID2;TIMP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2106529419928296,-0.5943955268218776,0.930327868852459,0.9887824874172431,1.0,4/15,16.36%,CCT3;CCT6A;SHQ1;RUVBL1
prerank,signal release from synapse (GO:0099643),0.24907954104549587,0.5937396489392863,0.9375,0.9747370585196422,1.0,9/43,21.32%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,establishment of melanosome localization (GO:0032401),0.2764392421760691,0.5920539140269852,0.9154228855721394,0.9755563054584128,1.0,2/19,9.82%,MYO5A;RAB11A
prerank,innate immune response in mucosa (GO:0002227),0.3043536768925237,0.5911824324462174,0.9015691868758916,0.9757871864069064,1.0,1/10,12.30%,DEFA6
prerank,melanosome localization (GO:0032400),0.26952823524045294,0.5906721421334026,0.9211165048543689,0.975791952995193,1.0,4/21,18.15%,MYO5A;RAB11A;RAB27B;VPS33B
prerank,intraciliary retrograde transport (GO:0035721),-0.23096924049582532,-0.5905223653941407,0.9375,0.9888168470648154,1.0,6/12,29.57%,WDR35;IFT43;DYNC2I2;IFT122;WDR19;DYNC2H1
prerank,cognition (GO:0050890),0.24629290823903424,0.5885543040828926,0.9555061179087876,0.9768543224359466,1.0,12/42,21.39%,TNF;CHD7;PTCHD1;LINS1;CYFIP1;CTNS;SLC1A4;NF1;CUX2;TUSC3;SETD5;MAGT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.26363255261342255,0.5882399660340835,0.929678188319428,0.9767358083011828,1.0,8/25,27.53%,NDST1;FUT9;B3GALNT1;NDST2;NDST4;B3GALT2;EXT2;B3GNT9
prerank,microtubule polymerization (GO:0046785),0.25707785632669244,0.5879816263146813,0.9286536248561565,0.976588318774445,1.0,4/29,12.77%,FGF13;TUBGCP6;TUBGCP4;RANBP9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.28039042712212847,0.5878840347004376,0.9210526315789473,0.9763310953405356,1.0,2/16,7.37%,MEF2A;SLC9A1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.26174268932370726,0.5876068189080984,0.9345029239766082,0.9762045245137503,1.0,5/27,15.11%,SLC7A8;SLC25A38;SLC36A4;SLC25A18;SLC1A4
prerank,mitochondrial gene expression (GO:0140053),0.2498522978525486,0.5875295937986564,0.9470124013528749,0.9759422558669573,1.0,15/42,27.38%,FOXO3;GATB;MRPL51;LARS2;TWNK;MRPS21;MRPS14;TFAM;MRPL12;GATC;MRPS34;MRPS12;MRPS15;MRPL16;MRPS24
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2708799576052869,0.5874664606469128,0.9163591635916359,0.9753462174368757,1.0,7/21,24.85%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2708799576052869,0.5874664606469128,0.9163591635916359,0.9753462174368757,1.0,7/21,24.85%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.279563392641119,0.5872726873166548,0.9268929503916449,0.9751504749179534,1.0,8/16,28.88%,NAA40;NAA50;NAA25;NAA15;NAA80;NAA10;CREBBP;EP300
prerank,chemical synaptic transmission (GO:0007268),0.22574428089233395,0.5868997921640617,0.998,0.9750788021042602,1.0,35/284,15.92%,PCDHB6;PRKAR2B;SNCA;APOE;KCNIP2;CEL;AKAP5;NRGN;ATXN3;RIMBP2;APBA1;PTCHD1;STXBP3;CACNA1A;CACNB4;GABRA5;SYT10;CDH8;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;STAC3;GABRA4;CACNA1B;PDZD11;SLC1A4;MPZ;GRIA1;RPS6KA2;DNAJC5
prerank,protein autoubiquitination (GO:0051865),0.2396159770138807,0.5866038255694116,0.9582887700534759,0.9749602130350792,1.0,8/61,13.60%,RNF19B;UBE2D3;TRAF2;RNF4;NFX1;RNF10;ITCH;STUB1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.25045447594787257,0.5865788971636859,0.9402810304449649,0.9746589050801754,1.0,4/31,13.51%,TGFBR1;TGFBR2;DYNC2I1;MEGF8
prerank,transport along microtubule (GO:0010970),0.28795957529566296,0.5864138214192128,0.9014844804318488,0.9744499933966242,1.0,3/13,11.51%,APBA1;ARHGAP21;BORCS5
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2673558627570347,0.5859593827653311,0.9432098765432099,0.9744016007333415,1.0,1/20,2.77%,MTHFS
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2504565296161168,0.5858935874099382,0.9465301478953356,0.9741273787672561,1.0,6/32,18.94%,TAOK3;BABAM2;FZR1;FOXN3;BABAM1;TAOK1
prerank,positive regulation of RNA splicing (GO:0033120),0.25764354649654564,0.5852298969985501,0.9354460093896714,0.9742131315870456,1.0,5/29,15.80%,ERN1;CIRBP;TRA2B;PRDX6;THRAP3
prerank,regulation of primary metabolic process (GO:0080090),0.22975731197409516,0.584690811028811,0.9778449144008057,0.9742539518540481,1.0,25/126,19.67%,PSAP;SREBF2;APOE;ZFP69;PSMB10;TBL1XR1;TBL1X;PSMA2;ADIPOR1;PSME3;SMARCD3;GPS2;PSMB5;PSMD8;SREBF1;FASN;PSMD7;PSMB9;ACACA;PPARD;NFYA;PSMD2;RXRA;ROCK2;C1QTNF2
prerank,regulation of cation transmembrane transport (GO:1904062),0.2579545315791921,0.5843088818913238,0.9191090269636577,0.9741624848475342,1.0,5/29,17.43%,KCNIP2;WNK1;CD63;CACNA1D;SCN5A
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.2968105807735242,0.58391069336759,0.9322033898305084,0.9741013078996116,1.0,2/11,12.33%,P4HB;FYN
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2911385457262261,0.5838616319474378,0.9163237311385459,0.9738186612463553,1.0,2/12,14.05%,CCT8;CCT5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23062447185955104,0.5835635343937281,0.974120082815735,0.973692897287232,1.0,13/87,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;FASTKD3;UQCC1;CHCHD4;NDUFV1;NDUFS6;IMMP2L;NDUFAB1;COX20;NDUFB11
prerank,negative regulation of DNA recombination (GO:0045910),0.24614302021814682,0.5831346825748871,0.9542981501632208,0.9736442116417167,1.0,12/43,25.84%,MAD2L2;ATRX;POLR2L;SHLD1;POLR2E;SHLD2;TINF2;TERF2;PARP3;TERF2IP;KLHL15;ZRANB3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2885714155096537,0.5826267214773628,0.9107648725212465,0.9736446602801638,1.0,4/12,27.56%,ADCY8;PPP3CB;PLA2G6;STX4
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2335413845808245,0.5824428937587377,0.975051975051975,0.9734398062345505,1.0,6/72,13.58%,CBL;GRB2;RAB14;FLRT1;POLR2L;FIBP
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.27159938692732255,0.5816485874973235,0.9311688311688312,0.9736375992343478,1.0,2/18,8.96%,BCL2L1;BAK1
prerank,aminoglycan biosynthetic process (GO:0006023),0.24047298620183502,0.5807098515753005,0.9490238611713666,0.9739151444265429,1.0,8/49,16.12%,HEXA;AGRN;NDST1;XYLT1;B3GALNT1;B4GALT7;PXYLP1;NDST2
prerank,negative regulation of translation (GO:0017148),0.23243532155136934,0.5798608013554212,0.9661885245901639,0.9741163004703474,1.0,23/87,23.64%,CNOT8;YTHDF3;EIF4EBP2;LARP1;EPRS1;CPEB3;TPR;METTL3;PCIF1;IGF2BP3;CPEB4;PUS7;MEX3D;CPEB2;AGO2;ROCK2;FTO;LSM14A;CNOT7;CNOT1;EIF3E;RACK1;ILF3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.2867467603293752,0.579677393545615,0.9142857142857143,0.9739052653640722,1.0,6/12,24.97%,CBS;PHGDH;PSAT1;SERINC3;SEPHS2;PSPH
prerank,adherens junction organization (GO:0034332),0.23852450739664116,0.5795533923642685,0.9572368421052632,0.9736629092078191,1.0,15/48,22.05%,PIP5K1C;CTNNB1;ACTB;CDH8;VCL;CDH9;CDH12;CADM1;DCHS1;CDH19;CSK;CDH20;RAMP2;CDH15;CDH3
prerank,ribosome assembly (GO:0042255),0.2412096679885068,0.5774652273713747,0.946524064171123,0.9745941921270274,1.0,15/47,25.61%,ERAL1;RPL6;MDN1;RPS14;RRS1;RPL11;RPS27;RRP7A;EFL1;RPS15;RPS5;RPL10;EIF2A;C1QBP;RPL5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24580693228724623,0.5769168287960443,0.945823927765237,0.9746131949745485,1.0,10/37,23.39%,DDIT3;BCL2L1;TP53;BECN1;BMF;DNM1L;FIS1;RPS7;BID;RACK1
prerank,toxin transport (GO:1901998),0.30291039398942476,0.5768226299542787,0.9263888888888889,0.9743658828378269,1.0,3/10,24.52%,ANTXR2;RAB29;ANTXR1
prerank,retinal metabolic process (GO:0042574),-0.22876354063534518,-0.5763856286089764,0.984,0.9937564832537079,1.0,1/12,5.92%,RDH10
prerank,myelination in peripheral nervous system (GO:0022011),0.28633536549068433,0.5755872843276857,0.9322493224932249,0.9747837761588497,1.0,6/13,26.45%,SKI;PRX;NF1;DICER1;CNTNAP1;LGI4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.28377626945051887,0.5738232469108,0.9340659340659341,0.9754678610838656,1.0,3/13,17.56%,ALG2;DPAGT1;ALG11
prerank,leukotriene biosynthetic process (GO:0019370),-0.20819865180805897,-0.5737144225134305,0.9693486590038314,0.9930899609044832,1.0,1/14,2.21%,LTA4H
prerank,regulation of double-strand break repair (GO:2000779),0.24571786801394455,0.5730279487987028,0.9382022471910112,0.9756088389968608,1.0,13/39,26.32%,MGMT;ACTR2;SETD2;RNF169;SLF2;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP;DDX11;SIRT7;TRIP12
prerank,inorganic anion transmembrane transport (GO:0098661),0.23121379043599788,0.5705853394528303,0.9610115911485775,0.9767111432955194,1.0,7/63,13.67%,SLC37A2;GABRA5;XPR1;GLRA2;SLC20A2;SLC25A30;GABRA4
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.29392170163223397,0.5705852913739992,0.9143258426966292,0.9760814133514218,1.0,3/10,19.67%,MGMT;ALKBH5;FTO
prerank,DNA dealkylation (GO:0035510),0.29392170163223397,0.5705852913739992,0.9143258426966292,0.9760814133514218,1.0,3/10,19.67%,MGMT;ALKBH5;FTO
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.25449137548467754,0.5696230716083341,0.9400749063670412,0.9763213612335256,1.0,1/23,2.04%,COPS6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.24509854900162925,0.5693133562138561,0.9511918274687855,0.976187971771344,1.0,1/37,0.90%,TGFB1
prerank,negative regulation of cation channel activity (GO:2001258),0.2538485585399965,0.5677685023026166,0.936969696969697,0.9767786932499413,1.0,4/26,17.83%,PKD2;EPO;GNB5;GSTM2
prerank,DNA catabolic process (GO:0006308),0.2858231376033348,0.5666423470382876,0.9251798561151079,0.9771359041104428,1.0,4/11,25.85%,REXO4;DNASE1L1;XRN2;DFFB
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.24855760954819345,0.56612562373107,0.9389671361502347,0.9771098437956341,1.0,13/31,26.40%,LRP8;LZTS3;TANC2;LRRK2;EPHA4;PTEN;CUX2;RELN;CDK5R1;CFL1;EFNA1;DBNL;NGEF
prerank,mesenchymal cell development (GO:0014031),-0.19399261461381168,-0.5659331833125831,0.9607843137254902,0.9944409299188687,1.0,9/18,35.43%,FOXC1;PEF1;CDH2;HEY2;SOX8;TCOF1;KBTBD8;SOX11;KLHL12
prerank,rRNA modification (GO:0000154),0.2600023739398436,0.5645086202756444,0.9328358208955224,0.9776987098664651,1.0,3/21,18.54%,FBL;ZCCHC4;NSUN4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.18857352384125034,-0.563520651323996,0.968609865470852,0.9935912753326726,1.0,7/18,28.40%,CCT3;CCT6A;SHQ1;RUVBL1;PARN;NOP10;RUVBL2
prerank,protein prenylation (GO:0018342),0.28910278690308533,0.5600303002539478,0.9106382978723404,0.9798605431631497,1.0,1/10,9.22%,CHML
prerank,RNA modification (GO:0009451),0.23103153130772044,0.5598273953523669,0.9689507494646681,0.9796732522597268,1.0,10/54,18.54%,RBM15B;ADAR;CDKAL1;TRMT1;CTU1;METTL3;ADARB1;BCDIN3D;PUS7;NSUN4
prerank,neurotransmitter secretion (GO:0007269),0.2338548414217675,0.5596878736681564,0.9522222222222222,0.9794261644898811,1.0,9/44,21.32%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.2891903101934955,0.5588360213501323,0.9199438202247191,0.9795833825859792,1.0,1/10,6.70%,TP53
prerank,regulation of mitotic spindle organization (GO:0060236),0.24018510140285504,0.5584909232603906,0.9498289623717218,0.9794598590323005,1.0,5/35,15.82%,NUP62;TPR;CLTC;DYNC1H1;PDCD6IP
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.24637539189660684,0.5579411654382908,0.9474912485414235,0.9794380444855298,1.0,8/29,24.85%,GTF2H1;CDK7;ERCC5;GTF2H5;RAD23B;PARP1;XPC;RPA1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.25415243237557533,0.5576048361079372,0.9413173652694611,0.979311687760928,1.0,7/22,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,gastrulation (GO:0007369),0.26985135228403934,0.5569435204470058,0.9343832020997376,0.9793537001451983,1.0,3/15,16.59%,LRP5;MEGF8;TASOR
prerank,regulation of membrane repolarization (GO:0060306),-0.21026633006634088,-0.5536448957054628,0.9688715953307393,0.995459565428785,1.0,1/13,1.12%,CAV1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.25106757425545656,0.5529230125388049,0.9574209245742092,0.9811802147605199,1.0,5/25,19.49%,PYCARD;TP53;BMF;TNFSF10;DNM1L
prerank,male meiosis I (GO:0007141),-0.1933265570127864,-0.5528144867472458,0.9656652360515021,0.9939675925082959,1.0,7/16,41.60%,ZSCAN21;MYBL1;FOXJ2;HSF2BP;SYCP3;TDRD9;DDX4
prerank,metallo-sulfur cluster assembly (GO:0031163),0.24843555609640514,0.551169502646129,0.9553903345724907,0.9817823106206246,1.0,4/22,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2527120774728908,0.5504868001998504,0.9431396786155748,0.9818303862739335,1.0,1/22,2.37%,GTF2H1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.27249082595888463,0.5499510366956677,0.9277777777777778,0.9817953797813044,1.0,4/12,23.86%,ABCD1;FADS1;ACOT8;FADS2
prerank,histone H3 deacetylation (GO:0070932),0.26114602834899037,0.5481517876687713,0.9482993197278912,0.9823878394381086,1.0,4/15,18.78%,HDAC4;HDAC9;SMARCAD1;PER1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.25859079144570907,0.5469383528124687,0.9501965923984272,0.9826531759524673,1.0,2/17,16.94%,NOS1AP;KCNRG
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.24358091323306713,0.5457803799420523,0.9551886792452831,0.9829212940997446,1.0,5/27,18.78%,FBXL22;TP53;FBXL3;PPP1CC;PER1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23139416508084829,0.5457499352849271,0.9595628415300547,0.9826187888970318,1.0,10/41,20.95%,NUP62;SEH1L;TPR;NUP205;LACC1;HIF1A;GCK;PGAM1;SEC13;NUP54
prerank,respiratory electron transport chain (GO:0022904),0.26437531504628187,0.5455076384104917,0.9327956989247311,0.9824262704970124,1.0,5/14,20.75%,PPARGC1A;SLC25A18;SDHB;ETFDH;SDHA
prerank,negative regulation of mRNA processing (GO:0050686),-0.19094562350872787,-0.5454271234490093,0.9829059829059829,0.9947572676840487,1.0,15/15,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;BARD1;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,multivesicular body assembly (GO:0036258),0.2366932414158585,0.5453423533488365,0.9549132947976878,0.9821955418514937,1.0,5/30,16.98%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.25827153773636113,0.5450390974504419,0.9526315789473684,0.9820327597514991,1.0,1/16,3.66%,VTA1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2753569578278555,0.5420666975508495,0.9426470588235294,0.9828675365836198,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2753569578278555,0.5420666975508495,0.9426470588235294,0.9828675365836198,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2319767494684692,0.5413800328242706,0.9635949943117179,0.9828722310910898,1.0,8/36,19.70%,HFE;AQP11;USP7;SDCBP;PSME3IP1;RPL11;GIPC1;TLK2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2442509416315215,0.5399339967550025,0.9539800995024875,0.9832508125724959,1.0,7/23,23.68%,TIMM22;AGK;BMF;HSP90AA1;TIMM29;TIMM8B;HSPA4
prerank,protein hydroxylation (GO:0018126),0.25808967003739236,0.5378003715975188,0.9484396200814111,0.9839309810516926,1.0,2/15,9.78%,ASPH;P3H2
prerank,protein import into peroxisome matrix (GO:0016558),0.2704382604772142,0.5367629344496363,0.9544235924932976,0.9841089176649287,1.0,2/12,11.57%,PEX13;PEX7
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.24767027828402238,0.5367213703220153,0.9513444302176697,0.9838145151441531,1.0,6/18,25.24%,ANXA1;HDAC9;FGF2;VEGFA;KDR;AKT3
prerank,Golgi inheritance (GO:0048313),-0.21008571227175243,-0.5354677582524756,0.9702970297029703,0.9961089456267147,1.0,6/11,37.39%,STK25;GOLGA2;PLK5;YWHAZ;GBF1;PLK3
prerank,DNA recombination (GO:0006310),0.22796708266347598,0.5346290756129317,0.9633740288568258,0.9844647770383265,1.0,7/37,21.43%,EXO1;HMGB1;RAD54L;RAD51B;ERCC1;RAD51D;RPAIN
prerank,aerobic respiration (GO:0009060),0.24628843568224631,0.5338350742253992,0.9531442663378545,0.9845087973774911,1.0,4/20,17.69%,MTFR2;UQCRB;ME3;SDHB
prerank,positive regulation of phospholipase activity (GO:0010518),0.2423478672022633,0.5330677050795082,0.9689826302729528,0.9845397301640955,1.0,7/22,24.58%,GNA13;NTF3;PDPK1;PLAA;PLA2G5;FGF2;ABL2
prerank,response to interleukin-4 (GO:0070670),0.279141296842634,0.5327698906364934,0.9424778761061947,0.9843522929152302,1.0,10/10,72.10%,SHPK;XBP1;TCF7;DCSTAMP;XCL1;CITED1;RUFY4;GATA3;JAK3;LEF1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.1909336347083569,-0.5305201878820798,0.9959514170040485,0.9956943613040244,1.0,14/14,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.22728255596395874,0.5305124578775783,0.9686450167973124,0.9850250469647772,1.0,5/35,13.58%,SEMA4D;PLXNB2;SEMA4A;NRP1;ARHGDIA
prerank,RNA biosynthetic process (GO:0032774),-0.14876857441567104,-0.5296544632974853,1.0,0.9941762352003217,1.0,7/31,21.89%,TBP;TAF13;POLA1;POLA2;TERT;PRIM1;TAF7
prerank,positive regulation of embryonic development (GO:0040019),-0.1710086876846076,-0.5291137876845743,0.9824561403508771,0.9925654410245727,1.0,8/19,37.44%,WNT4;ZBED3;RBM19;NIBAN2;PLCB1;OSR1;TLE6;LHX1
prerank,iron-sulfur cluster assembly (GO:0016226),0.23467409604763573,0.5283907894656085,0.9599514563106796,0.9856269186540394,1.0,4/24,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2502045893836351,0.5267036199193471,0.9532467532467532,0.9860105914070341,1.0,6/16,23.59%,TNKS2;SLX4;TINF2;TERF2;ERCC4;PARP1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.26409078125722213,0.5237963025245325,0.9424964936886395,0.9869025294403931,1.0,2/11,13.52%,DERL1;TOR1A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.24178648040219952,0.5233752383240289,0.9621212121212122,0.9867468991358271,1.0,8/20,26.95%,NRP1;SORL1;LRP1;VTN;IGF1;CCN4;IGFBP3;NDRG4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.19729202131867257,-0.5228584215369838,0.9776951672862454,0.9923553226413889,1.0,4/13,24.84%,HACD1;ELOVL5;ELOVL1;HACD2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.20227590759761682,-0.5225500864703251,0.9826989619377162,0.9906778576068557,1.0,5/13,29.04%,SPRED2;ATM;EEF1E1;HIC1;PLA2R1
prerank,tRNA processing (GO:0008033),0.21100103734542955,0.5208300295660664,0.9862142099681867,0.9874494203869999,1.0,8/61,14.15%,TSEN15;ELAC2;CDKAL1;TRMT1;TRMT10A;CTU1;RTRAF;DDX1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.20849495604837456,0.5203415120453971,0.9802904564315352,0.9873269321426897,1.0,16/72,21.10%,TRAF2;MAP3K14;PSMB10;MALT1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;REL;PSMD2;BIRC2;FBXW11;BIRC3;DICER1
prerank,anion transmembrane transport (GO:0098656),0.21008385329863066,0.5193753677612547,0.9895833333333334,0.9873848782272334,1.0,10/67,17.03%,LRRC8D;SLC7A8;SLC25A38;SLC36A4;ABCC1;SLC25A18;SLC25A30;SLC35A3;LRRC8C;SLC13A3
prerank,multivesicular body organization (GO:0036257),0.2233748527520898,0.5148212800169061,0.9642445213379469,0.9888438485626032,1.0,5/31,16.98%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.24454031209278976,0.5139398572597218,0.9565217391304348,0.9888625597508934,1.0,1/15,4.36%,SKI
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.21004480648443816,0.5107308859191474,0.987460815047022,0.9897330705434607,1.0,13/59,26.42%,LPL;LIPC;NDUFAB1;OSBP;ACACA;OSBPL7;ACOT8;GATM;CYP27A1;OSBPL3;XBP1;HSD17B8;HOGA1
prerank,positive regulation of rRNA processing (GO:2000234),-0.205672909251208,-0.5105189603339471,0.9738562091503268,0.9917783541594825,1.0,2/10,14.42%,RIOK2;UTP15
prerank,inner mitochondrial membrane organization (GO:0007007),0.21083836335363118,0.5067070568425932,0.9835706462212487,0.9908498097203061,1.0,12/47,23.66%,ATP5MC2;ATP5F1E;TIMM22;AGK;ATP5F1A;ATP5PD;ATP5MG;GHITM;ATP5MF;LETM1;TIMM29;TIMM8B
prerank,P-body assembly (GO:0033962),0.25520207374784526,0.5046061194053009,0.9532085561497327,0.9912757874025522,1.0,2/12,12.21%,RC3H1;DYNC1H1
prerank,homocysteine metabolic process (GO:0050667),0.24980442585320503,0.5041387160980119,0.9568345323741008,0.9911140150834233,1.0,2/11,16.86%,MMUT;CBS
prerank,amide transport (GO:0042886),0.22272486949181325,0.5025516017457107,0.965352449223417,0.991328174167131,1.0,3/26,10.46%,AQP11;SLC14A2;TAP1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.2551365634410989,0.49782300352827774,0.9658753709198813,0.99258035102103,1.0,2/10,17.51%,IMPACT;VHL
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19815453277699296,0.49629549979721305,0.9906735751295337,0.9927630702531055,1.0,20/84,23.93%,APOE;CNOT8;LARP1;EPRS1;CPEB3;ORMDL2;SORL1;PCIF1;RTN1;IGF2BP3;RTN4;PUS7;BIN1;LSM14A;PIN1;CNOT7;CNOT1;RACK1;ILF3;IGF1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.20140882487074158,0.4962643930761232,0.9948024948024948,0.9924595402783571,1.0,19/72,25.64%,GTF2H1;PNRC2;DNA2;POLD3;DDX1;ERCC5;REXO4;OGG1;GTF2H5;ERCC1;DICER1;DCP1B;RNASE6;ERCC4;PARP1;DNASE1L1;XRN2;RPA1;DXO
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.22207579353317564,0.4946616574844862,0.9817961165048543,0.9923408284542171,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.22207579353317564,0.4946616574844862,0.9817961165048543,0.9923408284542171,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.21530920060331826,0.4938070825737962,0.9835487661574618,0.992280880483632,1.0,29/29,78.51%,TRIP13;SIRT7;RAD21;BAG6;RNF212;KASH5;SYCE1;SYCE3;SYCP1;TERB2;HORMAD1;ANKRD31;RNF212B;RAD21L1;IHO1;STAG3;TEX12;MEIOB;MAJIN;SYCE2;REC8;TEX11;ZCWPW1;SYCP2;FANCD2;MEI4;TERB1;P3H4;PRDM9
prerank,serine family amino acid catabolic process (GO:0009071),0.25560404187285435,0.49308756531828585,0.9629629629629629,0.9921921245889653,1.0,2/10,16.86%,THNSL2;CBS
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2136552088218455,0.49179986526582636,0.9768518518518519,0.9922741772346259,1.0,1/28,2.51%,LFNG
prerank,ribosomal large subunit assembly (GO:0000027),0.22312776486031072,0.4900070317425508,0.9775147928994082,0.9925006399894566,1.0,4/24,16.37%,RPL6;MDN1;RRS1;RPL11
prerank,positive regulation of transporter activity (GO:0032411),-0.18313661476644905,-0.4858571270437559,0.9962406015037594,0.9947400403976883,1.0,13/13,81.71%,NR1H3;KCTD7;STK39;SYNGR3;SGK2;TRPC6;PDZK1;PON1;ADIPOQ;KMT2A;WNK3;SGK1;RXRA
prerank,exit from mitosis (GO:0010458),0.2407071782922073,0.485156474466538,0.9726775956284153,0.9935934575648409,1.0,1/12,6.58%,UBE2S
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.15551786948056026,-0.4792075435520563,1.0,0.9939754406272694,1.0,20/20,84.47%,AKAP13;RAPGEF2;DRD2;PDE4D;ADRB2;ADRB1;GPR101;DRD3;ADRB3;ADRA2C;ADRA2B;DRD5;DRD1;ADRA2A;ADRA1A;ADRA1D;ADRA1B;ZDHHC21;ADCY9;LMBRD2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.22477439282501555,0.479053006127268,0.9732484076433121,0.9949299786913441,1.0,1/18,4.59%,SEL1L
prerank,positive regulation of mitochondrial translation (GO:0070131),0.23406358839697655,0.47876741140880275,0.9840848806366048,0.9946848749769427,1.0,2/14,13.93%,FASTKD3;RCC1L
prerank,nucleoside phosphate catabolic process (GO:1901292),0.23546429229849916,0.47751296229935414,0.9725274725274725,0.9947035758411494,1.0,4/13,25.17%,ENTPD1;ENTPD2;ENTPD3;ITPA
prerank,regulation of endopeptidase activity (GO:0052548),0.19427586430182173,0.47474401023187923,0.9947033898305084,0.9950657098247068,1.0,12/59,24.51%,VSIR;TIMP1;PSME3;PSMB9;FURIN;PICALM;BIRC2;ATP13A2;BIRC3;VTN;PRELID1;SERPINA2
prerank,negative regulation of transferase activity (GO:0051348),0.21265198344401687,0.4743170793473998,0.9880810488676997,0.9948641165519763,1.0,7/28,21.91%,TP53;PRDX3;SRC;GSK3A;INPP5K;GSK3B;ERCC4
prerank,nucleic acid-templated transcription (GO:0097659),0.20006837873347988,0.47362287979255746,0.992090395480226,0.9947234102977214,1.0,11/42,26.24%,MEF2A;MMS19;POLR2L;CREBL2;POLR2E;FUBP3;POLR3A;PAX8;PWP1;XAB2;PTMA
prerank,engulfment of apoptotic cell (GO:0043652),0.22676798212174956,0.4671630785407941,0.9803664921465969,0.995911332401688,1.0,4/15,22.16%,THBS1;XKR4;MEGF10;RHOG
prerank,regulation of response to stress (GO:0080134),0.24242638452244322,0.4666018128907989,0.9741750358680057,0.9957300113287915,1.0,2/10,18.51%,ADCY8;CORO2B
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.22403692435915518,0.46376433274945106,0.9784791965566715,0.9960289341421495,1.0,5/14,23.58%,PNP;NMNAT3;AK8;AK5;AK1
prerank,peptidyl-methionine modification (GO:0018206),0.23301372158551015,0.46286786878026287,0.9760225669957687,0.9958954621722174,1.0,3/12,20.75%,METAP2;NAA25;NAA15
prerank,lipid droplet organization (GO:0034389),0.20906730711142738,0.46016807613882066,0.9900990099009901,0.996160585651329,1.0,1/22,5.78%,CDS2
prerank,regulation of histone deacetylation (GO:0031063),0.22668226780210113,0.4579054321272396,0.9792243767313019,0.996315219893585,1.0,6/13,29.48%,AKAP8L;ZBTB7B;CTBP1;SPHK2;SAP30BP;PRMT6
prerank,bile acid metabolic process (GO:0008206),0.20326077495889305,0.4550112118331554,0.9907192575406032,0.9965574707892082,1.0,7/27,23.88%,NPC1;OSBP;GBA2;OSBPL7;ACOT8;CYP27A1;OSBPL3
prerank,response to light stimulus (GO:0009416),0.1877034811378425,0.45421659451798607,0.9968017057569296,0.9963953089908826,1.0,6/55,15.69%,CIRBP;UVSSA;USF1;UBE4B;ERCC5;ERCC6
prerank,regulation of mitochondrial translation (GO:0070129),0.2079880455943793,0.4491471558963972,0.9862155388471178,0.9970305578619774,1.0,4/21,21.55%,FASTKD3;RCC1L;MTG2;RPUSD4
prerank,proteoglycan biosynthetic process (GO:0030166),0.19452183941031034,0.4483381990899857,0.994199535962877,0.9968602949246801,1.0,12/31,29.16%,XYLT1;EXTL3;B4GALT7;PXYLP1;B3GAT2;IGF1;EXT2;CHST11;BMPR1B;CHST9;HS3ST3B1;CHST12
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.21479081460183647,0.44820351713575385,0.9852348993288591,0.9965709722759438,1.0,4/16,21.44%,ADIPOR1;FOXK1;PRKN;SCARB2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.22837272026462407,0.4435425678259898,0.9913669064748202,0.9970619676794543,1.0,1/10,8.24%,DGKD
prerank,regulation of spindle assembly (GO:0090169),0.19775010116226932,0.4396912666595329,0.9917061611374408,0.9973685448434433,1.0,5/25,19.79%,RNF4;TPR;DYNC1H1;PDCD6IP;SENP6
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.19245218633554842,0.43735711355136525,0.9941107184923439,0.9974068959100275,1.0,10/29,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;PPIA;RPA1;HSP90AB1;ANKRD28
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20557679869788675,0.43704262111356945,0.9922879177377892,0.9971499318413372,1.0,2/18,14.07%,LIG3;POLD3
prerank,regulation of phosphate metabolic process (GO:0019220),0.20689863842975753,0.4317477054154505,0.9919463087248322,0.9976079721520891,1.0,3/16,18.57%,SMG7;PGAM1;TIGAR
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2198857573284791,0.4261107436064384,0.988388969521045,0.9980416149887154,1.0,10/10,78.03%,TUT7;DIS3L2;CHFR;NEDD8;UBB;TUT4;RPS27A;UBA52;ISG15;UBC
prerank,regulation of DNA recombination (GO:0000018),0.1858100157317138,0.4232962209941304,0.9976387249114522,0.9980922399639904,1.0,8/32,22.85%,SETD2;SMARCAD1;KPNA1;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP
prerank,mitotic cytokinetic process (GO:1902410),0.19277190608375683,0.42088759853300955,0.9911727616645649,0.998061232070927,1.0,5/20,24.66%,CNTROB;PDCD6IP;RHOA;MITD1;CHMP1A
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.17455459356170508,0.41708586227027106,0.996629213483146,0.9981844020882493,1.0,4/39,16.81%,RASL10B;HFE;SOX4;GCK
prerank,cellular response to interleukin-4 (GO:0071353),0.21413448413301714,0.41555538656551394,0.9896142433234422,0.9980442233971256,1.0,1/10,13.18%,SHPK
prerank,telomere maintenance via telomerase (GO:0007004),0.17998883473643884,0.40836234421719236,0.9964539007092199,0.9984796177401487,1.0,9/28,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;RPA1;HSP90AB1;ANKRD28
prerank,negative regulation of RNA splicing (GO:0033119),0.18533488595023642,0.39865663211112623,0.9949811794228356,0.9990093934577402,1.0,8/19,27.70%,PTBP2;SRSF6;SRSF10;PTBP1;RPS13;C1QBP;PCBP4;SRSF4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.196271139541957,0.38953069379692584,0.9958217270194986,0.9993367578268335,1.0,5/12,27.46%,SOX9;GDNF;VEGFA;PAX8;SIX4
prerank,mitotic recombination (GO:0006312),0.1879389249229609,0.3882603748255033,0.9986824769433466,0.9991082122066454,1.0,4/15,21.33%,TEP1;ERCC1;RAD51D;NSMCE2
prerank,sphingosine metabolic process (GO:0006670),0.17984678161227705,0.3832356152283826,0.9974489795918368,0.9991093308558538,1.0,4/17,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,monosaccharide transmembrane transport (GO:0015749),0.17519623233908957,0.3726484465295657,0.9986876640419947,0.9993780329396675,1.0,16/16,82.50%,SLC2A12;SLC45A3;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A10;SLC23A2;SLC23A1;SLC2A2;SLC2A9;SLC2A8;SLC5A3;SLC50A1
prerank,epithelial cell morphogenesis (GO:0003382),0.1726077654174066,0.36635502463001446,1.0,0.9993412640341199,1.0,2/17,15.95%,SIPA1L3;COL22A1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.18197225535120198,0.35419169993914057,0.9985250737463127,0.9994473539179088,1.0,10/10,81.81%,CDC42;ECT2;SIRT2;NEK2;CCNB1;RCC2;SPAG5;KNSTRN;RACGAP1;APC
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.15015927360656323,0.3197788727886906,1.0,0.9998015010999081,1.0,2/18,16.34%,RAB11A;RAD51B
